<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>Pancreatobiliary Pathology Society Journal Watch</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>
<script>/*! jQuery v1.11.3 | (c) 2005, 2015 jQuery Foundation, Inc. | jquery.org/license */
!function(a,b){"object"==typeof module&&"object"==typeof module.exports?module.exports=a.document?b(a,!0):function(a){if(!a.document)throw new Error("jQuery requires a window with a document");return b(a)}:b(a)}("undefined"!=typeof window?window:this,function(a,b){var c=[],d=c.slice,e=c.concat,f=c.push,g=c.indexOf,h={},i=h.toString,j=h.hasOwnProperty,k={},l="1.11.3",m=function(a,b){return new m.fn.init(a,b)},n=/^[\s\uFEFF\xA0]+|[\s\uFEFF\xA0]+$/g,o=/^-ms-/,p=/-([\da-z])/gi,q=function(a,b){return b.toUpperCase()};m.fn=m.prototype={jquery:l,constructor:m,selector:"",length:0,toArray:function(){return d.call(this)},get:function(a){return null!=a?0>a?this[a+this.length]:this[a]:d.call(this)},pushStack:function(a){var b=m.merge(this.constructor(),a);return b.prevObject=this,b.context=this.context,b},each:function(a,b){return m.each(this,a,b)},map:function(a){return this.pushStack(m.map(this,function(b,c){return a.call(b,c,b)}))},slice:function(){return this.pushStack(d.apply(this,arguments))},first:function(){return this.eq(0)},last:function(){return this.eq(-1)},eq:function(a){var b=this.length,c=+a+(0>a?b:0);return this.pushStack(c>=0&&b>c?[this[c]]:[])},end:function(){return this.prevObject||this.constructor(null)},push:f,sort:c.sort,splice:c.splice},m.extend=m.fn.extend=function(){var a,b,c,d,e,f,g=arguments[0]||{},h=1,i=arguments.length,j=!1;for("boolean"==typeof g&&(j=g,g=arguments[h]||{},h++),"object"==typeof g||m.isFunction(g)||(g={}),h===i&&(g=this,h--);i>h;h++)if(null!=(e=arguments[h]))for(d in e)a=g[d],c=e[d],g!==c&&(j&&c&&(m.isPlainObject(c)||(b=m.isArray(c)))?(b?(b=!1,f=a&&m.isArray(a)?a:[]):f=a&&m.isPlainObject(a)?a:{},g[d]=m.extend(j,f,c)):void 0!==c&&(g[d]=c));return g},m.extend({expando:"jQuery"+(l+Math.random()).replace(/\D/g,""),isReady:!0,error:function(a){throw new Error(a)},noop:function(){},isFunction:function(a){return"function"===m.type(a)},isArray:Array.isArray||function(a){return"array"===m.type(a)},isWindow:function(a){return null!=a&&a==a.window},isNumeric:function(a){return!m.isArray(a)&&a-parseFloat(a)+1>=0},isEmptyObject:function(a){var b;for(b in a)return!1;return!0},isPlainObject:function(a){var b;if(!a||"object"!==m.type(a)||a.nodeType||m.isWindow(a))return!1;try{if(a.constructor&&!j.call(a,"constructor")&&!j.call(a.constructor.prototype,"isPrototypeOf"))return!1}catch(c){return!1}if(k.ownLast)for(b in a)return j.call(a,b);for(b in a);return void 0===b||j.call(a,b)},type:function(a){return null==a?a+"":"object"==typeof a||"function"==typeof a?h[i.call(a)]||"object":typeof a},globalEval:function(b){b&&m.trim(b)&&(a.execScript||function(b){a.eval.call(a,b)})(b)},camelCase:function(a){return a.replace(o,"ms-").replace(p,q)},nodeName:function(a,b){return a.nodeName&&a.nodeName.toLowerCase()===b.toLowerCase()},each:function(a,b,c){var d,e=0,f=a.length,g=r(a);if(c){if(g){for(;f>e;e++)if(d=b.apply(a[e],c),d===!1)break}else for(e in a)if(d=b.apply(a[e],c),d===!1)break}else if(g){for(;f>e;e++)if(d=b.call(a[e],e,a[e]),d===!1)break}else for(e in a)if(d=b.call(a[e],e,a[e]),d===!1)break;return a},trim:function(a){return null==a?"":(a+"").replace(n,"")},makeArray:function(a,b){var c=b||[];return null!=a&&(r(Object(a))?m.merge(c,"string"==typeof a?[a]:a):f.call(c,a)),c},inArray:function(a,b,c){var d;if(b){if(g)return g.call(b,a,c);for(d=b.length,c=c?0>c?Math.max(0,d+c):c:0;d>c;c++)if(c in b&&b[c]===a)return c}return-1},merge:function(a,b){var c=+b.length,d=0,e=a.length;while(c>d)a[e++]=b[d++];if(c!==c)while(void 0!==b[d])a[e++]=b[d++];return a.length=e,a},grep:function(a,b,c){for(var d,e=[],f=0,g=a.length,h=!c;g>f;f++)d=!b(a[f],f),d!==h&&e.push(a[f]);return e},map:function(a,b,c){var d,f=0,g=a.length,h=r(a),i=[];if(h)for(;g>f;f++)d=b(a[f],f,c),null!=d&&i.push(d);else for(f in a)d=b(a[f],f,c),null!=d&&i.push(d);return e.apply([],i)},guid:1,proxy:function(a,b){var c,e,f;return"string"==typeof b&&(f=a[b],b=a,a=f),m.isFunction(a)?(c=d.call(arguments,2),e=function(){return a.apply(b||this,c.concat(d.call(arguments)))},e.guid=a.guid=a.guid||m.guid++,e):void 0},now:function(){return+new Date},support:k}),m.each("Boolean Number String Function Array Date RegExp Object Error".split(" "),function(a,b){h["[object "+b+"]"]=b.toLowerCase()});function r(a){var b="length"in a&&a.length,c=m.type(a);return"function"===c||m.isWindow(a)?!1:1===a.nodeType&&b?!0:"array"===c||0===b||"number"==typeof b&&b>0&&b-1 in a}var s=function(a){var b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u="sizzle"+1*new Date,v=a.document,w=0,x=0,y=ha(),z=ha(),A=ha(),B=function(a,b){return a===b&&(l=!0),0},C=1<<31,D={}.hasOwnProperty,E=[],F=E.pop,G=E.push,H=E.push,I=E.slice,J=function(a,b){for(var c=0,d=a.length;d>c;c++)if(a[c]===b)return c;return-1},K="checked|selected|async|autofocus|autoplay|controls|defer|disabled|hidden|ismap|loop|multiple|open|readonly|required|scoped",L="[\\x20\\t\\r\\n\\f]",M="(?:\\\\.|[\\w-]|[^\\x00-\\xa0])+",N=M.replace("w","w#"),O="\\["+L+"*("+M+")(?:"+L+"*([*^$|!~]?=)"+L+"*(?:'((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\"|("+N+"))|)"+L+"*\\]",P=":("+M+")(?:\\((('((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\")|((?:\\\\.|[^\\\\()[\\]]|"+O+")*)|.*)\\)|)",Q=new RegExp(L+"+","g"),R=new RegExp("^"+L+"+|((?:^|[^\\\\])(?:\\\\.)*)"+L+"+$","g"),S=new RegExp("^"+L+"*,"+L+"*"),T=new RegExp("^"+L+"*([>+~]|"+L+")"+L+"*"),U=new RegExp("="+L+"*([^\\]'\"]*?)"+L+"*\\]","g"),V=new RegExp(P),W=new RegExp("^"+N+"$"),X={ID:new RegExp("^#("+M+")"),CLASS:new RegExp("^\\.("+M+")"),TAG:new RegExp("^("+M.replace("w","w*")+")"),ATTR:new RegExp("^"+O),PSEUDO:new RegExp("^"+P),CHILD:new RegExp("^:(only|first|last|nth|nth-last)-(child|of-type)(?:\\("+L+"*(even|odd|(([+-]|)(\\d*)n|)"+L+"*(?:([+-]|)"+L+"*(\\d+)|))"+L+"*\\)|)","i"),bool:new RegExp("^(?:"+K+")$","i"),needsContext:new RegExp("^"+L+"*[>+~]|:(even|odd|eq|gt|lt|nth|first|last)(?:\\("+L+"*((?:-\\d)?\\d*)"+L+"*\\)|)(?=[^-]|$)","i")},Y=/^(?:input|select|textarea|button)$/i,Z=/^h\d$/i,$=/^[^{]+\{\s*\[native \w/,_=/^(?:#([\w-]+)|(\w+)|\.([\w-]+))$/,aa=/[+~]/,ba=/'|\\/g,ca=new RegExp("\\\\([\\da-f]{1,6}"+L+"?|("+L+")|.)","ig"),da=function(a,b,c){var d="0x"+b-65536;return d!==d||c?b:0>d?String.fromCharCode(d+65536):String.fromCharCode(d>>10|55296,1023&d|56320)},ea=function(){m()};try{H.apply(E=I.call(v.childNodes),v.childNodes),E[v.childNodes.length].nodeType}catch(fa){H={apply:E.length?function(a,b){G.apply(a,I.call(b))}:function(a,b){var c=a.length,d=0;while(a[c++]=b[d++]);a.length=c-1}}}function ga(a,b,d,e){var f,h,j,k,l,o,r,s,w,x;if((b?b.ownerDocument||b:v)!==n&&m(b),b=b||n,d=d||[],k=b.nodeType,"string"!=typeof a||!a||1!==k&&9!==k&&11!==k)return d;if(!e&&p){if(11!==k&&(f=_.exec(a)))if(j=f[1]){if(9===k){if(h=b.getElementById(j),!h||!h.parentNode)return d;if(h.id===j)return d.push(h),d}else if(b.ownerDocument&&(h=b.ownerDocument.getElementById(j))&&t(b,h)&&h.id===j)return d.push(h),d}else{if(f[2])return H.apply(d,b.getElementsByTagName(a)),d;if((j=f[3])&&c.getElementsByClassName)return H.apply(d,b.getElementsByClassName(j)),d}if(c.qsa&&(!q||!q.test(a))){if(s=r=u,w=b,x=1!==k&&a,1===k&&"object"!==b.nodeName.toLowerCase()){o=g(a),(r=b.getAttribute("id"))?s=r.replace(ba,"\\$&"):b.setAttribute("id",s),s="[id='"+s+"'] ",l=o.length;while(l--)o[l]=s+ra(o[l]);w=aa.test(a)&&pa(b.parentNode)||b,x=o.join(",")}if(x)try{return H.apply(d,w.querySelectorAll(x)),d}catch(y){}finally{r||b.removeAttribute("id")}}}return i(a.replace(R,"$1"),b,d,e)}function ha(){var a=[];function b(c,e){return a.push(c+" ")>d.cacheLength&&delete b[a.shift()],b[c+" "]=e}return b}function ia(a){return a[u]=!0,a}function ja(a){var b=n.createElement("div");try{return!!a(b)}catch(c){return!1}finally{b.parentNode&&b.parentNode.removeChild(b),b=null}}function ka(a,b){var c=a.split("|"),e=a.length;while(e--)d.attrHandle[c[e]]=b}function la(a,b){var c=b&&a,d=c&&1===a.nodeType&&1===b.nodeType&&(~b.sourceIndex||C)-(~a.sourceIndex||C);if(d)return d;if(c)while(c=c.nextSibling)if(c===b)return-1;return a?1:-1}function ma(a){return function(b){var c=b.nodeName.toLowerCase();return"input"===c&&b.type===a}}function na(a){return function(b){var c=b.nodeName.toLowerCase();return("input"===c||"button"===c)&&b.type===a}}function oa(a){return ia(function(b){return b=+b,ia(function(c,d){var e,f=a([],c.length,b),g=f.length;while(g--)c[e=f[g]]&&(c[e]=!(d[e]=c[e]))})})}function pa(a){return a&&"undefined"!=typeof a.getElementsByTagName&&a}c=ga.support={},f=ga.isXML=function(a){var b=a&&(a.ownerDocument||a).documentElement;return b?"HTML"!==b.nodeName:!1},m=ga.setDocument=function(a){var b,e,g=a?a.ownerDocument||a:v;return g!==n&&9===g.nodeType&&g.documentElement?(n=g,o=g.documentElement,e=g.defaultView,e&&e!==e.top&&(e.addEventListener?e.addEventListener("unload",ea,!1):e.attachEvent&&e.attachEvent("onunload",ea)),p=!f(g),c.attributes=ja(function(a){return a.className="i",!a.getAttribute("className")}),c.getElementsByTagName=ja(function(a){return a.appendChild(g.createComment("")),!a.getElementsByTagName("*").length}),c.getElementsByClassName=$.test(g.getElementsByClassName),c.getById=ja(function(a){return o.appendChild(a).id=u,!g.getElementsByName||!g.getElementsByName(u).length}),c.getById?(d.find.ID=function(a,b){if("undefined"!=typeof b.getElementById&&p){var c=b.getElementById(a);return c&&c.parentNode?[c]:[]}},d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){return a.getAttribute("id")===b}}):(delete d.find.ID,d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){var c="undefined"!=typeof a.getAttributeNode&&a.getAttributeNode("id");return c&&c.value===b}}),d.find.TAG=c.getElementsByTagName?function(a,b){return"undefined"!=typeof b.getElementsByTagName?b.getElementsByTagName(a):c.qsa?b.querySelectorAll(a):void 0}:function(a,b){var c,d=[],e=0,f=b.getElementsByTagName(a);if("*"===a){while(c=f[e++])1===c.nodeType&&d.push(c);return d}return f},d.find.CLASS=c.getElementsByClassName&&function(a,b){return p?b.getElementsByClassName(a):void 0},r=[],q=[],(c.qsa=$.test(g.querySelectorAll))&&(ja(function(a){o.appendChild(a).innerHTML="<a id='"+u+"'></a><select id='"+u+"-\f]' msallowcapture=''><option selected=''></option></select>",a.querySelectorAll("[msallowcapture^='']").length&&q.push("[*^$]="+L+"*(?:''|\"\")"),a.querySelectorAll("[selected]").length||q.push("\\["+L+"*(?:value|"+K+")"),a.querySelectorAll("[id~="+u+"-]").length||q.push("~="),a.querySelectorAll(":checked").length||q.push(":checked"),a.querySelectorAll("a#"+u+"+*").length||q.push(".#.+[+~]")}),ja(function(a){var b=g.createElement("input");b.setAttribute("type","hidden"),a.appendChild(b).setAttribute("name","D"),a.querySelectorAll("[name=d]").length&&q.push("name"+L+"*[*^$|!~]?="),a.querySelectorAll(":enabled").length||q.push(":enabled",":disabled"),a.querySelectorAll("*,:x"),q.push(",.*:")})),(c.matchesSelector=$.test(s=o.matches||o.webkitMatchesSelector||o.mozMatchesSelector||o.oMatchesSelector||o.msMatchesSelector))&&ja(function(a){c.disconnectedMatch=s.call(a,"div"),s.call(a,"[s!='']:x"),r.push("!=",P)}),q=q.length&&new RegExp(q.join("|")),r=r.length&&new RegExp(r.join("|")),b=$.test(o.compareDocumentPosition),t=b||$.test(o.contains)?function(a,b){var c=9===a.nodeType?a.documentElement:a,d=b&&b.parentNode;return a===d||!(!d||1!==d.nodeType||!(c.contains?c.contains(d):a.compareDocumentPosition&&16&a.compareDocumentPosition(d)))}:function(a,b){if(b)while(b=b.parentNode)if(b===a)return!0;return!1},B=b?function(a,b){if(a===b)return l=!0,0;var d=!a.compareDocumentPosition-!b.compareDocumentPosition;return d?d:(d=(a.ownerDocument||a)===(b.ownerDocument||b)?a.compareDocumentPosition(b):1,1&d||!c.sortDetached&&b.compareDocumentPosition(a)===d?a===g||a.ownerDocument===v&&t(v,a)?-1:b===g||b.ownerDocument===v&&t(v,b)?1:k?J(k,a)-J(k,b):0:4&d?-1:1)}:function(a,b){if(a===b)return l=!0,0;var c,d=0,e=a.parentNode,f=b.parentNode,h=[a],i=[b];if(!e||!f)return a===g?-1:b===g?1:e?-1:f?1:k?J(k,a)-J(k,b):0;if(e===f)return la(a,b);c=a;while(c=c.parentNode)h.unshift(c);c=b;while(c=c.parentNode)i.unshift(c);while(h[d]===i[d])d++;return d?la(h[d],i[d]):h[d]===v?-1:i[d]===v?1:0},g):n},ga.matches=function(a,b){return ga(a,null,null,b)},ga.matchesSelector=function(a,b){if((a.ownerDocument||a)!==n&&m(a),b=b.replace(U,"='$1']"),!(!c.matchesSelector||!p||r&&r.test(b)||q&&q.test(b)))try{var d=s.call(a,b);if(d||c.disconnectedMatch||a.document&&11!==a.document.nodeType)return d}catch(e){}return ga(b,n,null,[a]).length>0},ga.contains=function(a,b){return(a.ownerDocument||a)!==n&&m(a),t(a,b)},ga.attr=function(a,b){(a.ownerDocument||a)!==n&&m(a);var e=d.attrHandle[b.toLowerCase()],f=e&&D.call(d.attrHandle,b.toLowerCase())?e(a,b,!p):void 0;return void 0!==f?f:c.attributes||!p?a.getAttribute(b):(f=a.getAttributeNode(b))&&f.specified?f.value:null},ga.error=function(a){throw new Error("Syntax error, unrecognized expression: "+a)},ga.uniqueSort=function(a){var b,d=[],e=0,f=0;if(l=!c.detectDuplicates,k=!c.sortStable&&a.slice(0),a.sort(B),l){while(b=a[f++])b===a[f]&&(e=d.push(f));while(e--)a.splice(d[e],1)}return k=null,a},e=ga.getText=function(a){var b,c="",d=0,f=a.nodeType;if(f){if(1===f||9===f||11===f){if("string"==typeof a.textContent)return a.textContent;for(a=a.firstChild;a;a=a.nextSibling)c+=e(a)}else if(3===f||4===f)return a.nodeValue}else while(b=a[d++])c+=e(b);return c},d=ga.selectors={cacheLength:50,createPseudo:ia,match:X,attrHandle:{},find:{},relative:{">":{dir:"parentNode",first:!0}," ":{dir:"parentNode"},"+":{dir:"previousSibling",first:!0},"~":{dir:"previousSibling"}},preFilter:{ATTR:function(a){return a[1]=a[1].replace(ca,da),a[3]=(a[3]||a[4]||a[5]||"").replace(ca,da),"~="===a[2]&&(a[3]=" "+a[3]+" "),a.slice(0,4)},CHILD:function(a){return a[1]=a[1].toLowerCase(),"nth"===a[1].slice(0,3)?(a[3]||ga.error(a[0]),a[4]=+(a[4]?a[5]+(a[6]||1):2*("even"===a[3]||"odd"===a[3])),a[5]=+(a[7]+a[8]||"odd"===a[3])):a[3]&&ga.error(a[0]),a},PSEUDO:function(a){var b,c=!a[6]&&a[2];return X.CHILD.test(a[0])?null:(a[3]?a[2]=a[4]||a[5]||"":c&&V.test(c)&&(b=g(c,!0))&&(b=c.indexOf(")",c.length-b)-c.length)&&(a[0]=a[0].slice(0,b),a[2]=c.slice(0,b)),a.slice(0,3))}},filter:{TAG:function(a){var b=a.replace(ca,da).toLowerCase();return"*"===a?function(){return!0}:function(a){return a.nodeName&&a.nodeName.toLowerCase()===b}},CLASS:function(a){var b=y[a+" "];return b||(b=new RegExp("(^|"+L+")"+a+"("+L+"|$)"))&&y(a,function(a){return b.test("string"==typeof a.className&&a.className||"undefined"!=typeof a.getAttribute&&a.getAttribute("class")||"")})},ATTR:function(a,b,c){return function(d){var e=ga.attr(d,a);return null==e?"!="===b:b?(e+="","="===b?e===c:"!="===b?e!==c:"^="===b?c&&0===e.indexOf(c):"*="===b?c&&e.indexOf(c)>-1:"$="===b?c&&e.slice(-c.length)===c:"~="===b?(" "+e.replace(Q," ")+" ").indexOf(c)>-1:"|="===b?e===c||e.slice(0,c.length+1)===c+"-":!1):!0}},CHILD:function(a,b,c,d,e){var f="nth"!==a.slice(0,3),g="last"!==a.slice(-4),h="of-type"===b;return 1===d&&0===e?function(a){return!!a.parentNode}:function(b,c,i){var j,k,l,m,n,o,p=f!==g?"nextSibling":"previousSibling",q=b.parentNode,r=h&&b.nodeName.toLowerCase(),s=!i&&!h;if(q){if(f){while(p){l=b;while(l=l[p])if(h?l.nodeName.toLowerCase()===r:1===l.nodeType)return!1;o=p="only"===a&&!o&&"nextSibling"}return!0}if(o=[g?q.firstChild:q.lastChild],g&&s){k=q[u]||(q[u]={}),j=k[a]||[],n=j[0]===w&&j[1],m=j[0]===w&&j[2],l=n&&q.childNodes[n];while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if(1===l.nodeType&&++m&&l===b){k[a]=[w,n,m];break}}else if(s&&(j=(b[u]||(b[u]={}))[a])&&j[0]===w)m=j[1];else while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if((h?l.nodeName.toLowerCase()===r:1===l.nodeType)&&++m&&(s&&((l[u]||(l[u]={}))[a]=[w,m]),l===b))break;return m-=e,m===d||m%d===0&&m/d>=0}}},PSEUDO:function(a,b){var c,e=d.pseudos[a]||d.setFilters[a.toLowerCase()]||ga.error("unsupported pseudo: "+a);return e[u]?e(b):e.length>1?(c=[a,a,"",b],d.setFilters.hasOwnProperty(a.toLowerCase())?ia(function(a,c){var d,f=e(a,b),g=f.length;while(g--)d=J(a,f[g]),a[d]=!(c[d]=f[g])}):function(a){return e(a,0,c)}):e}},pseudos:{not:ia(function(a){var b=[],c=[],d=h(a.replace(R,"$1"));return d[u]?ia(function(a,b,c,e){var f,g=d(a,null,e,[]),h=a.length;while(h--)(f=g[h])&&(a[h]=!(b[h]=f))}):function(a,e,f){return b[0]=a,d(b,null,f,c),b[0]=null,!c.pop()}}),has:ia(function(a){return function(b){return ga(a,b).length>0}}),contains:ia(function(a){return a=a.replace(ca,da),function(b){return(b.textContent||b.innerText||e(b)).indexOf(a)>-1}}),lang:ia(function(a){return W.test(a||"")||ga.error("unsupported lang: "+a),a=a.replace(ca,da).toLowerCase(),function(b){var c;do if(c=p?b.lang:b.getAttribute("xml:lang")||b.getAttribute("lang"))return c=c.toLowerCase(),c===a||0===c.indexOf(a+"-");while((b=b.parentNode)&&1===b.nodeType);return!1}}),target:function(b){var c=a.location&&a.location.hash;return c&&c.slice(1)===b.id},root:function(a){return a===o},focus:function(a){return a===n.activeElement&&(!n.hasFocus||n.hasFocus())&&!!(a.type||a.href||~a.tabIndex)},enabled:function(a){return a.disabled===!1},disabled:function(a){return a.disabled===!0},checked:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&!!a.checked||"option"===b&&!!a.selected},selected:function(a){return a.parentNode&&a.parentNode.selectedIndex,a.selected===!0},empty:function(a){for(a=a.firstChild;a;a=a.nextSibling)if(a.nodeType<6)return!1;return!0},parent:function(a){return!d.pseudos.empty(a)},header:function(a){return Z.test(a.nodeName)},input:function(a){return Y.test(a.nodeName)},button:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&"button"===a.type||"button"===b},text:function(a){var b;return"input"===a.nodeName.toLowerCase()&&"text"===a.type&&(null==(b=a.getAttribute("type"))||"text"===b.toLowerCase())},first:oa(function(){return[0]}),last:oa(function(a,b){return[b-1]}),eq:oa(function(a,b,c){return[0>c?c+b:c]}),even:oa(function(a,b){for(var c=0;b>c;c+=2)a.push(c);return a}),odd:oa(function(a,b){for(var c=1;b>c;c+=2)a.push(c);return a}),lt:oa(function(a,b,c){for(var d=0>c?c+b:c;--d>=0;)a.push(d);return a}),gt:oa(function(a,b,c){for(var d=0>c?c+b:c;++d<b;)a.push(d);return a})}},d.pseudos.nth=d.pseudos.eq;for(b in{radio:!0,checkbox:!0,file:!0,password:!0,image:!0})d.pseudos[b]=ma(b);for(b in{submit:!0,reset:!0})d.pseudos[b]=na(b);function qa(){}qa.prototype=d.filters=d.pseudos,d.setFilters=new qa,g=ga.tokenize=function(a,b){var c,e,f,g,h,i,j,k=z[a+" "];if(k)return b?0:k.slice(0);h=a,i=[],j=d.preFilter;while(h){(!c||(e=S.exec(h)))&&(e&&(h=h.slice(e[0].length)||h),i.push(f=[])),c=!1,(e=T.exec(h))&&(c=e.shift(),f.push({value:c,type:e[0].replace(R," ")}),h=h.slice(c.length));for(g in d.filter)!(e=X[g].exec(h))||j[g]&&!(e=j[g](e))||(c=e.shift(),f.push({value:c,type:g,matches:e}),h=h.slice(c.length));if(!c)break}return b?h.length:h?ga.error(a):z(a,i).slice(0)};function ra(a){for(var b=0,c=a.length,d="";c>b;b++)d+=a[b].value;return d}function sa(a,b,c){var d=b.dir,e=c&&"parentNode"===d,f=x++;return b.first?function(b,c,f){while(b=b[d])if(1===b.nodeType||e)return a(b,c,f)}:function(b,c,g){var h,i,j=[w,f];if(g){while(b=b[d])if((1===b.nodeType||e)&&a(b,c,g))return!0}else while(b=b[d])if(1===b.nodeType||e){if(i=b[u]||(b[u]={}),(h=i[d])&&h[0]===w&&h[1]===f)return j[2]=h[2];if(i[d]=j,j[2]=a(b,c,g))return!0}}}function ta(a){return a.length>1?function(b,c,d){var e=a.length;while(e--)if(!a[e](b,c,d))return!1;return!0}:a[0]}function ua(a,b,c){for(var d=0,e=b.length;e>d;d++)ga(a,b[d],c);return c}function va(a,b,c,d,e){for(var f,g=[],h=0,i=a.length,j=null!=b;i>h;h++)(f=a[h])&&(!c||c(f,d,e))&&(g.push(f),j&&b.push(h));return g}function wa(a,b,c,d,e,f){return d&&!d[u]&&(d=wa(d)),e&&!e[u]&&(e=wa(e,f)),ia(function(f,g,h,i){var j,k,l,m=[],n=[],o=g.length,p=f||ua(b||"*",h.nodeType?[h]:h,[]),q=!a||!f&&b?p:va(p,m,a,h,i),r=c?e||(f?a:o||d)?[]:g:q;if(c&&c(q,r,h,i),d){j=va(r,n),d(j,[],h,i),k=j.length;while(k--)(l=j[k])&&(r[n[k]]=!(q[n[k]]=l))}if(f){if(e||a){if(e){j=[],k=r.length;while(k--)(l=r[k])&&j.push(q[k]=l);e(null,r=[],j,i)}k=r.length;while(k--)(l=r[k])&&(j=e?J(f,l):m[k])>-1&&(f[j]=!(g[j]=l))}}else r=va(r===g?r.splice(o,r.length):r),e?e(null,g,r,i):H.apply(g,r)})}function xa(a){for(var b,c,e,f=a.length,g=d.relative[a[0].type],h=g||d.relative[" "],i=g?1:0,k=sa(function(a){return a===b},h,!0),l=sa(function(a){return J(b,a)>-1},h,!0),m=[function(a,c,d){var e=!g&&(d||c!==j)||((b=c).nodeType?k(a,c,d):l(a,c,d));return b=null,e}];f>i;i++)if(c=d.relative[a[i].type])m=[sa(ta(m),c)];else{if(c=d.filter[a[i].type].apply(null,a[i].matches),c[u]){for(e=++i;f>e;e++)if(d.relative[a[e].type])break;return wa(i>1&&ta(m),i>1&&ra(a.slice(0,i-1).concat({value:" "===a[i-2].type?"*":""})).replace(R,"$1"),c,e>i&&xa(a.slice(i,e)),f>e&&xa(a=a.slice(e)),f>e&&ra(a))}m.push(c)}return ta(m)}function ya(a,b){var c=b.length>0,e=a.length>0,f=function(f,g,h,i,k){var l,m,o,p=0,q="0",r=f&&[],s=[],t=j,u=f||e&&d.find.TAG("*",k),v=w+=null==t?1:Math.random()||.1,x=u.length;for(k&&(j=g!==n&&g);q!==x&&null!=(l=u[q]);q++){if(e&&l){m=0;while(o=a[m++])if(o(l,g,h)){i.push(l);break}k&&(w=v)}c&&((l=!o&&l)&&p--,f&&r.push(l))}if(p+=q,c&&q!==p){m=0;while(o=b[m++])o(r,s,g,h);if(f){if(p>0)while(q--)r[q]||s[q]||(s[q]=F.call(i));s=va(s)}H.apply(i,s),k&&!f&&s.length>0&&p+b.length>1&&ga.uniqueSort(i)}return k&&(w=v,j=t),r};return c?ia(f):f}return h=ga.compile=function(a,b){var c,d=[],e=[],f=A[a+" "];if(!f){b||(b=g(a)),c=b.length;while(c--)f=xa(b[c]),f[u]?d.push(f):e.push(f);f=A(a,ya(e,d)),f.selector=a}return f},i=ga.select=function(a,b,e,f){var i,j,k,l,m,n="function"==typeof a&&a,o=!f&&g(a=n.selector||a);if(e=e||[],1===o.length){if(j=o[0]=o[0].slice(0),j.length>2&&"ID"===(k=j[0]).type&&c.getById&&9===b.nodeType&&p&&d.relative[j[1].type]){if(b=(d.find.ID(k.matches[0].replace(ca,da),b)||[])[0],!b)return e;n&&(b=b.parentNode),a=a.slice(j.shift().value.length)}i=X.needsContext.test(a)?0:j.length;while(i--){if(k=j[i],d.relative[l=k.type])break;if((m=d.find[l])&&(f=m(k.matches[0].replace(ca,da),aa.test(j[0].type)&&pa(b.parentNode)||b))){if(j.splice(i,1),a=f.length&&ra(j),!a)return H.apply(e,f),e;break}}}return(n||h(a,o))(f,b,!p,e,aa.test(a)&&pa(b.parentNode)||b),e},c.sortStable=u.split("").sort(B).join("")===u,c.detectDuplicates=!!l,m(),c.sortDetached=ja(function(a){return 1&a.compareDocumentPosition(n.createElement("div"))}),ja(function(a){return a.innerHTML="<a href='#'></a>","#"===a.firstChild.getAttribute("href")})||ka("type|href|height|width",function(a,b,c){return c?void 0:a.getAttribute(b,"type"===b.toLowerCase()?1:2)}),c.attributes&&ja(function(a){return a.innerHTML="<input/>",a.firstChild.setAttribute("value",""),""===a.firstChild.getAttribute("value")})||ka("value",function(a,b,c){return c||"input"!==a.nodeName.toLowerCase()?void 0:a.defaultValue}),ja(function(a){return null==a.getAttribute("disabled")})||ka(K,function(a,b,c){var d;return c?void 0:a[b]===!0?b.toLowerCase():(d=a.getAttributeNode(b))&&d.specified?d.value:null}),ga}(a);m.find=s,m.expr=s.selectors,m.expr[":"]=m.expr.pseudos,m.unique=s.uniqueSort,m.text=s.getText,m.isXMLDoc=s.isXML,m.contains=s.contains;var t=m.expr.match.needsContext,u=/^<(\w+)\s*\/?>(?:<\/\1>|)$/,v=/^.[^:#\[\.,]*$/;function w(a,b,c){if(m.isFunction(b))return m.grep(a,function(a,d){return!!b.call(a,d,a)!==c});if(b.nodeType)return m.grep(a,function(a){return a===b!==c});if("string"==typeof b){if(v.test(b))return m.filter(b,a,c);b=m.filter(b,a)}return m.grep(a,function(a){return m.inArray(a,b)>=0!==c})}m.filter=function(a,b,c){var d=b[0];return c&&(a=":not("+a+")"),1===b.length&&1===d.nodeType?m.find.matchesSelector(d,a)?[d]:[]:m.find.matches(a,m.grep(b,function(a){return 1===a.nodeType}))},m.fn.extend({find:function(a){var b,c=[],d=this,e=d.length;if("string"!=typeof a)return this.pushStack(m(a).filter(function(){for(b=0;e>b;b++)if(m.contains(d[b],this))return!0}));for(b=0;e>b;b++)m.find(a,d[b],c);return c=this.pushStack(e>1?m.unique(c):c),c.selector=this.selector?this.selector+" "+a:a,c},filter:function(a){return this.pushStack(w(this,a||[],!1))},not:function(a){return this.pushStack(w(this,a||[],!0))},is:function(a){return!!w(this,"string"==typeof a&&t.test(a)?m(a):a||[],!1).length}});var x,y=a.document,z=/^(?:\s*(<[\w\W]+>)[^>]*|#([\w-]*))$/,A=m.fn.init=function(a,b){var c,d;if(!a)return this;if("string"==typeof a){if(c="<"===a.charAt(0)&&">"===a.charAt(a.length-1)&&a.length>=3?[null,a,null]:z.exec(a),!c||!c[1]&&b)return!b||b.jquery?(b||x).find(a):this.constructor(b).find(a);if(c[1]){if(b=b instanceof m?b[0]:b,m.merge(this,m.parseHTML(c[1],b&&b.nodeType?b.ownerDocument||b:y,!0)),u.test(c[1])&&m.isPlainObject(b))for(c in b)m.isFunction(this[c])?this[c](b[c]):this.attr(c,b[c]);return this}if(d=y.getElementById(c[2]),d&&d.parentNode){if(d.id!==c[2])return x.find(a);this.length=1,this[0]=d}return this.context=y,this.selector=a,this}return a.nodeType?(this.context=this[0]=a,this.length=1,this):m.isFunction(a)?"undefined"!=typeof x.ready?x.ready(a):a(m):(void 0!==a.selector&&(this.selector=a.selector,this.context=a.context),m.makeArray(a,this))};A.prototype=m.fn,x=m(y);var B=/^(?:parents|prev(?:Until|All))/,C={children:!0,contents:!0,next:!0,prev:!0};m.extend({dir:function(a,b,c){var d=[],e=a[b];while(e&&9!==e.nodeType&&(void 0===c||1!==e.nodeType||!m(e).is(c)))1===e.nodeType&&d.push(e),e=e[b];return d},sibling:function(a,b){for(var c=[];a;a=a.nextSibling)1===a.nodeType&&a!==b&&c.push(a);return c}}),m.fn.extend({has:function(a){var b,c=m(a,this),d=c.length;return this.filter(function(){for(b=0;d>b;b++)if(m.contains(this,c[b]))return!0})},closest:function(a,b){for(var c,d=0,e=this.length,f=[],g=t.test(a)||"string"!=typeof a?m(a,b||this.context):0;e>d;d++)for(c=this[d];c&&c!==b;c=c.parentNode)if(c.nodeType<11&&(g?g.index(c)>-1:1===c.nodeType&&m.find.matchesSelector(c,a))){f.push(c);break}return this.pushStack(f.length>1?m.unique(f):f)},index:function(a){return a?"string"==typeof a?m.inArray(this[0],m(a)):m.inArray(a.jquery?a[0]:a,this):this[0]&&this[0].parentNode?this.first().prevAll().length:-1},add:function(a,b){return this.pushStack(m.unique(m.merge(this.get(),m(a,b))))},addBack:function(a){return this.add(null==a?this.prevObject:this.prevObject.filter(a))}});function D(a,b){do a=a[b];while(a&&1!==a.nodeType);return a}m.each({parent:function(a){var b=a.parentNode;return b&&11!==b.nodeType?b:null},parents:function(a){return m.dir(a,"parentNode")},parentsUntil:function(a,b,c){return m.dir(a,"parentNode",c)},next:function(a){return D(a,"nextSibling")},prev:function(a){return D(a,"previousSibling")},nextAll:function(a){return m.dir(a,"nextSibling")},prevAll:function(a){return m.dir(a,"previousSibling")},nextUntil:function(a,b,c){return m.dir(a,"nextSibling",c)},prevUntil:function(a,b,c){return m.dir(a,"previousSibling",c)},siblings:function(a){return m.sibling((a.parentNode||{}).firstChild,a)},children:function(a){return m.sibling(a.firstChild)},contents:function(a){return m.nodeName(a,"iframe")?a.contentDocument||a.contentWindow.document:m.merge([],a.childNodes)}},function(a,b){m.fn[a]=function(c,d){var e=m.map(this,b,c);return"Until"!==a.slice(-5)&&(d=c),d&&"string"==typeof d&&(e=m.filter(d,e)),this.length>1&&(C[a]||(e=m.unique(e)),B.test(a)&&(e=e.reverse())),this.pushStack(e)}});var E=/\S+/g,F={};function G(a){var b=F[a]={};return m.each(a.match(E)||[],function(a,c){b[c]=!0}),b}m.Callbacks=function(a){a="string"==typeof a?F[a]||G(a):m.extend({},a);var b,c,d,e,f,g,h=[],i=!a.once&&[],j=function(l){for(c=a.memory&&l,d=!0,f=g||0,g=0,e=h.length,b=!0;h&&e>f;f++)if(h[f].apply(l[0],l[1])===!1&&a.stopOnFalse){c=!1;break}b=!1,h&&(i?i.length&&j(i.shift()):c?h=[]:k.disable())},k={add:function(){if(h){var d=h.length;!function f(b){m.each(b,function(b,c){var d=m.type(c);"function"===d?a.unique&&k.has(c)||h.push(c):c&&c.length&&"string"!==d&&f(c)})}(arguments),b?e=h.length:c&&(g=d,j(c))}return this},remove:function(){return h&&m.each(arguments,function(a,c){var d;while((d=m.inArray(c,h,d))>-1)h.splice(d,1),b&&(e>=d&&e--,f>=d&&f--)}),this},has:function(a){return a?m.inArray(a,h)>-1:!(!h||!h.length)},empty:function(){return h=[],e=0,this},disable:function(){return h=i=c=void 0,this},disabled:function(){return!h},lock:function(){return i=void 0,c||k.disable(),this},locked:function(){return!i},fireWith:function(a,c){return!h||d&&!i||(c=c||[],c=[a,c.slice?c.slice():c],b?i.push(c):j(c)),this},fire:function(){return k.fireWith(this,arguments),this},fired:function(){return!!d}};return k},m.extend({Deferred:function(a){var b=[["resolve","done",m.Callbacks("once memory"),"resolved"],["reject","fail",m.Callbacks("once memory"),"rejected"],["notify","progress",m.Callbacks("memory")]],c="pending",d={state:function(){return c},always:function(){return e.done(arguments).fail(arguments),this},then:function(){var a=arguments;return m.Deferred(function(c){m.each(b,function(b,f){var g=m.isFunction(a[b])&&a[b];e[f[1]](function(){var a=g&&g.apply(this,arguments);a&&m.isFunction(a.promise)?a.promise().done(c.resolve).fail(c.reject).progress(c.notify):c[f[0]+"With"](this===d?c.promise():this,g?[a]:arguments)})}),a=null}).promise()},promise:function(a){return null!=a?m.extend(a,d):d}},e={};return d.pipe=d.then,m.each(b,function(a,f){var g=f[2],h=f[3];d[f[1]]=g.add,h&&g.add(function(){c=h},b[1^a][2].disable,b[2][2].lock),e[f[0]]=function(){return e[f[0]+"With"](this===e?d:this,arguments),this},e[f[0]+"With"]=g.fireWith}),d.promise(e),a&&a.call(e,e),e},when:function(a){var b=0,c=d.call(arguments),e=c.length,f=1!==e||a&&m.isFunction(a.promise)?e:0,g=1===f?a:m.Deferred(),h=function(a,b,c){return function(e){b[a]=this,c[a]=arguments.length>1?d.call(arguments):e,c===i?g.notifyWith(b,c):--f||g.resolveWith(b,c)}},i,j,k;if(e>1)for(i=new Array(e),j=new Array(e),k=new Array(e);e>b;b++)c[b]&&m.isFunction(c[b].promise)?c[b].promise().done(h(b,k,c)).fail(g.reject).progress(h(b,j,i)):--f;return f||g.resolveWith(k,c),g.promise()}});var H;m.fn.ready=function(a){return m.ready.promise().done(a),this},m.extend({isReady:!1,readyWait:1,holdReady:function(a){a?m.readyWait++:m.ready(!0)},ready:function(a){if(a===!0?!--m.readyWait:!m.isReady){if(!y.body)return setTimeout(m.ready);m.isReady=!0,a!==!0&&--m.readyWait>0||(H.resolveWith(y,[m]),m.fn.triggerHandler&&(m(y).triggerHandler("ready"),m(y).off("ready")))}}});function I(){y.addEventListener?(y.removeEventListener("DOMContentLoaded",J,!1),a.removeEventListener("load",J,!1)):(y.detachEvent("onreadystatechange",J),a.detachEvent("onload",J))}function J(){(y.addEventListener||"load"===event.type||"complete"===y.readyState)&&(I(),m.ready())}m.ready.promise=function(b){if(!H)if(H=m.Deferred(),"complete"===y.readyState)setTimeout(m.ready);else if(y.addEventListener)y.addEventListener("DOMContentLoaded",J,!1),a.addEventListener("load",J,!1);else{y.attachEvent("onreadystatechange",J),a.attachEvent("onload",J);var c=!1;try{c=null==a.frameElement&&y.documentElement}catch(d){}c&&c.doScroll&&!function e(){if(!m.isReady){try{c.doScroll("left")}catch(a){return setTimeout(e,50)}I(),m.ready()}}()}return H.promise(b)};var K="undefined",L;for(L in m(k))break;k.ownLast="0"!==L,k.inlineBlockNeedsLayout=!1,m(function(){var a,b,c,d;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="display:inline;margin:0;border:0;padding:1px;width:1px;zoom:1",k.inlineBlockNeedsLayout=a=3===b.offsetWidth,a&&(c.style.zoom=1)),c.removeChild(d))}),function(){var a=y.createElement("div");if(null==k.deleteExpando){k.deleteExpando=!0;try{delete a.test}catch(b){k.deleteExpando=!1}}a=null}(),m.acceptData=function(a){var b=m.noData[(a.nodeName+" ").toLowerCase()],c=+a.nodeType||1;return 1!==c&&9!==c?!1:!b||b!==!0&&a.getAttribute("classid")===b};var M=/^(?:\{[\w\W]*\}|\[[\w\W]*\])$/,N=/([A-Z])/g;function O(a,b,c){if(void 0===c&&1===a.nodeType){var d="data-"+b.replace(N,"-$1").toLowerCase();if(c=a.getAttribute(d),"string"==typeof c){try{c="true"===c?!0:"false"===c?!1:"null"===c?null:+c+""===c?+c:M.test(c)?m.parseJSON(c):c}catch(e){}m.data(a,b,c)}else c=void 0}return c}function P(a){var b;for(b in a)if(("data"!==b||!m.isEmptyObject(a[b]))&&"toJSON"!==b)return!1;

return!0}function Q(a,b,d,e){if(m.acceptData(a)){var f,g,h=m.expando,i=a.nodeType,j=i?m.cache:a,k=i?a[h]:a[h]&&h;if(k&&j[k]&&(e||j[k].data)||void 0!==d||"string"!=typeof b)return k||(k=i?a[h]=c.pop()||m.guid++:h),j[k]||(j[k]=i?{}:{toJSON:m.noop}),("object"==typeof b||"function"==typeof b)&&(e?j[k]=m.extend(j[k],b):j[k].data=m.extend(j[k].data,b)),g=j[k],e||(g.data||(g.data={}),g=g.data),void 0!==d&&(g[m.camelCase(b)]=d),"string"==typeof b?(f=g[b],null==f&&(f=g[m.camelCase(b)])):f=g,f}}function R(a,b,c){if(m.acceptData(a)){var d,e,f=a.nodeType,g=f?m.cache:a,h=f?a[m.expando]:m.expando;if(g[h]){if(b&&(d=c?g[h]:g[h].data)){m.isArray(b)?b=b.concat(m.map(b,m.camelCase)):b in d?b=[b]:(b=m.camelCase(b),b=b in d?[b]:b.split(" ")),e=b.length;while(e--)delete d[b[e]];if(c?!P(d):!m.isEmptyObject(d))return}(c||(delete g[h].data,P(g[h])))&&(f?m.cleanData([a],!0):k.deleteExpando||g!=g.window?delete g[h]:g[h]=null)}}}m.extend({cache:{},noData:{"applet ":!0,"embed ":!0,"object ":"clsid:D27CDB6E-AE6D-11cf-96B8-444553540000"},hasData:function(a){return a=a.nodeType?m.cache[a[m.expando]]:a[m.expando],!!a&&!P(a)},data:function(a,b,c){return Q(a,b,c)},removeData:function(a,b){return R(a,b)},_data:function(a,b,c){return Q(a,b,c,!0)},_removeData:function(a,b){return R(a,b,!0)}}),m.fn.extend({data:function(a,b){var c,d,e,f=this[0],g=f&&f.attributes;if(void 0===a){if(this.length&&(e=m.data(f),1===f.nodeType&&!m._data(f,"parsedAttrs"))){c=g.length;while(c--)g[c]&&(d=g[c].name,0===d.indexOf("data-")&&(d=m.camelCase(d.slice(5)),O(f,d,e[d])));m._data(f,"parsedAttrs",!0)}return e}return"object"==typeof a?this.each(function(){m.data(this,a)}):arguments.length>1?this.each(function(){m.data(this,a,b)}):f?O(f,a,m.data(f,a)):void 0},removeData:function(a){return this.each(function(){m.removeData(this,a)})}}),m.extend({queue:function(a,b,c){var d;return a?(b=(b||"fx")+"queue",d=m._data(a,b),c&&(!d||m.isArray(c)?d=m._data(a,b,m.makeArray(c)):d.push(c)),d||[]):void 0},dequeue:function(a,b){b=b||"fx";var c=m.queue(a,b),d=c.length,e=c.shift(),f=m._queueHooks(a,b),g=function(){m.dequeue(a,b)};"inprogress"===e&&(e=c.shift(),d--),e&&("fx"===b&&c.unshift("inprogress"),delete f.stop,e.call(a,g,f)),!d&&f&&f.empty.fire()},_queueHooks:function(a,b){var c=b+"queueHooks";return m._data(a,c)||m._data(a,c,{empty:m.Callbacks("once memory").add(function(){m._removeData(a,b+"queue"),m._removeData(a,c)})})}}),m.fn.extend({queue:function(a,b){var c=2;return"string"!=typeof a&&(b=a,a="fx",c--),arguments.length<c?m.queue(this[0],a):void 0===b?this:this.each(function(){var c=m.queue(this,a,b);m._queueHooks(this,a),"fx"===a&&"inprogress"!==c[0]&&m.dequeue(this,a)})},dequeue:function(a){return this.each(function(){m.dequeue(this,a)})},clearQueue:function(a){return this.queue(a||"fx",[])},promise:function(a,b){var c,d=1,e=m.Deferred(),f=this,g=this.length,h=function(){--d||e.resolveWith(f,[f])};"string"!=typeof a&&(b=a,a=void 0),a=a||"fx";while(g--)c=m._data(f[g],a+"queueHooks"),c&&c.empty&&(d++,c.empty.add(h));return h(),e.promise(b)}});var S=/[+-]?(?:\d*\.|)\d+(?:[eE][+-]?\d+|)/.source,T=["Top","Right","Bottom","Left"],U=function(a,b){return a=b||a,"none"===m.css(a,"display")||!m.contains(a.ownerDocument,a)},V=m.access=function(a,b,c,d,e,f,g){var h=0,i=a.length,j=null==c;if("object"===m.type(c)){e=!0;for(h in c)m.access(a,b,h,c[h],!0,f,g)}else if(void 0!==d&&(e=!0,m.isFunction(d)||(g=!0),j&&(g?(b.call(a,d),b=null):(j=b,b=function(a,b,c){return j.call(m(a),c)})),b))for(;i>h;h++)b(a[h],c,g?d:d.call(a[h],h,b(a[h],c)));return e?a:j?b.call(a):i?b(a[0],c):f},W=/^(?:checkbox|radio)$/i;!function(){var a=y.createElement("input"),b=y.createElement("div"),c=y.createDocumentFragment();if(b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",k.leadingWhitespace=3===b.firstChild.nodeType,k.tbody=!b.getElementsByTagName("tbody").length,k.htmlSerialize=!!b.getElementsByTagName("link").length,k.html5Clone="<:nav></:nav>"!==y.createElement("nav").cloneNode(!0).outerHTML,a.type="checkbox",a.checked=!0,c.appendChild(a),k.appendChecked=a.checked,b.innerHTML="<textarea>x</textarea>",k.noCloneChecked=!!b.cloneNode(!0).lastChild.defaultValue,c.appendChild(b),b.innerHTML="<input type='radio' checked='checked' name='t'/>",k.checkClone=b.cloneNode(!0).cloneNode(!0).lastChild.checked,k.noCloneEvent=!0,b.attachEvent&&(b.attachEvent("onclick",function(){k.noCloneEvent=!1}),b.cloneNode(!0).click()),null==k.deleteExpando){k.deleteExpando=!0;try{delete b.test}catch(d){k.deleteExpando=!1}}}(),function(){var b,c,d=y.createElement("div");for(b in{submit:!0,change:!0,focusin:!0})c="on"+b,(k[b+"Bubbles"]=c in a)||(d.setAttribute(c,"t"),k[b+"Bubbles"]=d.attributes[c].expando===!1);d=null}();var X=/^(?:input|select|textarea)$/i,Y=/^key/,Z=/^(?:mouse|pointer|contextmenu)|click/,$=/^(?:focusinfocus|focusoutblur)$/,_=/^([^.]*)(?:\.(.+)|)$/;function aa(){return!0}function ba(){return!1}function ca(){try{return y.activeElement}catch(a){}}m.event={global:{},add:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m._data(a);if(r){c.handler&&(i=c,c=i.handler,e=i.selector),c.guid||(c.guid=m.guid++),(g=r.events)||(g=r.events={}),(k=r.handle)||(k=r.handle=function(a){return typeof m===K||a&&m.event.triggered===a.type?void 0:m.event.dispatch.apply(k.elem,arguments)},k.elem=a),b=(b||"").match(E)||[""],h=b.length;while(h--)f=_.exec(b[h])||[],o=q=f[1],p=(f[2]||"").split(".").sort(),o&&(j=m.event.special[o]||{},o=(e?j.delegateType:j.bindType)||o,j=m.event.special[o]||{},l=m.extend({type:o,origType:q,data:d,handler:c,guid:c.guid,selector:e,needsContext:e&&m.expr.match.needsContext.test(e),namespace:p.join(".")},i),(n=g[o])||(n=g[o]=[],n.delegateCount=0,j.setup&&j.setup.call(a,d,p,k)!==!1||(a.addEventListener?a.addEventListener(o,k,!1):a.attachEvent&&a.attachEvent("on"+o,k))),j.add&&(j.add.call(a,l),l.handler.guid||(l.handler.guid=c.guid)),e?n.splice(n.delegateCount++,0,l):n.push(l),m.event.global[o]=!0);a=null}},remove:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m.hasData(a)&&m._data(a);if(r&&(k=r.events)){b=(b||"").match(E)||[""],j=b.length;while(j--)if(h=_.exec(b[j])||[],o=q=h[1],p=(h[2]||"").split(".").sort(),o){l=m.event.special[o]||{},o=(d?l.delegateType:l.bindType)||o,n=k[o]||[],h=h[2]&&new RegExp("(^|\\.)"+p.join("\\.(?:.*\\.|)")+"(\\.|$)"),i=f=n.length;while(f--)g=n[f],!e&&q!==g.origType||c&&c.guid!==g.guid||h&&!h.test(g.namespace)||d&&d!==g.selector&&("**"!==d||!g.selector)||(n.splice(f,1),g.selector&&n.delegateCount--,l.remove&&l.remove.call(a,g));i&&!n.length&&(l.teardown&&l.teardown.call(a,p,r.handle)!==!1||m.removeEvent(a,o,r.handle),delete k[o])}else for(o in k)m.event.remove(a,o+b[j],c,d,!0);m.isEmptyObject(k)&&(delete r.handle,m._removeData(a,"events"))}},trigger:function(b,c,d,e){var f,g,h,i,k,l,n,o=[d||y],p=j.call(b,"type")?b.type:b,q=j.call(b,"namespace")?b.namespace.split("."):[];if(h=l=d=d||y,3!==d.nodeType&&8!==d.nodeType&&!$.test(p+m.event.triggered)&&(p.indexOf(".")>=0&&(q=p.split("."),p=q.shift(),q.sort()),g=p.indexOf(":")<0&&"on"+p,b=b[m.expando]?b:new m.Event(p,"object"==typeof b&&b),b.isTrigger=e?2:3,b.namespace=q.join("."),b.namespace_re=b.namespace?new RegExp("(^|\\.)"+q.join("\\.(?:.*\\.|)")+"(\\.|$)"):null,b.result=void 0,b.target||(b.target=d),c=null==c?[b]:m.makeArray(c,[b]),k=m.event.special[p]||{},e||!k.trigger||k.trigger.apply(d,c)!==!1)){if(!e&&!k.noBubble&&!m.isWindow(d)){for(i=k.delegateType||p,$.test(i+p)||(h=h.parentNode);h;h=h.parentNode)o.push(h),l=h;l===(d.ownerDocument||y)&&o.push(l.defaultView||l.parentWindow||a)}n=0;while((h=o[n++])&&!b.isPropagationStopped())b.type=n>1?i:k.bindType||p,f=(m._data(h,"events")||{})[b.type]&&m._data(h,"handle"),f&&f.apply(h,c),f=g&&h[g],f&&f.apply&&m.acceptData(h)&&(b.result=f.apply(h,c),b.result===!1&&b.preventDefault());if(b.type=p,!e&&!b.isDefaultPrevented()&&(!k._default||k._default.apply(o.pop(),c)===!1)&&m.acceptData(d)&&g&&d[p]&&!m.isWindow(d)){l=d[g],l&&(d[g]=null),m.event.triggered=p;try{d[p]()}catch(r){}m.event.triggered=void 0,l&&(d[g]=l)}return b.result}},dispatch:function(a){a=m.event.fix(a);var b,c,e,f,g,h=[],i=d.call(arguments),j=(m._data(this,"events")||{})[a.type]||[],k=m.event.special[a.type]||{};if(i[0]=a,a.delegateTarget=this,!k.preDispatch||k.preDispatch.call(this,a)!==!1){h=m.event.handlers.call(this,a,j),b=0;while((f=h[b++])&&!a.isPropagationStopped()){a.currentTarget=f.elem,g=0;while((e=f.handlers[g++])&&!a.isImmediatePropagationStopped())(!a.namespace_re||a.namespace_re.test(e.namespace))&&(a.handleObj=e,a.data=e.data,c=((m.event.special[e.origType]||{}).handle||e.handler).apply(f.elem,i),void 0!==c&&(a.result=c)===!1&&(a.preventDefault(),a.stopPropagation()))}return k.postDispatch&&k.postDispatch.call(this,a),a.result}},handlers:function(a,b){var c,d,e,f,g=[],h=b.delegateCount,i=a.target;if(h&&i.nodeType&&(!a.button||"click"!==a.type))for(;i!=this;i=i.parentNode||this)if(1===i.nodeType&&(i.disabled!==!0||"click"!==a.type)){for(e=[],f=0;h>f;f++)d=b[f],c=d.selector+" ",void 0===e[c]&&(e[c]=d.needsContext?m(c,this).index(i)>=0:m.find(c,this,null,[i]).length),e[c]&&e.push(d);e.length&&g.push({elem:i,handlers:e})}return h<b.length&&g.push({elem:this,handlers:b.slice(h)}),g},fix:function(a){if(a[m.expando])return a;var b,c,d,e=a.type,f=a,g=this.fixHooks[e];g||(this.fixHooks[e]=g=Z.test(e)?this.mouseHooks:Y.test(e)?this.keyHooks:{}),d=g.props?this.props.concat(g.props):this.props,a=new m.Event(f),b=d.length;while(b--)c=d[b],a[c]=f[c];return a.target||(a.target=f.srcElement||y),3===a.target.nodeType&&(a.target=a.target.parentNode),a.metaKey=!!a.metaKey,g.filter?g.filter(a,f):a},props:"altKey bubbles cancelable ctrlKey currentTarget eventPhase metaKey relatedTarget shiftKey target timeStamp view which".split(" "),fixHooks:{},keyHooks:{props:"char charCode key keyCode".split(" "),filter:function(a,b){return null==a.which&&(a.which=null!=b.charCode?b.charCode:b.keyCode),a}},mouseHooks:{props:"button buttons clientX clientY fromElement offsetX offsetY pageX pageY screenX screenY toElement".split(" "),filter:function(a,b){var c,d,e,f=b.button,g=b.fromElement;return null==a.pageX&&null!=b.clientX&&(d=a.target.ownerDocument||y,e=d.documentElement,c=d.body,a.pageX=b.clientX+(e&&e.scrollLeft||c&&c.scrollLeft||0)-(e&&e.clientLeft||c&&c.clientLeft||0),a.pageY=b.clientY+(e&&e.scrollTop||c&&c.scrollTop||0)-(e&&e.clientTop||c&&c.clientTop||0)),!a.relatedTarget&&g&&(a.relatedTarget=g===a.target?b.toElement:g),a.which||void 0===f||(a.which=1&f?1:2&f?3:4&f?2:0),a}},special:{load:{noBubble:!0},focus:{trigger:function(){if(this!==ca()&&this.focus)try{return this.focus(),!1}catch(a){}},delegateType:"focusin"},blur:{trigger:function(){return this===ca()&&this.blur?(this.blur(),!1):void 0},delegateType:"focusout"},click:{trigger:function(){return m.nodeName(this,"input")&&"checkbox"===this.type&&this.click?(this.click(),!1):void 0},_default:function(a){return m.nodeName(a.target,"a")}},beforeunload:{postDispatch:function(a){void 0!==a.result&&a.originalEvent&&(a.originalEvent.returnValue=a.result)}}},simulate:function(a,b,c,d){var e=m.extend(new m.Event,c,{type:a,isSimulated:!0,originalEvent:{}});d?m.event.trigger(e,null,b):m.event.dispatch.call(b,e),e.isDefaultPrevented()&&c.preventDefault()}},m.removeEvent=y.removeEventListener?function(a,b,c){a.removeEventListener&&a.removeEventListener(b,c,!1)}:function(a,b,c){var d="on"+b;a.detachEvent&&(typeof a[d]===K&&(a[d]=null),a.detachEvent(d,c))},m.Event=function(a,b){return this instanceof m.Event?(a&&a.type?(this.originalEvent=a,this.type=a.type,this.isDefaultPrevented=a.defaultPrevented||void 0===a.defaultPrevented&&a.returnValue===!1?aa:ba):this.type=a,b&&m.extend(this,b),this.timeStamp=a&&a.timeStamp||m.now(),void(this[m.expando]=!0)):new m.Event(a,b)},m.Event.prototype={isDefaultPrevented:ba,isPropagationStopped:ba,isImmediatePropagationStopped:ba,preventDefault:function(){var a=this.originalEvent;this.isDefaultPrevented=aa,a&&(a.preventDefault?a.preventDefault():a.returnValue=!1)},stopPropagation:function(){var a=this.originalEvent;this.isPropagationStopped=aa,a&&(a.stopPropagation&&a.stopPropagation(),a.cancelBubble=!0)},stopImmediatePropagation:function(){var a=this.originalEvent;this.isImmediatePropagationStopped=aa,a&&a.stopImmediatePropagation&&a.stopImmediatePropagation(),this.stopPropagation()}},m.each({mouseenter:"mouseover",mouseleave:"mouseout",pointerenter:"pointerover",pointerleave:"pointerout"},function(a,b){m.event.special[a]={delegateType:b,bindType:b,handle:function(a){var c,d=this,e=a.relatedTarget,f=a.handleObj;return(!e||e!==d&&!m.contains(d,e))&&(a.type=f.origType,c=f.handler.apply(this,arguments),a.type=b),c}}}),k.submitBubbles||(m.event.special.submit={setup:function(){return m.nodeName(this,"form")?!1:void m.event.add(this,"click._submit keypress._submit",function(a){var b=a.target,c=m.nodeName(b,"input")||m.nodeName(b,"button")?b.form:void 0;c&&!m._data(c,"submitBubbles")&&(m.event.add(c,"submit._submit",function(a){a._submit_bubble=!0}),m._data(c,"submitBubbles",!0))})},postDispatch:function(a){a._submit_bubble&&(delete a._submit_bubble,this.parentNode&&!a.isTrigger&&m.event.simulate("submit",this.parentNode,a,!0))},teardown:function(){return m.nodeName(this,"form")?!1:void m.event.remove(this,"._submit")}}),k.changeBubbles||(m.event.special.change={setup:function(){return X.test(this.nodeName)?(("checkbox"===this.type||"radio"===this.type)&&(m.event.add(this,"propertychange._change",function(a){"checked"===a.originalEvent.propertyName&&(this._just_changed=!0)}),m.event.add(this,"click._change",function(a){this._just_changed&&!a.isTrigger&&(this._just_changed=!1),m.event.simulate("change",this,a,!0)})),!1):void m.event.add(this,"beforeactivate._change",function(a){var b=a.target;X.test(b.nodeName)&&!m._data(b,"changeBubbles")&&(m.event.add(b,"change._change",function(a){!this.parentNode||a.isSimulated||a.isTrigger||m.event.simulate("change",this.parentNode,a,!0)}),m._data(b,"changeBubbles",!0))})},handle:function(a){var b=a.target;return this!==b||a.isSimulated||a.isTrigger||"radio"!==b.type&&"checkbox"!==b.type?a.handleObj.handler.apply(this,arguments):void 0},teardown:function(){return m.event.remove(this,"._change"),!X.test(this.nodeName)}}),k.focusinBubbles||m.each({focus:"focusin",blur:"focusout"},function(a,b){var c=function(a){m.event.simulate(b,a.target,m.event.fix(a),!0)};m.event.special[b]={setup:function(){var d=this.ownerDocument||this,e=m._data(d,b);e||d.addEventListener(a,c,!0),m._data(d,b,(e||0)+1)},teardown:function(){var d=this.ownerDocument||this,e=m._data(d,b)-1;e?m._data(d,b,e):(d.removeEventListener(a,c,!0),m._removeData(d,b))}}}),m.fn.extend({on:function(a,b,c,d,e){var f,g;if("object"==typeof a){"string"!=typeof b&&(c=c||b,b=void 0);for(f in a)this.on(f,b,c,a[f],e);return this}if(null==c&&null==d?(d=b,c=b=void 0):null==d&&("string"==typeof b?(d=c,c=void 0):(d=c,c=b,b=void 0)),d===!1)d=ba;else if(!d)return this;return 1===e&&(g=d,d=function(a){return m().off(a),g.apply(this,arguments)},d.guid=g.guid||(g.guid=m.guid++)),this.each(function(){m.event.add(this,a,d,c,b)})},one:function(a,b,c,d){return this.on(a,b,c,d,1)},off:function(a,b,c){var d,e;if(a&&a.preventDefault&&a.handleObj)return d=a.handleObj,m(a.delegateTarget).off(d.namespace?d.origType+"."+d.namespace:d.origType,d.selector,d.handler),this;if("object"==typeof a){for(e in a)this.off(e,b,a[e]);return this}return(b===!1||"function"==typeof b)&&(c=b,b=void 0),c===!1&&(c=ba),this.each(function(){m.event.remove(this,a,c,b)})},trigger:function(a,b){return this.each(function(){m.event.trigger(a,b,this)})},triggerHandler:function(a,b){var c=this[0];return c?m.event.trigger(a,b,c,!0):void 0}});function da(a){var b=ea.split("|"),c=a.createDocumentFragment();if(c.createElement)while(b.length)c.createElement(b.pop());return c}var ea="abbr|article|aside|audio|bdi|canvas|data|datalist|details|figcaption|figure|footer|header|hgroup|mark|meter|nav|output|progress|section|summary|time|video",fa=/ jQuery\d+="(?:null|\d+)"/g,ga=new RegExp("<(?:"+ea+")[\\s/>]","i"),ha=/^\s+/,ia=/<(?!area|br|col|embed|hr|img|input|link|meta|param)(([\w:]+)[^>]*)\/>/gi,ja=/<([\w:]+)/,ka=/<tbody/i,la=/<|&#?\w+;/,ma=/<(?:script|style|link)/i,na=/checked\s*(?:[^=]|=\s*.checked.)/i,oa=/^$|\/(?:java|ecma)script/i,pa=/^true\/(.*)/,qa=/^\s*<!(?:\[CDATA\[|--)|(?:\]\]|--)>\s*$/g,ra={option:[1,"<select multiple='multiple'>","</select>"],legend:[1,"<fieldset>","</fieldset>"],area:[1,"<map>","</map>"],param:[1,"<object>","</object>"],thead:[1,"<table>","</table>"],tr:[2,"<table><tbody>","</tbody></table>"],col:[2,"<table><tbody></tbody><colgroup>","</colgroup></table>"],td:[3,"<table><tbody><tr>","</tr></tbody></table>"],_default:k.htmlSerialize?[0,"",""]:[1,"X<div>","</div>"]},sa=da(y),ta=sa.appendChild(y.createElement("div"));ra.optgroup=ra.option,ra.tbody=ra.tfoot=ra.colgroup=ra.caption=ra.thead,ra.th=ra.td;function ua(a,b){var c,d,e=0,f=typeof a.getElementsByTagName!==K?a.getElementsByTagName(b||"*"):typeof a.querySelectorAll!==K?a.querySelectorAll(b||"*"):void 0;if(!f)for(f=[],c=a.childNodes||a;null!=(d=c[e]);e++)!b||m.nodeName(d,b)?f.push(d):m.merge(f,ua(d,b));return void 0===b||b&&m.nodeName(a,b)?m.merge([a],f):f}function va(a){W.test(a.type)&&(a.defaultChecked=a.checked)}function wa(a,b){return m.nodeName(a,"table")&&m.nodeName(11!==b.nodeType?b:b.firstChild,"tr")?a.getElementsByTagName("tbody")[0]||a.appendChild(a.ownerDocument.createElement("tbody")):a}function xa(a){return a.type=(null!==m.find.attr(a,"type"))+"/"+a.type,a}function ya(a){var b=pa.exec(a.type);return b?a.type=b[1]:a.removeAttribute("type"),a}function za(a,b){for(var c,d=0;null!=(c=a[d]);d++)m._data(c,"globalEval",!b||m._data(b[d],"globalEval"))}function Aa(a,b){if(1===b.nodeType&&m.hasData(a)){var c,d,e,f=m._data(a),g=m._data(b,f),h=f.events;if(h){delete g.handle,g.events={};for(c in h)for(d=0,e=h[c].length;e>d;d++)m.event.add(b,c,h[c][d])}g.data&&(g.data=m.extend({},g.data))}}function Ba(a,b){var c,d,e;if(1===b.nodeType){if(c=b.nodeName.toLowerCase(),!k.noCloneEvent&&b[m.expando]){e=m._data(b);for(d in e.events)m.removeEvent(b,d,e.handle);b.removeAttribute(m.expando)}"script"===c&&b.text!==a.text?(xa(b).text=a.text,ya(b)):"object"===c?(b.parentNode&&(b.outerHTML=a.outerHTML),k.html5Clone&&a.innerHTML&&!m.trim(b.innerHTML)&&(b.innerHTML=a.innerHTML)):"input"===c&&W.test(a.type)?(b.defaultChecked=b.checked=a.checked,b.value!==a.value&&(b.value=a.value)):"option"===c?b.defaultSelected=b.selected=a.defaultSelected:("input"===c||"textarea"===c)&&(b.defaultValue=a.defaultValue)}}m.extend({clone:function(a,b,c){var d,e,f,g,h,i=m.contains(a.ownerDocument,a);if(k.html5Clone||m.isXMLDoc(a)||!ga.test("<"+a.nodeName+">")?f=a.cloneNode(!0):(ta.innerHTML=a.outerHTML,ta.removeChild(f=ta.firstChild)),!(k.noCloneEvent&&k.noCloneChecked||1!==a.nodeType&&11!==a.nodeType||m.isXMLDoc(a)))for(d=ua(f),h=ua(a),g=0;null!=(e=h[g]);++g)d[g]&&Ba(e,d[g]);if(b)if(c)for(h=h||ua(a),d=d||ua(f),g=0;null!=(e=h[g]);g++)Aa(e,d[g]);else Aa(a,f);return d=ua(f,"script"),d.length>0&&za(d,!i&&ua(a,"script")),d=h=e=null,f},buildFragment:function(a,b,c,d){for(var e,f,g,h,i,j,l,n=a.length,o=da(b),p=[],q=0;n>q;q++)if(f=a[q],f||0===f)if("object"===m.type(f))m.merge(p,f.nodeType?[f]:f);else if(la.test(f)){h=h||o.appendChild(b.createElement("div")),i=(ja.exec(f)||["",""])[1].toLowerCase(),l=ra[i]||ra._default,h.innerHTML=l[1]+f.replace(ia,"<$1></$2>")+l[2],e=l[0];while(e--)h=h.lastChild;if(!k.leadingWhitespace&&ha.test(f)&&p.push(b.createTextNode(ha.exec(f)[0])),!k.tbody){f="table"!==i||ka.test(f)?"<table>"!==l[1]||ka.test(f)?0:h:h.firstChild,e=f&&f.childNodes.length;while(e--)m.nodeName(j=f.childNodes[e],"tbody")&&!j.childNodes.length&&f.removeChild(j)}m.merge(p,h.childNodes),h.textContent="";while(h.firstChild)h.removeChild(h.firstChild);h=o.lastChild}else p.push(b.createTextNode(f));h&&o.removeChild(h),k.appendChecked||m.grep(ua(p,"input"),va),q=0;while(f=p[q++])if((!d||-1===m.inArray(f,d))&&(g=m.contains(f.ownerDocument,f),h=ua(o.appendChild(f),"script"),g&&za(h),c)){e=0;while(f=h[e++])oa.test(f.type||"")&&c.push(f)}return h=null,o},cleanData:function(a,b){for(var d,e,f,g,h=0,i=m.expando,j=m.cache,l=k.deleteExpando,n=m.event.special;null!=(d=a[h]);h++)if((b||m.acceptData(d))&&(f=d[i],g=f&&j[f])){if(g.events)for(e in g.events)n[e]?m.event.remove(d,e):m.removeEvent(d,e,g.handle);j[f]&&(delete j[f],l?delete d[i]:typeof d.removeAttribute!==K?d.removeAttribute(i):d[i]=null,c.push(f))}}}),m.fn.extend({text:function(a){return V(this,function(a){return void 0===a?m.text(this):this.empty().append((this[0]&&this[0].ownerDocument||y).createTextNode(a))},null,a,arguments.length)},append:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.appendChild(a)}})},prepend:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.insertBefore(a,b.firstChild)}})},before:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this)})},after:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this.nextSibling)})},remove:function(a,b){for(var c,d=a?m.filter(a,this):this,e=0;null!=(c=d[e]);e++)b||1!==c.nodeType||m.cleanData(ua(c)),c.parentNode&&(b&&m.contains(c.ownerDocument,c)&&za(ua(c,"script")),c.parentNode.removeChild(c));return this},empty:function(){for(var a,b=0;null!=(a=this[b]);b++){1===a.nodeType&&m.cleanData(ua(a,!1));while(a.firstChild)a.removeChild(a.firstChild);a.options&&m.nodeName(a,"select")&&(a.options.length=0)}return this},clone:function(a,b){return a=null==a?!1:a,b=null==b?a:b,this.map(function(){return m.clone(this,a,b)})},html:function(a){return V(this,function(a){var b=this[0]||{},c=0,d=this.length;if(void 0===a)return 1===b.nodeType?b.innerHTML.replace(fa,""):void 0;if(!("string"!=typeof a||ma.test(a)||!k.htmlSerialize&&ga.test(a)||!k.leadingWhitespace&&ha.test(a)||ra[(ja.exec(a)||["",""])[1].toLowerCase()])){a=a.replace(ia,"<$1></$2>");try{for(;d>c;c++)b=this[c]||{},1===b.nodeType&&(m.cleanData(ua(b,!1)),b.innerHTML=a);b=0}catch(e){}}b&&this.empty().append(a)},null,a,arguments.length)},replaceWith:function(){var a=arguments[0];return this.domManip(arguments,function(b){a=this.parentNode,m.cleanData(ua(this)),a&&a.replaceChild(b,this)}),a&&(a.length||a.nodeType)?this:this.remove()},detach:function(a){return this.remove(a,!0)},domManip:function(a,b){a=e.apply([],a);var c,d,f,g,h,i,j=0,l=this.length,n=this,o=l-1,p=a[0],q=m.isFunction(p);if(q||l>1&&"string"==typeof p&&!k.checkClone&&na.test(p))return this.each(function(c){var d=n.eq(c);q&&(a[0]=p.call(this,c,d.html())),d.domManip(a,b)});if(l&&(i=m.buildFragment(a,this[0].ownerDocument,!1,this),c=i.firstChild,1===i.childNodes.length&&(i=c),c)){for(g=m.map(ua(i,"script"),xa),f=g.length;l>j;j++)d=i,j!==o&&(d=m.clone(d,!0,!0),f&&m.merge(g,ua(d,"script"))),b.call(this[j],d,j);if(f)for(h=g[g.length-1].ownerDocument,m.map(g,ya),j=0;f>j;j++)d=g[j],oa.test(d.type||"")&&!m._data(d,"globalEval")&&m.contains(h,d)&&(d.src?m._evalUrl&&m._evalUrl(d.src):m.globalEval((d.text||d.textContent||d.innerHTML||"").replace(qa,"")));i=c=null}return this}}),m.each({appendTo:"append",prependTo:"prepend",insertBefore:"before",insertAfter:"after",replaceAll:"replaceWith"},function(a,b){m.fn[a]=function(a){for(var c,d=0,e=[],g=m(a),h=g.length-1;h>=d;d++)c=d===h?this:this.clone(!0),m(g[d])[b](c),f.apply(e,c.get());return this.pushStack(e)}});var Ca,Da={};function Ea(b,c){var d,e=m(c.createElement(b)).appendTo(c.body),f=a.getDefaultComputedStyle&&(d=a.getDefaultComputedStyle(e[0]))?d.display:m.css(e[0],"display");return e.detach(),f}function Fa(a){var b=y,c=Da[a];return c||(c=Ea(a,b),"none"!==c&&c||(Ca=(Ca||m("<iframe frameborder='0' width='0' height='0'/>")).appendTo(b.documentElement),b=(Ca[0].contentWindow||Ca[0].contentDocument).document,b.write(),b.close(),c=Ea(a,b),Ca.detach()),Da[a]=c),c}!function(){var a;k.shrinkWrapBlocks=function(){if(null!=a)return a;a=!1;var b,c,d;return c=y.getElementsByTagName("body")[0],c&&c.style?(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:1px;width:1px;zoom:1",b.appendChild(y.createElement("div")).style.width="5px",a=3!==b.offsetWidth),c.removeChild(d),a):void 0}}();var Ga=/^margin/,Ha=new RegExp("^("+S+")(?!px)[a-z%]+$","i"),Ia,Ja,Ka=/^(top|right|bottom|left)$/;a.getComputedStyle?(Ia=function(b){return b.ownerDocument.defaultView.opener?b.ownerDocument.defaultView.getComputedStyle(b,null):a.getComputedStyle(b,null)},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c.getPropertyValue(b)||c[b]:void 0,c&&(""!==g||m.contains(a.ownerDocument,a)||(g=m.style(a,b)),Ha.test(g)&&Ga.test(b)&&(d=h.width,e=h.minWidth,f=h.maxWidth,h.minWidth=h.maxWidth=h.width=g,g=c.width,h.width=d,h.minWidth=e,h.maxWidth=f)),void 0===g?g:g+""}):y.documentElement.currentStyle&&(Ia=function(a){return a.currentStyle},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c[b]:void 0,null==g&&h&&h[b]&&(g=h[b]),Ha.test(g)&&!Ka.test(b)&&(d=h.left,e=a.runtimeStyle,f=e&&e.left,f&&(e.left=a.currentStyle.left),h.left="fontSize"===b?"1em":g,g=h.pixelLeft+"px",h.left=d,f&&(e.left=f)),void 0===g?g:g+""||"auto"});function La(a,b){return{get:function(){var c=a();if(null!=c)return c?void delete this.get:(this.get=b).apply(this,arguments)}}}!function(){var b,c,d,e,f,g,h;if(b=y.createElement("div"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=d&&d.style){c.cssText="float:left;opacity:.5",k.opacity="0.5"===c.opacity,k.cssFloat=!!c.cssFloat,b.style.backgroundClip="content-box",b.cloneNode(!0).style.backgroundClip="",k.clearCloneStyle="content-box"===b.style.backgroundClip,k.boxSizing=""===c.boxSizing||""===c.MozBoxSizing||""===c.WebkitBoxSizing,m.extend(k,{reliableHiddenOffsets:function(){return null==g&&i(),g},boxSizingReliable:function(){return null==f&&i(),f},pixelPosition:function(){return null==e&&i(),e},reliableMarginRight:function(){return null==h&&i(),h}});function i(){var b,c,d,i;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),b.style.cssText="-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;display:block;margin-top:1%;top:1%;border:1px;padding:1px;width:4px;position:absolute",e=f=!1,h=!0,a.getComputedStyle&&(e="1%"!==(a.getComputedStyle(b,null)||{}).top,f="4px"===(a.getComputedStyle(b,null)||{width:"4px"}).width,i=b.appendChild(y.createElement("div")),i.style.cssText=b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:0",i.style.marginRight=i.style.width="0",b.style.width="1px",h=!parseFloat((a.getComputedStyle(i,null)||{}).marginRight),b.removeChild(i)),b.innerHTML="<table><tr><td></td><td>t</td></tr></table>",i=b.getElementsByTagName("td"),i[0].style.cssText="margin:0;border:0;padding:0;display:none",g=0===i[0].offsetHeight,g&&(i[0].style.display="",i[1].style.display="none",g=0===i[0].offsetHeight),c.removeChild(d))}}}(),m.swap=function(a,b,c,d){var e,f,g={};for(f in b)g[f]=a.style[f],a.style[f]=b[f];e=c.apply(a,d||[]);for(f in b)a.style[f]=g[f];return e};var Ma=/alpha\([^)]*\)/i,Na=/opacity\s*=\s*([^)]*)/,Oa=/^(none|table(?!-c[ea]).+)/,Pa=new RegExp("^("+S+")(.*)$","i"),Qa=new RegExp("^([+-])=("+S+")","i"),Ra={position:"absolute",visibility:"hidden",display:"block"},Sa={letterSpacing:"0",fontWeight:"400"},Ta=["Webkit","O","Moz","ms"];function Ua(a,b){if(b in a)return b;var c=b.charAt(0).toUpperCase()+b.slice(1),d=b,e=Ta.length;while(e--)if(b=Ta[e]+c,b in a)return b;return d}function Va(a,b){for(var c,d,e,f=[],g=0,h=a.length;h>g;g++)d=a[g],d.style&&(f[g]=m._data(d,"olddisplay"),c=d.style.display,b?(f[g]||"none"!==c||(d.style.display=""),""===d.style.display&&U(d)&&(f[g]=m._data(d,"olddisplay",Fa(d.nodeName)))):(e=U(d),(c&&"none"!==c||!e)&&m._data(d,"olddisplay",e?c:m.css(d,"display"))));for(g=0;h>g;g++)d=a[g],d.style&&(b&&"none"!==d.style.display&&""!==d.style.display||(d.style.display=b?f[g]||"":"none"));return a}function Wa(a,b,c){var d=Pa.exec(b);return d?Math.max(0,d[1]-(c||0))+(d[2]||"px"):b}function Xa(a,b,c,d,e){for(var f=c===(d?"border":"content")?4:"width"===b?1:0,g=0;4>f;f+=2)"margin"===c&&(g+=m.css(a,c+T[f],!0,e)),d?("content"===c&&(g-=m.css(a,"padding"+T[f],!0,e)),"margin"!==c&&(g-=m.css(a,"border"+T[f]+"Width",!0,e))):(g+=m.css(a,"padding"+T[f],!0,e),"padding"!==c&&(g+=m.css(a,"border"+T[f]+"Width",!0,e)));return g}function Ya(a,b,c){var d=!0,e="width"===b?a.offsetWidth:a.offsetHeight,f=Ia(a),g=k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,f);if(0>=e||null==e){if(e=Ja(a,b,f),(0>e||null==e)&&(e=a.style[b]),Ha.test(e))return e;d=g&&(k.boxSizingReliable()||e===a.style[b]),e=parseFloat(e)||0}return e+Xa(a,b,c||(g?"border":"content"),d,f)+"px"}m.extend({cssHooks:{opacity:{get:function(a,b){if(b){var c=Ja(a,"opacity");return""===c?"1":c}}}},cssNumber:{columnCount:!0,fillOpacity:!0,flexGrow:!0,flexShrink:!0,fontWeight:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,widows:!0,zIndex:!0,zoom:!0},cssProps:{"float":k.cssFloat?"cssFloat":"styleFloat"},style:function(a,b,c,d){if(a&&3!==a.nodeType&&8!==a.nodeType&&a.style){var e,f,g,h=m.camelCase(b),i=a.style;if(b=m.cssProps[h]||(m.cssProps[h]=Ua(i,h)),g=m.cssHooks[b]||m.cssHooks[h],void 0===c)return g&&"get"in g&&void 0!==(e=g.get(a,!1,d))?e:i[b];if(f=typeof c,"string"===f&&(e=Qa.exec(c))&&(c=(e[1]+1)*e[2]+parseFloat(m.css(a,b)),f="number"),null!=c&&c===c&&("number"!==f||m.cssNumber[h]||(c+="px"),k.clearCloneStyle||""!==c||0!==b.indexOf("background")||(i[b]="inherit"),!(g&&"set"in g&&void 0===(c=g.set(a,c,d)))))try{i[b]=c}catch(j){}}},css:function(a,b,c,d){var e,f,g,h=m.camelCase(b);return b=m.cssProps[h]||(m.cssProps[h]=Ua(a.style,h)),g=m.cssHooks[b]||m.cssHooks[h],g&&"get"in g&&(f=g.get(a,!0,c)),void 0===f&&(f=Ja(a,b,d)),"normal"===f&&b in Sa&&(f=Sa[b]),""===c||c?(e=parseFloat(f),c===!0||m.isNumeric(e)?e||0:f):f}}),m.each(["height","width"],function(a,b){m.cssHooks[b]={get:function(a,c,d){return c?Oa.test(m.css(a,"display"))&&0===a.offsetWidth?m.swap(a,Ra,function(){return Ya(a,b,d)}):Ya(a,b,d):void 0},set:function(a,c,d){var e=d&&Ia(a);return Wa(a,c,d?Xa(a,b,d,k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,e),e):0)}}}),k.opacity||(m.cssHooks.opacity={get:function(a,b){return Na.test((b&&a.currentStyle?a.currentStyle.filter:a.style.filter)||"")?.01*parseFloat(RegExp.$1)+"":b?"1":""},set:function(a,b){var c=a.style,d=a.currentStyle,e=m.isNumeric(b)?"alpha(opacity="+100*b+")":"",f=d&&d.filter||c.filter||"";c.zoom=1,(b>=1||""===b)&&""===m.trim(f.replace(Ma,""))&&c.removeAttribute&&(c.removeAttribute("filter"),""===b||d&&!d.filter)||(c.filter=Ma.test(f)?f.replace(Ma,e):f+" "+e)}}),m.cssHooks.marginRight=La(k.reliableMarginRight,function(a,b){return b?m.swap(a,{display:"inline-block"},Ja,[a,"marginRight"]):void 0}),m.each({margin:"",padding:"",border:"Width"},function(a,b){m.cssHooks[a+b]={expand:function(c){for(var d=0,e={},f="string"==typeof c?c.split(" "):[c];4>d;d++)e[a+T[d]+b]=f[d]||f[d-2]||f[0];return e}},Ga.test(a)||(m.cssHooks[a+b].set=Wa)}),m.fn.extend({css:function(a,b){return V(this,function(a,b,c){var d,e,f={},g=0;if(m.isArray(b)){for(d=Ia(a),e=b.length;e>g;g++)f[b[g]]=m.css(a,b[g],!1,d);return f}return void 0!==c?m.style(a,b,c):m.css(a,b)},a,b,arguments.length>1)},show:function(){return Va(this,!0)},hide:function(){return Va(this)},toggle:function(a){return"boolean"==typeof a?a?this.show():this.hide():this.each(function(){U(this)?m(this).show():m(this).hide()})}});function Za(a,b,c,d,e){
return new Za.prototype.init(a,b,c,d,e)}m.Tween=Za,Za.prototype={constructor:Za,init:function(a,b,c,d,e,f){this.elem=a,this.prop=c,this.easing=e||"swing",this.options=b,this.start=this.now=this.cur(),this.end=d,this.unit=f||(m.cssNumber[c]?"":"px")},cur:function(){var a=Za.propHooks[this.prop];return a&&a.get?a.get(this):Za.propHooks._default.get(this)},run:function(a){var b,c=Za.propHooks[this.prop];return this.options.duration?this.pos=b=m.easing[this.easing](a,this.options.duration*a,0,1,this.options.duration):this.pos=b=a,this.now=(this.end-this.start)*b+this.start,this.options.step&&this.options.step.call(this.elem,this.now,this),c&&c.set?c.set(this):Za.propHooks._default.set(this),this}},Za.prototype.init.prototype=Za.prototype,Za.propHooks={_default:{get:function(a){var b;return null==a.elem[a.prop]||a.elem.style&&null!=a.elem.style[a.prop]?(b=m.css(a.elem,a.prop,""),b&&"auto"!==b?b:0):a.elem[a.prop]},set:function(a){m.fx.step[a.prop]?m.fx.step[a.prop](a):a.elem.style&&(null!=a.elem.style[m.cssProps[a.prop]]||m.cssHooks[a.prop])?m.style(a.elem,a.prop,a.now+a.unit):a.elem[a.prop]=a.now}}},Za.propHooks.scrollTop=Za.propHooks.scrollLeft={set:function(a){a.elem.nodeType&&a.elem.parentNode&&(a.elem[a.prop]=a.now)}},m.easing={linear:function(a){return a},swing:function(a){return.5-Math.cos(a*Math.PI)/2}},m.fx=Za.prototype.init,m.fx.step={};var $a,_a,ab=/^(?:toggle|show|hide)$/,bb=new RegExp("^(?:([+-])=|)("+S+")([a-z%]*)$","i"),cb=/queueHooks$/,db=[ib],eb={"*":[function(a,b){var c=this.createTween(a,b),d=c.cur(),e=bb.exec(b),f=e&&e[3]||(m.cssNumber[a]?"":"px"),g=(m.cssNumber[a]||"px"!==f&&+d)&&bb.exec(m.css(c.elem,a)),h=1,i=20;if(g&&g[3]!==f){f=f||g[3],e=e||[],g=+d||1;do h=h||".5",g/=h,m.style(c.elem,a,g+f);while(h!==(h=c.cur()/d)&&1!==h&&--i)}return e&&(g=c.start=+g||+d||0,c.unit=f,c.end=e[1]?g+(e[1]+1)*e[2]:+e[2]),c}]};function fb(){return setTimeout(function(){$a=void 0}),$a=m.now()}function gb(a,b){var c,d={height:a},e=0;for(b=b?1:0;4>e;e+=2-b)c=T[e],d["margin"+c]=d["padding"+c]=a;return b&&(d.opacity=d.width=a),d}function hb(a,b,c){for(var d,e=(eb[b]||[]).concat(eb["*"]),f=0,g=e.length;g>f;f++)if(d=e[f].call(c,b,a))return d}function ib(a,b,c){var d,e,f,g,h,i,j,l,n=this,o={},p=a.style,q=a.nodeType&&U(a),r=m._data(a,"fxshow");c.queue||(h=m._queueHooks(a,"fx"),null==h.unqueued&&(h.unqueued=0,i=h.empty.fire,h.empty.fire=function(){h.unqueued||i()}),h.unqueued++,n.always(function(){n.always(function(){h.unqueued--,m.queue(a,"fx").length||h.empty.fire()})})),1===a.nodeType&&("height"in b||"width"in b)&&(c.overflow=[p.overflow,p.overflowX,p.overflowY],j=m.css(a,"display"),l="none"===j?m._data(a,"olddisplay")||Fa(a.nodeName):j,"inline"===l&&"none"===m.css(a,"float")&&(k.inlineBlockNeedsLayout&&"inline"!==Fa(a.nodeName)?p.zoom=1:p.display="inline-block")),c.overflow&&(p.overflow="hidden",k.shrinkWrapBlocks()||n.always(function(){p.overflow=c.overflow[0],p.overflowX=c.overflow[1],p.overflowY=c.overflow[2]}));for(d in b)if(e=b[d],ab.exec(e)){if(delete b[d],f=f||"toggle"===e,e===(q?"hide":"show")){if("show"!==e||!r||void 0===r[d])continue;q=!0}o[d]=r&&r[d]||m.style(a,d)}else j=void 0;if(m.isEmptyObject(o))"inline"===("none"===j?Fa(a.nodeName):j)&&(p.display=j);else{r?"hidden"in r&&(q=r.hidden):r=m._data(a,"fxshow",{}),f&&(r.hidden=!q),q?m(a).show():n.done(function(){m(a).hide()}),n.done(function(){var b;m._removeData(a,"fxshow");for(b in o)m.style(a,b,o[b])});for(d in o)g=hb(q?r[d]:0,d,n),d in r||(r[d]=g.start,q&&(g.end=g.start,g.start="width"===d||"height"===d?1:0))}}function jb(a,b){var c,d,e,f,g;for(c in a)if(d=m.camelCase(c),e=b[d],f=a[c],m.isArray(f)&&(e=f[1],f=a[c]=f[0]),c!==d&&(a[d]=f,delete a[c]),g=m.cssHooks[d],g&&"expand"in g){f=g.expand(f),delete a[d];for(c in f)c in a||(a[c]=f[c],b[c]=e)}else b[d]=e}function kb(a,b,c){var d,e,f=0,g=db.length,h=m.Deferred().always(function(){delete i.elem}),i=function(){if(e)return!1;for(var b=$a||fb(),c=Math.max(0,j.startTime+j.duration-b),d=c/j.duration||0,f=1-d,g=0,i=j.tweens.length;i>g;g++)j.tweens[g].run(f);return h.notifyWith(a,[j,f,c]),1>f&&i?c:(h.resolveWith(a,[j]),!1)},j=h.promise({elem:a,props:m.extend({},b),opts:m.extend(!0,{specialEasing:{}},c),originalProperties:b,originalOptions:c,startTime:$a||fb(),duration:c.duration,tweens:[],createTween:function(b,c){var d=m.Tween(a,j.opts,b,c,j.opts.specialEasing[b]||j.opts.easing);return j.tweens.push(d),d},stop:function(b){var c=0,d=b?j.tweens.length:0;if(e)return this;for(e=!0;d>c;c++)j.tweens[c].run(1);return b?h.resolveWith(a,[j,b]):h.rejectWith(a,[j,b]),this}}),k=j.props;for(jb(k,j.opts.specialEasing);g>f;f++)if(d=db[f].call(j,a,k,j.opts))return d;return m.map(k,hb,j),m.isFunction(j.opts.start)&&j.opts.start.call(a,j),m.fx.timer(m.extend(i,{elem:a,anim:j,queue:j.opts.queue})),j.progress(j.opts.progress).done(j.opts.done,j.opts.complete).fail(j.opts.fail).always(j.opts.always)}m.Animation=m.extend(kb,{tweener:function(a,b){m.isFunction(a)?(b=a,a=["*"]):a=a.split(" ");for(var c,d=0,e=a.length;e>d;d++)c=a[d],eb[c]=eb[c]||[],eb[c].unshift(b)},prefilter:function(a,b){b?db.unshift(a):db.push(a)}}),m.speed=function(a,b,c){var d=a&&"object"==typeof a?m.extend({},a):{complete:c||!c&&b||m.isFunction(a)&&a,duration:a,easing:c&&b||b&&!m.isFunction(b)&&b};return d.duration=m.fx.off?0:"number"==typeof d.duration?d.duration:d.duration in m.fx.speeds?m.fx.speeds[d.duration]:m.fx.speeds._default,(null==d.queue||d.queue===!0)&&(d.queue="fx"),d.old=d.complete,d.complete=function(){m.isFunction(d.old)&&d.old.call(this),d.queue&&m.dequeue(this,d.queue)},d},m.fn.extend({fadeTo:function(a,b,c,d){return this.filter(U).css("opacity",0).show().end().animate({opacity:b},a,c,d)},animate:function(a,b,c,d){var e=m.isEmptyObject(a),f=m.speed(b,c,d),g=function(){var b=kb(this,m.extend({},a),f);(e||m._data(this,"finish"))&&b.stop(!0)};return g.finish=g,e||f.queue===!1?this.each(g):this.queue(f.queue,g)},stop:function(a,b,c){var d=function(a){var b=a.stop;delete a.stop,b(c)};return"string"!=typeof a&&(c=b,b=a,a=void 0),b&&a!==!1&&this.queue(a||"fx",[]),this.each(function(){var b=!0,e=null!=a&&a+"queueHooks",f=m.timers,g=m._data(this);if(e)g[e]&&g[e].stop&&d(g[e]);else for(e in g)g[e]&&g[e].stop&&cb.test(e)&&d(g[e]);for(e=f.length;e--;)f[e].elem!==this||null!=a&&f[e].queue!==a||(f[e].anim.stop(c),b=!1,f.splice(e,1));(b||!c)&&m.dequeue(this,a)})},finish:function(a){return a!==!1&&(a=a||"fx"),this.each(function(){var b,c=m._data(this),d=c[a+"queue"],e=c[a+"queueHooks"],f=m.timers,g=d?d.length:0;for(c.finish=!0,m.queue(this,a,[]),e&&e.stop&&e.stop.call(this,!0),b=f.length;b--;)f[b].elem===this&&f[b].queue===a&&(f[b].anim.stop(!0),f.splice(b,1));for(b=0;g>b;b++)d[b]&&d[b].finish&&d[b].finish.call(this);delete c.finish})}}),m.each(["toggle","show","hide"],function(a,b){var c=m.fn[b];m.fn[b]=function(a,d,e){return null==a||"boolean"==typeof a?c.apply(this,arguments):this.animate(gb(b,!0),a,d,e)}}),m.each({slideDown:gb("show"),slideUp:gb("hide"),slideToggle:gb("toggle"),fadeIn:{opacity:"show"},fadeOut:{opacity:"hide"},fadeToggle:{opacity:"toggle"}},function(a,b){m.fn[a]=function(a,c,d){return this.animate(b,a,c,d)}}),m.timers=[],m.fx.tick=function(){var a,b=m.timers,c=0;for($a=m.now();c<b.length;c++)a=b[c],a()||b[c]!==a||b.splice(c--,1);b.length||m.fx.stop(),$a=void 0},m.fx.timer=function(a){m.timers.push(a),a()?m.fx.start():m.timers.pop()},m.fx.interval=13,m.fx.start=function(){_a||(_a=setInterval(m.fx.tick,m.fx.interval))},m.fx.stop=function(){clearInterval(_a),_a=null},m.fx.speeds={slow:600,fast:200,_default:400},m.fn.delay=function(a,b){return a=m.fx?m.fx.speeds[a]||a:a,b=b||"fx",this.queue(b,function(b,c){var d=setTimeout(b,a);c.stop=function(){clearTimeout(d)}})},function(){var a,b,c,d,e;b=y.createElement("div"),b.setAttribute("className","t"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=y.createElement("select"),e=c.appendChild(y.createElement("option")),a=b.getElementsByTagName("input")[0],d.style.cssText="top:1px",k.getSetAttribute="t"!==b.className,k.style=/top/.test(d.getAttribute("style")),k.hrefNormalized="/a"===d.getAttribute("href"),k.checkOn=!!a.value,k.optSelected=e.selected,k.enctype=!!y.createElement("form").enctype,c.disabled=!0,k.optDisabled=!e.disabled,a=y.createElement("input"),a.setAttribute("value",""),k.input=""===a.getAttribute("value"),a.value="t",a.setAttribute("type","radio"),k.radioValue="t"===a.value}();var lb=/\r/g;m.fn.extend({val:function(a){var b,c,d,e=this[0];{if(arguments.length)return d=m.isFunction(a),this.each(function(c){var e;1===this.nodeType&&(e=d?a.call(this,c,m(this).val()):a,null==e?e="":"number"==typeof e?e+="":m.isArray(e)&&(e=m.map(e,function(a){return null==a?"":a+""})),b=m.valHooks[this.type]||m.valHooks[this.nodeName.toLowerCase()],b&&"set"in b&&void 0!==b.set(this,e,"value")||(this.value=e))});if(e)return b=m.valHooks[e.type]||m.valHooks[e.nodeName.toLowerCase()],b&&"get"in b&&void 0!==(c=b.get(e,"value"))?c:(c=e.value,"string"==typeof c?c.replace(lb,""):null==c?"":c)}}}),m.extend({valHooks:{option:{get:function(a){var b=m.find.attr(a,"value");return null!=b?b:m.trim(m.text(a))}},select:{get:function(a){for(var b,c,d=a.options,e=a.selectedIndex,f="select-one"===a.type||0>e,g=f?null:[],h=f?e+1:d.length,i=0>e?h:f?e:0;h>i;i++)if(c=d[i],!(!c.selected&&i!==e||(k.optDisabled?c.disabled:null!==c.getAttribute("disabled"))||c.parentNode.disabled&&m.nodeName(c.parentNode,"optgroup"))){if(b=m(c).val(),f)return b;g.push(b)}return g},set:function(a,b){var c,d,e=a.options,f=m.makeArray(b),g=e.length;while(g--)if(d=e[g],m.inArray(m.valHooks.option.get(d),f)>=0)try{d.selected=c=!0}catch(h){d.scrollHeight}else d.selected=!1;return c||(a.selectedIndex=-1),e}}}}),m.each(["radio","checkbox"],function(){m.valHooks[this]={set:function(a,b){return m.isArray(b)?a.checked=m.inArray(m(a).val(),b)>=0:void 0}},k.checkOn||(m.valHooks[this].get=function(a){return null===a.getAttribute("value")?"on":a.value})});var mb,nb,ob=m.expr.attrHandle,pb=/^(?:checked|selected)$/i,qb=k.getSetAttribute,rb=k.input;m.fn.extend({attr:function(a,b){return V(this,m.attr,a,b,arguments.length>1)},removeAttr:function(a){return this.each(function(){m.removeAttr(this,a)})}}),m.extend({attr:function(a,b,c){var d,e,f=a.nodeType;if(a&&3!==f&&8!==f&&2!==f)return typeof a.getAttribute===K?m.prop(a,b,c):(1===f&&m.isXMLDoc(a)||(b=b.toLowerCase(),d=m.attrHooks[b]||(m.expr.match.bool.test(b)?nb:mb)),void 0===c?d&&"get"in d&&null!==(e=d.get(a,b))?e:(e=m.find.attr(a,b),null==e?void 0:e):null!==c?d&&"set"in d&&void 0!==(e=d.set(a,c,b))?e:(a.setAttribute(b,c+""),c):void m.removeAttr(a,b))},removeAttr:function(a,b){var c,d,e=0,f=b&&b.match(E);if(f&&1===a.nodeType)while(c=f[e++])d=m.propFix[c]||c,m.expr.match.bool.test(c)?rb&&qb||!pb.test(c)?a[d]=!1:a[m.camelCase("default-"+c)]=a[d]=!1:m.attr(a,c,""),a.removeAttribute(qb?c:d)},attrHooks:{type:{set:function(a,b){if(!k.radioValue&&"radio"===b&&m.nodeName(a,"input")){var c=a.value;return a.setAttribute("type",b),c&&(a.value=c),b}}}}}),nb={set:function(a,b,c){return b===!1?m.removeAttr(a,c):rb&&qb||!pb.test(c)?a.setAttribute(!qb&&m.propFix[c]||c,c):a[m.camelCase("default-"+c)]=a[c]=!0,c}},m.each(m.expr.match.bool.source.match(/\w+/g),function(a,b){var c=ob[b]||m.find.attr;ob[b]=rb&&qb||!pb.test(b)?function(a,b,d){var e,f;return d||(f=ob[b],ob[b]=e,e=null!=c(a,b,d)?b.toLowerCase():null,ob[b]=f),e}:function(a,b,c){return c?void 0:a[m.camelCase("default-"+b)]?b.toLowerCase():null}}),rb&&qb||(m.attrHooks.value={set:function(a,b,c){return m.nodeName(a,"input")?void(a.defaultValue=b):mb&&mb.set(a,b,c)}}),qb||(mb={set:function(a,b,c){var d=a.getAttributeNode(c);return d||a.setAttributeNode(d=a.ownerDocument.createAttribute(c)),d.value=b+="","value"===c||b===a.getAttribute(c)?b:void 0}},ob.id=ob.name=ob.coords=function(a,b,c){var d;return c?void 0:(d=a.getAttributeNode(b))&&""!==d.value?d.value:null},m.valHooks.button={get:function(a,b){var c=a.getAttributeNode(b);return c&&c.specified?c.value:void 0},set:mb.set},m.attrHooks.contenteditable={set:function(a,b,c){mb.set(a,""===b?!1:b,c)}},m.each(["width","height"],function(a,b){m.attrHooks[b]={set:function(a,c){return""===c?(a.setAttribute(b,"auto"),c):void 0}}})),k.style||(m.attrHooks.style={get:function(a){return a.style.cssText||void 0},set:function(a,b){return a.style.cssText=b+""}});var sb=/^(?:input|select|textarea|button|object)$/i,tb=/^(?:a|area)$/i;m.fn.extend({prop:function(a,b){return V(this,m.prop,a,b,arguments.length>1)},removeProp:function(a){return a=m.propFix[a]||a,this.each(function(){try{this[a]=void 0,delete this[a]}catch(b){}})}}),m.extend({propFix:{"for":"htmlFor","class":"className"},prop:function(a,b,c){var d,e,f,g=a.nodeType;if(a&&3!==g&&8!==g&&2!==g)return f=1!==g||!m.isXMLDoc(a),f&&(b=m.propFix[b]||b,e=m.propHooks[b]),void 0!==c?e&&"set"in e&&void 0!==(d=e.set(a,c,b))?d:a[b]=c:e&&"get"in e&&null!==(d=e.get(a,b))?d:a[b]},propHooks:{tabIndex:{get:function(a){var b=m.find.attr(a,"tabindex");return b?parseInt(b,10):sb.test(a.nodeName)||tb.test(a.nodeName)&&a.href?0:-1}}}}),k.hrefNormalized||m.each(["href","src"],function(a,b){m.propHooks[b]={get:function(a){return a.getAttribute(b,4)}}}),k.optSelected||(m.propHooks.selected={get:function(a){var b=a.parentNode;return b&&(b.selectedIndex,b.parentNode&&b.parentNode.selectedIndex),null}}),m.each(["tabIndex","readOnly","maxLength","cellSpacing","cellPadding","rowSpan","colSpan","useMap","frameBorder","contentEditable"],function(){m.propFix[this.toLowerCase()]=this}),k.enctype||(m.propFix.enctype="encoding");var ub=/[\t\r\n\f]/g;m.fn.extend({addClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j="string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).addClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):" ")){f=0;while(e=b[f++])d.indexOf(" "+e+" ")<0&&(d+=e+" ");g=m.trim(d),c.className!==g&&(c.className=g)}return this},removeClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j=0===arguments.length||"string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).removeClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):"")){f=0;while(e=b[f++])while(d.indexOf(" "+e+" ")>=0)d=d.replace(" "+e+" "," ");g=a?m.trim(d):"",c.className!==g&&(c.className=g)}return this},toggleClass:function(a,b){var c=typeof a;return"boolean"==typeof b&&"string"===c?b?this.addClass(a):this.removeClass(a):this.each(m.isFunction(a)?function(c){m(this).toggleClass(a.call(this,c,this.className,b),b)}:function(){if("string"===c){var b,d=0,e=m(this),f=a.match(E)||[];while(b=f[d++])e.hasClass(b)?e.removeClass(b):e.addClass(b)}else(c===K||"boolean"===c)&&(this.className&&m._data(this,"__className__",this.className),this.className=this.className||a===!1?"":m._data(this,"__className__")||"")})},hasClass:function(a){for(var b=" "+a+" ",c=0,d=this.length;d>c;c++)if(1===this[c].nodeType&&(" "+this[c].className+" ").replace(ub," ").indexOf(b)>=0)return!0;return!1}}),m.each("blur focus focusin focusout load resize scroll unload click dblclick mousedown mouseup mousemove mouseover mouseout mouseenter mouseleave change select submit keydown keypress keyup error contextmenu".split(" "),function(a,b){m.fn[b]=function(a,c){return arguments.length>0?this.on(b,null,a,c):this.trigger(b)}}),m.fn.extend({hover:function(a,b){return this.mouseenter(a).mouseleave(b||a)},bind:function(a,b,c){return this.on(a,null,b,c)},unbind:function(a,b){return this.off(a,null,b)},delegate:function(a,b,c,d){return this.on(b,a,c,d)},undelegate:function(a,b,c){return 1===arguments.length?this.off(a,"**"):this.off(b,a||"**",c)}});var vb=m.now(),wb=/\?/,xb=/(,)|(\[|{)|(}|])|"(?:[^"\\\r\n]|\\["\\\/bfnrt]|\\u[\da-fA-F]{4})*"\s*:?|true|false|null|-?(?!0\d)\d+(?:\.\d+|)(?:[eE][+-]?\d+|)/g;m.parseJSON=function(b){if(a.JSON&&a.JSON.parse)return a.JSON.parse(b+"");var c,d=null,e=m.trim(b+"");return e&&!m.trim(e.replace(xb,function(a,b,e,f){return c&&b&&(d=0),0===d?a:(c=e||b,d+=!f-!e,"")}))?Function("return "+e)():m.error("Invalid JSON: "+b)},m.parseXML=function(b){var c,d;if(!b||"string"!=typeof b)return null;try{a.DOMParser?(d=new DOMParser,c=d.parseFromString(b,"text/xml")):(c=new ActiveXObject("Microsoft.XMLDOM"),c.async="false",c.loadXML(b))}catch(e){c=void 0}return c&&c.documentElement&&!c.getElementsByTagName("parsererror").length||m.error("Invalid XML: "+b),c};var yb,zb,Ab=/#.*$/,Bb=/([?&])_=[^&]*/,Cb=/^(.*?):[ \t]*([^\r\n]*)\r?$/gm,Db=/^(?:about|app|app-storage|.+-extension|file|res|widget):$/,Eb=/^(?:GET|HEAD)$/,Fb=/^\/\//,Gb=/^([\w.+-]+:)(?:\/\/(?:[^\/?#]*@|)([^\/?#:]*)(?::(\d+)|)|)/,Hb={},Ib={},Jb="*/".concat("*");try{zb=location.href}catch(Kb){zb=y.createElement("a"),zb.href="",zb=zb.href}yb=Gb.exec(zb.toLowerCase())||[];function Lb(a){return function(b,c){"string"!=typeof b&&(c=b,b="*");var d,e=0,f=b.toLowerCase().match(E)||[];if(m.isFunction(c))while(d=f[e++])"+"===d.charAt(0)?(d=d.slice(1)||"*",(a[d]=a[d]||[]).unshift(c)):(a[d]=a[d]||[]).push(c)}}function Mb(a,b,c,d){var e={},f=a===Ib;function g(h){var i;return e[h]=!0,m.each(a[h]||[],function(a,h){var j=h(b,c,d);return"string"!=typeof j||f||e[j]?f?!(i=j):void 0:(b.dataTypes.unshift(j),g(j),!1)}),i}return g(b.dataTypes[0])||!e["*"]&&g("*")}function Nb(a,b){var c,d,e=m.ajaxSettings.flatOptions||{};for(d in b)void 0!==b[d]&&((e[d]?a:c||(c={}))[d]=b[d]);return c&&m.extend(!0,a,c),a}function Ob(a,b,c){var d,e,f,g,h=a.contents,i=a.dataTypes;while("*"===i[0])i.shift(),void 0===e&&(e=a.mimeType||b.getResponseHeader("Content-Type"));if(e)for(g in h)if(h[g]&&h[g].test(e)){i.unshift(g);break}if(i[0]in c)f=i[0];else{for(g in c){if(!i[0]||a.converters[g+" "+i[0]]){f=g;break}d||(d=g)}f=f||d}return f?(f!==i[0]&&i.unshift(f),c[f]):void 0}function Pb(a,b,c,d){var e,f,g,h,i,j={},k=a.dataTypes.slice();if(k[1])for(g in a.converters)j[g.toLowerCase()]=a.converters[g];f=k.shift();while(f)if(a.responseFields[f]&&(c[a.responseFields[f]]=b),!i&&d&&a.dataFilter&&(b=a.dataFilter(b,a.dataType)),i=f,f=k.shift())if("*"===f)f=i;else if("*"!==i&&i!==f){if(g=j[i+" "+f]||j["* "+f],!g)for(e in j)if(h=e.split(" "),h[1]===f&&(g=j[i+" "+h[0]]||j["* "+h[0]])){g===!0?g=j[e]:j[e]!==!0&&(f=h[0],k.unshift(h[1]));break}if(g!==!0)if(g&&a["throws"])b=g(b);else try{b=g(b)}catch(l){return{state:"parsererror",error:g?l:"No conversion from "+i+" to "+f}}}return{state:"success",data:b}}m.extend({active:0,lastModified:{},etag:{},ajaxSettings:{url:zb,type:"GET",isLocal:Db.test(yb[1]),global:!0,processData:!0,async:!0,contentType:"application/x-www-form-urlencoded; charset=UTF-8",accepts:{"*":Jb,text:"text/plain",html:"text/html",xml:"application/xml, text/xml",json:"application/json, text/javascript"},contents:{xml:/xml/,html:/html/,json:/json/},responseFields:{xml:"responseXML",text:"responseText",json:"responseJSON"},converters:{"* text":String,"text html":!0,"text json":m.parseJSON,"text xml":m.parseXML},flatOptions:{url:!0,context:!0}},ajaxSetup:function(a,b){return b?Nb(Nb(a,m.ajaxSettings),b):Nb(m.ajaxSettings,a)},ajaxPrefilter:Lb(Hb),ajaxTransport:Lb(Ib),ajax:function(a,b){"object"==typeof a&&(b=a,a=void 0),b=b||{};var c,d,e,f,g,h,i,j,k=m.ajaxSetup({},b),l=k.context||k,n=k.context&&(l.nodeType||l.jquery)?m(l):m.event,o=m.Deferred(),p=m.Callbacks("once memory"),q=k.statusCode||{},r={},s={},t=0,u="canceled",v={readyState:0,getResponseHeader:function(a){var b;if(2===t){if(!j){j={};while(b=Cb.exec(f))j[b[1].toLowerCase()]=b[2]}b=j[a.toLowerCase()]}return null==b?null:b},getAllResponseHeaders:function(){return 2===t?f:null},setRequestHeader:function(a,b){var c=a.toLowerCase();return t||(a=s[c]=s[c]||a,r[a]=b),this},overrideMimeType:function(a){return t||(k.mimeType=a),this},statusCode:function(a){var b;if(a)if(2>t)for(b in a)q[b]=[q[b],a[b]];else v.always(a[v.status]);return this},abort:function(a){var b=a||u;return i&&i.abort(b),x(0,b),this}};if(o.promise(v).complete=p.add,v.success=v.done,v.error=v.fail,k.url=((a||k.url||zb)+"").replace(Ab,"").replace(Fb,yb[1]+"//"),k.type=b.method||b.type||k.method||k.type,k.dataTypes=m.trim(k.dataType||"*").toLowerCase().match(E)||[""],null==k.crossDomain&&(c=Gb.exec(k.url.toLowerCase()),k.crossDomain=!(!c||c[1]===yb[1]&&c[2]===yb[2]&&(c[3]||("http:"===c[1]?"80":"443"))===(yb[3]||("http:"===yb[1]?"80":"443")))),k.data&&k.processData&&"string"!=typeof k.data&&(k.data=m.param(k.data,k.traditional)),Mb(Hb,k,b,v),2===t)return v;h=m.event&&k.global,h&&0===m.active++&&m.event.trigger("ajaxStart"),k.type=k.type.toUpperCase(),k.hasContent=!Eb.test(k.type),e=k.url,k.hasContent||(k.data&&(e=k.url+=(wb.test(e)?"&":"?")+k.data,delete k.data),k.cache===!1&&(k.url=Bb.test(e)?e.replace(Bb,"$1_="+vb++):e+(wb.test(e)?"&":"?")+"_="+vb++)),k.ifModified&&(m.lastModified[e]&&v.setRequestHeader("If-Modified-Since",m.lastModified[e]),m.etag[e]&&v.setRequestHeader("If-None-Match",m.etag[e])),(k.data&&k.hasContent&&k.contentType!==!1||b.contentType)&&v.setRequestHeader("Content-Type",k.contentType),v.setRequestHeader("Accept",k.dataTypes[0]&&k.accepts[k.dataTypes[0]]?k.accepts[k.dataTypes[0]]+("*"!==k.dataTypes[0]?", "+Jb+"; q=0.01":""):k.accepts["*"]);for(d in k.headers)v.setRequestHeader(d,k.headers[d]);if(k.beforeSend&&(k.beforeSend.call(l,v,k)===!1||2===t))return v.abort();u="abort";for(d in{success:1,error:1,complete:1})v[d](k[d]);if(i=Mb(Ib,k,b,v)){v.readyState=1,h&&n.trigger("ajaxSend",[v,k]),k.async&&k.timeout>0&&(g=setTimeout(function(){v.abort("timeout")},k.timeout));try{t=1,i.send(r,x)}catch(w){if(!(2>t))throw w;x(-1,w)}}else x(-1,"No Transport");function x(a,b,c,d){var j,r,s,u,w,x=b;2!==t&&(t=2,g&&clearTimeout(g),i=void 0,f=d||"",v.readyState=a>0?4:0,j=a>=200&&300>a||304===a,c&&(u=Ob(k,v,c)),u=Pb(k,u,v,j),j?(k.ifModified&&(w=v.getResponseHeader("Last-Modified"),w&&(m.lastModified[e]=w),w=v.getResponseHeader("etag"),w&&(m.etag[e]=w)),204===a||"HEAD"===k.type?x="nocontent":304===a?x="notmodified":(x=u.state,r=u.data,s=u.error,j=!s)):(s=x,(a||!x)&&(x="error",0>a&&(a=0))),v.status=a,v.statusText=(b||x)+"",j?o.resolveWith(l,[r,x,v]):o.rejectWith(l,[v,x,s]),v.statusCode(q),q=void 0,h&&n.trigger(j?"ajaxSuccess":"ajaxError",[v,k,j?r:s]),p.fireWith(l,[v,x]),h&&(n.trigger("ajaxComplete",[v,k]),--m.active||m.event.trigger("ajaxStop")))}return v},getJSON:function(a,b,c){return m.get(a,b,c,"json")},getScript:function(a,b){return m.get(a,void 0,b,"script")}}),m.each(["get","post"],function(a,b){m[b]=function(a,c,d,e){return m.isFunction(c)&&(e=e||d,d=c,c=void 0),m.ajax({url:a,type:b,dataType:e,data:c,success:d})}}),m._evalUrl=function(a){return m.ajax({url:a,type:"GET",dataType:"script",async:!1,global:!1,"throws":!0})},m.fn.extend({wrapAll:function(a){if(m.isFunction(a))return this.each(function(b){m(this).wrapAll(a.call(this,b))});if(this[0]){var b=m(a,this[0].ownerDocument).eq(0).clone(!0);this[0].parentNode&&b.insertBefore(this[0]),b.map(function(){var a=this;while(a.firstChild&&1===a.firstChild.nodeType)a=a.firstChild;return a}).append(this)}return this},wrapInner:function(a){return this.each(m.isFunction(a)?function(b){m(this).wrapInner(a.call(this,b))}:function(){var b=m(this),c=b.contents();c.length?c.wrapAll(a):b.append(a)})},wrap:function(a){var b=m.isFunction(a);return this.each(function(c){m(this).wrapAll(b?a.call(this,c):a)})},unwrap:function(){return this.parent().each(function(){m.nodeName(this,"body")||m(this).replaceWith(this.childNodes)}).end()}}),m.expr.filters.hidden=function(a){return a.offsetWidth<=0&&a.offsetHeight<=0||!k.reliableHiddenOffsets()&&"none"===(a.style&&a.style.display||m.css(a,"display"))},m.expr.filters.visible=function(a){return!m.expr.filters.hidden(a)};var Qb=/%20/g,Rb=/\[\]$/,Sb=/\r?\n/g,Tb=/^(?:submit|button|image|reset|file)$/i,Ub=/^(?:input|select|textarea|keygen)/i;function Vb(a,b,c,d){var e;if(m.isArray(b))m.each(b,function(b,e){c||Rb.test(a)?d(a,e):Vb(a+"["+("object"==typeof e?b:"")+"]",e,c,d)});else if(c||"object"!==m.type(b))d(a,b);else for(e in b)Vb(a+"["+e+"]",b[e],c,d)}m.param=function(a,b){var c,d=[],e=function(a,b){b=m.isFunction(b)?b():null==b?"":b,d[d.length]=encodeURIComponent(a)+"="+encodeURIComponent(b)};if(void 0===b&&(b=m.ajaxSettings&&m.ajaxSettings.traditional),m.isArray(a)||a.jquery&&!m.isPlainObject(a))m.each(a,function(){e(this.name,this.value)});else for(c in a)Vb(c,a[c],b,e);return d.join("&").replace(Qb,"+")},m.fn.extend({serialize:function(){return m.param(this.serializeArray())},serializeArray:function(){return this.map(function(){var a=m.prop(this,"elements");return a?m.makeArray(a):this}).filter(function(){var a=this.type;return this.name&&!m(this).is(":disabled")&&Ub.test(this.nodeName)&&!Tb.test(a)&&(this.checked||!W.test(a))}).map(function(a,b){var c=m(this).val();return null==c?null:m.isArray(c)?m.map(c,function(a){return{name:b.name,value:a.replace(Sb,"\r\n")}}):{name:b.name,value:c.replace(Sb,"\r\n")}}).get()}}),m.ajaxSettings.xhr=void 0!==a.ActiveXObject?function(){return!this.isLocal&&/^(get|post|head|put|delete|options)$/i.test(this.type)&&Zb()||$b()}:Zb;var Wb=0,Xb={},Yb=m.ajaxSettings.xhr();a.attachEvent&&a.attachEvent("onunload",function(){for(var a in Xb)Xb[a](void 0,!0)}),k.cors=!!Yb&&"withCredentials"in Yb,Yb=k.ajax=!!Yb,Yb&&m.ajaxTransport(function(a){if(!a.crossDomain||k.cors){var b;return{send:function(c,d){var e,f=a.xhr(),g=++Wb;if(f.open(a.type,a.url,a.async,a.username,a.password),a.xhrFields)for(e in a.xhrFields)f[e]=a.xhrFields[e];a.mimeType&&f.overrideMimeType&&f.overrideMimeType(a.mimeType),a.crossDomain||c["X-Requested-With"]||(c["X-Requested-With"]="XMLHttpRequest");for(e in c)void 0!==c[e]&&f.setRequestHeader(e,c[e]+"");f.send(a.hasContent&&a.data||null),b=function(c,e){var h,i,j;if(b&&(e||4===f.readyState))if(delete Xb[g],b=void 0,f.onreadystatechange=m.noop,e)4!==f.readyState&&f.abort();else{j={},h=f.status,"string"==typeof f.responseText&&(j.text=f.responseText);try{i=f.statusText}catch(k){i=""}h||!a.isLocal||a.crossDomain?1223===h&&(h=204):h=j.text?200:404}j&&d(h,i,j,f.getAllResponseHeaders())},a.async?4===f.readyState?setTimeout(b):f.onreadystatechange=Xb[g]=b:b()},abort:function(){b&&b(void 0,!0)}}}});function Zb(){try{return new a.XMLHttpRequest}catch(b){}}function $b(){try{return new a.ActiveXObject("Microsoft.XMLHTTP")}catch(b){}}m.ajaxSetup({accepts:{script:"text/javascript, application/javascript, application/ecmascript, application/x-ecmascript"},contents:{script:/(?:java|ecma)script/},converters:{"text script":function(a){return m.globalEval(a),a}}}),m.ajaxPrefilter("script",function(a){void 0===a.cache&&(a.cache=!1),a.crossDomain&&(a.type="GET",a.global=!1)}),m.ajaxTransport("script",function(a){if(a.crossDomain){var b,c=y.head||m("head")[0]||y.documentElement;return{send:function(d,e){b=y.createElement("script"),b.async=!0,a.scriptCharset&&(b.charset=a.scriptCharset),b.src=a.url,b.onload=b.onreadystatechange=function(a,c){(c||!b.readyState||/loaded|complete/.test(b.readyState))&&(b.onload=b.onreadystatechange=null,b.parentNode&&b.parentNode.removeChild(b),b=null,c||e(200,"success"))},c.insertBefore(b,c.firstChild)},abort:function(){b&&b.onload(void 0,!0)}}}});var _b=[],ac=/(=)\?(?=&|$)|\?\?/;m.ajaxSetup({jsonp:"callback",jsonpCallback:function(){var a=_b.pop()||m.expando+"_"+vb++;return this[a]=!0,a}}),m.ajaxPrefilter("json jsonp",function(b,c,d){var e,f,g,h=b.jsonp!==!1&&(ac.test(b.url)?"url":"string"==typeof b.data&&!(b.contentType||"").indexOf("application/x-www-form-urlencoded")&&ac.test(b.data)&&"data");return h||"jsonp"===b.dataTypes[0]?(e=b.jsonpCallback=m.isFunction(b.jsonpCallback)?b.jsonpCallback():b.jsonpCallback,h?b[h]=b[h].replace(ac,"$1"+e):b.jsonp!==!1&&(b.url+=(wb.test(b.url)?"&":"?")+b.jsonp+"="+e),b.converters["script json"]=function(){return g||m.error(e+" was not called"),g[0]},b.dataTypes[0]="json",f=a[e],a[e]=function(){g=arguments},d.always(function(){a[e]=f,b[e]&&(b.jsonpCallback=c.jsonpCallback,_b.push(e)),g&&m.isFunction(f)&&f(g[0]),g=f=void 0}),"script"):void 0}),m.parseHTML=function(a,b,c){if(!a||"string"!=typeof a)return null;"boolean"==typeof b&&(c=b,b=!1),b=b||y;var d=u.exec(a),e=!c&&[];return d?[b.createElement(d[1])]:(d=m.buildFragment([a],b,e),e&&e.length&&m(e).remove(),m.merge([],d.childNodes))};var bc=m.fn.load;m.fn.load=function(a,b,c){if("string"!=typeof a&&bc)return bc.apply(this,arguments);var d,e,f,g=this,h=a.indexOf(" ");return h>=0&&(d=m.trim(a.slice(h,a.length)),a=a.slice(0,h)),m.isFunction(b)?(c=b,b=void 0):b&&"object"==typeof b&&(f="POST"),g.length>0&&m.ajax({url:a,type:f,dataType:"html",data:b}).done(function(a){e=arguments,g.html(d?m("<div>").append(m.parseHTML(a)).find(d):a)}).complete(c&&function(a,b){g.each(c,e||[a.responseText,b,a])}),this},m.each(["ajaxStart","ajaxStop","ajaxComplete","ajaxError","ajaxSuccess","ajaxSend"],function(a,b){m.fn[b]=function(a){return this.on(b,a)}}),m.expr.filters.animated=function(a){return m.grep(m.timers,function(b){return a===b.elem}).length};var cc=a.document.documentElement;function dc(a){return m.isWindow(a)?a:9===a.nodeType?a.defaultView||a.parentWindow:!1}m.offset={setOffset:function(a,b,c){var d,e,f,g,h,i,j,k=m.css(a,"position"),l=m(a),n={};"static"===k&&(a.style.position="relative"),h=l.offset(),f=m.css(a,"top"),i=m.css(a,"left"),j=("absolute"===k||"fixed"===k)&&m.inArray("auto",[f,i])>-1,j?(d=l.position(),g=d.top,e=d.left):(g=parseFloat(f)||0,e=parseFloat(i)||0),m.isFunction(b)&&(b=b.call(a,c,h)),null!=b.top&&(n.top=b.top-h.top+g),null!=b.left&&(n.left=b.left-h.left+e),"using"in b?b.using.call(a,n):l.css(n)}},m.fn.extend({offset:function(a){if(arguments.length)return void 0===a?this:this.each(function(b){m.offset.setOffset(this,a,b)});var b,c,d={top:0,left:0},e=this[0],f=e&&e.ownerDocument;if(f)return b=f.documentElement,m.contains(b,e)?(typeof e.getBoundingClientRect!==K&&(d=e.getBoundingClientRect()),c=dc(f),{top:d.top+(c.pageYOffset||b.scrollTop)-(b.clientTop||0),left:d.left+(c.pageXOffset||b.scrollLeft)-(b.clientLeft||0)}):d},position:function(){if(this[0]){var a,b,c={top:0,left:0},d=this[0];return"fixed"===m.css(d,"position")?b=d.getBoundingClientRect():(a=this.offsetParent(),b=this.offset(),m.nodeName(a[0],"html")||(c=a.offset()),c.top+=m.css(a[0],"borderTopWidth",!0),c.left+=m.css(a[0],"borderLeftWidth",!0)),{top:b.top-c.top-m.css(d,"marginTop",!0),left:b.left-c.left-m.css(d,"marginLeft",!0)}}},offsetParent:function(){return this.map(function(){var a=this.offsetParent||cc;while(a&&!m.nodeName(a,"html")&&"static"===m.css(a,"position"))a=a.offsetParent;return a||cc})}}),m.each({scrollLeft:"pageXOffset",scrollTop:"pageYOffset"},function(a,b){var c=/Y/.test(b);m.fn[a]=function(d){return V(this,function(a,d,e){var f=dc(a);return void 0===e?f?b in f?f[b]:f.document.documentElement[d]:a[d]:void(f?f.scrollTo(c?m(f).scrollLeft():e,c?e:m(f).scrollTop()):a[d]=e)},a,d,arguments.length,null)}}),m.each(["top","left"],function(a,b){m.cssHooks[b]=La(k.pixelPosition,function(a,c){return c?(c=Ja(a,b),Ha.test(c)?m(a).position()[b]+"px":c):void 0})}),m.each({Height:"height",Width:"width"},function(a,b){m.each({padding:"inner"+a,content:b,"":"outer"+a},function(c,d){m.fn[d]=function(d,e){var f=arguments.length&&(c||"boolean"!=typeof d),g=c||(d===!0||e===!0?"margin":"border");return V(this,function(b,c,d){var e;return m.isWindow(b)?b.document.documentElement["client"+a]:9===b.nodeType?(e=b.documentElement,Math.max(b.body["scroll"+a],e["scroll"+a],b.body["offset"+a],e["offset"+a],e["client"+a])):void 0===d?m.css(b,c,g):m.style(b,c,d,g)},b,f?d:void 0,f,null)}})}),m.fn.size=function(){return this.length},m.fn.andSelf=m.fn.addBack,"function"==typeof define&&define.amd&&define("jquery",[],function(){return m});var ec=a.jQuery,fc=a.$;return m.noConflict=function(b){return a.$===m&&(a.$=fc),b&&a.jQuery===m&&(a.jQuery=ec),m},typeof b===K&&(a.jQuery=a.$=m),m});
</script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<style type="text/css">@font-face {
font-family: 'Roboto';
font-style: normal;
font-weight: 300;
src: url(data:application/x-font-truetype;base64,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) format('truetype');
}
@font-face {
font-family: 'Roboto';
font-style: normal;
font-weight: 400;
src: url(data:application/x-font-truetype;base64,AAEAAAASAQAABAAgR0RFRgUwBPIAAHGoAAAATEdQT1PO9uRJAABx9AAADQ5HU1VClCaeUgAAfwQAAACIT1MvMqCnsaYAAGkIAAAAYGNtYXDigyFaAABqUAAAAzhjdnQgJEEG5QAAcCAAAABMZnBnbWf0XKsAAG2IAAABvGdhc3AACAATAABxnAAAAAxnbHlmCBgu+gAAASwAAGImaGRteAQC+OIAAGloAAAA6GhlYWT4RqsOAABlNAAAADZoaGVhCroGfQAAaOQAAAAkaG10eIFaUZ8AAGVsAAADdmxvY2E6/CGoAABjdAAAAb5tYXhwAw4C+QAAY1QAAAAgbmFtZRBvLKkAAHBsAAABEHBvc3T/bQBkAABxfAAAACBwcmVwdKCP7AAAb0QAAADbAAUAZAAAAygFsAADAAYACQAMAA8AcbIMEBEREjmwDBCwANCwDBCwBtCwDBCwCdCwDBCwDdAAsABFWLACLxuxAhw+WbAARViwAC8bsQAQPlmyBAIAERI5sgUCABESObIHAgAREjmyCAIAERI5sQoM9LIMAgAREjmyDQIAERI5sAIQsQ4M9DAxISERIQMRAQERAQMhATUBIQMo/TwCxDb+7v66AQzkAgP+/gEC/f0FsPqkBQf9fQJ3+xECeP1eAl6IAl4AAgCg//UBewWwAAMADAAvALAARViwAi8bsQIcPlmwAEVYsAsvG7ELED5ZsgYFCitYIdgb9FmyAQYCERI5MDEBIwMzAzQ2MhYUBiImAVunDcLJN2w4OGw3AZsEFfqtLT09Wjs7AAIAiAQSAiMGAAAEAAkAGQCwAy+yAgoDERI5sAIvsAfQsAMQsAjQMDEBAyMTMwUDIxMzARUebwGMAQ4ebwGMBXj+mgHuiP6aAe4AAgB3AAAE0wWwABsAHwCPALAARViwDC8bsQwcPlmwAEVYsBAvG7EQHD5ZsABFWLACLxuxAhA+WbAARViwGi8bsRoQPlmyHQwCERI5fLAdLxiyAAMKK1gh2Bv0WbAE0LAdELAG0LAdELAL0LALL7IIAworWCHYG/RZsAsQsA7QsAsQsBLQsAgQsBTQsB0QsBbQsAAQsBjQsAgQsB7QMDEBIQMjEyM1IRMhNSETMwMhEzMDMxUjAzMVIwMjAyETIQL9/vhQj1DvAQlF/v4BHVKPUgEIUpBSzOdF4ftQkJ4BCEX++AGa/mYBmokBYosBoP5gAaD+YIv+non+ZgIjAWIAAAEAbv8wBBEGnAArAGYAsABFWLAJLxuxCRw+WbAARViwIi8bsSIQPlmyAiIJERI5sAkQsAzQsAkQsBDQsAkQshMBCitYIdgb9FmwAhCyGQEKK1gh2Bv0WbAiELAf0LAiELAm0LAiELIpAQorWCHYG/RZMDEBNCYnJiY1NDY3NTMVFhYVIzQmIyIGFRQWBBYWFRQGBxUjNSYmNTMUFjMyNgNYgZnVw7+nlai7uIZyd36FATGrUcu3lLrTuZKGg5YBd1x+M0HRoaTSFNvcF+zNjaZ7bmZ5Y3eeaqnOE7+/EefGi5Z+AAUAaf/rBYMFxQANABoAJgA0ADgAeACwAEVYsAMvG7EDHD5ZsABFWLAjLxuxIxA+WbADELAK0LAKL7IRBAorWCHYG/RZsAMQshgECitYIdgb9FmwIxCwHdCwHS+wIxCyKgQKK1gh2Bv0WbAdELIxBAorWCHYG/RZsjUjAxESObA1L7I3AyMREjmwNy8wMRM0NjMyFhUVFAYjIiY1FxQWMzI2NTU0JiIGFQE0NiAWFRUUBiAmNRcUFjMyNjU1NCYjIgYVBScBF2mng4Wlp4GCqopYSkdXVpRWAjunAQaop/78qopYSkhWV0lHWf4HaQLHaQSYg6qriEeEp6eLB05lYlVJTmZmUvzRg6moi0eDqaeLBk9lY1VKT2RjVPNCBHJCAAMAZf/sBPMFxAAeACcAMwCFALAARViwCS8bsQkcPlmwAEVYsBwvG7EcED5ZsABFWLAYLxuxGBA+WbIiHAkREjmyKgkcERI5sgMiKhESObIQKiIREjmyEQkcERI5shMcCRESObIZHAkREjmyFhEZERI5sBwQsh8BCitYIdgb9FmyIR8RERI5sAkQsjEBCitYIdgb9FkwMRM0NjcmJjU0NjMyFhUUBgcHATY1MxQHFyMnBgYjIiQFMjcBBwYVFBYDFBc3NjY1NCYjIgZldaVhQsSolsRZb2sBRESne9DeYUrHZ9X+/gHXk3r+nSGnmSJ2dkQyZExSYAGHabB1dpBHpryvhViVUk/+fYKf/6j5c0JF4ktwAakYe4J2jgPlYJBTMFc+Q1lvAAEAZwQhAP0GAAAEABAAsAMvsgIFAxESObACLzAxEwMjEzP9FYEBlQWR/pAB3wABAIX+KgKVBmsAEQAJALAOL7AELzAxEzQSEjcXBgIDBxATFhcHJicChXnwgSaSuwkBjVV1JoV57AJP4gGgAVRGenD+NP7jVf5+/uSqYHFKrgFUAAABACb+KgI3BmsAEQAJALAOL7AELzAxARQCAgcnNhITNTQCAic3FhISAjd18YQnmrsCWJ1iJ4TvdwJF3/5n/qZJcXYB8QEvINIBaQEeUHFJ/qr+ZAABABwCYQNVBbAADgAgALAARViwBC8bsQQcPlmwANAZsAAvGLAJ0BmwCS8YMDEBJTcFAzMDJRcFEwcDAycBSv7SLgEuCZkKASku/s3GfLq0fQPXWpdwAVj+o26YW/7xXgEg/udbAAABAE4AkgQ0BLYACwAaALAJL7AA0LAJELIGAQorWCHYG/RZsAPQMDEBIRUhESMRITUhETMCngGW/mq6/moBlroDDa/+NAHMrwGpAAEAHf7eATQA2wAIABcAsAkvsgQFCitYIdgb9FmwANCwAC8wMRMnNjc1MxUUBoZpXgS1Y/7eSIOLp5FlygAAAQAlAh8CDQK2AAMAEQCwAi+yAQEKK1gh2Bv0WTAxASE1IQIN/hgB6AIflwABAJD/9QF2ANEACQAbALAARViwBy8bsQcQPlmyAgUKK1gh2Bv0WTAxNzQ2MhYVFAYiJpA5cjs7cjlhMEBAMC4+PgABABL/gwMQBbAAAwATALAAL7AARViwAi8bsQIcPlkwMRcjATOxnwJgnn0GLQAAAgBz/+wECgXEAA0AGwA5ALAARViwCi8bsQocPlmwAEVYsAMvG7EDED5ZsAoQshEBCitYIdgb9FmwAxCyGAEKK1gh2Bv0WTAxARACIyICAzUQEjMyEhMnNCYjIgYHERQWMzI2NwQK3uzp4ATe7eveA7mEj46CAomLiYUDAm3+u/7EATUBM/cBQQE4/tP+xg3r19be/tjs4dTkAAEAqgAAAtkFtwAGADkAsABFWLAFLxuxBRw+WbAARViwAC8bsQAQPlmyBAAFERI5sAQvsgMBCitYIdgb9FmyAgMFERI5MDEhIxEFNSUzAtm6/osCEh0E0YmoxwAAAQBdAAAEMwXEABcATQCwAEVYsBAvG7EQHD5ZsABFWLAALxuxABA+WbIXAQorWCHYG/RZsALQsgMQFxESObAQELIJAQorWCHYG/RZsBAQsAzQshUXEBESOTAxISE1ATY2NTQmIyIGFSM0JDMyFhUUAQEhBDP8RgH4cFWKc4qZuQED2cvs/u7+egLbhQIwf59VcpKdjMn41bHX/tf+WQABAF7/7AP5BcQAJgB4ALAARViwDS8bsQ0cPlmwAEVYsBkvG7EZED5ZsgANGRESObAAL7LPAAFdsp8AAXGyLwABXbJfAAFysA0QsgYBCitYIdgb9FmwDRCwCdCwABCyJgEKK1gh2Bv0WbITJgAREjmwGRCwHNCwGRCyHwEKK1gh2Bv0WTAxATM2NjUQIyIGFSM0NjMyFhUUBgcWFhUUBCAkNTMUFjMyNjU0JicjAYaLg5b/eI+5/cPO6ntqeIP/AP5m/v+6ln6GjpyTiwMyAoZyAQCJca3l2sJfsiwmsH/E5t62c4qMg3+IAgACADUAAARQBbAACgAOAEkAsABFWLAJLxuxCRw+WbAARViwBC8bsQQQPlmyAQkEERI5sAEvsgIBCitYIdgb9FmwBtCwARCwC9CyCAYLERI5sg0JBBESOTAxATMVIxEjESE1ATMBIREHA4bKyrr9aQKMxf2BAcUWAemX/q4BUm0D8fw5AsooAAEAmv/sBC0FsAAdAGEAsABFWLABLxuxARw+WbAARViwDS8bsQ0QPlmwARCyBAEKK1gh2Bv0WbIHDQEREjmwBy+yGgEKK1gh2Bv0WbIFBxoREjmwDRCwEdCwDRCyFAEKK1gh2Bv0WbAHELAd0DAxExMhFSEDNjMyEhUUAiMiJiczFhYzMjY1NCYjIgcHzkoC6v2zLGuIx+rz2sH0Ea8RkHaBk5+EeUUxAtoC1qv+cz/++eDh/v3WvX1/sJuSsTUoAAIAhP/sBBwFsQAUACEATgCwAEVYsAAvG7EAHD5ZsABFWLANLxuxDRA+WbAAELIBAQorWCHYG/RZsgcNABESObAHL7IVAQorWCHYG/RZsA0QshwBCitYIdgb9FkwMQEVIwYEBzYzMhIVFAIjIgA1NRAAJQMiBgcVFBYzMjY1NCYDTyLY/wAUc8e+4/XO0f78AVcBU9JfoB+ieX2PkQWxnQT44YT+9NTh/vIBQf1HAZIBqQX9cHJWRLTcuJWWuQABAE0AAAQlBbAABgAyALAARViwBS8bsQUcPlmwAEVYsAEvG7EBED5ZsAUQsgMBCitYIdgb9FmyAAMFERI5MDEBASMBITUhBCX9pcICWfzsA9gFSPq4BRiYAAADAHD/7AQOBcQAFwAhACsAYQCwAEVYsBUvG7EVHD5ZsABFWLAJLxuxCRA+WbInCRUREjmwJy+yzycBXbIaAQorWCHYG/RZsgMaJxESObIPJxoREjmwCRCyHwEKK1gh2Bv0WbAVELIiAQorWCHYG/RZMDEBFAYHFhYVFAYjIiY1NDY3JiY1NDYzMhYDNCYiBhQWMzI2ASIGFRQWMjY0JgPsc2Jyhf/Q0v2BcmFw7MHA7Zeb+peTg4KU/upth4XehYoENG2qMDG8d73g4bx2vjEwqmy42Nj8oXqamPiOjwQah3RviYnejAAAAgBk//8D+AXEABcAJABYALAARViwCy8bsQscPlmwAEVYsBMvG7ETED5ZsgMTCxESObADL7IAAwsREjmwExCyFAEKK1gh2Bv0WbADELIYAQorWCHYG/RZsAsQsh8BCitYIdgb9FkwMQEGBiMiJiY1NDY2MzISERUQAAUjNTM2NiUyNjc1NCYjIgYVFBYDPjqhYH67Zm/MiNj5/rD+rSQn5fb+7l2dJJ55epSPAoBFVHzhiJLqfP69/uk2/lf+eQWcBOf6clRKtuS7mZXBAP//AIb/9QFtBEQAJgAS9gABBwAS//cDcwAQALAARViwDS8bsQ0YPlkwMf//ACn+3gFVBEQAJwAS/98DcwEGABAMAAAQALAARViwAy8bsQMYPlkwMQABAEgAwwN6BEoABgAWALAARViwBS8bsQUYPlmwAtCwAi8wMQEFFQE1ARUBCAJy/M4DMgKE/cQBe5IBesQAAAIAmAGPA9oDzwADAAcAJQCwBy+wA9CwAy+yAAEKK1gh2Bv0WbAHELIEAQorWCHYG/RZMDEBITUhESE1IQPa/L4DQvy+A0IDLqH9wKAAAAEAhgDEA9wESwAGABYAsABFWLACLxuxAhg+WbAF0LAFLzAxAQE1ARUBNQMb/WsDVvyqAooBA77+hpL+hcAAAgBL//UDdgXEABgAIQBRALAARViwEC8bsRAcPlmwAEVYsCAvG7EgED5ZshsFCitYIdgb9FmyABsQERI5sgQQABESObAQELIJAQorWCHYG/RZsBAQsAzQshUAEBESOTAxATY2Nzc2NTQmIyIGFSM2NjMyFhUUBwcGFQM0NjIWFAYiJgFlAjJNg1RuaWZ8uQLjtr3Tom1JwTdsODhsNwGad4pUh19taXdsW6LHy7GvqmxRmP7DLT09Wjs7AAACAGr+OwbWBZcANQBCAGgAsDIvsABFWLAILxuxCBA+WbAD0LIPMggREjmwDy+yBQgPERI5sAgQsjkCCitYIdgb9FmwFdCwMhCyGwIKK1gh2Bv0WbAIELAq0LAqL7IjAgorWCHYG/RZsA8QskACCitYIdgb9FkwMQEGAiMiJwYGIyImNzYSNjMyFhcDBjMyNjcSACEiBAIHBhIEMzI2NxcGBiMiJAITEhIkMzIEEgEGFjMyNjc3EyYjIgYGygzYtbs1NotKjpITD3m/aVGAUDQTk3GMBhP+uf6yyf7ItAsMkAEn0Vq1PCU+zWn6/pizDAzeAXzv+QFkrvvyDlFYPG8kAS44QHWZAfby/uioVVPozaUBA5QrP/3W5+C0AYUBmMf+iPb4/pPBLCNzJzLhAacBGwETAbfv4P5a/pCOmGZfCQH3He4AAAIAHAAABR0FsAAHAAoARgCwAEVYsAQvG7EEHD5ZsABFWLACLxuxAhA+WbAARViwBi8bsQYQPlmyCQQCERI5sAkvsgABCitYIdgb9FmyCgQCERI5MDEBIQMjATMBIwEhAwPN/Z6JxgIsqAItxf1NAe/4AXz+hAWw+lACGgKpAAMAqQAABIgFsAAOABYAHwBVALAARViwAS8bsQEcPlmwAEVYsAAvG7EAED5ZshcAARESObAXL7IPAQorWCHYG/RZsggPFxESObAAELIQAQorWCHYG/RZsAEQsh8BCitYIdgb9FkwMTMRITIWFRQGBxYWFRQGIwERITI2NRAhJSEyNjU0JiMhqQHc7e90ZHaJ/uj+xwE9hpv+4v7AASJ+l4yP/uQFsMTAZp0rIbmAxOACqf30i3oBB5p+bHhtAAABAHf/7ATYBcQAHABFALAARViwCy8bsQscPlmwAEVYsAMvG7EDED5ZsAsQsA/QsAsQshIBCitYIdgb9FmwAxCyGQEKK1gh2Bv0WbADELAc0DAxAQYEIyAAETU0EiQzMgAXIyYmIyICFRUUEjMyNjcE2Bv+4e7+/v7JkQEKr+gBGBfBGaeWuNHGsqCrHAHO5/sBcgE2jMsBNKX+/eWunP7w+43t/uiRtAACAKkAAATGBbAACwAVADkAsABFWLABLxuxARw+WbAARViwAC8bsQAQPlmwARCyDAEKK1gh2Bv0WbAAELINAQorWCHYG/RZMDEzESEyBBIXFRQCBAcDETMyEjU1NAInqQGbvgEknwGf/tnE08re9+nWBbCo/srJXc7+yqYCBRL7iwEU/1X4ARMCAAABAKkAAARGBbAACwBOALAARViwBi8bsQYcPlmwAEVYsAQvG7EEED5ZsgsEBhESObALL7IAAQorWCHYG/RZsAQQsgIBCitYIdgb9FmwBhCyCAEKK1gh2Bv0WTAxASERIRUhESEVIREhA+D9iQLd/GMDk/0tAncCof38nQWwnv4sAAEAqQAABC8FsAAJAEAAsABFWLAELxuxBBw+WbAARViwAi8bsQIQPlmyCQIEERI5sAkvsgABCitYIdgb9FmwBBCyBgEKK1gh2Bv0WTAxASERIxEhFSERIQPM/Z3AA4b9OgJjAoP9fQWwnv4OAAEAev/sBNwFxAAfAGIAsABFWLALLxuxCxw+WbAARViwAy8bsQMQPlmwCxCwD9CwCxCyEQEKK1gh2Bv0WbADELIYAQorWCHYG/RZsh4DCxESObAeL7QPHh8eAl20Px5PHgJdsh0BCitYIdgb9FkwMSUGBCMiJAInNRAAITIEFyMCISICAxUUEjMyNjcRITUhBNxK/vewsv7slwIBMwEW5AEWH8A2/t7BxwHgv2yiNf6vAhC/ammnATTLfwFJAWrp1gEh/vH+/3f1/t8wOQFHnAABAKkAAAUIBbAACwBVALAARViwBi8bsQYcPlmwAEVYsAovG7EKHD5ZsABFWLAALxuxABA+WbAARViwBC8bsQQQPlmwABCwCdCwCS+ynwkBcrIvCQFdsgIBCitYIdgb9FkwMSEjESERIxEzESERMwUIwf0iwMAC3sECof1fBbD9jgJyAAABALcAAAF3BbAAAwAdALAARViwAi8bsQIcPlmwAEVYsAAvG7EAED5ZMDEhIxEzAXfAwAWwAAABADX/7APMBbAADwAuALAARViwAC8bsQAcPlmwAEVYsAUvG7EFED5ZsAnQsAUQsgwBCitYIdgb9FkwMQEzERQGIyImNTMUFjMyNjcDC8H70dnywImCd5MBBbD7+dHs3sh9jJaHAAABAKkAAAUFBbAACwB0ALAARViwBS8bsQUcPlmwAEVYsAcvG7EHHD5ZsABFWLACLxuxAhA+WbAARViwCy8bsQsQPlmyAAIFERI5QBFKAFoAagB6AIoAmgCqALoACF2yOQABXbIGBQIREjlAEzYGRgZWBmYGdgaGBpYGpga2BgldMDEBBxEjETMRATMBASMCG7LAwAKH6P3DAmrmAqW5/hQFsP0wAtD9ffzTAAEAqQAABBwFsAAFACgAsABFWLAELxuxBBw+WbAARViwAi8bsQIQPlmyAAEKK1gh2Bv0WTAxJSEVIREzAWoCsvyNwZ2dBbAAAAEAqQAABlIFsAAOAFkAsABFWLAALxuxABw+WbAARViwAi8bsQIcPlmwAEVYsAQvG7EEED5ZsABFWLAILxuxCBA+WbAARViwDC8bsQwQPlmyAQAEERI5sgcABBESObIKAAQREjkwMQkCMxEjERMBIwETESMRAaEB3AHc+cAS/iKT/iMTwAWw+1wEpPpQAjcCZPtlBJj9n/3JBbAAAAEAqQAABQgFsAAJAEyyAQoLERI5ALAARViwBS8bsQUcPlmwAEVYsAgvG7EIHD5ZsABFWLAALxuxABA+WbAARViwAy8bsQMQPlmyAgUAERI5sgcFABESOTAxISMBESMRMwERMwUIwf0jwcEC378EYvueBbD7mQRnAAIAdv/sBQkFxAARAB8AOQCwAEVYsA0vG7ENHD5ZsABFWLAELxuxBBA+WbANELIVAQorWCHYG/RZsAQQshwBCitYIdgb9FkwMQEUAgQjIiQCJzU0EiQzMgQSFScQAiMiAgcVFBIzMhI3BQmQ/viwrP72kwKSAQusrwELkL/Qu7bRA9O5uswDAqnW/sGoqQE5zmnSAUKrqf6/1QIBAwEV/uv2a/v+4QEP/QAAAgCpAAAEwAWwAAoAEwBNsgoUFRESObAKELAM0ACwAEVYsAMvG7EDHD5ZsABFWLABLxuxARA+WbILAwEREjmwCy+yAAEKK1gh2Bv0WbADELISAQorWCHYG/RZMDEBESMRITIEFRQEIyUhMjY1NCYnIQFpwAIZ7wEP/vf3/qkBWZqkpI/+nAI6/cYFsPTJ1OWdkYmCnAMAAgBt/woFBgXEABUAIgBNsggjJBESObAIELAZ0ACwAEVYsBEvG7ERHD5ZsABFWLAILxuxCBA+WbIDCBEREjmwERCyGQEKK1gh2Bv0WbAIELIgAQorWCHYG/RZMDEBFAIHBQclBiMiJAInNTQSJDMyBBIVJxACIyICBxUUEiASNwUBhnkBBIP+zUhQrP72kwKSAQussAELkMDNvrXRA9EBdMwDAqnT/s9WzHn0EqkBOc5p0gFCq6r+wdUBAQEBF/7r9mv6/uABD/0AAAIAqAAABMkFsAAOABcAYbIFGBkREjmwBRCwFtAAsABFWLAELxuxBBw+WbAARViwAi8bsQIQPlmwAEVYsA0vG7ENED5ZshAEAhESObAQL7IAAQorWCHYG/RZsgsABBESObAEELIWAQorWCHYG/RZMDEBIREjESEyBBUUBgcBFSMBITI2NTQmJyECv/6qwQHi9gEJk4MBVs79bgEnj6mhmP7aAk39swWw4NaIyjL9lgwC6pR8h5ABAAABAFD/7ARyBcQAJgBhsgAnKBESOQCwAEVYsAYvG7EGHD5ZsABFWLAaLxuxGhA+WbAGELAL0LAGELIOAQorWCHYG/RZsiYaBhESObAmELIUAQorWCHYG/RZsBoQsB/QsBoQsiIBCitYIdgb9FkwMQEmJjU0JDMyFhYVIzQmIyIGFRQWBBYWFRQEIyIkJjUzFBYzMjY0JgJW9+EBE9yW64HBqJmOn5cBa81j/uznlv78jcHDo5iilgKJR8+YrOF0zHmEl31vWXtme6RvsdVzyH+EmXzWdQAAAQAxAAAElwWwAAcALgCwAEVYsAYvG7EGHD5ZsABFWLACLxuxAhA+WbAGELIAAQorWCHYG/RZsATQMDEBIREjESE1IQSX/iy//i0EZgUS+u4FEp4AAQCM/+wEqgWwABIAPLIFExQREjkAsABFWLAALxuxABw+WbAARViwCS8bsQkcPlmwAEVYsAUvG7EFED5Zsg4BCitYIdgb9FkwMQERBgAHByIAJxEzERQWMzI2NREEqgH+/9wz7/7kAr6uoaOtBbD8Is7++hACAQLiA+D8Jp6vrp4D2wAAAQAcAAAE/QWwAAYAOLIABwgREjkAsABFWLABLxuxARw+WbAARViwBS8bsQUcPlmwAEVYsAMvG7EDED5ZsgABAxESOTAxJQEzASMBMwKLAaDS/eSq/eXR/wSx+lAFsAAAAQA9AAAG7QWwABIAWQCwAEVYsAMvG7EDHD5ZsABFWLAILxuxCBw+WbAARViwES8bsREcPlmwAEVYsAovG7EKED5ZsABFWLAPLxuxDxA+WbIBAwoREjmyBgMKERI5sg0DChESOTAxARc3ATMBFzcTMwEjAScHASMBMwHjHCkBIKIBGSgf4sH+n6/+1BcX/smv/qDAAcvArQP4/AiwxAPk+lAEJW9v+9sFsAABADkAAATOBbAACwBrALAARViwAS8bsQEcPlmwAEVYsAovG7EKHD5ZsABFWLAELxuxBBA+WbAARViwBy8bsQcQPlmyAAEEERI5QAmGAJYApgC2AARdsgYBBBESOUAJiQaZBqkGuQYEXbIDAAYREjmyCQYAERI5MDEBATMBASMBASMBATMChAFd4v40Adfk/pr+mOMB2P4z4QOCAi79Lv0iAjj9yALeAtIAAAEADwAABLsFsAAIADEAsABFWLABLxuxARw+WbAARViwBy8bsQccPlmwAEVYsAQvG7EEED5ZsgABBBESOTAxAQEzAREjEQEzAmUBfNr+CsD+CtwC1QLb/G/94QIfA5EAAAEAVgAABHoFsAAJAEQAsABFWLAHLxuxBxw+WbAARViwAi8bsQIQPlmyAAEKK1gh2Bv0WbIEAAIREjmwBxCyBQEKK1gh2Bv0WbIJBQcREjkwMSUhFSE1ASE1IRUBOQNB+9wDHvzvA/ednZAEgp6NAAABAJL+yAILBoAABwAiALAEL7AHL7IAAQorWCHYG/RZsAQQsgMBCitYIdgb9FkwMQEjETMVIREhAgu/v/6HAXkF6Pl4mAe4AAABACj/gwM4BbAAAwATALACL7AARViwAC8bsQAcPlkwMRMzASMosAJgsAWw+dMAAQAJ/sgBgwaAAAcAJQCwAi+wAS+wAhCyBQEKK1gh2Bv0WbABELIGAQorWCHYG/RZMDETIREhNTMRIwkBev6GwcEGgPhImAaIAAABAEAC2QMUBbAABgAnsgAHCBESOQCwAEVYsAMvG7EDHD5ZsADQsgEHAxESObABL7AF0DAxAQMjATMBIwGqvqwBK38BKqsEu/4eAtf9KQABAAT/aQOYAAAAAwAbALAARViwAy8bsQMQPlmyAAEKK1gh2Bv0WTAxBSE1IQOY/GwDlJeXAAABADkE2AHaBf4AAwAjALABL7IPAQFdsADQGbAALxiwARCwAtCwAi+0DwIfAgJdMDEBIwEzAdqf/v7fBNgBJgAAAgBt/+wD6gROAB4AKAB5shcpKhESObAXELAg0ACwAEVYsBcvG7EXGD5ZsABFWLAELxuxBBA+WbAARViwAC8bsQAQPlmyAhcEERI5sgsXBBESObALL7AXELIPAQorWCHYG/RZshILFxESObAEELIfAQorWCHYG/RZsAsQsiMBCitYIdgb9FkwMSEmJwYjIiY1NCQzMzU0JiMiBhUjNDY2MzIWFxEUFxUlMjY3NSMgFRQWAygQCoGzoM0BAem0dHFjhrpzxXa71AQm/gtXnCOR/qx0IFKGtYupu1Vhc2RHUZdYu6T+DpVYEI1aSN7HV2IAAgCM/+wEIAYAAA4AGQBkshIaGxESObASELAD0ACwCC+wAEVYsAwvG7EMGD5ZsABFWLADLxuxAxA+WbAARViwBi8bsQYQPlmyBQgDERI5sgoMAxESObAMELISAQorWCHYG/RZsAMQshcBCitYIdgb9FkwMQEUAiMiJwcjETMRNiASESc0JiMiBxEWMzI2BCDkwM1wCaq5cAGK4bmSibdQVbSFlAIR+P7TkX0GAP3Di/7W/v0Fvc6q/iyqzgABAFz/7APsBE4AHQBJshAeHxESOQCwAEVYsBAvG7EQGD5ZsABFWLAILxuxCBA+WbIAAQorWCHYG/RZsAgQsAPQsBAQsBTQsBAQshcBCitYIdgb9FkwMSUyNjczDgIjIgARNTQ2NjMyFhcjJiYjIgYVFRQWAj5jlAivBXbFbt3++3TZlLbxCK8Ij2mNm5qDeFpdqGQBJwEAH572iNquaYfLwCO7ygAAAgBf/+wD8AYAAA8AGgBkshgbHBESObAYELAD0ACwBi+wAEVYsAMvG7EDGD5ZsABFWLAMLxuxDBA+WbAARViwCC8bsQgQPlmyBQMMERI5sgoDDBESObAMELITAQorWCHYG/RZsAMQshgBCitYIdgb9FkwMRM0EjMyFxEzESMnBiMiAjUXFBYzMjcRJiMiBl/sv75vuaoJb8a87bmYhrBRU6yImAIm+QEvggI0+gB0iAE0+Ae40J4B8ZnSAAACAF3/7APzBE4AFQAdAGmyCB4fERI5sAgQsBbQALAARViwCC8bsQgYPlmwAEVYsAAvG7EAED5ZshoIABESObAaL7S/Gs8aAl2yDAEKK1gh2Bv0WbAAELIQAQorWCHYG/RZshMIABESObAIELIWAQorWCHYG/RZMDEFIgA1NTQ2NjMyEhEVIRYWMzI2NxcGASIGByE1JiYCTdz+7HvdgdPq/SMEs4piiDNxiP7ZcJgSAh4IiBQBIfIiof2P/ur+/U2gxVBCWNEDyqOTDo2bAAEAPAAAAsoGFQAVAGOyDxYXERI5ALAARViwCC8bsQgePlmwAEVYsAMvG7EDGD5ZsABFWLARLxuxERg+WbAARViwAC8bsQAQPlmwAxCyAQEKK1gh2Bv0WbAIELINAQorWCHYG/RZsAEQsBPQsBTQMDEzESM1MzU0NjMyFwcmIyIGFRUzFSMR56uruqpAPwovNVpi5+cDq49vrr4RlglpYnKP/FUAAgBg/lYD8gROABkAJACDsiIlJhESObAiELAL0ACwAEVYsAMvG7EDGD5ZsABFWLAGLxuxBhg+WbAARViwCy8bsQsSPlmwAEVYsBcvG7EXED5ZsgUDFxESObIPFwsREjmwCxCyEQEKK1gh2Bv0WbIVAxcREjmwFxCyHQEKK1gh2Bv0WbADELIiAQorWCHYG/RZMDETNBIzMhc3MxEUBiMiJic3FjMyNjU1BiMiAjcUFjMyNxEmIyIGYOrBxm8JqfnSdeA7YHesh5dvwL7rupaHr1JVqoeYAib9ASuMePvg0vJkV2+TmIpdgAEy87fRnwHum9IAAAEAjAAAA98GAAARAEmyChITERI5ALAQL7AARViwAi8bsQIYPlmwAEVYsAUvG7EFED5ZsABFWLAOLxuxDhA+WbIAAgUREjmwAhCyCgEKK1gh2Bv0WTAxATYzIBMRIxEmJiMiBgcRIxEzAUV7xQFXA7kBaW9aiCa5uQO3l/59/TUCzHVwYE78/QYAAAIAjQAAAWgFxAADAAwAPrIGDQ4REjmwBhCwAdAAsABFWLACLxuxAhg+WbAARViwAC8bsQAQPlmwAhCwCtCwCi+yBgUKK1gh2Bv0WTAxISMRMwM0NjIWFAYiJgFVubnIN2w4OGw3BDoBHy0+Plo8PAAC/7/+SwFZBcQADAAWAEmyEBcYERI5sBAQsADQALAARViwDC8bsQwYPlmwAEVYsAMvG7EDEj5ZsggBCitYIdgb9FmwDBCwFdCwFS+yEAUKK1gh2Bv0WTAxAREQISInNRYzMjY1EQM0NjMyFhQGIiYBS/7lPTQgND5BEzc1Njg4bDYEOvtJ/sgSlAhDUwS7AR8sPz5aPDwAAAEAjQAABAwGAAAMAHUAsABFWLAELxuxBB4+WbAARViwCC8bsQgYPlmwAEVYsAIvG7ECED5ZsABFWLALLxuxCxA+WbIACAIREjlAFToASgBaAGoAegCKAJoAqgC6AMoACl2yBggCERI5QBU2BkYGVgZmBnYGhgaWBqYGtgbGBgpdMDEBBxEjETMRNwEzAQEjAbp0ubljAVHh/lsB1tkB9Xn+hAYA/F93AWT+PP2KAAEAnAAAAVUGAAADAB0AsABFWLACLxuxAh4+WbAARViwAC8bsQAQPlkwMSEjETMBVbm5BgAAAAEAiwAABngETgAdAHeyBB4fERI5ALAARViwAy8bsQMYPlmwAEVYsAgvG7EIGD5ZsABFWLAALxuxABg+WbAARViwCy8bsQsQPlmwAEVYsBQvG7EUED5ZsABFWLAbLxuxGxA+WbIBCAsREjmyBQgLERI5sAgQshABCitYIdgb9FmwGNAwMQEXNjMyFzY2MyATESMRNCYjIgYHESMRNCMiBxEjEQE6BXfK41I2rXYBZAa5an1niAu657ZDuQQ6eIyuTmD+h/0rAsp0c3to/TICxeyb/OoEOgABAIwAAAPfBE4AEQBTsgsSExESOQCwAEVYsAMvG7EDGD5ZsABFWLAALxuxABg+WbAARViwBi8bsQYQPlmwAEVYsA8vG7EPED5ZsgEDBhESObADELILAQorWCHYG/RZMDEBFzYzIBMRIxEmJiMiBgcRIxEBOwZ8yAFXA7kBaW9aiCa5BDqInP59/TUCzHVwYE78/QQ6AAACAFv/7AQ0BE4ADwAbAEOyDBwdERI5sAwQsBPQALAARViwBC8bsQQYPlmwAEVYsAwvG7EMED5ZshMBCitYIdgb9FmwBBCyGQEKK1gh2Bv0WTAxEzQ2NjMyABUVFAYGIyIANRcUFjMyNjU0JiMiBlt934/dARF54ZLc/u+6p4yNpqmMiagCJ5/+iv7O/g2e+4wBMvwJtNrdx7Ld2gACAIz+YAQeBE4ADwAaAG6yExscERI5sBMQsAzQALAARViwDC8bsQwYPlmwAEVYsAkvG7EJGD5ZsABFWLAGLxuxBhI+WbAARViwAy8bsQMQPlmyBQwDERI5sgoMAxESObAMELITAQorWCHYG/RZsAMQshgBCitYIdgb9FkwMQEUAiMiJxEjETMXNjMyEhEnNCYjIgcRFjMyNgQe4sHFcbmpCXHJw+O5nIioVFOrhZ0CEff+0n399wXaeIz+2v76BLfUlf37lNMAAAIAX/5gA+8ETgAPABoAa7IYGxwREjmwGBCwA9AAsABFWLADLxuxAxg+WbAARViwBi8bsQYYPlmwAEVYsAgvG7EIEj5ZsABFWLAMLxuxDBA+WbIFAwwREjmyCgMMERI5shMBCitYIdgb9FmwAxCyGAEKK1gh2Bv0WTAxEzQSMzIXNzMRIxEGIyICNRcUFjMyNxEmIyIGX+rFwG8IqrlwusTpuZ2FpVdYooaeAib/ASmBbfomAgR4ATH8CLrUkgISj9UAAQCMAAAClwROAA0ARrIEDg8REjkAsABFWLALLxuxCxg+WbAARViwCC8bsQgYPlmwAEVYsAUvG7EFED5ZsAsQsgIBCitYIdgb9FmyCQsFERI5MDEBJiMiBxEjETMXNjMyFwKXKjG2Qbm0A1unNhwDlAeb/QAEOn2RDgABAF//7AO7BE4AJgBhsgknKBESOQCwAEVYsAkvG7EJGD5ZsABFWLAcLxuxHBA+WbIDHAkREjmwCRCwDdCwCRCyEAEKK1gh2Bv0WbADELIVAQorWCHYG/RZsBwQsCHQsBwQsiQBCitYIdgb9FkwMQE0JiQmJjU0NjMyFhUjNCYjIgYVFBYEFhYVFAYjIiYmNTMWFjMyNgMCcf7npU/hr7jluoFiZXJqARWsU+i5gshxuQWLcml/AR9LUzxUdFCFuL6UTG5YR0NEPlZ5V5GvXKVgXW1VAAEACf/sAlYFQAAVAF+yDhYXERI5ALAARViwAS8bsQEYPlmwAEVYsBMvG7ETGD5ZsABFWLANLxuxDRA+WbABELAA0LAAL7ABELIDAQorWCHYG/RZsA0QsggBCitYIdgb9FmwAxCwEdCwEtAwMQERMxUjERQWMzI3FQYjIiY1ESM1MxEBh8rKNkEgOElFfH7FxQVA/vqP/WFBQQyWFJaKAp+PAQYAAQCI/+wD3AQ6ABAAU7IKERIREjkAsABFWLAGLxuxBhg+WbAARViwDS8bsQ0YPlmwAEVYsAIvG7ECED5ZsABFWLAQLxuxEBA+WbIADQIREjmwAhCyCgEKK1gh2Bv0WTAxJQYjIiYnETMRFDMyNxEzESMDKGzRrbUBucjURrmwa3/JxQLA/UX2ngMT+8YAAAEAIQAAA7oEOgAGADiyAAcIERI5ALAARViwAS8bsQEYPlmwAEVYsAUvG7EFGD5ZsABFWLADLxuxAxA+WbIABQMREjkwMSUBMwEjATMB8QEMvf58jf54vfsDP/vGBDoAAAEAKwAABdMEOgAMAGCyBQ0OERI5ALAARViwAS8bsQEYPlmwAEVYsAgvG7EIGD5ZsABFWLALLxuxCxg+WbAARViwAy8bsQMQPlmwAEVYsAYvG7EGED5ZsgALAxESObIFCwMREjmyCgsDERI5MDElEzMBIwEBIwEzExMzBErQuf7Flv75/wCW/sa41fyV/wM7+8YDNPzMBDr81gMqAAEAKQAAA8oEOgALAFMAsABFWLABLxuxARg+WbAARViwCi8bsQoYPlmwAEVYsAQvG7EEED5ZsABFWLAHLxuxBxA+WbIACgQREjmyBgoEERI5sgMABhESObIJBgAREjkwMQETMwEBIwMDIwEBMwH38Nj+ngFt1vr61wFt/p7WAq8Bi/3p/d0Blf5rAiMCFwABABb+SwOwBDoADwBJsgAQERESOQCwAEVYsAEvG7EBGD5ZsABFWLAOLxuxDhg+WbAARViwBS8bsQUSPlmyAA4FERI5sgkBCitYIdgb9FmwABCwDdAwMQETMwECIycnNRcyNjc3ATMB7vzG/k1l3CNFMl5pIin+fsoBDwMr+x/+8gMNlgRMZW4ELgABAFgAAAOzBDoACQBEALAARViwBy8bsQcYPlmwAEVYsAIvG7ECED5ZsgABCitYIdgb9FmyBAACERI5sAcQsgUBCitYIdgb9FmyCQUHERI5MDElIRUhNQEhNSEVAToCefylAlX9tAM0l5eIAxmZgwAAAQBA/pICngY9ABgAMbITGRoREjkAsA0vsAAvsgcNABESObAHL7IfBwFdsgYDCitYIdgb9FmyEwYHERI5MDEBJiY1NTQjNTI1NTY2NxcGERUUBxYVFRIXAnixs9TUAq+zJtGnpwPO/pIy5bzH85Hy0LfhM3ND/ubK41la5c7+7UIAAAEAr/7yAUQFsAADABMAsAAvsABFWLACLxuxAhw+WTAxASMRMwFElZX+8ga+AAABABP+kgJyBj0AGAAxsgUZGhESOQCwCy+wGC+yEQsYERI5sBEvsh8RAV2yEgMKK1gh2Bv0WbIFEhEREjkwMRc2EzU0NyY1NRAnNxYWFxUUMxUiFRUUBgcTywe1tdEmsbIB1NS1r/tBAQrc51RS6csBGkNzMuG50u+R88q84jIAAAEAgwGSBO8DIgAXAEKyERgZERI5ALAARViwDy8bsQ8WPlmwANCwDxCwFNCwFC+yAwEKK1gh2Bv0WbAPELIIAQorWCHYG/RZsAMQsAvQMDEBFAYjIi4CIyIGFQc0NjMyFhYXFzI2NQTvu4lIgKlKKk5UobiLTIywQB1MXwMJntk1lCRrXgKgzkChCgJ0XwACAIv+mAFmBE0AAwAMADKyBg0OERI5sAYQsADQALACL7AARViwCy8bsQsYPlmyBgUKK1gh2Bv0WbIBAgYREjkwMRMzEyMTFAYiJjQ2MhaqqA3CyTdsODhsNwKs++wFTC0+Plo8PAABAGn/CwP5BSYAIQBSsgAiIxESOQCwAEVYsBQvG7EUGD5ZsABFWLAKLxuxChA+WbAH0LIAAQorWCHYG/RZsAoQsAPQsBQQsBHQsBQQsBjQsBQQshsBCitYIdgb9FkwMSUyNjczBgYHFSM1JgI1NTQSNzUzFRYWFyMmJiMiBhUVFBYCSmSUCK8GxpC5s8jKsbmWwAavCI9pjZubg3lZfska6eoiARzcI9QBHSHi3xfUlmmHy8Aju8oAAQBbAAAEaAXEACEAfLIcIiMREjkAsABFWLAULxuxFBw+WbAARViwBS8bsQUQPlmyHxQFERI5sB8vsl8fAXKyjx8BcbK/HwFdsgABCitYIdgb9FmwBRCyAwEKK1gh2Bv0WbAH0LAI0LAAELAN0LAfELAP0LAUELAY0LAUELIbAQorWCHYG/RZMDEBFxQHIQchNTM2Njc1JyM1MwM0NjMyFhUjNCYjIgYVEyEVAcEIPgLdAfv4TSgyAgiloAn1yL7ev39vaYIJAT8CbtyaW52dCYNgCN2dAQTH7tSxa3yaff78nQAAAgBp/+UFWwTxABsAKgA/sgIrLBESObACELAn0ACwAEVYsAIvG7ECED5ZsBDQsBAvsAIQsh8BCitYIdgb9FmwEBCyJwEKK1gh2Bv0WTAxJQYjIicHJzcmNTQ3JzcXNjMyFzcXBxYVFAcXBwEUFhYyNjY1NCYmIyIGBgRPn9HPn4aCi2hwk4KTnsPEn5WEl25mj4T8YHPE4sRxccVwccRzcISCiIeNnMrOo5eIlnh5mImao8vEn5CIAnt71Hp703t603l41AAAAQAfAAAErQWwABYAawCwAEVYsBYvG7EWHD5ZsABFWLABLxuxARw+WbAARViwDC8bsQwQPlmyDxMDK7IADBYREjm0DxMfEwJdsBMQsAPQsBMQshICCitYIdgb9FmwBtCwDxCwB9CwDxCyDgIKK1gh2Bv0WbAK0DAxAQEzASEVIRUhFSERIxEhNSE1ITUhATMCZgFs2/5eATj+gAGA/oDB/oYBev6GATn+XtwDDgKi/TB9pXz+vgFCfKV9AtAAAAIAk/7yAU0FsAADAAcAGACwAC+wAEVYsAYvG7EGHD5ZsgUBAyswMRMRMxERIxEzk7q6uv7yAxf86QPIAvYAAgBa/hEEeQXEADQARACAsiNFRhESObAjELA10ACwCC+wAEVYsCMvG7EjHD5ZshYIIxESObAWELI/AQorWCHYG/RZsgIWPxESObAIELAO0LAIELIRAQorWCHYG/RZsjAjCBESObAwELI3AQorWCHYG/RZsh03MBESObAjELAn0LAjELIqAQorWCHYG/RZMDEBFAcWFhUUBCMiJicmNTcUFjMyNjU0JicuAjU0NyYmNTQkMzIEFSM0JiMiBhUUFhYEHgIlJicGBhUUFhYEFzY2NTQmBHm6RUj+/ORwyUaLurSciKaO0bbAXbZCRwEL3ugBBLmoi46hOIcBH6lxOv3hWktQSzaFARwsTlSLAa+9VTGIZKjHODlxzQKCl3VgWWk+MG+bb7pYMYhkpsjizX2bc2JFUEFQSGGBqxgbE2VFRlBCUhEUZUVYbQAAAgBmBPAC7wXFAAgAEQAdALAHL7ICBQorWCHYG/RZsAvQsAcQsBDQsBAvMDETNDYyFhQGIiYlNDYyFhQGIiZmN2w4OGw3Aa43bDg4bDcFWy09PVo8PCstPj5aPDwAAAMAW//rBeYFxAAbACoAOQCVsic6OxESObAnELAD0LAnELA20ACwAEVYsC4vG7EuHD5ZsABFWLA2LxuxNhA+WbIDNi4REjmwAy+0DwMfAwJdsgouNhESObAKL7QAChAKAl2yDgoDERI5shECCitYIdgb9FmwAxCyGAIKK1gh2Bv0WbIbAwoREjmwNhCyIAQKK1gh2Bv0WbAuELInBAorWCHYG/RZMDEBFAYjIiY1NTQ2MzIWFSM0JiMiBhUVFBYzMjY1JRQSBCAkEjU0AiQjIgQCBzQSJCAEEhUUAgQjIiQCBF+tnp29v5ugrJJfW15sbF5cXf0BoAETAUABEqCe/u2hoP7sn3O7AUsBgAFKu7T+tcbF/rW2AlWZodO2brDTpJVjVYp7cXiKVGWErP7bpqYBJayqASKnpf7cqsoBWsfH/qbKxf6o0c8BWAAAAgCTArMDDwXEABsAJQBssg4mJxESObAOELAd0ACwAEVYsBUvG7EVHD5ZsgQmFRESObAEL7AA0LICBBUREjmyCwQVERI5sAsvsBUQsg4DCitYIdgb9FmyEQsVERI5sAQQshwDCitYIdgb9FmwCxCyIAQKK1gh2Bv0WTAxASYnBiMiJjU0NjMzNTQjIgYVJzQ2MzIWFREUFyUyNjc1IwYGFRQCagwGTIB3gqesbHxFT6GsiYWaGv6kK1gccFNZAsEiJlZ8Z294NIc2Mwxngo+G/sRhUXsoG44BPzNe//8AZgCXA2QDswAmAJr6/gAHAJoBRP/+AAEAfwF3A74DIAAFABoAsAQvsAHQsAEvsAQQsgIBCitYIdgb9FkwMQEjESE1IQO+uv17Az8BdwEIoQAEAFr/6wXlBcQADgAeADQAPQCpsjY+PxESObA2ELAL0LA2ELAT0LA2ELAj0ACwAEVYsAMvG7EDHD5ZsABFWLALLxuxCxA+WbITBAorWCHYG/RZsAMQshsECitYIdgb9FmyIAsDERI5sCAvsiIDCxESObAiL7QAIhAiAl2yNSAiERI5sDUvsr81AV20ADUQNQJdsh8CCitYIdgb9FmyKB81ERI5sCAQsC/QsC8vsCIQsj0CCitYIdgb9FkwMRM0EiQgBBIVFAIEIyIkAjcUEgQzMiQSNTQCJCMiBAIFESMRITIWFRQHFhcVFBcVIyY0JyYnJzM2NjU0JiMjWrsBSwGAAUq7tP61xsX+tbZzoAEToKEBFJ2d/uyhoP7snwHAjQEUmamAegERkQ4DEHOwnEhYTmSKAtnKAVrHx/6mysX+qNHPAVjHrP7bpqkBIqyrASGnpf7c9f6uA1GDfXtBMpo9ViYQJLkRYASAAkI2ST0AAAEAeAUhA0IFsAADABEAsAEvsgIDCitYIdgb9FkwMQEhNSEDQv02AsoFIY8AAgCCA8ACfAXEAAsAFgAvALAARViwAy8bsQMcPlmwDNCwDC+yCQIKK1gh2Bv0WbADELISAgorWCHYG/RZMDETNDYzMhYVFAYjIiYXMjY1NCYjIgYUFoKVamiTk2hplv82Sko2N0tLBMBonJtpapaWFkc5OktPbEoAAgBhAAAD9QTzAAsADwBGALAJL7AARViwDS8bsQ0QPlmwCRCwANCwCRCyBgEKK1gh2Bv0WbAD0LANELIOAQorWCHYG/RZsgUOBhESObQLBRsFAl0wMQEhFSERIxEhNSERMwEhNSECiQFs/pSn/n8BgacBQfy9A0MDVpf+YgGelwGd+w2YAAABAEICmwKrBbsAFgBUsggXGBESOQCwAEVYsA4vG7EOHD5ZsABFWLAALxuxABQ+WbIWAgorWCHYG/RZsALQsgMOFhESObAOELIIAgorWCHYG/RZsA4QsAvQshQWDhESOTAxASE1ATY1NCYjIgYVIzQ2IBYVFA8CIQKr/akBLG1APEtHnacBCJprVLABjwKbbAEaZkUxPUw5cpR/bmhrT5EAAQA+Ao8CmgW6ACYAibIgJygREjkAsABFWLAOLxuxDhw+WbAARViwGS8bsRkUPlmyABkOERI5sAAvtm8AfwCPAANdsj8AAXG2DwAfAC8AA12yXwABcrAOELIHAgorWCHYG/RZsgoOGRESObAAELImBAorWCHYG/RZshQmABESObIdGQ4REjmwGRCyIAIKK1gh2Bv0WTAxATMyNjU0JiMiBhUjNDYzMhYVFAYHFhUUBiMiJjUzFBYzMjY1NCcjAQlUSkg/RjlLnaN8iZxGQpWqiISmnk9DRkmcWARlPTAtOjMpYnt5aDdbGSmPan1+ay08PDNxAgAAAQB7BNgCHAX+AAMAIwCwAi+yDwIBXbAA0LAAL7QPAB8AAl2wAhCwA9AZsAMvGDAxATMBIwE84P70lQX+/toAAAEAmv5gA+4EOgASAFCyDRMUERI5ALAARViwAC8bsQAYPlmwAEVYsAcvG7EHGD5ZsABFWLAQLxuxEBI+WbAARViwDS8bsQ0QPlmyBAEKK1gh2Bv0WbILBw0REjkwMQERFhYzMjcRMxEjJwYjIicRIxEBUwFndMc+uqcJXaqTUbkEOv2Ho5yYAyD7xnOHSf4rBdoAAQBDAAADQAWwAAoAK7ICCwwREjkAsABFWLAILxuxCBw+WbAARViwAC8bsQAQPlmyAQAIERI5MDEhESMiJDU0JDMhEQKGVOb+9wEK5gENAgj+1tX/+lAAAAEAkwJrAXkDSQAJABayAwoLERI5ALACL7EICitY2BvcWTAxEzQ2MhYVFAYiJpM5cjs7cjkC2TBAQDAvPz8AAQB0/k0BqgAAAA4AQbIFDxAREjkAsABFWLAALxuxABA+WbAARViwBi8bsQYSPlm0EwYjBgJdsgEGABESObEHCitY2BvcWbABELAN0DAxIQcWFRQGIycyNjU0Jic3AR0MmaCPB09XQGIgNBuSYXFrNC8sKgmGAAEAegKiAe8FtwAGAECyAQcIERI5ALAARViwBS8bsQUcPlmwAEVYsAAvG7EAFD5ZsgQABRESObAEL7IDAgorWCHYG/RZsgIDBRESOTAxASMRBzUlMwHvndgBYxICogJZOYB1AAACAHoCsgMnBcQADAAaAECyAxscERI5sAMQsBDQALAARViwAy8bsQMcPlmyChsDERI5sAovshADCitYIdgb9FmwAxCyFwMKK1gh2Bv0WTAxEzQ2MzIWFRUUBiAmNRcUFjMyNjU1NCYjIgYHeryam7y7/sy+o2FUU19hU1FgAgRjnsPBpkqfwsKlBmRyc2VOY3JuYQD//wBmAJgDeAO1ACYAmw0AAAcAmwFqAAD//wBVAAAFkQWtACcAov/bApgAJwCcARgACAEHAKUC1gAAABAAsABFWLAFLxuxBRw+WTAx//8AUAAABckFrQAnAJwA7AAIACcAov/WApgBBwCjAx4AAAAQALAARViwCS8bsQkcPlkwMf//AG8AAAXtBbsAJwCcAZcACAAnAKUDMgAAAQcApAAxApsAEACwAEVYsCEvG7EhHD5ZMDEAAgBE/n8DeARNABgAIgBXsgkjJBESObAJELAc0ACwEC+wAEVYsCEvG7EhGD5ZsgAQIRESObIDEAAREjmwEBCyCQEKK1gh2Bv0WbAQELAM0LIVABAREjmwIRCyGwUKK1gh2Bv0WTAxAQ4DBwcUFjMyNjUzBgYjIiY1NDc3NjUTFAYiJjU0NjIWAkwBKWC4CwJ0bWR9uQLht8TWoG1CwTdsODhsNwKoan92wWMlbXNxW6HMybOtr3FOkgE9LT4+LSw8PAAC//IAAAdXBbAADwASAHcAsABFWLAGLxuxBhw+WbAARViwAC8bsQAQPlmwAEVYsAQvG7EEED5ZshEGABESObARL7ICAQorWCHYG/RZsAYQsggBCitYIdgb9FmyCwAGERI5sAsvsgwBCitYIdgb9FmwABCyDgEKK1gh2Bv0WbISBgAREjkwMSEhAyEDIwEhFSETIRUhEyEBIQMHV/yND/3MzeIDcAO3/U0UAk79uBYCwfqvAcgfAWH+nwWwmP4pl/3tAXgC3QABAFkAzgPdBGMACwA4ALADL7IJDAMREjmwCS+yCgkDERI5sgQDCRESObIBCgQREjmwAxCwBdCyBwQKERI5sAkQsAvQMDETAQE3AQEXAQEHAQFZAUr+uHcBSQFJd/64AUp3/rX+tQFJAVABT3v+sQFPe/6x/rB7AVH+rwAAAwB2/6MFHQXsABcAIAApAGayBCorERI5sAQQsB3QsAQQsCbQALAARViwEC8bsRAcPlmwAEVYsAQvG7EEED5ZshoQBBESObIjEAQREjmwIxCwG9CwEBCyHQEKK1gh2Bv0WbAaELAk0LAEELImAQorWCHYG/RZMDEBFAIEIyInByM3JhE1NBIkMzIXNzMHFhMFFBcBJiMiAgcFNCcBFjMyEjcFCZD++LCrg2GOkL6SAQus1pRnjZ+JAvwsYgI0Zqa20QMDFTj921t5uswDAqnW/sGoUpvnwAFoU9IBQqt9pf+7/tpj9I0DiG/+6/YNtoP8j0ABD/0AAgCmAAAEXQWwAA0AFgBXsgkXGBESObAJELAQ0ACwAEVYsAAvG7EAHD5ZsABFWLALLxuxCxA+WbIBAAsREjmwAS+yEAALERI5sBAvsgkBCitYIdgb9FmwARCyDgEKK1gh2Bv0WTAxAREhMhYWFRQEIyERIxETESEyNjU0JicBYAEXk9x3/vjj/u66ugEVjqCgiAWw/ttpwn7C5/7HBbD+Q/3el3h7lwEAAQCL/+wEagYSACoAabIhKywREjkAsABFWLAFLxuxBR4+WbAARViwEy8bsRMQPlmwAEVYsAAvG7EAED5ZsgoTBRESObIOBRMREjmwExCyGgEKK1gh2Bv0WbIgEwUREjmyIwUTERI5sAUQsigBCitYIdgb9FkwMSEjETQ2MzIWFRQGFRQeAhUUBiMiJic3FhYzMjY1NC4CNTQ2NTQmIyIRAUS5z7q0xYBLvFbLtlG1JisxhzVrcUq9V4toWNoEV9Drs599y0UzX5CITJ+yLBybICxeUjRgk4pRWc9UXmv+2wADAE7/7AZ8BE4AKgA1AD0AxrICPj8REjmwAhCwLtCwAhCwOdAAsABFWLAXLxuxFxg+WbAARViwHS8bsR0YPlmwAEVYsAAvG7EAED5ZsABFWLAFLxuxBRA+WbICHQAREjmyDAUXERI5sAwvtL8MzwwCXbAXELIQAQorWCHYG/RZshMMFxESObIaHQAREjmyOh0AERI5sDovtL86zzoCXbIhAQorWCHYG/RZsAAQsiUBCitYIdgb9FmyKB0AERI5sCvQsAwQsi8BCitYIdgb9FmwEBCwNtAwMQUgJwYGIyImNTQ2MzM1NCYjIgYVJzQ2MzIWFzY2MzISFRUhFhYzMjc3FwYlMjY3NSMGBhUUFgEiBgchNTQmBO7++4hB4o2nvOPd325oaYy48rtzsDI/rmnS6P0oB66VlHkvQJ78CUieMuR1jGoDUHOVEQIahhS0Vl6tl52uVWt7blETj7VTU09X/v/pc7C/TB+IeZZKNu0CblNNXQM0q4sfhJMAAAIAfv/sBC0GLAAdACsAVLIHLC0REjmwBxCwKNAAsABFWLAZLxuxGR4+WbAARViwBy8bsQcQPlmyDxkHERI5sA8vshEZBxESObIiAQorWCHYG/RZsAcQsigBCitYIdgb9FkwMQESERUUBgYjIiYmNTQ2NjMyFyYnByc3Jic3Fhc3FwMnJiYjIgYVFBYzMjY1AzT5ddiGh9x5cM+Bo3kwjdpJwIS3Oe+vvUloAiGLXJGip4B9mQUV/vj+Z12e/ZCB4IaT6YJyw42UY4NbMZ82i4Fk/PM4PUm/p4zE4rgAAAMARwCsBC0EugADAA0AFwBOsgcYGRESObAHELAA0LAHELAR0ACwAi+yAQEKK1gh2Bv0WbACELEMCitY2BvcWbEGCitY2BvcWbABELEQCitY2BvcWbEWCitY2BvcWTAxASE1IQE0NjIWFRQGIiYRNDYyFhUUBiImBC38GgPm/aA5cjs7cjk5cjs7cjkCWLgBOjBAQDAvPj78/jBAQDAuPz8AAAMAW/96BDQEuAAVAB0AJgBjsgQnKBESObAEELAb0LAEELAj0ACwAEVYsAQvG7EEGD5ZsABFWLAPLxuxDxA+WbIjAQorWCHYG/RZsiEjBBESObAhELAY0LAEELIbAQorWCHYG/RZshkbDxESObAZELAg0DAxEzQ2NjMyFzczBxYRFAYGIyInByM3JhMUFwEmIyIGBTQnARYzMjY1W3vhj25eSXxmw3zgkGhWSnxkzblhAVc+SIqoAmZX/qw3QounAief/YsqlM2a/sCe/okjlcuVATfCbwK2INq1tm/9UBnbuQACAJX+YAQnBgAADwAaAGSyGBscERI5sBgQsAzQALAIL7AARViwDC8bsQwYPlmwAEVYsAYvG7EGEj5ZsABFWLADLxuxAxA+WbIFDAMREjmyCgwDERI5sAwQshMBCitYIdgb9FmwAxCyGAEKK1gh2Bv0WTAxARQCIyInESMRMxE2MzISESc0JiMiBxEWMzI2BCfiwcVxublxwsPjuZyIqFRTq4WdAhH3/tJ9/fcHoP3KhP7a/voEt9SV/fuU0wAAAQCbAAABVQQ6AAMAHQCwAEVYsAIvG7ECGD5ZsABFWLAALxuxABA+WTAxISMRMwFVuroEOgAAAgBo/+sHCQXEABcAIwCRsgEkJRESObABELAa0ACwAEVYsAwvG7EMHD5ZsABFWLAOLxuxDhw+WbAARViwAC8bsQAQPlmwAEVYsAMvG7EDED5ZsA4QshABCitYIdgb9FmyEwAOERI5sBMvshQBCitYIdgb9FmwABCyFgEKK1gh2Bv0WbADELIYAQorWCHYG/RZsAwQsh0BCitYIdgb9FkwMSEhBiMiJgInETQSNjMyFyEVIREhFSERIQUyNxEmIyIGBxEUFgcJ/LCycqL+jAGL/qJ8qgNG/S0Cd/2JAt37jHFmbWytwgLDFZYBD6sBNawBEZcUnv4snf38Gw4Ejg/lz/7H0+sAAAMAYf/sBwAETgAgACwANACWsgY1NhESObAGELAm0LAGELAw0ACwAEVYsAQvG7EEGD5ZsABFWLAKLxuxChg+WbAARViwFy8bsRcQPlmwAEVYsB0vG7EdED5ZsgcKFxESObIxChcREjmwMS+yDgEKK1gh2Bv0WbAXELISAQorWCHYG/RZshQKFxESObIaChcREjmwJNCwBBCyKgEKK1gh2Bv0WbAt0DAxEzQ2NjMyFhc2NjMyFhUVIRYWMzI3FwYjIiYnBgYjIgA1FxQWMzI2NTQmIyIGJSIGByE1NCZheduOick9QcRwz+r9Mgekhrx4Son1h80/PseG3P74uaCLiaChioeiBC1jlhYCDokCJ6D+iXVkZnP+63SqxWx+hHBkY3EBMP4Jt9jXzrbZ1tajihp9lgAAAQCpBOQDBgYAAAgANACwBC+wB9CwBy+0DwcfBwJdsgUEBxESORmwBS8YsAHQGbABLxiwBBCwAtCyAwQHERI5MDEBFSMnByM1EzMDBpmWlZn2cATuCqqqDAEQAAACAHkEtAInBlAACQAUACqyAxUWERI5sAMQsA3QALADL7AH0LAHL7I/BwFdsAMQsA3QsAcQsBLQMDEBFAYjIiY0NjIWBRQWMzI2NCYjIgYCJ3xbXHt7uHv+tUMxMERDMTJCBYBXdXasenpWL0RCYkVGAAABAHsE2QM+BegAFwA+ALADL7AI0LAIL7QPCB8IAl2wAxCwC9CwCy+wCBCyDwMKK1gh2Bv0WbADELIUAworWCHYG/RZsA8QsBfQMDEBFAYjIi4CIyIGFSc0NjMyHgIzMjY1Az57XCk8YSscKTp8eV0jOGAzHys5BdxshhQ+DT8xB2uMFDoSRC3//wCiAosEjQMiAEYAn9kATM1AAP//AJACiwXJAyIARgCfhABmZkAAAAEAYAQxAXgGEwAIACGyCAkKERI5ALAARViwAC8bsQAePlmyBQkAERI5sAUvMDEBFwYHFSM1NDYBDmpdA7hhBhNIf5OIdGbIAAEAMAQWAUcGAAAIACGyCAkKERI5ALAARViwBC8bsQQePlmyAAkEERI5sAAvMDETJzY3NTMVBgaZaV0DtwFhBBZIgpCQgmTHAAEAJP7lATsAtQAIAB6yCAkKERI5ALAJL7IEBQorWCHYG/RZsADQsAAvMDETJzY3NTMVFAaNaVsDuWP+5Ul/knZkZcr//wBoBDECuwYTACYAkwgAAAcAkwFDAAD//wA8BBYChgYAACYAlAwAAAcAlAE/AAAAAgAk/tMCZAD2AAgAEQAwsgoSExESObAKELAF0ACwEi+yBAUKK1gh2Bv0WbAA0LAAL7AJ0LAJL7AEELAN0DAxEyc2NzUzFRQGFyc2NzUzFRQGjWlbA7lj3WlbA7ph/tNIiZm5pGzTQEiJmbmka9EAAAEAigIXAiIDywANABayCg4PERI5ALADL7EKCitY2BvcWTAxEzQ2MzIWFRUUBiMiJjWKb1xbcm5eXW8DBFdwbV0lV25vWAABAGwAmQIgA7UABgAQALAFL7ICBwUREjmwAi8wMQEBIwE1ATMBHgECjf7ZASeNAib+cwGEEwGFAAEAWQCYAg4DtQAGABAAsAAvsgMHABESObADLzAxEwEVASMBAecBJ/7ZjgEC/v4Dtf57E/57AY4BjwABADsAbgNqBSIAAwAJALAAL7ACLzAxNycBF6NoAsdobkIEckIA//8ANgKQArsFpQMHAKUAAAKQABMAsABFWLAJLxuxCRw+WbAN0DAxAAABAF//7AQcBcQAIwCHshUkJRESOQCwAEVYsBYvG7EWHD5ZsABFWLAJLxuxCRA+WbIjCRYREjmwIy+yAAIKK1gh2Bv0WbAJELIEAQorWCHYG/RZsAAQsAzQsCMQsA/QsCMQsB/QsB8vtg8fHx8vHwNdsiACCitYIdgb9FmwENCwHxCwE9CwFhCyGwEKK1gh2Bv0WTAxASEWFjMyNxcGIyIAAyM1MzUjNTMSADMyFwcmIyIGByEVIRUhA1H+gAS0pXRmFHh4+P7jBrKysrIKAR3zaocUbW6ksQYBf/6AAYACHcPSIqAeASUBDHyJfQEGAR8foiPLvH2JAAEAqAKLA+sDIgADABsAsABFWLACLxuxAhY+WbIBAQorWCHYG/RZMDEBITUhA+v8vQNDAouXAAIAHwAAA80GFQAVABkAg7IIGhsREjmwCBCwF9AAsABFWLAILxuxCB4+WbAARViwAy8bsQMYPlmwAEVYsBEvG7ERGD5ZsABFWLAYLxuxGBg+WbAARViwAC8bsQAQPlmwAEVYsBYvG7EWED5ZsAMQsgEBCitYIdgb9FmwCBCyDQEKK1gh2Bv0WbABELAT0LAU0DAxMxEjNTM1NDYzMhcHJiMiBhUVMxUjESEjETPKq6vPvXCrH31xd2nd3QJJuroDq49ctco9nDJra16P/FUEOgABADwAAAPpBhUAFgBcALAARViwEi8bsRIePlmwAEVYsAYvG7EGGD5ZsABFWLAJLxuxCRA+WbAARViwFi8bsRYQPlmwEhCyAgEKK1gh2Bv0WbAGELIHAQorWCHYG/RZsAvQsAYQsA7QMDEBJiMiFRUzFSMRIxEjNTM1NjYzMgURIwMwfEzI5+e5q6sBwLFlASu5BWMU0muP/FUDq492rbg9+igAAAEAegAAAe8DFQAGADUAsABFWLAFLxuxBRY+WbAARViwAS8bsQEQPlmyBAUBERI5sAQvsgMCCitYIdgb9FmwAtAwMSEjEQc1JTMB753YAWMSAlk5gHUAAQBCAAACqwMgABYAVLIIFxgREjkAsABFWLAOLxuxDhY+WbAARViwAC8bsQAQPlmyFQIKK1gh2Bv0WbAC0LIUFQ4REjmyAw4UERI5sA4QsggCCitYIdgb9FmwDhCwC9AwMSEhNQE2NTQmIyIGFSM0NiAWFRQPAiECq/2pASxtQDxLR52nAQiaa1SwAY9sARpmRTE9TDlylH9uaGtPkQABAD7/9QKaAyAAJgBxALAARViwDi8bsQ4WPlmwAEVYsBkvG7EZED5ZsgAZDhESOXywAC8YtoAAkACgAANdsA4QsgcCCitYIdgb9FmyCgAHERI5sAAQsiYCCitYIdgb9FmyFCYAERI5sBkQsiACCitYIdgb9FmyHSYgERI5MDEBMzI2NTQmIyIGFSM0NjMyFhUUBgcWFRQGIyImNTMUFjMyNjU0JyMBCVRKSD9GOUudo3yJnEZClaqIhKaeT0NGSZxYAcs9MC06Mylie3loN1sZKY9qfX5rLTw8M3ECAAACADYAAAK7AxUACgAOAEkAsABFWLAJLxuxCRY+WbAARViwBC8bsQQQPlmyAQkEERI5sAEvsgICCitYIdgb9FmwBtCwARCwC9CyCAsGERI5sg0JBBESOTAxATMVIxUjNSEnATMBMxEHAlBra53+iQYBeaH+hN8RASuCqalmAgb+FgEhHP//ACUCHwINArYCBgARAAAAAgAlAAAE5AWwAA8AHQBmALAARViwBS8bsQUcPlmwAEVYsAAvG7EAED5ZsgQABRESObAEL7LPBAFdsi8EAV2ynwQBcbIBAQorWCHYG/RZsBHQsAAQshIBCitYIdgb9FmwBRCyGwEKK1gh2Bv0WbAEELAc0DAxMxEjNTMRITIEEhcVFAIEBxMhETMyEjc1NAInIxEhx6KiAZu+ASSfAZ/+2cRH/ubJ3vcB6dbgARoCmpcCf6j+ysldzv7KpgICmv4DARL5XfgBEwL+HwD//wAcAAAFHQc0AiYAJQAAAQcARAEwATYAFACwAEVYsAQvG7EEHD5ZsQwI9DAx//8AHAAABR0HNAImACUAAAEHAHUBvwE2ABQAsABFWLAFLxuxBRw+WbENCPQwMf//ABwAAAUdBzYCJgAlAAABBwCOAMkBNgAUALAARViwBC8bsQQcPlmxDwb0MDH//wAcAAAFHQciAiYAJQAAAQcAkADFAToAFACwAEVYsAUvG7EFHD5ZsQ4E9DAx//8AHAAABR0G+wImACUAAAEHAGoA+QE2ABcAsABFWLAELxuxBBw+WbERBPSwG9AwMQD//wAcAAAFHQeRAiYAJQAAAQcAjwFQAUEAFwCwAEVYsAQvG7EEHD5ZsQ4G9LAY0DAxAP//AHf+RATYBcQCJgAnAAAABwB5AdL/9///AKkAAARGB0ACJgApAAABBwBEAPsBQgAUALAARViwBi8bsQYcPlmxDQj0MDH//wCpAAAERgdAAiYAKQAAAQcAdQGKAUIAFACwAEVYsAYvG7EGHD5ZsQ4I9DAx//8AqQAABEYHQgImACkAAAEHAI4AlAFCABQAsABFWLAGLxuxBhw+WbEQBvQwMf//AKkAAARGBwcCJgApAAABBwBqAMQBQgAXALAARViwBi8bsQYcPlmxEgT0sBvQMDEA////4AAAAYEHQAImAC0AAAEHAET/pwFCABQAsABFWLACLxuxAhw+WbEFCPQwMf//ALAAAAJRB0ACJgAtAAABBwB1ADUBQgAUALAARViwAy8bsQMcPlmxBgj0MDH////pAAACRgdCAiYALQAAAQcAjv9AAUIAFACwAEVYsAIvG7ECHD5ZsQgG9DAx////1gAAAl8HBwImAC0AAAEHAGr/cAFCABcAsABFWLACLxuxAhw+WbEKBPSwFNAwMQD//wCpAAAFCAciAiYAMgAAAQcAkAD7AToAFACwAEVYsAYvG7EGHD5ZsQ0E9DAx//8Adv/sBQkHNgImADMAAAEHAEQBUgE4ABQAsABFWLANLxuxDRw+WbEhCPQwMf//AHb/7AUJBzYCJgAzAAABBwB1AeEBOAAUALAARViwDS8bsQ0cPlmxIgj0MDH//wB2/+wFCQc4AiYAMwAAAQcAjgDrATgAFACwAEVYsA0vG7ENHD5ZsSIG9DAx//8Adv/sBQkHJAImADMAAAEHAJAA5wE8ABQAsABFWLANLxuxDRw+WbEjBPQwMf//AHb/7AUJBv0CJgAzAAABBwBqARsBOAAXALAARViwDS8bsQ0cPlmxJwT0sDDQMDEA//8AjP/sBKoHNAImADkAAAEHAEQBKwE2ABQAsABFWLAKLxuxChw+WbEUCPQwMf//AIz/7ASqBzQCJgA5AAABBwB1AboBNgAUALAARViwEi8bsRIcPlmxFQj0MDH//wCM/+wEqgc2AiYAOQAAAQcAjgDEATYAFACwAEVYsAovG7EKHD5ZsRcG9DAx//8AjP/sBKoG+wImADkAAAEHAGoA9AE2ABcAsABFWLAKLxuxChw+WbEZBPSwI9AwMQD//wAPAAAEuwc0AiYAPQAAAQcAdQGIATYAFACwAEVYsAEvG7EBHD5ZsQsI9DAx//8Abf/sA+oF/gImAEUAAAEHAEQA1QAAABQAsABFWLAXLxuxFxg+WbEqCfQwMf//AG3/7APqBf4CJgBFAAABBwB1AWQAAAAUALAARViwFy8bsRcYPlmxKwn0MDH//wBt/+wD6gYAAiYARQAAAQYAjm4AABQAsABFWLAXLxuxFxg+WbErAfQwMf//AG3/7APqBewCJgBFAAABBgCQagQAFACwAEVYsBcvG7EXGD5ZsSwB9DAx//8Abf/sA+oFxQImAEUAAAEHAGoAngAAABcAsABFWLAXLxuxFxg+WbEwAfSwOdAwMQD//wBt/+wD6gZbAiYARQAAAQcAjwD1AAsAFwCwAEVYsBcvG7EXGD5ZsSwE9LA20DAxAP//AFz+RAPsBE4CJgBHAAAABwB5AT//9///AF3/7APzBf4CJgBJAAABBwBEAMUAAAAUALAARViwCC8bsQgYPlmxHwn0MDH//wBd/+wD8wX+AiYASQAAAQcAdQFUAAAAFACwAEVYsAgvG7EIGD5ZsSAJ9DAx//8AXf/sA/MGAAImAEkAAAEGAI5eAAAUALAARViwCC8bsQgYPlmxIAH0MDH//wBd/+wD8wXFAiYASQAAAQcAagCOAAAAFwCwAEVYsAgvG7EIGD5ZsSUB9LAu0DAxAP///8YAAAFnBf0CJgCLAAABBgBEjf8AFACwAEVYsAIvG7ECGD5ZsQUJ9DAx//8AlgAAAjcF/QImAIsAAAEGAHUb/wAUALAARViwAy8bsQMYPlmxBgn0MDH////PAAACLAX/AiYAiwAAAQcAjv8m//8AFACwAEVYsAIvG7ECGD5ZsQgB9DAx////vAAAAkUFxAImAIsAAAEHAGr/Vv//ABcAsABFWLACLxuxAhg+WbELAfSwFNAwMQD//wCMAAAD3wXsAiYAUgAAAQYAkGEEABQAsABFWLADLxuxAxg+WbEVAfQwMf//AFv/7AQ0Bf4CJgBTAAABBwBEAM8AAAAUALAARViwBC8bsQQYPlmxHQn0MDH//wBb/+wENAX+AiYAUwAAAQcAdQFeAAAAFACwAEVYsAQvG7EEGD5ZsR4J9DAx//8AW//sBDQGAAImAFMAAAEGAI5oAAAUALAARViwBC8bsQQYPlmxHgH0MDH//wBb/+wENAXsAiYAUwAAAQYAkGQEABQAsABFWLAELxuxBBg+WbEfAfQwMf//AFv/7AQ0BcUCJgBTAAABBwBqAJgAAAAXALAARViwBC8bsQQYPlmxIwH0sCzQMDEA//8AiP/sA9wF/gImAFkAAAEHAEQAxwAAABQAsABFWLAHLxuxBxg+WbESCfQwMf//AIj/7APcBf4CJgBZAAABBwB1AVYAAAAUALAARViwDS8bsQ0YPlmxEwn0MDH//wCI/+wD3AYAAiYAWQAAAQYAjmAAABQAsABFWLAHLxuxBxg+WbEVAfQwMf//AIj/7APcBcUCJgBZAAABBwBqAJAAAAAXALAARViwBy8bsQcYPlmxGAH0sCHQMDEA//8AFv5LA7AF/gImAF0AAAEHAHUBGwAAABQAsABFWLABLxuxARg+WbESCfQwMf//ABb+SwOwBcUCJgBdAAABBgBqVQAAFwCwAEVYsA8vG7EPGD5ZsRcB9LAg0DAxAAAAAAEAAADeAI8AFgBUAAUAAQAAAAAADgAAAgACFAAGAAEAAABhAGEAYQBhAGEAkwC4ATgBqgI6As0C5AMOAzgDawOQA68DxQPmA/0ESgR4BMcFPAV/Bd8GPgZrBt8HRgdbB3AHjwe2B9UIMwjWCRUJdAnICg0KTQqDCusLLQtIC3sL0Av0DEIMfgzTDR4Ngw3fDkoOdA62DuYPOw+QD8AP+BAcEDMQWBB/EJoQuhEyEZAR4xJBEqgS+hN0E7kT8RQ9FJQUrxUaFWUVsxYXFngWtRcfF3EXuBfoGDYYfRjCGPoZOxlSGZIZ2RoMGmga2hs9G5wbuxxgHI8dNR2jHa8dzB6EHpoe1h8ZH2kf5CAEIE0geSCYINMhBSFPIVshdSGPIakiCiJtIqsjJiN6I+okqCUXJWgl2SY4JlMm1idwJ54n1ygbKCUoLyhTKHcomSilKLEo6SkMKSgpRSlYKWwp6CoDKmsqvSroKzcrpivoK+gr8CxWLG0shCybLLIsyyzkLPAtBy0eLTUtTi1lLXwtky2sLcMt2i3xLgguHy44Lk8uZi59LpYurS7ELtsu8S8HLyAvOS9FL1wvcy+JL6IvuC/OL+Uv/jAUMCswQjBYMG4whzCeMLUwyzDkMPsxEwAAAAEAAAACAAAwG1GuXw889QAbCAAAAAAAxPARLgAAAADQ206a+hv91QkwCHMAAAAJAAIAAAAAAAADjABkAAAAAAAAAAAB+wAAAfsAAAIPAKACjwCIBO0AdwR+AG4F3ABpBPkAZQFlAGcCvACFAsgAJgNyABwEiQBOAZIAHQI1ACUCGwCQA0wAEgR+AHMEfgCqBH4AXQR+AF4EfgA1BH4AmgR+AIQEfgBNBH4AcAR+AGQB8ACGAbEAKQQRAEgEZACYBC4AhgPHAEsHLwBqBTgAHAT7AKkFNQB3BT8AqQSMAKkEbACpBXMAegW0AKkCLQC3BGoANQUEAKkETgCpBvwAqQW0AKkFgAB2BQwAqQWAAG0E7QCoBL8AUATGADEFMACMBRcAHAcZAD0FBAA5BM4ADwTKAFYCHwCSA0gAKAIfAAkDWABAA5wABAJ5ADkEWgBtBH0AjAQwAFwEgwBfBD0AXQLHADwEfQBgBGgAjAHxAI0B6f+/BA4AjQHxAJwHAwCLBGoAjASQAFsEfQCMBIwAXwK1AIwEIABfAp0ACQRpAIgD4AAhBgMAKwP3ACkDyQAWA/cAWAK1AEAB8wCvArUAEwVxAIMB8wCLBGAAaQSmAFsFtABpBNgAHwHrAJME6ABaA1gAZgZJAFsDkwCTA8EAZgRuAH8GSgBaA6oAeAL9AIIERgBhAu8AQgLvAD4CggB7BIgAmgPpAEMCFgCTAfsAdALvAHoDowB6A8AAZgXcAFUGNQBQBjkAbwPJAEQHev/yBEQAWQWAAHYEugCmBMIAiwbBAE4EsAB+BJEARwSIAFsEnACVAfoAmwehAGgHRABhA8QAqQKtAHkDxgB7BUAAogY/AJABmQBgAZkAMAGXACQC1ABoAtsAPALBACQCsgCKAmYAbAJmAFkDowA7Au8ANgR+AF8EkgCoBG4AHwSLADwC7wB6Au8AQgLvAD4C7wA2AfsAAAI1ACUFXQAlBTgAHAU4ABwFOAAcBTgAHAU4ABwFOAAcBTUAdwSMAKkEjACpBIwAqQSMAKkCLf/gAi0AsAIt/+kCLf/WBbQAqQWAAHYFgAB2BYAAdgWAAHYFgAB2BTAAjAUwAIwFMACMBTAAjATOAA8EWgBtBFoAbQRaAG0EWgBtBFoAbQRaAG0EMABcBD0AXQQ9AF0EPQBdBD0AXQH6/8YB+gCWAfr/zwH6/7wEagCMBJAAWwSQAFsEkABbBJAAWwSQAFsEaQCIBGkAiARpAIgEaQCIA8kAFgAWAAAAAQAAB2z+DAAACUn6G/5KCTAAAQAAAAAAAAAAAAAAAAAAAN0AAwSFAZAABQAABZoFMwAAAR8FmgUzAAAD0QBmAgAAAAIAAAAAAAAAAADgAAr/UAAhfwAAACEAAAAAR09PRwBAAAD//QYA/gAAZgeaAgAgAAGfAAAAAAQ6BbAAIAAgAAIAAAABAAAA4AkJBAAAAgICAwYFBwYCAwMEBQICAgQFBQUFBQUFBQUFAgIFBQUECAYGBgYFBQYGAgUGBQgGBgYGBgUFBgYIBgUFAgQCBAQDBQUFBQUDBQUCAgUCCAUFBQUDBQMFBAcEBAQDAgMGAgUFBgUCBgQHBAQFBwQDBQMDAwUEAgIDBAQHBwcECAUGBQUIBQUFBQIJCAQDBAYHAgICAwMDAwMDBAMFBQUFAwMDAwICBgYGBgYGBgYFBQUFAgICAgYGBgYGBgYGBgYFBQUFBQUFBQUFBQUCAgICBQUFBQUFBQUFBQQEAAAAAwAAAAMAAAAcAAMAAQAAABwAAwAKAAABYAAEAUQAAAA2ACAABAAWAAAADQB+AKAArACtAL8AxgDPAOYA7wD/ATEBUwLGAtoC3CAUIBogHiAiIDogRCB0IKwiEv//AAAAAAANACAAoAChAK0ArgDAAMcA0ADnAPABMQFSAsYC2gLcIBMgGCAcICIgOSBEIHQgrCIS//8AAf/2/+QABv/C//r/wQAA/+gAAP/iAAD/Wv86/cj9tf204H7ge+B64HfgYeBY4Cnf8t6NAAEAAAAAAAAAAAAAAAAAAAAoAAAAMgAAAFwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAqQCqAKsArACtAK4AgQCoALgAuQC6ALsAvAC9AIIAgwC+AL8AwADBAMIAhACFAMMAxADFAMYAxwDIAIYAhwDSANMA1ADVANYA1wCIAIkA2ADZANoA2wDcAIoA3QAMAAAAAAHYAAAAAAAAACYAAAAAAAAAAAAAAAEAAAANAAAADQAAAAMAAAAgAAAAfgAAAAQAAACgAAAAoAAAAKYAAAChAAAArAAAAGMAAACtAAAArQAAAKcAAACuAAAAvwAAAG8AAADAAAAAxQAAAKkAAADGAAAAxgAAAIEAAADHAAAAzwAAAK8AAADQAAAA0AAAAKgAAADRAAAA1gAAALgAAADXAAAA2AAAAIIAAADZAAAA3QAAAL4AAADeAAAA3wAAAIQAAADgAAAA5QAAAMMAAADmAAAA5gAAAIYAAADnAAAA7wAAAMkAAADwAAAA8AAAAIcAAADxAAAA9gAAANIAAAD3AAAA+AAAAIgAAAD5AAAA/QAAANgAAAD+AAAA/gAAAIoAAAD/AAAA/wAAAN0AAAExAAABMQAAAIsAAAFSAAABUwAAAIwAAALGAAACxgAAAI4AAALaAAAC2gAAAI8AAALcAAAC3AAAAJAAACATAAAgFAAAAJEAACAYAAAgGgAAAJMAACAcAAAgHgAAAJYAACAiAAAgIgAAAJkAACA5AAAgOgAAAJoAACBEAAAgRAAAAJwAACB0AAAgdAAAAJ0AACCsAAAgrAAAAJ4AACISAAAiEgAAAJ+wACxLsAlQWLEBAY5ZuAH/hbCEHbEJA19eLbABLCAgRWlEsAFgLbACLLABKiEtsAMsIEawAyVGUlgjWSCKIIpJZIogRiBoYWSwBCVGIGhhZFJYI2WKWS8gsABTWGkgsABUWCGwQFkbaSCwAFRYIbBAZVlZOi2wBCwgRrAEJUZSWCOKWSBGIGphZLAEJUYgamFkUlgjilkv/S2wBSxLILADJlBYUViwgEQbsEBEWRshISBFsMBQWLDARBshWVktsAYsICBFaUSwAWAgIEV9aRhEsAFgLbAHLLAGKi2wCCxLILADJlNYsEAbsABZioogsAMmU1gjIbCAioobiiNZILADJlNYIyGwwIqKG4ojWSCwAyZTWCMhuAEAioobiiNZILADJlNYIyG4AUCKihuKI1kgsAMmU1iwAyVFuAGAUFgjIbgBgCMhG7ADJUUjISMhWRshWUQtsAksS1NYRUQbISFZLbAKLLAkRS2wCyywJUUtsAwssScBiCCKU1i5QAAEAGO4CACIVFi5ACQD6HBZG7AjU1iwIIi4EABUWLkAJAPocFlZWS2wDSywQIi4IABaWLElAEQbuQAlA+hEWS2wDCuwACsAsgEOAisBsg8BAisBtw86MCUbEAAIKwC3AUg7LiEUAAgrtwJYSDgoFAAIK7cDUkM0JRYACCu3BF5NPCsZAAgrtwU2LCIZDwAIK7cGcV1GMhsACCu3B5F3XDojAAgrtwh+Z1A5GgAIK7cJVEU2JhcACCu3CnZgSzYdAAgrtwuDZE46IwAIK7cM2bKKYzwACCu3DRQRDQkGAAgrtw48MiccEQAIKwCyEAoHK7AAIEV9aRhEsjASAXOysBQBc7JQFAF0soAUAXSycBQBdbIPHAFzsm8cAXUAACoAnQCAAIoAeADUAGQATgBaAIcAYABWADQCPAC8AMQAAAAU/mAAFAKbACADIQALBDoAFASNABAFsAAUBhgAFQGmABEGwAAOAAAAAAAAAAcAWgADAAEECQABAAwAAAADAAEECQACAA4ADAADAAEECQADAAwAAAADAAEECQAEAAwAAAADAAEECQAFACwAGgADAAEECQAGABwARgADAAEECQAOAFQAYgBSAG8AYgBvAHQAbwBSAGUAZwB1AGwAYQByAFYAZQByAHMAaQBvAG4AIAAyAC4AMAAwADEAMQAwADEAOwAgADIAMAAxADQAUgBvAGIAbwB0AG8ALQBSAGUAZwB1AGwAYQByAGgAdAB0AHAAOgAvAC8AdwB3AHcALgBhAHAAYQBjAGgAZQAuAG8AcgBnAC8AbABpAGMAZQBuAHMAZQBzAC8ATABJAEMARQBOAFMARQAtADIALgAwAAMAAAAAAAD/agBkAAAAAAAAAAAAAAAAAAAAAAAAAAAAAQACAAgAAv//AA8AAQAAAAwAAAAAAAAAAgAKACUAPgABAEUAXgABAHkAeQADAIEAgQABAIMAgwABAIYAhgABAIkAiQABAIsAjQABAKAAoQACAKgA3QABAAEAAAAKAFQAdAAEREZMVAAaY3lybAAmZ3JlawAybGF0bgA+AAQAAAAA//8AAQAAAAQAAAAA//8AAQABAAQAAAAA//8AAQACAAQAAAAA//8AAQADAARrZXJuABprZXJuABprZXJuABprZXJuABoAAAABAAAAAQAEAAIAAAAEAA4CDgOSBFIAAQCCAAQAAAA8AYgBiAD+AY4BnAG0AaoBBAEKARABtAEWASABQgFUAboBZgH0AWwB9AH0AfQB9AF6AfoB+gGIAYgBiAGIAbQBjgGOAY4BjgGOAY4BnAGqAaoBqgGqAbQBtAG0AbQBtAG6AfQB9AH0AfQB9AH0AfQB9AH0AfQB+gH6AAEAPAAGAAsAEwAlACcAKAApACoALwAwADMANAA4ADoAOwA9AD4ASQBKAEwAUQBSAFMAVgBaAF0AkwCUAJYAlwCoAKkAqgCrAKwArQCuAK8AsACxALIAswC5ALoAuwC8AL0AwgDKAMsAzADNANIA0wDUANUA1gDXANwA3QABABP/IAABAFb/5gABAFv/wQABAFv/pAACAFgADgCB/58ACAAE/9gAVv+1AFv/xwBt/rgAfP8oAIH/TQCG/44Aif+hAAQADQAUAEEAEQBW/+IAYQATAAQADQAPAEEADABW/+sAYQAOAAEAW//lAAMADQAUAEEAEgBhABMAAwBKAA8AWAAyAFsAEQABAFsACwADACP/wwBY/+8AW//fAAMADf/mAEH/9ABh/+8AAgBK/+4AW//qAAEAgf/fAA4ACv/iAA0AFAAO/88AQQASAEr/6gBW/9gAWP/qAGEAEwBt/64AfP/NAIH/oACG/8EAif/AAJn/0wABAJT/sAABAEoADQABABgABAAAAAcAKgAwAEIA/AESASQBPgABAAcABAAMACoANQA2AD8ASgABADj/2AAEADoAFAA7ABIAPQAWAMIAFgAuABD/FgAS/xYAJf9WAC7++AA4ABQARf/eAEf/6wBI/+sASf/rAEv/6wBT/+sAVf/rAFn/6gBa/+gAXf/oAI3/6wCV/xYAmP8WAKn/VgCq/1YAq/9WAKz/VgCt/1YArv9WAMP/3gDE/94Axf/eAMb/3gDH/94AyP/eAMn/6wDK/+sAy//rAMz/6wDN/+sA0//rANT/6wDV/+sA1v/rANf/6wDY/+oA2f/qANr/6gDb/+oA3P/oAN3/6AAFADj/1QA6/+QAO//sAD3/3QDC/90ABAA4/7AAOv/tAD3/0ADC/9AABgAu/+4AOf/uAL7/7gC//+4AwP/uAMH/7gARAAYAEAALABAAR//oAEj/6ABJ/+gAS//oAFX/6ACN/+gAkwAQAJQAEACWABAAlwAQAMn/6ADK/+gAy//oAMz/6ADN/+gAAQAUAAQAAAAFACIAUABqAHwAlgABAAUATwBYAFsAXwCUAAsAR//sAEj/7ABJ/+wAS//sAFX/7ACN/+wAyf/sAMr/7ADL/+wAzP/sAM3/7AAGAFP/7ADT/+wA1P/sANX/7ADW/+wA1//sAAQAEP+EABL/hACV/4QAmP+EAAYALv/sADn/7AC+/+wAv//sAMD/7ADB/+wACgBMACAATwAgAFAAIABT/4AAV/+QANP/gADU/4AA1f+AANb/gADX/4AAAgVQAAQAAAXGBwgAHAAYAAD/zv/1/+//iP/0/7v/f//1AAz/qf+iAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD/5QAAAAD/6P/JAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD/4wAAAAAAAP/kABIAEQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD/5QAAAAD/6v/V/+v/6v+a/+kAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD/4wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD/5gAAAAAAAP/tAAAAFP/vAAAAAAAAAAAAAAAAAAD/7QAAAAAAAAAAAAAAAAAAAAD/uP/kAAAAAP+dAA8AEP+h/8QAEAAQ/7EAAP8mAAD/nf+z/xj/k//w/4//jP8QAAD/2P/hAAAAAP/lAAAAAP/pAAAAAAAAAAAAAAAAAAD/5gAA/8D/6QAAAAAAAAAAAAD/e/+//8r+sAAA/3H+7f/UAAD/Uf8RABMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADwAAAAAAAP/zAAAAAAAAAAAAAAAA/3b/4f68/+b/8wAAAAAAAAAA//UAAP84AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA/+oAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD/9f/zAAAAAP/SAAAAAP/kAAAAAAAA/7UAAP8fAAD/1AAA/9sAAAAA/9IAAAAAAAD/4f/nAAAAAP/rAAAAAP/rAAAADgAAAAAAAAAAAAD/5gAA/9IAAAAAAAAAAAAAAAD/7P/j/6AAAP+/ABEAEf/Z/+IAEgAS/6IADf8tAAD/v//p/8z/2P/w/7f/xv+gAAAAAAAAAAAAAP/hAAAADv/tAAAAAAAA/9UAAP+FAAD/4QAA/8QAAAAA/98AAAAAAAD/5f/mAAAAAP/rAAAAAP/tAAAAAAAAAA0AAAAAAAD/6wAAAAAAAAAAAAAAAAAAAAD/8QAAAAD/vQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD/9QAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD/9QAAAAD/4wAAAAAAAAAA//EAAAAAAAAAAAAAAAAAAP/xAAAAAAAAAAAAAAAAAAD/8wAAAAD/8gAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD/mAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD/8QAAAAD/eAAAAAAAAAAA//AAAAAAAAAAAAAAAAAAAP/rAAAAAAAAAAAAAAAAAAAAAAAAAAAAD//xAAAAAAAAAAAAAAAAAAAAAP+VAAD/8wAAAAAAAAAA//EAAAAAAAAAEgAAAAAAEP/sAAAAAAAAAAAAAAAAAAAAAP+FAAD/7QAAAAAAAAAA/9gAAAAAAAAAAAAAAAAAAP/sAAAAAAAAAAAAAAAAAAAAAAAAAAD/7AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAP/wAAAAAAAAAAAAAAAAAAAAAAAAAAD/8AAAAAAAAAAAAAAAAAAAAAAAAAAAAAD/lf/DAAAAAAAAAAAAAAAA/4gAAAAAAAD/xQAAAAD/7AAA/87/sAAAAAAAAAAAAAD/VgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAIAEwAGAAYAAAALAAsAAQAQABAAAgASABIAAwAlACkABAAsADQACQA4AD4AEgBFAEcAGQBJAEkAHABMAEwAHQBRAFQAHgBWAFYAIgBaAFoAIwBcAF4AJACKAIoAJwCTAJgAKACoAM0ALgDSANcAVADcAN0AWgACADUABgAGABoACwALABoAEAAQABsAEgASABsAJgAmAAEAJwAnAAQAKAAoAAMAKQApAAUALAAtAAIALgAuAAoALwAvAAcAMAAwAAgAMQAyAAIAMwAzAAMANAA0AAkAOAA4AAYAOQA5AAoAOgA6AAsAOwA7AA4APAA8AAwAPQA9AA0APgA+AA8ARQBFABAARgBGABIARwBHABEASQBJABMATABMABQAUQBSABQAUwBTABUAVABUABIAVgBWABcAWgBaABYAXABcABgAXQBdABYAXgBeABkAigCKABIAkwCUABoAlQCVABsAlgCXABoAmACYABsAqACoAAMArwCvAAQAsACzAAUAtAC4AAIAuQC9AAMAvgDBAAoAwgDCAA0AwwDIABAAyQDJABEAygDNABMA0gDSABQA0wDXABUA3ADdABYAAgA0AAYABgAEAAsACwAEABAAEAAOABEAEQASABIAEgAOACUAJQAMACcAJwACACsAKwACAC4ALgAXADMAMwACADUANQACADcANwAUADgAOAAHADkAOQADADoAOgAKADsAOwAGADwAPAANAD0APQALAD4APgAPAEUARQAVAEcASQAQAEsASwAQAFEAUgATAFMAUwAFAFQAVAATAFUAVQAQAFcAVwAWAFkAWQAIAFoAWgABAFwAXAARAF0AXQABAF4AXgAJAIMAgwACAIwAjAACAI0AjQAQAJEAkgASAJMAlAAEAJUAlQAOAJYAlwAEAJgAmAAOAKcApwASAKkArgAMAK8ArwACALkAvQACAL4AwQADAMIAwgALAMMAyAAVAMkAzQAQANIA0gATANMA1wAFANgA2wAIANwA3QABAAAAAQAAAAoALABIAAFsYXRuAAgACgABVFVSIAASAAD//wABAAAAAP//AAEAAQACbGlnYQAObGlnYQAWAAAAAgAAAAEAAAABAAEAAgAGACAABAAAAAEACAABACwAAQAIAAEABACgAAIATQAEAAAAAQAIAAEAEgABAAgAAQAEAKEAAgBQAAEAAQBK) format('truetype');
}
@font-face {
font-family: 'Roboto';
font-style: normal;
font-weight: 500;
src: url(data:application/x-font-truetype;base64,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) format('truetype');
}
@font-face {
font-family: 'Roboto';
font-style: normal;
font-weight: 700;
src: url(data:application/x-font-truetype;base64,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) format('truetype');
}
html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}article,aside,details,figcaption,figure,footer,header,hgroup,main,menu,nav,section,summary{display:block}audio,canvas,progress,video{display:inline-block;vertical-align:baseline}audio:not([controls]){display:none;height:0}[hidden],template{display:none}a{background-color:transparent}a:active,a:hover{outline:0}abbr[title]{border-bottom:1px dotted}b,strong{font-weight:bold}dfn{font-style:italic}h1{font-size:2em;margin:0.67em 0}mark{background:#ff0;color:#000}small{font-size:80%}sub,sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sup{top:-0.5em}sub{bottom:-0.25em}img{border:0}svg:not(:root){overflow:hidden}figure{margin:1em 40px}hr{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;height:0}pre{overflow:auto}code,kbd,pre,samp{font-family:monospace, monospace;font-size:1em}button,input,optgroup,select,textarea{color:inherit;font:inherit;margin:0}button{overflow:visible}button,select{text-transform:none}button,html input[type="button"],input[type="reset"],input[type="submit"]{-webkit-appearance:button;cursor:pointer}button[disabled],html input[disabled]{cursor:default}button::-moz-focus-inner,input::-moz-focus-inner{border:0;padding:0}input{line-height:normal}input[type="checkbox"],input[type="radio"]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;padding:0}input[type="number"]::-webkit-inner-spin-button,input[type="number"]::-webkit-outer-spin-button{height:auto}input[type="search"]{-webkit-appearance:textfield;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}input[type="search"]::-webkit-search-cancel-button,input[type="search"]::-webkit-search-decoration{-webkit-appearance:none}fieldset{border:1px solid #c0c0c0;margin:0 2px;padding:0.35em 0.625em 0.75em}legend{border:0;padding:0}textarea{overflow:auto}optgroup{font-weight:bold}table{border-collapse:collapse;border-spacing:0}td,th{padding:0}@media print{*,*:before,*:after{background:transparent !important;color:#000 !important;-webkit-box-shadow:none !important;box-shadow:none !important;text-shadow:none !important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}abbr[title]:after{content:" (" attr(title) ")"}a[href^="#"]:after,a[href^="javascript:"]:after{content:""}pre,blockquote{border:1px solid #999;page-break-inside:avoid}thead{display:table-header-group}tr,img{page-break-inside:avoid}img{max-width:100% !important}p,h2,h3{orphans:3;widows:3}h2,h3{page-break-after:avoid}.navbar{display:none}.btn>.caret,.dropup>.btn>.caret{border-top-color:#000 !important}.label{border:1px solid #000}.table{border-collapse:collapse !important}.table td,.table th{background-color:#fff !important}.table-bordered th,.table-bordered td{border:1px solid #ddd !important}}@font-face{font-family:'Glyphicons Halflings';src:url(data:application/vnd.ms-fontobject;base64,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);src:url(data:application/vnd.ms-fontobject;base64,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) format('embedded-opentype'),url(data:application/font-woff;base64,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) format('woff'),url(data:application/x-font-truetype;base64,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) format('truetype'),url(data:image/svg+xml;base64,<?xml version="1.0" standalone="no"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd" >
<svg xmlns="http://www.w3.org/2000/svg">
<metadata></metadata>
<defs>
<font id="glyphicons_halflingsregular" horiz-adv-x="1200" >
<font-face units-per-em="1200" ascent="960" descent="-240" />
<missing-glyph horiz-adv-x="500" />
<glyph horiz-adv-x="0" />
<glyph horiz-adv-x="400" />
<glyph unicode=" " />
<glyph unicode="*" d="M600 1100q15 0 34 -1.5t30 -3.5l11 -1q10 -2 17.5 -10.5t7.5 -18.5v-224l158 158q7 7 18 8t19 -6l106 -106q7 -8 6 -19t-8 -18l-158 -158h224q10 0 18.5 -7.5t10.5 -17.5q6 -41 6 -75q0 -15 -1.5 -34t-3.5 -30l-1 -11q-2 -10 -10.5 -17.5t-18.5 -7.5h-224l158 -158 q7 -7 8 -18t-6 -19l-106 -106q-8 -7 -19 -6t-18 8l-158 158v-224q0 -10 -7.5 -18.5t-17.5 -10.5q-41 -6 -75 -6q-15 0 -34 1.5t-30 3.5l-11 1q-10 2 -17.5 10.5t-7.5 18.5v224l-158 -158q-7 -7 -18 -8t-19 6l-106 106q-7 8 -6 19t8 18l158 158h-224q-10 0 -18.5 7.5 t-10.5 17.5q-6 41 -6 75q0 15 1.5 34t3.5 30l1 11q2 10 10.5 17.5t18.5 7.5h224l-158 158q-7 7 -8 18t6 19l106 106q8 7 19 6t18 -8l158 -158v224q0 10 7.5 18.5t17.5 10.5q41 6 75 6z" />
<glyph unicode="+" d="M450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-350h350q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-350v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v350h-350q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5 h350v350q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xa0;" />
<glyph unicode="&#xa5;" d="M825 1100h250q10 0 12.5 -5t-5.5 -13l-364 -364q-6 -6 -11 -18h268q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-100h275q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-174q0 -11 -7.5 -18.5t-18.5 -7.5h-148q-11 0 -18.5 7.5t-7.5 18.5v174 h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h125v100h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h118q-5 12 -11 18l-364 364q-8 8 -5.5 13t12.5 5h250q25 0 43 -18l164 -164q8 -8 18 -8t18 8l164 164q18 18 43 18z" />
<glyph unicode="&#x2000;" horiz-adv-x="650" />
<glyph unicode="&#x2001;" horiz-adv-x="1300" />
<glyph unicode="&#x2002;" horiz-adv-x="650" />
<glyph unicode="&#x2003;" horiz-adv-x="1300" />
<glyph unicode="&#x2004;" horiz-adv-x="433" />
<glyph unicode="&#x2005;" horiz-adv-x="325" />
<glyph unicode="&#x2006;" horiz-adv-x="216" />
<glyph unicode="&#x2007;" horiz-adv-x="216" />
<glyph unicode="&#x2008;" horiz-adv-x="162" />
<glyph unicode="&#x2009;" horiz-adv-x="260" />
<glyph unicode="&#x200a;" horiz-adv-x="72" />
<glyph unicode="&#x202f;" horiz-adv-x="260" />
<glyph unicode="&#x205f;" horiz-adv-x="325" />
<glyph unicode="&#x20ac;" d="M744 1198q242 0 354 -189q60 -104 66 -209h-181q0 45 -17.5 82.5t-43.5 61.5t-58 40.5t-60.5 24t-51.5 7.5q-19 0 -40.5 -5.5t-49.5 -20.5t-53 -38t-49 -62.5t-39 -89.5h379l-100 -100h-300q-6 -50 -6 -100h406l-100 -100h-300q9 -74 33 -132t52.5 -91t61.5 -54.5t59 -29 t47 -7.5q22 0 50.5 7.5t60.5 24.5t58 41t43.5 61t17.5 80h174q-30 -171 -128 -278q-107 -117 -274 -117q-206 0 -324 158q-36 48 -69 133t-45 204h-217l100 100h112q1 47 6 100h-218l100 100h134q20 87 51 153.5t62 103.5q117 141 297 141z" />
<glyph unicode="&#x20bd;" d="M428 1200h350q67 0 120 -13t86 -31t57 -49.5t35 -56.5t17 -64.5t6.5 -60.5t0.5 -57v-16.5v-16.5q0 -36 -0.5 -57t-6.5 -61t-17 -65t-35 -57t-57 -50.5t-86 -31.5t-120 -13h-178l-2 -100h288q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-138v-175q0 -11 -5.5 -18 t-15.5 -7h-149q-10 0 -17.5 7.5t-7.5 17.5v175h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v100h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v475q0 10 7.5 17.5t17.5 7.5zM600 1000v-300h203q64 0 86.5 33t22.5 119q0 84 -22.5 116t-86.5 32h-203z" />
<glyph unicode="&#x2212;" d="M250 700h800q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#x231b;" d="M1000 1200v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-50v-100q0 -91 -49.5 -165.5t-130.5 -109.5q81 -35 130.5 -109.5t49.5 -165.5v-150h50q21 0 35.5 -14.5t14.5 -35.5v-150h-800v150q0 21 14.5 35.5t35.5 14.5h50v150q0 91 49.5 165.5t130.5 109.5q-81 35 -130.5 109.5 t-49.5 165.5v100h-50q-21 0 -35.5 14.5t-14.5 35.5v150h800zM400 1000v-100q0 -60 32.5 -109.5t87.5 -73.5q28 -12 44 -37t16 -55t-16 -55t-44 -37q-55 -24 -87.5 -73.5t-32.5 -109.5v-150h400v150q0 60 -32.5 109.5t-87.5 73.5q-28 12 -44 37t-16 55t16 55t44 37 q55 24 87.5 73.5t32.5 109.5v100h-400z" />
<glyph unicode="&#x25fc;" horiz-adv-x="500" d="M0 0z" />
<glyph unicode="&#x2601;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -206.5q0 -121 -85 -207.5t-205 -86.5h-750q-79 0 -135.5 57t-56.5 137q0 69 42.5 122.5t108.5 67.5q-2 12 -2 37q0 153 108 260.5t260 107.5z" />
<glyph unicode="&#x26fa;" d="M774 1193.5q16 -9.5 20.5 -27t-5.5 -33.5l-136 -187l467 -746h30q20 0 35 -18.5t15 -39.5v-42h-1200v42q0 21 15 39.5t35 18.5h30l468 746l-135 183q-10 16 -5.5 34t20.5 28t34 5.5t28 -20.5l111 -148l112 150q9 16 27 20.5t34 -5zM600 200h377l-182 112l-195 534v-646z " />
<glyph unicode="&#x2709;" d="M25 1100h1150q10 0 12.5 -5t-5.5 -13l-564 -567q-8 -8 -18 -8t-18 8l-564 567q-8 8 -5.5 13t12.5 5zM18 882l264 -264q8 -8 8 -18t-8 -18l-264 -264q-8 -8 -13 -5.5t-5 12.5v550q0 10 5 12.5t13 -5.5zM918 618l264 264q8 8 13 5.5t5 -12.5v-550q0 -10 -5 -12.5t-13 5.5 l-264 264q-8 8 -8 18t8 18zM818 482l364 -364q8 -8 5.5 -13t-12.5 -5h-1150q-10 0 -12.5 5t5.5 13l364 364q8 8 18 8t18 -8l164 -164q8 -8 18 -8t18 8l164 164q8 8 18 8t18 -8z" />
<glyph unicode="&#x270f;" d="M1011 1210q19 0 33 -13l153 -153q13 -14 13 -33t-13 -33l-99 -92l-214 214l95 96q13 14 32 14zM1013 800l-615 -614l-214 214l614 614zM317 96l-333 -112l110 335z" />
<glyph unicode="&#xe001;" d="M700 650v-550h250q21 0 35.5 -14.5t14.5 -35.5v-50h-800v50q0 21 14.5 35.5t35.5 14.5h250v550l-500 550h1200z" />
<glyph unicode="&#xe002;" d="M368 1017l645 163q39 15 63 0t24 -49v-831q0 -55 -41.5 -95.5t-111.5 -63.5q-79 -25 -147 -4.5t-86 75t25.5 111.5t122.5 82q72 24 138 8v521l-600 -155v-606q0 -42 -44 -90t-109 -69q-79 -26 -147 -5.5t-86 75.5t25.5 111.5t122.5 82.5q72 24 138 7v639q0 38 14.5 59 t53.5 34z" />
<glyph unicode="&#xe003;" d="M500 1191q100 0 191 -39t156.5 -104.5t104.5 -156.5t39 -191l-1 -2l1 -5q0 -141 -78 -262l275 -274q23 -26 22.5 -44.5t-22.5 -42.5l-59 -58q-26 -20 -46.5 -20t-39.5 20l-275 274q-119 -77 -261 -77l-5 1l-2 -1q-100 0 -191 39t-156.5 104.5t-104.5 156.5t-39 191 t39 191t104.5 156.5t156.5 104.5t191 39zM500 1022q-88 0 -162 -43t-117 -117t-43 -162t43 -162t117 -117t162 -43t162 43t117 117t43 162t-43 162t-117 117t-162 43z" />
<glyph unicode="&#xe005;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104z" />
<glyph unicode="&#xe006;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429z" />
<glyph unicode="&#xe007;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429zM477 700h-240l197 -142l-74 -226 l193 139l195 -140l-74 229l192 140h-234l-78 211z" />
<glyph unicode="&#xe008;" d="M600 1200q124 0 212 -88t88 -212v-250q0 -46 -31 -98t-69 -52v-75q0 -10 6 -21.5t15 -17.5l358 -230q9 -5 15 -16.5t6 -21.5v-93q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v93q0 10 6 21.5t15 16.5l358 230q9 6 15 17.5t6 21.5v75q-38 0 -69 52 t-31 98v250q0 124 88 212t212 88z" />
<glyph unicode="&#xe009;" d="M25 1100h1150q10 0 17.5 -7.5t7.5 -17.5v-1050q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v1050q0 10 7.5 17.5t17.5 7.5zM100 1000v-100h100v100h-100zM875 1000h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5t17.5 -7.5h550 q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM1000 1000v-100h100v100h-100zM100 800v-100h100v100h-100zM1000 800v-100h100v100h-100zM100 600v-100h100v100h-100zM1000 600v-100h100v100h-100zM875 500h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5 t17.5 -7.5h550q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM100 400v-100h100v100h-100zM1000 400v-100h100v100h-100zM100 200v-100h100v100h-100zM1000 200v-100h100v100h-100z" />
<glyph unicode="&#xe010;" d="M50 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM50 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe011;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM850 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 700h200q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h200 q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5 t35.5 14.5z" />
<glyph unicode="&#xe012;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h700q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe013;" d="M465 477l571 571q8 8 18 8t17 -8l177 -177q8 -7 8 -17t-8 -18l-783 -784q-7 -8 -17.5 -8t-17.5 8l-384 384q-8 8 -8 18t8 17l177 177q7 8 17 8t18 -8l171 -171q7 -7 18 -7t18 7z" />
<glyph unicode="&#xe014;" d="M904 1083l178 -179q8 -8 8 -18.5t-8 -17.5l-267 -268l267 -268q8 -7 8 -17.5t-8 -18.5l-178 -178q-8 -8 -18.5 -8t-17.5 8l-268 267l-268 -267q-7 -8 -17.5 -8t-18.5 8l-178 178q-8 8 -8 18.5t8 17.5l267 268l-267 268q-8 7 -8 17.5t8 18.5l178 178q8 8 18.5 8t17.5 -8 l268 -267l268 268q7 7 17.5 7t18.5 -7z" />
<glyph unicode="&#xe015;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM425 900h150q10 0 17.5 -7.5t7.5 -17.5v-75h75q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5 t-17.5 -7.5h-75v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-75q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v75q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe016;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM325 800h350q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-350q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe017;" d="M550 1200h100q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM800 975v166q167 -62 272 -209.5t105 -331.5q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5 t-184.5 123t-123 184.5t-45.5 224q0 184 105 331.5t272 209.5v-166q-103 -55 -165 -155t-62 -220q0 -116 57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5q0 120 -62 220t-165 155z" />
<glyph unicode="&#xe018;" d="M1025 1200h150q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM725 800h150q10 0 17.5 -7.5t7.5 -17.5v-750q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v750 q0 10 7.5 17.5t17.5 7.5zM425 500h150q10 0 17.5 -7.5t7.5 -17.5v-450q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v450q0 10 7.5 17.5t17.5 7.5zM125 300h150q10 0 17.5 -7.5t7.5 -17.5v-250q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5 v250q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe019;" d="M600 1174q33 0 74 -5l38 -152l5 -1q49 -14 94 -39l5 -2l134 80q61 -48 104 -105l-80 -134l3 -5q25 -44 39 -93l1 -6l152 -38q5 -43 5 -73q0 -34 -5 -74l-152 -38l-1 -6q-15 -49 -39 -93l-3 -5l80 -134q-48 -61 -104 -105l-134 81l-5 -3q-44 -25 -94 -39l-5 -2l-38 -151 q-43 -5 -74 -5q-33 0 -74 5l-38 151l-5 2q-49 14 -94 39l-5 3l-134 -81q-60 48 -104 105l80 134l-3 5q-25 45 -38 93l-2 6l-151 38q-6 42 -6 74q0 33 6 73l151 38l2 6q13 48 38 93l3 5l-80 134q47 61 105 105l133 -80l5 2q45 25 94 39l5 1l38 152q43 5 74 5zM600 815 q-89 0 -152 -63t-63 -151.5t63 -151.5t152 -63t152 63t63 151.5t-63 151.5t-152 63z" />
<glyph unicode="&#xe020;" d="M500 1300h300q41 0 70.5 -29.5t29.5 -70.5v-100h275q10 0 17.5 -7.5t7.5 -17.5v-75h-1100v75q0 10 7.5 17.5t17.5 7.5h275v100q0 41 29.5 70.5t70.5 29.5zM500 1200v-100h300v100h-300zM1100 900v-800q0 -41 -29.5 -70.5t-70.5 -29.5h-700q-41 0 -70.5 29.5t-29.5 70.5 v800h900zM300 800v-700h100v700h-100zM500 800v-700h100v700h-100zM700 800v-700h100v700h-100zM900 800v-700h100v700h-100z" />
<glyph unicode="&#xe021;" d="M18 618l620 608q8 7 18.5 7t17.5 -7l608 -608q8 -8 5.5 -13t-12.5 -5h-175v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v375h-300v-375q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v575h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe022;" d="M600 1200v-400q0 -41 29.5 -70.5t70.5 -29.5h300v-650q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5h450zM1000 800h-250q-21 0 -35.5 14.5t-14.5 35.5v250z" />
<glyph unicode="&#xe023;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h50q10 0 17.5 -7.5t7.5 -17.5v-275h175q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe024;" d="M1300 0h-538l-41 400h-242l-41 -400h-538l431 1200h209l-21 -300h162l-20 300h208zM515 800l-27 -300h224l-27 300h-170z" />
<glyph unicode="&#xe025;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-450h191q20 0 25.5 -11.5t-7.5 -27.5l-327 -400q-13 -16 -32 -16t-32 16l-327 400q-13 16 -7.5 27.5t25.5 11.5h191v450q0 21 14.5 35.5t35.5 14.5zM1125 400h50q10 0 17.5 -7.5t7.5 -17.5v-350q0 -10 -7.5 -17.5t-17.5 -7.5 h-1050q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h50q10 0 17.5 -7.5t7.5 -17.5v-175h900v175q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe026;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -275q-13 -16 -32 -16t-32 16l-223 275q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z " />
<glyph unicode="&#xe027;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM632 914l223 -275q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5l223 275q13 16 32 16 t32 -16z" />
<glyph unicode="&#xe028;" d="M225 1200h750q10 0 19.5 -7t12.5 -17l186 -652q7 -24 7 -49v-425q0 -12 -4 -27t-9 -17q-12 -6 -37 -6h-1100q-12 0 -27 4t-17 8q-6 13 -6 38l1 425q0 25 7 49l185 652q3 10 12.5 17t19.5 7zM878 1000h-556q-10 0 -19 -7t-11 -18l-87 -450q-2 -11 4 -18t16 -7h150 q10 0 19.5 -7t11.5 -17l38 -152q2 -10 11.5 -17t19.5 -7h250q10 0 19.5 7t11.5 17l38 152q2 10 11.5 17t19.5 7h150q10 0 16 7t4 18l-87 450q-2 11 -11 18t-19 7z" />
<glyph unicode="&#xe029;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM540 820l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe030;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-362q0 -10 -7.5 -17.5t-17.5 -7.5h-362q-11 0 -13 5.5t5 12.5l133 133q-109 76 -238 76q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5h150q0 -117 -45.5 -224 t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117z" />
<glyph unicode="&#xe031;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-361q0 -11 -7.5 -18.5t-18.5 -7.5h-361q-11 0 -13 5.5t5 12.5l134 134q-110 75 -239 75q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5h-150q0 117 45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117zM1027 600h150 q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5q-192 0 -348 118l-134 -134q-7 -8 -12.5 -5.5t-5.5 12.5v360q0 11 7.5 18.5t18.5 7.5h360q10 0 12.5 -5.5t-5.5 -12.5l-133 -133q110 -76 240 -76q116 0 214.5 57t155.5 155.5t57 214.5z" />
<glyph unicode="&#xe032;" d="M125 1200h1050q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-1050q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM1075 1000h-850q-10 0 -17.5 -7.5t-7.5 -17.5v-850q0 -10 7.5 -17.5t17.5 -7.5h850q10 0 17.5 7.5t7.5 17.5v850 q0 10 -7.5 17.5t-17.5 7.5zM325 900h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 900h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 700h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 700h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 500h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 500h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 300h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 300h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe033;" d="M900 800v200q0 83 -58.5 141.5t-141.5 58.5h-300q-82 0 -141 -59t-59 -141v-200h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h900q41 0 70.5 29.5t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5h-100zM400 800v150q0 21 15 35.5t35 14.5h200 q20 0 35 -14.5t15 -35.5v-150h-300z" />
<glyph unicode="&#xe034;" d="M125 1100h50q10 0 17.5 -7.5t7.5 -17.5v-1075h-100v1075q0 10 7.5 17.5t17.5 7.5zM1075 1052q4 0 9 -2q16 -6 16 -23v-421q0 -6 -3 -12q-33 -59 -66.5 -99t-65.5 -58t-56.5 -24.5t-52.5 -6.5q-26 0 -57.5 6.5t-52.5 13.5t-60 21q-41 15 -63 22.5t-57.5 15t-65.5 7.5 q-85 0 -160 -57q-7 -5 -15 -5q-6 0 -11 3q-14 7 -14 22v438q22 55 82 98.5t119 46.5q23 2 43 0.5t43 -7t32.5 -8.5t38 -13t32.5 -11q41 -14 63.5 -21t57 -14t63.5 -7q103 0 183 87q7 8 18 8z" />
<glyph unicode="&#xe035;" d="M600 1175q116 0 227 -49.5t192.5 -131t131 -192.5t49.5 -227v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v300q0 127 -70.5 231.5t-184.5 161.5t-245 57t-245 -57t-184.5 -161.5t-70.5 -231.5v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50 q-10 0 -17.5 7.5t-7.5 17.5v300q0 116 49.5 227t131 192.5t192.5 131t227 49.5zM220 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460q0 8 6 14t14 6zM820 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460 q0 8 6 14t14 6z" />
<glyph unicode="&#xe036;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM900 668l120 120q7 7 17 7t17 -7l34 -34q7 -7 7 -17t-7 -17l-120 -120l120 -120q7 -7 7 -17 t-7 -17l-34 -34q-7 -7 -17 -7t-17 7l-120 119l-120 -119q-7 -7 -17 -7t-17 7l-34 34q-7 7 -7 17t7 17l119 120l-119 120q-7 7 -7 17t7 17l34 34q7 8 17 8t17 -8z" />
<glyph unicode="&#xe037;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6 l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238q-6 8 -4.5 18t9.5 17l29 22q7 5 15 5z" />
<glyph unicode="&#xe038;" d="M967 1004h3q11 -1 17 -10q135 -179 135 -396q0 -105 -34 -206.5t-98 -185.5q-7 -9 -17 -10h-3q-9 0 -16 6l-42 34q-8 6 -9 16t5 18q111 150 111 328q0 90 -29.5 176t-84.5 157q-6 9 -5 19t10 16l42 33q7 5 15 5zM321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5 t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238 q-6 8 -4.5 18.5t9.5 16.5l29 22q7 5 15 5z" />
<glyph unicode="&#xe039;" d="M500 900h100v-100h-100v-100h-400v-100h-100v600h500v-300zM1200 700h-200v-100h200v-200h-300v300h-200v300h-100v200h600v-500zM100 1100v-300h300v300h-300zM800 1100v-300h300v300h-300zM300 900h-100v100h100v-100zM1000 900h-100v100h100v-100zM300 500h200v-500 h-500v500h200v100h100v-100zM800 300h200v-100h-100v-100h-200v100h-100v100h100v200h-200v100h300v-300zM100 400v-300h300v300h-300zM300 200h-100v100h100v-100zM1200 200h-100v100h100v-100zM700 0h-100v100h100v-100zM1200 0h-300v100h300v-100z" />
<glyph unicode="&#xe040;" d="M100 200h-100v1000h100v-1000zM300 200h-100v1000h100v-1000zM700 200h-200v1000h200v-1000zM900 200h-100v1000h100v-1000zM1200 200h-200v1000h200v-1000zM400 0h-300v100h300v-100zM600 0h-100v91h100v-91zM800 0h-100v91h100v-91zM1100 0h-200v91h200v-91z" />
<glyph unicode="&#xe041;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe042;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM800 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-56 56l424 426l-700 700h150zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5 t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe043;" d="M300 1200h825q75 0 75 -75v-900q0 -25 -18 -43l-64 -64q-8 -8 -13 -5.5t-5 12.5v950q0 10 -7.5 17.5t-17.5 7.5h-700q-25 0 -43 -18l-64 -64q-8 -8 -5.5 -13t12.5 -5h700q10 0 17.5 -7.5t7.5 -17.5v-950q0 -10 -7.5 -17.5t-17.5 -7.5h-850q-10 0 -17.5 7.5t-7.5 17.5v975 q0 25 18 43l139 139q18 18 43 18z" />
<glyph unicode="&#xe044;" d="M250 1200h800q21 0 35.5 -14.5t14.5 -35.5v-1150l-450 444l-450 -445v1151q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe045;" d="M822 1200h-444q-11 0 -19 -7.5t-9 -17.5l-78 -301q-7 -24 7 -45l57 -108q6 -9 17.5 -15t21.5 -6h450q10 0 21.5 6t17.5 15l62 108q14 21 7 45l-83 301q-1 10 -9 17.5t-19 7.5zM1175 800h-150q-10 0 -21 -6.5t-15 -15.5l-78 -156q-4 -9 -15 -15.5t-21 -6.5h-550 q-10 0 -21 6.5t-15 15.5l-78 156q-4 9 -15 15.5t-21 6.5h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-650q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h750q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5 t7.5 17.5v650q0 10 -7.5 17.5t-17.5 7.5zM850 200h-500q-10 0 -19.5 -7t-11.5 -17l-38 -152q-2 -10 3.5 -17t15.5 -7h600q10 0 15.5 7t3.5 17l-38 152q-2 10 -11.5 17t-19.5 7z" />
<glyph unicode="&#xe046;" d="M500 1100h200q56 0 102.5 -20.5t72.5 -50t44 -59t25 -50.5l6 -20h150q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5h150q2 8 6.5 21.5t24 48t45 61t72 48t102.5 21.5zM900 800v-100 h100v100h-100zM600 730q-95 0 -162.5 -67.5t-67.5 -162.5t67.5 -162.5t162.5 -67.5t162.5 67.5t67.5 162.5t-67.5 162.5t-162.5 67.5zM600 603q43 0 73 -30t30 -73t-30 -73t-73 -30t-73 30t-30 73t30 73t73 30z" />
<glyph unicode="&#xe047;" d="M681 1199l385 -998q20 -50 60 -92q18 -19 36.5 -29.5t27.5 -11.5l10 -2v-66h-417v66q53 0 75 43.5t5 88.5l-82 222h-391q-58 -145 -92 -234q-11 -34 -6.5 -57t25.5 -37t46 -20t55 -6v-66h-365v66q56 24 84 52q12 12 25 30.5t20 31.5l7 13l399 1006h93zM416 521h340 l-162 457z" />
<glyph unicode="&#xe048;" d="M753 641q5 -1 14.5 -4.5t36 -15.5t50.5 -26.5t53.5 -40t50.5 -54.5t35.5 -70t14.5 -87q0 -67 -27.5 -125.5t-71.5 -97.5t-98.5 -66.5t-108.5 -40.5t-102 -13h-500v89q41 7 70.5 32.5t29.5 65.5v827q0 24 -0.5 34t-3.5 24t-8.5 19.5t-17 13.5t-28 12.5t-42.5 11.5v71 l471 -1q57 0 115.5 -20.5t108 -57t80.5 -94t31 -124.5q0 -51 -15.5 -96.5t-38 -74.5t-45 -50.5t-38.5 -30.5zM400 700h139q78 0 130.5 48.5t52.5 122.5q0 41 -8.5 70.5t-29.5 55.5t-62.5 39.5t-103.5 13.5h-118v-350zM400 200h216q80 0 121 50.5t41 130.5q0 90 -62.5 154.5 t-156.5 64.5h-159v-400z" />
<glyph unicode="&#xe049;" d="M877 1200l2 -57q-83 -19 -116 -45.5t-40 -66.5l-132 -839q-9 -49 13 -69t96 -26v-97h-500v97q186 16 200 98l173 832q3 17 3 30t-1.5 22.5t-9 17.5t-13.5 12.5t-21.5 10t-26 8.5t-33.5 10q-13 3 -19 5v57h425z" />
<glyph unicode="&#xe050;" d="M1300 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM175 1000h-75v-800h75l-125 -167l-125 167h75v800h-75l125 167z" />
<glyph unicode="&#xe051;" d="M1100 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-650q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v650h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM1167 50l-167 -125v75h-800v-75l-167 125l167 125v-75h800v75z" />
<glyph unicode="&#xe052;" d="M50 1100h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe053;" d="M250 1100h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM250 500h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe054;" d="M500 950v100q0 21 14.5 35.5t35.5 14.5h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5zM100 650v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000 q-21 0 -35.5 14.5t-14.5 35.5zM300 350v100q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5zM0 50v100q0 21 14.5 35.5t35.5 14.5h1100q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5z" />
<glyph unicode="&#xe055;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe056;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 1100h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 800h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 500h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 500h800q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 200h800 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe057;" d="M400 0h-100v1100h100v-1100zM550 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM267 550l-167 -125v75h-200v100h200v75zM550 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe058;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM900 0h-100v1100h100v-1100zM50 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM1100 600h200v-100h-200v-75l-167 125l167 125v-75zM50 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe059;" d="M75 1000h750q31 0 53 -22t22 -53v-650q0 -31 -22 -53t-53 -22h-750q-31 0 -53 22t-22 53v650q0 31 22 53t53 22zM1200 300l-300 300l300 300v-600z" />
<glyph unicode="&#xe060;" d="M44 1100h1112q18 0 31 -13t13 -31v-1012q0 -18 -13 -31t-31 -13h-1112q-18 0 -31 13t-13 31v1012q0 18 13 31t31 13zM100 1000v-737l247 182l298 -131l-74 156l293 318l236 -288v500h-1000zM342 884q56 0 95 -39t39 -94.5t-39 -95t-95 -39.5t-95 39.5t-39 95t39 94.5 t95 39z" />
<glyph unicode="&#xe062;" d="M648 1169q117 0 216 -60t156.5 -161t57.5 -218q0 -115 -70 -258q-69 -109 -158 -225.5t-143 -179.5l-54 -62q-9 8 -25.5 24.5t-63.5 67.5t-91 103t-98.5 128t-95.5 148q-60 132 -60 249q0 88 34 169.5t91.5 142t137 96.5t166.5 36zM652.5 974q-91.5 0 -156.5 -65 t-65 -157t65 -156.5t156.5 -64.5t156.5 64.5t65 156.5t-65 157t-156.5 65z" />
<glyph unicode="&#xe063;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 173v854q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57z" />
<glyph unicode="&#xe064;" d="M554 1295q21 -72 57.5 -143.5t76 -130t83 -118t82.5 -117t70 -116t49.5 -126t18.5 -136.5q0 -71 -25.5 -135t-68.5 -111t-99 -82t-118.5 -54t-125.5 -23q-84 5 -161.5 34t-139.5 78.5t-99 125t-37 164.5q0 69 18 136.5t49.5 126.5t69.5 116.5t81.5 117.5t83.5 119 t76.5 131t58.5 143zM344 710q-23 -33 -43.5 -70.5t-40.5 -102.5t-17 -123q1 -37 14.5 -69.5t30 -52t41 -37t38.5 -24.5t33 -15q21 -7 32 -1t13 22l6 34q2 10 -2.5 22t-13.5 19q-5 4 -14 12t-29.5 40.5t-32.5 73.5q-26 89 6 271q2 11 -6 11q-8 1 -15 -10z" />
<glyph unicode="&#xe065;" d="M1000 1013l108 115q2 1 5 2t13 2t20.5 -1t25 -9.5t28.5 -21.5q22 -22 27 -43t0 -32l-6 -10l-108 -115zM350 1100h400q50 0 105 -13l-187 -187h-368q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v182l200 200v-332 q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM1009 803l-362 -362l-161 -50l55 170l355 355z" />
<glyph unicode="&#xe066;" d="M350 1100h361q-164 -146 -216 -200h-195q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5l200 153v-103q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M824 1073l339 -301q8 -7 8 -17.5t-8 -17.5l-340 -306q-7 -6 -12.5 -4t-6.5 11v203q-26 1 -54.5 0t-78.5 -7.5t-92 -17.5t-86 -35t-70 -57q10 59 33 108t51.5 81.5t65 58.5t68.5 40.5t67 24.5t56 13.5t40 4.5v210q1 10 6.5 12.5t13.5 -4.5z" />
<glyph unicode="&#xe067;" d="M350 1100h350q60 0 127 -23l-178 -177h-349q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v69l200 200v-219q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M643 639l395 395q7 7 17.5 7t17.5 -7l101 -101q7 -7 7 -17.5t-7 -17.5l-531 -532q-7 -7 -17.5 -7t-17.5 7l-248 248q-7 7 -7 17.5t7 17.5l101 101q7 7 17.5 7t17.5 -7l111 -111q8 -7 18 -7t18 7z" />
<glyph unicode="&#xe068;" d="M318 918l264 264q8 8 18 8t18 -8l260 -264q7 -8 4.5 -13t-12.5 -5h-170v-200h200v173q0 10 5 12t13 -5l264 -260q8 -7 8 -17.5t-8 -17.5l-264 -265q-8 -7 -13 -5t-5 12v173h-200v-200h170q10 0 12.5 -5t-4.5 -13l-260 -264q-8 -8 -18 -8t-18 8l-264 264q-8 8 -5.5 13 t12.5 5h175v200h-200v-173q0 -10 -5 -12t-13 5l-264 265q-8 7 -8 17.5t8 17.5l264 260q8 7 13 5t5 -12v-173h200v200h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe069;" d="M250 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe070;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5 t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe071;" d="M1200 1050v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-492 480q-15 14 -15 35t15 35l492 480q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25z" />
<glyph unicode="&#xe072;" d="M243 1074l814 -498q18 -11 18 -26t-18 -26l-814 -498q-18 -11 -30.5 -4t-12.5 28v1000q0 21 12.5 28t30.5 -4z" />
<glyph unicode="&#xe073;" d="M250 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM650 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe074;" d="M1100 950v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe075;" d="M500 612v438q0 21 10.5 25t25.5 -10l492 -480q15 -14 15 -35t-15 -35l-492 -480q-15 -14 -25.5 -10t-10.5 25v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10z" />
<glyph unicode="&#xe076;" d="M1048 1102l100 1q20 0 35 -14.5t15 -35.5l5 -1000q0 -21 -14.5 -35.5t-35.5 -14.5l-100 -1q-21 0 -35.5 14.5t-14.5 35.5l-2 437l-463 -454q-14 -15 -24.5 -10.5t-10.5 25.5l-2 437l-462 -455q-15 -14 -25.5 -9.5t-10.5 24.5l-5 1000q0 21 10.5 25.5t25.5 -10.5l466 -450 l-2 438q0 20 10.5 24.5t25.5 -9.5l466 -451l-2 438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe077;" d="M850 1100h100q21 0 35.5 -14.5t14.5 -35.5v-1000q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10l464 -453v438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe078;" d="M686 1081l501 -540q15 -15 10.5 -26t-26.5 -11h-1042q-22 0 -26.5 11t10.5 26l501 540q15 15 36 15t36 -15zM150 400h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe079;" d="M885 900l-352 -353l352 -353l-197 -198l-552 552l552 550z" />
<glyph unicode="&#xe080;" d="M1064 547l-551 -551l-198 198l353 353l-353 353l198 198z" />
<glyph unicode="&#xe081;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM650 900h-100q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-150 q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5h150v-150q0 -21 14.5 -35.5t35.5 -14.5h100q21 0 35.5 14.5t14.5 35.5v150h150q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-150v150q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe082;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM850 700h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5 t35.5 -14.5h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe083;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM741.5 913q-12.5 0 -21.5 -9l-120 -120l-120 120q-9 9 -21.5 9 t-21.5 -9l-141 -141q-9 -9 -9 -21.5t9 -21.5l120 -120l-120 -120q-9 -9 -9 -21.5t9 -21.5l141 -141q9 -9 21.5 -9t21.5 9l120 120l120 -120q9 -9 21.5 -9t21.5 9l141 141q9 9 9 21.5t-9 21.5l-120 120l120 120q9 9 9 21.5t-9 21.5l-141 141q-9 9 -21.5 9z" />
<glyph unicode="&#xe084;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM546 623l-84 85q-7 7 -17.5 7t-18.5 -7l-139 -139q-7 -8 -7 -18t7 -18 l242 -241q7 -8 17.5 -8t17.5 8l375 375q7 7 7 17.5t-7 18.5l-139 139q-7 7 -17.5 7t-17.5 -7z" />
<glyph unicode="&#xe085;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM588 941q-29 0 -59 -5.5t-63 -20.5t-58 -38.5t-41.5 -63t-16.5 -89.5 q0 -25 20 -25h131q30 -5 35 11q6 20 20.5 28t45.5 8q20 0 31.5 -10.5t11.5 -28.5q0 -23 -7 -34t-26 -18q-1 0 -13.5 -4t-19.5 -7.5t-20 -10.5t-22 -17t-18.5 -24t-15.5 -35t-8 -46q-1 -8 5.5 -16.5t20.5 -8.5h173q7 0 22 8t35 28t37.5 48t29.5 74t12 100q0 47 -17 83 t-42.5 57t-59.5 34.5t-64 18t-59 4.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe086;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM675 1000h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5 t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5zM675 700h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h75v-200h-75q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h350q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5 t-17.5 7.5h-75v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe087;" d="M525 1200h150q10 0 17.5 -7.5t7.5 -17.5v-194q103 -27 178.5 -102.5t102.5 -178.5h194q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-194q-27 -103 -102.5 -178.5t-178.5 -102.5v-194q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v194 q-103 27 -178.5 102.5t-102.5 178.5h-194q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h194q27 103 102.5 178.5t178.5 102.5v194q0 10 7.5 17.5t17.5 7.5zM700 893v-168q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v168q-68 -23 -119 -74 t-74 -119h168q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-168q23 -68 74 -119t119 -74v168q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-168q68 23 119 74t74 119h-168q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h168 q-23 68 -74 119t-119 74z" />
<glyph unicode="&#xe088;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM759 823l64 -64q7 -7 7 -17.5t-7 -17.5l-124 -124l124 -124q7 -7 7 -17.5t-7 -17.5l-64 -64q-7 -7 -17.5 -7t-17.5 7l-124 124l-124 -124q-7 -7 -17.5 -7t-17.5 7l-64 64 q-7 7 -7 17.5t7 17.5l124 124l-124 124q-7 7 -7 17.5t7 17.5l64 64q7 7 17.5 7t17.5 -7l124 -124l124 124q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe089;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM782 788l106 -106q7 -7 7 -17.5t-7 -17.5l-320 -321q-8 -7 -18 -7t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l197 197q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe090;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5q0 -120 65 -225 l587 587q-105 65 -225 65zM965 819l-584 -584q104 -62 219 -62q116 0 214.5 57t155.5 155.5t57 214.5q0 115 -62 219z" />
<glyph unicode="&#xe091;" d="M39 582l522 427q16 13 27.5 8t11.5 -26v-291h550q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-550v-291q0 -21 -11.5 -26t-27.5 8l-522 427q-16 13 -16 32t16 32z" />
<glyph unicode="&#xe092;" d="M639 1009l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291h-550q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h550v291q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe093;" d="M682 1161l427 -522q13 -16 8 -27.5t-26 -11.5h-291v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v550h-291q-21 0 -26 11.5t8 27.5l427 522q13 16 32 16t32 -16z" />
<glyph unicode="&#xe094;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-550h291q21 0 26 -11.5t-8 -27.5l-427 -522q-13 -16 -32 -16t-32 16l-427 522q-13 16 -8 27.5t26 11.5h291v550q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe095;" d="M639 1109l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291q-94 -2 -182 -20t-170.5 -52t-147 -92.5t-100.5 -135.5q5 105 27 193.5t67.5 167t113 135t167 91.5t225.5 42v262q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe096;" d="M850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5zM350 0h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249 q8 7 18 7t18 -7l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5z" />
<glyph unicode="&#xe097;" d="M1014 1120l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249q8 7 18 7t18 -7zM250 600h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5z" />
<glyph unicode="&#xe101;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM704 900h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5 t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe102;" d="M260 1200q9 0 19 -2t15 -4l5 -2q22 -10 44 -23l196 -118q21 -13 36 -24q29 -21 37 -12q11 13 49 35l196 118q22 13 45 23q17 7 38 7q23 0 47 -16.5t37 -33.5l13 -16q14 -21 18 -45l25 -123l8 -44q1 -9 8.5 -14.5t17.5 -5.5h61q10 0 17.5 -7.5t7.5 -17.5v-50 q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 -7.5t-7.5 -17.5v-175h-400v300h-200v-300h-400v175q0 10 -7.5 17.5t-17.5 7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5h61q11 0 18 3t7 8q0 4 9 52l25 128q5 25 19 45q2 3 5 7t13.5 15t21.5 19.5t26.5 15.5 t29.5 7zM915 1079l-166 -162q-7 -7 -5 -12t12 -5h219q10 0 15 7t2 17l-51 149q-3 10 -11 12t-15 -6zM463 917l-177 157q-8 7 -16 5t-11 -12l-51 -143q-3 -10 2 -17t15 -7h231q11 0 12.5 5t-5.5 12zM500 0h-375q-10 0 -17.5 7.5t-7.5 17.5v375h400v-400zM1100 400v-375 q0 -10 -7.5 -17.5t-17.5 -7.5h-375v400h400z" />
<glyph unicode="&#xe103;" d="M1165 1190q8 3 21 -6.5t13 -17.5q-2 -178 -24.5 -323.5t-55.5 -245.5t-87 -174.5t-102.5 -118.5t-118 -68.5t-118.5 -33t-120 -4.5t-105 9.5t-90 16.5q-61 12 -78 11q-4 1 -12.5 0t-34 -14.5t-52.5 -40.5l-153 -153q-26 -24 -37 -14.5t-11 43.5q0 64 42 102q8 8 50.5 45 t66.5 58q19 17 35 47t13 61q-9 55 -10 102.5t7 111t37 130t78 129.5q39 51 80 88t89.5 63.5t94.5 45t113.5 36t129 31t157.5 37t182 47.5zM1116 1098q-8 9 -22.5 -3t-45.5 -50q-38 -47 -119 -103.5t-142 -89.5l-62 -33q-56 -30 -102 -57t-104 -68t-102.5 -80.5t-85.5 -91 t-64 -104.5q-24 -56 -31 -86t2 -32t31.5 17.5t55.5 59.5q25 30 94 75.5t125.5 77.5t147.5 81q70 37 118.5 69t102 79.5t99 111t86.5 148.5q22 50 24 60t-6 19z" />
<glyph unicode="&#xe104;" d="M653 1231q-39 -67 -54.5 -131t-10.5 -114.5t24.5 -96.5t47.5 -80t63.5 -62.5t68.5 -46.5t65 -30q-4 7 -17.5 35t-18.5 39.5t-17 39.5t-17 43t-13 42t-9.5 44.5t-2 42t4 43t13.5 39t23 38.5q96 -42 165 -107.5t105 -138t52 -156t13 -159t-19 -149.5q-13 -55 -44 -106.5 t-68 -87t-78.5 -64.5t-72.5 -45t-53 -22q-72 -22 -127 -11q-31 6 -13 19q6 3 17 7q13 5 32.5 21t41 44t38.5 63.5t21.5 81.5t-6.5 94.5t-50 107t-104 115.5q10 -104 -0.5 -189t-37 -140.5t-65 -93t-84 -52t-93.5 -11t-95 24.5q-80 36 -131.5 114t-53.5 171q-2 23 0 49.5 t4.5 52.5t13.5 56t27.5 60t46 64.5t69.5 68.5q-8 -53 -5 -102.5t17.5 -90t34 -68.5t44.5 -39t49 -2q31 13 38.5 36t-4.5 55t-29 64.5t-36 75t-26 75.5q-15 85 2 161.5t53.5 128.5t85.5 92.5t93.5 61t81.5 25.5z" />
<glyph unicode="&#xe105;" d="M600 1094q82 0 160.5 -22.5t140 -59t116.5 -82.5t94.5 -95t68 -95t42.5 -82.5t14 -57.5t-14 -57.5t-43 -82.5t-68.5 -95t-94.5 -95t-116.5 -82.5t-140 -59t-159.5 -22.5t-159.5 22.5t-140 59t-116.5 82.5t-94.5 95t-68.5 95t-43 82.5t-14 57.5t14 57.5t42.5 82.5t68 95 t94.5 95t116.5 82.5t140 59t160.5 22.5zM888 829q-15 15 -18 12t5 -22q25 -57 25 -119q0 -124 -88 -212t-212 -88t-212 88t-88 212q0 59 23 114q8 19 4.5 22t-17.5 -12q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q22 -36 47 -71t70 -82t92.5 -81t113 -58.5t133.5 -24.5 t133.5 24t113 58.5t92.5 81.5t70 81.5t47 70.5q11 18 9 42.5t-14 41.5q-90 117 -163 189zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l35 34q14 15 12.5 33.5t-16.5 33.5q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe106;" d="M592 0h-148l31 120q-91 20 -175.5 68.5t-143.5 106.5t-103.5 119t-66.5 110t-22 76q0 21 14 57.5t42.5 82.5t68 95t94.5 95t116.5 82.5t140 59t160.5 22.5q61 0 126 -15l32 121h148zM944 770l47 181q108 -85 176.5 -192t68.5 -159q0 -26 -19.5 -71t-59.5 -102t-93 -112 t-129 -104.5t-158 -75.5l46 173q77 49 136 117t97 131q11 18 9 42.5t-14 41.5q-54 70 -107 130zM310 824q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q18 -30 39 -60t57 -70.5t74 -73t90 -61t105 -41.5l41 154q-107 18 -178.5 101.5t-71.5 193.5q0 59 23 114q8 19 4.5 22 t-17.5 -12zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l12 11l22 86l-3 4q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe107;" d="M-90 100l642 1066q20 31 48 28.5t48 -35.5l642 -1056q21 -32 7.5 -67.5t-50.5 -35.5h-1294q-37 0 -50.5 34t7.5 66zM155 200h345v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h345l-445 723zM496 700h208q20 0 32 -14.5t8 -34.5l-58 -252 q-4 -20 -21.5 -34.5t-37.5 -14.5h-54q-20 0 -37.5 14.5t-21.5 34.5l-58 252q-4 20 8 34.5t32 14.5z" />
<glyph unicode="&#xe108;" d="M650 1200q62 0 106 -44t44 -106v-339l363 -325q15 -14 26 -38.5t11 -44.5v-41q0 -20 -12 -26.5t-29 5.5l-359 249v-263q100 -93 100 -113v-64q0 -21 -13 -29t-32 1l-205 128l-205 -128q-19 -9 -32 -1t-13 29v64q0 20 100 113v263l-359 -249q-17 -12 -29 -5.5t-12 26.5v41 q0 20 11 44.5t26 38.5l363 325v339q0 62 44 106t106 44z" />
<glyph unicode="&#xe109;" d="M850 1200h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-150h-1100v150q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5h100q21 0 35.5 -14.5t14.5 -35.5v-50h500v50q0 21 14.5 35.5t35.5 14.5zM1100 800v-750q0 -21 -14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v750h1100zM100 600v-100h100v100h-100zM300 600v-100h100v100h-100zM500 600v-100h100v100h-100zM700 600v-100h100v100h-100zM900 600v-100h100v100h-100zM100 400v-100h100v100h-100zM300 400v-100h100v100h-100zM500 400 v-100h100v100h-100zM700 400v-100h100v100h-100zM900 400v-100h100v100h-100zM100 200v-100h100v100h-100zM300 200v-100h100v100h-100zM500 200v-100h100v100h-100zM700 200v-100h100v100h-100zM900 200v-100h100v100h-100z" />
<glyph unicode="&#xe110;" d="M1135 1165l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-159l-600 -600h-291q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h209l600 600h241v150q0 21 10.5 25t24.5 -10zM522 819l-141 -141l-122 122h-209q-21 0 -35.5 14.5 t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h291zM1135 565l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-241l-181 181l141 141l122 -122h159v150q0 21 10.5 25t24.5 -10z" />
<glyph unicode="&#xe111;" d="M100 1100h1000q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-596l-304 -300v300h-100q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5z" />
<glyph unicode="&#xe112;" d="M150 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM850 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM1100 800v-300q0 -41 -3 -77.5t-15 -89.5t-32 -96t-58 -89t-89 -77t-129 -51t-174 -20t-174 20 t-129 51t-89 77t-58 89t-32 96t-15 89.5t-3 77.5v300h300v-250v-27v-42.5t1.5 -41t5 -38t10 -35t16.5 -30t25.5 -24.5t35 -19t46.5 -12t60 -4t60 4.5t46.5 12.5t35 19.5t25 25.5t17 30.5t10 35t5 38t2 40.5t-0.5 42v25v250h300z" />
<glyph unicode="&#xe113;" d="M1100 411l-198 -199l-353 353l-353 -353l-197 199l551 551z" />
<glyph unicode="&#xe114;" d="M1101 789l-550 -551l-551 551l198 199l353 -353l353 353z" />
<glyph unicode="&#xe115;" d="M404 1000h746q21 0 35.5 -14.5t14.5 -35.5v-551h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v401h-381zM135 984l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-400h385l215 -200h-750q-21 0 -35.5 14.5 t-14.5 35.5v550h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe116;" d="M56 1200h94q17 0 31 -11t18 -27l38 -162h896q24 0 39 -18.5t10 -42.5l-100 -475q-5 -21 -27 -42.5t-55 -21.5h-633l48 -200h535q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-50q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-300v-50 q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-31q-18 0 -32.5 10t-20.5 19l-5 10l-201 961h-54q-20 0 -35 14.5t-15 35.5t15 35.5t35 14.5z" />
<glyph unicode="&#xe117;" d="M1200 1000v-100h-1200v100h200q0 41 29.5 70.5t70.5 29.5h300q41 0 70.5 -29.5t29.5 -70.5h500zM0 800h1200v-800h-1200v800z" />
<glyph unicode="&#xe118;" d="M200 800l-200 -400v600h200q0 41 29.5 70.5t70.5 29.5h300q42 0 71 -29.5t29 -70.5h500v-200h-1000zM1500 700l-300 -700h-1200l300 700h1200z" />
<glyph unicode="&#xe119;" d="M635 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-601h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v601h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe120;" d="M936 864l249 -229q14 -15 14 -35.5t-14 -35.5l-249 -229q-15 -15 -25.5 -10.5t-10.5 24.5v151h-600v-151q0 -20 -10.5 -24.5t-25.5 10.5l-249 229q-14 15 -14 35.5t14 35.5l249 229q15 15 25.5 10.5t10.5 -25.5v-149h600v149q0 21 10.5 25.5t25.5 -10.5z" />
<glyph unicode="&#xe121;" d="M1169 400l-172 732q-5 23 -23 45.5t-38 22.5h-672q-20 0 -38 -20t-23 -41l-172 -739h1138zM1100 300h-1000q-41 0 -70.5 -29.5t-29.5 -70.5v-100q0 -41 29.5 -70.5t70.5 -29.5h1000q41 0 70.5 29.5t29.5 70.5v100q0 41 -29.5 70.5t-70.5 29.5zM800 100v100h100v-100h-100 zM1000 100v100h100v-100h-100z" />
<glyph unicode="&#xe122;" d="M1150 1100q21 0 35.5 -14.5t14.5 -35.5v-850q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v850q0 21 14.5 35.5t35.5 14.5zM1000 200l-675 200h-38l47 -276q3 -16 -5.5 -20t-29.5 -4h-7h-84q-20 0 -34.5 14t-18.5 35q-55 337 -55 351v250v6q0 16 1 23.5t6.5 14 t17.5 6.5h200l675 250v-850zM0 750v-250q-4 0 -11 0.5t-24 6t-30 15t-24 30t-11 48.5v50q0 26 10.5 46t25 30t29 16t25.5 7z" />
<glyph unicode="&#xe123;" d="M553 1200h94q20 0 29 -10.5t3 -29.5l-18 -37q83 -19 144 -82.5t76 -140.5l63 -327l118 -173h17q19 0 33 -14.5t14 -35t-13 -40.5t-31 -27q-8 -4 -23 -9.5t-65 -19.5t-103 -25t-132.5 -20t-158.5 -9q-57 0 -115 5t-104 12t-88.5 15.5t-73.5 17.5t-54.5 16t-35.5 12l-11 4 q-18 8 -31 28t-13 40.5t14 35t33 14.5h17l118 173l63 327q15 77 76 140t144 83l-18 32q-6 19 3.5 32t28.5 13zM498 110q50 -6 102 -6q53 0 102 6q-12 -49 -39.5 -79.5t-62.5 -30.5t-63 30.5t-39 79.5z" />
<glyph unicode="&#xe124;" d="M800 946l224 78l-78 -224l234 -45l-180 -155l180 -155l-234 -45l78 -224l-224 78l-45 -234l-155 180l-155 -180l-45 234l-224 -78l78 224l-234 45l180 155l-180 155l234 45l-78 224l224 -78l45 234l155 -180l155 180z" />
<glyph unicode="&#xe125;" d="M650 1200h50q40 0 70 -40.5t30 -84.5v-150l-28 -125h328q40 0 70 -40.5t30 -84.5v-100q0 -45 -29 -74l-238 -344q-16 -24 -38 -40.5t-45 -16.5h-250q-7 0 -42 25t-66 50l-31 25h-61q-45 0 -72.5 18t-27.5 57v400q0 36 20 63l145 196l96 198q13 28 37.5 48t51.5 20z M650 1100l-100 -212l-150 -213v-375h100l136 -100h214l250 375v125h-450l50 225v175h-50zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe126;" d="M600 1100h250q23 0 45 -16.5t38 -40.5l238 -344q29 -29 29 -74v-100q0 -44 -30 -84.5t-70 -40.5h-328q28 -118 28 -125v-150q0 -44 -30 -84.5t-70 -40.5h-50q-27 0 -51.5 20t-37.5 48l-96 198l-145 196q-20 27 -20 63v400q0 39 27.5 57t72.5 18h61q124 100 139 100z M50 1000h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM636 1000l-136 -100h-100v-375l150 -213l100 -212h50v175l-50 225h450v125l-250 375h-214z" />
<glyph unicode="&#xe127;" d="M356 873l363 230q31 16 53 -6l110 -112q13 -13 13.5 -32t-11.5 -34l-84 -121h302q84 0 138 -38t54 -110t-55 -111t-139 -39h-106l-131 -339q-6 -21 -19.5 -41t-28.5 -20h-342q-7 0 -90 81t-83 94v525q0 17 14 35.5t28 28.5zM400 792v-503l100 -89h293l131 339 q6 21 19.5 41t28.5 20h203q21 0 30.5 25t0.5 50t-31 25h-456h-7h-6h-5.5t-6 0.5t-5 1.5t-5 2t-4 2.5t-4 4t-2.5 4.5q-12 25 5 47l146 183l-86 83zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe128;" d="M475 1103l366 -230q2 -1 6 -3.5t14 -10.5t18 -16.5t14.5 -20t6.5 -22.5v-525q0 -13 -86 -94t-93 -81h-342q-15 0 -28.5 20t-19.5 41l-131 339h-106q-85 0 -139.5 39t-54.5 111t54 110t138 38h302l-85 121q-11 15 -10.5 34t13.5 32l110 112q22 22 53 6zM370 945l146 -183 q17 -22 5 -47q-2 -2 -3.5 -4.5t-4 -4t-4 -2.5t-5 -2t-5 -1.5t-6 -0.5h-6h-6.5h-6h-475v-100h221q15 0 29 -20t20 -41l130 -339h294l106 89v503l-342 236zM1050 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5 v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe129;" d="M550 1294q72 0 111 -55t39 -139v-106l339 -131q21 -6 41 -19.5t20 -28.5v-342q0 -7 -81 -90t-94 -83h-525q-17 0 -35.5 14t-28.5 28l-9 14l-230 363q-16 31 6 53l112 110q13 13 32 13.5t34 -11.5l121 -84v302q0 84 38 138t110 54zM600 972v203q0 21 -25 30.5t-50 0.5 t-25 -31v-456v-7v-6v-5.5t-0.5 -6t-1.5 -5t-2 -5t-2.5 -4t-4 -4t-4.5 -2.5q-25 -12 -47 5l-183 146l-83 -86l236 -339h503l89 100v293l-339 131q-21 6 -41 19.5t-20 28.5zM450 200h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe130;" d="M350 1100h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5zM600 306v-106q0 -84 -39 -139t-111 -55t-110 54t-38 138v302l-121 -84q-15 -12 -34 -11.5t-32 13.5l-112 110 q-22 22 -6 53l230 363q1 2 3.5 6t10.5 13.5t16.5 17t20 13.5t22.5 6h525q13 0 94 -83t81 -90v-342q0 -15 -20 -28.5t-41 -19.5zM308 900l-236 -339l83 -86l183 146q22 17 47 5q2 -1 4.5 -2.5t4 -4t2.5 -4t2 -5t1.5 -5t0.5 -6v-5.5v-6v-7v-456q0 -22 25 -31t50 0.5t25 30.5 v203q0 15 20 28.5t41 19.5l339 131v293l-89 100h-503z" />
<glyph unicode="&#xe131;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM914 632l-275 223q-16 13 -27.5 8t-11.5 -26v-137h-275 q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h275v-137q0 -21 11.5 -26t27.5 8l275 223q16 13 16 32t-16 32z" />
<glyph unicode="&#xe132;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM561 855l-275 -223q-16 -13 -16 -32t16 -32l275 -223q16 -13 27.5 -8 t11.5 26v137h275q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5h-275v137q0 21 -11.5 26t-27.5 -8z" />
<glyph unicode="&#xe133;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM855 639l-223 275q-13 16 -32 16t-32 -16l-223 -275q-13 -16 -8 -27.5 t26 -11.5h137v-275q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v275h137q21 0 26 11.5t-8 27.5z" />
<glyph unicode="&#xe134;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM675 900h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-275h-137q-21 0 -26 -11.5 t8 -27.5l223 -275q13 -16 32 -16t32 16l223 275q13 16 8 27.5t-26 11.5h-137v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe135;" d="M600 1176q116 0 222.5 -46t184 -123.5t123.5 -184t46 -222.5t-46 -222.5t-123.5 -184t-184 -123.5t-222.5 -46t-222.5 46t-184 123.5t-123.5 184t-46 222.5t46 222.5t123.5 184t184 123.5t222.5 46zM627 1101q-15 -12 -36.5 -20.5t-35.5 -12t-43 -8t-39 -6.5 q-15 -3 -45.5 0t-45.5 -2q-20 -7 -51.5 -26.5t-34.5 -34.5q-3 -11 6.5 -22.5t8.5 -18.5q-3 -34 -27.5 -91t-29.5 -79q-9 -34 5 -93t8 -87q0 -9 17 -44.5t16 -59.5q12 0 23 -5t23.5 -15t19.5 -14q16 -8 33 -15t40.5 -15t34.5 -12q21 -9 52.5 -32t60 -38t57.5 -11 q7 -15 -3 -34t-22.5 -40t-9.5 -38q13 -21 23 -34.5t27.5 -27.5t36.5 -18q0 -7 -3.5 -16t-3.5 -14t5 -17q104 -2 221 112q30 29 46.5 47t34.5 49t21 63q-13 8 -37 8.5t-36 7.5q-15 7 -49.5 15t-51.5 19q-18 0 -41 -0.5t-43 -1.5t-42 -6.5t-38 -16.5q-51 -35 -66 -12 q-4 1 -3.5 25.5t0.5 25.5q-6 13 -26.5 17.5t-24.5 6.5q1 15 -0.5 30.5t-7 28t-18.5 11.5t-31 -21q-23 -25 -42 4q-19 28 -8 58q6 16 22 22q6 -1 26 -1.5t33.5 -4t19.5 -13.5q7 -12 18 -24t21.5 -20.5t20 -15t15.5 -10.5l5 -3q2 12 7.5 30.5t8 34.5t-0.5 32q-3 18 3.5 29 t18 22.5t15.5 24.5q6 14 10.5 35t8 31t15.5 22.5t34 22.5q-6 18 10 36q8 0 24 -1.5t24.5 -1.5t20 4.5t20.5 15.5q-10 23 -31 42.5t-37.5 29.5t-49 27t-43.5 23q0 1 2 8t3 11.5t1.5 10.5t-1 9.5t-4.5 4.5q31 -13 58.5 -14.5t38.5 2.5l12 5q5 28 -9.5 46t-36.5 24t-50 15 t-41 20q-18 -4 -37 0zM613 994q0 -17 8 -42t17 -45t9 -23q-8 1 -39.5 5.5t-52.5 10t-37 16.5q3 11 16 29.5t16 25.5q10 -10 19 -10t14 6t13.5 14.5t16.5 12.5z" />
<glyph unicode="&#xe136;" d="M756 1157q164 92 306 -9l-259 -138l145 -232l251 126q6 -89 -34 -156.5t-117 -110.5q-60 -34 -127 -39.5t-126 16.5l-596 -596q-15 -16 -36.5 -16t-36.5 16l-111 110q-15 15 -15 36.5t15 37.5l600 599q-34 101 5.5 201.5t135.5 154.5z" />
<glyph unicode="&#xe137;" horiz-adv-x="1220" d="M100 1196h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 1096h-200v-100h200v100zM100 796h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 696h-500v-100h500v100zM100 396h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 296h-300v-100h300v100z " />
<glyph unicode="&#xe138;" d="M150 1200h900q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM700 500v-300l-200 -200v500l-350 500h900z" />
<glyph unicode="&#xe139;" d="M500 1200h200q41 0 70.5 -29.5t29.5 -70.5v-100h300q41 0 70.5 -29.5t29.5 -70.5v-400h-500v100h-200v-100h-500v400q0 41 29.5 70.5t70.5 29.5h300v100q0 41 29.5 70.5t70.5 29.5zM500 1100v-100h200v100h-200zM1200 400v-200q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v200h1200z" />
<glyph unicode="&#xe140;" d="M50 1200h300q21 0 25 -10.5t-10 -24.5l-94 -94l199 -199q7 -8 7 -18t-7 -18l-106 -106q-8 -7 -18 -7t-18 7l-199 199l-94 -94q-14 -14 -24.5 -10t-10.5 25v300q0 21 14.5 35.5t35.5 14.5zM850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-199 -199q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l199 199l-94 94q-14 14 -10 24.5t25 10.5zM364 470l106 -106q7 -8 7 -18t-7 -18l-199 -199l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l199 199 q8 7 18 7t18 -7zM1071 271l94 94q14 14 24.5 10t10.5 -25v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -25 10.5t10 24.5l94 94l-199 199q-7 8 -7 18t7 18l106 106q8 7 18 7t18 -7z" />
<glyph unicode="&#xe141;" d="M596 1192q121 0 231.5 -47.5t190 -127t127 -190t47.5 -231.5t-47.5 -231.5t-127 -190.5t-190 -127t-231.5 -47t-231.5 47t-190.5 127t-127 190.5t-47 231.5t47 231.5t127 190t190.5 127t231.5 47.5zM596 1010q-112 0 -207.5 -55.5t-151 -151t-55.5 -207.5t55.5 -207.5 t151 -151t207.5 -55.5t207.5 55.5t151 151t55.5 207.5t-55.5 207.5t-151 151t-207.5 55.5zM454.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38.5 -16.5t-38.5 16.5t-16 39t16 38.5t38.5 16zM754.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38 -16.5q-14 0 -29 10l-55 -145 q17 -23 17 -51q0 -36 -25.5 -61.5t-61.5 -25.5t-61.5 25.5t-25.5 61.5q0 32 20.5 56.5t51.5 29.5l122 126l1 1q-9 14 -9 28q0 23 16 39t38.5 16zM345.5 709q22.5 0 38.5 -16t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16zM854.5 709q22.5 0 38.5 -16 t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16z" />
<glyph unicode="&#xe142;" d="M546 173l469 470q91 91 99 192q7 98 -52 175.5t-154 94.5q-22 4 -47 4q-34 0 -66.5 -10t-56.5 -23t-55.5 -38t-48 -41.5t-48.5 -47.5q-376 -375 -391 -390q-30 -27 -45 -41.5t-37.5 -41t-32 -46.5t-16 -47.5t-1.5 -56.5q9 -62 53.5 -95t99.5 -33q74 0 125 51l548 548 q36 36 20 75q-7 16 -21.5 26t-32.5 10q-26 0 -50 -23q-13 -12 -39 -38l-341 -338q-15 -15 -35.5 -15.5t-34.5 13.5t-14 34.5t14 34.5q327 333 361 367q35 35 67.5 51.5t78.5 16.5q14 0 29 -1q44 -8 74.5 -35.5t43.5 -68.5q14 -47 2 -96.5t-47 -84.5q-12 -11 -32 -32 t-79.5 -81t-114.5 -115t-124.5 -123.5t-123 -119.5t-96.5 -89t-57 -45q-56 -27 -120 -27q-70 0 -129 32t-93 89q-48 78 -35 173t81 163l511 511q71 72 111 96q91 55 198 55q80 0 152 -33q78 -36 129.5 -103t66.5 -154q17 -93 -11 -183.5t-94 -156.5l-482 -476 q-15 -15 -36 -16t-37 14t-17.5 34t14.5 35z" />
<glyph unicode="&#xe143;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104zM896 972q-33 0 -64.5 -19t-56.5 -46t-47.5 -53.5t-43.5 -45.5t-37.5 -19t-36 19t-40 45.5t-43 53.5t-54 46t-65.5 19q-67 0 -122.5 -55.5t-55.5 -132.5q0 -23 13.5 -51t46 -65t57.5 -63t76 -75l22 -22q15 -14 44 -44t50.5 -51t46 -44t41 -35t23 -12 t23.5 12t42.5 36t46 44t52.5 52t44 43q4 4 12 13q43 41 63.5 62t52 55t46 55t26 46t11.5 44q0 79 -53 133.5t-120 54.5z" />
<glyph unicode="&#xe144;" d="M776.5 1214q93.5 0 159.5 -66l141 -141q66 -66 66 -160q0 -42 -28 -95.5t-62 -87.5l-29 -29q-31 53 -77 99l-18 18l95 95l-247 248l-389 -389l212 -212l-105 -106l-19 18l-141 141q-66 66 -66 159t66 159l283 283q65 66 158.5 66zM600 706l105 105q10 -8 19 -17l141 -141 q66 -66 66 -159t-66 -159l-283 -283q-66 -66 -159 -66t-159 66l-141 141q-66 66 -66 159.5t66 159.5l55 55q29 -55 75 -102l18 -17l-95 -95l247 -248l389 389z" />
<glyph unicode="&#xe145;" d="M603 1200q85 0 162 -15t127 -38t79 -48t29 -46v-953q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-41 0 -70.5 29.5t-29.5 70.5v953q0 21 30 46.5t81 48t129 37.5t163 15zM300 1000v-700h600v700h-600zM600 254q-43 0 -73.5 -30.5t-30.5 -73.5t30.5 -73.5t73.5 -30.5t73.5 30.5 t30.5 73.5t-30.5 73.5t-73.5 30.5z" />
<glyph unicode="&#xe146;" d="M902 1185l283 -282q15 -15 15 -36t-14.5 -35.5t-35.5 -14.5t-35 15l-36 35l-279 -267v-300l-212 210l-308 -307l-280 -203l203 280l307 308l-210 212h300l267 279l-35 36q-15 14 -15 35t14.5 35.5t35.5 14.5t35 -15z" />
<glyph unicode="&#xe148;" d="M700 1248v-78q38 -5 72.5 -14.5t75.5 -31.5t71 -53.5t52 -84t24 -118.5h-159q-4 36 -10.5 59t-21 45t-40 35.5t-64.5 20.5v-307l64 -13q34 -7 64 -16.5t70 -32t67.5 -52.5t47.5 -80t20 -112q0 -139 -89 -224t-244 -97v-77h-100v79q-150 16 -237 103q-40 40 -52.5 93.5 t-15.5 139.5h139q5 -77 48.5 -126t117.5 -65v335l-27 8q-46 14 -79 26.5t-72 36t-63 52t-40 72.5t-16 98q0 70 25 126t67.5 92t94.5 57t110 27v77h100zM600 754v274q-29 -4 -50 -11t-42 -21.5t-31.5 -41.5t-10.5 -65q0 -29 7 -50.5t16.5 -34t28.5 -22.5t31.5 -14t37.5 -10 q9 -3 13 -4zM700 547v-310q22 2 42.5 6.5t45 15.5t41.5 27t29 42t12 59.5t-12.5 59.5t-38 44.5t-53 31t-66.5 24.5z" />
<glyph unicode="&#xe149;" d="M561 1197q84 0 160.5 -40t123.5 -109.5t47 -147.5h-153q0 40 -19.5 71.5t-49.5 48.5t-59.5 26t-55.5 9q-37 0 -79 -14.5t-62 -35.5q-41 -44 -41 -101q0 -26 13.5 -63t26.5 -61t37 -66q6 -9 9 -14h241v-100h-197q8 -50 -2.5 -115t-31.5 -95q-45 -62 -99 -112 q34 10 83 17.5t71 7.5q32 1 102 -16t104 -17q83 0 136 30l50 -147q-31 -19 -58 -30.5t-55 -15.5t-42 -4.5t-46 -0.5q-23 0 -76 17t-111 32.5t-96 11.5q-39 -3 -82 -16t-67 -25l-23 -11l-55 145q4 3 16 11t15.5 10.5t13 9t15.5 12t14.5 14t17.5 18.5q48 55 54 126.5 t-30 142.5h-221v100h166q-23 47 -44 104q-7 20 -12 41.5t-6 55.5t6 66.5t29.5 70.5t58.5 71q97 88 263 88z" />
<glyph unicode="&#xe150;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM935 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-900h-200v900h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe151;" d="M1000 700h-100v100h-100v-100h-100v500h300v-500zM400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM801 1100v-200h100v200h-100zM1000 350l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150z " />
<glyph unicode="&#xe152;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 1050l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150zM1000 0h-100v100h-100v-100h-100v500h300v-500zM801 400v-200h100v200h-100z " />
<glyph unicode="&#xe153;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 700h-100v400h-100v100h200v-500zM1100 0h-100v100h-200v400h300v-500zM901 400v-200h100v200h-100z" />
<glyph unicode="&#xe154;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1100 700h-100v100h-200v400h300v-500zM901 1100v-200h100v200h-100zM1000 0h-100v400h-100v100h200v-500z" />
<glyph unicode="&#xe155;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM900 1000h-200v200h200v-200zM1000 700h-300v200h300v-200zM1100 400h-400v200h400v-200zM1200 100h-500v200h500v-200z" />
<glyph unicode="&#xe156;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1200 1000h-500v200h500v-200zM1100 700h-400v200h400v-200zM1000 400h-300v200h300v-200zM900 100h-200v200h200v-200z" />
<glyph unicode="&#xe157;" d="M350 1100h400q162 0 256 -93.5t94 -256.5v-400q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5z" />
<glyph unicode="&#xe158;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-163 0 -256.5 92.5t-93.5 257.5v400q0 163 94 256.5t256 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM440 770l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe159;" d="M350 1100h400q163 0 256.5 -94t93.5 -256v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 163 92.5 256.5t257.5 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM350 700h400q21 0 26.5 -12t-6.5 -28l-190 -253q-12 -17 -30 -17t-30 17l-190 253q-12 16 -6.5 28t26.5 12z" />
<glyph unicode="&#xe160;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -163 -92.5 -256.5t-257.5 -93.5h-400q-163 0 -256.5 94t-93.5 256v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM580 693l190 -253q12 -16 6.5 -28t-26.5 -12h-400q-21 0 -26.5 12t6.5 28l190 253q12 17 30 17t30 -17z" />
<glyph unicode="&#xe161;" d="M550 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h450q41 0 70.5 29.5t29.5 70.5v500q0 41 -29.5 70.5t-70.5 29.5h-450q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM338 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe162;" d="M793 1182l9 -9q8 -10 5 -27q-3 -11 -79 -225.5t-78 -221.5l300 1q24 0 32.5 -17.5t-5.5 -35.5q-1 0 -133.5 -155t-267 -312.5t-138.5 -162.5q-12 -15 -26 -15h-9l-9 8q-9 11 -4 32q2 9 42 123.5t79 224.5l39 110h-302q-23 0 -31 19q-10 21 6 41q75 86 209.5 237.5 t228 257t98.5 111.5q9 16 25 16h9z" />
<glyph unicode="&#xe163;" d="M350 1100h400q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-450q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h450q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400 q0 165 92.5 257.5t257.5 92.5zM938 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe164;" d="M750 1200h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -10.5 -25t-24.5 10l-109 109l-312 -312q-15 -15 -35.5 -15t-35.5 15l-141 141q-15 15 -15 35.5t15 35.5l312 312l-109 109q-14 14 -10 24.5t25 10.5zM456 900h-156q-41 0 -70.5 -29.5t-29.5 -70.5v-500 q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v148l200 200v-298q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5h300z" />
<glyph unicode="&#xe165;" d="M600 1186q119 0 227.5 -46.5t187 -125t125 -187t46.5 -227.5t-46.5 -227.5t-125 -187t-187 -125t-227.5 -46.5t-227.5 46.5t-187 125t-125 187t-46.5 227.5t46.5 227.5t125 187t187 125t227.5 46.5zM600 1022q-115 0 -212 -56.5t-153.5 -153.5t-56.5 -212t56.5 -212 t153.5 -153.5t212 -56.5t212 56.5t153.5 153.5t56.5 212t-56.5 212t-153.5 153.5t-212 56.5zM600 794q80 0 137 -57t57 -137t-57 -137t-137 -57t-137 57t-57 137t57 137t137 57z" />
<glyph unicode="&#xe166;" d="M450 1200h200q21 0 35.5 -14.5t14.5 -35.5v-350h245q20 0 25 -11t-9 -26l-383 -426q-14 -15 -33.5 -15t-32.5 15l-379 426q-13 15 -8.5 26t25.5 11h250v350q0 21 14.5 35.5t35.5 14.5zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe167;" d="M583 1182l378 -435q14 -15 9 -31t-26 -16h-244v-250q0 -20 -17 -35t-39 -15h-200q-20 0 -32 14.5t-12 35.5v250h-250q-20 0 -25.5 16.5t8.5 31.5l383 431q14 16 33.5 17t33.5 -14zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe168;" d="M396 723l369 369q7 7 17.5 7t17.5 -7l139 -139q7 -8 7 -18.5t-7 -17.5l-525 -525q-7 -8 -17.5 -8t-17.5 8l-292 291q-7 8 -7 18t7 18l139 139q8 7 18.5 7t17.5 -7zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50 h-100z" />
<glyph unicode="&#xe169;" d="M135 1023l142 142q14 14 35 14t35 -14l77 -77l-212 -212l-77 76q-14 15 -14 36t14 35zM655 855l210 210q14 14 24.5 10t10.5 -25l-2 -599q-1 -20 -15.5 -35t-35.5 -15l-597 -1q-21 0 -25 10.5t10 24.5l208 208l-154 155l212 212zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5 v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe170;" d="M350 1200l599 -2q20 -1 35 -15.5t15 -35.5l1 -597q0 -21 -10.5 -25t-24.5 10l-208 208l-155 -154l-212 212l155 154l-210 210q-14 14 -10 24.5t25 10.5zM524 512l-76 -77q-15 -14 -36 -14t-35 14l-142 142q-14 14 -14 35t14 35l77 77zM50 300h1000q21 0 35.5 -14.5 t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe171;" d="M1200 103l-483 276l-314 -399v423h-399l1196 796v-1096zM483 424v-230l683 953z" />
<glyph unicode="&#xe172;" d="M1100 1000v-850q0 -21 -14.5 -35.5t-35.5 -14.5h-150v400h-700v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200z" />
<glyph unicode="&#xe173;" d="M1100 1000l-2 -149l-299 -299l-95 95q-9 9 -21.5 9t-21.5 -9l-149 -147h-312v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1132 638l106 -106q7 -7 7 -17.5t-7 -17.5l-420 -421q-8 -7 -18 -7 t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l297 297q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe174;" d="M1100 1000v-269l-103 -103l-134 134q-15 15 -33.5 16.5t-34.5 -12.5l-266 -266h-329v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1202 572l70 -70q15 -15 15 -35.5t-15 -35.5l-131 -131 l131 -131q15 -15 15 -35.5t-15 -35.5l-70 -70q-15 -15 -35.5 -15t-35.5 15l-131 131l-131 -131q-15 -15 -35.5 -15t-35.5 15l-70 70q-15 15 -15 35.5t15 35.5l131 131l-131 131q-15 15 -15 35.5t15 35.5l70 70q15 15 35.5 15t35.5 -15l131 -131l131 131q15 15 35.5 15 t35.5 -15z" />
<glyph unicode="&#xe175;" d="M1100 1000v-300h-350q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-500v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM850 600h100q21 0 35.5 -14.5t14.5 -35.5v-250h150q21 0 25 -10.5t-10 -24.5 l-230 -230q-14 -14 -35 -14t-35 14l-230 230q-14 14 -10 24.5t25 10.5h150v250q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe176;" d="M1100 1000v-400l-165 165q-14 15 -35 15t-35 -15l-263 -265h-402v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM935 565l230 -229q14 -15 10 -25.5t-25 -10.5h-150v-250q0 -20 -14.5 -35 t-35.5 -15h-100q-21 0 -35.5 15t-14.5 35v250h-150q-21 0 -25 10.5t10 25.5l230 229q14 15 35 15t35 -15z" />
<glyph unicode="&#xe177;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-150h-1200v150q0 21 14.5 35.5t35.5 14.5zM1200 800v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v550h1200zM100 500v-200h400v200h-400z" />
<glyph unicode="&#xe178;" d="M935 1165l248 -230q14 -14 14 -35t-14 -35l-248 -230q-14 -14 -24.5 -10t-10.5 25v150h-400v200h400v150q0 21 10.5 25t24.5 -10zM200 800h-50q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v-200zM400 800h-100v200h100v-200zM18 435l247 230 q14 14 24.5 10t10.5 -25v-150h400v-200h-400v-150q0 -21 -10.5 -25t-24.5 10l-247 230q-15 14 -15 35t15 35zM900 300h-100v200h100v-200zM1000 500h51q20 0 34.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-34.5 -14.5h-51v200z" />
<glyph unicode="&#xe179;" d="M862 1073l276 116q25 18 43.5 8t18.5 -41v-1106q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v397q-4 1 -11 5t-24 17.5t-30 29t-24 42t-11 56.5v359q0 31 18.5 65t43.5 52zM550 1200q22 0 34.5 -12.5t14.5 -24.5l1 -13v-450q0 -28 -10.5 -59.5 t-25 -56t-29 -45t-25.5 -31.5l-10 -11v-447q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v447q-4 4 -11 11.5t-24 30.5t-30 46t-24 55t-11 60v450q0 2 0.5 5.5t4 12t8.5 15t14.5 12t22.5 5.5q20 0 32.5 -12.5t14.5 -24.5l3 -13v-350h100v350v5.5t2.5 12 t7 15t15 12t25.5 5.5q23 0 35.5 -12.5t13.5 -24.5l1 -13v-350h100v350q0 2 0.5 5.5t3 12t7 15t15 12t24.5 5.5z" />
<glyph unicode="&#xe180;" d="M1200 1100v-56q-4 0 -11 -0.5t-24 -3t-30 -7.5t-24 -15t-11 -24v-888q0 -22 25 -34.5t50 -13.5l25 -2v-56h-400v56q75 0 87.5 6.5t12.5 43.5v394h-500v-394q0 -37 12.5 -43.5t87.5 -6.5v-56h-400v56q4 0 11 0.5t24 3t30 7.5t24 15t11 24v888q0 22 -25 34.5t-50 13.5 l-25 2v56h400v-56q-75 0 -87.5 -6.5t-12.5 -43.5v-394h500v394q0 37 -12.5 43.5t-87.5 6.5v56h400z" />
<glyph unicode="&#xe181;" d="M675 1000h375q21 0 35.5 -14.5t14.5 -35.5v-150h-105l-295 -98v98l-200 200h-400l100 100h375zM100 900h300q41 0 70.5 -29.5t29.5 -70.5v-500q0 -41 -29.5 -70.5t-70.5 -29.5h-300q-41 0 -70.5 29.5t-29.5 70.5v500q0 41 29.5 70.5t70.5 29.5zM100 800v-200h300v200 h-300zM1100 535l-400 -133v163l400 133v-163zM100 500v-200h300v200h-300zM1100 398v-248q0 -21 -14.5 -35.5t-35.5 -14.5h-375l-100 -100h-375l-100 100h400l200 200h105z" />
<glyph unicode="&#xe182;" d="M17 1007l162 162q17 17 40 14t37 -22l139 -194q14 -20 11 -44.5t-20 -41.5l-119 -118q102 -142 228 -268t267 -227l119 118q17 17 42.5 19t44.5 -12l192 -136q19 -14 22.5 -37.5t-13.5 -40.5l-163 -162q-3 -1 -9.5 -1t-29.5 2t-47.5 6t-62.5 14.5t-77.5 26.5t-90 42.5 t-101.5 60t-111 83t-119 108.5q-74 74 -133.5 150.5t-94.5 138.5t-60 119.5t-34.5 100t-15 74.5t-4.5 48z" />
<glyph unicode="&#xe183;" d="M600 1100q92 0 175 -10.5t141.5 -27t108.5 -36.5t81.5 -40t53.5 -37t31 -27l9 -10v-200q0 -21 -14.5 -33t-34.5 -9l-202 34q-20 3 -34.5 20t-14.5 38v146q-141 24 -300 24t-300 -24v-146q0 -21 -14.5 -38t-34.5 -20l-202 -34q-20 -3 -34.5 9t-14.5 33v200q3 4 9.5 10.5 t31 26t54 37.5t80.5 39.5t109 37.5t141 26.5t175 10.5zM600 795q56 0 97 -9.5t60 -23.5t30 -28t12 -24l1 -10v-50l365 -303q14 -15 24.5 -40t10.5 -45v-212q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v212q0 20 10.5 45t24.5 40l365 303v50 q0 4 1 10.5t12 23t30 29t60 22.5t97 10z" />
<glyph unicode="&#xe184;" d="M1100 700l-200 -200h-600l-200 200v500h200v-200h200v200h200v-200h200v200h200v-500zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5 t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe185;" d="M700 1100h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-1000h300v1000q0 41 -29.5 70.5t-70.5 29.5zM1100 800h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-700h300v700q0 41 -29.5 70.5t-70.5 29.5zM400 0h-300v400q0 41 29.5 70.5t70.5 29.5h100q41 0 70.5 -29.5t29.5 -70.5v-400z " />
<glyph unicode="&#xe186;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe187;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 300h-100v200h-100v-200h-100v500h100v-200h100v200h100v-500zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe188;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-300h200v-100h-300v500h300v-100zM900 700h-200v-300h200v-100h-300v500h300v-100z" />
<glyph unicode="&#xe189;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 400l-300 150l300 150v-300zM900 550l-300 -150v300z" />
<glyph unicode="&#xe190;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM900 300h-700v500h700v-500zM800 700h-130q-38 0 -66.5 -43t-28.5 -108t27 -107t68 -42h130v300zM300 700v-300 h130q41 0 68 42t27 107t-28.5 108t-66.5 43h-130z" />
<glyph unicode="&#xe191;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 300h-100v400h-100v100h200v-500z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe192;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM300 700h200v-400h-300v500h100v-100zM900 300h-100v400h-100v100h200v-500zM300 600v-200h100v200h-100z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe193;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 500l-199 -200h-100v50l199 200v150h-200v100h300v-300zM900 300h-100v400h-100v100h200v-500zM701 300h-100 v100h100v-100z" />
<glyph unicode="&#xe194;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700h-300v-200h300v-100h-300l-100 100v200l100 100h300v-100z" />
<glyph unicode="&#xe195;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700v-100l-50 -50l100 -100v-50h-100l-100 100h-150v-100h-100v400h300zM500 700v-100h200v100h-200z" />
<glyph unicode="&#xe197;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -207t-85 -207t-205 -86.5h-128v250q0 21 -14.5 35.5t-35.5 14.5h-300q-21 0 -35.5 -14.5t-14.5 -35.5v-250h-222q-80 0 -136 57.5t-56 136.5q0 69 43 122.5t108 67.5q-2 19 -2 37q0 100 49 185 t134 134t185 49zM525 500h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -244q-13 -16 -32 -16t-32 16l-223 244q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe198;" d="M502 1089q110 0 201 -59.5t135 -156.5q43 15 89 15q121 0 206 -86.5t86 -206.5q0 -99 -60 -181t-150 -110l-378 360q-13 16 -31.5 16t-31.5 -16l-381 -365h-9q-79 0 -135.5 57.5t-56.5 136.5q0 69 43 122.5t108 67.5q-2 19 -2 38q0 100 49 184.5t133.5 134t184.5 49.5z M632 467l223 -228q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5q199 204 223 228q19 19 31.5 19t32.5 -19z" />
<glyph unicode="&#xe199;" d="M700 100v100h400l-270 300h170l-270 300h170l-300 333l-300 -333h170l-270 -300h170l-270 -300h400v-100h-50q-21 0 -35.5 -14.5t-14.5 -35.5v-50h400v50q0 21 -14.5 35.5t-35.5 14.5h-50z" />
<glyph unicode="&#xe200;" d="M600 1179q94 0 167.5 -56.5t99.5 -145.5q89 -6 150.5 -71.5t61.5 -155.5q0 -61 -29.5 -112.5t-79.5 -82.5q9 -29 9 -55q0 -74 -52.5 -126.5t-126.5 -52.5q-55 0 -100 30v-251q21 0 35.5 -14.5t14.5 -35.5v-50h-300v50q0 21 14.5 35.5t35.5 14.5v251q-45 -30 -100 -30 q-74 0 -126.5 52.5t-52.5 126.5q0 18 4 38q-47 21 -75.5 65t-28.5 97q0 74 52.5 126.5t126.5 52.5q5 0 23 -2q0 2 -1 10t-1 13q0 116 81.5 197.5t197.5 81.5z" />
<glyph unicode="&#xe201;" d="M1010 1010q111 -111 150.5 -260.5t0 -299t-150.5 -260.5q-83 -83 -191.5 -126.5t-218.5 -43.5t-218.5 43.5t-191.5 126.5q-111 111 -150.5 260.5t0 299t150.5 260.5q83 83 191.5 126.5t218.5 43.5t218.5 -43.5t191.5 -126.5zM476 1065q-4 0 -8 -1q-121 -34 -209.5 -122.5 t-122.5 -209.5q-4 -12 2.5 -23t18.5 -14l36 -9q3 -1 7 -1q23 0 29 22q27 96 98 166q70 71 166 98q11 3 17.5 13.5t3.5 22.5l-9 35q-3 13 -14 19q-7 4 -15 4zM512 920q-4 0 -9 -2q-80 -24 -138.5 -82.5t-82.5 -138.5q-4 -13 2 -24t19 -14l34 -9q4 -1 8 -1q22 0 28 21 q18 58 58.5 98.5t97.5 58.5q12 3 18 13.5t3 21.5l-9 35q-3 12 -14 19q-7 4 -15 4zM719.5 719.5q-49.5 49.5 -119.5 49.5t-119.5 -49.5t-49.5 -119.5t49.5 -119.5t119.5 -49.5t119.5 49.5t49.5 119.5t-49.5 119.5zM855 551q-22 0 -28 -21q-18 -58 -58.5 -98.5t-98.5 -57.5 q-11 -4 -17 -14.5t-3 -21.5l9 -35q3 -12 14 -19q7 -4 15 -4q4 0 9 2q80 24 138.5 82.5t82.5 138.5q4 13 -2.5 24t-18.5 14l-34 9q-4 1 -8 1zM1000 515q-23 0 -29 -22q-27 -96 -98 -166q-70 -71 -166 -98q-11 -3 -17.5 -13.5t-3.5 -22.5l9 -35q3 -13 14 -19q7 -4 15 -4 q4 0 8 1q121 34 209.5 122.5t122.5 209.5q4 12 -2.5 23t-18.5 14l-36 9q-3 1 -7 1z" />
<glyph unicode="&#xe202;" d="M700 800h300v-380h-180v200h-340v-200h-380v755q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM700 300h162l-212 -212l-212 212h162v200h100v-200zM520 0h-395q-10 0 -17.5 7.5t-7.5 17.5v395zM1000 220v-195q0 -10 -7.5 -17.5t-17.5 -7.5h-195z" />
<glyph unicode="&#xe203;" d="M700 800h300v-520l-350 350l-550 -550v1095q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM862 200h-162v-200h-100v200h-162l212 212zM480 0h-355q-10 0 -17.5 7.5t-7.5 17.5v55h380v-80zM1000 80v-55q0 -10 -7.5 -17.5t-17.5 -7.5h-155v80h180z" />
<glyph unicode="&#xe204;" d="M1162 800h-162v-200h100l100 -100h-300v300h-162l212 212zM200 800h200q27 0 40 -2t29.5 -10.5t23.5 -30t7 -57.5h300v-100h-600l-200 -350v450h100q0 36 7 57.5t23.5 30t29.5 10.5t40 2zM800 400h240l-240 -400h-800l300 500h500v-100z" />
<glyph unicode="&#xe205;" d="M650 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM1000 850v150q41 0 70.5 -29.5t29.5 -70.5v-800 q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-1 0 -20 4l246 246l-326 326v324q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM412 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe206;" d="M450 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM800 850v150q41 0 70.5 -29.5t29.5 -70.5v-500 h-200v-300h200q0 -36 -7 -57.5t-23.5 -30t-29.5 -10.5t-40 -2h-600q-41 0 -70.5 29.5t-29.5 70.5v800q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM1212 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe209;" d="M658 1197l637 -1104q23 -38 7 -65.5t-60 -27.5h-1276q-44 0 -60 27.5t7 65.5l637 1104q22 39 54 39t54 -39zM704 800h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM500 300v-100h200 v100h-200z" />
<glyph unicode="&#xe210;" d="M425 1100h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM825 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM25 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5zM425 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5 v150q0 10 7.5 17.5t17.5 7.5zM25 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe211;" d="M700 1200h100v-200h-100v-100h350q62 0 86.5 -39.5t-3.5 -94.5l-66 -132q-41 -83 -81 -134h-772q-40 51 -81 134l-66 132q-28 55 -3.5 94.5t86.5 39.5h350v100h-100v200h100v100h200v-100zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100 h-950l138 100h-13q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe212;" d="M600 1300q40 0 68.5 -29.5t28.5 -70.5h-194q0 41 28.5 70.5t68.5 29.5zM443 1100h314q18 -37 18 -75q0 -8 -3 -25h328q41 0 44.5 -16.5t-30.5 -38.5l-175 -145h-678l-178 145q-34 22 -29 38.5t46 16.5h328q-3 17 -3 25q0 38 18 75zM250 700h700q21 0 35.5 -14.5 t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-150v-200l275 -200h-950l275 200v200h-150q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe213;" d="M600 1181q75 0 128 -53t53 -128t-53 -128t-128 -53t-128 53t-53 128t53 128t128 53zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13 l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe214;" d="M600 1300q47 0 92.5 -53.5t71 -123t25.5 -123.5q0 -78 -55.5 -133.5t-133.5 -55.5t-133.5 55.5t-55.5 133.5q0 62 34 143l144 -143l111 111l-163 163q34 26 63 26zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45 zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe215;" d="M600 1200l300 -161v-139h-300q0 -57 18.5 -108t50 -91.5t63 -72t70 -67.5t57.5 -61h-530q-60 83 -90.5 177.5t-30.5 178.5t33 164.5t87.5 139.5t126 96.5t145.5 41.5v-98zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100 h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe216;" d="M600 1300q41 0 70.5 -29.5t29.5 -70.5v-78q46 -26 73 -72t27 -100v-50h-400v50q0 54 27 100t73 72v78q0 41 29.5 70.5t70.5 29.5zM400 800h400q54 0 100 -27t72 -73h-172v-100h200v-100h-200v-100h200v-100h-200v-100h200q0 -83 -58.5 -141.5t-141.5 -58.5h-400 q-83 0 -141.5 58.5t-58.5 141.5v400q0 83 58.5 141.5t141.5 58.5z" />
<glyph unicode="&#xe218;" d="M150 1100h900q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM125 400h950q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-283l224 -224q13 -13 13 -31.5t-13 -32 t-31.5 -13.5t-31.5 13l-88 88h-524l-87 -88q-13 -13 -32 -13t-32 13.5t-13 32t13 31.5l224 224h-289q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM541 300l-100 -100h324l-100 100h-124z" />
<glyph unicode="&#xe219;" d="M200 1100h800q83 0 141.5 -58.5t58.5 -141.5v-200h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100v200q0 83 58.5 141.5t141.5 58.5zM100 600h1000q41 0 70.5 -29.5 t29.5 -70.5v-300h-1200v300q0 41 29.5 70.5t70.5 29.5zM300 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200zM1100 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200z" />
<glyph unicode="&#xe221;" d="M480 1165l682 -683q31 -31 31 -75.5t-31 -75.5l-131 -131h-481l-517 518q-32 31 -32 75.5t32 75.5l295 296q31 31 75.5 31t76.5 -31zM108 794l342 -342l303 304l-341 341zM250 100h800q21 0 35.5 -14.5t14.5 -35.5v-50h-900v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe223;" d="M1057 647l-189 506q-8 19 -27.5 33t-40.5 14h-400q-21 0 -40.5 -14t-27.5 -33l-189 -506q-8 -19 1.5 -33t30.5 -14h625v-150q0 -21 14.5 -35.5t35.5 -14.5t35.5 14.5t14.5 35.5v150h125q21 0 30.5 14t1.5 33zM897 0h-595v50q0 21 14.5 35.5t35.5 14.5h50v50 q0 21 14.5 35.5t35.5 14.5h48v300h200v-300h47q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-50z" />
<glyph unicode="&#xe224;" d="M900 800h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-375v591l-300 300v84q0 10 7.5 17.5t17.5 7.5h375v-400zM1200 900h-200v200zM400 600h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-650q-10 0 -17.5 7.5t-7.5 17.5v950q0 10 7.5 17.5t17.5 7.5h375v-400zM700 700h-200v200z " />
<glyph unicode="&#xe225;" d="M484 1095h195q75 0 146 -32.5t124 -86t89.5 -122.5t48.5 -142q18 -14 35 -20q31 -10 64.5 6.5t43.5 48.5q10 34 -15 71q-19 27 -9 43q5 8 12.5 11t19 -1t23.5 -16q41 -44 39 -105q-3 -63 -46 -106.5t-104 -43.5h-62q-7 -55 -35 -117t-56 -100l-39 -234q-3 -20 -20 -34.5 t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l12 70q-49 -14 -91 -14h-195q-24 0 -65 8l-11 -64q-3 -20 -20 -34.5t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l26 157q-84 74 -128 175l-159 53q-19 7 -33 26t-14 40v50q0 21 14.5 35.5t35.5 14.5h124q11 87 56 166l-111 95 q-16 14 -12.5 23.5t24.5 9.5h203q116 101 250 101zM675 1000h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h250q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe226;" d="M641 900l423 247q19 8 42 2.5t37 -21.5l32 -38q14 -15 12.5 -36t-17.5 -34l-139 -120h-390zM50 1100h106q67 0 103 -17t66 -71l102 -212h823q21 0 35.5 -14.5t14.5 -35.5v-50q0 -21 -14 -40t-33 -26l-737 -132q-23 -4 -40 6t-26 25q-42 67 -100 67h-300q-62 0 -106 44 t-44 106v200q0 62 44 106t106 44zM173 928h-80q-19 0 -28 -14t-9 -35v-56q0 -51 42 -51h134q16 0 21.5 8t5.5 24q0 11 -16 45t-27 51q-18 28 -43 28zM550 727q-32 0 -54.5 -22.5t-22.5 -54.5t22.5 -54.5t54.5 -22.5t54.5 22.5t22.5 54.5t-22.5 54.5t-54.5 22.5zM130 389 l152 130q18 19 34 24t31 -3.5t24.5 -17.5t25.5 -28q28 -35 50.5 -51t48.5 -13l63 5l48 -179q13 -61 -3.5 -97.5t-67.5 -79.5l-80 -69q-47 -40 -109 -35.5t-103 51.5l-130 151q-40 47 -35.5 109.5t51.5 102.5zM380 377l-102 -88q-31 -27 2 -65l37 -43q13 -15 27.5 -19.5 t31.5 6.5l61 53q19 16 14 49q-2 20 -12 56t-17 45q-11 12 -19 14t-23 -8z" />
<glyph unicode="&#xe227;" d="M625 1200h150q10 0 17.5 -7.5t7.5 -17.5v-109q79 -33 131 -87.5t53 -128.5q1 -46 -15 -84.5t-39 -61t-46 -38t-39 -21.5l-17 -6q6 0 15 -1.5t35 -9t50 -17.5t53 -30t50 -45t35.5 -64t14.5 -84q0 -59 -11.5 -105.5t-28.5 -76.5t-44 -51t-49.5 -31.5t-54.5 -16t-49.5 -6.5 t-43.5 -1v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-100v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-175q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v600h-75q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5h175v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h100v75q0 10 7.5 17.5t17.5 7.5zM400 900v-200h263q28 0 48.5 10.5t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-263zM400 500v-200h363q28 0 48.5 10.5 t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-363z" />
<glyph unicode="&#xe230;" d="M212 1198h780q86 0 147 -61t61 -147v-416q0 -51 -18 -142.5t-36 -157.5l-18 -66q-29 -87 -93.5 -146.5t-146.5 -59.5h-572q-82 0 -147 59t-93 147q-8 28 -20 73t-32 143.5t-20 149.5v416q0 86 61 147t147 61zM600 1045q-70 0 -132.5 -11.5t-105.5 -30.5t-78.5 -41.5 t-57 -45t-36 -41t-20.5 -30.5l-6 -12l156 -243h560l156 243q-2 5 -6 12.5t-20 29.5t-36.5 42t-57 44.5t-79 42t-105 29.5t-132.5 12zM762 703h-157l195 261z" />
<glyph unicode="&#xe231;" d="M475 1300h150q103 0 189 -86t86 -189v-500q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe232;" d="M475 1300h96q0 -150 89.5 -239.5t239.5 -89.5v-446q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe233;" d="M1294 767l-638 -283l-378 170l-78 -60v-224l100 -150v-199l-150 148l-150 -149v200l100 150v250q0 4 -0.5 10.5t0 9.5t1 8t3 8t6.5 6l47 40l-147 65l642 283zM1000 380l-350 -166l-350 166v147l350 -165l350 165v-147z" />
<glyph unicode="&#xe234;" d="M250 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM650 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM1050 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe235;" d="M550 1100q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 700q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 300q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe236;" d="M125 1100h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM125 700h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM125 300h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe237;" d="M350 1200h500q162 0 256 -93.5t94 -256.5v-500q0 -165 -93.5 -257.5t-256.5 -92.5h-500q-165 0 -257.5 92.5t-92.5 257.5v500q0 165 92.5 257.5t257.5 92.5zM900 1000h-600q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h600q41 0 70.5 29.5 t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5zM350 900h500q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-500q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 14.5 35.5t35.5 14.5zM400 800v-200h400v200h-400z" />
<glyph unicode="&#xe238;" d="M150 1100h1000q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe239;" d="M650 1187q87 -67 118.5 -156t0 -178t-118.5 -155q-87 66 -118.5 155t0 178t118.5 156zM300 800q124 0 212 -88t88 -212q-124 0 -212 88t-88 212zM1000 800q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM300 500q124 0 212 -88t88 -212q-124 0 -212 88t-88 212z M1000 500q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM700 199v-144q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v142q40 -4 43 -4q17 0 57 6z" />
<glyph unicode="&#xe240;" d="M745 878l69 19q25 6 45 -12l298 -295q11 -11 15 -26.5t-2 -30.5q-5 -14 -18 -23.5t-28 -9.5h-8q1 0 1 -13q0 -29 -2 -56t-8.5 -62t-20 -63t-33 -53t-51 -39t-72.5 -14h-146q-184 0 -184 288q0 24 10 47q-20 4 -62 4t-63 -4q11 -24 11 -47q0 -288 -184 -288h-142 q-48 0 -84.5 21t-56 51t-32 71.5t-16 75t-3.5 68.5q0 13 2 13h-7q-15 0 -27.5 9.5t-18.5 23.5q-6 15 -2 30.5t15 25.5l298 296q20 18 46 11l76 -19q20 -5 30.5 -22.5t5.5 -37.5t-22.5 -31t-37.5 -5l-51 12l-182 -193h891l-182 193l-44 -12q-20 -5 -37.5 6t-22.5 31t6 37.5 t31 22.5z" />
<glyph unicode="&#xe241;" d="M1200 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM500 450h-25q0 15 -4 24.5t-9 14.5t-17 7.5t-20 3t-25 0.5h-100v-425q0 -11 12.5 -17.5t25.5 -7.5h12v-50h-200v50q50 0 50 25v425h-100q-17 0 -25 -0.5t-20 -3t-17 -7.5t-9 -14.5t-4 -24.5h-25v150h500v-150z" />
<glyph unicode="&#xe242;" d="M1000 300v50q-25 0 -55 32q-14 14 -25 31t-16 27l-4 11l-289 747h-69l-300 -754q-18 -35 -39 -56q-9 -9 -24.5 -18.5t-26.5 -14.5l-11 -5v-50h273v50q-49 0 -78.5 21.5t-11.5 67.5l69 176h293l61 -166q13 -34 -3.5 -66.5t-55.5 -32.5v-50h312zM412 691l134 342l121 -342 h-255zM1100 150v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe243;" d="M50 1200h1100q21 0 35.5 -14.5t14.5 -35.5v-1100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5zM611 1118h-70q-13 0 -18 -12l-299 -753q-17 -32 -35 -51q-18 -18 -56 -34q-12 -5 -12 -18v-50q0 -8 5.5 -14t14.5 -6 h273q8 0 14 6t6 14v50q0 8 -6 14t-14 6q-55 0 -71 23q-10 14 0 39l63 163h266l57 -153q11 -31 -6 -55q-12 -17 -36 -17q-8 0 -14 -6t-6 -14v-50q0 -8 6 -14t14 -6h313q8 0 14 6t6 14v50q0 7 -5.5 13t-13.5 7q-17 0 -42 25q-25 27 -40 63h-1l-288 748q-5 12 -19 12zM639 611 h-197l103 264z" />
<glyph unicode="&#xe244;" d="M1200 1100h-1200v100h1200v-100zM50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 1000h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM700 900v-300h300v300h-300z" />
<glyph unicode="&#xe245;" d="M50 1200h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 700h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM700 600v-300h300v300h-300zM1200 0h-1200v100h1200v-100z" />
<glyph unicode="&#xe246;" d="M50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-350h100v150q0 21 14.5 35.5t35.5 14.5h400q21 0 35.5 -14.5t14.5 -35.5v-150h100v-100h-100v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v150h-100v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM700 700v-300h300v300h-300z" />
<glyph unicode="&#xe247;" d="M100 0h-100v1200h100v-1200zM250 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM300 1000v-300h300v300h-300zM250 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe248;" d="M600 1100h150q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-100h450q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h350v100h-150q-21 0 -35.5 14.5 t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h150v100h100v-100zM400 1000v-300h300v300h-300z" />
<glyph unicode="&#xe249;" d="M1200 0h-100v1200h100v-1200zM550 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM600 1000v-300h300v300h-300zM50 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe250;" d="M865 565l-494 -494q-23 -23 -41 -23q-14 0 -22 13.5t-8 38.5v1000q0 25 8 38.5t22 13.5q18 0 41 -23l494 -494q14 -14 14 -35t-14 -35z" />
<glyph unicode="&#xe251;" d="M335 635l494 494q29 29 50 20.5t21 -49.5v-1000q0 -41 -21 -49.5t-50 20.5l-494 494q-14 14 -14 35t14 35z" />
<glyph unicode="&#xe252;" d="M100 900h1000q41 0 49.5 -21t-20.5 -50l-494 -494q-14 -14 -35 -14t-35 14l-494 494q-29 29 -20.5 50t49.5 21z" />
<glyph unicode="&#xe253;" d="M635 865l494 -494q29 -29 20.5 -50t-49.5 -21h-1000q-41 0 -49.5 21t20.5 50l494 494q14 14 35 14t35 -14z" />
<glyph unicode="&#xe254;" d="M700 741v-182l-692 -323v221l413 193l-413 193v221zM1200 0h-800v200h800v-200z" />
<glyph unicode="&#xe255;" d="M1200 900h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300zM0 700h50q0 21 4 37t9.5 26.5t18 17.5t22 11t28.5 5.5t31 2t37 0.5h100v-550q0 -22 -25 -34.5t-50 -13.5l-25 -2v-100h400v100q-4 0 -11 0.5t-24 3t-30 7t-24 15t-11 24.5v550h100q25 0 37 -0.5t31 -2 t28.5 -5.5t22 -11t18 -17.5t9.5 -26.5t4 -37h50v300h-800v-300z" />
<glyph unicode="&#xe256;" d="M800 700h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-100v-550q0 -22 25 -34.5t50 -14.5l25 -1v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v550h-100q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h800v-300zM1100 200h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300z" />
<glyph unicode="&#xe257;" d="M701 1098h160q16 0 21 -11t-7 -23l-464 -464l464 -464q12 -12 7 -23t-21 -11h-160q-13 0 -23 9l-471 471q-7 8 -7 18t7 18l471 471q10 9 23 9z" />
<glyph unicode="&#xe258;" d="M339 1098h160q13 0 23 -9l471 -471q7 -8 7 -18t-7 -18l-471 -471q-10 -9 -23 -9h-160q-16 0 -21 11t7 23l464 464l-464 464q-12 12 -7 23t21 11z" />
<glyph unicode="&#xe259;" d="M1087 882q11 -5 11 -21v-160q0 -13 -9 -23l-471 -471q-8 -7 -18 -7t-18 7l-471 471q-9 10 -9 23v160q0 16 11 21t23 -7l464 -464l464 464q12 12 23 7z" />
<glyph unicode="&#xe260;" d="M618 993l471 -471q9 -10 9 -23v-160q0 -16 -11 -21t-23 7l-464 464l-464 -464q-12 -12 -23 -7t-11 21v160q0 13 9 23l471 471q8 7 18 7t18 -7z" />
<glyph unicode="&#xf8ff;" d="M1000 1200q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM450 1000h100q21 0 40 -14t26 -33l79 -194q5 1 16 3q34 6 54 9.5t60 7t65.5 1t61 -10t56.5 -23t42.5 -42t29 -64t5 -92t-19.5 -121.5q-1 -7 -3 -19.5t-11 -50t-20.5 -73t-32.5 -81.5t-46.5 -83t-64 -70 t-82.5 -50q-13 -5 -42 -5t-65.5 2.5t-47.5 2.5q-14 0 -49.5 -3.5t-63 -3.5t-43.5 7q-57 25 -104.5 78.5t-75 111.5t-46.5 112t-26 90l-7 35q-15 63 -18 115t4.5 88.5t26 64t39.5 43.5t52 25.5t58.5 13t62.5 2t59.5 -4.5t55.5 -8l-147 192q-12 18 -5.5 30t27.5 12z" />
<glyph unicode="&#x1f511;" d="M250 1200h600q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-500l-255 -178q-19 -9 -32 -1t-13 29v650h-150q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM400 1100v-100h300v100h-300z" />
<glyph unicode="&#x1f6aa;" d="M250 1200h750q39 0 69.5 -40.5t30.5 -84.5v-933l-700 -117v950l600 125h-700v-1000h-100v1025q0 23 15.5 49t34.5 26zM500 525v-100l100 20v100z" />
</font>
</defs></svg> ) format('svg')}.glyphicon{position:relative;top:1px;display:inline-block;font-family:'Glyphicons Halflings';font-style:normal;font-weight:normal;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.glyphicon-asterisk:before{content:"\002a"}.glyphicon-plus:before{content:"\002b"}.glyphicon-euro:before,.glyphicon-eur:before{content:"\20ac"}.glyphicon-minus:before{content:"\2212"}.glyphicon-cloud:before{content:"\2601"}.glyphicon-envelope:before{content:"\2709"}.glyphicon-pencil:before{content:"\270f"}.glyphicon-glass:before{content:"\e001"}.glyphicon-music:before{content:"\e002"}.glyphicon-search:before{content:"\e003"}.glyphicon-heart:before{content:"\e005"}.glyphicon-star:before{content:"\e006"}.glyphicon-star-empty:before{content:"\e007"}.glyphicon-user:before{content:"\e008"}.glyphicon-film:before{content:"\e009"}.glyphicon-th-large:before{content:"\e010"}.glyphicon-th:before{content:"\e011"}.glyphicon-th-list:before{content:"\e012"}.glyphicon-ok:before{content:"\e013"}.glyphicon-remove:before{content:"\e014"}.glyphicon-zoom-in:before{content:"\e015"}.glyphicon-zoom-out:before{content:"\e016"}.glyphicon-off:before{content:"\e017"}.glyphicon-signal:before{content:"\e018"}.glyphicon-cog:before{content:"\e019"}.glyphicon-trash:before{content:"\e020"}.glyphicon-home:before{content:"\e021"}.glyphicon-file:before{content:"\e022"}.glyphicon-time:before{content:"\e023"}.glyphicon-road:before{content:"\e024"}.glyphicon-download-alt:before{content:"\e025"}.glyphicon-download:before{content:"\e026"}.glyphicon-upload:before{content:"\e027"}.glyphicon-inbox:before{content:"\e028"}.glyphicon-play-circle:before{content:"\e029"}.glyphicon-repeat:before{content:"\e030"}.glyphicon-refresh:before{content:"\e031"}.glyphicon-list-alt:before{content:"\e032"}.glyphicon-lock:before{content:"\e033"}.glyphicon-flag:before{content:"\e034"}.glyphicon-headphones:before{content:"\e035"}.glyphicon-volume-off:before{content:"\e036"}.glyphicon-volume-down:before{content:"\e037"}.glyphicon-volume-up:before{content:"\e038"}.glyphicon-qrcode:before{content:"\e039"}.glyphicon-barcode:before{content:"\e040"}.glyphicon-tag:before{content:"\e041"}.glyphicon-tags:before{content:"\e042"}.glyphicon-book:before{content:"\e043"}.glyphicon-bookmark:before{content:"\e044"}.glyphicon-print:before{content:"\e045"}.glyphicon-camera:before{content:"\e046"}.glyphicon-font:before{content:"\e047"}.glyphicon-bold:before{content:"\e048"}.glyphicon-italic:before{content:"\e049"}.glyphicon-text-height:before{content:"\e050"}.glyphicon-text-width:before{content:"\e051"}.glyphicon-align-left:before{content:"\e052"}.glyphicon-align-center:before{content:"\e053"}.glyphicon-align-right:before{content:"\e054"}.glyphicon-align-justify:before{content:"\e055"}.glyphicon-list:before{content:"\e056"}.glyphicon-indent-left:before{content:"\e057"}.glyphicon-indent-right:before{content:"\e058"}.glyphicon-facetime-video:before{content:"\e059"}.glyphicon-picture:before{content:"\e060"}.glyphicon-map-marker:before{content:"\e062"}.glyphicon-adjust:before{content:"\e063"}.glyphicon-tint:before{content:"\e064"}.glyphicon-edit:before{content:"\e065"}.glyphicon-share:before{content:"\e066"}.glyphicon-check:before{content:"\e067"}.glyphicon-move:before{content:"\e068"}.glyphicon-step-backward:before{content:"\e069"}.glyphicon-fast-backward:before{content:"\e070"}.glyphicon-backward:before{content:"\e071"}.glyphicon-play:before{content:"\e072"}.glyphicon-pause:before{content:"\e073"}.glyphicon-stop:before{content:"\e074"}.glyphicon-forward:before{content:"\e075"}.glyphicon-fast-forward:before{content:"\e076"}.glyphicon-step-forward:before{content:"\e077"}.glyphicon-eject:before{content:"\e078"}.glyphicon-chevron-left:before{content:"\e079"}.glyphicon-chevron-right:before{content:"\e080"}.glyphicon-plus-sign:before{content:"\e081"}.glyphicon-minus-sign:before{content:"\e082"}.glyphicon-remove-sign:before{content:"\e083"}.glyphicon-ok-sign:before{content:"\e084"}.glyphicon-question-sign:before{content:"\e085"}.glyphicon-info-sign:before{content:"\e086"}.glyphicon-screenshot:before{content:"\e087"}.glyphicon-remove-circle:before{content:"\e088"}.glyphicon-ok-circle:before{content:"\e089"}.glyphicon-ban-circle:before{content:"\e090"}.glyphicon-arrow-left:before{content:"\e091"}.glyphicon-arrow-right:before{content:"\e092"}.glyphicon-arrow-up:before{content:"\e093"}.glyphicon-arrow-down:before{content:"\e094"}.glyphicon-share-alt:before{content:"\e095"}.glyphicon-resize-full:before{content:"\e096"}.glyphicon-resize-small:before{content:"\e097"}.glyphicon-exclamation-sign:before{content:"\e101"}.glyphicon-gift:before{content:"\e102"}.glyphicon-leaf:before{content:"\e103"}.glyphicon-fire:before{content:"\e104"}.glyphicon-eye-open:before{content:"\e105"}.glyphicon-eye-close:before{content:"\e106"}.glyphicon-warning-sign:before{content:"\e107"}.glyphicon-plane:before{content:"\e108"}.glyphicon-calendar:before{content:"\e109"}.glyphicon-random:before{content:"\e110"}.glyphicon-comment:before{content:"\e111"}.glyphicon-magnet:before{content:"\e112"}.glyphicon-chevron-up:before{content:"\e113"}.glyphicon-chevron-down:before{content:"\e114"}.glyphicon-retweet:before{content:"\e115"}.glyphicon-shopping-cart:before{content:"\e116"}.glyphicon-folder-close:before{content:"\e117"}.glyphicon-folder-open:before{content:"\e118"}.glyphicon-resize-vertical:before{content:"\e119"}.glyphicon-resize-horizontal:before{content:"\e120"}.glyphicon-hdd:before{content:"\e121"}.glyphicon-bullhorn:before{content:"\e122"}.glyphicon-bell:before{content:"\e123"}.glyphicon-certificate:before{content:"\e124"}.glyphicon-thumbs-up:before{content:"\e125"}.glyphicon-thumbs-down:before{content:"\e126"}.glyphicon-hand-right:before{content:"\e127"}.glyphicon-hand-left:before{content:"\e128"}.glyphicon-hand-up:before{content:"\e129"}.glyphicon-hand-down:before{content:"\e130"}.glyphicon-circle-arrow-right:before{content:"\e131"}.glyphicon-circle-arrow-left:before{content:"\e132"}.glyphicon-circle-arrow-up:before{content:"\e133"}.glyphicon-circle-arrow-down:before{content:"\e134"}.glyphicon-globe:before{content:"\e135"}.glyphicon-wrench:before{content:"\e136"}.glyphicon-tasks:before{content:"\e137"}.glyphicon-filter:before{content:"\e138"}.glyphicon-briefcase:before{content:"\e139"}.glyphicon-fullscreen:before{content:"\e140"}.glyphicon-dashboard:before{content:"\e141"}.glyphicon-paperclip:before{content:"\e142"}.glyphicon-heart-empty:before{content:"\e143"}.glyphicon-link:before{content:"\e144"}.glyphicon-phone:before{content:"\e145"}.glyphicon-pushpin:before{content:"\e146"}.glyphicon-usd:before{content:"\e148"}.glyphicon-gbp:before{content:"\e149"}.glyphicon-sort:before{content:"\e150"}.glyphicon-sort-by-alphabet:before{content:"\e151"}.glyphicon-sort-by-alphabet-alt:before{content:"\e152"}.glyphicon-sort-by-order:before{content:"\e153"}.glyphicon-sort-by-order-alt:before{content:"\e154"}.glyphicon-sort-by-attributes:before{content:"\e155"}.glyphicon-sort-by-attributes-alt:before{content:"\e156"}.glyphicon-unchecked:before{content:"\e157"}.glyphicon-expand:before{content:"\e158"}.glyphicon-collapse-down:before{content:"\e159"}.glyphicon-collapse-up:before{content:"\e160"}.glyphicon-log-in:before{content:"\e161"}.glyphicon-flash:before{content:"\e162"}.glyphicon-log-out:before{content:"\e163"}.glyphicon-new-window:before{content:"\e164"}.glyphicon-record:before{content:"\e165"}.glyphicon-save:before{content:"\e166"}.glyphicon-open:before{content:"\e167"}.glyphicon-saved:before{content:"\e168"}.glyphicon-import:before{content:"\e169"}.glyphicon-export:before{content:"\e170"}.glyphicon-send:before{content:"\e171"}.glyphicon-floppy-disk:before{content:"\e172"}.glyphicon-floppy-saved:before{content:"\e173"}.glyphicon-floppy-remove:before{content:"\e174"}.glyphicon-floppy-save:before{content:"\e175"}.glyphicon-floppy-open:before{content:"\e176"}.glyphicon-credit-card:before{content:"\e177"}.glyphicon-transfer:before{content:"\e178"}.glyphicon-cutlery:before{content:"\e179"}.glyphicon-header:before{content:"\e180"}.glyphicon-compressed:before{content:"\e181"}.glyphicon-earphone:before{content:"\e182"}.glyphicon-phone-alt:before{content:"\e183"}.glyphicon-tower:before{content:"\e184"}.glyphicon-stats:before{content:"\e185"}.glyphicon-sd-video:before{content:"\e186"}.glyphicon-hd-video:before{content:"\e187"}.glyphicon-subtitles:before{content:"\e188"}.glyphicon-sound-stereo:before{content:"\e189"}.glyphicon-sound-dolby:before{content:"\e190"}.glyphicon-sound-5-1:before{content:"\e191"}.glyphicon-sound-6-1:before{content:"\e192"}.glyphicon-sound-7-1:before{content:"\e193"}.glyphicon-copyright-mark:before{content:"\e194"}.glyphicon-registration-mark:before{content:"\e195"}.glyphicon-cloud-download:before{content:"\e197"}.glyphicon-cloud-upload:before{content:"\e198"}.glyphicon-tree-conifer:before{content:"\e199"}.glyphicon-tree-deciduous:before{content:"\e200"}.glyphicon-cd:before{content:"\e201"}.glyphicon-save-file:before{content:"\e202"}.glyphicon-open-file:before{content:"\e203"}.glyphicon-level-up:before{content:"\e204"}.glyphicon-copy:before{content:"\e205"}.glyphicon-paste:before{content:"\e206"}.glyphicon-alert:before{content:"\e209"}.glyphicon-equalizer:before{content:"\e210"}.glyphicon-king:before{content:"\e211"}.glyphicon-queen:before{content:"\e212"}.glyphicon-pawn:before{content:"\e213"}.glyphicon-bishop:before{content:"\e214"}.glyphicon-knight:before{content:"\e215"}.glyphicon-baby-formula:before{content:"\e216"}.glyphicon-tent:before{content:"\26fa"}.glyphicon-blackboard:before{content:"\e218"}.glyphicon-bed:before{content:"\e219"}.glyphicon-apple:before{content:"\f8ff"}.glyphicon-erase:before{content:"\e221"}.glyphicon-hourglass:before{content:"\231b"}.glyphicon-lamp:before{content:"\e223"}.glyphicon-duplicate:before{content:"\e224"}.glyphicon-piggy-bank:before{content:"\e225"}.glyphicon-scissors:before{content:"\e226"}.glyphicon-bitcoin:before{content:"\e227"}.glyphicon-btc:before{content:"\e227"}.glyphicon-xbt:before{content:"\e227"}.glyphicon-yen:before{content:"\00a5"}.glyphicon-jpy:before{content:"\00a5"}.glyphicon-ruble:before{content:"\20bd"}.glyphicon-rub:before{content:"\20bd"}.glyphicon-scale:before{content:"\e230"}.glyphicon-ice-lolly:before{content:"\e231"}.glyphicon-ice-lolly-tasted:before{content:"\e232"}.glyphicon-education:before{content:"\e233"}.glyphicon-option-horizontal:before{content:"\e234"}.glyphicon-option-vertical:before{content:"\e235"}.glyphicon-menu-hamburger:before{content:"\e236"}.glyphicon-modal-window:before{content:"\e237"}.glyphicon-oil:before{content:"\e238"}.glyphicon-grain:before{content:"\e239"}.glyphicon-sunglasses:before{content:"\e240"}.glyphicon-text-size:before{content:"\e241"}.glyphicon-text-color:before{content:"\e242"}.glyphicon-text-background:before{content:"\e243"}.glyphicon-object-align-top:before{content:"\e244"}.glyphicon-object-align-bottom:before{content:"\e245"}.glyphicon-object-align-horizontal:before{content:"\e246"}.glyphicon-object-align-left:before{content:"\e247"}.glyphicon-object-align-vertical:before{content:"\e248"}.glyphicon-object-align-right:before{content:"\e249"}.glyphicon-triangle-right:before{content:"\e250"}.glyphicon-triangle-left:before{content:"\e251"}.glyphicon-triangle-bottom:before{content:"\e252"}.glyphicon-triangle-top:before{content:"\e253"}.glyphicon-console:before{content:"\e254"}.glyphicon-superscript:before{content:"\e255"}.glyphicon-subscript:before{content:"\e256"}.glyphicon-menu-left:before{content:"\e257"}.glyphicon-menu-right:before{content:"\e258"}.glyphicon-menu-down:before{content:"\e259"}.glyphicon-menu-up:before{content:"\e260"}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}*:before,*:after{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:rgba(0,0,0,0)}body{font-family:"Roboto","Helvetica Neue",Helvetica,Arial,sans-serif;font-size:13px;line-height:1.846;color:#666666;background-color:#ffffff}input,button,select,textarea{font-family:inherit;font-size:inherit;line-height:inherit}a{color:#2196f3;text-decoration:none}a:hover,a:focus{color:#0a6ebd;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}figure{margin:0}img{vertical-align:middle}.img-responsive,.thumbnail>img,.thumbnail a>img,.carousel-inner>.item>img,.carousel-inner>.item>a>img{display:block;max-width:100%;height:auto}.img-rounded{border-radius:3px}.img-thumbnail{padding:4px;line-height:1.846;background-color:#ffffff;border:1px solid #dddddd;border-radius:3px;-webkit-transition:all .2s ease-in-out;-o-transition:all .2s ease-in-out;transition:all .2s ease-in-out;display:inline-block;max-width:100%;height:auto}.img-circle{border-radius:50%}hr{margin-top:23px;margin-bottom:23px;border:0;border-top:1px solid #eeeeee}.sr-only{position:absolute;width:1px;height:1px;margin:-1px;padding:0;overflow:hidden;clip:rect(0, 0, 0, 0);border:0}.sr-only-focusable:active,.sr-only-focusable:focus{position:static;width:auto;height:auto;margin:0;overflow:visible;clip:auto}[role="button"]{cursor:pointer}h1,h2,h3,h4,h5,h6,.h1,.h2,.h3,.h4,.h5,.h6{font-family:inherit;font-weight:400;line-height:1.1;color:#444444}h1 small,h2 small,h3 small,h4 small,h5 small,h6 small,.h1 small,.h2 small,.h3 small,.h4 small,.h5 small,.h6 small,h1 .small,h2 .small,h3 .small,h4 .small,h5 .small,h6 .small,.h1 .small,.h2 .small,.h3 .small,.h4 .small,.h5 .small,.h6 .small{font-weight:normal;line-height:1;color:#bbbbbb}h1,.h1,h2,.h2,h3,.h3{margin-top:23px;margin-bottom:11.5px}h1 small,.h1 small,h2 small,.h2 small,h3 small,.h3 small,h1 .small,.h1 .small,h2 .small,.h2 .small,h3 .small,.h3 .small{font-size:65%}h4,.h4,h5,.h5,h6,.h6{margin-top:11.5px;margin-bottom:11.5px}h4 small,.h4 small,h5 small,.h5 small,h6 small,.h6 small,h4 .small,.h4 .small,h5 .small,.h5 .small,h6 .small,.h6 .small{font-size:75%}h1,.h1{font-size:56px}h2,.h2{font-size:45px}h3,.h3{font-size:34px}h4,.h4{font-size:24px}h5,.h5{font-size:20px}h6,.h6{font-size:14px}p{margin:0 0 11.5px}.lead{margin-bottom:23px;font-size:14px;font-weight:300;line-height:1.4}@media (min-width:768px){.lead{font-size:19.5px}}small,.small{font-size:92%}mark,.mark{background-color:#ffe0b2;padding:.2em}.text-left{text-align:left}.text-right{text-align:right}.text-center{text-align:center}.text-justify{text-align:justify}.text-nowrap{white-space:nowrap}.text-lowercase{text-transform:lowercase}.text-uppercase{text-transform:uppercase}.text-capitalize{text-transform:capitalize}.text-muted{color:#bbbbbb}.text-primary{color:#2196f3}a.text-primary:hover,a.text-primary:focus{color:#0c7cd5}.text-success{color:#4caf50}a.text-success:hover,a.text-success:focus{color:#3d8b40}.text-info{color:#9c27b0}a.text-info:hover,a.text-info:focus{color:#771e86}.text-warning{color:#ff9800}a.text-warning:hover,a.text-warning:focus{color:#cc7a00}.text-danger{color:#e51c23}a.text-danger:hover,a.text-danger:focus{color:#b9151b}.bg-primary{color:#fff;background-color:#2196f3}a.bg-primary:hover,a.bg-primary:focus{background-color:#0c7cd5}.bg-success{background-color:#dff0d8}a.bg-success:hover,a.bg-success:focus{background-color:#c1e2b3}.bg-info{background-color:#e1bee7}a.bg-info:hover,a.bg-info:focus{background-color:#d099d9}.bg-warning{background-color:#ffe0b2}a.bg-warning:hover,a.bg-warning:focus{background-color:#ffcb7f}.bg-danger{background-color:#f9bdbb}a.bg-danger:hover,a.bg-danger:focus{background-color:#f5908c}.page-header{padding-bottom:10.5px;margin:46px 0 23px;border-bottom:1px solid #eeeeee}ul,ol{margin-top:0;margin-bottom:11.5px}ul ul,ol ul,ul ol,ol ol{margin-bottom:0}.list-unstyled{padding-left:0;list-style:none}.list-inline{padding-left:0;list-style:none;margin-left:-5px}.list-inline>li{display:inline-block;padding-left:5px;padding-right:5px}dl{margin-top:0;margin-bottom:23px}dt,dd{line-height:1.846}dt{font-weight:bold}dd{margin-left:0}@media (min-width:768px){.dl-horizontal dt{float:left;width:160px;clear:left;text-align:right;overflow:hidden;text-overflow:ellipsis;white-space:nowrap}.dl-horizontal dd{margin-left:180px}}abbr[title],abbr[data-original-title]{cursor:help;border-bottom:1px dotted #bbbbbb}.initialism{font-size:90%;text-transform:uppercase}blockquote{padding:11.5px 23px;margin:0 0 23px;font-size:16.25px;border-left:5px solid #eeeeee}blockquote p:last-child,blockquote ul:last-child,blockquote ol:last-child{margin-bottom:0}blockquote footer,blockquote small,blockquote .small{display:block;font-size:80%;line-height:1.846;color:#bbbbbb}blockquote footer:before,blockquote small:before,blockquote .small:before{content:'\2014 \00A0'}.blockquote-reverse,blockquote.pull-right{padding-right:15px;padding-left:0;border-right:5px solid #eeeeee;border-left:0;text-align:right}.blockquote-reverse footer:before,blockquote.pull-right footer:before,.blockquote-reverse small:before,blockquote.pull-right small:before,.blockquote-reverse .small:before,blockquote.pull-right .small:before{content:''}.blockquote-reverse footer:after,blockquote.pull-right footer:after,.blockquote-reverse small:after,blockquote.pull-right small:after,.blockquote-reverse .small:after,blockquote.pull-right .small:after{content:'\00A0 \2014'}address{margin-bottom:23px;font-style:normal;line-height:1.846}code,kbd,pre,samp{font-family:monospace}code{padding:2px 4px;font-size:90%;color:#c7254e;background-color:#f9f2f4;border-radius:3px}kbd{padding:2px 4px;font-size:90%;color:#ffffff;background-color:#333333;border-radius:3px;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,0.25);box-shadow:inset 0 -1px 0 rgba(0,0,0,0.25)}kbd kbd{padding:0;font-size:100%;font-weight:bold;-webkit-box-shadow:none;box-shadow:none}pre{display:block;padding:11px;margin:0 0 11.5px;font-size:12px;line-height:1.846;word-break:break-all;word-wrap:break-word;color:#212121;background-color:#f5f5f5;border:1px solid #cccccc;border-radius:3px}pre code{padding:0;font-size:inherit;color:inherit;white-space:pre-wrap;background-color:transparent;border-radius:0}.pre-scrollable{max-height:340px;overflow-y:scroll}.container{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}.row{margin-left:-15px;margin-right:-15px}.col-xs-1,.col-sm-1,.col-md-1,.col-lg-1,.col-xs-2,.col-sm-2,.col-md-2,.col-lg-2,.col-xs-3,.col-sm-3,.col-md-3,.col-lg-3,.col-xs-4,.col-sm-4,.col-md-4,.col-lg-4,.col-xs-5,.col-sm-5,.col-md-5,.col-lg-5,.col-xs-6,.col-sm-6,.col-md-6,.col-lg-6,.col-xs-7,.col-sm-7,.col-md-7,.col-lg-7,.col-xs-8,.col-sm-8,.col-md-8,.col-lg-8,.col-xs-9,.col-sm-9,.col-md-9,.col-lg-9,.col-xs-10,.col-sm-10,.col-md-10,.col-lg-10,.col-xs-11,.col-sm-11,.col-md-11,.col-lg-11,.col-xs-12,.col-sm-12,.col-md-12,.col-lg-12{position:relative;min-height:1px;padding-left:15px;padding-right:15px}.col-xs-1,.col-xs-2,.col-xs-3,.col-xs-4,.col-xs-5,.col-xs-6,.col-xs-7,.col-xs-8,.col-xs-9,.col-xs-10,.col-xs-11,.col-xs-12{float:left}.col-xs-12{width:100%}.col-xs-11{width:91.66666667%}.col-xs-10{width:83.33333333%}.col-xs-9{width:75%}.col-xs-8{width:66.66666667%}.col-xs-7{width:58.33333333%}.col-xs-6{width:50%}.col-xs-5{width:41.66666667%}.col-xs-4{width:33.33333333%}.col-xs-3{width:25%}.col-xs-2{width:16.66666667%}.col-xs-1{width:8.33333333%}.col-xs-pull-12{right:100%}.col-xs-pull-11{right:91.66666667%}.col-xs-pull-10{right:83.33333333%}.col-xs-pull-9{right:75%}.col-xs-pull-8{right:66.66666667%}.col-xs-pull-7{right:58.33333333%}.col-xs-pull-6{right:50%}.col-xs-pull-5{right:41.66666667%}.col-xs-pull-4{right:33.33333333%}.col-xs-pull-3{right:25%}.col-xs-pull-2{right:16.66666667%}.col-xs-pull-1{right:8.33333333%}.col-xs-pull-0{right:auto}.col-xs-push-12{left:100%}.col-xs-push-11{left:91.66666667%}.col-xs-push-10{left:83.33333333%}.col-xs-push-9{left:75%}.col-xs-push-8{left:66.66666667%}.col-xs-push-7{left:58.33333333%}.col-xs-push-6{left:50%}.col-xs-push-5{left:41.66666667%}.col-xs-push-4{left:33.33333333%}.col-xs-push-3{left:25%}.col-xs-push-2{left:16.66666667%}.col-xs-push-1{left:8.33333333%}.col-xs-push-0{left:auto}.col-xs-offset-12{margin-left:100%}.col-xs-offset-11{margin-left:91.66666667%}.col-xs-offset-10{margin-left:83.33333333%}.col-xs-offset-9{margin-left:75%}.col-xs-offset-8{margin-left:66.66666667%}.col-xs-offset-7{margin-left:58.33333333%}.col-xs-offset-6{margin-left:50%}.col-xs-offset-5{margin-left:41.66666667%}.col-xs-offset-4{margin-left:33.33333333%}.col-xs-offset-3{margin-left:25%}.col-xs-offset-2{margin-left:16.66666667%}.col-xs-offset-1{margin-left:8.33333333%}.col-xs-offset-0{margin-left:0%}@media (min-width:768px){.col-sm-1,.col-sm-2,.col-sm-3,.col-sm-4,.col-sm-5,.col-sm-6,.col-sm-7,.col-sm-8,.col-sm-9,.col-sm-10,.col-sm-11,.col-sm-12{float:left}.col-sm-12{width:100%}.col-sm-11{width:91.66666667%}.col-sm-10{width:83.33333333%}.col-sm-9{width:75%}.col-sm-8{width:66.66666667%}.col-sm-7{width:58.33333333%}.col-sm-6{width:50%}.col-sm-5{width:41.66666667%}.col-sm-4{width:33.33333333%}.col-sm-3{width:25%}.col-sm-2{width:16.66666667%}.col-sm-1{width:8.33333333%}.col-sm-pull-12{right:100%}.col-sm-pull-11{right:91.66666667%}.col-sm-pull-10{right:83.33333333%}.col-sm-pull-9{right:75%}.col-sm-pull-8{right:66.66666667%}.col-sm-pull-7{right:58.33333333%}.col-sm-pull-6{right:50%}.col-sm-pull-5{right:41.66666667%}.col-sm-pull-4{right:33.33333333%}.col-sm-pull-3{right:25%}.col-sm-pull-2{right:16.66666667%}.col-sm-pull-1{right:8.33333333%}.col-sm-pull-0{right:auto}.col-sm-push-12{left:100%}.col-sm-push-11{left:91.66666667%}.col-sm-push-10{left:83.33333333%}.col-sm-push-9{left:75%}.col-sm-push-8{left:66.66666667%}.col-sm-push-7{left:58.33333333%}.col-sm-push-6{left:50%}.col-sm-push-5{left:41.66666667%}.col-sm-push-4{left:33.33333333%}.col-sm-push-3{left:25%}.col-sm-push-2{left:16.66666667%}.col-sm-push-1{left:8.33333333%}.col-sm-push-0{left:auto}.col-sm-offset-12{margin-left:100%}.col-sm-offset-11{margin-left:91.66666667%}.col-sm-offset-10{margin-left:83.33333333%}.col-sm-offset-9{margin-left:75%}.col-sm-offset-8{margin-left:66.66666667%}.col-sm-offset-7{margin-left:58.33333333%}.col-sm-offset-6{margin-left:50%}.col-sm-offset-5{margin-left:41.66666667%}.col-sm-offset-4{margin-left:33.33333333%}.col-sm-offset-3{margin-left:25%}.col-sm-offset-2{margin-left:16.66666667%}.col-sm-offset-1{margin-left:8.33333333%}.col-sm-offset-0{margin-left:0%}}@media (min-width:992px){.col-md-1,.col-md-2,.col-md-3,.col-md-4,.col-md-5,.col-md-6,.col-md-7,.col-md-8,.col-md-9,.col-md-10,.col-md-11,.col-md-12{float:left}.col-md-12{width:100%}.col-md-11{width:91.66666667%}.col-md-10{width:83.33333333%}.col-md-9{width:75%}.col-md-8{width:66.66666667%}.col-md-7{width:58.33333333%}.col-md-6{width:50%}.col-md-5{width:41.66666667%}.col-md-4{width:33.33333333%}.col-md-3{width:25%}.col-md-2{width:16.66666667%}.col-md-1{width:8.33333333%}.col-md-pull-12{right:100%}.col-md-pull-11{right:91.66666667%}.col-md-pull-10{right:83.33333333%}.col-md-pull-9{right:75%}.col-md-pull-8{right:66.66666667%}.col-md-pull-7{right:58.33333333%}.col-md-pull-6{right:50%}.col-md-pull-5{right:41.66666667%}.col-md-pull-4{right:33.33333333%}.col-md-pull-3{right:25%}.col-md-pull-2{right:16.66666667%}.col-md-pull-1{right:8.33333333%}.col-md-pull-0{right:auto}.col-md-push-12{left:100%}.col-md-push-11{left:91.66666667%}.col-md-push-10{left:83.33333333%}.col-md-push-9{left:75%}.col-md-push-8{left:66.66666667%}.col-md-push-7{left:58.33333333%}.col-md-push-6{left:50%}.col-md-push-5{left:41.66666667%}.col-md-push-4{left:33.33333333%}.col-md-push-3{left:25%}.col-md-push-2{left:16.66666667%}.col-md-push-1{left:8.33333333%}.col-md-push-0{left:auto}.col-md-offset-12{margin-left:100%}.col-md-offset-11{margin-left:91.66666667%}.col-md-offset-10{margin-left:83.33333333%}.col-md-offset-9{margin-left:75%}.col-md-offset-8{margin-left:66.66666667%}.col-md-offset-7{margin-left:58.33333333%}.col-md-offset-6{margin-left:50%}.col-md-offset-5{margin-left:41.66666667%}.col-md-offset-4{margin-left:33.33333333%}.col-md-offset-3{margin-left:25%}.col-md-offset-2{margin-left:16.66666667%}.col-md-offset-1{margin-left:8.33333333%}.col-md-offset-0{margin-left:0%}}@media (min-width:1200px){.col-lg-1,.col-lg-2,.col-lg-3,.col-lg-4,.col-lg-5,.col-lg-6,.col-lg-7,.col-lg-8,.col-lg-9,.col-lg-10,.col-lg-11,.col-lg-12{float:left}.col-lg-12{width:100%}.col-lg-11{width:91.66666667%}.col-lg-10{width:83.33333333%}.col-lg-9{width:75%}.col-lg-8{width:66.66666667%}.col-lg-7{width:58.33333333%}.col-lg-6{width:50%}.col-lg-5{width:41.66666667%}.col-lg-4{width:33.33333333%}.col-lg-3{width:25%}.col-lg-2{width:16.66666667%}.col-lg-1{width:8.33333333%}.col-lg-pull-12{right:100%}.col-lg-pull-11{right:91.66666667%}.col-lg-pull-10{right:83.33333333%}.col-lg-pull-9{right:75%}.col-lg-pull-8{right:66.66666667%}.col-lg-pull-7{right:58.33333333%}.col-lg-pull-6{right:50%}.col-lg-pull-5{right:41.66666667%}.col-lg-pull-4{right:33.33333333%}.col-lg-pull-3{right:25%}.col-lg-pull-2{right:16.66666667%}.col-lg-pull-1{right:8.33333333%}.col-lg-pull-0{right:auto}.col-lg-push-12{left:100%}.col-lg-push-11{left:91.66666667%}.col-lg-push-10{left:83.33333333%}.col-lg-push-9{left:75%}.col-lg-push-8{left:66.66666667%}.col-lg-push-7{left:58.33333333%}.col-lg-push-6{left:50%}.col-lg-push-5{left:41.66666667%}.col-lg-push-4{left:33.33333333%}.col-lg-push-3{left:25%}.col-lg-push-2{left:16.66666667%}.col-lg-push-1{left:8.33333333%}.col-lg-push-0{left:auto}.col-lg-offset-12{margin-left:100%}.col-lg-offset-11{margin-left:91.66666667%}.col-lg-offset-10{margin-left:83.33333333%}.col-lg-offset-9{margin-left:75%}.col-lg-offset-8{margin-left:66.66666667%}.col-lg-offset-7{margin-left:58.33333333%}.col-lg-offset-6{margin-left:50%}.col-lg-offset-5{margin-left:41.66666667%}.col-lg-offset-4{margin-left:33.33333333%}.col-lg-offset-3{margin-left:25%}.col-lg-offset-2{margin-left:16.66666667%}.col-lg-offset-1{margin-left:8.33333333%}.col-lg-offset-0{margin-left:0%}}table{background-color:transparent}caption{padding-top:8px;padding-bottom:8px;color:#bbbbbb;text-align:left}th{}.table{width:100%;max-width:100%;margin-bottom:23px}.table>thead>tr>th,.table>tbody>tr>th,.table>tfoot>tr>th,.table>thead>tr>td,.table>tbody>tr>td,.table>tfoot>tr>td{padding:8px;line-height:1.846;vertical-align:top;border-top:1px solid #dddddd}.table>thead>tr>th{vertical-align:bottom;border-bottom:2px solid #dddddd}.table>caption+thead>tr:first-child>th,.table>colgroup+thead>tr:first-child>th,.table>thead:first-child>tr:first-child>th,.table>caption+thead>tr:first-child>td,.table>colgroup+thead>tr:first-child>td,.table>thead:first-child>tr:first-child>td{border-top:0}.table>tbody+tbody{border-top:2px solid #dddddd}.table .table{background-color:#ffffff}.table-condensed>thead>tr>th,.table-condensed>tbody>tr>th,.table-condensed>tfoot>tr>th,.table-condensed>thead>tr>td,.table-condensed>tbody>tr>td,.table-condensed>tfoot>tr>td{padding:5px}.table-bordered{border:1px solid #dddddd}.table-bordered>thead>tr>th,.table-bordered>tbody>tr>th,.table-bordered>tfoot>tr>th,.table-bordered>thead>tr>td,.table-bordered>tbody>tr>td,.table-bordered>tfoot>tr>td{border:1px solid #dddddd}.table-bordered>thead>tr>th,.table-bordered>thead>tr>td{border-bottom-width:2px}.table-striped>tbody>tr:nth-of-type(odd){background-color:#f9f9f9}.table-hover>tbody>tr:hover{background-color:#f5f5f5}table col[class*="col-"]{position:static;float:none;display:table-column}table td[class*="col-"],table th[class*="col-"]{position:static;float:none;display:table-cell}.table>thead>tr>td.active,.table>tbody>tr>td.active,.table>tfoot>tr>td.active,.table>thead>tr>th.active,.table>tbody>tr>th.active,.table>tfoot>tr>th.active,.table>thead>tr.active>td,.table>tbody>tr.active>td,.table>tfoot>tr.active>td,.table>thead>tr.active>th,.table>tbody>tr.active>th,.table>tfoot>tr.active>th{background-color:#f5f5f5}.table-hover>tbody>tr>td.active:hover,.table-hover>tbody>tr>th.active:hover,.table-hover>tbody>tr.active:hover>td,.table-hover>tbody>tr:hover>.active,.table-hover>tbody>tr.active:hover>th{background-color:#e8e8e8}.table>thead>tr>td.success,.table>tbody>tr>td.success,.table>tfoot>tr>td.success,.table>thead>tr>th.success,.table>tbody>tr>th.success,.table>tfoot>tr>th.success,.table>thead>tr.success>td,.table>tbody>tr.success>td,.table>tfoot>tr.success>td,.table>thead>tr.success>th,.table>tbody>tr.success>th,.table>tfoot>tr.success>th{background-color:#dff0d8}.table-hover>tbody>tr>td.success:hover,.table-hover>tbody>tr>th.success:hover,.table-hover>tbody>tr.success:hover>td,.table-hover>tbody>tr:hover>.success,.table-hover>tbody>tr.success:hover>th{background-color:#d0e9c6}.table>thead>tr>td.info,.table>tbody>tr>td.info,.table>tfoot>tr>td.info,.table>thead>tr>th.info,.table>tbody>tr>th.info,.table>tfoot>tr>th.info,.table>thead>tr.info>td,.table>tbody>tr.info>td,.table>tfoot>tr.info>td,.table>thead>tr.info>th,.table>tbody>tr.info>th,.table>tfoot>tr.info>th{background-color:#e1bee7}.table-hover>tbody>tr>td.info:hover,.table-hover>tbody>tr>th.info:hover,.table-hover>tbody>tr.info:hover>td,.table-hover>tbody>tr:hover>.info,.table-hover>tbody>tr.info:hover>th{background-color:#d8abe0}.table>thead>tr>td.warning,.table>tbody>tr>td.warning,.table>tfoot>tr>td.warning,.table>thead>tr>th.warning,.table>tbody>tr>th.warning,.table>tfoot>tr>th.warning,.table>thead>tr.warning>td,.table>tbody>tr.warning>td,.table>tfoot>tr.warning>td,.table>thead>tr.warning>th,.table>tbody>tr.warning>th,.table>tfoot>tr.warning>th{background-color:#ffe0b2}.table-hover>tbody>tr>td.warning:hover,.table-hover>tbody>tr>th.warning:hover,.table-hover>tbody>tr.warning:hover>td,.table-hover>tbody>tr:hover>.warning,.table-hover>tbody>tr.warning:hover>th{background-color:#ffd699}.table>thead>tr>td.danger,.table>tbody>tr>td.danger,.table>tfoot>tr>td.danger,.table>thead>tr>th.danger,.table>tbody>tr>th.danger,.table>tfoot>tr>th.danger,.table>thead>tr.danger>td,.table>tbody>tr.danger>td,.table>tfoot>tr.danger>td,.table>thead>tr.danger>th,.table>tbody>tr.danger>th,.table>tfoot>tr.danger>th{background-color:#f9bdbb}.table-hover>tbody>tr>td.danger:hover,.table-hover>tbody>tr>th.danger:hover,.table-hover>tbody>tr.danger:hover>td,.table-hover>tbody>tr:hover>.danger,.table-hover>tbody>tr.danger:hover>th{background-color:#f7a6a4}.table-responsive{overflow-x:auto;min-height:0.01%}@media screen and (max-width:767px){.table-responsive{width:100%;margin-bottom:17.25px;overflow-y:hidden;-ms-overflow-style:-ms-autohiding-scrollbar;border:1px solid #dddddd}.table-responsive>.table{margin-bottom:0}.table-responsive>.table>thead>tr>th,.table-responsive>.table>tbody>tr>th,.table-responsive>.table>tfoot>tr>th,.table-responsive>.table>thead>tr>td,.table-responsive>.table>tbody>tr>td,.table-responsive>.table>tfoot>tr>td{white-space:nowrap}.table-responsive>.table-bordered{border:0}.table-responsive>.table-bordered>thead>tr>th:first-child,.table-responsive>.table-bordered>tbody>tr>th:first-child,.table-responsive>.table-bordered>tfoot>tr>th:first-child,.table-responsive>.table-bordered>thead>tr>td:first-child,.table-responsive>.table-bordered>tbody>tr>td:first-child,.table-responsive>.table-bordered>tfoot>tr>td:first-child{border-left:0}.table-responsive>.table-bordered>thead>tr>th:last-child,.table-responsive>.table-bordered>tbody>tr>th:last-child,.table-responsive>.table-bordered>tfoot>tr>th:last-child,.table-responsive>.table-bordered>thead>tr>td:last-child,.table-responsive>.table-bordered>tbody>tr>td:last-child,.table-responsive>.table-bordered>tfoot>tr>td:last-child{border-right:0}.table-responsive>.table-bordered>tbody>tr:last-child>th,.table-responsive>.table-bordered>tfoot>tr:last-child>th,.table-responsive>.table-bordered>tbody>tr:last-child>td,.table-responsive>.table-bordered>tfoot>tr:last-child>td{border-bottom:0}}fieldset{padding:0;margin:0;border:0;min-width:0}legend{display:block;width:100%;padding:0;margin-bottom:23px;font-size:19.5px;line-height:inherit;color:#212121;border:0;border-bottom:1px solid #e5e5e5}label{display:inline-block;max-width:100%;margin-bottom:5px;font-weight:bold}input[type="search"]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}input[type="radio"],input[type="checkbox"]{margin:4px 0 0;margin-top:1px \9;line-height:normal}input[type="file"]{display:block}input[type="range"]{display:block;width:100%}select[multiple],select[size]{height:auto}input[type="file"]:focus,input[type="radio"]:focus,input[type="checkbox"]:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}output{display:block;padding-top:7px;font-size:13px;line-height:1.846;color:#666666}.form-control{display:block;width:100%;height:37px;padding:6px 16px;font-size:13px;line-height:1.846;color:#666666;background-color:transparent;background-image:none;border:1px solid transparent;border-radius:3px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);-webkit-transition:border-color ease-in-out .15s,-webkit-box-shadow ease-in-out .15s;-o-transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s;transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s}.form-control:focus{border-color:#66afe9;outline:0;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 8px rgba(102,175,233,0.6);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 8px rgba(102,175,233,0.6)}.form-control::-moz-placeholder{color:#bbbbbb;opacity:1}.form-control:-ms-input-placeholder{color:#bbbbbb}.form-control::-webkit-input-placeholder{color:#bbbbbb}.form-control::-ms-expand{border:0;background-color:transparent}.form-control[disabled],.form-control[readonly],fieldset[disabled] .form-control{background-color:transparent;opacity:1}.form-control[disabled],fieldset[disabled] .form-control{cursor:not-allowed}textarea.form-control{height:auto}input[type="search"]{-webkit-appearance:none}@media screen and (-webkit-min-device-pixel-ratio:0){input[type="date"].form-control,input[type="time"].form-control,input[type="datetime-local"].form-control,input[type="month"].form-control{line-height:37px}input[type="date"].input-sm,input[type="time"].input-sm,input[type="datetime-local"].input-sm,input[type="month"].input-sm,.input-group-sm input[type="date"],.input-group-sm input[type="time"],.input-group-sm input[type="datetime-local"],.input-group-sm input[type="month"]{line-height:30px}input[type="date"].input-lg,input[type="time"].input-lg,input[type="datetime-local"].input-lg,input[type="month"].input-lg,.input-group-lg input[type="date"],.input-group-lg input[type="time"],.input-group-lg input[type="datetime-local"],.input-group-lg input[type="month"]{line-height:45px}}.form-group{margin-bottom:15px}.radio,.checkbox{position:relative;display:block;margin-top:10px;margin-bottom:10px}.radio label,.checkbox label{min-height:23px;padding-left:20px;margin-bottom:0;font-weight:normal;cursor:pointer}.radio input[type="radio"],.radio-inline input[type="radio"],.checkbox input[type="checkbox"],.checkbox-inline input[type="checkbox"]{position:absolute;margin-left:-20px;margin-top:4px \9}.radio+.radio,.checkbox+.checkbox{margin-top:-5px}.radio-inline,.checkbox-inline{position:relative;display:inline-block;padding-left:20px;margin-bottom:0;vertical-align:middle;font-weight:normal;cursor:pointer}.radio-inline+.radio-inline,.checkbox-inline+.checkbox-inline{margin-top:0;margin-left:10px}input[type="radio"][disabled],input[type="checkbox"][disabled],input[type="radio"].disabled,input[type="checkbox"].disabled,fieldset[disabled] input[type="radio"],fieldset[disabled] input[type="checkbox"]{cursor:not-allowed}.radio-inline.disabled,.checkbox-inline.disabled,fieldset[disabled] .radio-inline,fieldset[disabled] .checkbox-inline{cursor:not-allowed}.radio.disabled label,.checkbox.disabled label,fieldset[disabled] .radio label,fieldset[disabled] .checkbox label{cursor:not-allowed}.form-control-static{padding-top:7px;padding-bottom:7px;margin-bottom:0;min-height:36px}.form-control-static.input-lg,.form-control-static.input-sm{padding-left:0;padding-right:0}.input-sm{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-sm{height:30px;line-height:30px}textarea.input-sm,select[multiple].input-sm{height:auto}.form-group-sm .form-control{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.form-group-sm select.form-control{height:30px;line-height:30px}.form-group-sm textarea.form-control,.form-group-sm select[multiple].form-control{height:auto}.form-group-sm .form-control-static{height:30px;min-height:35px;padding:6px 10px;font-size:12px;line-height:1.5}.input-lg{height:45px;padding:10px 16px;font-size:17px;line-height:1.3333333;border-radius:3px}select.input-lg{height:45px;line-height:45px}textarea.input-lg,select[multiple].input-lg{height:auto}.form-group-lg .form-control{height:45px;padding:10px 16px;font-size:17px;line-height:1.3333333;border-radius:3px}.form-group-lg select.form-control{height:45px;line-height:45px}.form-group-lg textarea.form-control,.form-group-lg select[multiple].form-control{height:auto}.form-group-lg .form-control-static{height:45px;min-height:40px;padding:11px 16px;font-size:17px;line-height:1.3333333}.has-feedback{position:relative}.has-feedback .form-control{padding-right:46.25px}.form-control-feedback{position:absolute;top:0;right:0;z-index:2;display:block;width:37px;height:37px;line-height:37px;text-align:center;pointer-events:none}.input-lg+.form-control-feedback,.input-group-lg+.form-control-feedback,.form-group-lg .form-control+.form-control-feedback{width:45px;height:45px;line-height:45px}.input-sm+.form-control-feedback,.input-group-sm+.form-control-feedback,.form-group-sm .form-control+.form-control-feedback{width:30px;height:30px;line-height:30px}.has-success .help-block,.has-success .control-label,.has-success .radio,.has-success .checkbox,.has-success .radio-inline,.has-success .checkbox-inline,.has-success.radio label,.has-success.checkbox label,.has-success.radio-inline label,.has-success.checkbox-inline label{color:#4caf50}.has-success .form-control{border-color:#4caf50;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075)}.has-success .form-control:focus{border-color:#3d8b40;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #92cf94;box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #92cf94}.has-success .input-group-addon{color:#4caf50;border-color:#4caf50;background-color:#dff0d8}.has-success .form-control-feedback{color:#4caf50}.has-warning .help-block,.has-warning .control-label,.has-warning .radio,.has-warning .checkbox,.has-warning .radio-inline,.has-warning .checkbox-inline,.has-warning.radio label,.has-warning.checkbox label,.has-warning.radio-inline label,.has-warning.checkbox-inline label{color:#ff9800}.has-warning .form-control{border-color:#ff9800;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075)}.has-warning .form-control:focus{border-color:#cc7a00;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #ffc166;box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #ffc166}.has-warning .input-group-addon{color:#ff9800;border-color:#ff9800;background-color:#ffe0b2}.has-warning .form-control-feedback{color:#ff9800}.has-error .help-block,.has-error .control-label,.has-error .radio,.has-error .checkbox,.has-error .radio-inline,.has-error .checkbox-inline,.has-error.radio label,.has-error.checkbox label,.has-error.radio-inline label,.has-error.checkbox-inline label{color:#e51c23}.has-error .form-control{border-color:#e51c23;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075)}.has-error .form-control:focus{border-color:#b9151b;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #ef787c;box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #ef787c}.has-error .input-group-addon{color:#e51c23;border-color:#e51c23;background-color:#f9bdbb}.has-error .form-control-feedback{color:#e51c23}.has-feedback label~.form-control-feedback{top:28px}.has-feedback label.sr-only~.form-control-feedback{top:0}.help-block{display:block;margin-top:5px;margin-bottom:10px;color:#a6a6a6}@media (min-width:768px){.form-inline .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.form-inline .form-control{display:inline-block;width:auto;vertical-align:middle}.form-inline .form-control-static{display:inline-block}.form-inline .input-group{display:inline-table;vertical-align:middle}.form-inline .input-group .input-group-addon,.form-inline .input-group .input-group-btn,.form-inline .input-group .form-control{width:auto}.form-inline .input-group>.form-control{width:100%}.form-inline .control-label{margin-bottom:0;vertical-align:middle}.form-inline .radio,.form-inline .checkbox{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.form-inline .radio label,.form-inline .checkbox label{padding-left:0}.form-inline .radio input[type="radio"],.form-inline .checkbox input[type="checkbox"]{position:relative;margin-left:0}.form-inline .has-feedback .form-control-feedback{top:0}}.form-horizontal .radio,.form-horizontal .checkbox,.form-horizontal .radio-inline,.form-horizontal .checkbox-inline{margin-top:0;margin-bottom:0;padding-top:7px}.form-horizontal .radio,.form-horizontal .checkbox{min-height:30px}.form-horizontal .form-group{margin-left:-15px;margin-right:-15px}@media (min-width:768px){.form-horizontal .control-label{text-align:right;margin-bottom:0;padding-top:7px}}.form-horizontal .has-feedback .form-control-feedback{right:15px}@media (min-width:768px){.form-horizontal .form-group-lg .control-label{padding-top:11px;font-size:17px}}@media (min-width:768px){.form-horizontal .form-group-sm .control-label{padding-top:6px;font-size:12px}}.btn{display:inline-block;margin-bottom:0;font-weight:normal;text-align:center;vertical-align:middle;-ms-touch-action:manipulation;touch-action:manipulation;cursor:pointer;background-image:none;border:1px solid transparent;white-space:nowrap;padding:6px 16px;font-size:13px;line-height:1.846;border-radius:3px;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none}.btn:focus,.btn:active:focus,.btn.active:focus,.btn.focus,.btn:active.focus,.btn.active.focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}.btn:hover,.btn:focus,.btn.focus{color:#444444;text-decoration:none}.btn:active,.btn.active{outline:0;background-image:none;-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,0.125);box-shadow:inset 0 3px 5px rgba(0,0,0,0.125)}.btn.disabled,.btn[disabled],fieldset[disabled] .btn{cursor:not-allowed;opacity:0.65;filter:alpha(opacity=65);-webkit-box-shadow:none;box-shadow:none}a.btn.disabled,fieldset[disabled] a.btn{pointer-events:none}.btn-default{color:#444444;background-color:#ffffff;border-color:transparent}.btn-default:focus,.btn-default.focus{color:#444444;background-color:#e6e6e6;border-color:rgba(0,0,0,0)}.btn-default:hover{color:#444444;background-color:#e6e6e6;border-color:rgba(0,0,0,0)}.btn-default:active,.btn-default.active,.open>.dropdown-toggle.btn-default{color:#444444;background-color:#e6e6e6;border-color:rgba(0,0,0,0)}.btn-default:active:hover,.btn-default.active:hover,.open>.dropdown-toggle.btn-default:hover,.btn-default:active:focus,.btn-default.active:focus,.open>.dropdown-toggle.btn-default:focus,.btn-default:active.focus,.btn-default.active.focus,.open>.dropdown-toggle.btn-default.focus{color:#444444;background-color:#d4d4d4;border-color:rgba(0,0,0,0)}.btn-default:active,.btn-default.active,.open>.dropdown-toggle.btn-default{background-image:none}.btn-default.disabled:hover,.btn-default[disabled]:hover,fieldset[disabled] .btn-default:hover,.btn-default.disabled:focus,.btn-default[disabled]:focus,fieldset[disabled] .btn-default:focus,.btn-default.disabled.focus,.btn-default[disabled].focus,fieldset[disabled] .btn-default.focus{background-color:#ffffff;border-color:transparent}.btn-default .badge{color:#ffffff;background-color:#444444}.btn-primary{color:#ffffff;background-color:#2196f3;border-color:transparent}.btn-primary:focus,.btn-primary.focus{color:#ffffff;background-color:#0c7cd5;border-color:rgba(0,0,0,0)}.btn-primary:hover{color:#ffffff;background-color:#0c7cd5;border-color:rgba(0,0,0,0)}.btn-primary:active,.btn-primary.active,.open>.dropdown-toggle.btn-primary{color:#ffffff;background-color:#0c7cd5;border-color:rgba(0,0,0,0)}.btn-primary:active:hover,.btn-primary.active:hover,.open>.dropdown-toggle.btn-primary:hover,.btn-primary:active:focus,.btn-primary.active:focus,.open>.dropdown-toggle.btn-primary:focus,.btn-primary:active.focus,.btn-primary.active.focus,.open>.dropdown-toggle.btn-primary.focus{color:#ffffff;background-color:#0a68b4;border-color:rgba(0,0,0,0)}.btn-primary:active,.btn-primary.active,.open>.dropdown-toggle.btn-primary{background-image:none}.btn-primary.disabled:hover,.btn-primary[disabled]:hover,fieldset[disabled] .btn-primary:hover,.btn-primary.disabled:focus,.btn-primary[disabled]:focus,fieldset[disabled] .btn-primary:focus,.btn-primary.disabled.focus,.btn-primary[disabled].focus,fieldset[disabled] .btn-primary.focus{background-color:#2196f3;border-color:transparent}.btn-primary .badge{color:#2196f3;background-color:#ffffff}.btn-success{color:#ffffff;background-color:#4caf50;border-color:transparent}.btn-success:focus,.btn-success.focus{color:#ffffff;background-color:#3d8b40;border-color:rgba(0,0,0,0)}.btn-success:hover{color:#ffffff;background-color:#3d8b40;border-color:rgba(0,0,0,0)}.btn-success:active,.btn-success.active,.open>.dropdown-toggle.btn-success{color:#ffffff;background-color:#3d8b40;border-color:rgba(0,0,0,0)}.btn-success:active:hover,.btn-success.active:hover,.open>.dropdown-toggle.btn-success:hover,.btn-success:active:focus,.btn-success.active:focus,.open>.dropdown-toggle.btn-success:focus,.btn-success:active.focus,.btn-success.active.focus,.open>.dropdown-toggle.btn-success.focus{color:#ffffff;background-color:#327334;border-color:rgba(0,0,0,0)}.btn-success:active,.btn-success.active,.open>.dropdown-toggle.btn-success{background-image:none}.btn-success.disabled:hover,.btn-success[disabled]:hover,fieldset[disabled] .btn-success:hover,.btn-success.disabled:focus,.btn-success[disabled]:focus,fieldset[disabled] .btn-success:focus,.btn-success.disabled.focus,.btn-success[disabled].focus,fieldset[disabled] .btn-success.focus{background-color:#4caf50;border-color:transparent}.btn-success .badge{color:#4caf50;background-color:#ffffff}.btn-info{color:#ffffff;background-color:#9c27b0;border-color:transparent}.btn-info:focus,.btn-info.focus{color:#ffffff;background-color:#771e86;border-color:rgba(0,0,0,0)}.btn-info:hover{color:#ffffff;background-color:#771e86;border-color:rgba(0,0,0,0)}.btn-info:active,.btn-info.active,.open>.dropdown-toggle.btn-info{color:#ffffff;background-color:#771e86;border-color:rgba(0,0,0,0)}.btn-info:active:hover,.btn-info.active:hover,.open>.dropdown-toggle.btn-info:hover,.btn-info:active:focus,.btn-info.active:focus,.open>.dropdown-toggle.btn-info:focus,.btn-info:active.focus,.btn-info.active.focus,.open>.dropdown-toggle.btn-info.focus{color:#ffffff;background-color:#5d1769;border-color:rgba(0,0,0,0)}.btn-info:active,.btn-info.active,.open>.dropdown-toggle.btn-info{background-image:none}.btn-info.disabled:hover,.btn-info[disabled]:hover,fieldset[disabled] .btn-info:hover,.btn-info.disabled:focus,.btn-info[disabled]:focus,fieldset[disabled] .btn-info:focus,.btn-info.disabled.focus,.btn-info[disabled].focus,fieldset[disabled] .btn-info.focus{background-color:#9c27b0;border-color:transparent}.btn-info .badge{color:#9c27b0;background-color:#ffffff}.btn-warning{color:#ffffff;background-color:#ff9800;border-color:transparent}.btn-warning:focus,.btn-warning.focus{color:#ffffff;background-color:#cc7a00;border-color:rgba(0,0,0,0)}.btn-warning:hover{color:#ffffff;background-color:#cc7a00;border-color:rgba(0,0,0,0)}.btn-warning:active,.btn-warning.active,.open>.dropdown-toggle.btn-warning{color:#ffffff;background-color:#cc7a00;border-color:rgba(0,0,0,0)}.btn-warning:active:hover,.btn-warning.active:hover,.open>.dropdown-toggle.btn-warning:hover,.btn-warning:active:focus,.btn-warning.active:focus,.open>.dropdown-toggle.btn-warning:focus,.btn-warning:active.focus,.btn-warning.active.focus,.open>.dropdown-toggle.btn-warning.focus{color:#ffffff;background-color:#a86400;border-color:rgba(0,0,0,0)}.btn-warning:active,.btn-warning.active,.open>.dropdown-toggle.btn-warning{background-image:none}.btn-warning.disabled:hover,.btn-warning[disabled]:hover,fieldset[disabled] .btn-warning:hover,.btn-warning.disabled:focus,.btn-warning[disabled]:focus,fieldset[disabled] .btn-warning:focus,.btn-warning.disabled.focus,.btn-warning[disabled].focus,fieldset[disabled] .btn-warning.focus{background-color:#ff9800;border-color:transparent}.btn-warning .badge{color:#ff9800;background-color:#ffffff}.btn-danger{color:#ffffff;background-color:#e51c23;border-color:transparent}.btn-danger:focus,.btn-danger.focus{color:#ffffff;background-color:#b9151b;border-color:rgba(0,0,0,0)}.btn-danger:hover{color:#ffffff;background-color:#b9151b;border-color:rgba(0,0,0,0)}.btn-danger:active,.btn-danger.active,.open>.dropdown-toggle.btn-danger{color:#ffffff;background-color:#b9151b;border-color:rgba(0,0,0,0)}.btn-danger:active:hover,.btn-danger.active:hover,.open>.dropdown-toggle.btn-danger:hover,.btn-danger:active:focus,.btn-danger.active:focus,.open>.dropdown-toggle.btn-danger:focus,.btn-danger:active.focus,.btn-danger.active.focus,.open>.dropdown-toggle.btn-danger.focus{color:#ffffff;background-color:#991216;border-color:rgba(0,0,0,0)}.btn-danger:active,.btn-danger.active,.open>.dropdown-toggle.btn-danger{background-image:none}.btn-danger.disabled:hover,.btn-danger[disabled]:hover,fieldset[disabled] .btn-danger:hover,.btn-danger.disabled:focus,.btn-danger[disabled]:focus,fieldset[disabled] .btn-danger:focus,.btn-danger.disabled.focus,.btn-danger[disabled].focus,fieldset[disabled] .btn-danger.focus{background-color:#e51c23;border-color:transparent}.btn-danger .badge{color:#e51c23;background-color:#ffffff}.btn-link{color:#2196f3;font-weight:normal;border-radius:0}.btn-link,.btn-link:active,.btn-link.active,.btn-link[disabled],fieldset[disabled] .btn-link{background-color:transparent;-webkit-box-shadow:none;box-shadow:none}.btn-link,.btn-link:hover,.btn-link:focus,.btn-link:active{border-color:transparent}.btn-link:hover,.btn-link:focus{color:#0a6ebd;text-decoration:underline;background-color:transparent}.btn-link[disabled]:hover,fieldset[disabled] .btn-link:hover,.btn-link[disabled]:focus,fieldset[disabled] .btn-link:focus{color:#bbbbbb;text-decoration:none}.btn-lg,.btn-group-lg>.btn{padding:10px 16px;font-size:17px;line-height:1.3333333;border-radius:3px}.btn-sm,.btn-group-sm>.btn{padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.btn-xs,.btn-group-xs>.btn{padding:1px 5px;font-size:12px;line-height:1.5;border-radius:3px}.btn-block{display:block;width:100%}.btn-block+.btn-block{margin-top:5px}input[type="submit"].btn-block,input[type="reset"].btn-block,input[type="button"].btn-block{width:100%}.fade{opacity:0;-webkit-transition:opacity 0.15s linear;-o-transition:opacity 0.15s linear;transition:opacity 0.15s linear}.fade.in{opacity:1}.collapse{display:none}.collapse.in{display:block}tr.collapse.in{display:table-row}tbody.collapse.in{display:table-row-group}.collapsing{position:relative;height:0;overflow:hidden;-webkit-transition-property:height, visibility;-o-transition-property:height, visibility;transition-property:height, visibility;-webkit-transition-duration:0.35s;-o-transition-duration:0.35s;transition-duration:0.35s;-webkit-transition-timing-function:ease;-o-transition-timing-function:ease;transition-timing-function:ease}.caret{display:inline-block;width:0;height:0;margin-left:2px;vertical-align:middle;border-top:4px dashed;border-top:4px solid \9;border-right:4px solid transparent;border-left:4px solid transparent}.dropup,.dropdown{position:relative}.dropdown-toggle:focus{outline:0}.dropdown-menu{position:absolute;top:100%;left:0;z-index:1000;display:none;float:left;min-width:160px;padding:5px 0;margin:2px 0 0;list-style:none;font-size:13px;text-align:left;background-color:#ffffff;border:1px solid #cccccc;border:1px solid rgba(0,0,0,0.15);border-radius:3px;-webkit-box-shadow:0 6px 12px rgba(0,0,0,0.175);box-shadow:0 6px 12px rgba(0,0,0,0.175);-webkit-background-clip:padding-box;background-clip:padding-box}.dropdown-menu.pull-right{right:0;left:auto}.dropdown-menu .divider{height:1px;margin:10.5px 0;overflow:hidden;background-color:#e5e5e5}.dropdown-menu>li>a{display:block;padding:3px 20px;clear:both;font-weight:normal;line-height:1.846;color:#666666;white-space:nowrap}.dropdown-menu>li>a:hover,.dropdown-menu>li>a:focus{text-decoration:none;color:#141414;background-color:#eeeeee}.dropdown-menu>.active>a,.dropdown-menu>.active>a:hover,.dropdown-menu>.active>a:focus{color:#ffffff;text-decoration:none;outline:0;background-color:#2196f3}.dropdown-menu>.disabled>a,.dropdown-menu>.disabled>a:hover,.dropdown-menu>.disabled>a:focus{color:#bbbbbb}.dropdown-menu>.disabled>a:hover,.dropdown-menu>.disabled>a:focus{text-decoration:none;background-color:transparent;background-image:none;filter:progid:DXImageTransform.Microsoft.gradient(enabled=false);cursor:not-allowed}.open>.dropdown-menu{display:block}.open>a{outline:0}.dropdown-menu-right{left:auto;right:0}.dropdown-menu-left{left:0;right:auto}.dropdown-header{display:block;padding:3px 20px;font-size:12px;line-height:1.846;color:#bbbbbb;white-space:nowrap}.dropdown-backdrop{position:fixed;left:0;right:0;bottom:0;top:0;z-index:990}.pull-right>.dropdown-menu{right:0;left:auto}.dropup .caret,.navbar-fixed-bottom .dropdown .caret{border-top:0;border-bottom:4px dashed;border-bottom:4px solid \9;content:""}.dropup .dropdown-menu,.navbar-fixed-bottom .dropdown .dropdown-menu{top:auto;bottom:100%;margin-bottom:2px}@media (min-width:768px){.navbar-right .dropdown-menu{left:auto;right:0}.navbar-right .dropdown-menu-left{left:0;right:auto}}.btn-group,.btn-group-vertical{position:relative;display:inline-block;vertical-align:middle}.btn-group>.btn,.btn-group-vertical>.btn{position:relative;float:left}.btn-group>.btn:hover,.btn-group-vertical>.btn:hover,.btn-group>.btn:focus,.btn-group-vertical>.btn:focus,.btn-group>.btn:active,.btn-group-vertical>.btn:active,.btn-group>.btn.active,.btn-group-vertical>.btn.active{z-index:2}.btn-group .btn+.btn,.btn-group .btn+.btn-group,.btn-group .btn-group+.btn,.btn-group .btn-group+.btn-group{margin-left:-1px}.btn-toolbar{margin-left:-5px}.btn-toolbar .btn,.btn-toolbar .btn-group,.btn-toolbar .input-group{float:left}.btn-toolbar>.btn,.btn-toolbar>.btn-group,.btn-toolbar>.input-group{margin-left:5px}.btn-group>.btn:not(:first-child):not(:last-child):not(.dropdown-toggle){border-radius:0}.btn-group>.btn:first-child{margin-left:0}.btn-group>.btn:first-child:not(:last-child):not(.dropdown-toggle){border-bottom-right-radius:0;border-top-right-radius:0}.btn-group>.btn:last-child:not(:first-child),.btn-group>.dropdown-toggle:not(:first-child){border-bottom-left-radius:0;border-top-left-radius:0}.btn-group>.btn-group{float:left}.btn-group>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-bottom-right-radius:0;border-top-right-radius:0}.btn-group>.btn-group:last-child:not(:first-child)>.btn:first-child{border-bottom-left-radius:0;border-top-left-radius:0}.btn-group .dropdown-toggle:active,.btn-group.open .dropdown-toggle{outline:0}.btn-group>.btn+.dropdown-toggle{padding-left:8px;padding-right:8px}.btn-group>.btn-lg+.dropdown-toggle{padding-left:12px;padding-right:12px}.btn-group.open .dropdown-toggle{-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,0.125);box-shadow:inset 0 3px 5px rgba(0,0,0,0.125)}.btn-group.open .dropdown-toggle.btn-link{-webkit-box-shadow:none;box-shadow:none}.btn .caret{margin-left:0}.btn-lg .caret{border-width:5px 5px 0;border-bottom-width:0}.dropup .btn-lg .caret{border-width:0 5px 5px}.btn-group-vertical>.btn,.btn-group-vertical>.btn-group,.btn-group-vertical>.btn-group>.btn{display:block;float:none;width:100%;max-width:100%}.btn-group-vertical>.btn-group>.btn{float:none}.btn-group-vertical>.btn+.btn,.btn-group-vertical>.btn+.btn-group,.btn-group-vertical>.btn-group+.btn,.btn-group-vertical>.btn-group+.btn-group{margin-top:-1px;margin-left:0}.btn-group-vertical>.btn:not(:first-child):not(:last-child){border-radius:0}.btn-group-vertical>.btn:first-child:not(:last-child){border-top-right-radius:3px;border-top-left-radius:3px;border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn:last-child:not(:first-child){border-top-right-radius:0;border-top-left-radius:0;border-bottom-right-radius:3px;border-bottom-left-radius:3px}.btn-group-vertical>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group-vertical>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group-vertical>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn-group:last-child:not(:first-child)>.btn:first-child{border-top-right-radius:0;border-top-left-radius:0}.btn-group-justified{display:table;width:100%;table-layout:fixed;border-collapse:separate}.btn-group-justified>.btn,.btn-group-justified>.btn-group{float:none;display:table-cell;width:1%}.btn-group-justified>.btn-group .btn{width:100%}.btn-group-justified>.btn-group .dropdown-menu{left:auto}[data-toggle="buttons"]>.btn input[type="radio"],[data-toggle="buttons"]>.btn-group>.btn input[type="radio"],[data-toggle="buttons"]>.btn input[type="checkbox"],[data-toggle="buttons"]>.btn-group>.btn input[type="checkbox"]{position:absolute;clip:rect(0, 0, 0, 0);pointer-events:none}.input-group{position:relative;display:table;border-collapse:separate}.input-group[class*="col-"]{float:none;padding-left:0;padding-right:0}.input-group .form-control{position:relative;z-index:2;float:left;width:100%;margin-bottom:0}.input-group .form-control:focus{z-index:3}.input-group-lg>.form-control,.input-group-lg>.input-group-addon,.input-group-lg>.input-group-btn>.btn{height:45px;padding:10px 16px;font-size:17px;line-height:1.3333333;border-radius:3px}select.input-group-lg>.form-control,select.input-group-lg>.input-group-addon,select.input-group-lg>.input-group-btn>.btn{height:45px;line-height:45px}textarea.input-group-lg>.form-control,textarea.input-group-lg>.input-group-addon,textarea.input-group-lg>.input-group-btn>.btn,select[multiple].input-group-lg>.form-control,select[multiple].input-group-lg>.input-group-addon,select[multiple].input-group-lg>.input-group-btn>.btn{height:auto}.input-group-sm>.form-control,.input-group-sm>.input-group-addon,.input-group-sm>.input-group-btn>.btn{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-group-sm>.form-control,select.input-group-sm>.input-group-addon,select.input-group-sm>.input-group-btn>.btn{height:30px;line-height:30px}textarea.input-group-sm>.form-control,textarea.input-group-sm>.input-group-addon,textarea.input-group-sm>.input-group-btn>.btn,select[multiple].input-group-sm>.form-control,select[multiple].input-group-sm>.input-group-addon,select[multiple].input-group-sm>.input-group-btn>.btn{height:auto}.input-group-addon,.input-group-btn,.input-group .form-control{display:table-cell}.input-group-addon:not(:first-child):not(:last-child),.input-group-btn:not(:first-child):not(:last-child),.input-group .form-control:not(:first-child):not(:last-child){border-radius:0}.input-group-addon,.input-group-btn{width:1%;white-space:nowrap;vertical-align:middle}.input-group-addon{padding:6px 16px;font-size:13px;font-weight:normal;line-height:1;color:#666666;text-align:center;background-color:transparent;border:1px solid transparent;border-radius:3px}.input-group-addon.input-sm{padding:5px 10px;font-size:12px;border-radius:3px}.input-group-addon.input-lg{padding:10px 16px;font-size:17px;border-radius:3px}.input-group-addon input[type="radio"],.input-group-addon input[type="checkbox"]{margin-top:0}.input-group .form-control:first-child,.input-group-addon:first-child,.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group>.btn,.input-group-btn:first-child>.dropdown-toggle,.input-group-btn:last-child>.btn:not(:last-child):not(.dropdown-toggle),.input-group-btn:last-child>.btn-group:not(:last-child)>.btn{border-bottom-right-radius:0;border-top-right-radius:0}.input-group-addon:first-child{border-right:0}.input-group .form-control:last-child,.input-group-addon:last-child,.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group>.btn,.input-group-btn:last-child>.dropdown-toggle,.input-group-btn:first-child>.btn:not(:first-child),.input-group-btn:first-child>.btn-group:not(:first-child)>.btn{border-bottom-left-radius:0;border-top-left-radius:0}.input-group-addon:last-child{border-left:0}.input-group-btn{position:relative;font-size:0;white-space:nowrap}.input-group-btn>.btn{position:relative}.input-group-btn>.btn+.btn{margin-left:-1px}.input-group-btn>.btn:hover,.input-group-btn>.btn:focus,.input-group-btn>.btn:active{z-index:2}.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group{margin-right:-1px}.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group{z-index:2;margin-left:-1px}.nav{margin-bottom:0;padding-left:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:hover,.nav>li>a:focus{text-decoration:none;background-color:#eeeeee}.nav>li.disabled>a{color:#bbbbbb}.nav>li.disabled>a:hover,.nav>li.disabled>a:focus{color:#bbbbbb;text-decoration:none;background-color:transparent;cursor:not-allowed}.nav .open>a,.nav .open>a:hover,.nav .open>a:focus{background-color:#eeeeee;border-color:#2196f3}.nav .nav-divider{height:1px;margin:10.5px 0;overflow:hidden;background-color:#e5e5e5}.nav>li>a>img{max-width:none}.nav-tabs{border-bottom:1px solid transparent}.nav-tabs>li{float:left;margin-bottom:-1px}.nav-tabs>li>a{margin-right:2px;line-height:1.846;border:1px solid transparent;border-radius:3px 3px 0 0}.nav-tabs>li>a:hover{border-color:#eeeeee #eeeeee transparent}.nav-tabs>li.active>a,.nav-tabs>li.active>a:hover,.nav-tabs>li.active>a:focus{color:#666666;background-color:transparent;border:1px solid transparent;border-bottom-color:transparent;cursor:default}.nav-tabs.nav-justified{width:100%;border-bottom:0}.nav-tabs.nav-justified>li{float:none}.nav-tabs.nav-justified>li>a{text-align:center;margin-bottom:5px}.nav-tabs.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-tabs.nav-justified>li{display:table-cell;width:1%}.nav-tabs.nav-justified>li>a{margin-bottom:0}}.nav-tabs.nav-justified>li>a{margin-right:0;border-radius:3px}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:hover,.nav-tabs.nav-justified>.active>a:focus{border:1px solid transparent}@media (min-width:768px){.nav-tabs.nav-justified>li>a{border-bottom:1px solid transparent;border-radius:3px 3px 0 0}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:hover,.nav-tabs.nav-justified>.active>a:focus{border-bottom-color:#ffffff}}.nav-pills>li{float:left}.nav-pills>li>a{border-radius:3px}.nav-pills>li+li{margin-left:2px}.nav-pills>li.active>a,.nav-pills>li.active>a:hover,.nav-pills>li.active>a:focus{color:#ffffff;background-color:#2196f3}.nav-stacked>li{float:none}.nav-stacked>li+li{margin-top:2px;margin-left:0}.nav-justified{width:100%}.nav-justified>li{float:none}.nav-justified>li>a{text-align:center;margin-bottom:5px}.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-justified>li{display:table-cell;width:1%}.nav-justified>li>a{margin-bottom:0}}.nav-tabs-justified{border-bottom:0}.nav-tabs-justified>li>a{margin-right:0;border-radius:3px}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:hover,.nav-tabs-justified>.active>a:focus{border:1px solid transparent}@media (min-width:768px){.nav-tabs-justified>li>a{border-bottom:1px solid transparent;border-radius:3px 3px 0 0}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:hover,.nav-tabs-justified>.active>a:focus{border-bottom-color:#ffffff}}.tab-content>.tab-pane{display:none}.tab-content>.active{display:block}.nav-tabs .dropdown-menu{margin-top:-1px;border-top-right-radius:0;border-top-left-radius:0}.navbar{position:relative;min-height:64px;margin-bottom:23px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:3px}}@media (min-width:768px){.navbar-header{float:left}}.navbar-collapse{overflow-x:visible;padding-right:15px;padding-left:15px;border-top:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,0.1);box-shadow:inset 0 1px 0 rgba(255,255,255,0.1);-webkit-overflow-scrolling:touch}.navbar-collapse.in{overflow-y:auto}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;-webkit-box-shadow:none;box-shadow:none}.navbar-collapse.collapse{display:block !important;height:auto !important;padding-bottom:0;overflow:visible !important}.navbar-collapse.in{overflow-y:visible}.navbar-fixed-top .navbar-collapse,.navbar-static-top .navbar-collapse,.navbar-fixed-bottom .navbar-collapse{padding-left:0;padding-right:0}}.navbar-fixed-top .navbar-collapse,.navbar-fixed-bottom .navbar-collapse{max-height:340px}@media (max-device-width:480px) and (orientation:landscape){.navbar-fixed-top .navbar-collapse,.navbar-fixed-bottom .navbar-collapse{max-height:200px}}.container>.navbar-header,.container-fluid>.navbar-header,.container>.navbar-collapse,.container-fluid>.navbar-collapse{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container>.navbar-header,.container-fluid>.navbar-header,.container>.navbar-collapse,.container-fluid>.navbar-collapse{margin-right:0;margin-left:0}}.navbar-static-top{z-index:1000;border-width:0 0 1px}@media (min-width:768px){.navbar-static-top{border-radius:0}}.navbar-fixed-top,.navbar-fixed-bottom{position:fixed;right:0;left:0;z-index:1030}@media (min-width:768px){.navbar-fixed-top,.navbar-fixed-bottom{border-radius:0}}.navbar-fixed-top{top:0;border-width:0 0 1px}.navbar-fixed-bottom{bottom:0;margin-bottom:0;border-width:1px 0 0}.navbar-brand{float:left;padding:20.5px 15px;font-size:17px;line-height:23px;height:64px}.navbar-brand:hover,.navbar-brand:focus{text-decoration:none}.navbar-brand>img{display:block}@media (min-width:768px){.navbar>.container .navbar-brand,.navbar>.container-fluid .navbar-brand{margin-left:-15px}}.navbar-toggle{position:relative;float:right;margin-right:15px;padding:9px 10px;margin-top:15px;margin-bottom:15px;background-color:transparent;background-image:none;border:1px solid transparent;border-radius:3px}.navbar-toggle:focus{outline:0}.navbar-toggle .icon-bar{display:block;width:22px;height:2px;border-radius:1px}.navbar-toggle .icon-bar+.icon-bar{margin-top:4px}@media (min-width:768px){.navbar-toggle{display:none}}.navbar-nav{margin:10.25px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:23px}@media (max-width:767px){.navbar-nav .open .dropdown-menu{position:static;float:none;width:auto;margin-top:0;background-color:transparent;border:0;-webkit-box-shadow:none;box-shadow:none}.navbar-nav .open .dropdown-menu>li>a,.navbar-nav .open .dropdown-menu .dropdown-header{padding:5px 15px 5px 25px}.navbar-nav .open .dropdown-menu>li>a{line-height:23px}.navbar-nav .open .dropdown-menu>li>a:hover,.navbar-nav .open .dropdown-menu>li>a:focus{background-image:none}}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:20.5px;padding-bottom:20.5px}}.navbar-form{margin-left:-15px;margin-right:-15px;padding:10px 15px;border-top:1px solid transparent;border-bottom:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,0.1),0 1px 0 rgba(255,255,255,0.1);box-shadow:inset 0 1px 0 rgba(255,255,255,0.1),0 1px 0 rgba(255,255,255,0.1);margin-top:13.5px;margin-bottom:13.5px}@media (min-width:768px){.navbar-form .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.navbar-form .form-control{display:inline-block;width:auto;vertical-align:middle}.navbar-form .form-control-static{display:inline-block}.navbar-form .input-group{display:inline-table;vertical-align:middle}.navbar-form .input-group .input-group-addon,.navbar-form .input-group .input-group-btn,.navbar-form .input-group .form-control{width:auto}.navbar-form .input-group>.form-control{width:100%}.navbar-form .control-label{margin-bottom:0;vertical-align:middle}.navbar-form .radio,.navbar-form .checkbox{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.navbar-form .radio label,.navbar-form .checkbox label{padding-left:0}.navbar-form .radio input[type="radio"],.navbar-form .checkbox input[type="checkbox"]{position:relative;margin-left:0}.navbar-form .has-feedback .form-control-feedback{top:0}}@media (max-width:767px){.navbar-form .form-group{margin-bottom:5px}.navbar-form .form-group:last-child{margin-bottom:0}}@media (min-width:768px){.navbar-form{width:auto;border:0;margin-left:0;margin-right:0;padding-top:0;padding-bottom:0;-webkit-box-shadow:none;box-shadow:none}}.navbar-nav>li>.dropdown-menu{margin-top:0;border-top-right-radius:0;border-top-left-radius:0}.navbar-fixed-bottom .navbar-nav>li>.dropdown-menu{margin-bottom:0;border-top-right-radius:3px;border-top-left-radius:3px;border-bottom-right-radius:0;border-bottom-left-radius:0}.navbar-btn{margin-top:13.5px;margin-bottom:13.5px}.navbar-btn.btn-sm{margin-top:17px;margin-bottom:17px}.navbar-btn.btn-xs{margin-top:21px;margin-bottom:21px}.navbar-text{margin-top:20.5px;margin-bottom:20.5px}@media (min-width:768px){.navbar-text{float:left;margin-left:15px;margin-right:15px}}@media (min-width:768px){.navbar-left{float:left !important}.navbar-right{float:right !important;margin-right:-15px}.navbar-right~.navbar-right{margin-right:0}}.navbar-default{background-color:#ffffff;border-color:transparent}.navbar-default .navbar-brand{color:#666666}.navbar-default .navbar-brand:hover,.navbar-default .navbar-brand:focus{color:#212121;background-color:transparent}.navbar-default .navbar-text{color:#bbbbbb}.navbar-default .navbar-nav>li>a{color:#666666}.navbar-default .navbar-nav>li>a:hover,.navbar-default .navbar-nav>li>a:focus{color:#212121;background-color:transparent}.navbar-default .navbar-nav>.active>a,.navbar-default .navbar-nav>.active>a:hover,.navbar-default .navbar-nav>.active>a:focus{color:#212121;background-color:#eeeeee}.navbar-default .navbar-nav>.disabled>a,.navbar-default .navbar-nav>.disabled>a:hover,.navbar-default .navbar-nav>.disabled>a:focus{color:#cccccc;background-color:transparent}.navbar-default .navbar-toggle{border-color:transparent}.navbar-default .navbar-toggle:hover,.navbar-default .navbar-toggle:focus{background-color:transparent}.navbar-default .navbar-toggle .icon-bar{background-color:rgba(0,0,0,0.5)}.navbar-default .navbar-collapse,.navbar-default .navbar-form{border-color:transparent}.navbar-default .navbar-nav>.open>a,.navbar-default .navbar-nav>.open>a:hover,.navbar-default .navbar-nav>.open>a:focus{background-color:#eeeeee;color:#212121}@media (max-width:767px){.navbar-default .navbar-nav .open .dropdown-menu>li>a{color:#666666}.navbar-default .navbar-nav .open .dropdown-menu>li>a:hover,.navbar-default .navbar-nav .open .dropdown-menu>li>a:focus{color:#212121;background-color:transparent}.navbar-default .navbar-nav .open .dropdown-menu>.active>a,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:hover,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:focus{color:#212121;background-color:#eeeeee}.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:hover,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:focus{color:#cccccc;background-color:transparent}}.navbar-default .navbar-link{color:#666666}.navbar-default .navbar-link:hover{color:#212121}.navbar-default .btn-link{color:#666666}.navbar-default .btn-link:hover,.navbar-default .btn-link:focus{color:#212121}.navbar-default .btn-link[disabled]:hover,fieldset[disabled] .navbar-default .btn-link:hover,.navbar-default .btn-link[disabled]:focus,fieldset[disabled] .navbar-default .btn-link:focus{color:#cccccc}.navbar-inverse{background-color:#2196f3;border-color:transparent}.navbar-inverse .navbar-brand{color:#b2dbfb}.navbar-inverse .navbar-brand:hover,.navbar-inverse .navbar-brand:focus{color:#ffffff;background-color:transparent}.navbar-inverse .navbar-text{color:#bbbbbb}.navbar-inverse .navbar-nav>li>a{color:#b2dbfb}.navbar-inverse .navbar-nav>li>a:hover,.navbar-inverse .navbar-nav>li>a:focus{color:#ffffff;background-color:transparent}.navbar-inverse .navbar-nav>.active>a,.navbar-inverse .navbar-nav>.active>a:hover,.navbar-inverse .navbar-nav>.active>a:focus{color:#ffffff;background-color:#0c7cd5}.navbar-inverse .navbar-nav>.disabled>a,.navbar-inverse .navbar-nav>.disabled>a:hover,.navbar-inverse .navbar-nav>.disabled>a:focus{color:#444444;background-color:transparent}.navbar-inverse .navbar-toggle{border-color:transparent}.navbar-inverse .navbar-toggle:hover,.navbar-inverse .navbar-toggle:focus{background-color:transparent}.navbar-inverse .navbar-toggle .icon-bar{background-color:rgba(0,0,0,0.5)}.navbar-inverse .navbar-collapse,.navbar-inverse .navbar-form{border-color:#0c84e4}.navbar-inverse .navbar-nav>.open>a,.navbar-inverse .navbar-nav>.open>a:hover,.navbar-inverse .navbar-nav>.open>a:focus{background-color:#0c7cd5;color:#ffffff}@media (max-width:767px){.navbar-inverse .navbar-nav .open .dropdown-menu>.dropdown-header{border-color:transparent}.navbar-inverse .navbar-nav .open .dropdown-menu .divider{background-color:transparent}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a{color:#b2dbfb}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:hover,.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:focus{color:#ffffff;background-color:transparent}.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:hover,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:focus{color:#ffffff;background-color:#0c7cd5}.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:hover,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:focus{color:#444444;background-color:transparent}}.navbar-inverse .navbar-link{color:#b2dbfb}.navbar-inverse .navbar-link:hover{color:#ffffff}.navbar-inverse .btn-link{color:#b2dbfb}.navbar-inverse .btn-link:hover,.navbar-inverse .btn-link:focus{color:#ffffff}.navbar-inverse .btn-link[disabled]:hover,fieldset[disabled] .navbar-inverse .btn-link:hover,.navbar-inverse .btn-link[disabled]:focus,fieldset[disabled] .navbar-inverse .btn-link:focus{color:#444444}.breadcrumb{padding:8px 15px;margin-bottom:23px;list-style:none;background-color:#f5f5f5;border-radius:3px}.breadcrumb>li{display:inline-block}.breadcrumb>li+li:before{content:"/\00a0";padding:0 5px;color:#cccccc}.breadcrumb>.active{color:#bbbbbb}.pagination{display:inline-block;padding-left:0;margin:23px 0;border-radius:3px}.pagination>li{display:inline}.pagination>li>a,.pagination>li>span{position:relative;float:left;padding:6px 16px;line-height:1.846;text-decoration:none;color:#2196f3;background-color:#ffffff;border:1px solid #dddddd;margin-left:-1px}.pagination>li:first-child>a,.pagination>li:first-child>span{margin-left:0;border-bottom-left-radius:3px;border-top-left-radius:3px}.pagination>li:last-child>a,.pagination>li:last-child>span{border-bottom-right-radius:3px;border-top-right-radius:3px}.pagination>li>a:hover,.pagination>li>span:hover,.pagination>li>a:focus,.pagination>li>span:focus{z-index:2;color:#0a6ebd;background-color:#eeeeee;border-color:#dddddd}.pagination>.active>a,.pagination>.active>span,.pagination>.active>a:hover,.pagination>.active>span:hover,.pagination>.active>a:focus,.pagination>.active>span:focus{z-index:3;color:#ffffff;background-color:#2196f3;border-color:#2196f3;cursor:default}.pagination>.disabled>span,.pagination>.disabled>span:hover,.pagination>.disabled>span:focus,.pagination>.disabled>a,.pagination>.disabled>a:hover,.pagination>.disabled>a:focus{color:#bbbbbb;background-color:#ffffff;border-color:#dddddd;cursor:not-allowed}.pagination-lg>li>a,.pagination-lg>li>span{padding:10px 16px;font-size:17px;line-height:1.3333333}.pagination-lg>li:first-child>a,.pagination-lg>li:first-child>span{border-bottom-left-radius:3px;border-top-left-radius:3px}.pagination-lg>li:last-child>a,.pagination-lg>li:last-child>span{border-bottom-right-radius:3px;border-top-right-radius:3px}.pagination-sm>li>a,.pagination-sm>li>span{padding:5px 10px;font-size:12px;line-height:1.5}.pagination-sm>li:first-child>a,.pagination-sm>li:first-child>span{border-bottom-left-radius:3px;border-top-left-radius:3px}.pagination-sm>li:last-child>a,.pagination-sm>li:last-child>span{border-bottom-right-radius:3px;border-top-right-radius:3px}.pager{padding-left:0;margin:23px 0;list-style:none;text-align:center}.pager li{display:inline}.pager li>a,.pager li>span{display:inline-block;padding:5px 14px;background-color:#ffffff;border:1px solid #dddddd;border-radius:15px}.pager li>a:hover,.pager li>a:focus{text-decoration:none;background-color:#eeeeee}.pager .next>a,.pager .next>span{float:right}.pager .previous>a,.pager .previous>span{float:left}.pager .disabled>a,.pager .disabled>a:hover,.pager .disabled>a:focus,.pager .disabled>span{color:#bbbbbb;background-color:#ffffff;cursor:not-allowed}.label{display:inline;padding:.2em .6em .3em;font-size:75%;font-weight:bold;line-height:1;color:#ffffff;text-align:center;white-space:nowrap;vertical-align:baseline;border-radius:.25em}a.label:hover,a.label:focus{color:#ffffff;text-decoration:none;cursor:pointer}.label:empty{display:none}.btn .label{position:relative;top:-1px}.label-default{background-color:#bbbbbb}.label-default[href]:hover,.label-default[href]:focus{background-color:#a2a2a2}.label-primary{background-color:#2196f3}.label-primary[href]:hover,.label-primary[href]:focus{background-color:#0c7cd5}.label-success{background-color:#4caf50}.label-success[href]:hover,.label-success[href]:focus{background-color:#3d8b40}.label-info{background-color:#9c27b0}.label-info[href]:hover,.label-info[href]:focus{background-color:#771e86}.label-warning{background-color:#ff9800}.label-warning[href]:hover,.label-warning[href]:focus{background-color:#cc7a00}.label-danger{background-color:#e51c23}.label-danger[href]:hover,.label-danger[href]:focus{background-color:#b9151b}.badge{display:inline-block;min-width:10px;padding:3px 7px;font-size:12px;font-weight:normal;color:#ffffff;line-height:1;vertical-align:middle;white-space:nowrap;text-align:center;background-color:#bbbbbb;border-radius:10px}.badge:empty{display:none}.btn .badge{position:relative;top:-1px}.btn-xs .badge,.btn-group-xs>.btn .badge{top:0;padding:1px 5px}a.badge:hover,a.badge:focus{color:#ffffff;text-decoration:none;cursor:pointer}.list-group-item.active>.badge,.nav-pills>.active>a>.badge{color:#2196f3;background-color:#ffffff}.list-group-item>.badge{float:right}.list-group-item>.badge+.badge{margin-right:5px}.nav-pills>li>a>.badge{margin-left:3px}.jumbotron{padding-top:30px;padding-bottom:30px;margin-bottom:30px;color:inherit;background-color:#f9f9f9}.jumbotron h1,.jumbotron .h1{color:#444444}.jumbotron p{margin-bottom:15px;font-size:20px;font-weight:200}.jumbotron>hr{border-top-color:#e0e0e0}.container .jumbotron,.container-fluid .jumbotron{border-radius:3px;padding-left:15px;padding-right:15px}.jumbotron .container{max-width:100%}@media screen and (min-width:768px){.jumbotron{padding-top:48px;padding-bottom:48px}.container .jumbotron,.container-fluid .jumbotron{padding-left:60px;padding-right:60px}.jumbotron h1,.jumbotron .h1{font-size:59px}}.thumbnail{display:block;padding:4px;margin-bottom:23px;line-height:1.846;background-color:#ffffff;border:1px solid #dddddd;border-radius:3px;-webkit-transition:border .2s ease-in-out;-o-transition:border .2s ease-in-out;transition:border .2s ease-in-out}.thumbnail>img,.thumbnail a>img{margin-left:auto;margin-right:auto}a.thumbnail:hover,a.thumbnail:focus,a.thumbnail.active{border-color:#2196f3}.thumbnail .caption{padding:9px;color:#666666}.alert{padding:15px;margin-bottom:23px;border:1px solid transparent;border-radius:3px}.alert h4{margin-top:0;color:inherit}.alert .alert-link{font-weight:bold}.alert>p,.alert>ul{margin-bottom:0}.alert>p+p{margin-top:5px}.alert-dismissable,.alert-dismissible{padding-right:35px}.alert-dismissable .close,.alert-dismissible .close{position:relative;top:-2px;right:-21px;color:inherit}.alert-success{background-color:#dff0d8;border-color:#d6e9c6;color:#4caf50}.alert-success hr{border-top-color:#c9e2b3}.alert-success .alert-link{color:#3d8b40}.alert-info{background-color:#e1bee7;border-color:#cba4dd;color:#9c27b0}.alert-info hr{border-top-color:#c191d6}.alert-info .alert-link{color:#771e86}.alert-warning{background-color:#ffe0b2;border-color:#ffc599;color:#ff9800}.alert-warning hr{border-top-color:#ffb67f}.alert-warning .alert-link{color:#cc7a00}.alert-danger{background-color:#f9bdbb;border-color:#f7a4af;color:#e51c23}.alert-danger hr{border-top-color:#f58c9a}.alert-danger .alert-link{color:#b9151b}@-webkit-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@-o-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}.progress{overflow:hidden;height:23px;margin-bottom:23px;background-color:#f5f5f5;border-radius:3px;-webkit-box-shadow:inset 0 1px 2px rgba(0,0,0,0.1);box-shadow:inset 0 1px 2px rgba(0,0,0,0.1)}.progress-bar{float:left;width:0%;height:100%;font-size:12px;line-height:23px;color:#ffffff;text-align:center;background-color:#2196f3;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,0.15);box-shadow:inset 0 -1px 0 rgba(0,0,0,0.15);-webkit-transition:width 0.6s ease;-o-transition:width 0.6s ease;transition:width 0.6s ease}.progress-striped .progress-bar,.progress-bar-striped{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);-webkit-background-size:40px 40px;background-size:40px 40px}.progress.active .progress-bar,.progress-bar.active{-webkit-animation:progress-bar-stripes 2s linear infinite;-o-animation:progress-bar-stripes 2s linear infinite;animation:progress-bar-stripes 2s linear infinite}.progress-bar-success{background-color:#4caf50}.progress-striped .progress-bar-success{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent)}.progress-bar-info{background-color:#9c27b0}.progress-striped .progress-bar-info{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent)}.progress-bar-warning{background-color:#ff9800}.progress-striped .progress-bar-warning{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent)}.progress-bar-danger{background-color:#e51c23}.progress-striped .progress-bar-danger{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent)}.media{margin-top:15px}.media:first-child{margin-top:0}.media,.media-body{zoom:1;overflow:hidden}.media-body{width:10000px}.media-object{display:block}.media-object.img-thumbnail{max-width:none}.media-right,.media>.pull-right{padding-left:10px}.media-left,.media>.pull-left{padding-right:10px}.media-left,.media-right,.media-body{display:table-cell;vertical-align:top}.media-middle{vertical-align:middle}.media-bottom{vertical-align:bottom}.media-heading{margin-top:0;margin-bottom:5px}.media-list{padding-left:0;list-style:none}.list-group{margin-bottom:20px;padding-left:0}.list-group-item{position:relative;display:block;padding:10px 15px;margin-bottom:-1px;background-color:#ffffff;border:1px solid #dddddd}.list-group-item:first-child{border-top-right-radius:3px;border-top-left-radius:3px}.list-group-item:last-child{margin-bottom:0;border-bottom-right-radius:3px;border-bottom-left-radius:3px}a.list-group-item,button.list-group-item{color:#555555}a.list-group-item .list-group-item-heading,button.list-group-item .list-group-item-heading{color:#333333}a.list-group-item:hover,button.list-group-item:hover,a.list-group-item:focus,button.list-group-item:focus{text-decoration:none;color:#555555;background-color:#f5f5f5}button.list-group-item{width:100%;text-align:left}.list-group-item.disabled,.list-group-item.disabled:hover,.list-group-item.disabled:focus{background-color:#eeeeee;color:#bbbbbb;cursor:not-allowed}.list-group-item.disabled .list-group-item-heading,.list-group-item.disabled:hover .list-group-item-heading,.list-group-item.disabled:focus .list-group-item-heading{color:inherit}.list-group-item.disabled .list-group-item-text,.list-group-item.disabled:hover .list-group-item-text,.list-group-item.disabled:focus .list-group-item-text{color:#bbbbbb}.list-group-item.active,.list-group-item.active:hover,.list-group-item.active:focus{z-index:2;color:#ffffff;background-color:#2196f3;border-color:#2196f3}.list-group-item.active .list-group-item-heading,.list-group-item.active:hover .list-group-item-heading,.list-group-item.active:focus .list-group-item-heading,.list-group-item.active .list-group-item-heading>small,.list-group-item.active:hover .list-group-item-heading>small,.list-group-item.active:focus .list-group-item-heading>small,.list-group-item.active .list-group-item-heading>.small,.list-group-item.active:hover .list-group-item-heading>.small,.list-group-item.active:focus .list-group-item-heading>.small{color:inherit}.list-group-item.active .list-group-item-text,.list-group-item.active:hover .list-group-item-text,.list-group-item.active:focus .list-group-item-text{color:#e3f2fd}.list-group-item-success{color:#4caf50;background-color:#dff0d8}a.list-group-item-success,button.list-group-item-success{color:#4caf50}a.list-group-item-success .list-group-item-heading,button.list-group-item-success .list-group-item-heading{color:inherit}a.list-group-item-success:hover,button.list-group-item-success:hover,a.list-group-item-success:focus,button.list-group-item-success:focus{color:#4caf50;background-color:#d0e9c6}a.list-group-item-success.active,button.list-group-item-success.active,a.list-group-item-success.active:hover,button.list-group-item-success.active:hover,a.list-group-item-success.active:focus,button.list-group-item-success.active:focus{color:#fff;background-color:#4caf50;border-color:#4caf50}.list-group-item-info{color:#9c27b0;background-color:#e1bee7}a.list-group-item-info,button.list-group-item-info{color:#9c27b0}a.list-group-item-info .list-group-item-heading,button.list-group-item-info .list-group-item-heading{color:inherit}a.list-group-item-info:hover,button.list-group-item-info:hover,a.list-group-item-info:focus,button.list-group-item-info:focus{color:#9c27b0;background-color:#d8abe0}a.list-group-item-info.active,button.list-group-item-info.active,a.list-group-item-info.active:hover,button.list-group-item-info.active:hover,a.list-group-item-info.active:focus,button.list-group-item-info.active:focus{color:#fff;background-color:#9c27b0;border-color:#9c27b0}.list-group-item-warning{color:#ff9800;background-color:#ffe0b2}a.list-group-item-warning,button.list-group-item-warning{color:#ff9800}a.list-group-item-warning .list-group-item-heading,button.list-group-item-warning .list-group-item-heading{color:inherit}a.list-group-item-warning:hover,button.list-group-item-warning:hover,a.list-group-item-warning:focus,button.list-group-item-warning:focus{color:#ff9800;background-color:#ffd699}a.list-group-item-warning.active,button.list-group-item-warning.active,a.list-group-item-warning.active:hover,button.list-group-item-warning.active:hover,a.list-group-item-warning.active:focus,button.list-group-item-warning.active:focus{color:#fff;background-color:#ff9800;border-color:#ff9800}.list-group-item-danger{color:#e51c23;background-color:#f9bdbb}a.list-group-item-danger,button.list-group-item-danger{color:#e51c23}a.list-group-item-danger .list-group-item-heading,button.list-group-item-danger .list-group-item-heading{color:inherit}a.list-group-item-danger:hover,button.list-group-item-danger:hover,a.list-group-item-danger:focus,button.list-group-item-danger:focus{color:#e51c23;background-color:#f7a6a4}a.list-group-item-danger.active,button.list-group-item-danger.active,a.list-group-item-danger.active:hover,button.list-group-item-danger.active:hover,a.list-group-item-danger.active:focus,button.list-group-item-danger.active:focus{color:#fff;background-color:#e51c23;border-color:#e51c23}.list-group-item-heading{margin-top:0;margin-bottom:5px}.list-group-item-text{margin-bottom:0;line-height:1.3}.panel{margin-bottom:23px;background-color:#ffffff;border:1px solid transparent;border-radius:3px;-webkit-box-shadow:0 1px 1px rgba(0,0,0,0.05);box-shadow:0 1px 1px rgba(0,0,0,0.05)}.panel-body{padding:15px}.panel-heading{padding:10px 15px;border-bottom:1px solid transparent;border-top-right-radius:2px;border-top-left-radius:2px}.panel-heading>.dropdown .dropdown-toggle{color:inherit}.panel-title{margin-top:0;margin-bottom:0;font-size:15px;color:inherit}.panel-title>a,.panel-title>small,.panel-title>.small,.panel-title>small>a,.panel-title>.small>a{color:inherit}.panel-footer{padding:10px 15px;background-color:#f5f5f5;border-top:1px solid #dddddd;border-bottom-right-radius:2px;border-bottom-left-radius:2px}.panel>.list-group,.panel>.panel-collapse>.list-group{margin-bottom:0}.panel>.list-group .list-group-item,.panel>.panel-collapse>.list-group .list-group-item{border-width:1px 0;border-radius:0}.panel>.list-group:first-child .list-group-item:first-child,.panel>.panel-collapse>.list-group:first-child .list-group-item:first-child{border-top:0;border-top-right-radius:2px;border-top-left-radius:2px}.panel>.list-group:last-child .list-group-item:last-child,.panel>.panel-collapse>.list-group:last-child .list-group-item:last-child{border-bottom:0;border-bottom-right-radius:2px;border-bottom-left-radius:2px}.panel>.panel-heading+.panel-collapse>.list-group .list-group-item:first-child{border-top-right-radius:0;border-top-left-radius:0}.panel-heading+.list-group .list-group-item:first-child{border-top-width:0}.list-group+.panel-footer{border-top-width:0}.panel>.table,.panel>.table-responsive>.table,.panel>.panel-collapse>.table{margin-bottom:0}.panel>.table caption,.panel>.table-responsive>.table caption,.panel>.panel-collapse>.table caption{padding-left:15px;padding-right:15px}.panel>.table:first-child,.panel>.table-responsive:first-child>.table:first-child{border-top-right-radius:2px;border-top-left-radius:2px}.panel>.table:first-child>thead:first-child>tr:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child{border-top-left-radius:2px;border-top-right-radius:2px}.panel>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table:first-child>thead:first-child>tr:first-child th:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:first-child{border-top-left-radius:2px}.panel>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table:first-child>thead:first-child>tr:first-child th:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:last-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:last-child{border-top-right-radius:2px}.panel>.table:last-child,.panel>.table-responsive:last-child>.table:last-child{border-bottom-right-radius:2px;border-bottom-left-radius:2px}.panel>.table:last-child>tbody:last-child>tr:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child{border-bottom-left-radius:2px;border-bottom-right-radius:2px}.panel>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:first-child{border-bottom-left-radius:2px}.panel>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:last-child{border-bottom-right-radius:2px}.panel>.panel-body+.table,.panel>.panel-body+.table-responsive,.panel>.table+.panel-body,.panel>.table-responsive+.panel-body{border-top:1px solid #dddddd}.panel>.table>tbody:first-child>tr:first-child th,.panel>.table>tbody:first-child>tr:first-child td{border-top:0}.panel>.table-bordered,.panel>.table-responsive>.table-bordered{border:0}.panel>.table-bordered>thead>tr>th:first-child,.panel>.table-responsive>.table-bordered>thead>tr>th:first-child,.panel>.table-bordered>tbody>tr>th:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:first-child,.panel>.table-bordered>tfoot>tr>th:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:first-child,.panel>.table-bordered>thead>tr>td:first-child,.panel>.table-responsive>.table-bordered>thead>tr>td:first-child,.panel>.table-bordered>tbody>tr>td:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:first-child,.panel>.table-bordered>tfoot>tr>td:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:first-child{border-left:0}.panel>.table-bordered>thead>tr>th:last-child,.panel>.table-responsive>.table-bordered>thead>tr>th:last-child,.panel>.table-bordered>tbody>tr>th:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:last-child,.panel>.table-bordered>tfoot>tr>th:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:last-child,.panel>.table-bordered>thead>tr>td:last-child,.panel>.table-responsive>.table-bordered>thead>tr>td:last-child,.panel>.table-bordered>tbody>tr>td:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:last-child,.panel>.table-bordered>tfoot>tr>td:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:last-child{border-right:0}.panel>.table-bordered>thead>tr:first-child>td,.panel>.table-responsive>.table-bordered>thead>tr:first-child>td,.panel>.table-bordered>tbody>tr:first-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>td,.panel>.table-bordered>thead>tr:first-child>th,.panel>.table-responsive>.table-bordered>thead>tr:first-child>th,.panel>.table-bordered>tbody>tr:first-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>th{border-bottom:0}.panel>.table-bordered>tbody>tr:last-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>td,.panel>.table-bordered>tfoot>tr:last-child>td,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>td,.panel>.table-bordered>tbody>tr:last-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>th,.panel>.table-bordered>tfoot>tr:last-child>th,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>th{border-bottom:0}.panel>.table-responsive{border:0;margin-bottom:0}.panel-group{margin-bottom:23px}.panel-group .panel{margin-bottom:0;border-radius:3px}.panel-group .panel+.panel{margin-top:5px}.panel-group .panel-heading{border-bottom:0}.panel-group .panel-heading+.panel-collapse>.panel-body,.panel-group .panel-heading+.panel-collapse>.list-group{border-top:1px solid #dddddd}.panel-group .panel-footer{border-top:0}.panel-group .panel-footer+.panel-collapse .panel-body{border-bottom:1px solid #dddddd}.panel-default{border-color:#dddddd}.panel-default>.panel-heading{color:#212121;background-color:#f5f5f5;border-color:#dddddd}.panel-default>.panel-heading+.panel-collapse>.panel-body{border-top-color:#dddddd}.panel-default>.panel-heading .badge{color:#f5f5f5;background-color:#212121}.panel-default>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#dddddd}.panel-primary{border-color:#2196f3}.panel-primary>.panel-heading{color:#ffffff;background-color:#2196f3;border-color:#2196f3}.panel-primary>.panel-heading+.panel-collapse>.panel-body{border-top-color:#2196f3}.panel-primary>.panel-heading .badge{color:#2196f3;background-color:#ffffff}.panel-primary>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#2196f3}.panel-success{border-color:#d6e9c6}.panel-success>.panel-heading{color:#ffffff;background-color:#4caf50;border-color:#d6e9c6}.panel-success>.panel-heading+.panel-collapse>.panel-body{border-top-color:#d6e9c6}.panel-success>.panel-heading .badge{color:#4caf50;background-color:#ffffff}.panel-success>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#d6e9c6}.panel-info{border-color:#cba4dd}.panel-info>.panel-heading{color:#ffffff;background-color:#9c27b0;border-color:#cba4dd}.panel-info>.panel-heading+.panel-collapse>.panel-body{border-top-color:#cba4dd}.panel-info>.panel-heading .badge{color:#9c27b0;background-color:#ffffff}.panel-info>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#cba4dd}.panel-warning{border-color:#ffc599}.panel-warning>.panel-heading{color:#ffffff;background-color:#ff9800;border-color:#ffc599}.panel-warning>.panel-heading+.panel-collapse>.panel-body{border-top-color:#ffc599}.panel-warning>.panel-heading .badge{color:#ff9800;background-color:#ffffff}.panel-warning>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#ffc599}.panel-danger{border-color:#f7a4af}.panel-danger>.panel-heading{color:#ffffff;background-color:#e51c23;border-color:#f7a4af}.panel-danger>.panel-heading+.panel-collapse>.panel-body{border-top-color:#f7a4af}.panel-danger>.panel-heading .badge{color:#e51c23;background-color:#ffffff}.panel-danger>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#f7a4af}.embed-responsive{position:relative;display:block;height:0;padding:0;overflow:hidden}.embed-responsive .embed-responsive-item,.embed-responsive iframe,.embed-responsive embed,.embed-responsive object,.embed-responsive video{position:absolute;top:0;left:0;bottom:0;height:100%;width:100%;border:0}.embed-responsive-16by9{padding-bottom:56.25%}.embed-responsive-4by3{padding-bottom:75%}.well{min-height:20px;padding:19px;margin-bottom:20px;background-color:#f9f9f9;border:1px solid transparent;border-radius:3px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.05);box-shadow:inset 0 1px 1px rgba(0,0,0,0.05)}.well blockquote{border-color:#ddd;border-color:rgba(0,0,0,0.15)}.well-lg{padding:24px;border-radius:3px}.well-sm{padding:9px;border-radius:3px}.close{float:right;font-size:19.5px;font-weight:normal;line-height:1;color:#000000;text-shadow:none;opacity:0.2;filter:alpha(opacity=20)}.close:hover,.close:focus{color:#000000;text-decoration:none;cursor:pointer;opacity:0.5;filter:alpha(opacity=50)}button.close{padding:0;cursor:pointer;background:transparent;border:0;-webkit-appearance:none}.modal-open{overflow:hidden}.modal{display:none;overflow:hidden;position:fixed;top:0;right:0;bottom:0;left:0;z-index:1050;-webkit-overflow-scrolling:touch;outline:0}.modal.fade .modal-dialog{-webkit-transform:translate(0, -25%);-ms-transform:translate(0, -25%);-o-transform:translate(0, -25%);transform:translate(0, -25%);-webkit-transition:-webkit-transform .3s ease-out;-o-transition:-o-transform .3s ease-out;transition:transform .3s ease-out}.modal.in .modal-dialog{-webkit-transform:translate(0, 0);-ms-transform:translate(0, 0);-o-transform:translate(0, 0);transform:translate(0, 0)}.modal-open .modal{overflow-x:hidden;overflow-y:auto}.modal-dialog{position:relative;width:auto;margin:10px}.modal-content{position:relative;background-color:#ffffff;border:1px solid #999999;border:1px solid transparent;border-radius:3px;-webkit-box-shadow:0 3px 9px rgba(0,0,0,0.5);box-shadow:0 3px 9px rgba(0,0,0,0.5);-webkit-background-clip:padding-box;background-clip:padding-box;outline:0}.modal-backdrop{position:fixed;top:0;right:0;bottom:0;left:0;z-index:1040;background-color:#000000}.modal-backdrop.fade{opacity:0;filter:alpha(opacity=0)}.modal-backdrop.in{opacity:0.5;filter:alpha(opacity=50)}.modal-header{padding:15px;border-bottom:1px solid transparent}.modal-header .close{margin-top:-2px}.modal-title{margin:0;line-height:1.846}.modal-body{position:relative;padding:15px}.modal-footer{padding:15px;text-align:right;border-top:1px solid transparent}.modal-footer .btn+.btn{margin-left:5px;margin-bottom:0}.modal-footer .btn-group .btn+.btn{margin-left:-1px}.modal-footer .btn-block+.btn-block{margin-left:0}.modal-scrollbar-measure{position:absolute;top:-9999px;width:50px;height:50px;overflow:scroll}@media (min-width:768px){.modal-dialog{width:600px;margin:30px auto}.modal-content{-webkit-box-shadow:0 5px 15px rgba(0,0,0,0.5);box-shadow:0 5px 15px rgba(0,0,0,0.5)}.modal-sm{width:300px}}@media (min-width:992px){.modal-lg{width:900px}}.tooltip{position:absolute;z-index:1070;display:block;font-family:"Roboto","Helvetica Neue",Helvetica,Arial,sans-serif;font-style:normal;font-weight:normal;letter-spacing:normal;line-break:auto;line-height:1.846;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;white-space:normal;word-break:normal;word-spacing:normal;word-wrap:normal;font-size:12px;opacity:0;filter:alpha(opacity=0)}.tooltip.in{opacity:0.9;filter:alpha(opacity=90)}.tooltip.top{margin-top:-3px;padding:5px 0}.tooltip.right{margin-left:3px;padding:0 5px}.tooltip.bottom{margin-top:3px;padding:5px 0}.tooltip.left{margin-left:-3px;padding:0 5px}.tooltip-inner{max-width:200px;padding:3px 8px;color:#ffffff;text-align:center;background-color:#727272;border-radius:3px}.tooltip-arrow{position:absolute;width:0;height:0;border-color:transparent;border-style:solid}.tooltip.top .tooltip-arrow{bottom:0;left:50%;margin-left:-5px;border-width:5px 5px 0;border-top-color:#727272}.tooltip.top-left .tooltip-arrow{bottom:0;right:5px;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#727272}.tooltip.top-right .tooltip-arrow{bottom:0;left:5px;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#727272}.tooltip.right .tooltip-arrow{top:50%;left:0;margin-top:-5px;border-width:5px 5px 5px 0;border-right-color:#727272}.tooltip.left .tooltip-arrow{top:50%;right:0;margin-top:-5px;border-width:5px 0 5px 5px;border-left-color:#727272}.tooltip.bottom .tooltip-arrow{top:0;left:50%;margin-left:-5px;border-width:0 5px 5px;border-bottom-color:#727272}.tooltip.bottom-left .tooltip-arrow{top:0;right:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#727272}.tooltip.bottom-right .tooltip-arrow{top:0;left:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#727272}.popover{position:absolute;top:0;left:0;z-index:1060;display:none;max-width:276px;padding:1px;font-family:"Roboto","Helvetica Neue",Helvetica,Arial,sans-serif;font-style:normal;font-weight:normal;letter-spacing:normal;line-break:auto;line-height:1.846;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;white-space:normal;word-break:normal;word-spacing:normal;word-wrap:normal;font-size:13px;background-color:#ffffff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid transparent;border-radius:3px;-webkit-box-shadow:0 5px 10px rgba(0,0,0,0.2);box-shadow:0 5px 10px rgba(0,0,0,0.2)}.popover.top{margin-top:-10px}.popover.right{margin-left:10px}.popover.bottom{margin-top:10px}.popover.left{margin-left:-10px}.popover-title{margin:0;padding:8px 14px;font-size:13px;background-color:#f7f7f7;border-bottom:1px solid #ebebeb;border-radius:2px 2px 0 0}.popover-content{padding:9px 14px}.popover>.arrow,.popover>.arrow:after{position:absolute;display:block;width:0;height:0;border-color:transparent;border-style:solid}.popover>.arrow{border-width:11px}.popover>.arrow:after{border-width:10px;content:""}.popover.top>.arrow{left:50%;margin-left:-11px;border-bottom-width:0;border-top-color:rgba(0,0,0,0);border-top-color:rgba(0,0,0,0.075);bottom:-11px}.popover.top>.arrow:after{content:" ";bottom:1px;margin-left:-10px;border-bottom-width:0;border-top-color:#ffffff}.popover.right>.arrow{top:50%;left:-11px;margin-top:-11px;border-left-width:0;border-right-color:rgba(0,0,0,0);border-right-color:rgba(0,0,0,0.075)}.popover.right>.arrow:after{content:" ";left:1px;bottom:-10px;border-left-width:0;border-right-color:#ffffff}.popover.bottom>.arrow{left:50%;margin-left:-11px;border-top-width:0;border-bottom-color:rgba(0,0,0,0);border-bottom-color:rgba(0,0,0,0.075);top:-11px}.popover.bottom>.arrow:after{content:" ";top:1px;margin-left:-10px;border-top-width:0;border-bottom-color:#ffffff}.popover.left>.arrow{top:50%;right:-11px;margin-top:-11px;border-right-width:0;border-left-color:rgba(0,0,0,0);border-left-color:rgba(0,0,0,0.075)}.popover.left>.arrow:after{content:" ";right:1px;border-right-width:0;border-left-color:#ffffff;bottom:-10px}.carousel{position:relative}.carousel-inner{position:relative;overflow:hidden;width:100%}.carousel-inner>.item{display:none;position:relative;-webkit-transition:.6s ease-in-out left;-o-transition:.6s ease-in-out left;transition:.6s ease-in-out left}.carousel-inner>.item>img,.carousel-inner>.item>a>img{line-height:1}@media all and (transform-3d),(-webkit-transform-3d){.carousel-inner>.item{-webkit-transition:-webkit-transform .6s ease-in-out;-o-transition:-o-transform .6s ease-in-out;transition:transform .6s ease-in-out;-webkit-backface-visibility:hidden;backface-visibility:hidden;-webkit-perspective:1000px;perspective:1000px}.carousel-inner>.item.next,.carousel-inner>.item.active.right{-webkit-transform:translate3d(100%, 0, 0);transform:translate3d(100%, 0, 0);left:0}.carousel-inner>.item.prev,.carousel-inner>.item.active.left{-webkit-transform:translate3d(-100%, 0, 0);transform:translate3d(-100%, 0, 0);left:0}.carousel-inner>.item.next.left,.carousel-inner>.item.prev.right,.carousel-inner>.item.active{-webkit-transform:translate3d(0, 0, 0);transform:translate3d(0, 0, 0);left:0}}.carousel-inner>.active,.carousel-inner>.next,.carousel-inner>.prev{display:block}.carousel-inner>.active{left:0}.carousel-inner>.next,.carousel-inner>.prev{position:absolute;top:0;width:100%}.carousel-inner>.next{left:100%}.carousel-inner>.prev{left:-100%}.carousel-inner>.next.left,.carousel-inner>.prev.right{left:0}.carousel-inner>.active.left{left:-100%}.carousel-inner>.active.right{left:100%}.carousel-control{position:absolute;top:0;left:0;bottom:0;width:15%;opacity:0.5;filter:alpha(opacity=50);font-size:20px;color:#ffffff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,0.6);background-color:rgba(0,0,0,0)}.carousel-control.left{background-image:-webkit-linear-gradient(left, rgba(0,0,0,0.5) 0, rgba(0,0,0,0.0001) 100%);background-image:-o-linear-gradient(left, rgba(0,0,0,0.5) 0, rgba(0,0,0,0.0001) 100%);background-image:-webkit-gradient(linear, left top, right top, from(rgba(0,0,0,0.5)), to(rgba(0,0,0,0.0001)));background-image:linear-gradient(to right, rgba(0,0,0,0.5) 0, rgba(0,0,0,0.0001) 100%);background-repeat:repeat-x;filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#80000000', endColorstr='#00000000', GradientType=1)}.carousel-control.right{left:auto;right:0;background-image:-webkit-linear-gradient(left, rgba(0,0,0,0.0001) 0, rgba(0,0,0,0.5) 100%);background-image:-o-linear-gradient(left, rgba(0,0,0,0.0001) 0, rgba(0,0,0,0.5) 100%);background-image:-webkit-gradient(linear, left top, right top, from(rgba(0,0,0,0.0001)), to(rgba(0,0,0,0.5)));background-image:linear-gradient(to right, rgba(0,0,0,0.0001) 0, rgba(0,0,0,0.5) 100%);background-repeat:repeat-x;filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#00000000', endColorstr='#80000000', GradientType=1)}.carousel-control:hover,.carousel-control:focus{outline:0;color:#ffffff;text-decoration:none;opacity:0.9;filter:alpha(opacity=90)}.carousel-control .icon-prev,.carousel-control .icon-next,.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right{position:absolute;top:50%;margin-top:-10px;z-index:5;display:inline-block}.carousel-control .icon-prev,.carousel-control .glyphicon-chevron-left{left:50%;margin-left:-10px}.carousel-control .icon-next,.carousel-control .glyphicon-chevron-right{right:50%;margin-right:-10px}.carousel-control .icon-prev,.carousel-control .icon-next{width:20px;height:20px;line-height:1;font-family:serif}.carousel-control .icon-prev:before{content:'\2039'}.carousel-control .icon-next:before{content:'\203a'}.carousel-indicators{position:absolute;bottom:10px;left:50%;z-index:15;width:60%;margin-left:-30%;padding-left:0;list-style:none;text-align:center}.carousel-indicators li{display:inline-block;width:10px;height:10px;margin:1px;text-indent:-999px;border:1px solid #ffffff;border-radius:10px;cursor:pointer;background-color:#000 \9;background-color:rgba(0,0,0,0)}.carousel-indicators .active{margin:0;width:12px;height:12px;background-color:#ffffff}.carousel-caption{position:absolute;left:15%;right:15%;bottom:20px;z-index:10;padding-top:20px;padding-bottom:20px;color:#ffffff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,0.6)}.carousel-caption .btn{text-shadow:none}@media screen and (min-width:768px){.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right,.carousel-control .icon-prev,.carousel-control .icon-next{width:30px;height:30px;margin-top:-10px;font-size:30px}.carousel-control .glyphicon-chevron-left,.carousel-control .icon-prev{margin-left:-10px}.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next{margin-right:-10px}.carousel-caption{left:20%;right:20%;padding-bottom:30px}.carousel-indicators{bottom:20px}}.clearfix:before,.clearfix:after,.dl-horizontal dd:before,.dl-horizontal dd:after,.container:before,.container:after,.container-fluid:before,.container-fluid:after,.row:before,.row:after,.form-horizontal .form-group:before,.form-horizontal .form-group:after,.btn-toolbar:before,.btn-toolbar:after,.btn-group-vertical>.btn-group:before,.btn-group-vertical>.btn-group:after,.nav:before,.nav:after,.navbar:before,.navbar:after,.navbar-header:before,.navbar-header:after,.navbar-collapse:before,.navbar-collapse:after,.pager:before,.pager:after,.panel-body:before,.panel-body:after,.modal-header:before,.modal-header:after,.modal-footer:before,.modal-footer:after{content:" ";display:table}.clearfix:after,.dl-horizontal dd:after,.container:after,.container-fluid:after,.row:after,.form-horizontal .form-group:after,.btn-toolbar:after,.btn-group-vertical>.btn-group:after,.nav:after,.navbar:after,.navbar-header:after,.navbar-collapse:after,.pager:after,.panel-body:after,.modal-header:after,.modal-footer:after{clear:both}.center-block{display:block;margin-left:auto;margin-right:auto}.pull-right{float:right !important}.pull-left{float:left !important}.hide{display:none !important}.show{display:block !important}.invisible{visibility:hidden}.text-hide{font:0/0 a;color:transparent;text-shadow:none;background-color:transparent;border:0}.hidden{display:none !important}.affix{position:fixed}@-ms-viewport{width:device-width}.visible-xs,.visible-sm,.visible-md,.visible-lg{display:none !important}.visible-xs-block,.visible-xs-inline,.visible-xs-inline-block,.visible-sm-block,.visible-sm-inline,.visible-sm-inline-block,.visible-md-block,.visible-md-inline,.visible-md-inline-block,.visible-lg-block,.visible-lg-inline,.visible-lg-inline-block{display:none !important}@media (max-width:767px){.visible-xs{display:block !important}table.visible-xs{display:table !important}tr.visible-xs{display:table-row !important}th.visible-xs,td.visible-xs{display:table-cell !important}}@media (max-width:767px){.visible-xs-block{display:block !important}}@media (max-width:767px){.visible-xs-inline{display:inline !important}}@media (max-width:767px){.visible-xs-inline-block{display:inline-block !important}}@media (min-width:768px) and (max-width:991px){.visible-sm{display:block !important}table.visible-sm{display:table !important}tr.visible-sm{display:table-row !important}th.visible-sm,td.visible-sm{display:table-cell !important}}@media (min-width:768px) and (max-width:991px){.visible-sm-block{display:block !important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline{display:inline !important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline-block{display:inline-block !important}}@media (min-width:992px) and (max-width:1199px){.visible-md{display:block !important}table.visible-md{display:table !important}tr.visible-md{display:table-row !important}th.visible-md,td.visible-md{display:table-cell !important}}@media (min-width:992px) and (max-width:1199px){.visible-md-block{display:block !important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline{display:inline !important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline-block{display:inline-block !important}}@media (min-width:1200px){.visible-lg{display:block !important}table.visible-lg{display:table !important}tr.visible-lg{display:table-row !important}th.visible-lg,td.visible-lg{display:table-cell !important}}@media (min-width:1200px){.visible-lg-block{display:block !important}}@media (min-width:1200px){.visible-lg-inline{display:inline !important}}@media (min-width:1200px){.visible-lg-inline-block{display:inline-block !important}}@media (max-width:767px){.hidden-xs{display:none !important}}@media (min-width:768px) and (max-width:991px){.hidden-sm{display:none !important}}@media (min-width:992px) and (max-width:1199px){.hidden-md{display:none !important}}@media (min-width:1200px){.hidden-lg{display:none !important}}.visible-print{display:none !important}@media print{.visible-print{display:block !important}table.visible-print{display:table !important}tr.visible-print{display:table-row !important}th.visible-print,td.visible-print{display:table-cell !important}}.visible-print-block{display:none !important}@media print{.visible-print-block{display:block !important}}.visible-print-inline{display:none !important}@media print{.visible-print-inline{display:inline !important}}.visible-print-inline-block{display:none !important}@media print{.visible-print-inline-block{display:inline-block !important}}@media print{.hidden-print{display:none !important}}.navbar{border:none;-webkit-box-shadow:0 1px 2px rgba(0,0,0,0.3);box-shadow:0 1px 2px rgba(0,0,0,0.3)}.navbar-brand{font-size:24px}.navbar-inverse .navbar-form input[type=text],.navbar-inverse .navbar-form input[type=password]{color:#fff;-webkit-box-shadow:inset 0 -1px 0 #b2dbfb;box-shadow:inset 0 -1px 0 #b2dbfb}.navbar-inverse .navbar-form input[type=text]::-moz-placeholder,.navbar-inverse .navbar-form input[type=password]::-moz-placeholder{color:#b2dbfb;opacity:1}.navbar-inverse .navbar-form input[type=text]:-ms-input-placeholder,.navbar-inverse .navbar-form input[type=password]:-ms-input-placeholder{color:#b2dbfb}.navbar-inverse .navbar-form input[type=text]::-webkit-input-placeholder,.navbar-inverse .navbar-form input[type=password]::-webkit-input-placeholder{color:#b2dbfb}.navbar-inverse .navbar-form input[type=text]:focus,.navbar-inverse .navbar-form input[type=password]:focus{-webkit-box-shadow:inset 0 -2px 0 #fff;box-shadow:inset 0 -2px 0 #fff}.btn-default{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-default:focus{background-color:#ffffff}.btn-default:hover,.btn-default:active:hover{background-color:#f0f0f0}.btn-default:active{background-color:#e0e0e0;background-image:-webkit-radial-gradient(circle, #e0e0e0 10%, #fff 11%);background-image:-o-radial-gradient(circle, #e0e0e0 10%, #fff 11%);background-image:radial-gradient(circle, #e0e0e0 10%, #fff 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn-primary{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-primary:focus{background-color:#2196f3}.btn-primary:hover,.btn-primary:active:hover{background-color:#0d87e9}.btn-primary:active{background-color:#0b76cc;background-image:-webkit-radial-gradient(circle, #0b76cc 10%, #2196f3 11%);background-image:-o-radial-gradient(circle, #0b76cc 10%, #2196f3 11%);background-image:radial-gradient(circle, #0b76cc 10%, #2196f3 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn-success{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-success:focus{background-color:#4caf50}.btn-success:hover,.btn-success:active:hover{background-color:#439a46}.btn-success:active{background-color:#39843c;background-image:-webkit-radial-gradient(circle, #39843c 10%, #4caf50 11%);background-image:-o-radial-gradient(circle, #39843c 10%, #4caf50 11%);background-image:radial-gradient(circle, #39843c 10%, #4caf50 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn-info{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-info:focus{background-color:#9c27b0}.btn-info:hover,.btn-info:active:hover{background-color:#862197}.btn-info:active{background-color:#701c7e;background-image:-webkit-radial-gradient(circle, #701c7e 10%, #9c27b0 11%);background-image:-o-radial-gradient(circle, #701c7e 10%, #9c27b0 11%);background-image:radial-gradient(circle, #701c7e 10%, #9c27b0 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn-warning{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-warning:focus{background-color:#ff9800}.btn-warning:hover,.btn-warning:active:hover{background-color:#e08600}.btn-warning:active{background-color:#c27400;background-image:-webkit-radial-gradient(circle, #c27400 10%, #ff9800 11%);background-image:-o-radial-gradient(circle, #c27400 10%, #ff9800 11%);background-image:radial-gradient(circle, #c27400 10%, #ff9800 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn-danger{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-danger:focus{background-color:#e51c23}.btn-danger:hover,.btn-danger:active:hover{background-color:#cb171e}.btn-danger:active{background-color:#b0141a;background-image:-webkit-radial-gradient(circle, #b0141a 10%, #e51c23 11%);background-image:-o-radial-gradient(circle, #b0141a 10%, #e51c23 11%);background-image:radial-gradient(circle, #b0141a 10%, #e51c23 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn-link{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-link:focus{background-color:#ffffff}.btn-link:hover,.btn-link:active:hover{background-color:#f0f0f0}.btn-link:active{background-color:#e0e0e0;background-image:-webkit-radial-gradient(circle, #e0e0e0 10%, #fff 11%);background-image:-o-radial-gradient(circle, #e0e0e0 10%, #fff 11%);background-image:radial-gradient(circle, #e0e0e0 10%, #fff 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn{text-transform:uppercase;border:none;-webkit-box-shadow:1px 1px 4px rgba(0,0,0,0.4);box-shadow:1px 1px 4px rgba(0,0,0,0.4);-webkit-transition:all 0.4s;-o-transition:all 0.4s;transition:all 0.4s}.btn-link{border-radius:3px;-webkit-box-shadow:none;box-shadow:none;color:#444444}.btn-link:hover,.btn-link:focus{-webkit-box-shadow:none;box-shadow:none;color:#444444;text-decoration:none}.btn-default.disabled{background-color:rgba(0,0,0,0.1);color:rgba(0,0,0,0.4);opacity:1}.btn-group .btn+.btn,.btn-group .btn+.btn-group,.btn-group .btn-group+.btn,.btn-group .btn-group+.btn-group{margin-left:0}.btn-group-vertical>.btn+.btn,.btn-group-vertical>.btn+.btn-group,.btn-group-vertical>.btn-group+.btn,.btn-group-vertical>.btn-group+.btn-group{margin-top:0}body{-webkit-font-smoothing:antialiased;letter-spacing:.1px}p{margin:0 0 1em}input,button{-webkit-font-smoothing:antialiased;letter-spacing:.1px}a{-webkit-transition:all 0.2s;-o-transition:all 0.2s;transition:all 0.2s}.table-hover>tbody>tr,.table-hover>tbody>tr>th,.table-hover>tbody>tr>td{-webkit-transition:all 0.2s;-o-transition:all 0.2s;transition:all 0.2s}label{font-weight:normal}textarea,textarea.form-control,input.form-control,input[type=text],input[type=password],input[type=email],input[type=number],[type=text].form-control,[type=password].form-control,[type=email].form-control,[type=tel].form-control,[contenteditable].form-control{padding:0;border:none;border-radius:0;-webkit-appearance:none;-webkit-box-shadow:inset 0 -1px 0 #ddd;box-shadow:inset 0 -1px 0 #ddd;font-size:16px}textarea:focus,textarea.form-control:focus,input.form-control:focus,input[type=text]:focus,input[type=password]:focus,input[type=email]:focus,input[type=number]:focus,[type=text].form-control:focus,[type=password].form-control:focus,[type=email].form-control:focus,[type=tel].form-control:focus,[contenteditable].form-control:focus{-webkit-box-shadow:inset 0 -2px 0 #2196f3;box-shadow:inset 0 -2px 0 #2196f3}textarea[disabled],textarea.form-control[disabled],input.form-control[disabled],input[type=text][disabled],input[type=password][disabled],input[type=email][disabled],input[type=number][disabled],[type=text].form-control[disabled],[type=password].form-control[disabled],[type=email].form-control[disabled],[type=tel].form-control[disabled],[contenteditable].form-control[disabled],textarea[readonly],textarea.form-control[readonly],input.form-control[readonly],input[type=text][readonly],input[type=password][readonly],input[type=email][readonly],input[type=number][readonly],[type=text].form-control[readonly],[type=password].form-control[readonly],[type=email].form-control[readonly],[type=tel].form-control[readonly],[contenteditable].form-control[readonly]{-webkit-box-shadow:none;box-shadow:none;border-bottom:1px dotted #ddd}textarea.input-sm,textarea.form-control.input-sm,input.form-control.input-sm,input[type=text].input-sm,input[type=password].input-sm,input[type=email].input-sm,input[type=number].input-sm,[type=text].form-control.input-sm,[type=password].form-control.input-sm,[type=email].form-control.input-sm,[type=tel].form-control.input-sm,[contenteditable].form-control.input-sm{font-size:12px}textarea.input-lg,textarea.form-control.input-lg,input.form-control.input-lg,input[type=text].input-lg,input[type=password].input-lg,input[type=email].input-lg,input[type=number].input-lg,[type=text].form-control.input-lg,[type=password].form-control.input-lg,[type=email].form-control.input-lg,[type=tel].form-control.input-lg,[contenteditable].form-control.input-lg{font-size:17px}select,select.form-control{border:0;border-radius:0;-webkit-appearance:none;-moz-appearance:none;appearance:none;padding-left:0;padding-right:0\9;background-image:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABoAAAAaCAMAAACelLz8AAAAJ1BMVEVmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmaP/QSjAAAADHRSTlMAAgMJC0uWpKa6wMxMdjkoAAAANUlEQVR4AeXJyQEAERAAsNl7Hf3X6xt0QL6JpZWq30pdvdadme+0PMdzvHm8YThHcT1H7K0BtOMDniZhWOgAAAAASUVORK5CYII=);-webkit-background-size:13px 13px;background-size:13px;background-repeat:no-repeat;background-position:right center;-webkit-box-shadow:inset 0 -1px 0 #ddd;box-shadow:inset 0 -1px 0 #ddd;font-size:16px;line-height:1.5}select::-ms-expand,select.form-control::-ms-expand{display:none}select.input-sm,select.form-control.input-sm{font-size:12px}select.input-lg,select.form-control.input-lg{font-size:17px}select:focus,select.form-control:focus{-webkit-box-shadow:inset 0 -2px 0 #2196f3;box-shadow:inset 0 -2px 0 #2196f3;background-image:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABoAAAAaCAMAAACelLz8AAAAJ1BMVEUhISEhISEhISEhISEhISEhISEhISEhISEhISEhISEhISEhISEhISF8S9ewAAAADHRSTlMAAgMJC0uWpKa6wMxMdjkoAAAANUlEQVR4AeXJyQEAERAAsNl7Hf3X6xt0QL6JpZWq30pdvdadme+0PMdzvHm8YThHcT1H7K0BtOMDniZhWOgAAAAASUVORK5CYII=)}select[multiple],select.form-control[multiple]{background:none}.radio label,.radio-inline label,.checkbox label,.checkbox-inline label{padding-left:25px}.radio input[type="radio"],.radio-inline input[type="radio"],.checkbox input[type="radio"],.checkbox-inline input[type="radio"],.radio input[type="checkbox"],.radio-inline input[type="checkbox"],.checkbox input[type="checkbox"],.checkbox-inline input[type="checkbox"]{margin-left:-25px}input[type="radio"],.radio input[type="radio"],.radio-inline input[type="radio"]{position:relative;margin-top:6px;margin-right:4px;vertical-align:top;border:none;background-color:transparent;-webkit-appearance:none;appearance:none;cursor:pointer}input[type="radio"]:focus,.radio input[type="radio"]:focus,.radio-inline input[type="radio"]:focus{outline:none}input[type="radio"]:before,.radio input[type="radio"]:before,.radio-inline input[type="radio"]:before,input[type="radio"]:after,.radio input[type="radio"]:after,.radio-inline input[type="radio"]:after{content:"";display:block;width:18px;height:18px;border-radius:50%;-webkit-transition:240ms;-o-transition:240ms;transition:240ms}input[type="radio"]:before,.radio input[type="radio"]:before,.radio-inline input[type="radio"]:before{position:absolute;left:0;top:-3px;background-color:#2196f3;-webkit-transform:scale(0);-ms-transform:scale(0);-o-transform:scale(0);transform:scale(0)}input[type="radio"]:after,.radio input[type="radio"]:after,.radio-inline input[type="radio"]:after{position:relative;top:-3px;border:2px solid #666666}input[type="radio"]:checked:before,.radio input[type="radio"]:checked:before,.radio-inline input[type="radio"]:checked:before{-webkit-transform:scale(.5);-ms-transform:scale(.5);-o-transform:scale(.5);transform:scale(.5)}input[type="radio"]:disabled:checked:before,.radio input[type="radio"]:disabled:checked:before,.radio-inline input[type="radio"]:disabled:checked:before{background-color:#bbbbbb}input[type="radio"]:checked:after,.radio input[type="radio"]:checked:after,.radio-inline input[type="radio"]:checked:after{border-color:#2196f3}input[type="radio"]:disabled:after,.radio input[type="radio"]:disabled:after,.radio-inline input[type="radio"]:disabled:after,input[type="radio"]:disabled:checked:after,.radio input[type="radio"]:disabled:checked:after,.radio-inline input[type="radio"]:disabled:checked:after{border-color:#bbbbbb}input[type="checkbox"],.checkbox input[type="checkbox"],.checkbox-inline input[type="checkbox"]{position:relative;border:none;margin-bottom:-4px;-webkit-appearance:none;appearance:none;cursor:pointer}input[type="checkbox"]:focus,.checkbox input[type="checkbox"]:focus,.checkbox-inline input[type="checkbox"]:focus{outline:none}input[type="checkbox"]:focus:after,.checkbox input[type="checkbox"]:focus:after,.checkbox-inline input[type="checkbox"]:focus:after{border-color:#2196f3}input[type="checkbox"]:after,.checkbox input[type="checkbox"]:after,.checkbox-inline input[type="checkbox"]:after{content:"";display:block;width:18px;height:18px;margin-top:-2px;margin-right:5px;border:2px solid #666666;border-radius:2px;-webkit-transition:240ms;-o-transition:240ms;transition:240ms}input[type="checkbox"]:checked:before,.checkbox input[type="checkbox"]:checked:before,.checkbox-inline input[type="checkbox"]:checked:before{content:"";position:absolute;top:0;left:6px;display:table;width:6px;height:12px;border:2px solid #fff;border-top-width:0;border-left-width:0;-webkit-transform:rotate(45deg);-ms-transform:rotate(45deg);-o-transform:rotate(45deg);transform:rotate(45deg)}input[type="checkbox"]:checked:after,.checkbox input[type="checkbox"]:checked:after,.checkbox-inline input[type="checkbox"]:checked:after{background-color:#2196f3;border-color:#2196f3}input[type="checkbox"]:disabled:after,.checkbox input[type="checkbox"]:disabled:after,.checkbox-inline input[type="checkbox"]:disabled:after{border-color:#bbbbbb}input[type="checkbox"]:disabled:checked:after,.checkbox input[type="checkbox"]:disabled:checked:after,.checkbox-inline input[type="checkbox"]:disabled:checked:after{background-color:#bbbbbb;border-color:transparent}.has-warning input:not([type=checkbox]),.has-warning .form-control,.has-warning input.form-control[readonly],.has-warning input[type=text][readonly],.has-warning [type=text].form-control[readonly],.has-warning input:not([type=checkbox]):focus,.has-warning .form-control:focus{border-bottom:none;-webkit-box-shadow:inset 0 -2px 0 #ff9800;box-shadow:inset 0 -2px 0 #ff9800}.has-error input:not([type=checkbox]),.has-error .form-control,.has-error input.form-control[readonly],.has-error input[type=text][readonly],.has-error [type=text].form-control[readonly],.has-error input:not([type=checkbox]):focus,.has-error .form-control:focus{border-bottom:none;-webkit-box-shadow:inset 0 -2px 0 #e51c23;box-shadow:inset 0 -2px 0 #e51c23}.has-success input:not([type=checkbox]),.has-success .form-control,.has-success input.form-control[readonly],.has-success input[type=text][readonly],.has-success [type=text].form-control[readonly],.has-success input:not([type=checkbox]):focus,.has-success .form-control:focus{border-bottom:none;-webkit-box-shadow:inset 0 -2px 0 #4caf50;box-shadow:inset 0 -2px 0 #4caf50}.has-warning .input-group-addon,.has-error .input-group-addon,.has-success .input-group-addon{color:#666666;border-color:transparent;background-color:transparent}.nav-tabs>li>a,.nav-tabs>li>a:focus{margin-right:0;background-color:transparent;border:none;color:#666666;-webkit-box-shadow:inset 0 -1px 0 #ddd;box-shadow:inset 0 -1px 0 #ddd;-webkit-transition:all 0.2s;-o-transition:all 0.2s;transition:all 0.2s}.nav-tabs>li>a:hover,.nav-tabs>li>a:focus:hover{background-color:transparent;-webkit-box-shadow:inset 0 -2px 0 #2196f3;box-shadow:inset 0 -2px 0 #2196f3;color:#2196f3}.nav-tabs>li.active>a,.nav-tabs>li.active>a:focus{border:none;-webkit-box-shadow:inset 0 -2px 0 #2196f3;box-shadow:inset 0 -2px 0 #2196f3;color:#2196f3}.nav-tabs>li.active>a:hover,.nav-tabs>li.active>a:focus:hover{border:none;color:#2196f3}.nav-tabs>li.disabled>a{-webkit-box-shadow:inset 0 -1px 0 #ddd;box-shadow:inset 0 -1px 0 #ddd}.nav-tabs.nav-justified>li>a,.nav-tabs.nav-justified>li>a:hover,.nav-tabs.nav-justified>li>a:focus,.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:hover,.nav-tabs.nav-justified>.active>a:focus{border:none}.nav-tabs .dropdown-menu{margin-top:0}.dropdown-menu{margin-top:0;border:none;-webkit-box-shadow:0 1px 4px rgba(0,0,0,0.3);box-shadow:0 1px 4px rgba(0,0,0,0.3)}.alert{border:none;color:#fff}.alert-success{background-color:#4caf50}.alert-info{background-color:#9c27b0}.alert-warning{background-color:#ff9800}.alert-danger{background-color:#e51c23}.alert a:not(.close),.alert .alert-link{color:#fff;font-weight:bold}.alert .close{color:#fff}.badge{padding:4px 6px 4px}.progress{position:relative;z-index:1;height:6px;border-radius:0;-webkit-box-shadow:none;box-shadow:none}.progress-bar{-webkit-box-shadow:none;box-shadow:none}.progress-bar:last-child{border-radius:0 3px 3px 0}.progress-bar:last-child:before{display:block;content:"";position:absolute;width:100%;height:100%;left:0;right:0;z-index:-1;background-color:#cae6fc}.progress-bar-success:last-child.progress-bar:before{background-color:#c7e7c8}.progress-bar-info:last-child.progress-bar:before{background-color:#edc9f3}.progress-bar-warning:last-child.progress-bar:before{background-color:#ffe0b3}.progress-bar-danger:last-child.progress-bar:before{background-color:#f28e92}.close{font-size:34px;font-weight:300;line-height:24px;opacity:0.6;-webkit-transition:all 0.2s;-o-transition:all 0.2s;transition:all 0.2s}.close:hover{opacity:1}.list-group-item{padding:15px}.list-group-item-text{color:#bbbbbb}.well{border-radius:0;-webkit-box-shadow:none;box-shadow:none}.panel{border:none;border-radius:2px;-webkit-box-shadow:0 1px 4px rgba(0,0,0,0.3);box-shadow:0 1px 4px rgba(0,0,0,0.3)}.panel-heading{border-bottom:none}.panel-footer{border-top:none}.popover{border:none;-webkit-box-shadow:0 1px 4px rgba(0,0,0,0.3);box-shadow:0 1px 4px rgba(0,0,0,0.3)}.carousel-caption h1,.carousel-caption h2,.carousel-caption h3,.carousel-caption h4,.carousel-caption h5,.carousel-caption h6{color:inherit}
</style>
<script>/*!
 * Bootstrap v3.3.5 (http://getbootstrap.com)
 * Copyright 2011-2015 Twitter, Inc.
 * Licensed under the MIT license
 */
if("undefined"==typeof jQuery)throw new Error("Bootstrap's JavaScript requires jQuery");+function(a){"use strict";var b=a.fn.jquery.split(" ")[0].split(".");if(b[0]<2&&b[1]<9||1==b[0]&&9==b[1]&&b[2]<1)throw new Error("Bootstrap's JavaScript requires jQuery version 1.9.1 or higher")}(jQuery),+function(a){"use strict";function b(){var a=document.createElement("bootstrap"),b={WebkitTransition:"webkitTransitionEnd",MozTransition:"transitionend",OTransition:"oTransitionEnd otransitionend",transition:"transitionend"};for(var c in b)if(void 0!==a.style[c])return{end:b[c]};return!1}a.fn.emulateTransitionEnd=function(b){var c=!1,d=this;a(this).one("bsTransitionEnd",function(){c=!0});var e=function(){c||a(d).trigger(a.support.transition.end)};return setTimeout(e,b),this},a(function(){a.support.transition=b(),a.support.transition&&(a.event.special.bsTransitionEnd={bindType:a.support.transition.end,delegateType:a.support.transition.end,handle:function(b){return a(b.target).is(this)?b.handleObj.handler.apply(this,arguments):void 0}})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var c=a(this),e=c.data("bs.alert");e||c.data("bs.alert",e=new d(this)),"string"==typeof b&&e[b].call(c)})}var c='[data-dismiss="alert"]',d=function(b){a(b).on("click",c,this.close)};d.VERSION="3.3.5",d.TRANSITION_DURATION=150,d.prototype.close=function(b){function c(){g.detach().trigger("closed.bs.alert").remove()}var e=a(this),f=e.attr("data-target");f||(f=e.attr("href"),f=f&&f.replace(/.*(?=#[^\s]*$)/,""));var g=a(f);b&&b.preventDefault(),g.length||(g=e.closest(".alert")),g.trigger(b=a.Event("close.bs.alert")),b.isDefaultPrevented()||(g.removeClass("in"),a.support.transition&&g.hasClass("fade")?g.one("bsTransitionEnd",c).emulateTransitionEnd(d.TRANSITION_DURATION):c())};var e=a.fn.alert;a.fn.alert=b,a.fn.alert.Constructor=d,a.fn.alert.noConflict=function(){return a.fn.alert=e,this},a(document).on("click.bs.alert.data-api",c,d.prototype.close)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.button"),f="object"==typeof b&&b;e||d.data("bs.button",e=new c(this,f)),"toggle"==b?e.toggle():b&&e.setState(b)})}var c=function(b,d){this.$element=a(b),this.options=a.extend({},c.DEFAULTS,d),this.isLoading=!1};c.VERSION="3.3.5",c.DEFAULTS={loadingText:"loading..."},c.prototype.setState=function(b){var c="disabled",d=this.$element,e=d.is("input")?"val":"html",f=d.data();b+="Text",null==f.resetText&&d.data("resetText",d[e]()),setTimeout(a.proxy(function(){d[e](null==f[b]?this.options[b]:f[b]),"loadingText"==b?(this.isLoading=!0,d.addClass(c).attr(c,c)):this.isLoading&&(this.isLoading=!1,d.removeClass(c).removeAttr(c))},this),0)},c.prototype.toggle=function(){var a=!0,b=this.$element.closest('[data-toggle="buttons"]');if(b.length){var c=this.$element.find("input");"radio"==c.prop("type")?(c.prop("checked")&&(a=!1),b.find(".active").removeClass("active"),this.$element.addClass("active")):"checkbox"==c.prop("type")&&(c.prop("checked")!==this.$element.hasClass("active")&&(a=!1),this.$element.toggleClass("active")),c.prop("checked",this.$element.hasClass("active")),a&&c.trigger("change")}else this.$element.attr("aria-pressed",!this.$element.hasClass("active")),this.$element.toggleClass("active")};var d=a.fn.button;a.fn.button=b,a.fn.button.Constructor=c,a.fn.button.noConflict=function(){return a.fn.button=d,this},a(document).on("click.bs.button.data-api",'[data-toggle^="button"]',function(c){var d=a(c.target);d.hasClass("btn")||(d=d.closest(".btn")),b.call(d,"toggle"),a(c.target).is('input[type="radio"]')||a(c.target).is('input[type="checkbox"]')||c.preventDefault()}).on("focus.bs.button.data-api blur.bs.button.data-api",'[data-toggle^="button"]',function(b){a(b.target).closest(".btn").toggleClass("focus",/^focus(in)?$/.test(b.type))})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.carousel"),f=a.extend({},c.DEFAULTS,d.data(),"object"==typeof b&&b),g="string"==typeof b?b:f.slide;e||d.data("bs.carousel",e=new c(this,f)),"number"==typeof b?e.to(b):g?e[g]():f.interval&&e.pause().cycle()})}var c=function(b,c){this.$element=a(b),this.$indicators=this.$element.find(".carousel-indicators"),this.options=c,this.paused=null,this.sliding=null,this.interval=null,this.$active=null,this.$items=null,this.options.keyboard&&this.$element.on("keydown.bs.carousel",a.proxy(this.keydown,this)),"hover"==this.options.pause&&!("ontouchstart"in document.documentElement)&&this.$element.on("mouseenter.bs.carousel",a.proxy(this.pause,this)).on("mouseleave.bs.carousel",a.proxy(this.cycle,this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=600,c.DEFAULTS={interval:5e3,pause:"hover",wrap:!0,keyboard:!0},c.prototype.keydown=function(a){if(!/input|textarea/i.test(a.target.tagName)){switch(a.which){case 37:this.prev();break;case 39:this.next();break;default:return}a.preventDefault()}},c.prototype.cycle=function(b){return b||(this.paused=!1),this.interval&&clearInterval(this.interval),this.options.interval&&!this.paused&&(this.interval=setInterval(a.proxy(this.next,this),this.options.interval)),this},c.prototype.getItemIndex=function(a){return this.$items=a.parent().children(".item"),this.$items.index(a||this.$active)},c.prototype.getItemForDirection=function(a,b){var c=this.getItemIndex(b),d="prev"==a&&0===c||"next"==a&&c==this.$items.length-1;if(d&&!this.options.wrap)return b;var e="prev"==a?-1:1,f=(c+e)%this.$items.length;return this.$items.eq(f)},c.prototype.to=function(a){var b=this,c=this.getItemIndex(this.$active=this.$element.find(".item.active"));return a>this.$items.length-1||0>a?void 0:this.sliding?this.$element.one("slid.bs.carousel",function(){b.to(a)}):c==a?this.pause().cycle():this.slide(a>c?"next":"prev",this.$items.eq(a))},c.prototype.pause=function(b){return b||(this.paused=!0),this.$element.find(".next, .prev").length&&a.support.transition&&(this.$element.trigger(a.support.transition.end),this.cycle(!0)),this.interval=clearInterval(this.interval),this},c.prototype.next=function(){return this.sliding?void 0:this.slide("next")},c.prototype.prev=function(){return this.sliding?void 0:this.slide("prev")},c.prototype.slide=function(b,d){var e=this.$element.find(".item.active"),f=d||this.getItemForDirection(b,e),g=this.interval,h="next"==b?"left":"right",i=this;if(f.hasClass("active"))return this.sliding=!1;var j=f[0],k=a.Event("slide.bs.carousel",{relatedTarget:j,direction:h});if(this.$element.trigger(k),!k.isDefaultPrevented()){if(this.sliding=!0,g&&this.pause(),this.$indicators.length){this.$indicators.find(".active").removeClass("active");var l=a(this.$indicators.children()[this.getItemIndex(f)]);l&&l.addClass("active")}var m=a.Event("slid.bs.carousel",{relatedTarget:j,direction:h});return a.support.transition&&this.$element.hasClass("slide")?(f.addClass(b),f[0].offsetWidth,e.addClass(h),f.addClass(h),e.one("bsTransitionEnd",function(){f.removeClass([b,h].join(" ")).addClass("active"),e.removeClass(["active",h].join(" ")),i.sliding=!1,setTimeout(function(){i.$element.trigger(m)},0)}).emulateTransitionEnd(c.TRANSITION_DURATION)):(e.removeClass("active"),f.addClass("active"),this.sliding=!1,this.$element.trigger(m)),g&&this.cycle(),this}};var d=a.fn.carousel;a.fn.carousel=b,a.fn.carousel.Constructor=c,a.fn.carousel.noConflict=function(){return a.fn.carousel=d,this};var e=function(c){var d,e=a(this),f=a(e.attr("data-target")||(d=e.attr("href"))&&d.replace(/.*(?=#[^\s]+$)/,""));if(f.hasClass("carousel")){var g=a.extend({},f.data(),e.data()),h=e.attr("data-slide-to");h&&(g.interval=!1),b.call(f,g),h&&f.data("bs.carousel").to(h),c.preventDefault()}};a(document).on("click.bs.carousel.data-api","[data-slide]",e).on("click.bs.carousel.data-api","[data-slide-to]",e),a(window).on("load",function(){a('[data-ride="carousel"]').each(function(){var c=a(this);b.call(c,c.data())})})}(jQuery),+function(a){"use strict";function b(b){var c,d=b.attr("data-target")||(c=b.attr("href"))&&c.replace(/.*(?=#[^\s]+$)/,"");return a(d)}function c(b){return this.each(function(){var c=a(this),e=c.data("bs.collapse"),f=a.extend({},d.DEFAULTS,c.data(),"object"==typeof b&&b);!e&&f.toggle&&/show|hide/.test(b)&&(f.toggle=!1),e||c.data("bs.collapse",e=new d(this,f)),"string"==typeof b&&e[b]()})}var d=function(b,c){this.$element=a(b),this.options=a.extend({},d.DEFAULTS,c),this.$trigger=a('[data-toggle="collapse"][href="#'+b.id+'"],[data-toggle="collapse"][data-target="#'+b.id+'"]'),this.transitioning=null,this.options.parent?this.$parent=this.getParent():this.addAriaAndCollapsedClass(this.$element,this.$trigger),this.options.toggle&&this.toggle()};d.VERSION="3.3.5",d.TRANSITION_DURATION=350,d.DEFAULTS={toggle:!0},d.prototype.dimension=function(){var a=this.$element.hasClass("width");return a?"width":"height"},d.prototype.show=function(){if(!this.transitioning&&!this.$element.hasClass("in")){var b,e=this.$parent&&this.$parent.children(".panel").children(".in, .collapsing");if(!(e&&e.length&&(b=e.data("bs.collapse"),b&&b.transitioning))){var f=a.Event("show.bs.collapse");if(this.$element.trigger(f),!f.isDefaultPrevented()){e&&e.length&&(c.call(e,"hide"),b||e.data("bs.collapse",null));var g=this.dimension();this.$element.removeClass("collapse").addClass("collapsing")[g](0).attr("aria-expanded",!0),this.$trigger.removeClass("collapsed").attr("aria-expanded",!0),this.transitioning=1;var h=function(){this.$element.removeClass("collapsing").addClass("collapse in")[g](""),this.transitioning=0,this.$element.trigger("shown.bs.collapse")};if(!a.support.transition)return h.call(this);var i=a.camelCase(["scroll",g].join("-"));this.$element.one("bsTransitionEnd",a.proxy(h,this)).emulateTransitionEnd(d.TRANSITION_DURATION)[g](this.$element[0][i])}}}},d.prototype.hide=function(){if(!this.transitioning&&this.$element.hasClass("in")){var b=a.Event("hide.bs.collapse");if(this.$element.trigger(b),!b.isDefaultPrevented()){var c=this.dimension();this.$element[c](this.$element[c]())[0].offsetHeight,this.$element.addClass("collapsing").removeClass("collapse in").attr("aria-expanded",!1),this.$trigger.addClass("collapsed").attr("aria-expanded",!1),this.transitioning=1;var e=function(){this.transitioning=0,this.$element.removeClass("collapsing").addClass("collapse").trigger("hidden.bs.collapse")};return a.support.transition?void this.$element[c](0).one("bsTransitionEnd",a.proxy(e,this)).emulateTransitionEnd(d.TRANSITION_DURATION):e.call(this)}}},d.prototype.toggle=function(){this[this.$element.hasClass("in")?"hide":"show"]()},d.prototype.getParent=function(){return a(this.options.parent).find('[data-toggle="collapse"][data-parent="'+this.options.parent+'"]').each(a.proxy(function(c,d){var e=a(d);this.addAriaAndCollapsedClass(b(e),e)},this)).end()},d.prototype.addAriaAndCollapsedClass=function(a,b){var c=a.hasClass("in");a.attr("aria-expanded",c),b.toggleClass("collapsed",!c).attr("aria-expanded",c)};var e=a.fn.collapse;a.fn.collapse=c,a.fn.collapse.Constructor=d,a.fn.collapse.noConflict=function(){return a.fn.collapse=e,this},a(document).on("click.bs.collapse.data-api",'[data-toggle="collapse"]',function(d){var e=a(this);e.attr("data-target")||d.preventDefault();var f=b(e),g=f.data("bs.collapse"),h=g?"toggle":e.data();c.call(f,h)})}(jQuery),+function(a){"use strict";function b(b){var c=b.attr("data-target");c||(c=b.attr("href"),c=c&&/#[A-Za-z]/.test(c)&&c.replace(/.*(?=#[^\s]*$)/,""));var d=c&&a(c);return d&&d.length?d:b.parent()}function c(c){c&&3===c.which||(a(e).remove(),a(f).each(function(){var d=a(this),e=b(d),f={relatedTarget:this};e.hasClass("open")&&(c&&"click"==c.type&&/input|textarea/i.test(c.target.tagName)&&a.contains(e[0],c.target)||(e.trigger(c=a.Event("hide.bs.dropdown",f)),c.isDefaultPrevented()||(d.attr("aria-expanded","false"),e.removeClass("open").trigger("hidden.bs.dropdown",f))))}))}function d(b){return this.each(function(){var c=a(this),d=c.data("bs.dropdown");d||c.data("bs.dropdown",d=new g(this)),"string"==typeof b&&d[b].call(c)})}var e=".dropdown-backdrop",f='[data-toggle="dropdown"]',g=function(b){a(b).on("click.bs.dropdown",this.toggle)};g.VERSION="3.3.5",g.prototype.toggle=function(d){var e=a(this);if(!e.is(".disabled, :disabled")){var f=b(e),g=f.hasClass("open");if(c(),!g){"ontouchstart"in document.documentElement&&!f.closest(".navbar-nav").length&&a(document.createElement("div")).addClass("dropdown-backdrop").insertAfter(a(this)).on("click",c);var h={relatedTarget:this};if(f.trigger(d=a.Event("show.bs.dropdown",h)),d.isDefaultPrevented())return;e.trigger("focus").attr("aria-expanded","true"),f.toggleClass("open").trigger("shown.bs.dropdown",h)}return!1}},g.prototype.keydown=function(c){if(/(38|40|27|32)/.test(c.which)&&!/input|textarea/i.test(c.target.tagName)){var d=a(this);if(c.preventDefault(),c.stopPropagation(),!d.is(".disabled, :disabled")){var e=b(d),g=e.hasClass("open");if(!g&&27!=c.which||g&&27==c.which)return 27==c.which&&e.find(f).trigger("focus"),d.trigger("click");var h=" li:not(.disabled):visible a",i=e.find(".dropdown-menu"+h);if(i.length){var j=i.index(c.target);38==c.which&&j>0&&j--,40==c.which&&j<i.length-1&&j++,~j||(j=0),i.eq(j).trigger("focus")}}}};var h=a.fn.dropdown;a.fn.dropdown=d,a.fn.dropdown.Constructor=g,a.fn.dropdown.noConflict=function(){return a.fn.dropdown=h,this},a(document).on("click.bs.dropdown.data-api",c).on("click.bs.dropdown.data-api",".dropdown form",function(a){a.stopPropagation()}).on("click.bs.dropdown.data-api",f,g.prototype.toggle).on("keydown.bs.dropdown.data-api",f,g.prototype.keydown).on("keydown.bs.dropdown.data-api",".dropdown-menu",g.prototype.keydown)}(jQuery),+function(a){"use strict";function b(b,d){return this.each(function(){var e=a(this),f=e.data("bs.modal"),g=a.extend({},c.DEFAULTS,e.data(),"object"==typeof b&&b);f||e.data("bs.modal",f=new c(this,g)),"string"==typeof b?f[b](d):g.show&&f.show(d)})}var c=function(b,c){this.options=c,this.$body=a(document.body),this.$element=a(b),this.$dialog=this.$element.find(".modal-dialog"),this.$backdrop=null,this.isShown=null,this.originalBodyPad=null,this.scrollbarWidth=0,this.ignoreBackdropClick=!1,this.options.remote&&this.$element.find(".modal-content").load(this.options.remote,a.proxy(function(){this.$element.trigger("loaded.bs.modal")},this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=300,c.BACKDROP_TRANSITION_DURATION=150,c.DEFAULTS={backdrop:!0,keyboard:!0,show:!0},c.prototype.toggle=function(a){return this.isShown?this.hide():this.show(a)},c.prototype.show=function(b){var d=this,e=a.Event("show.bs.modal",{relatedTarget:b});this.$element.trigger(e),this.isShown||e.isDefaultPrevented()||(this.isShown=!0,this.checkScrollbar(),this.setScrollbar(),this.$body.addClass("modal-open"),this.escape(),this.resize(),this.$element.on("click.dismiss.bs.modal",'[data-dismiss="modal"]',a.proxy(this.hide,this)),this.$dialog.on("mousedown.dismiss.bs.modal",function(){d.$element.one("mouseup.dismiss.bs.modal",function(b){a(b.target).is(d.$element)&&(d.ignoreBackdropClick=!0)})}),this.backdrop(function(){var e=a.support.transition&&d.$element.hasClass("fade");d.$element.parent().length||d.$element.appendTo(d.$body),d.$element.show().scrollTop(0),d.adjustDialog(),e&&d.$element[0].offsetWidth,d.$element.addClass("in"),d.enforceFocus();var f=a.Event("shown.bs.modal",{relatedTarget:b});e?d.$dialog.one("bsTransitionEnd",function(){d.$element.trigger("focus").trigger(f)}).emulateTransitionEnd(c.TRANSITION_DURATION):d.$element.trigger("focus").trigger(f)}))},c.prototype.hide=function(b){b&&b.preventDefault(),b=a.Event("hide.bs.modal"),this.$element.trigger(b),this.isShown&&!b.isDefaultPrevented()&&(this.isShown=!1,this.escape(),this.resize(),a(document).off("focusin.bs.modal"),this.$element.removeClass("in").off("click.dismiss.bs.modal").off("mouseup.dismiss.bs.modal"),this.$dialog.off("mousedown.dismiss.bs.modal"),a.support.transition&&this.$element.hasClass("fade")?this.$element.one("bsTransitionEnd",a.proxy(this.hideModal,this)).emulateTransitionEnd(c.TRANSITION_DURATION):this.hideModal())},c.prototype.enforceFocus=function(){a(document).off("focusin.bs.modal").on("focusin.bs.modal",a.proxy(function(a){this.$element[0]===a.target||this.$element.has(a.target).length||this.$element.trigger("focus")},this))},c.prototype.escape=function(){this.isShown&&this.options.keyboard?this.$element.on("keydown.dismiss.bs.modal",a.proxy(function(a){27==a.which&&this.hide()},this)):this.isShown||this.$element.off("keydown.dismiss.bs.modal")},c.prototype.resize=function(){this.isShown?a(window).on("resize.bs.modal",a.proxy(this.handleUpdate,this)):a(window).off("resize.bs.modal")},c.prototype.hideModal=function(){var a=this;this.$element.hide(),this.backdrop(function(){a.$body.removeClass("modal-open"),a.resetAdjustments(),a.resetScrollbar(),a.$element.trigger("hidden.bs.modal")})},c.prototype.removeBackdrop=function(){this.$backdrop&&this.$backdrop.remove(),this.$backdrop=null},c.prototype.backdrop=function(b){var d=this,e=this.$element.hasClass("fade")?"fade":"";if(this.isShown&&this.options.backdrop){var f=a.support.transition&&e;if(this.$backdrop=a(document.createElement("div")).addClass("modal-backdrop "+e).appendTo(this.$body),this.$element.on("click.dismiss.bs.modal",a.proxy(function(a){return this.ignoreBackdropClick?void(this.ignoreBackdropClick=!1):void(a.target===a.currentTarget&&("static"==this.options.backdrop?this.$element[0].focus():this.hide()))},this)),f&&this.$backdrop[0].offsetWidth,this.$backdrop.addClass("in"),!b)return;f?this.$backdrop.one("bsTransitionEnd",b).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):b()}else if(!this.isShown&&this.$backdrop){this.$backdrop.removeClass("in");var g=function(){d.removeBackdrop(),b&&b()};a.support.transition&&this.$element.hasClass("fade")?this.$backdrop.one("bsTransitionEnd",g).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):g()}else b&&b()},c.prototype.handleUpdate=function(){this.adjustDialog()},c.prototype.adjustDialog=function(){var a=this.$element[0].scrollHeight>document.documentElement.clientHeight;this.$element.css({paddingLeft:!this.bodyIsOverflowing&&a?this.scrollbarWidth:"",paddingRight:this.bodyIsOverflowing&&!a?this.scrollbarWidth:""})},c.prototype.resetAdjustments=function(){this.$element.css({paddingLeft:"",paddingRight:""})},c.prototype.checkScrollbar=function(){var a=window.innerWidth;if(!a){var b=document.documentElement.getBoundingClientRect();a=b.right-Math.abs(b.left)}this.bodyIsOverflowing=document.body.clientWidth<a,this.scrollbarWidth=this.measureScrollbar()},c.prototype.setScrollbar=function(){var a=parseInt(this.$body.css("padding-right")||0,10);this.originalBodyPad=document.body.style.paddingRight||"",this.bodyIsOverflowing&&this.$body.css("padding-right",a+this.scrollbarWidth)},c.prototype.resetScrollbar=function(){this.$body.css("padding-right",this.originalBodyPad)},c.prototype.measureScrollbar=function(){var a=document.createElement("div");a.className="modal-scrollbar-measure",this.$body.append(a);var b=a.offsetWidth-a.clientWidth;return this.$body[0].removeChild(a),b};var d=a.fn.modal;a.fn.modal=b,a.fn.modal.Constructor=c,a.fn.modal.noConflict=function(){return a.fn.modal=d,this},a(document).on("click.bs.modal.data-api",'[data-toggle="modal"]',function(c){var d=a(this),e=d.attr("href"),f=a(d.attr("data-target")||e&&e.replace(/.*(?=#[^\s]+$)/,"")),g=f.data("bs.modal")?"toggle":a.extend({remote:!/#/.test(e)&&e},f.data(),d.data());d.is("a")&&c.preventDefault(),f.one("show.bs.modal",function(a){a.isDefaultPrevented()||f.one("hidden.bs.modal",function(){d.is(":visible")&&d.trigger("focus")})}),b.call(f,g,this)})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tooltip"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.tooltip",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.type=null,this.options=null,this.enabled=null,this.timeout=null,this.hoverState=null,this.$element=null,this.inState=null,this.init("tooltip",a,b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.DEFAULTS={animation:!0,placement:"top",selector:!1,template:'<div class="tooltip" role="tooltip"><div class="tooltip-arrow"></div><div class="tooltip-inner"></div></div>',trigger:"hover focus",title:"",delay:0,html:!1,container:!1,viewport:{selector:"body",padding:0}},c.prototype.init=function(b,c,d){if(this.enabled=!0,this.type=b,this.$element=a(c),this.options=this.getOptions(d),this.$viewport=this.options.viewport&&a(a.isFunction(this.options.viewport)?this.options.viewport.call(this,this.$element):this.options.viewport.selector||this.options.viewport),this.inState={click:!1,hover:!1,focus:!1},this.$element[0]instanceof document.constructor&&!this.options.selector)throw new Error("`selector` option must be specified when initializing "+this.type+" on the window.document object!");for(var e=this.options.trigger.split(" "),f=e.length;f--;){var g=e[f];if("click"==g)this.$element.on("click."+this.type,this.options.selector,a.proxy(this.toggle,this));else if("manual"!=g){var h="hover"==g?"mouseenter":"focusin",i="hover"==g?"mouseleave":"focusout";this.$element.on(h+"."+this.type,this.options.selector,a.proxy(this.enter,this)),this.$element.on(i+"."+this.type,this.options.selector,a.proxy(this.leave,this))}}this.options.selector?this._options=a.extend({},this.options,{trigger:"manual",selector:""}):this.fixTitle()},c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.getOptions=function(b){return b=a.extend({},this.getDefaults(),this.$element.data(),b),b.delay&&"number"==typeof b.delay&&(b.delay={show:b.delay,hide:b.delay}),b},c.prototype.getDelegateOptions=function(){var b={},c=this.getDefaults();return this._options&&a.each(this._options,function(a,d){c[a]!=d&&(b[a]=d)}),b},c.prototype.enter=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusin"==b.type?"focus":"hover"]=!0),c.tip().hasClass("in")||"in"==c.hoverState?void(c.hoverState="in"):(clearTimeout(c.timeout),c.hoverState="in",c.options.delay&&c.options.delay.show?void(c.timeout=setTimeout(function(){"in"==c.hoverState&&c.show()},c.options.delay.show)):c.show())},c.prototype.isInStateTrue=function(){for(var a in this.inState)if(this.inState[a])return!0;return!1},c.prototype.leave=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusout"==b.type?"focus":"hover"]=!1),c.isInStateTrue()?void 0:(clearTimeout(c.timeout),c.hoverState="out",c.options.delay&&c.options.delay.hide?void(c.timeout=setTimeout(function(){"out"==c.hoverState&&c.hide()},c.options.delay.hide)):c.hide())},c.prototype.show=function(){var b=a.Event("show.bs."+this.type);if(this.hasContent()&&this.enabled){this.$element.trigger(b);var d=a.contains(this.$element[0].ownerDocument.documentElement,this.$element[0]);if(b.isDefaultPrevented()||!d)return;var e=this,f=this.tip(),g=this.getUID(this.type);this.setContent(),f.attr("id",g),this.$element.attr("aria-describedby",g),this.options.animation&&f.addClass("fade");var h="function"==typeof this.options.placement?this.options.placement.call(this,f[0],this.$element[0]):this.options.placement,i=/\s?auto?\s?/i,j=i.test(h);j&&(h=h.replace(i,"")||"top"),f.detach().css({top:0,left:0,display:"block"}).addClass(h).data("bs."+this.type,this),this.options.container?f.appendTo(this.options.container):f.insertAfter(this.$element),this.$element.trigger("inserted.bs."+this.type);var k=this.getPosition(),l=f[0].offsetWidth,m=f[0].offsetHeight;if(j){var n=h,o=this.getPosition(this.$viewport);h="bottom"==h&&k.bottom+m>o.bottom?"top":"top"==h&&k.top-m<o.top?"bottom":"right"==h&&k.right+l>o.width?"left":"left"==h&&k.left-l<o.left?"right":h,f.removeClass(n).addClass(h)}var p=this.getCalculatedOffset(h,k,l,m);this.applyPlacement(p,h);var q=function(){var a=e.hoverState;e.$element.trigger("shown.bs."+e.type),e.hoverState=null,"out"==a&&e.leave(e)};a.support.transition&&this.$tip.hasClass("fade")?f.one("bsTransitionEnd",q).emulateTransitionEnd(c.TRANSITION_DURATION):q()}},c.prototype.applyPlacement=function(b,c){var d=this.tip(),e=d[0].offsetWidth,f=d[0].offsetHeight,g=parseInt(d.css("margin-top"),10),h=parseInt(d.css("margin-left"),10);isNaN(g)&&(g=0),isNaN(h)&&(h=0),b.top+=g,b.left+=h,a.offset.setOffset(d[0],a.extend({using:function(a){d.css({top:Math.round(a.top),left:Math.round(a.left)})}},b),0),d.addClass("in");var i=d[0].offsetWidth,j=d[0].offsetHeight;"top"==c&&j!=f&&(b.top=b.top+f-j);var k=this.getViewportAdjustedDelta(c,b,i,j);k.left?b.left+=k.left:b.top+=k.top;var l=/top|bottom/.test(c),m=l?2*k.left-e+i:2*k.top-f+j,n=l?"offsetWidth":"offsetHeight";d.offset(b),this.replaceArrow(m,d[0][n],l)},c.prototype.replaceArrow=function(a,b,c){this.arrow().css(c?"left":"top",50*(1-a/b)+"%").css(c?"top":"left","")},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle();a.find(".tooltip-inner")[this.options.html?"html":"text"](b),a.removeClass("fade in top bottom left right")},c.prototype.hide=function(b){function d(){"in"!=e.hoverState&&f.detach(),e.$element.removeAttr("aria-describedby").trigger("hidden.bs."+e.type),b&&b()}var e=this,f=a(this.$tip),g=a.Event("hide.bs."+this.type);return this.$element.trigger(g),g.isDefaultPrevented()?void 0:(f.removeClass("in"),a.support.transition&&f.hasClass("fade")?f.one("bsTransitionEnd",d).emulateTransitionEnd(c.TRANSITION_DURATION):d(),this.hoverState=null,this)},c.prototype.fixTitle=function(){var a=this.$element;(a.attr("title")||"string"!=typeof a.attr("data-original-title"))&&a.attr("data-original-title",a.attr("title")||"").attr("title","")},c.prototype.hasContent=function(){return this.getTitle()},c.prototype.getPosition=function(b){b=b||this.$element;var c=b[0],d="BODY"==c.tagName,e=c.getBoundingClientRect();null==e.width&&(e=a.extend({},e,{width:e.right-e.left,height:e.bottom-e.top}));var f=d?{top:0,left:0}:b.offset(),g={scroll:d?document.documentElement.scrollTop||document.body.scrollTop:b.scrollTop()},h=d?{width:a(window).width(),height:a(window).height()}:null;return a.extend({},e,g,h,f)},c.prototype.getCalculatedOffset=function(a,b,c,d){return"bottom"==a?{top:b.top+b.height,left:b.left+b.width/2-c/2}:"top"==a?{top:b.top-d,left:b.left+b.width/2-c/2}:"left"==a?{top:b.top+b.height/2-d/2,left:b.left-c}:{top:b.top+b.height/2-d/2,left:b.left+b.width}},c.prototype.getViewportAdjustedDelta=function(a,b,c,d){var e={top:0,left:0};if(!this.$viewport)return e;var f=this.options.viewport&&this.options.viewport.padding||0,g=this.getPosition(this.$viewport);if(/right|left/.test(a)){var h=b.top-f-g.scroll,i=b.top+f-g.scroll+d;h<g.top?e.top=g.top-h:i>g.top+g.height&&(e.top=g.top+g.height-i)}else{var j=b.left-f,k=b.left+f+c;j<g.left?e.left=g.left-j:k>g.right&&(e.left=g.left+g.width-k)}return e},c.prototype.getTitle=function(){var a,b=this.$element,c=this.options;return a=b.attr("data-original-title")||("function"==typeof c.title?c.title.call(b[0]):c.title)},c.prototype.getUID=function(a){do a+=~~(1e6*Math.random());while(document.getElementById(a));return a},c.prototype.tip=function(){if(!this.$tip&&(this.$tip=a(this.options.template),1!=this.$tip.length))throw new Error(this.type+" `template` option must consist of exactly 1 top-level element!");return this.$tip},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".tooltip-arrow")},c.prototype.enable=function(){this.enabled=!0},c.prototype.disable=function(){this.enabled=!1},c.prototype.toggleEnabled=function(){this.enabled=!this.enabled},c.prototype.toggle=function(b){var c=this;b&&(c=a(b.currentTarget).data("bs."+this.type),c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c))),b?(c.inState.click=!c.inState.click,c.isInStateTrue()?c.enter(c):c.leave(c)):c.tip().hasClass("in")?c.leave(c):c.enter(c)},c.prototype.destroy=function(){var a=this;clearTimeout(this.timeout),this.hide(function(){a.$element.off("."+a.type).removeData("bs."+a.type),a.$tip&&a.$tip.detach(),a.$tip=null,a.$arrow=null,a.$viewport=null})};var d=a.fn.tooltip;a.fn.tooltip=b,a.fn.tooltip.Constructor=c,a.fn.tooltip.noConflict=function(){return a.fn.tooltip=d,this}}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.popover"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.popover",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.init("popover",a,b)};if(!a.fn.tooltip)throw new Error("Popover requires tooltip.js");c.VERSION="3.3.5",c.DEFAULTS=a.extend({},a.fn.tooltip.Constructor.DEFAULTS,{placement:"right",trigger:"click",content:"",template:'<div class="popover" role="tooltip"><div class="arrow"></div><h3 class="popover-title"></h3><div class="popover-content"></div></div>'}),c.prototype=a.extend({},a.fn.tooltip.Constructor.prototype),c.prototype.constructor=c,c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle(),c=this.getContent();a.find(".popover-title")[this.options.html?"html":"text"](b),a.find(".popover-content").children().detach().end()[this.options.html?"string"==typeof c?"html":"append":"text"](c),a.removeClass("fade top bottom left right in"),a.find(".popover-title").html()||a.find(".popover-title").hide()},c.prototype.hasContent=function(){return this.getTitle()||this.getContent()},c.prototype.getContent=function(){var a=this.$element,b=this.options;return a.attr("data-content")||("function"==typeof b.content?b.content.call(a[0]):b.content)},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".arrow")};var d=a.fn.popover;a.fn.popover=b,a.fn.popover.Constructor=c,a.fn.popover.noConflict=function(){return a.fn.popover=d,this}}(jQuery),+function(a){"use strict";function b(c,d){this.$body=a(document.body),this.$scrollElement=a(a(c).is(document.body)?window:c),this.options=a.extend({},b.DEFAULTS,d),this.selector=(this.options.target||"")+" .nav li > a",this.offsets=[],this.targets=[],this.activeTarget=null,this.scrollHeight=0,this.$scrollElement.on("scroll.bs.scrollspy",a.proxy(this.process,this)),this.refresh(),this.process()}function c(c){return this.each(function(){var d=a(this),e=d.data("bs.scrollspy"),f="object"==typeof c&&c;e||d.data("bs.scrollspy",e=new b(this,f)),"string"==typeof c&&e[c]()})}b.VERSION="3.3.5",b.DEFAULTS={offset:10},b.prototype.getScrollHeight=function(){return this.$scrollElement[0].scrollHeight||Math.max(this.$body[0].scrollHeight,document.documentElement.scrollHeight)},b.prototype.refresh=function(){var b=this,c="offset",d=0;this.offsets=[],this.targets=[],this.scrollHeight=this.getScrollHeight(),a.isWindow(this.$scrollElement[0])||(c="position",d=this.$scrollElement.scrollTop()),this.$body.find(this.selector).map(function(){var b=a(this),e=b.data("target")||b.attr("href"),f=/^#./.test(e)&&a(e);return f&&f.length&&f.is(":visible")&&[[f[c]().top+d,e]]||null}).sort(function(a,b){return a[0]-b[0]}).each(function(){b.offsets.push(this[0]),b.targets.push(this[1])})},b.prototype.process=function(){var a,b=this.$scrollElement.scrollTop()+this.options.offset,c=this.getScrollHeight(),d=this.options.offset+c-this.$scrollElement.height(),e=this.offsets,f=this.targets,g=this.activeTarget;if(this.scrollHeight!=c&&this.refresh(),b>=d)return g!=(a=f[f.length-1])&&this.activate(a);if(g&&b<e[0])return this.activeTarget=null,this.clear();for(a=e.length;a--;)g!=f[a]&&b>=e[a]&&(void 0===e[a+1]||b<e[a+1])&&this.activate(f[a])},b.prototype.activate=function(b){this.activeTarget=b,this.clear();var c=this.selector+'[data-target="'+b+'"],'+this.selector+'[href="'+b+'"]',d=a(c).parents("li").addClass("active");d.parent(".dropdown-menu").length&&(d=d.closest("li.dropdown").addClass("active")),
d.trigger("activate.bs.scrollspy")},b.prototype.clear=function(){a(this.selector).parentsUntil(this.options.target,".active").removeClass("active")};var d=a.fn.scrollspy;a.fn.scrollspy=c,a.fn.scrollspy.Constructor=b,a.fn.scrollspy.noConflict=function(){return a.fn.scrollspy=d,this},a(window).on("load.bs.scrollspy.data-api",function(){a('[data-spy="scroll"]').each(function(){var b=a(this);c.call(b,b.data())})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tab");e||d.data("bs.tab",e=new c(this)),"string"==typeof b&&e[b]()})}var c=function(b){this.element=a(b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.prototype.show=function(){var b=this.element,c=b.closest("ul:not(.dropdown-menu)"),d=b.data("target");if(d||(d=b.attr("href"),d=d&&d.replace(/.*(?=#[^\s]*$)/,"")),!b.parent("li").hasClass("active")){var e=c.find(".active:last a"),f=a.Event("hide.bs.tab",{relatedTarget:b[0]}),g=a.Event("show.bs.tab",{relatedTarget:e[0]});if(e.trigger(f),b.trigger(g),!g.isDefaultPrevented()&&!f.isDefaultPrevented()){var h=a(d);this.activate(b.closest("li"),c),this.activate(h,h.parent(),function(){e.trigger({type:"hidden.bs.tab",relatedTarget:b[0]}),b.trigger({type:"shown.bs.tab",relatedTarget:e[0]})})}}},c.prototype.activate=function(b,d,e){function f(){g.removeClass("active").find("> .dropdown-menu > .active").removeClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!1),b.addClass("active").find('[data-toggle="tab"]').attr("aria-expanded",!0),h?(b[0].offsetWidth,b.addClass("in")):b.removeClass("fade"),b.parent(".dropdown-menu").length&&b.closest("li.dropdown").addClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!0),e&&e()}var g=d.find("> .active"),h=e&&a.support.transition&&(g.length&&g.hasClass("fade")||!!d.find("> .fade").length);g.length&&h?g.one("bsTransitionEnd",f).emulateTransitionEnd(c.TRANSITION_DURATION):f(),g.removeClass("in")};var d=a.fn.tab;a.fn.tab=b,a.fn.tab.Constructor=c,a.fn.tab.noConflict=function(){return a.fn.tab=d,this};var e=function(c){c.preventDefault(),b.call(a(this),"show")};a(document).on("click.bs.tab.data-api",'[data-toggle="tab"]',e).on("click.bs.tab.data-api",'[data-toggle="pill"]',e)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.affix"),f="object"==typeof b&&b;e||d.data("bs.affix",e=new c(this,f)),"string"==typeof b&&e[b]()})}var c=function(b,d){this.options=a.extend({},c.DEFAULTS,d),this.$target=a(this.options.target).on("scroll.bs.affix.data-api",a.proxy(this.checkPosition,this)).on("click.bs.affix.data-api",a.proxy(this.checkPositionWithEventLoop,this)),this.$element=a(b),this.affixed=null,this.unpin=null,this.pinnedOffset=null,this.checkPosition()};c.VERSION="3.3.5",c.RESET="affix affix-top affix-bottom",c.DEFAULTS={offset:0,target:window},c.prototype.getState=function(a,b,c,d){var e=this.$target.scrollTop(),f=this.$element.offset(),g=this.$target.height();if(null!=c&&"top"==this.affixed)return c>e?"top":!1;if("bottom"==this.affixed)return null!=c?e+this.unpin<=f.top?!1:"bottom":a-d>=e+g?!1:"bottom";var h=null==this.affixed,i=h?e:f.top,j=h?g:b;return null!=c&&c>=e?"top":null!=d&&i+j>=a-d?"bottom":!1},c.prototype.getPinnedOffset=function(){if(this.pinnedOffset)return this.pinnedOffset;this.$element.removeClass(c.RESET).addClass("affix");var a=this.$target.scrollTop(),b=this.$element.offset();return this.pinnedOffset=b.top-a},c.prototype.checkPositionWithEventLoop=function(){setTimeout(a.proxy(this.checkPosition,this),1)},c.prototype.checkPosition=function(){if(this.$element.is(":visible")){var b=this.$element.height(),d=this.options.offset,e=d.top,f=d.bottom,g=Math.max(a(document).height(),a(document.body).height());"object"!=typeof d&&(f=e=d),"function"==typeof e&&(e=d.top(this.$element)),"function"==typeof f&&(f=d.bottom(this.$element));var h=this.getState(g,b,e,f);if(this.affixed!=h){null!=this.unpin&&this.$element.css("top","");var i="affix"+(h?"-"+h:""),j=a.Event(i+".bs.affix");if(this.$element.trigger(j),j.isDefaultPrevented())return;this.affixed=h,this.unpin="bottom"==h?this.getPinnedOffset():null,this.$element.removeClass(c.RESET).addClass(i).trigger(i.replace("affix","affixed")+".bs.affix")}"bottom"==h&&this.$element.offset({top:g-b-f})}};var d=a.fn.affix;a.fn.affix=b,a.fn.affix.Constructor=c,a.fn.affix.noConflict=function(){return a.fn.affix=d,this},a(window).on("load",function(){a('[data-spy="affix"]').each(function(){var c=a(this),d=c.data();d.offset=d.offset||{},null!=d.offsetBottom&&(d.offset.bottom=d.offsetBottom),null!=d.offsetTop&&(d.offset.top=d.offsetTop),b.call(c,d)})})}(jQuery);</script>
<script>/**
* @preserve HTML5 Shiv 3.7.2 | @afarkas @jdalton @jon_neal @rem | MIT/GPL2 Licensed
*/
// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a,b){function c(a,b){var c=a.createElement("p"),d=a.getElementsByTagName("head")[0]||a.documentElement;return c.innerHTML="x<style>"+b+"</style>",d.insertBefore(c.lastChild,d.firstChild)}function d(){var a=t.elements;return"string"==typeof a?a.split(" "):a}function e(a,b){var c=t.elements;"string"!=typeof c&&(c=c.join(" ")),"string"!=typeof a&&(a=a.join(" ")),t.elements=c+" "+a,j(b)}function f(a){var b=s[a[q]];return b||(b={},r++,a[q]=r,s[r]=b),b}function g(a,c,d){if(c||(c=b),l)return c.createElement(a);d||(d=f(c));var e;return e=d.cache[a]?d.cache[a].cloneNode():p.test(a)?(d.cache[a]=d.createElem(a)).cloneNode():d.createElem(a),!e.canHaveChildren||o.test(a)||e.tagUrn?e:d.frag.appendChild(e)}function h(a,c){if(a||(a=b),l)return a.createDocumentFragment();c=c||f(a);for(var e=c.frag.cloneNode(),g=0,h=d(),i=h.length;i>g;g++)e.createElement(h[g]);return e}function i(a,b){b.cache||(b.cache={},b.createElem=a.createElement,b.createFrag=a.createDocumentFragment,b.frag=b.createFrag()),a.createElement=function(c){return t.shivMethods?g(c,a,b):b.createElem(c)},a.createDocumentFragment=Function("h,f","return function(){var n=f.cloneNode(),c=n.createElement;h.shivMethods&&("+d().join().replace(/[\w\-:]+/g,function(a){return b.createElem(a),b.frag.createElement(a),'c("'+a+'")'})+");return n}")(t,b.frag)}function j(a){a||(a=b);var d=f(a);return!t.shivCSS||k||d.hasCSS||(d.hasCSS=!!c(a,"article,aside,dialog,figcaption,figure,footer,header,hgroup,main,nav,section{display:block}mark{background:#FF0;color:#000}template{display:none}")),l||i(a,d),a}var k,l,m="3.7.2",n=a.html5||{},o=/^<|^(?:button|map|select|textarea|object|iframe|option|optgroup)$/i,p=/^(?:a|b|code|div|fieldset|h1|h2|h3|h4|h5|h6|i|label|li|ol|p|q|span|strong|style|table|tbody|td|th|tr|ul)$/i,q="_html5shiv",r=0,s={};!function(){try{var a=b.createElement("a");a.innerHTML="<xyz></xyz>",k="hidden"in a,l=1==a.childNodes.length||function(){b.createElement("a");var a=b.createDocumentFragment();return"undefined"==typeof a.cloneNode||"undefined"==typeof a.createDocumentFragment||"undefined"==typeof a.createElement}()}catch(c){k=!0,l=!0}}();var t={elements:n.elements||"abbr article aside audio bdi canvas data datalist details dialog figcaption figure footer header hgroup main mark meter nav output picture progress section summary template time video",version:m,shivCSS:n.shivCSS!==!1,supportsUnknownElements:l,shivMethods:n.shivMethods!==!1,type:"default",shivDocument:j,createElement:g,createDocumentFragment:h,addElements:e};a.html5=t,j(b)}(this,document);
};
</script>
<script>/*! Respond.js v1.4.2: min/max-width media query polyfill * Copyright 2013 Scott Jehl
 * Licensed under https://github.com/scottjehl/Respond/blob/master/LICENSE-MIT
 *  */

// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a){"use strict";a.matchMedia=a.matchMedia||function(a){var b,c=a.documentElement,d=c.firstElementChild||c.firstChild,e=a.createElement("body"),f=a.createElement("div");return f.id="mq-test-1",f.style.cssText="position:absolute;top:-100em",e.style.background="none",e.appendChild(f),function(a){return f.innerHTML='&shy;<style media="'+a+'"> #mq-test-1 { width: 42px; }</style>',c.insertBefore(e,d),b=42===f.offsetWidth,c.removeChild(e),{matches:b,media:a}}}(a.document)}(this),function(a){"use strict";function b(){u(!0)}var c={};a.respond=c,c.update=function(){};var d=[],e=function(){var b=!1;try{b=new a.XMLHttpRequest}catch(c){b=new a.ActiveXObject("Microsoft.XMLHTTP")}return function(){return b}}(),f=function(a,b){var c=e();c&&(c.open("GET",a,!0),c.onreadystatechange=function(){4!==c.readyState||200!==c.status&&304!==c.status||b(c.responseText)},4!==c.readyState&&c.send(null))};if(c.ajax=f,c.queue=d,c.regex={media:/@media[^\{]+\{([^\{\}]*\{[^\}\{]*\})+/gi,keyframes:/@(?:\-(?:o|moz|webkit)\-)?keyframes[^\{]+\{(?:[^\{\}]*\{[^\}\{]*\})+[^\}]*\}/gi,urls:/(url\()['"]?([^\/\)'"][^:\)'"]+)['"]?(\))/g,findStyles:/@media *([^\{]+)\{([\S\s]+?)$/,only:/(only\s+)?([a-zA-Z]+)\s?/,minw:/\([\s]*min\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/,maxw:/\([\s]*max\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/},c.mediaQueriesSupported=a.matchMedia&&null!==a.matchMedia("only all")&&a.matchMedia("only all").matches,!c.mediaQueriesSupported){var g,h,i,j=a.document,k=j.documentElement,l=[],m=[],n=[],o={},p=30,q=j.getElementsByTagName("head")[0]||k,r=j.getElementsByTagName("base")[0],s=q.getElementsByTagName("link"),t=function(){var a,b=j.createElement("div"),c=j.body,d=k.style.fontSize,e=c&&c.style.fontSize,f=!1;return b.style.cssText="position:absolute;font-size:1em;width:1em",c||(c=f=j.createElement("body"),c.style.background="none"),k.style.fontSize="100%",c.style.fontSize="100%",c.appendChild(b),f&&k.insertBefore(c,k.firstChild),a=b.offsetWidth,f?k.removeChild(c):c.removeChild(b),k.style.fontSize=d,e&&(c.style.fontSize=e),a=i=parseFloat(a)},u=function(b){var c="clientWidth",d=k[c],e="CSS1Compat"===j.compatMode&&d||j.body[c]||d,f={},o=s[s.length-1],r=(new Date).getTime();if(b&&g&&p>r-g)return a.clearTimeout(h),h=a.setTimeout(u,p),void 0;g=r;for(var v in l)if(l.hasOwnProperty(v)){var w=l[v],x=w.minw,y=w.maxw,z=null===x,A=null===y,B="em";x&&(x=parseFloat(x)*(x.indexOf(B)>-1?i||t():1)),y&&(y=parseFloat(y)*(y.indexOf(B)>-1?i||t():1)),w.hasquery&&(z&&A||!(z||e>=x)||!(A||y>=e))||(f[w.media]||(f[w.media]=[]),f[w.media].push(m[w.rules]))}for(var C in n)n.hasOwnProperty(C)&&n[C]&&n[C].parentNode===q&&q.removeChild(n[C]);n.length=0;for(var D in f)if(f.hasOwnProperty(D)){var E=j.createElement("style"),F=f[D].join("\n");E.type="text/css",E.media=D,q.insertBefore(E,o.nextSibling),E.styleSheet?E.styleSheet.cssText=F:E.appendChild(j.createTextNode(F)),n.push(E)}},v=function(a,b,d){var e=a.replace(c.regex.keyframes,"").match(c.regex.media),f=e&&e.length||0;b=b.substring(0,b.lastIndexOf("/"));var g=function(a){return a.replace(c.regex.urls,"$1"+b+"$2$3")},h=!f&&d;b.length&&(b+="/"),h&&(f=1);for(var i=0;f>i;i++){var j,k,n,o;h?(j=d,m.push(g(a))):(j=e[i].match(c.regex.findStyles)&&RegExp.$1,m.push(RegExp.$2&&g(RegExp.$2))),n=j.split(","),o=n.length;for(var p=0;o>p;p++)k=n[p],l.push({media:k.split("(")[0].match(c.regex.only)&&RegExp.$2||"all",rules:m.length-1,hasquery:k.indexOf("(")>-1,minw:k.match(c.regex.minw)&&parseFloat(RegExp.$1)+(RegExp.$2||""),maxw:k.match(c.regex.maxw)&&parseFloat(RegExp.$1)+(RegExp.$2||"")})}u()},w=function(){if(d.length){var b=d.shift();f(b.href,function(c){v(c,b.href,b.media),o[b.href]=!0,a.setTimeout(function(){w()},0)})}},x=function(){for(var b=0;b<s.length;b++){var c=s[b],e=c.href,f=c.media,g=c.rel&&"stylesheet"===c.rel.toLowerCase();e&&g&&!o[e]&&(c.styleSheet&&c.styleSheet.rawCssText?(v(c.styleSheet.rawCssText,e,f),o[e]=!0):(!/^([a-zA-Z:]*\/\/)/.test(e)&&!r||e.replace(RegExp.$1,"").split("/")[0]===a.location.host)&&("//"===e.substring(0,2)&&(e=a.location.protocol+e),d.push({href:e,media:f})))}w()};x(),c.update=x,c.getEmValue=t,a.addEventListener?a.addEventListener("resize",b,!1):a.attachEvent&&a.attachEvent("onresize",b)}}(this);
};
</script>
<style type="text/css">.pagedtable {
overflow: auto;
padding-left: 8px;
padding-right: 8px;
}
.pagedtable-wrapper {
border: 1px solid #ccc;
border-radius: 4px;
margin-bottom: 10px;
}
.pagedtable table {
width: 100%;
max-width: 100%;
margin: 0;
}
.pagedtable th {
padding: 0 5px 0 5px;
border: none;
border-bottom: 2px solid #dddddd;
min-width: 45px;
}
.pagedtable-empty th {
display: none;
}
.pagedtable td {
padding: 0 4px 0 4px;
}
.pagedtable .even {
background-color: rgba(140, 140, 140, 0.1);
}
.pagedtable-padding-col {
display: none;
}
.pagedtable a {
-webkit-touch-callout: none;
-webkit-user-select: none;
-khtml-user-select: none;
-moz-user-select: none;
-ms-user-select: none;
user-select: none;
}
.pagedtable-index-nav {
cursor: pointer;
padding: 0 5px 0 5px;
float: right;
border: 0;
}
.pagedtable-index-nav-disabled {
cursor: default;
text-decoration: none;
color: #999;
}
a.pagedtable-index-nav-disabled:hover {
text-decoration: none;
color: #999;
}
.pagedtable-indexes {
cursor: pointer;
float: right;
border: 0;
}
.pagedtable-index-current {
cursor: default;
text-decoration: none;
font-weight: bold;
color: #333;
border: 0;
}
a.pagedtable-index-current:hover {
text-decoration: none;
font-weight: bold;
color: #333;
}
.pagedtable-index {
width: 30px;
display: inline-block;
text-align: center;
border: 0;
}
.pagedtable-index-separator-left {
display: inline-block;
color: #333;
font-size: 9px;
padding: 0 0 0 0;
cursor: default;
}
.pagedtable-index-separator-right {
display: inline-block;
color: #333;
font-size: 9px;
padding: 0 4px 0 0;
cursor: default;
}
.pagedtable-footer {
padding-top: 4px;
padding-bottom: 5px;
}
.pagedtable-not-empty .pagedtable-footer {
border-top: 2px solid #dddddd;
}
.pagedtable-info {
overflow: hidden;
color: #999;
white-space: nowrap;
text-overflow: ellipsis;
}
.pagedtable-header-name {
overflow: hidden;
text-overflow: ellipsis;
}
.pagedtable-header-type {
color: #999;
font-weight: 400;
}
.pagedtable-na-cell {
font-style: italic;
opacity: 0.3;
}
</style>
<script>// Production steps of ECMA-262, Edition 5, 15.4.4.18
// Reference: http://es5.github.io/#x15.4.4.18
if (!Array.prototype.forEach) {

  Array.prototype.forEach = function(callback, thisArg) {

    var T, k;

    if (this === null) {
      throw new TypeError(' this is null or not defined');
    }

    // 1. Let O be the result of calling toObject() passing the
    // |this| value as the argument.
    var O = Object(this);

    // 2. Let lenValue be the result of calling the Get() internal
    // method of O with the argument "length".
    // 3. Let len be toUint32(lenValue).
    var len = O.length >>> 0;

    // 4. If isCallable(callback) is false, throw a TypeError exception.
    // See: http://es5.github.com/#x9.11
    if (typeof callback !== "function") {
      throw new TypeError(callback + ' is not a function');
    }

    // 5. If thisArg was supplied, let T be thisArg; else let
    // T be undefined.
    if (arguments.length > 1) {
      T = thisArg;
    }

    // 6. Let k be 0
    k = 0;

    // 7. Repeat, while k < len
    while (k < len) {

      var kValue;

      // a. Let Pk be ToString(k).
      //    This is implicit for LHS operands of the in operator
      // b. Let kPresent be the result of calling the HasProperty
      //    internal method of O with argument Pk.
      //    This step can be combined with c
      // c. If kPresent is true, then
      if (k in O) {

        // i. Let kValue be the result of calling the Get internal
        // method of O with argument Pk.
        kValue = O[k];

        // ii. Call the Call internal method of callback with T as
        // the this value and argument list containing kValue, k, and O.
        callback.call(T, kValue, k, O);
      }
      // d. Increase k by 1.
      k++;
    }
    // 8. return undefined
  };
}

// Production steps of ECMA-262, Edition 5, 15.4.4.19
// Reference: http://es5.github.io/#x15.4.4.19
if (!Array.prototype.map) {

  Array.prototype.map = function(callback, thisArg) {

    var T, A, k;

    if (this == null) {
      throw new TypeError(' this is null or not defined');
    }

    // 1. Let O be the result of calling ToObject passing the |this|
    //    value as the argument.
    var O = Object(this);

    // 2. Let lenValue be the result of calling the Get internal
    //    method of O with the argument "length".
    // 3. Let len be ToUint32(lenValue).
    var len = O.length >>> 0;

    // 4. If IsCallable(callback) is false, throw a TypeError exception.
    // See: http://es5.github.com/#x9.11
    if (typeof callback !== 'function') {
      throw new TypeError(callback + ' is not a function');
    }

    // 5. If thisArg was supplied, let T be thisArg; else let T be undefined.
    if (arguments.length > 1) {
      T = thisArg;
    }

    // 6. Let A be a new array created as if by the expression new Array(len)
    //    where Array is the standard built-in constructor with that name and
    //    len is the value of len.
    A = new Array(len);

    // 7. Let k be 0
    k = 0;

    // 8. Repeat, while k < len
    while (k < len) {

      var kValue, mappedValue;

      // a. Let Pk be ToString(k).
      //   This is implicit for LHS operands of the in operator
      // b. Let kPresent be the result of calling the HasProperty internal
      //    method of O with argument Pk.
      //   This step can be combined with c
      // c. If kPresent is true, then
      if (k in O) {

        // i. Let kValue be the result of calling the Get internal
        //    method of O with argument Pk.
        kValue = O[k];

        // ii. Let mappedValue be the result of calling the Call internal
        //     method of callback with T as the this value and argument
        //     list containing kValue, k, and O.
        mappedValue = callback.call(T, kValue, k, O);

        // iii. Call the DefineOwnProperty internal method of A with arguments
        // Pk, Property Descriptor
        // { Value: mappedValue,
        //   Writable: true,
        //   Enumerable: true,
        //   Configurable: true },
        // and false.

        // In browsers that support Object.defineProperty, use the following:
        // Object.defineProperty(A, k, {
        //   value: mappedValue,
        //   writable: true,
        //   enumerable: true,
        //   configurable: true
        // });

        // For best browser support, use the following:
        A[k] = mappedValue;
      }
      // d. Increase k by 1.
      k++;
    }

    // 9. return A
    return A;
  };
}

var PagedTable = function (pagedTable) {
  var me = this;

  var source = function(pagedTable) {
    var sourceElems = [].slice.call(pagedTable.children).filter(function(e) {
      return e.hasAttribute("data-pagedtable-source");
    });

    if (sourceElems === null || sourceElems.length !== 1) {
      throw("A single data-pagedtable-source was not found");
    }

    return JSON.parse(sourceElems[0].innerHTML);
  }(pagedTable);

  var options = function(source) {
    var options = typeof(source.options) !== "undefined" &&
      source.options !== null ? source.options : {};

    var columns = typeof(options.columns) !== "undefined" ? options.columns : {};
    var rows = typeof(options.rows) !== "undefined" ? options.rows : {};

    var positiveIntOrNull = function(value) {
      return parseInt(value) >= 0 ? parseInt(value) : null;
    };

    return {
      pages: positiveIntOrNull(options.pages),
      rows: {
        min: positiveIntOrNull(rows.min),
        max: positiveIntOrNull(rows.max),
        total: positiveIntOrNull(rows.total)
      },
      columns: {
        min: positiveIntOrNull(columns.min),
        max: positiveIntOrNull(columns.max),
        total: positiveIntOrNull(columns.total)
      }
    };
  }(source);

  var Measurer = function() {

    // set some default initial values that will get adjusted in runtime
    me.measures = {
      padding: 12,
      character: 8,
      height: 15,
      defaults: true
    };

    me.calculate = function(measuresCell) {
      if (!me.measures.defaults)
        return;

      var measuresCellStyle = window.getComputedStyle(measuresCell, null);

      var newPadding = parsePadding(measuresCellStyle.paddingLeft) +
            parsePadding(measuresCellStyle.paddingRight);

      var sampleString = "ABCDEFGHIJ0123456789";
      var newCharacter = Math.ceil(measuresCell.clientWidth / sampleString.length);

      if (newPadding <= 0 || newCharacter <= 0)
        return;

      me.measures.padding = newPadding;
      me.measures.character = newCharacter;
      me.measures.height = measuresCell.clientHeight;
      me.measures.defaults = false;
    };

    return me;
  };

  var Page = function(data, options) {
    var me = this;

    var defaults = {
      max: 7,
      rows: 10
    };

    var totalPages = function() {
      return Math.ceil(data.length / me.rows);
    };

    me.number = 0;
    me.max = options.pages !== null ? options.pages : defaults.max;
    me.visible = me.max;
    me.rows = options.rows.min !== null ? options.rows.min : defaults.rows;
    me.total = totalPages();

    me.setRows = function(newRows) {
      me.rows = newRows;
      me.total = totalPages();
    };

    me.setPageNumber = function(newPageNumber) {
      if (newPageNumber < 0) newPageNumber = 0;
      if (newPageNumber >= me.total) newPageNumber = me.total - 1;

      me.number = newPageNumber;
    };

    me.setVisiblePages = function(visiblePages) {
      me.visible = Math.min(me.max, visiblePages);
      me.setPageNumber(me.number);
    };

    me.getVisiblePageRange = function() {
      var start = me.number - Math.max(Math.floor((me.visible - 1) / 2), 0);
      var end = me.number + Math.floor(me.visible / 2) + 1;
      var pageCount = me.total;

      if (start < 0) {
        var diffToStart = 0 - start;
        start += diffToStart;
        end += diffToStart;
      }

      if (end > pageCount) {
        var diffToEnd = end - pageCount;
        start -= diffToEnd;
        end -= diffToEnd;
      }

      start = start < 0 ? 0 : start;
      end = end >= pageCount ? pageCount : end;

      var first = false;
      var last = false;

      if (start > 0 && me.visible > 1) {
        start = start + 1;
        first = true;
      }

      if (end < pageCount && me.visible > 2) {
        end = end - 1;
        last = true;
      }

      return {
        first: first,
        start: start,
        end: end,
        last: last
      };
    };

    me.getRowStart = function() {
      var rowStart = page.number * page.rows;
      if (rowStart < 0)
        rowStart = 0;

      return rowStart;
    };

    me.getRowEnd = function() {
      var rowStart = me.getRowStart();
      return Math.min(rowStart + me.rows, data.length);
    };

    me.getPaddingRows = function() {
      var rowStart = me.getRowStart();
      var rowEnd = me.getRowEnd();
      return data.length > me.rows ? me.rows - (rowEnd - rowStart) : 0;
    };
  };

  var Columns = function(data, columns, options) {
    var me = this;

    me.defaults = {
      min: 5
    };

    me.number = 0;
    me.visible = 0;
    me.total = columns.length;
    me.subset = [];
    me.padding = 0;
    me.min = options.columns.min !== null ? options.columns.min : me.defaults.min;
    me.max = options.columns.max !== null ? options.columns.max : null;
    me.widths = {};

    var widthsLookAhead = Math.max(100, options.rows.min);
    var paddingColChars = 10;

    me.emptyNames = function() {
      columns.forEach(function(column) {
        if (columns.label !== null && columns.label !== "")
          return false;
      });

      return true;
    };

    var parsePadding = function(value) {
      return parseInt(value) >= 0 ? parseInt(value) : 0;
    };

    me.calculateWidths = function(measures) {
      columns.forEach(function(column) {
        var maxChars = Math.max(
          column.label.toString().length,
          column.type.toString().length
        );

        for (var idxRow = 0; idxRow < Math.min(widthsLookAhead, data.length); idxRow++) {
          maxChars = Math.max(maxChars, data[idxRow][column.name.toString()].length);
        }

        me.widths[column.name] = {
          // width in characters
          chars: maxChars,
          // width for the inner html columns
          inner: maxChars * measures.character,
          // width adding outer styles like padding
          outer: maxChars * measures.character + measures.padding
        };
      });
    };

    me.getWidth = function() {
      var widthOuter = 0;
      for (var idxCol = 0; idxCol < me.subset.length; idxCol++) {
        var columnName = me.subset[idxCol].name;
        widthOuter = widthOuter + me.widths[columnName].outer;
      }

      widthOuter = widthOuter + me.padding * paddingColChars * measurer.measures.character;

      if (me.hasMoreLeftColumns()) {
        widthOuter = widthOuter + columnNavigationWidthPX + measurer.measures.padding;
      }

      if (me.hasMoreRightColumns()) {
        widthOuter = widthOuter + columnNavigationWidthPX + measurer.measures.padding;
      }

      return widthOuter;
    };

    me.updateSlice = function() {
      if (me.number + me.visible >= me.total)
        me.number = me.total - me.visible;

      if (me.number < 0) me.number = 0;

      me.subset = columns.slice(me.number, Math.min(me.number + me.visible, me.total));

      me.subset = me.subset.map(function(column) {
        Object.keys(column).forEach(function(colKey) {
          column[colKey] = column[colKey] === null ? "" : column[colKey].toString();
        });

        column.width = null;
        return column;
      });
    };

    me.setVisibleColumns = function(columnNumber, newVisibleColumns, paddingCount) {
      me.number = columnNumber;
      me.visible = newVisibleColumns;
      me.padding = paddingCount;

      me.updateSlice();
    };

    me.incColumnNumber = function(increment) {
      me.number = me.number + increment;
    };

    me.setColumnNumber = function(newNumber) {
      me.number = newNumber;
    };

    me.setPaddingCount = function(newPadding) {
      me.padding = newPadding;
    };

    me.getPaddingCount = function() {
      return me.padding;
    };

    me.hasMoreLeftColumns = function() {
      return me.number > 0;
    };

    me.hasMoreRightColumns = function() {
      return me.number + me.visible < me.total;
    };

    me.updateSlice(0);
    return me;
  };

  var data = source.data;
  var page = new Page(data, options);
  var measurer = new Measurer(data, options);
  var columns = new Columns(data, source.columns, options);

  var table = null;
  var tableDiv = null;
  var header = null;
  var footer = null;
  var tbody = null;

  // Caches pagedTable.clientWidth, specially for webkit
  var cachedPagedTableClientWidth = null;

  var onChangeCallbacks = [];

  var clearSelection = function() {
    if(document.selection && document.selection.empty) {
      document.selection.empty();
    } else if(window.getSelection) {
      var sel = window.getSelection();
      sel.removeAllRanges();
    }
  };

  var columnNavigationWidthPX = 5;

  var renderColumnNavigation = function(increment, backwards) {
    var arrow = document.createElement("div");
    arrow.setAttribute("style",
      "border-top: " + columnNavigationWidthPX + "px solid transparent;" +
      "border-bottom: " + columnNavigationWidthPX + "px solid transparent;" +
      "border-" + (backwards ? "right" : "left") + ": " + columnNavigationWidthPX + "px solid;");

    var header = document.createElement("th");
    header.appendChild(arrow);
    header.setAttribute("style",
      "cursor: pointer;" +
      "vertical-align: middle;" +
      "min-width: " + columnNavigationWidthPX + "px;" +
      "width: " + columnNavigationWidthPX + "px;");

    header.onclick = function() {
      columns.incColumnNumber(backwards ? -1 : increment);

      me.animateColumns(backwards);
      renderFooter();

      clearSelection();
      triggerOnChange();
    };

    return header;
  };

  var maxColumnWidth = function(width) {
    var padding = 80;
    var columnMax = Math.max(cachedPagedTableClientWidth - padding, 0);

    return parseInt(width) > 0 ?
      Math.min(columnMax, parseInt(width)) + "px" :
      columnMax + "px";
  };

  var clearHeader = function() {
    var thead = pagedTable.querySelectorAll("thead")[0];
    thead.innerHTML = "";
  };

  var renderHeader = function(clear) {
    cachedPagedTableClientWidth = pagedTable.clientWidth;

    var fragment = document.createDocumentFragment();

    header = document.createElement("tr");
    fragment.appendChild(header);

    if (columns.number > 0)
      header.appendChild(renderColumnNavigation(-columns.visible, true));

    columns.subset = columns.subset.map(function(columnData) {
      var column = document.createElement("th");
      column.setAttribute("align", columnData.align);
      column.style.textAlign = columnData.align;

      column.style.maxWidth = maxColumnWidth(null);
      if (columnData.width) {
        column.style.minWidth =
          column.style.maxWidth = maxColumnWidth(columnData.width);
      }

      var columnName = document.createElement("div");
      columnName.setAttribute("class", "pagedtable-header-name");
      if (columnData.label === "") {
        columnName.innerHTML = "&nbsp;";
      }
      else {
        columnName.appendChild(document.createTextNode(columnData.label));
      }
      column.appendChild(columnName);

      var columnType = document.createElement("div");
      columnType.setAttribute("class", "pagedtable-header-type");
      if (columnData.type === "") {
        columnType.innerHTML = "&nbsp;";
      }
      else {
        columnType.appendChild(document.createTextNode("<" + columnData.type + ">"));
      }
      column.appendChild(columnType);

      header.appendChild(column);

      columnData.element = column;

      return columnData;
    });

    for (var idx = 0; idx < columns.getPaddingCount(); idx++) {
      var paddingCol = document.createElement("th");
      paddingCol.setAttribute("class", "pagedtable-padding-col");
      header.appendChild(paddingCol);
    }

    if (columns.number + columns.visible < columns.total)
      header.appendChild(renderColumnNavigation(columns.visible, false));

    if (typeof(clear) == "undefined" || clear) clearHeader();
    var thead = pagedTable.querySelectorAll("thead")[0];
    thead.appendChild(fragment);
  };

  me.animateColumns = function(backwards) {
    var thead = pagedTable.querySelectorAll("thead")[0];

    var headerOld = thead.querySelectorAll("tr")[0];
    var tbodyOld = table.querySelectorAll("tbody")[0];

    me.fitColumns(backwards);

    renderHeader(false);

    header.style.opacity = "0";
    header.style.transform = backwards ? "translateX(-30px)" : "translateX(30px)";
    header.style.transition = "transform 200ms linear, opacity 200ms";
    header.style.transitionDelay = "0";

    renderBody(false);

    if (headerOld) {
      headerOld.style.position = "absolute";
      headerOld.style.transform = "translateX(0px)";
      headerOld.style.opacity = "1";
      headerOld.style.transition = "transform 100ms linear, opacity 100ms";
      headerOld.setAttribute("class", "pagedtable-remove-head");
      if (headerOld.style.transitionEnd) {
        headerOld.addEventListener("transitionend", function() {
          var headerOldByClass = thead.querySelector(".pagedtable-remove-head");
          if (headerOldByClass) thead.removeChild(headerOldByClass);
        });
      }
      else {
        thead.removeChild(headerOld);
      }
    }

    if (tbodyOld) table.removeChild(tbodyOld);

    tbody.style.opacity = "0";
    tbody.style.transition = "transform 200ms linear, opacity 200ms";
    tbody.style.transitionDelay = "0ms";

    // force relayout
    window.getComputedStyle(header).opacity;
    window.getComputedStyle(tbody).opacity;

    if (headerOld) {
      headerOld.style.transform = backwards ? "translateX(20px)" : "translateX(-30px)";
      headerOld.style.opacity = "0";
    }

    header.style.transform = "translateX(0px)";
    header.style.opacity = "1";

    tbody.style.opacity = "1";
  }

  me.onChange = function(callback) {
    onChangeCallbacks.push(callback);
  };

  var triggerOnChange = function() {
    onChangeCallbacks.forEach(function(onChange) {
      onChange();
    });
  };

  var clearBody = function() {
    if (tbody) {
      table.removeChild(tbody);
      tbody = null;
    }
  };

  var renderBody = function(clear) {
    cachedPagedTableClientWidth = pagedTable.clientWidth

    var fragment = document.createDocumentFragment();

    var pageData = data.slice(page.getRowStart(), page.getRowEnd());

    pageData.forEach(function(dataRow, idxRow) {
      var htmlRow = document.createElement("tr");
      htmlRow.setAttribute("class", (idxRow % 2 !==0) ? "even" : "odd");

      if (columns.hasMoreLeftColumns())
        htmlRow.appendChild(document.createElement("td"));

      columns.subset.forEach(function(columnData) {
        var cellName = columnData.name;
        var dataCell = dataRow[cellName];
        var htmlCell = document.createElement("td");

        if (dataCell === "NA") htmlCell.setAttribute("class", "pagedtable-na-cell");
        if (dataCell === "__NA__") dataCell = "NA";

        var cellText = document.createTextNode(dataCell);
        htmlCell.appendChild(cellText);
        if (dataCell.length > 50) {
          htmlCell.setAttribute("title", dataCell);
        }
        htmlCell.setAttribute("align", columnData.align);
        htmlCell.style.textAlign = columnData.align;
        htmlCell.style.maxWidth = maxColumnWidth(null);
        if (columnData.width) {
          htmlCell.style.minWidth = htmlCell.style.maxWidth = maxColumnWidth(columnData.width);
        }
        htmlRow.appendChild(htmlCell);
      });

      for (var idx = 0; idx < columns.getPaddingCount(); idx++) {
        var paddingCol = document.createElement("td");
        paddingCol.setAttribute("class", "pagedtable-padding-col");
        htmlRow.appendChild(paddingCol);
      }

      if (columns.hasMoreRightColumns())
        htmlRow.appendChild(document.createElement("td"));

      fragment.appendChild(htmlRow);
    });

    for (var idxPadding = 0; idxPadding < page.getPaddingRows(); idxPadding++) {
      var paddingRow = document.createElement("tr");

      var paddingCellRow = document.createElement("td");
      paddingCellRow.innerHTML = "&nbsp;";
      paddingCellRow.setAttribute("colspan", "100%");
      paddingRow.appendChild(paddingCellRow);

      fragment.appendChild(paddingRow);
    }

    if (typeof(clear) == "undefined" || clear) clearBody();
    tbody = document.createElement("tbody");
    tbody.appendChild(fragment);

    table.appendChild(tbody);
  };

  var getLabelInfo = function() {
    var pageStart = page.getRowStart();
    var pageEnd = page.getRowEnd();
    var totalRows = data.length;

    var totalRowsLabel = options.rows.total ? options.rows.total : totalRows;
    var totalRowsLabelFormat = totalRowsLabel.toString().replace(/(\d)(?=(\d\d\d)+(?!\d))/g, '$1,');

    var infoText = (pageStart + 1) + "-" + pageEnd + " of " + totalRowsLabelFormat + " rows";
    if (totalRows < page.rows) {
      infoText = totalRowsLabel + " row" + (totalRows != 1 ? "s" : "");
    }
    if (columns.total > columns.visible) {
      var totalColumnsLabel = options.columns.total ? options.columns.total : columns.total;

      infoText = infoText + " | " + (columns.number + 1) + "-" +
        (Math.min(columns.number + columns.visible, columns.total)) +
        " of " + totalColumnsLabel + " columns";
    }

    return infoText;
  };

  var clearFooter = function() {
    footer = pagedTable.querySelectorAll("div.pagedtable-footer")[0];
    footer.innerHTML = "";

    return footer;
  };

  var createPageLink = function(idxPage) {
    var pageLink = document.createElement("a");
    pageLinkClass = idxPage === page.number ? "pagedtable-index pagedtable-index-current" : "pagedtable-index";
    pageLink.setAttribute("class", pageLinkClass);
    pageLink.setAttribute("data-page-index", idxPage);
    pageLink.onclick = function() {
      page.setPageNumber(parseInt(this.getAttribute("data-page-index")));
      renderBody();
      renderFooter();

      triggerOnChange();
    };

    pageLink.appendChild(document.createTextNode(idxPage + 1));

    return pageLink;
  }

  var renderFooter = function() {
    footer = clearFooter();

    var next = document.createElement("a");
    next.appendChild(document.createTextNode("Next"));
    next.onclick = function() {
      page.setPageNumber(page.number + 1);
      renderBody();
      renderFooter();

      triggerOnChange();
    };
    if (data.length > page.rows) footer.appendChild(next);

    var pageNumbers = document.createElement("div");
    pageNumbers.setAttribute("class", "pagedtable-indexes");

    var pageRange = page.getVisiblePageRange();

    if (pageRange.first) {
      var pageLink = createPageLink(0);
      pageNumbers.appendChild(pageLink);

      var pageSeparator = document.createElement("div");
      pageSeparator.setAttribute("class", "pagedtable-index-separator-left");
      pageSeparator.appendChild(document.createTextNode("..."))
      pageNumbers.appendChild(pageSeparator);
    }

    for (var idxPage = pageRange.start; idxPage < pageRange.end; idxPage++) {
      var pageLink = createPageLink(idxPage);

      pageNumbers.appendChild(pageLink);
    }

    if (pageRange.last) {
      var pageSeparator = document.createElement("div");
      pageSeparator.setAttribute("class", "pagedtable-index-separator-right");
      pageSeparator.appendChild(document.createTextNode("..."))
      pageNumbers.appendChild(pageSeparator);

      var pageLink = createPageLink(page.total - 1);
      pageNumbers.appendChild(pageLink);
    }

    if (data.length > page.rows) footer.appendChild(pageNumbers);

    var previous = document.createElement("a");
    previous.appendChild(document.createTextNode("Previous"));
    previous.onclick = function() {
      page.setPageNumber(page.number - 1);
      renderBody();
      renderFooter();

      triggerOnChange();
    };
    if (data.length > page.rows) footer.appendChild(previous);

    var infoLabel = document.createElement("div");
    infoLabel.setAttribute("class", "pagedtable-info");
    infoLabel.setAttribute("title", getLabelInfo());
    infoLabel.appendChild(document.createTextNode(getLabelInfo()));
    footer.appendChild(infoLabel);

    var enabledClass = "pagedtable-index-nav";
    var disabledClass = "pagedtable-index-nav pagedtable-index-nav-disabled";
    previous.setAttribute("class", page.number <= 0 ? disabledClass : enabledClass);
    next.setAttribute("class", (page.number + 1) * page.rows >= data.length ? disabledClass : enabledClass);
  };

  var measuresCell = null;

  var renderMeasures = function() {
    var measuresTable = document.createElement("table");
    measuresTable.style.visibility = "hidden";
    measuresTable.style.position = "absolute";
    measuresTable.style.whiteSpace = "nowrap";
    measuresTable.style.height = "auto";
    measuresTable.style.width = "auto";

    var measuresRow = document.createElement("tr");
    measuresTable.appendChild(measuresRow);

    measuresCell = document.createElement("td");
    var sampleString = "ABCDEFGHIJ0123456789";
    measuresCell.appendChild(document.createTextNode(sampleString));

    measuresRow.appendChild(measuresCell);

    tableDiv.appendChild(measuresTable);
  }

  me.init = function() {
    tableDiv = document.createElement("div");
    pagedTable.appendChild(tableDiv);
    var pagedTableClass = data.length > 0 ?
      "pagedtable pagedtable-not-empty" :
      "pagedtable pagedtable-empty";

    if (columns.total == 0 || (columns.emptyNames() && data.length == 0)) {
      pagedTableClass = pagedTableClass + " pagedtable-empty-columns";
    }

    tableDiv.setAttribute("class", pagedTableClass);

    renderMeasures();
    measurer.calculate(measuresCell);
    columns.calculateWidths(measurer.measures);

    table = document.createElement("table");
    table.setAttribute("cellspacing", "0");
    table.setAttribute("class", "table table-condensed");
    tableDiv.appendChild(table);

    table.appendChild(document.createElement("thead"));

    var footerDiv = document.createElement("div");
    footerDiv.setAttribute("class", "pagedtable-footer");
    tableDiv.appendChild(footerDiv);

    // if the host has not yet provided horizontal space, render hidden
    if (tableDiv.clientWidth <= 0) {
      tableDiv.style.opacity = "0";
    }

    me.render();

    // retry seizing columns later if the host has not provided space
    function retryFit() {
      if (tableDiv.clientWidth <= 0) {
        setTimeout(retryFit, 100);
      } else {
        me.render();
        triggerOnChange();
      }
    }
    if (tableDiv.clientWidth <= 0) {
      retryFit();
    }
  };

  var registerWidths = function() {
    columns.subset = columns.subset.map(function(column) {
      column.width = columns.widths[column.name].inner;
      return column;
    });
  };

  var parsePadding = function(value) {
    return parseInt(value) >= 0 ? parseInt(value) : 0;
  };

  me.fixedHeight = function() {
    return options.rows.max != null;
  }

  me.fitRows = function() {
    if (me.fixedHeight())
      return;

    measurer.calculate(measuresCell);

    var rows = options.rows.min !== null ? options.rows.min : 0;
    var headerHeight = header !== null && header.offsetHeight > 0 ? header.offsetHeight : 0;
    var footerHeight = footer !== null && footer.offsetHeight > 0 ? footer.offsetHeight : 0;

    if (pagedTable.offsetHeight > 0) {
      var availableHeight = pagedTable.offsetHeight - headerHeight - footerHeight;
      rows = Math.floor((availableHeight) / measurer.measures.height);
    }

    rows = options.rows.min !== null ? Math.max(options.rows.min, rows) : rows;

    page.setRows(rows);
  }

  // The goal of this function is to add as many columns as possible
  // starting from left-to-right, when the right most limit is reached
  // it tries to add columns from the left as well.
  //
  // When startBackwards is true columns are added from right-to-left
  me.fitColumns = function(startBackwards) {
    measurer.calculate(measuresCell);
    columns.calculateWidths(measurer.measures);

    if (tableDiv.clientWidth > 0) {
      tableDiv.style.opacity = 1;
    }

    var visibleColumns = tableDiv.clientWidth <= 0 ? Math.max(columns.min, 1) : 1;
    var columnNumber = columns.number;
    var paddingCount = 0;

    // track a list of added columns as we build the visible ones to allow us
    // to remove columns when they don't fit anymore.
    var columnHistory = [];

    var lastTableHeight = 0;
    var backwards = startBackwards;

    var tableDivStyle = window.getComputedStyle(tableDiv, null);
    var tableDivPadding = parsePadding(tableDivStyle.paddingLeft) +
      parsePadding(tableDivStyle.paddingRight);

    var addPaddingCol = false;
    var currentWidth = 0;

    while (true) {
      columns.setVisibleColumns(columnNumber, visibleColumns, paddingCount);
      currentWidth = columns.getWidth();

      if (tableDiv.clientWidth - tableDivPadding < currentWidth) {
        break;
      }

      columnHistory.push({
        columnNumber: columnNumber,
        visibleColumns: visibleColumns,
        paddingCount: paddingCount
      });

      if (columnHistory.length > 100) {
        console.error("More than 100 tries to fit columns, aborting");
        break;
      }

      if (columns.max !== null &&
        columns.visible + columns.getPaddingCount() >= columns.max) {
        break;
      }

      // if we run out of right-columns
      if (!backwards && columnNumber + columns.visible >= columns.total) {
        // if we started adding right-columns, try adding left-columns
        if (!startBackwards && columnNumber > 0) {
          backwards = true;
        }
        else if (columns.min === null || visibleColumns + columns.getPaddingCount() >= columns.min) {
          break;
        }
        else {
          paddingCount = paddingCount + 1;
        }
      }

      // if we run out of left-columns
      if (backwards && columnNumber == 0) {
        // if we started adding left-columns, try adding right-columns
        if (startBackwards && columnNumber + columns.visible < columns.total) {
          backwards = false;
        }
        else if (columns.min === null || visibleColumns + columns.getPaddingCount() >= columns.min) {
          break;
        }
        else {
          paddingCount = paddingCount + 1;
        }
      }

      // when moving backwards try fitting left columns first
      if (backwards && columnNumber > 0) {
        columnNumber = columnNumber - 1;
      }

      if (columnNumber + visibleColumns < columns.total) {
        visibleColumns = visibleColumns + 1;
      }
    }

    var lastRenderableColumn = {
        columnNumber: columnNumber,
        visibleColumns: visibleColumns,
        paddingCount: paddingCount
    };

    if (columnHistory.length > 0) {
      lastRenderableColumn = columnHistory[columnHistory.length - 1];
    }

    columns.setVisibleColumns(
      lastRenderableColumn.columnNumber,
      lastRenderableColumn.visibleColumns,
      lastRenderableColumn.paddingCount);

    if (pagedTable.offsetWidth > 0) {
      page.setVisiblePages(Math.max(Math.ceil(1.0 * (pagedTable.offsetWidth - 250) / 40), 2));
    }

    registerWidths();
  };

  me.fit = function(startBackwards) {
    me.fitRows();
    me.fitColumns(startBackwards);
  }

  me.render = function() {
    me.fitColumns(false);

    // render header/footer to measure height accurately
    renderHeader();
    renderFooter();

    me.fitRows();
    renderBody();

    // re-render footer to match new rows
    renderFooter();
  }

  var resizeLastWidth = -1;
  var resizeLastHeight = -1;
  var resizeNewWidth = -1;
  var resizeNewHeight = -1;
  var resizePending = false;

  me.resize = function(newWidth, newHeight) {

    function resizeDelayed() {
      resizePending = false;

      if (
        (resizeNewWidth !== resizeLastWidth) ||
        (!me.fixedHeight() && resizeNewHeight !== resizeLastHeight)
      ) {
        resizeLastWidth = resizeNewWidth;
        resizeLastHeight = resizeNewHeight;

        setTimeout(resizeDelayed, 200);
        resizePending = true;
      } else {
        me.render();
        triggerOnChange();

        resizeLastWidth = -1;
        resizeLastHeight = -1;
      }
    }

    resizeNewWidth = newWidth;
    resizeNewHeight = newHeight;

    if (!resizePending) resizeDelayed();
  };
};

var PagedTableDoc;
(function (PagedTableDoc) {
  var allPagedTables = [];

  PagedTableDoc.initAll = function() {
    allPagedTables = [];

    var pagedTables = [].slice.call(document.querySelectorAll('[data-pagedtable="false"],[data-pagedtable=""]'));
    pagedTables.forEach(function(pagedTable, idx) {
      pagedTable.setAttribute("data-pagedtable", "true");
      pagedTable.setAttribute("pagedtable-page", 0);
      pagedTable.setAttribute("class", "pagedtable-wrapper");

      var pagedTableInstance = new PagedTable(pagedTable);
      pagedTableInstance.init();

      allPagedTables.push(pagedTableInstance);
    });
  };

  PagedTableDoc.resizeAll = function() {
    allPagedTables.forEach(function(pagedTable) {
      pagedTable.render();
    });
  };

  window.addEventListener("resize", PagedTableDoc.resizeAll);

  return PagedTableDoc;
})(PagedTableDoc || (PagedTableDoc = {}));

window.onload = function() {
  PagedTableDoc.initAll();
};
</script>
<script>

/**
 * jQuery Plugin: Sticky Tabs
 *
 * @author Aidan Lister <aidan@php.net>
 * adapted by Ruben Arslan to activate parent tabs too
 * http://www.aidanlister.com/2014/03/persisting-the-tab-state-in-bootstrap/
 */
(function($) {
  "use strict";
  $.fn.rmarkdownStickyTabs = function() {
    var context = this;
    // Show the tab corresponding with the hash in the URL, or the first tab
    var showStuffFromHash = function() {
      var hash = window.location.hash;
      var selector = hash ? 'a[href="' + hash + '"]' : 'li.active > a';
      var $selector = $(selector, context);
      if($selector.data('toggle') === "tab") {
        $selector.tab('show');
        // walk up the ancestors of this element, show any hidden tabs
        $selector.parents('.section.tabset').each(function(i, elm) {
          var link = $('a[href="#' + $(elm).attr('id') + '"]');
          if(link.data('toggle') === "tab") {
            link.tab("show");
          }
        });
      }
    };


    // Set the correct tab when the page loads
    showStuffFromHash(context);

    // Set the correct tab when a user uses their back/forward button
    $(window).on('hashchange', function() {
      showStuffFromHash(context);
    });

    // Change the URL when tabs are clicked
    $('a', context).on('click', function(e) {
      history.pushState(null, null, this.href);
      showStuffFromHash(context);
    });

    return this;
  };
}(jQuery));

window.buildTabsets = function(tocID) {

  // build a tabset from a section div with the .tabset class
  function buildTabset(tabset) {

    // check for fade and pills options
    var fade = tabset.hasClass("tabset-fade");
    var pills = tabset.hasClass("tabset-pills");
    var navClass = pills ? "nav-pills" : "nav-tabs";

    // determine the heading level of the tabset and tabs
    var match = tabset.attr('class').match(/level(\d) /);
    if (match === null)
      return;
    var tabsetLevel = Number(match[1]);
    var tabLevel = tabsetLevel + 1;

    // find all subheadings immediately below
    var tabs = tabset.find("div.section.level" + tabLevel);
    if (!tabs.length)
      return;

    // create tablist and tab-content elements
    var tabList = $('<ul class="nav ' + navClass + '" role="tablist"></ul>');
    $(tabs[0]).before(tabList);
    var tabContent = $('<div class="tab-content"></div>');
    $(tabs[0]).before(tabContent);

    // build the tabset
    var activeTab = 0;
    tabs.each(function(i) {

      // get the tab div
      var tab = $(tabs[i]);

      // get the id then sanitize it for use with bootstrap tabs
      var id = tab.attr('id');

      // see if this is marked as the active tab
      if (tab.hasClass('active'))
        activeTab = i;

      // remove any table of contents entries associated with
      // this ID (since we'll be removing the heading element)
      $("div#" + tocID + " li a[href='#" + id + "']").parent().remove();

      // sanitize the id for use with bootstrap tabs
      id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
      tab.attr('id', id);

      // get the heading element within it, grab it's text, then remove it
      var heading = tab.find('h' + tabLevel + ':first');
      var headingText = heading.html();
      heading.remove();

      // build and append the tab list item
      var a = $('<a role="tab" data-toggle="tab">' + headingText + '</a>');
      a.attr('href', '#' + id);
      a.attr('aria-controls', id);
      var li = $('<li role="presentation"></li>');
      li.append(a);
      tabList.append(li);

      // set it's attributes
      tab.attr('role', 'tabpanel');
      tab.addClass('tab-pane');
      tab.addClass('tabbed-pane');
      if (fade)
        tab.addClass('fade');

      // move it into the tab content div
      tab.detach().appendTo(tabContent);
    });

    // set active tab
    $(tabList.children('li')[activeTab]).addClass('active');
    var active = $(tabContent.children('div.section')[activeTab]);
    active.addClass('active');
    if (fade)
      active.addClass('in');

    if (tabset.hasClass("tabset-sticky"))
      tabset.rmarkdownStickyTabs();
  }

  // convert section divs with the .tabset class to tabsets
  var tabsets = $("div.section.tabset");
  tabsets.each(function(i) {
    buildTabset($(tabsets[i]));
  });
};

</script>
<script>
window.initializeCodeFolding = function(show) {

  // handlers for show-all and hide all
  $("#rmd-show-all-code").click(function() {
    $('div.r-code-collapse').each(function() {
      $(this).collapse('show');
    });
  });
  $("#rmd-hide-all-code").click(function() {
    $('div.r-code-collapse').each(function() {
      $(this).collapse('hide');
    });
  });

  // index for unique code element ids
  var currentIndex = 1;

  // select all R code blocks
  var rCodeBlocks = $('pre.r, pre.python, pre.bash, pre.sql, pre.cpp, pre.stan, pre.julia');
  rCodeBlocks.each(function() {

    // create a collapsable div to wrap the code in
    var div = $('<div class="collapse r-code-collapse"></div>');
    if (show || $(this)[0].classList.contains('fold-show'))
      div.addClass('in');
    var id = 'rcode-643E0F36' + currentIndex++;
    div.attr('id', id);
    $(this).before(div);
    $(this).detach().appendTo(div);

    // add a show code button right above
    var showCodeText = $('<span>' + (show ? 'Hide' : 'Code') + '</span>');
    var showCodeButton = $('<button type="button" class="btn btn-default btn-xs code-folding-btn pull-right"></button>');
    showCodeButton.append(showCodeText);
    showCodeButton
        .attr('data-toggle', 'collapse')
        .attr('data-target', '#' + id)
        .attr('aria-expanded', show)
        .attr('aria-controls', id);

    var buttonRow = $('<div class="row"></div>');
    var buttonCol = $('<div class="col-md-12"></div>');

    buttonCol.append(showCodeButton);
    buttonRow.append(buttonCol);

    div.before(buttonRow);

    // update state of button on show/hide
    div.on('hidden.bs.collapse', function () {
      showCodeText.text('Code');
    });
    div.on('show.bs.collapse', function () {
      showCodeText.text('Hide');
    });
  });

}
</script>
<script>
window.initializeSourceEmbed = function(filename) {
  $("#rmd-download-source").click(function() {
    var src = $("#rmd-source-code").html();
    var a = document.createElement('a');
    a.href = "data:text/x-r-markdown;base64," + src;
    a.download = filename;
    document.body.appendChild(a);
    a.click();
    document.body.removeChild(a);
  });
};
</script>




<style type="text/css">
h1 {
  font-size: 34px;
}
h1.title {
  font-size: 38px;
}
h2 {
  font-size: 30px;
}
h3 {
  font-size: 24px;
}
h4 {
  font-size: 18px;
}
h5 {
  font-size: 16px;
}
h6 {
  font-size: 12px;
}
.table th:not([align]) {
  text-align: left;
}
#rmd-source-code {
  display: none;
}
</style>




<style type="text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
code {
  color: inherit;
  background-color: rgba(0, 0, 0, 0.04);
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
</style>

<style type="text/css">
.kable-table {
  border: 1px solid #ccc;
  border-radius: 4px;
  overflow: auto;
  padding-left: 8px;
  padding-right: 8px;
  margin-bottom: 20px;
  max-height: 350px;
}

.kable-table table {
  margin-bottom: 0px;
}

.kable-table table>thead>tr>th {
  border: none;
  border-bottom: 2px solid #dddddd;
}

.kable-table table>thead {
  background-color: #fff;
}
</style>


<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  background: white;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "";
  border: none;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->
<style type="text/css">
.code-folding-btn { margin-bottom: 4px; }
</style>




</head>

<body>


<div class="container-fluid main-container">




<div class="fluid-row" id="header">

<div class="btn-group pull-right">
<button type="button" class="btn btn-default btn-xs dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"><span>Code</span> <span class="caret"></span></button>
<ul class="dropdown-menu" style="min-width: 50px;">
<li><a id="rmd-download-source" href="#">Download Rmd</a></li>
</ul>
</div>



<h1 class="title toc-ignore">Pancreatobiliary Pathology Society Journal Watch</h1>
<h3 class="subtitle">Recent Articles that will be Selected</h3>
<h4 class="date">Last Update on 2020-07-02</h4>

</div>


<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<style type="text/css">

h1{
  text-align: center;
}
h2{
  text-align: center;
}
h3{
  text-align: center;
}
h4{
  text-align: center;
}
h4.date{
  text-align: center;
}

</style>
<!-- Open all links in new tab-->
<p><base target="_blank"></base></p>
<hr />
<div id="pbpath_jw" class="section level1 tabset tabset-fade tabset-pills">
<h1 class="tabset tabset-fade tabset-pills">PBPath Journal Watch Articles</h1>
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<hr />
<p><strong>Welcome to the PBPath Journal Watch!</strong></p>
<p>This bi-monthly journal watch features exciting recently published pancreas and biliary pathology articles that will provide up to date medical knowledge in our field. These articles will be showcased in several convenient categories, including surgical pathology, cytopathology, molecular pathology, pancreas, gallbladder, bile ducts, and ampulla among others. The articles in each category are in no particular order. See the list of journals we search regularly <a href="http://pbpath.org/pbpath-journal-watch/">here</a>. Previous months’ issues may be found in our <em><a href="http://pbpath.org/journal-watch-archive/">archive</a></em> and you may see <a href="http://pbpath.org/journal-watch-upcoming-issue/">drafts of the upcoming issue here</a>.</p>
<p>We encourage members to actively participate by recommending new articles and providing feedback using the <a href="#feedback" target="_self">forms provided below.</a></p>
<p><strong>We hope that you will enjoy the new PBPath Journal Watch!</strong></p>
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details>
<p><summary> Click here to see these articles and graphical summaries in other databases </summary></p>
<p>The <em>journal watch</em> articles are collected in <a href="https://doi.org/10.5281/zenodo.3635440">zenodo</a> and <a href="https://osf.io/3d67y/">OSF</a>.<br />
<a href="https://doi.org/10.5281/zenodo.3635440"><img src="data:image/svg+xml; charset=utf-8;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciCiAgICAgd2lkdGg9IjE4NiIgaGVpZ2h0PSIyMCI+CiAgICAgICAgPGxpbmVhckdyYWRpZW50IGlkPSJiIiB4Mj0iMCIgeTI9IjEwMCUiPgogICAgICAgICAgICA8c3RvcCBvZmZzZXQ9IjAiIHN0b3AtY29sb3I9IiNiYmIiIHN0b3Atb3BhY2l0eT0iLjEiLz4KICAgICAgICAgICAgPHN0b3Agb2Zmc2V0PSIxIiBzdG9wLW9wYWNpdHk9Ii4xIi8+CiAgICAgICAgPC9saW5lYXJHcmFkaWVudD4KICAgICAgICA8bWFzayBpZD0iYSIgd2lkdGg9IjE4NiIgaGVpZ2h0PSIyMCI+CiAgICAgICAgICAgIDxyZWN0IHdpZHRoPSIxODYiIGhlaWdodD0iMjAiIHJ4PSIzIgogICAgICAgICAgICBmaWxsPSIjZmZmIi8+CiAgICAgICAgPC9tYXNrPgogICAgICAgIDxnIG1hc2s9InVybCgjYSkiPgogICAgICAgICAgICA8cGF0aCBmaWxsPSIjNTU1IiBkPSJNMCAwaDMxdjIwSDB6IiAvPgogICAgICAgICAgICA8cGF0aCBmaWxsPSIjMDA3ZWM2IgogICAgICAgICAgICBkPSJNMzEgMGgxNTV2MjBIMzF6IgogICAgICAgICAgICAvPgogICAgICAgICAgICA8cGF0aCBmaWxsPSJ1cmwoI2IpIiBkPSJNMCAwaDE4NnYyMEgweiIgLz4KICAgICAgICA8L2c+CiAgICAgICAgPGcgZmlsbD0iI2ZmZiIgdGV4dC1hbmNob3I9Im1pZGRsZSIgZm9udC1mYW1pbHk9IkRlamFWdSBTYW5zLAogICAgICAgIFZlcmRhbmEsR2VuZXZhLHNhbnMtc2VyaWYiIGZvbnQtc2l6ZT0iMTEiPgogICAgICAgICAgICA8dGV4dCB4PSIxNiIgeT0iMTUiIGZpbGw9IiMwMTAxMDEiCiAgICAgICAgICAgIGZpbGwtb3BhY2l0eT0iLjMiPgogICAgICAgICAgICAgICAgRE9JCiAgICAgICAgICAgIDwvdGV4dD4KICAgICAgICAgICAgPHRleHQgeD0iMTYiIHk9IjE0Ij4KICAgICAgICAgICAgICAgIERPSQogICAgICAgICAgICA8L3RleHQ+CiAgICAgICAgICAgIDx0ZXh0IHg9IjEwOCIKICAgICAgICAgICAgeT0iMTUiIGZpbGw9IiMwMTAxMDEiIGZpbGwtb3BhY2l0eT0iLjMiPgogICAgICAgICAgICAgICAgMTAuNTI4MS96ZW5vZG8uMzYzNTQ0MAogICAgICAgICAgICA8L3RleHQ+CiAgICAgICAgICAgIDx0ZXh0IHg9IjEwOCIgeT0iMTQiPgogICAgICAgICAgICAgICAgMTAuNTI4MS96ZW5vZG8uMzYzNTQ0MAogICAgICAgICAgICA8L3RleHQ+CiAgICAgICAgPC9nPgogICAgPC9zdmc+" alt="DOI" /></a></p>
<p>To see these selected articles in <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32608526[uid] OR 32605910[uid] OR 32604170[uid] OR 32602003[uid] OR 32601356[uid] OR 32600082[uid] OR 32598087[uid] OR 32595109[uid] OR 32593808[uid] OR 32593337[uid] OR 32591464[uid] OR 32590950[uid] OR 32590886[uid] OR 32590619[uid] OR 32590618[uid] OR 32590617[uid] OR 32590541[uid] OR 32590541[uid] OR 32590456[uid] OR 32589187[uid] OR 32588265[uid] OR 32586937[uid] OR 32586351[uid] OR 32583198[uid] OR 32578066[uid] OR 32576698[uid] OR 32576148[uid] OR 32573984[uid] OR 32573775[uid] OR 32570025[uid] OR 32561070[uid] OR 32535975[uid] OR 32534711[uid] OR 32534711[uid] OR 32534704[uid] OR 32525623[uid] OR 32513848[uid] OR 32511899[uid] OR 32511134[uid] OR 32506819[uid] OR 32506156[uid] OR 32506156[uid] OR 32488621[uid] OR 32476131[uid] OR 32473032[uid] OR 32472717[uid] OR 32472097[uid] OR 32468246[uid] OR 32460791[uid] OR 32457409[uid] OR 32457408[uid] OR 32451945[uid] OR 32450151[uid] OR 32447492[uid] OR 32447492[uid] OR 32433407[uid] OR 32433400[uid] OR 32424767[uid] OR 32424583[uid] OR 32414657[uid] OR 32401429[uid] OR 32399832[uid] OR 32388775[uid] OR 32380013[uid] OR 32376951[uid] OR 32376198[uid] OR 32367668[uid] OR 32367502[uid] OR 32364613[uid] OR 32361926[uid] OR 32360245[uid] OR 32358589[uid] OR 32350415[uid] OR 32350089[uid] OR 32339496[uid] OR 32317534[uid] OR 32307617[uid] OR 32298138[uid] OR 32296928[uid] OR 32291497[uid] OR 32282768[uid] OR 32282767[uid] OR 32282764[uid] OR 32282761[uid] OR 32272125[uid] OR 32272125[uid] OR 32240619[uid] OR 32234757[uid] OR 32209898[uid] OR 32205290[uid] OR 32181510[uid] OR 32171280[uid] OR 32169826[uid] OR 32169826[uid] OR 32156747[uid] OR 32138704[uid] OR 32129902[uid] OR 32129902[uid] OR 32128564[uid] OR 32113937[uid]"> PubMed click here </a></p>
<p>To see these selected articles in <a href="https://www.lens.org/lens/scholar/search/results?q=pmid:32608526%20OR%20pmid:32605910%20OR%20pmid:32604170%20OR%20pmid:32602003%20OR%20pmid:32601356%20OR%20pmid:32600082%20OR%20pmid:32598087%20OR%20pmid:32595109%20OR%20pmid:32593808%20OR%20pmid:32593337%20OR%20pmid:32591464%20OR%20pmid:32590950%20OR%20pmid:32590886%20OR%20pmid:32590619%20OR%20pmid:32590618%20OR%20pmid:32590617%20OR%20pmid:32590541%20OR%20pmid:32590541%20OR%20pmid:32590456%20OR%20pmid:32589187%20OR%20pmid:32588265%20OR%20pmid:32586937%20OR%20pmid:32586351%20OR%20pmid:32583198%20OR%20pmid:32578066%20OR%20pmid:32576698%20OR%20pmid:32576148%20OR%20pmid:32573984%20OR%20pmid:32573775%20OR%20pmid:32570025%20OR%20pmid:32561070%20OR%20pmid:32535975%20OR%20pmid:32534711%20OR%20pmid:32534711%20OR%20pmid:32534704%20OR%20pmid:32525623%20OR%20pmid:32513848%20OR%20pmid:32511899%20OR%20pmid:32511134%20OR%20pmid:32506819%20OR%20pmid:32506156%20OR%20pmid:32506156%20OR%20pmid:32488621%20OR%20pmid:32476131%20OR%20pmid:32473032%20OR%20pmid:32472717%20OR%20pmid:32472097%20OR%20pmid:32468246%20OR%20pmid:32460791%20OR%20pmid:32457409%20OR%20pmid:32457408%20OR%20pmid:32451945%20OR%20pmid:32450151%20OR%20pmid:32447492%20OR%20pmid:32447492%20OR%20pmid:32433407%20OR%20pmid:32433400%20OR%20pmid:32424767%20OR%20pmid:32424583%20OR%20pmid:32414657%20OR%20pmid:32401429%20OR%20pmid:32399832%20OR%20pmid:32388775%20OR%20pmid:32380013%20OR%20pmid:32376951%20OR%20pmid:32376198%20OR%20pmid:32367668%20OR%20pmid:32367502%20OR%20pmid:32364613%20OR%20pmid:32361926%20OR%20pmid:32360245%20OR%20pmid:32358589%20OR%20pmid:32350415%20OR%20pmid:32350089%20OR%20pmid:32339496%20OR%20pmid:32317534%20OR%20pmid:32307617%20OR%20pmid:32298138%20OR%20pmid:32296928%20OR%20pmid:32291497%20OR%20pmid:32282768%20OR%20pmid:32282767%20OR%20pmid:32282764%20OR%20pmid:32282761%20OR%20pmid:32272125%20OR%20pmid:32272125%20OR%20pmid:32240619%20OR%20pmid:32234757%20OR%20pmid:32209898%20OR%20pmid:32205290%20OR%20pmid:32181510%20OR%20pmid:32171280%20OR%20pmid:32169826%20OR%20pmid:32169826%20OR%20pmid:32156747%20OR%20pmid:32138704%20OR%20pmid:32129902%20OR%20pmid:32129902%20OR%20pmid:32128564%20OR%20pmid:32113937&amp;toYear=2020&amp;fromYear=1950&amp;dateFilterField=year_published&amp;filterMap=%7B%7D&amp;preview=true"> Lens.org click here </a></p>
</details>
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<div style="page-break-after: always;"></div>
<div id="pancreas" class="section level2">
<h2>Pancreas</h2>
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Prevalence of histological features resembling autoimmune pancreatitis in neoplastic pancreas resections</strong> </summary></p>
<p><em>Histopathology 2020 Jul;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32608526" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32608526</a></p>
<p>INTRODUCTION: Type 1 and type 2 autoimmune pancreatitis (AIP) can mimic pancreatic neoplasia. Due to the small quantity of tissue in mass-targeted pancreas biopsies, inflammatory features may raise the differential of AIP. However, the frequency of AIP-like histology in neoplastic pancreas is not well characterized. Therefore, the specificity of inflammatory lesions on biopsy with respect to the diagnosis of AIP is uncertain. MATERIALS AND METHODS: Neoplastic pancreas resections performed at our institution between 2008 to 2019 were retrospectively reviewed. Features of AIP type 1 and 2 were assessed in the non-neoplastic areas. If features of IgG4-associated AIP were seen, IgG4 immunohistochemistry was performed. RESULTS: We identified 163 neoplastic pancreas resections. Of these, 34 had one or more types of inflammatory lesions in non-neoplastic pancreatic tissue. Dense lymphoplasmacytic inflammation mimicking type 1 AIP was found in 6 cases with mild to moderately increased IgG4 positive plasma cells. Neutrophilic infiltrates in small intralobular ducts were found in 20 cases. Mild extra-lobular ductitis or duct microabscess was found in 10 specimens. Marked neutrophilic duct destruction that resembled granulocytic epithelial lesions was found in 12 cases. Some cases showed multiple features. CONCLUSION: Approximately 20% of neoplastic pancreas resections showed focal areas that could raise the differential of AIP. More cases showed neutrophilic predominant inflammation, as seen in type 2 autoimmune pancreatitis, compared to dense lymphoplasmacytic infiltrates seen in type 1 AIP. Pathologists must be cautious when making a diagnosis of AIP on biopsy tissue based on histological findings alone.</p>
<p>doi: <a href="https://doi.org/10.1111/his.14197" class="uri">https://doi.org/10.1111/his.14197</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Circulating tumor DNA is prognostic and potentially predictive of eryaspase efficacy in second-line in patients with advanced pancreatic adenocarcinoma</strong> </summary></p>
<p><em>Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32605910" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32605910</a></p>
<p>BACKGROUND: Eryaspase is composed of L-asparaginase encapsulated in erythrocytes and has demonstrated significant efficacy in a randomized phase 2 trial. We assessed the prognostic and predictive value of circulating tumor DNA (ctDNA) in patients plasma included in this trial. PATIENTS AND METHODS: Samples prospectively collected pre-treatment were centrally analyzed by next-generation sequencing. Prognostic values of baseline ctDNA and ctDNA early changes between day 0 and 28 were assessed in both arms combined on objective response rate (ORR), progression free survival (PFS) and overall survival (OS); three groups were defined: negative ctDNA (Neg), ctDNA responders (Resp) and ctDNA non-responders (NResp). Predictive value of ctDNA for eryaspase efficacy was investigated. RESULTS: CtDNA was positive at baseline in 77 patients out of the 113 tested patients (68%). Detectable ctDNA was an independent negative prognostic factor for OS (4.6 vs 8.8 months; p=0.0025) and PFS (1.6 vs 3.3 months; p=0.00043). Early change in ctDNA levels was correlated with ORR (20 %, 26%, 0%; p&lt;0.04), PFS (3.7, 3.4, 1.6 months; p&lt;0.0001) and OS (11.7, 6.5, 4.3 months; p&lt;0.0001) according to the three defined groups (Neg, Res, NResp, respectively). In patients with ctDNA detectable at baseline, eryaspase was associated with better PFS (HR=0.53; 95% CI: 0.3-0.94) and OS (HR=0.52; 95% CI: 0.29-0.91). CONCLUSIONS: We confirm from a prospective randomized trial that 1/ the presence of ctDNA at baseline is a major prognostic factor, 2/ the early change of ctDNA correlates with treatment outcome and 3/ the ctDNA could be a predictive biomarker of eryaspase efficacy.</p>
<p>doi: <a href="https://doi.org/10.1158/1078-0432.CCR-20-0950" class="uri">https://doi.org/10.1158/1078-0432.CCR-20-0950</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>A Morphologic and Immunohistochemical Comparison of Nuclear ��-Catenin Expressing Testicular Sertoli Cell Tumors and Pancreatic Solid Pseudopapillary Neoplasms Supporting Their Continued Separate Classification</strong> </summary></p>
<p><em>The American journal of surgical pathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32604170" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32604170</a></p>
<p>Some recent reports suggested that many Sertoli cell tumors, not otherwise specified (SCTs-NOS) of the testis were analogs of the solid pseudopapillary neoplasm (SPN) of the pancreas. One of the most relied on pieces of information for this assertion was the shared occurrence in both neoplasms of exon 3 mutations of the CTNNB1 gene, which was reflected by nuclear β-catenin expression. We, therefore, compared the morphologic and immunohistochemical features of 18 SCTs-NOS with strong, diffuse nuclear β-catenin expression with 16 SPNs that also showed such positivity. Although there were clear similarities in the light microscopic features of these neoplasms, there were also significant differences that included, in SCT-NOS and SPN, respectively: hollow tubules (53% vs. 0%), sheet-like growth (44% vs. 94%), circumscription (79% vs. 25%), corded or trabecular patterns (81% vs. 31%), formation of papillae or pseudopapillae (24% vs. 69%), growth in nests or clusters (94% vs. 50%), perivascular pseudorosettes (13% vs. 56%), and rhabdoid cytology (6% vs. 50%). Commonly shared morphologic features included signet-ring cells, pale or foamy cytoplasm, myxoid stroma, cyst formation, perivascular hyalinization, and globular or band-like basement membrane deposits. On immunohistochemical study, sex cord markers were frequently positive in SCTs-NOS (steroidogenic factor-1-94%; FOXL2-87%; SOX9-69%; calretinin-60%; Wilms tumor-1-38%; inhibin-29%) whereas all of these markers were negative in the SPNs. We conclude that even though SCT-NOS and SPN share some morphologic features and nuclear immunoreactivity for β-catenin, there remain differences, both morphologically and immunohistochemically, between these neoplasms to the degree that SCT-NOS should not be equated with pancreatic SPN.</p>
<p>doi: <a href="https://doi.org/10.1097/PAS.0000000000001527" class="uri">https://doi.org/10.1097/PAS.0000000000001527</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Landscape of RAS Variations in 17,993 Pan-cancer Patients Identified by Next-generation Sequencing</strong> </summary></p>
<p><em>Pathology oncology research : POR 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32602003" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32602003</a></p>
<p>RAS family genes (HRAS, KRAS and NRAS) were frequently observed in several tumors. The expression of constitutively active RAS proteins mediated by RAS variations promote the development of tumors. KRAS is an important prognostic and drug resistance biomarker. It would also be a promising drug target. Several trials which evaluating the efficacy of RAS G12C inhibitor in solid tumors are initiated. Herein, we analyzed the alterations status of KRAS/NRAS/HRAS across diverse solid tumors. The sing nucleotide variants (SNV) and copy number variants (CNV) data of 17993 Chinese patients from 22 types of cancer were obtained in our database. Genomic profiling of DNA was performed through a next-generation sequencing on tissue. Only the pathogenic mutations and likely pathogenic mutations in clinical significance were rolled into our analysis. Among 17993 pan-cancer patients, the total RAS variants frequency was 22.58%. KRAS was the most frequently altered, followed by NRAS and HRAS. For the SNV, KRAS were most commonly found in pancreas cancer, intestine cancer and colorectal cancer. Further analysis among KRAS SNV patients showed that the mutation frequency of KRAS G12C, G12D, G12R, and G12V was 1.81%, 6.81%, 0.69% and 4.25%, respectively. A total of 21 in 22 types of solid tumors had KRAS G12C/D/R/V pathogenic or likely pathogenic mutation, which occurred most frequently in colorectal cancer, pancreas cancer and lung cancer. Our results suggested that a variety of solid tumors may harbor KRAS G12C/D/R/V mutation. These patients may benefit from KRAS inhibitors.</p>
<p>doi: <a href="https://doi.org/10.1007/s12253-020-00845-9" class="uri">https://doi.org/10.1007/s12253-020-00845-9</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Multiclass cancer classification in fresh frozen and formalin-fixed paraffin-embedded tissue by DigiWest multiplex protein analysis</strong> </summary></p>
<p><em>Laboratory investigation; a journal of technical methods and pathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32601356" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32601356</a></p>
<p>Histomorphology and immunohistochemistry are the most common ways of cancer classification in routine cancer diagnostics, but often reach their limits in determining the organ origin in metastasis. These cancers of unknown primary, which are mostly adenocarcinomas or squamous cell carcinomas, therefore require more sophisticated methodologies of classification. Here, we report a multiplex protein profiling-based approach for the classification of fresh frozen and formalin-fixed paraffin-embedded (FFPE) cancer tissue samples using the digital western blot technique DigiWest. A DigiWest-compatible FFPE extraction protocol was developed, and a total of 634 antibodies were tested in an initial set of 16 FFPE samples covering tumors from different origins. Of the 303 detected antibodies, 102 yielded significant correlation of signals in 25 pairs of fresh frozen and FFPE primary tumor samples, including head and neck squamous cell carcinomas (HNSC), lung squamous cell carcinomas (LUSC), lung adenocarcinomas (LUAD), colorectal adenocarcinomas (COAD), and pancreatic adenocarcinomas (PAAD). For this signature of 102 analytes (covering 88 total proteins and 14 phosphoproteins), a support vector machine (SVM) algorithm was developed. This allowed for the classification of the tissue of origin for all five tumor types studied here with high overall accuracies in both fresh frozen (90.4%) and FFPE (77.6%) samples. In addition, the SVM classifier reached an overall accuracy of 88% in an independent validation cohort of 25 FFPE tumor samples. Our results indicate that DigiWest-based protein profiling represents a valuable method for cancer classification, yielding conclusive and decisive data not only from fresh frozen specimens but also FFPE samples, thus making this approach attractive for routine clinical applications.</p>
<p>doi: <a href="https://doi.org/10.1038/s41374-020-0455-y" class="uri">https://doi.org/10.1038/s41374-020-0455-y</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Duration-dependent effects induced by titanium dioxide nanoparticles on pancreas of adult male albino rats (histological and biochemical study)</strong> </summary></p>
<p><em>Ultrastructural pathology 2020 Jun;():1-17</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32600082" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32600082</a></p>
<p>Titanium dioxide nanoparticles (TiO2NPs) have been widely used in numerous applications and enter the human body through different routes. This study aimed to investigate the effect of intraperitoneal TiO2NPs on the histological and biochemical structure of rat pancreas. Fifty adult male albino rats were divided into four groups. Group I (control) was equally divided into two subgroups. Groups II, III, and IV: rats received intraperitoneal TiO2NPs for 7, 14, and 45 days, respectively. Blood samples were taken for the estimation of blood glucose, serum insulin, serum α-amylase, and lipase activity levels. Sections of the pancreas were processed for light, electron microscope examination, and immunohistochemical detection of insulin protein. Other parts were exposed to Real-Time Polymerase Chain Reaction for Bax, Bcl-2, SOD, and GST mRNA gene expression. Results showed pancreatic tissue damage, including acinar and islet cells, which became worse with increased duration of exposure to TiO2NPs. Decreased immune expression of the insulin protein together with decreased serum insulin and increased blood glucose levels indicated the alteration of β cells. Decreased serum α-amylase and lipase activities indicated alteration of acinar cells. Increased Bax and decreased Bcl-2 mRNA expression levels showed the apoptotic effect of TiO2NPs caused by oxidative stress and evidenced by a significant reduction in the mRNA expression of SOD and GST in a duration-dependent manner. In conclusion: the present study stated that TiO2NPs exposure for long durations had toxic effects on both exocrine and endocrine pancreas mediated by apoptotic and oxidative stress pathways.</p>
<p>doi: <a href="https://doi.org/10.1080/01913123.2020.1786203" class="uri">https://doi.org/10.1080/01913123.2020.1786203</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Next-generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study</strong> </summary></p>
<p><em>Cancer cytopathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32598087" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32598087</a></p>
<p>BACKGROUND: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is a sensitive and specific tool in the risk stratification of pancreatic lesions, including cysts. The sensitivity and specificity of EUS-FNA has been shown to improve when cytology is combined with next-generation sequencing (NGS). Ideally, fresh cyst fluid is used for NGS. In this pilot study, we explore the possibility of sequencing DNA derived from residual alcohol-fixed pancreatic aspirates. METHODS: Residual cytologic fixatives (n = 42) from 39 patients who underwent EUS-FNA for pancreatic lesions were collected along with demographics, imaging, and laboratory studies. Samples were designated as nonneoplastic/nonmucinous benign (NB), mucinous cyst (MC), pancreatic ductal adenocarcinoma (PDAC), or well-differentiated neuroendocrine tumor (NET) on the basis of cytopathologic evaluation and sequenced on the Oncomine platform (ThermoFisher Scientific, Waltham, Massachusetts). RESULTS: Ten of 14 (71.4%) MCs exhibited clinically significant variants, including KRAS, GNAS, and TP53. Ten of 15 (66.7%) PDACs had KRAS alterations, and 9 of 15 (60%) showed variants in TP53. No variants were detected in any NETs. Only 1 of 9 (11.1%) NB aspirates showed variants in KRAS and MAP2K. Sequencing of formalin-fixed, paraffin-embedded tissue revealed variants identical to those detected in fixative-derived DNA in 4 of 5 cases (80%). CONCLUSION: Residual DNA from alcohol-fixed aspirates are an underutilized source for NGS. Sequencing residual fixative-derived DNA has the potential to be integrated into the workup of pancreatic aspirates, possibly impacting management.</p>
<p>doi: <a href="https://doi.org/10.1002/cncy.22315" class="uri">https://doi.org/10.1002/cncy.22315</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Reduction of inflammation in chronic pancreatitis using a soy bread intervention: A feasibility study</strong> </summary></p>
<p><em>Pancreatology : official journal of the International Association of Pancreatology (IAP) … [et al.] 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32595109" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32595109</a></p>
<p>INTRODUCTION: Chronic pancreatitis is a chronic inflammatory disease, which progresses to fibrosis. Currently there are no interventions to delay or stop the progression to irreversible organ damage. In this study, we assessed the tolerability and feasibility of administering soy bread to reduce circulating inflammatory mediators. METHODS: Subjects with chronic pancreatitis diagnosed using the American Pancreatic Association diagnostic guidelines were enrolled. During the dose escalation (DE) phase, subjects received one week of soy bread based using a 3 + 3 dose-escalation design, which was then followed by a maximally tolerated dose (MTD) phase with four weeks of intervention. Dose-limiting toxicities (DLTs) were monitored. Plasma cytokine levels were measured using a Meso Scale Discovery multiplex assay kit. Isoflavonoid excretion in 24-h urine collection was used to measure soy bread compliance. RESULTS: Nine subjects completed the DE phase, and one subject completed the MTD phase without any DLTs at a maximum dosage of three slices (99 mg of isoflavones) per day. Reported compliance to soy bread intervention was 98%, and this was confirmed with urinary isoflavones and their metabolites detected in all subjects. There was a significant decline in the TNF-α level during the DE phase (2.667 vs 2.382 pg/mL, p = 0.039); other levels were similar. CONCLUSIONS: In this feasibility study, there was excellent compliance with a short-term intervention using soy bread in chronic pancreatitis. Reduction was seen in at least one pro-inflammatory cytokine with short-term intervention. Larger cohorts and longer interventions with soy are warranted to assess the efficacy of reducing pro-inflammatory mediators of disease.</p>
<p>doi: <a href="https://doi.org/10.1016/j.pan.2020.04.018" class="uri">https://doi.org/10.1016/j.pan.2020.04.018</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>CRABP2 and FABP5 expression levels in diseased and normal pancreas</strong> </summary></p>
<p><em>Annals of diagnostic pathology 2020 Jun;47():151557</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32593808" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32593808</a></p>
<p>Recently, stromal targeting, by agents such as All trans retinoic acid (ATRA), has been regarded as a promising avenue for the treatment of pancreatic ductal adenocarcinoma (PDAC). The intra-cellular transportation of ATRA to the nuclear receptors is performed by either: fatty acid binding protein 5 (FABP5) or cellular retinoic acid binding protein 2 (CRABP2), dictating the transcription of downstream genes and, thus, eventual cell phenotype. Here, we explored the levels of each protein, in pancreatic tissues of patients presenting with a range of pancreatic diseases (pancreatic ductal adenocarcinoma (PDAC), chronic pancreatitis (CP), cholangiocarcinoma (CC)). We demonstrate that there is a significantly lower CRABP2 and FABP5 expression in activated fibroblasts or pancreatic stellate cells (PSC) in PDAC, as well as other diseased pancreas as in CC and CP, versus quiescent fibroblasts. The quiescent fibroblasts consistently show a pattern of high FABP5:CRABP2 ratio, whereas PSC in all non-PDAC tissues showed a low FABP5:CRABP2 ratio. PSC in PDAC patients had a range of FABP5:CRABP2 ratios (high, even and low). There was a lower CRABP2 expression in cancerous epithelial cells (PDAC) versus normal epithelial cells. This is also present in other disease states (CP, CC). Contrasting to the patterns seen for fibroblasts, the FABP5 expression in PDAC epithelial cells matched that of the normal epithelial cells. However, the normal epithelial cells had a high FABP5:CRABP2 ratio, compared to the PDAC epithelial cells. These ratios may have correlation with tumor progression, and overall survival. These findings could be confirmed in in vitro cell lysates. CRABP2 and FABP5 levels and ratios could serve as valuable biomarkers.</p>
<p>doi: <a href="https://doi.org/10.1016/j.anndiagpath.2020.151557" class="uri">https://doi.org/10.1016/j.anndiagpath.2020.151557</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Pancreatic cancer</strong> </summary></p>
<p><em>Lancet (London, England) 2020 Jun;395(10242):2008-2020</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32593337" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32593337</a></p>
<p>Pancreatic cancer is a highly fatal disease with a 5-year survival rate of approximately 10% in the USA, and it is becoming an increasingly common cause of cancer mortality. Risk factors for developing pancreatic cancer include family history, obesity, type 2 diabetes, and tobacco use. Patients typically present with advanced disease due to lack of or vague symptoms when the cancer is still localised. High quality computed tomography with intravenous contrast using a dual phase pancreatic protocol is typically the best method to detect a pancreatic tumour and to determine surgical resectability. Endoscopic ultrasound is an increasingly used complementary staging modality which also allows for diagnostic confirmation when combined with fine needle aspiration. Patients with pancreatic cancer are often divided into one of four categories based on extent of disease: resectable, borderline resectable, locally advanced, and metastatic; patient condition is also an important consideration. Surgical resection represents the only chance for cure, and advancements in adjuvant chemotherapy have improved long-term outcomes in these patients. Systemic chemotherapy combinations including FOLFIRINOX (5-fluorouracil, folinic acid [leucovorin], irinotecan, and oxaliplatin) and gemcitabine plus nab-paclitaxel remain the mainstay of treatment for patients with advanced disease. Data on the benefit of PARP inhibition as maintenance therapy in patients with germline BRCA1 or BRACA2 mutations might prove to be a harbinger of advancement in targeted therapy. Additional research efforts are focusing on modulating the pancreatic tumour microenvironment to enhance the efficacy of the immunotherapeutic strategies.</p>
<p>doi: <a href="https://doi.org/10.1016/S0140-6736(20)30974-0" class="uri">https://doi.org/10.1016/S0140-6736(20)30974-0</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>A Phase 2 Study of Allogeneic GM-CSF Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer</strong> </summary></p>
<p><em>Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32591464" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32591464</a></p>
<p>PURPOSE: This phase 2 study tested granulocyte-macrophage colony-stimulating factor-secreting allogeneic pancreatic tumor cells (GVAX) and ipilimumab in metastatic pancreatic ductal adenocarcinoma (PDA) in the maintenance setting. METHODS: Patients with PDA who were treated with front-line chemotherapy consisting of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) in the metastatic setting and had ongoing response or stable disease after 8-12 doses were eligible. Patients were randomized 1:1 to treatment with GVAX and ipilimumab given every 3 weeks for 4 doses then every 8 weeks (Arm A) or to FOLFIRINOX continuation (Arm B). The primary objective was to compare overall survival (OS) between the two arms. RESULTS: Eighty-two patients were included in the final analysis (Arm A: 40; Arm B: 42). The study was stopped for futility after interim analysis. Median overall survival (OS) was 9.38 months (95% CI: 5.0, 12.2) for Arm A and 14.7 months (95% CI: 11.6, 20.0) for Arm B (HR 1.75, p=0.019). Using immune related-response criteria, 2 partial responses (5.7%) were observed in Arm A and 4 (13.8%) in Arm B. GVAX + ipilimumab promoted T cell differentiation into effector memory phenotypes both in the periphery and in the tumor microenvironment and increased M1 macrophages in the tumor. CONCLUSIONS: GVAX and ipilimumab maintenance therapy did not improve OS over continuation of chemotherapy and resulted in a numerically inferior survival in metastatic PDA. However, clinical responses and biological effects on immune cells were observed. Further study of novel combinations in the maintenance treatment of metastatic PDA is feasible.</p>
<p>doi: <a href="https://doi.org/10.1158/1078-0432.CCR-20-1025" class="uri">https://doi.org/10.1158/1078-0432.CCR-20-1025</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas harboring KRAS and BRCA mutations: case report and whole exome sequencing analysis</strong> </summary></p>
<p><em>BMC gastroenterology 2020 Jun;20(1):202</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32590950" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32590950</a></p>
<p>BACKGROUND: Undifferentiated carcinoma with osteoclast-like giant cells (UC-OGC) is an extremely uncommon pancreatic neoplasm that comprises less than 1% of all exocrine pancreatic tumors. To date, cases and data from whole-exome sequencing (WES) analysis have been reported by specific studies. We report a case of pancreatic UC-OGC with a literature review, and provide novel insights into the molecular characteristics of this tumor entity. CASE PRESENTATION: A 31-year-old male presented with intermittent abdominal pain for several months, and positron emission tomography (PET) showed isolated high metabolic nodules during the pancreatic uncinate process that were likely to be malignant disease. Pathological examination after radical excision revealed UC-OGC associated with poorly differentiated adenocarcinoma at the head of the pancreas. The disease recurred 7.4 months after radical surgery. The KRAS p.G12D (c.35G &gt; A) and somatic BRCA2 p.R2896C (c.8686C &gt; T) mutations were detected by subsequent WES analysis. The patient showed no response to platinum-based systemic chemotherapy, and his condition quickly worsened. He finally died, with an overall survival of 1 year. CONCLUSIONS: As an extremely uncommon tumor entity, UC-OGC is really a unique variant of conventional pancreatic ductal adenocarcinoma due to its similarities, as shown by genomic WES analysis. Clinical examination and molecular analysis by WES could further indicate potential treatment strategies for UC-OGC.</p>
<p>doi: <a href="https://doi.org/10.1186/s12876-020-01351-7" class="uri">https://doi.org/10.1186/s12876-020-01351-7</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Optimal Treatment for Octogenarians With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study</strong> </summary></p>
<p><em>Pancreas 2020 Jul;49(6):837-844</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32590619" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32590619</a></p>
<p>OBJECTIVES: The objective of this study was to clarify the role of pancreatectomy for patients with resectable and borderline resectable pancreatic ductal adenocarcinoma aged 80 years or older using a nationwide audit by the Japan Pancreas Society. METHODS: Data were collected from 39 institutions from 2007 to 2014. The primary endpoint was overall survival, and secondary endpoints were surgical outcomes and predictive factors for prognosis. RESULTS: Data were obtained from 556 octogenarians who underwent pancreatectomy (n = 369, 66%), chemo(radio)therapy (n = 99, 18%), and palliative therapy (n = 88, 16%). Median survival times were 20.6, 18.6, and 8.8 months in each group, respectively. Even after propensity score matching, median survival time in the surgery group (22.8 months) was significantly higher than that in the chemotherapy group (18.5 months; hazard ratio, 0.64 [95% confidence interval, 0.44-0.93]; P = 0.020). Significant independent prognostic factors were body mass index, lymph node metastasis, and tumor diameter in the surgery group, and serum albumin level, American Society of Anesthesiologists classification, body mass index, modified Glasgow prognostic score, second-line chemotherapy, and tumor diameter in the chemotherapy group. CONCLUSIONS: Octogenarians with resectable/borderline resectable pancreatic ductal adenocarcinoma can be recommended for pancreatectomy according to mental and physical fitness for surgical procedures.</p>
<p>doi: <a href="https://doi.org/10.1097/MPA.0000000000001579" class="uri">https://doi.org/10.1097/MPA.0000000000001579</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Matrix Metalloproteinase 11 as a Novel Tumor Promoter and Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma</strong> </summary></p>
<p><em>Pancreas 2020 Jul;49(6):812-821</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32590618" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32590618</a></p>
<p>OBJECTIVES: Matrix metalloproteinase 11 (MMP-11) was found to be implicated in tumorigenesis in cancers. However, the significance of MMP-11 in pancreatic ductal adenocarcinoma (PDAC) is unclear. METHODS: In the study, we detected malignant biological behaviors of pancreatic cancer after downregulation of MMP-11. Furthermore, we explored the possible mechanism, and the diagnostic value of serum MMP-11 level was analyzed in 116 patients with pathologically confirmed PDAC. In addition, we explored their prognostic value in PDAC. RESULTS: We observed that MMP-11 could be expressed and activated in the cytoplasm of PDAC cells. Immunohistochemistry staining of PDAC tissues showed that MMP-11 was highly expressed in cancerous ductal epithelium instead of cancer stroma. We found that downregulation of MMP-11 inhibited proliferation of PDAC cell lines. The expression levels of cyclin-dependent kinase 4 and cyclin D1 were downregulated after MMP-11 knockdown. As for its clinical value, the serum level of MMP-11 was shown to be a potent promising diagnostic marker for PDAC. CONCLUSIONS: Matrix metalloproteinase 11 may act as a tumor promoter, playing a positive role in PDAC development. Serum MMP-11 also has great potential to be a promising diagnostic marker for PDAC.</p>
<p>doi: <a href="https://doi.org/10.1097/MPA.0000000000001583" class="uri">https://doi.org/10.1097/MPA.0000000000001583</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Carbon Ion Radiotherapy in the Treatment of Pancreatic Cancer: A Review</strong> </summary></p>
<p><em>Pancreas 2020 Jul;49(6):737-743</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32590617" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32590617</a></p>
<p>Pancreatic cancer is the fourth most common cause of cancer-related morality worldwide, and the prognosis remains poor despite aggressive therapy. Carbon ion radiotherapy has favorable radiobiological and physical characteristics in the treatment, including a higher linear energy transfer and higher relative biological effectiveness, which increase the cell kill while potentially reducing toxicities to nearby normal tissues. Although small, early clinical studies have shown promise in both the resectable and unresectable settings to improve local control and overall survival while minimizing toxicities. Currently, there are several trials, including 2 sponsored by institutions in the United States, investigating the role of carbon ion radiotherapy for the treatment of locally advanced pancreatic cancer.</p>
<p>doi: <a href="https://doi.org/10.1097/MPA.0000000000001566" class="uri">https://doi.org/10.1097/MPA.0000000000001566</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytologic Evaluation of Intraductal Papillary Mucinous Neoplasm and Mucinous Cystic Neoplasms of Pancreas</strong> </summary></p>
<p><em>American journal of clinical pathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32589187" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32589187</a></p>
<p>OBJECTIVES: To evaluate the role of endoscopic ultrasound-guided fine needle aspiration cytology in identifying mucinous cystic lesions (MCLs) in histologically proven cases of intraductal papillary mucinous neoplasm (IPMN) or mucinous cystic neoplasm (MCN) and risk of malignancy associated with each cytologic category based on the Papanicolaou Society of Cytopathology (PSC) guidelines. METHODS: All resected cases with histologic diagnosis of IPMN or MCN at our institution from January 1, 2004, to August 31, 2019, with associated cytology were included. Available cytology slides of nondiagnostic (ND), negative/benign (BN), and atypical cytology (AC) cases were reviewed and reclassified based on the PSC guidelines. RESULTS: A total of 120 cases were identified, including 57 IPMNs with low-grade or moderate dysplasia (LGD/MD) and high-grade dysplasia (HGD), 34 MCNs with LGD/MD or HGD, and 29 IPMNs with invasive malignancy. After cytology slide review and reclassification, we observed that ND and BN cases were paucicellular and lacked ancillary testing (carcinoembryonic antigen levels or KRAS mutation analysis). The risk-of-malignancy rates were 33% for ND, 11% for BN, 28.5% for AC, 17% for MCL, and 100% for suspicious/positive cytologic diagnosis. CONCLUSIONS: A multidisciplinary approach including combined use of cytology and ancillary testing is helpful in establishing a diagnosis of MCL and identifying associated malignancy.</p>
<p>doi: <a href="https://doi.org/10.1093/ajcp/aqaa079" class="uri">https://doi.org/10.1093/ajcp/aqaa079</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Distal Pancreatectomy with Celiac Axis Resection (Modified Appleby Procedure) and Arterial Reconstruction for Locally Advanced Pancreatic Adenocarcinoma After FOLFIRINOX Chemotherapy and Chemoradiation Therapy</strong> </summary></p>
<p><em>Annals of surgical oncology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32588265" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32588265</a></p>
<p>BACKGROUND: Resectability of pancreatic carcinoma (PC) is directly linked to vascular extension (Tempero MA et al. in J Natl Compr Canc Netw 15(8):1028-1061, 2017. <a href="https://doi.org/10.6004/jnccn.2017.0131" class="uri">https://doi.org/10.6004/jnccn.2017.0131</a>; Isaji S et al. in Pancreatology 18(1):2-11, 2018. <a href="https://doi.org/10.1016/j.pan.2017.11.011" class="uri">https://doi.org/10.1016/j.pan.2017.11.011</a>). Involvement of the celiac axis (CA) is typically a contraindication to surgery. High postoperative morbidity and subsequent poor prognosis have been observed in this case, especially for contact &gt; 180° requiring arterial resection (Tempero MA et al. 2017). Recent medical advances in PC treatment, such as FOLFIRINOX-based chemotherapy eventually followed by chemoradiation therapy, offer the potential to select tumour for surgery and to obtain a negative-margin resection even in case of unresectable PC at diagnosis (Suker M et al. in Lancet Oncol 17(6):801-10, 2016. <a href="https://doi.org/10.1016/s1470-2045(16)00172-8" class="uri">https://doi.org/10.1016/s1470-2045(16)00172-8</a>; Pietrasz D et al. in Ann Surg Oncol 26(1):109-117, 2019. <a href="https://doi.org/10.1245/s10434-018-6931-6" class="uri">https://doi.org/10.1245/s10434-018-6931-6</a>). A major pathologic response has been observed in more than 20% of patients after this treatment and is associated with an improved survival (Suker M et al. 2016; Pietrasz D et al. 2019). This evolution allows aggressive surgical strategies with the possibility of long-term disease control for patients showing a good response to induction treatment. PATIENT: This video presents the case of a 66-year-old man diagnosed with a locally advanced ductal adenocarcinoma of the pancreatic body with a 360° involvement of the CA and the hepatic artery. After eight courses of FOLFIRINOX chemotherapy and a capecitabin-based chemoradiation, a surgical exploration was planned for potential resection. TECHNIQUE: The key steps of the procedure are presented, i.e. surgical exposition, assessment of resectability with frozen sections of peri-arterial tissues, en bloc resection (Strasberg SM et al. in Surgery 133(5):521-527, 2003. <a href="https://doi.org/10.1067/msy.2003.146" class="uri">https://doi.org/10.1067/msy.2003.146</a>), and primary end-to-end arterial reconstruction. CONCLUSION: A modified Appleby operation for locally advanced PC is a technically challenging but feasible procedure in experienced teams. It offers the possibility of en bloc R0 resection of a locally advanced PC with the potential of long-term disease local control. This video may help surgeons to perform this complex intervention.</p>
<p>doi: <a href="https://doi.org/10.1245/s10434-020-08740-y" class="uri">https://doi.org/10.1245/s10434-020-08740-y</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: a Phase I Study</strong> </summary></p>
<p><em>Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32586937" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32586937</a></p>
<p>PURPOSE: The study goal was to determine safety, antitumor activity, and pharmacodynamic profile of mogamulizumab, an anti-CCR4 monoclonal antibody (mAb) targeting effector regulatory T cells (eTregs), in combination with mAb checkpoint inhibitors durvalumab or tremelimumab. EXPERIMENTAL DESIGN: This was a multicenter, phase I, dose-escalation study, followed by disease specific cohort expansion (NCT02301130). Mogamulizumab dose escalation proceeded with concurrent dose escalation of durvalumab or tremelimumab in patients with advanced solid tumors. Cohort expansion occurred with mogamulizumab 1 mg/kg plus durvalumab 10 mg/kg or tremelimumab 10 mg/kg in patients with advanced pancreatic cancer. RESULTS: Forty patients were enrolled during dose escalation, followed by 24 patients during dose expansion. No dose-limiting toxicities occurred during dose escalation. No new or unexpected toxicities were seen. Tolerability, the primary endpoint, was acceptable utilizing mogamulizumab 1 mg/kg plus durvalumab or tremelimumab 10 mg/kg in the combined dose-escalation and dose-expansion cohorts (each n = 19). At these doses, the objective response rate was 5.3% (95% CI: 0.1%, 26.0%) [1 partial response] with each combination treatment. At all doses, mogamulizumab treatment led to almost complete depletion of peripheral eTregs as well as reduction of intratumoral Tregs in the majority of patients. There was no clear correlation of clinical response with peripheral or intratumoral reduction in CCR4+ eTregs or with baseline degree of CCR4+ expression. CONCLUSIONS: Mogamulizumab in combination with durvalumab or tremelimumab did not result in potent antitumor efficacy in patients with advanced solid tumors. Tolerability of mogamulizumab 1 mg/kg combined with durvalumab or tremelimumab 10 mg/kg was acceptable.</p>
<p>doi: <a href="https://doi.org/10.1158/1078-0432.CCR-20-0328" class="uri">https://doi.org/10.1158/1078-0432.CCR-20-0328</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Predictors of surgical site infection after pancreaticoduodenectomy</strong> </summary></p>
<p><em>BMC gastroenterology 2020 Jun;20(1):201</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32586351" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32586351</a></p>
<p>BACKGROUND: Surgical site infection (SSI) is one of the most common complications after pancreaticoduodenectomy (PD). Thus, it is beneficial to preoperatively identify patients at high risk of developing SSI. The primary aim of the present study was to identify the factors associated with SSI after PD, and the secondary aim was to identify the adverse outcomes associated with the occurrence of SSI. METHODS: A single-centre retrospective study was conducted. All 280 patients who underwent PD at our institution from January 2008 to December 2018 were enrolled. Demographic and perioperative data were reviewed, and the potential risk factors for developing SSI and the adverse outcomes related to SSI were analysed. RESULTS: A total of 90 patients (32%) developed SSI. Fifty-one patients developed incisional SSI, and 39 developed organ/space SSI. Multivariate logistic analysis revealed that the significant risk factors for developing incisional SSI were preoperative biliary drainage (odds ratio, 3.04; 95% confidence interval, 1.36-6.79; p &lt; 0.05) and postoperative pancreatic fistula (odds ratio, 2.78; 95% confidence interval, 1.43-5.38; p &lt; 0.05), and the risk factors for developing organ/space SSI were preoperative cholangitis (odds ratio, 10.07; 95% confidence interval, 2.31-49.75; p &lt; 0.05) and pancreatic fistula (odds ratio, 6.531; 95% confidence interval, 2.30-18.51; p &lt; 0.05). Enterococcus spp., Escherichia coli and Klebsiella pneumoniae were the common bacterial pathogens that caused preoperative cholangitis as well as SSI after PD. The patients in the SSI group had a longer hospital stay and a higher rate of delayed gastric emptying than patients in the non-SSI group. CONCLUSIONS: The presence of postoperative pancreatic fistula was a significant risk factor for both incisional and organ/space SSI. Any efforts to reduce postoperative pancreatic fistula would decrease the incidence of incisional SSI as well as organ/space SSI after pancreaticoduodenectomy. Preoperative biliary drainage should be performed in selected patients to reduce the incidence of incisional SSI. Minimizing the occurrence of preoperative cholangitis would decrease the incidence of developing organ/space SSI.</p>
<p>doi: <a href="https://doi.org/10.1186/s12876-020-01350-8" class="uri">https://doi.org/10.1186/s12876-020-01350-8</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Predictors for Survival in an International Cohort of Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma</strong> </summary></p>
<p><em>Annals of surgical oncology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32583198" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32583198</a></p>
<p>BACKGROUND: Surgical factors, including resection of Gerota’s fascia, R0-resection, and lymph node yield, may be associated with survival after distal pancreatectomy (DP) for pancreatic ductal adenocarcinoma (PDAC), but evidence from large multicenter studies is lacking. This study aimed to identify predictors for overall survival after DP for PDAC, especially those related to surgical technique. PATIENTS AND METHODS: Data from an international retrospective cohort including patients from 11 European countries and the USA who underwent DP for PDAC (2007-2015) were analyzed. Cox proportional hazard analyses were performed and included Gerota’s fascia resection, R0 resection, lymph node ratio, extended resection, and a minimally invasive approach. RESULTS: Overall, 1200 patients from 34 centers with median follow-up of 15 months [interquartile range (IQR) 5-31 months] and median survival period of 30 months [95% confidence interval (CI), 27-33 months] were included. Gerota’s fascia resection [hazard ratio (HR) 0.74; p = 0.019], R0 resection (HR 0.70; p = 0.006), and decreased lymph node ratio (HR 0.28; p &lt; 0.001) were associated with improved overall survival, whereas extended resection (HR 1.75; p &lt; 0.001) was associated with worse overall survival. A minimally invasive approach did not improve survival as compared with an open approach (HR 1.14; p = 0.350). Adjuvant chemotherapy (HR 0.67; p = 0.003) was also associated with improved overall survival. CONCLUSIONS: This international cohort identified Gerota’s fascia resection, R0 resection, and decreased lymph node ratio as factors associated with improved overall survival during DP for PDAC. Surgeons should strive for R0 resection and adequate lymphadenectomy and could also consider Gerota’s fascia resection in their routine surgical approach.</p>
<p>doi: <a href="https://doi.org/10.1245/s10434-020-08658-5" class="uri">https://doi.org/10.1245/s10434-020-08658-5</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>HGT in the human and skin commensal Malassezia: A bacterially derived flavohemoglobin is required for NO resistance and host interaction</strong> </summary></p>
<p><em>Proceedings of the National Academy of Sciences of the United States of America 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32576698" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32576698</a></p>
<p>The skin of humans and animals is colonized by commensal and pathogenic fungi and bacteria that share this ecological niche and have established microbial interactions. Malassezia are the most abundant fungal skin inhabitant of warm-blooded animals and have been implicated in skin diseases and systemic disorders, including Crohn’s disease and pancreatic cancer. Flavohemoglobin is a key enzyme involved in microbial nitrosative stress resistance and nitric oxide degradation. Comparative genomics and phylogenetic analyses within the Malassezia genus revealed that flavohemoglobin-encoding genes were acquired through independent horizontal gene transfer events from different donor bacteria that are part of the mammalian microbiome. Through targeted gene deletion and functional complementation in Malassezia sympodialis, we demonstrated that bacterially derived flavohemoglobins are cytoplasmic proteins required for nitric oxide detoxification and nitrosative stress resistance under aerobic conditions. RNA-sequencing analysis revealed that endogenous accumulation of nitric oxide resulted in up-regulation of genes involved in stress response and down-regulation of the MalaS7 allergen-encoding genes. Solution of the high-resolution X-ray crystal structure of Malassezia flavohemoglobin revealed features conserved with both bacterial and fungal flavohemoglobins. In vivo pathogenesis is independent of Malassezia flavohemoglobin. Lastly, we identified an additional 30 genus- and species-specific horizontal gene transfer candidates that might have contributed to the evolution of this genus as the most common inhabitants of animal skin.</p>
<p>doi: <a href="https://doi.org/10.1073/pnas.2003473117" class="uri">https://doi.org/10.1073/pnas.2003473117</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears</strong> </summary></p>
<p><em>Cancer cytopathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32573984" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32573984</a></p>
<p>BACKGROUND: Insulinoma-associated protein 1 (INSM1) has recently emerged as a reliable nuclear immunostaining marker for detecting neuroendocrine tumors (NETs) in paraffin-embedded surgical samples and cytologic cell blocks, but the reliability of INSM1 staining on cytologic smears is understudied. This study investigated the performance of INSM1 staining on cytologic smears for the detection of various NETs in comparison with chromogranin (CG) and synaptophysin (SYN). METHODS: INSM1, CG, and SYN were stained on cytologic smears of 70 NETs, including 20 pancreatic NETs, 10 lung carcinoid tumors, 11 small cell lung carcinomas (SCLCs), 10 medullary thyroid carcinomas, 10 Merkel cell carcinomas, 4 thymic atypical carcinoid tumors, and 5 olfactory neuroblastomas. The detection rate, the percentage of positive cells, and the staining intensity were recorded. RESULTS: The overall detection rate of INSM1 (94%) was higher than the rates of CG (79%) and SYN (89%). The detection rate of INSM1 was higher than the rates of CG and SYN in SCLC, Merkel cell carcinoma, and olfactory neuroblastoma; higher than the rate of CG and equal to the rate of SYN in pancreatic NETs and medullary thyroid carcinoma; equal to the rate of CG and higher than the rate of SYN in thymic atypical carcinoid tumors; and equal to the rate of CG and lower than the rate of SYN in lung carcinoid tumors. INSM1 staining was easier to interpret than CG and SYN staining, especially in high-grade NETs. CONCLUSIONS: INSM1 can be reliably stained on cytologic smears and outperforms CG and SYN in the verification of clinically or radiologically suspected NETs.</p>
<p>doi: <a href="https://doi.org/10.1002/cncy.22310" class="uri">https://doi.org/10.1002/cncy.22310</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma</strong> </summary></p>
<p><em>Cancer 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32573775" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32573775</a></p>
<p>BACKGROUND: KRAS, TP53, CDKN2A, and SMAD4 are established driver genes in pancreatic ductal adenocarcinoma (PDAC). This study was aimed at determining whether the mutational status of driver genes and those involved in DNA repair pathways are associated with clinical outcomes for individuals who undergo resection. METHODS: Eligible individuals were those who underwent resection of PDAC and consented to targeted sequencing of their primary tumor via Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT). Genomic alterations were determined on the basis of MSK-IMPACT results from formalin-fixed, paraffin-embedded samples. Associations between genomic alterations and clinical outcomes were assessed. RESULTS: Targeted sequencing was performed on 283 primary tumors resected between 2004 and 2017. The median follow-up was 23 months among survivors. Alterations in KRAS and TP53 were associated with worse overall survival (OS) in comparison to wild type (median for KRAS, 38.8 months [95% CI, 33.0-45.5 months] vs 91.0 months [95% CI, 34.8 months to not available (NA)]; P = .043; median for TP53, 37.4 months [95% CI, 32.1-42.8 months] vs 65.0 months [95% CI, 33.0 months to NA]; P = .035). KRAS G12D mutations were associated with worse OS (median, 31.6 months [95% CI, 25.3-45.5 months] vs 39.2 months [95% CI, 37.4-75.2 months]; P = .012). TP53 truncating mutations (median, 39.6 months [95% CI, 32.4-75.2 months] vs 33.9 months [95% CI, 24.0-39.0 months]; P = .020) and those associated with loss of heterozygosity (median, 26.6 months [95% CI, 21.6-44.2 months] vs 39.2 months [95% CI, 34.5-49.1 months]; P = .048) had decreased OS. TP53 alterations were independently associated with OS in a multivariate analysis (hazard ratio, 1.54; 95% CI, 1.01-2.33; P = .042). Individuals with germline alterations in homologous recombination deficiency (HRD) genes had improved OS in comparison with those without them (median, not reached vs 37.0 months; 95% CI, 33.0-49.8 months; P = .035). CONCLUSIONS: In patients with resected PDAC, genomic alterations in KRAS and TP53 are associated with worse outcomes, whereas alterations in HRD genes are associated with a favorable prognosis. Further studies are needed to better define these alterations as biomarkers in resected PDAC.</p>
<p>doi: <a href="https://doi.org/10.1002/cncr.33038" class="uri">https://doi.org/10.1002/cncr.33038</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>The utility of immunohistochemical testing for mismatch repair proteins in fine needle aspiration specimens of pancreatic adenocarcinoma</strong> </summary></p>
<p><em>Annals of diagnostic pathology 2020 Jun;47():151552</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32570025" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32570025</a></p>
<p>INTRODUCTION: Microsatellite instability (MSI) testing is recommended for all colonic and endometrial carcinomas to screen for Lynch syndrome. The role of MSI testing in pancreatic adenocarcinoma has not been well-established. Screening can be done via immunohistochemical (IHC) staining for mismatch repair (MMR) proteins (MLH1, MSH2, MSH6, PMS2). We report our experience and the clinical utility of MMR IHC on pancreatic adenocarcinomas in fine-needle aspiration (FNA) specimens. MATERIALS AND METHODS: We performed a retrospective review to identify all patients diagnosed with pancreatic adenocarcinoma by FNA at our institution between December 2017 and September 2019. For cases with sufficient tumor cells for testing, the MMR results and morphology were summarized, as well as corresponding clinical information, including age, clinical stage, treatment, and concurrent other cancers. RESULTS: From December 2017 to September 2019, there were a total of 184 pancreatic FNAs with a diagnosis of adenocarcinoma. Of these 184 FNAs, 65 (35%) contained sufficient material in the cell block to perform IHC for MMR. The cell block material was collected in either RPMI or CytoLyt. Poor technical quality precluded interpretation of PMS2 in 4 cases and MSH6 in 2 cases. All other cases showed intact expression of all four proteins. CONCLUSIONS: IHC for MMR proteins can be done on specimens collected in RPMI or CytoLyt, but RPMI appears to be more reliable. None of the pancreatic adenocarcinomas in this study showed loss of MMR protein expression. Routine testing of MMR loss may not be indicated in pancreatic adenocarcinomas in the general patient population.</p>
<p>doi: <a href="https://doi.org/10.1016/j.anndiagpath.2020.151552" class="uri">https://doi.org/10.1016/j.anndiagpath.2020.151552</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging?</strong> </summary></p>
<p><em>Pancreatology : official journal of the International Association of Pancreatology (IAP) … [et al.] 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32561070" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32561070</a></p>
<p>BACKGROUND: Venous invasion is not included in the pancreatic ductal adenocarcinoma (PDAC) staging, and its correlation with prognosis remains unclear. We evaluated the prognostic impact of radiographic portal/superior mesenteric vein (PV/SMV) invasion, and its possibility of complementing T staging. METHODS: We identified patients with non-metastatic PDAC using our institutional cohort, and divided them according to PV/SMV invasion at imaging, defined as &gt;180-degree tumor-vessel interface or contour deformity. We conducted Cox proportional hazard regression, and compared survival in the original and 1:1 propensity score matched datasets. RESULTS: We identified 454 patients [PV/SMV(+): 172; PV/SMV(-): 282]. In the multivariate analysis, PV/SMV invasion, age (≥70 years), performance status, tumor size (2-4, &gt;4 cm), lymph nodes &gt;4, and arterial invasion was correlated with prognosis. The PV/SMV(+) group had a shorter overall survival (OS) than the PV/SMV(-) group in the original (14.4 vs. 20.9 months; P &lt; 0.001) and matched datasets (14.3 vs. 17.2 months; P = 0.009). Among patients without arterial invasion (cT1-cT3), the PV/SMV(+) group had a shorter OS (15.9 vs. 21.2 months; P = 0.002). Moreover, their OS did not differ from that of patients with arterial invasion (cT4) (15.9 vs. 14.4 months; P = 0.907). Patients with vessel (artery/vein) invasion had a shorter OS than those without vessel invasion (14.5 vs. 21.2 months; P &lt; 0.001). CONCLUSIONS: Radiographic PV/SMV invasion in non-metastatic PDAC was correlated with a poor prognosis. It could identify a group with shorter OS among patients without arterial invasion (cT1-cT3). It is suggested that inclusion of PV/SMV invasion in clinical T4 criteria should be considered.</p>
<p>doi: <a href="https://doi.org/10.1016/j.pan.2020.05.017" class="uri">https://doi.org/10.1016/j.pan.2020.05.017</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>The applicability of Papanicolaou Society of Cytopathology system on reporting endoscopic ultrasound guided fine needle aspiration cytology specimens of pancreatic lesions in situations with limited availability of ancillary tests. Experience at a single laboratory</strong> </summary></p>
<p><em>Cytopathology : official journal of the British Society for Clinical Cytology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32535975" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32535975</a></p>
<p>OBJECTIVE: The Papanicolaou Society of Cytopathology (PSC) system of reporting pancreatobiliary cytology is a standardized reporting nomenclature which uses a six-tiered scheme of diagnostic categories utilizing routine microscopy and ancillary tests such as biochemical and molecular analysis of cyst fluids and immunochemistry. The objective of this study was to determine the applicability of the PSC system on endoscopic ultrasound guided fine needle aspiration cytology (EUS-FNAC) samples reported at the cytopathology laboratory, Mubarak Al Kabeer Hospital, in Kuwait with special emphasis on situations with limited availability of ancillary tests. METHODS: 132 cases of EUS-FNAC samples from pancreatic lesions were categorized according to PSC system guidelines after examining the glass slides and reviewing the clinical, imaging and ancillary test findings. These review diagnoses were compared with the diagnoses rendered during initial reporting. Correlation with histopathology reports was done wherever available. RESULTS: In 23 (17.42 %) of 132 cases, recategorization was necessary between initial and reviewed diagnoses. In 16 cases, recategorizations were because of non-analogous categories between initial and reviewed diagnosis. In the remaining seven, they were due to identification of newer cytomorphological and imaging findings or because of issues arising from unavailability of sufficient material for ancillary investigations. CONCLUSION: All cases could be categorized using the PSC system with a moderate number of recategorizations between initial and reviewed diagnoses. In certain circumstances, limited availability of ancillary tests, resulted in non-diagnostic categories whereas in other such circumstances, diagnostic categories could be assigned with certain conceptual modifications to the PSC guidelines.</p>
<p>doi: <a href="https://doi.org/10.1111/cyt.12873" class="uri">https://doi.org/10.1111/cyt.12873</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Synchronous detection of SDHA-related gallbladder paraganglioma and pancreatic neuroendocrine tumor</strong> </summary></p>
<p><em>Pathology, research and practice 2020 Jul;216(7):153006</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32534711" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32534711</a></p>
<p>Primary gallbladder paragangliomas (PGLs) are exceedingly rare. PGLs are extraadrenal neuroendocrine tumors that are morphologically inseparable from intraadrenal pheochromocytomas. PGLs and pheochromocytomas are some of the most heritable tumor types in the body and are often associated with other tumors or part of a genetic syndrome. We report a case of gallbladder PGL presenting synchronously with pancreatic neuroendocrine tumor (NET) and pulmonary IgG4-related disease in a 74-year old male patient with disseminated prostate adenocarcinoma. Due to the high rate of germline mutations and the possible syndromal manifestation of PGLs as well as pancreatic NETs, this patient was offered genetic testing, and a pathogenic SDHA germline mutation was found. Immunohistochemically, there was loss of SDHA and SDHB in the PGL but neither in the NET nor in the prostate adenocarcinoma. To our knowledge, this case is the first report of gallbladder PGL associated with pancreatic NET. It is likely that the identified SDHA germline mutation played a role in the development of gallbladder PGL in this patient.</p>
<p>doi: <a href="https://doi.org/10.1016/j.prp.2020.153006" class="uri">https://doi.org/10.1016/j.prp.2020.153006</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Nondiagnostic fine needle aspirates of the pancreas: A root cause analysis</strong> </summary></p>
<p><em>Cancer cytopathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32525623" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32525623</a></p>
<p>BACKGROUND: Fine needle aspiration (FNA) of the pancreas is considered the primary and least invasive diagnostic method in the evaluation of pancreatic lesions. A nondiagnostic sample may trigger repeat FNA or a more invasive diagnostic procedure. The goal of this study was to identify the root causes of nondiagnostic samples. METHODS: We performed a retrospective review of FNAs of the pancreas categorized as nondiagnostic at our institution between 2008 and 2019. Medical records and slides were reviewed to identify the features described by imaging, rapid on-site evaluation, fluid chemistry, final cytology diagnosis, and final histology. A root cause analysis was performed using the Ishikawa (or fishbone) diagram and the 5 Whys method. RESULTS: A total of 30 cases were identified: 11 adenocarcinomas, 6 cases of pancreatitis, 4 intraductal papillary mucinous neoplasms, 3 serous cystadenomas, 3 neuroendocrine tumors, 1 mucinous cystic neoplasm, 1 retention cyst, and 1 case of Brunner gland hyperplasia. The root causes identified were: man in 8 cases, machine in 1 case, method in 17 cases, and material in 18 cases. In many cases, more than 1 root cause contributed to the problem. CONCLUSION: Material related errors contributed to the majority of nondiagnostic results and were primarily related to fibrotic cancers, chronic pancreatitis, absence of diagnostic criteria of cystic lesions, and technically challenging cases. Only 1 major interpretation error was identified. Sampling and interpretive errors contributed equally to man-related causes. For mucinous cysts, neoplastic mucin was difficult to identify in liquid-based preparations. Pathologists tended to issue a nondiagnostic categorization when epithelial cells are lacking and particularly when the nature and radiological impression of the cyst was not communicated.</p>
<p>doi: <a href="https://doi.org/10.1002/cncy.22301" class="uri">https://doi.org/10.1002/cncy.22301</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Detection of microsatellite instability in a panel of solid tumours with the Idylla MSI Test using extracted DNA</strong> </summary></p>
<p><em>Journal of clinical pathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32513848" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32513848</a></p>
<p>AIM: During the last few years, determination of microstatellite instability (MSI) status has become a routine part of clinical practice, essentially to detect Lynch syndrome. Recently, MSI testing has increased with the development of immunotherapy and has expanded to a large panel of solid tumours. The aim of our work was to evaluate a fully automated system developed by Biocartis, the Idylla MSI Test, which performs an MSI analysis within 150 min. METHODS: A comparison between pentaplex PCR, immunohistochemistry and Idylla MSI Test was performed in 53 colorectal carcinoma samples, 7 small intestine adenocarcinomas, 15 duodenal and pancreatic adenocarcinomas, 16 gastric tumours, 15 endometrial adenocarcinomas, 5 ovarian carcinomas and 4 cases of urinary tract tumours using extracted DNA. Limit-of-detection (LOD) experiment was also done using a commercial DNA known to harbour MSI phenotype. RESULTS: The overall sensitivity was 94% and the overall specificity was 100%. Two invalid and three false-negative results were observed. Our experiments showed that the amount of DNA loaded into the cartridge was decisive and should be superior to 25 ng. LOD comprised between 4% and 8%. CONCLUSION: Overall, we have demonstrated that the Idylla MSI Test is a rapid and valid option to detect MSI phenotype which can be used in a large panel of solid tumours.</p>
<p>doi: <a href="https://doi.org/10.1136/jclinpath-2020-206581" class="uri">https://doi.org/10.1136/jclinpath-2020-206581</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Next-generation sequencing in residual liquid-based cytology specimens for cancer genome analysis</strong> </summary></p>
<p><em>Diagnostic cytopathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32511899" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32511899</a></p>
<p>BACKGROUND: Cancer genome profiling of cytology specimens using next-generation sequencing (NGS) requires adequate and good-quality DNA. Genomic examination of cytology samples was conventionally performed on cell block (CB) or smear specimens than on residual liquid-based cytology (LBC) specimens, which are high-quality DNA sources even after long-term storage. METHODS: We estimated tumor fractions of 37 residual LBC specimens, including 30 fine needle aspiration (FNA) samples from the thyroid (12 papillary thyroid carcinomas and two malignant lymphomas), lymph node (13 metastatic carcinomas and one malignant lymphoma), and breast cancer (one phyllodes tumor and one invasive ductal carcinoma), two pancreatic carcinoma samples, and five liquid (ascites, pleural effusion, and cerebrospinal fluid) samples. The DNA was extracted from all samples and subjected to NGS using a customized cancer gene panel comprising 28 cancer-related genes. RESULTS: NGS analysis revealed somatic mutations corresponding to pathological diagnosis with adequate variant allele frequency (VAF) in 24 LBC specimens, which had significantly higher tumor fraction (72.5% ± 4.9%). Ten cases, including the five fluid samples, had very small tumor fractions (7.5% ± 2.3%) to obtain sufficient VAF. Other two samples had high tumor fractions but showed very low VAF, indicating the presence of fusion genes. The remaining one sample yielded no DNA recovery. CONCLUSION: The residual LBC specimens collected by FNA from the thyroid gland and lymph node were verified to carry high tumor fraction and could serve as an alternate source for molecular testing to screen and diagnose cancers without the use of CB or smears.</p>
<p>doi: <a href="https://doi.org/10.1002/dc.24511" class="uri">https://doi.org/10.1002/dc.24511</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors</strong> </summary></p>
<p><em>Annals of surgery 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32511134" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32511134</a></p>
<p>OBJECTIVE: To improve the prognostic accuracy of the eighth edition of AJCC staging system for pNETs with establishment and validation of a new staging system. BACKGROUND: Validation of the updated eighth AJCC staging system for pNETs has been limited and controversial. METHODS: Data from the SEER registry (1975-2016) (n = 3303) and a multi-institutional database (2000-2016) (n = 825) was used as development and validation cohorts, respectively. A mTNM was proposed by maintaining the eighth AJCC T and M definitions, and the recently proposed N status as N0 (no LNM), N1 (1-3 LNM), and N2 (≥4 LNM), but adopting a new stage classification. RESULTS: The eighth TNM staging system failed to stratify patients with stage I versus IIA, stage IIB versus IIIA, and overall stage I versus II relative to long-term OS in both database. There was a monotonic decrement in survival based on the proposed mTNM staging classification among patients derived from both the SEER (5-year OS, stage I 87.0% vs stage II 80.3% vs stage III 72.9% vs stage IV 57.2%, all P &lt; 0.001), and multi-institutional (5-year OS, stage I 97.6% vs stage II 82.7% vs stage III 78.4% vs stage IV 50.0%, all P &lt; 0.05) datasets. On multivariable analysis, mTNM staging remained strongly associated with prognosis, as the hazard of death incrementally increased with each stage among patients in the 2 cohorts. CONCLUSION: A mTNM pNETs clinical staging system using N0, N1, N2 nodal categories was better at stratifying patients relative to long-term OS than the eighth AJCC staging.</p>
<p>doi: <a href="https://doi.org/10.1097/SLA.0000000000004039" class="uri">https://doi.org/10.1097/SLA.0000000000004039</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Peribiliary glands pathology in a large series of end-stage alcohol-related liver disease</strong> </summary></p>
<p><em>Virchows Archiv : an international journal of pathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32506156" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32506156</a></p>
<p>The peribiliary glands are intramural or extramural structures with multiple functions related to bile secretion. The peribiliary glands can develop cystic alterations in several conditions, such as alcohol addiction. Peribiliary cysts can enlarge till being radiologically visible and mimic cancer. We studied 217 consecutive explanted livers for end-stage alcohol-related liver disease from the Pathology Unit of the Liver Unit at the King’s College Hospital in Denmark Hill, with particular focus on peribiliary glands. Our cohort consisted of 31 females and 186 males, with a median age of 51 and of 56 years respectively. 92,2% had established cirrhosis, 73,3% had only alcohol-induced liver disease, whilst 26,7% had other co-morbidities. We found a mild ectasia of the peribiliary glands (&lt;2 mm) in 37,8% and peribiliary cysts (&gt; = 2 mm) in 22,6% of cases. The diameter of the peribiliary glands varied from 1 mm to 8 mm. Inflammation of the peribiliary glands was found in the majority of cases with dilatation (p value = 0,000). 4,6% of the peribiliary cysts had low-grade intraductal papillary neoplasm of the bile ducts confined to the peribiliary glands. Pancreatic heterotopia was found in 10,6% and associated with the presence of ectasia. Our findings fit with what is reported in literature, such as the alcohol-induced damage at the peribiliary glands. Moreover these results underline the possible role of peribiliary glands in the development of the intraductal papillary neoplasm of the bile ducts, the biliary counterpart of the branch type intraductal mucinous neoplasm of the pancreas.</p>
<p>doi: <a href="https://doi.org/10.1007/s00428-020-02851-3" class="uri">https://doi.org/10.1007/s00428-020-02851-3</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Morphologic Variants of Pancreatic Neuroendocrine Tumors: Clinicopathologic Analysis and Prognostic Stratification</strong> </summary></p>
<p><em>Endocrine pathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32488621" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32488621</a></p>
<p>Better prognostication/stratification of pancreatic neuroendocrine tumors (PanNETs) is needed. In this detailed morpheomic study of 163 resected PanNETs, 11 unusual variants, some of which were not previously recognized, and others scarcely documented in the literature, were identified, and their pathologic characteristics were further analyzed. By behavior and clinicopathologic associations, these variants could be grouped into three prognostically different categories. I. More aggressive (20%). Included in this group were the variants that in average showed higher grade and stage and adverse outcome including oncocytic, plasmacytoid, lipid-rich and previously unrecognized hepatoid variants, which often had a more diffuse/broad-band growth pattern, with some also displaying discohesiveness. They were characterized by abundant cytoplasm and often had prominent nucleoli (as seen in metabolically active cells), thus the provisional name “metabolic cell phenotype.” Because of their diversion from classical neuroendocrine cytomorphology, these variants created challenges on original diagnostic workup, particularly hepatoid examples, which revealed Arginase 1/Hep Par-1 expression in 50%. II. Less aggressive (10%). These cases either showed signs of maturation, including nested growth, paraganglioid pattern (which was previously unrecognized), and organoid PanNETs such as “ductulo-insular” growth, or showed symplastic/degenerative changes, and despite their paradoxically disconcerting histology, were more benevolent in behavior. III. Undetermined. There were other variants including mammary tubulolobular-like, pseudoglandular, peliotic, and sclerotic PanNETs, which although diagnostically challenging, their biologic significance could not be determined because of rarity or heterogeneous characteristics. Prognostic associations: Features that were significantly different in the more aggressive group than the less aggressive group were median size (5.0 vs 1.6 cm, p &lt; 0.001), percentage of pT3+T4 cases (72% vs 12%, p &lt; 0.001), Ki67 index (5.3% vs 2.3%, p = 0.001), % G2 and G3 cases (77% vs 27%, p &lt; 0.001), and rate of lymph node and distant metastasis (96% vs 27%, p &lt; 0.001). In stepwise logistic regression model using the 3 established prognosticators of T stage, size, and grade along with morphology, only aggressive-morphology (metabolic cell phenotype) was found to be associated with metastatic behavior with an odds ratio of 5.9 with 95% confidence interval (C.I.) 1.688 to 22.945 and p value 0.007. In conclusion, PanNETs display various morphologic patterns that are not only challenging and important diagnostically but appear to have biologic significance. Tumors with more diffuse growth of cells with nucleoli and abundant cytoplasm and/or discohesion (oncocytic, hepatoid, lipid-rich, plasmacytoid PanNETs), provisionally termed “metabolic cell phenotype,” show aggressive characteristics and are an independent determinant of adverse outcome and thus may require closer post-surgical follow-up, whereas variants with more degenerative or mature features (ductuloinsular, pleomorphic, paraganglioma-like) appear to be more benevolent despite their more atypical and worrisome morphology.</p>
<p>doi: <a href="https://doi.org/10.1007/s12022-020-09628-z" class="uri">https://doi.org/10.1007/s12022-020-09628-z</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Cancer-associated fibroblasts are a useful cytological finding for diagnosing pancreatic ductal adenocarcinoma</strong> </summary></p>
<p><em>Cytopathology : official journal of the British Society for Clinical Cytology 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32472717" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32472717</a></p>
<p>BACKGROUND: Cancer-associated fibroblasts (CAFs) are activated fibroblasts or myofibroblaststhatplay a crucial role in the invasiveness of pancreatic ductal adenocarcinoma (PDAC). In this study, the cytological features and diagnostic significance of CAFsbased on pancreatic duct brushing cytology (PDBC) were evaluated. METHODS: The prevalence of fibrous stroma (FS) including CAFs on PDBC in 42 PDAC cases and 33 benign cases was retrospectively investigated. The average nuclear size of fibroblasts was compared between PDAC and benign cases to distinguish CAFs from normal FS. RESULTS: Overall, FSwas observed in 25 PDAC cases (60%) and 8 benign cases (24%). The average nuclear size of FS in PDAC cases was significantly larger than that in benign cases. From the receiver operating characteristics analysis, the cut-off value of the nuclear size of FS for the diagnosis of PDAC was defined as 10.22µm. FS with nuclei over 10.22µmin size in PDAC cases had clear prominent nucleoli. In contrast, FS in benign cases had no clear nucleoli. Thus, CAFs on PDBC were considered to be FS with nuclei over 10.22µmin size and prominent nucleoli. The presence of CAFs on PDBC had 100% positive predictive value and specificity for the diagnosis of PDAC. CONCLUSIONS: This study suggested that CAFs on PDBC could be distinguished from normal FS by large nuclear size (over 10.22µm) and prominent nucleoli and that CAFs on PDBC may be used for the diagnosis of PDAC.</p>
<p>doi: <a href="https://doi.org/10.1111/cyt.12868" class="uri">https://doi.org/10.1111/cyt.12868</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Angiotensin-converting enzyme 2 influences pancreatic and renal function in diabetic mice</strong> </summary></p>
<p><em>Laboratory investigation; a journal of technical methods and pathology 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32472097" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32472097</a></p>
<p>Type 1 diabetes is a T-cell mediated autoimmune disease characterized by pancreatic beta cells destruction. Angiotensin-converting enzyme 2 (ACE2), a component of renin-angiotensin system (RAS) has been identified in pancreas from type 2 diabetic mice and its overexpression prevents beta cell dysfunction. We studied the effect of ACE2 deletion on pancreatic and renal function in the nonobese diabetic mice, a model that mimics type 1 diabetes. ACE2-deficient NOD mice and the respective controls were generated. Pancreas function and immunohistochemistry studies were performed. Renal function and RAS gene expression were also analyzed. Renal proximal tubular cells were obtained from these animals to dissect the effect of ACE2 deficiency in these cells. In NOD mice, ACE2 deletion significantly worsened glucose homeostasis, decreased islet insulin content, increased beta cell oxidative stress, and RIPK1-positive islets as compared with control mice. Angiotensin-converting enzyme and angiotensin II type 1 receptor (AT1R) were also increased in ACE2-deficient mice. In kidneys of 30-day diabetic mice, ACE2 deletion decreased podocyte number within the glomeruli, and altered renal RAS gene expression in tubules. ACE2 deletion influenced the expression of fibrosis-related genes in isolated primary renal proximal tubular cells before diabetes onset in NOD mice. Our findings suggest that ACE2 deletion may have a deleterious impact on beta cell and renal function, by promoting oxidative stress and increasing necroptosis mediators. In addition, this effect is accompanied by RAS alterations in both pancreas and renal proximal tubular cells, indicating that ACE2 may exert a renopancreatic protective effect on type 1 diabetes, which is activated before diabetes starts.</p>
<p>doi: <a href="https://doi.org/10.1038/s41374-020-0440-5" class="uri">https://doi.org/10.1038/s41374-020-0440-5</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Chronic inflammatory changes and oxidative stress in the background of “pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm”</strong> </summary></p>
<p><em>Virchows Archiv : an international journal of pathology 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32468246" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32468246</a></p>
<p>Cases of “pancreatic ductal adenocarcinoma (PDAC) concomitant with intraductal papillary mucinous neoplasm” (IPMN) have multiple PDAC lesions more frequently than cases of “PDAC without IPMN”. However, the mechanism of carcinogenesis in this former disease category remains unknown. The main objective of this work was thus to investigate the effects of chronic inflammation on carcinogenesis in PDAC cases. We selected 31 “PDAC concomitant with IPMN” patients and 58 “PDAC without IPMN” patients and pathologically evaluated their background pancreatic parenchyma. Fibrosis and inflammation scores of background pancreas were higher in “PDAC concomitant with IPMN” than in “PDAC without IPMN” (P &lt; 0.0001 and P &lt; 0.0001, respectively), whereas the fatty infiltration score of background pancreas was high in “PDAC without IPMN” (P = 0.0024). Immunohistochemically, the expression of 8-hydroxy-2’-deoxyguanosine (8-OHDG), an oxidative stress marker, in the background pancreas was high in “PDAC concomitant with IPMN” compared with that in “PDAC without IPMN” (P &lt; 0.0001). Chronic inflammation activates oxidative stress in tissue throughout the pancreas and probably confers susceptibility to tumorigenesis in “PDAC concomitant with IPMN”.</p>
<p>doi: <a href="https://doi.org/10.1007/s00428-020-02844-2" class="uri">https://doi.org/10.1007/s00428-020-02844-2</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Intraductal pancreatic cancer is less responsive than cancer in the stroma to neoadjuvant chemotherapy</strong> </summary></p>
<p><em>Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32457408" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32457408</a></p>
<p>Neoadjuvant chemotherapy (NAC) is often the treatment of choice for borderline resectable and locally advanced invasive pancreatic ductal adenocarcinoma (PDAC); however, most cancers only partially respond to therapy. We hypothesized that the location of residual neoplastic cells in resected specimens following NAC could provide a clue as to the mechanisms of resistance. PDAC cells invade the stroma but can also invade back into and spread via the pancreatic ducts, which has been referred to as “cancerization of ducts” (COD). We compared the responsiveness to chemotherapy between PDAC cells in the stroma and PDAC cells in the duct. Pancreatic resections from a total of 174 PDAC patients (NAC, n = 97; immediate surgery, n = 77) were reviewed. On hematoxylin and eosin sections, COD was identified at the same prevalence in both groups (NAC: 50/97 cases, 52%; immediate surgery: 39/77 cases, 51%; p = 0.879, Fisher’s exact test). However, using quantitative image analysis of CK19 immunohistochemistry, we found that the proportion of cancer cells that were intraductal was significantly different between the NAC and immediate surgery groups (median; 12.7% vs. 1.99%, p &lt; 0.0001, Mann-Whitney U test). This proportion was highest in patients with marked therapy responses (36.2%) compared with patients with moderate or poor responses (7.21 &amp; 7.91%). In summary, our data suggest that intraductal components in PDAC are less responsive to chemotherapy than the remainder of the tumor, which could have important implications for therapeutic resistance.</p>
<p>doi: <a href="https://doi.org/10.1038/s41379-020-0572-6" class="uri">https://doi.org/10.1038/s41379-020-0572-6</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy</strong> </summary></p>
<p><em>Annals of surgical oncology 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32451945" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32451945</a></p>
<p>BACKGROUND: The association between a positive surgical margin and local recurrence after resection of pancreatic adenocarcinoma (PDAC) has been reported. Assessment of the location of the a positive margin and the specific site of local recurrence has not been well described. METHODS: A prospectively maintained database was queried for patients who underwent R0/R1 pancreaticoduodenectomy for PDAC between 2000 and 2015. The pancreatic, posterior, gastric/duodenal, anterior peritoneal, and bile duct margins were routinely assessed. Postoperative imaging was reviewed for the site of first recurrence, and local recurrence was defined as recurrence located in the remnant pancreas, surgical bed, or retroperitoneal site outside the surgical bed. RESULTS: During the study period, 891 patients underwent pancreaticoduodenectomy, and 390 patients had an initial local recurrence with or without distant metastases. The 5-year cumulative incidence of local recurrence by site included the remnant pancreas (4%; 95% confidence interval [CI], 3-5%), the surgical bed (35%; 95% CI, 32-39%), and other regional retroperitoneal site (4%; 95% CI, 3-6%). In the univariate analysis, positive posterior margin (hazard ratio [HR], 1.50; 95% CI, 1.17-1.91; p = 0.001) and positive lymph nodes (HR, 1.36; 95% CI, 1.06-1.75; p = 0.017) were associated with surgical bed recurrence, and in the multivariate analysis, positive posterior margin remained significant (HR, 1.40; 95% CI, 1.09-1.81; p = 0.009). An isolated local recurrence was found in 197 patients, and a positive posterior margin was associated with surgical bed recurrence in this subgroup (HR, 1.51; 95% CI, 1.08-2.10; p = 0.016). CONCLUSION: In this study, the primary association between site of margin positivity and site of local recurrence was between the posterior margin and surgical bed recurrence. Given this association and the limited ability to modify this margin intraoperatively, preoperative assessment should be emphasized.</p>
<p>doi: <a href="https://doi.org/10.1245/s10434-020-08600-9" class="uri">https://doi.org/10.1245/s10434-020-08600-9</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Beyond Stiffness: Collagen Signaling in Pancreatic Cancer and Pancreas Regeneration</strong> </summary></p>
<p><em>The American journal of pathology 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32450151" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32450151</a></p>
<p>This commentary highlights the article by Ruggeri et al that reports the importance of discoidin domain receptor 1 in tissue homeostasis in pancreatic injury and pancreatic ductal adenocarcinoma pathogenesis.</p>
<p>doi: <a href="https://doi.org/10.1016/j.ajpath.2020.05.005" class="uri">https://doi.org/10.1016/j.ajpath.2020.05.005</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Adenosquamous Carcinoma of the Pancreas Comprise a Heterogeneous Group of Tumors With the Worst Outcome: A Clinicopathological Analysis of 25 Cases Identified in 562 Pancreatic Carcinomas Resected With Curative Intent</strong> </summary></p>
<p><em>Pancreas 2020 5;49(5):683-691</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32433407" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32433407</a></p>
<p>OBJECTIVES: Information of the clinicopathological characteristics and outcome data of patients with adenosquamous carcinoma of the pancreas (ASCAP) remains limited. This study’s aim is to describe the clinical, pathological, and molecular characteristics of 25 resected ASCAPs. METHODS: Of all 25 cases, patient characteristics, follow-up data, and pathological/immunohistological features were reviewed and analyzed. RESULTS: In this 3-institutional retrospective analysis of 562 pancreatic cancer patients, we identified 25 cases with histologically confirmed ASCAP (4.4%). Follow-up was available in 21 ASCAP and 50 pancreatic ductal adenocarcinoma control patients with a median overall survival of 8.2 and 21 months, respectively. Age, tumor size, localization in the tail, lymph node status, and resection margin seem to be the most significant factors of survival in our ASCAP cohort. In contrast to pancreatic ductal adenocarcinoma, positive expression of p63, keratins K5/14, and the epidermal growth factor receptor are a robust marker profile of these tumors. CONCLUSIONS: Adenosquamous carcinoma of the pancreas comprises a group of neoplasms in which stage and adverse morphological features contribute to its bad prognosis. Further work must be pursued to improve detection and treatment options to reduce mortality. Specifically, differences in biology might become a target for the development of possible therapies.</p>
<p>doi: <a href="https://doi.org/10.1097/MPA.0000000000001548" class="uri">https://doi.org/10.1097/MPA.0000000000001548</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Clinical Utility of Histological and Radiological Evaluations of Tumor Necrosis for Predicting Prognosis in Pancreatic Cancer</strong> </summary></p>
<p><em>Pancreas 2020 5;49(5):634-641</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32433400" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32433400</a></p>
<p>OBJECTIVES: Tumor necrosis is often found in pancreatic ductal adenocarcinoma (PDAC). Objective histological assessment and adequate radiological detection of necrosis could be used as biomarkers for therapeutic decision. However, standardized clinical utility of necrosis remains unknown. Here, we aimed to determine the prognostic potential of histological and radiological evaluations of necrosis. METHODS: We investigated histological necrosis in 221 patients, who underwent surgery for PDAC, and classified its size as small (≤5 mm) or large (&gt;5 mm). We also evaluated poorly enhanced areas on preoperative computed tomography to assess their ability for predicting histological necrosis and postoperative prognosis. RESULTS: Tumor necrosis was found in 115 patients (52%) and was related to tumor area, lymph node metastasis, and lymphovascular invasion. Size of necrosis was significantly associated with tumor area, perimeter of necrosis, circularity of necrosis, number of ruptured cancer glands, and presence of collagen bundle (P &lt; 0.05 for all). Both presence of necrosis and their size were strongly correlated to postoperative prognosis. Patients with poorly enhanced areas showed worse prognosis (P &lt; 0.01). CONCLUSIONS: Our findings underline the capacity of histological and radiological assessment of tumor necrosis for prognosis prediction in PDAC.</p>
<p>doi: <a href="https://doi.org/10.1097/MPA.0000000000001539" class="uri">https://doi.org/10.1097/MPA.0000000000001539</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature</strong> </summary></p>
<p><em>Virchows Archiv : an international journal of pathology 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32424767" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32424767</a></p>
<p>Pancreatic carcinoma remains one of the leading cancer-related causes of death worldwide and is generally characterized by a dismal prognosis and limited potential for oncologic treatment. A rare subvariant of pancreatic cancer, undifferentiated carcinoma with osteoclast-like giant cells (UCOGC), has an unpredictable prognosis according to many previous studies, with unexpectedly long survival in individual cases. In this study, we collected, retrospectively, 13 cases of well-documented UCOGCs and performed immunohistochemistry focused on the expression of the programmed death-ligand 1 (PD-L1) and several other potential therapeutic and predictive markers (PanTRK, p53, MSH2, PMS2, and the number of tumor-infiltrating lymphocytes), to explore their correlation with the follow-up of the patients. As a control group, we examined 24 cases of conventional pancreatic ductal adenocarcinoma (PDAC). In our results, PanTRK was negative in all 24 cases. P53 did not show any significant differences between UCOGCs and PDACs, and the entire cohort was MSH2, MLH1, PMS2, and MSH6 positive. Significant differences were present in the analysis of PD-L1: UCOGCs were found to express PD-L1 significantly more frequently and have a higher number of tumor-infiltrating lymphocytes than PDAC. The expression of PD-L1 was related to significantly shorter survival in patients with UCOGC and in the entire cohort. Patients with PD-L1 negative UCOGCs displayed surprisingly long survival in comparison to PD-L1 positive UCOGCs and PDACs (both PD-L1+ and PD-L1-). We compared our results with previously published data, and, after statistical analysis, we were able to identify PD-L1 as an effective prognostic marker of UCOGC and suggest a strong need for a clinical trial of immune checkpoint immunotherapy in patients with advanced PD-L1 positive UCOGC.</p>
<p>doi: <a href="https://doi.org/10.1007/s00428-020-02830-8" class="uri">https://doi.org/10.1007/s00428-020-02830-8</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Grading Solid Pseudopapillary Tumors of the Pancreas: the Fudan Prognostic Index</strong> </summary></p>
<p><em>Annals of surgical oncology 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32424583" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32424583</a></p>
<p>BACKGROUND: Ki-67 has been shown to predict outcome of patients with solid pseudopapillary tumor of the pancreas (SPTP) but has not been incorporated into a formal classification system to predict recurrence-free survival (RFS). METHODS: This is a retrospective cohort study of patients with histologically confirmed diagnosis of SPTP who had at least 1 year of follow-up at two tertiary academic centers. Survival data were assessed by Kaplan-Meier method and multivariable Cox regression model. Prognostic performance was compared among various systems. RESULTS: A total of 193 consecutive patients were included, ranging in age from 12 to 70 years (median 33 years). Seven patients (3.6%) developed tumor recurrence. The 3-, 5-, and 10-year RFS rates were estimated at 96.9%, 96.1%, and 94.8%, respectively. For the AJCC staging system, patients with stage I had similar prognosis to those with stage II. For the ENETS staging system, patients with stage I to III had similar prognosis. Grade based on Ki-67 was superior to both the AJCC and ENETS systems for predicting survival. Multivariate analysis revealed that large tumor size [&gt; 10 cm; hazard ratio (HR), 6.177 95% confidence interval (CI), 1.289-29.603; P = 0.023] and Ki-67 (HR, 17.199 95% CI, 4.001-73.930; P &lt; 0.001) were independent predictors for RFS. The Fudan Prognostic Index based on the combination of Ki-67 and tumor size showed excellent discrimination for RFS and was more accurate and informative than other grading/staging systems. CONCLUSION: The Fudan Prognostic Index better predicts RFS compared with either Ki-67 alone or the current AJCC and ENETS TNM-based staging systems.</p>
<p>doi: <a href="https://doi.org/10.1245/s10434-020-08626-z" class="uri">https://doi.org/10.1245/s10434-020-08626-z</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Guidelines on the histopathology of chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and the European Pancreatic Club</strong> </summary></p>
<p><em>Pancreatology : official journal of the International Association of Pancreatology (IAP) … [et al.] 2020 Jun;20(4):586-593</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32414657" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32414657</a></p>
<p>BACKGROUND: Chronic pancreatitis is a complex multifactorial fibro-inflammatory disease. Consensus guidelines are needed for the histopathological evaluation of non-autoimmune chronic pancreatitis (CP). METHODS: An international working group with experts on the histopathology of CP evaluated 15 statements generated from evidence on seven key clinically relevant questions. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was used to evaluate the level of evidence available for each statement. To determine the level of agreement, the working group voted on the statements for strength of agreement, using a nine-point Likert scale, and Cronbach’s alpha reliability coefficients were calculated. RESULTS: Strong consensus was obtained for 12 statements relating to all seven key questions including that: the cardinal features of CP are the triad of fibrosis, loss of acinar tissue and duct changes; there are no unique histopathological features that distinguish the different aetiologies of CP; clinical history and laboratory investigations, including genetic testing, are important in establishing the aetiology of CP; there is no reproducible and universally accepted histological grading system for assessing severity of CP, although classification as “mild”, “moderate” and “severe” is usually applied; scoring systems for fibrosis are not validated for clinical use; asymptomatic fibrosis is a common finding associated with ageing, and not necessarily evidence of CP; there are no obvious diagnostic macroscopic features of early CP; histopathology is not the gold standard for the diagnosis of CP; and cytology alone is not a reliable method for the diagnosis of CP. CONCLUSIONS: Cardinal histopathological features of CP are well-defined and internationally accepted and pathological assessment is relevant for the purpose of differential diagnosis with other pancreatic diseases, especially cancer. However, a reliable diagnosis of CP requires integration of clinical, laboratory and imaging features and cannot be made by histology alone.</p>
<p>doi: <a href="https://doi.org/10.1016/j.pan.2020.04.009" class="uri">https://doi.org/10.1016/j.pan.2020.04.009</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Ki-67 proliferation index in neuroendocrine tumors: Can augmented reality microscopy with image analysis improve scoring?</strong> </summary></p>
<p><em>Cancer cytopathology 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32401429" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32401429</a></p>
<p>BACKGROUND: The Ki-67 index is important for grading neuroendocrine tumors (NETs) in cytology. However, different counting methods exist. Recently, augmented reality microscopy (ARM) has enabled real-time image analysis using glass slides. The objective of the current study was to compare different traditional Ki-67 scoring methods in cell block material with newer methods such as ARM. METHODS: Ki-67 immunostained slides from 50 NETs of varying grades were retrieved (39 from the pancreas and 11 metastases). Methods with which to quantify the Ki-67 index in up to 3 hot spots included: 1) “eyeball” estimation (EE); 2) printed image manual counting (PIMC); 3) ARM with live image analysis; and 4) image analysis using whole-slide images (WSI) (field of view [FOV] and the entire slide). RESULTS: The Ki-67 index obtained using the different methods varied. The pairwise kappa results varied from no agreement for image analysis using digital image analysis WSI (FOV) and histology to near-perfect agreement for ARM and PIMC. Using surgical pathology as the gold standard, the EE method was found to have the highest concordance rate (84.2%), followed by WSI analysis of the entire slide (73.7%) and then both the ARM and PIMC methods (63.2% for both). The PIMC method was the most time-consuming whereas image analysis using WSI (FOV) was the fastest method followed by ARM. CONCLUSIONS: The Ki-67 index for NETs in cell block material varied by the method used for scoring, which may affect grade. PIMC was the most time-consuming method, and EE had the highest concordance rate. Although real-time automated counting using image analysis demonstrated inaccuracies, ARM streamlined and hastened the task of Ki-67 quantification in NETs.</p>
<p>doi: <a href="https://doi.org/10.1002/cncy.22272" class="uri">https://doi.org/10.1002/cncy.22272</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Amyloid-Rich Pancreatic Neuroendocrine Tumors: a Potential Diagnostic Pitfall in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology (EUS-FNAC)</strong> </summary></p>
<p><em>Endocrine pathology 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32399832" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32399832</a></p>
<p>Pancreatic neuroendocrine tumors (PanNETs) are rare neoplasms that include even rarer variants that may pose different diagnostic problems, especially in fine needle aspiration cytology (FNAC). We describe the diagnostic clues of the amyloid-rich variant of PanNETs in endoscopic ultrasound (EUS)-guided fine needle aspiration cytology (EUS-FNAC). Three cases of PanNETs with an amyloid-rich stromal component were retrieved and retrospectively reviewed. For every case, the pancreatic lesion was investigated by a EUS-FNAC procedure. The final diagnosis was supported by immunocytochemistry and Congo red staining. All cases had similar EUS-FNAC features: neoplastic cells were entrapped in an eosinophilic, homogeneous dense and amorphous matrix. The neuroendocrine nature was confirmed by immunoexpression of synaptophysin and chromogranin A, while the amorphous stroma was characterized as amyloid based on positive Congo red staining. Regarding the hormonal profile, no insulin or proinsulin reactivity was observed, but all cases were diffusely positive for amylin. The diagnosis of uncommon variants of PanNETs, such as the amyloid-rich, is challenging especially in EUS-FNAC procedures because of a unique and misleading morphology, potentially mimicking fibrotic conditions and amyloid deposition within systemic amyloidosis. In cytology specimens, the presence of amorphous material requires amyloid deposition to be considered in the differential diagnosis of pancreatic neoplasms with neuroendocrine phenotype.</p>
<p>doi: <a href="https://doi.org/10.1007/s12022-020-09625-2" class="uri">https://doi.org/10.1007/s12022-020-09625-2</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient Pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift</strong> </summary></p>
<p><em>Endocrine pathology 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32388775" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32388775</a></p>
<p>Pancreatic neuroendocrine carcinomas (NECs) are rare and very aggressive neoplasms with dismal prognosis, especially when metastatic or with negative prognostic factors, such as vascular invasion. To the best of our knowledge, no case of pancreatic NEC with mismatch repair deficiency has been reported to date. We describe a 62-year-old patient who underwent pancreaticoduodenectomy for a NEC located in the pancreatic head, with peripancreatic lymph node metastases. Tumor necrosis was prominent and the Ki67 proliferative index was 60%. One year after the diagnosis, the patient experienced recurrence with a left supraclavicular lymph node metastasis, which was surgically removed, followed by standard cisplatin-etoposide chemotherapy. Neoplastic cells showed combined loss of expression of MLH1 and PMS2 in both primary tumor and lymph node metastasis. Microsatellite instability (MSI) test using a mononucleotide repeats pentaplex PCR (BAT-25, BAT-26, NR-21, NR-22, and NR-24) revealed minimal mononucleotide shifts showing deletion of less than 3 bp at NR-21, BAT-26, NR-24, and NR-22 loci. MLH1 methylation analysis revealed absence of the gene promoter methylation. BRAF and KRAS mutations were not detected. In gut, NECs’ mismatch repair deficiency phenotype has been reported in about 10% of cases, and it represents an independent factor of more favorable outcome. Likewise, our patient is currently alive with a follow-up of more than 12 years after pancreaticoduodenectomy, by itself an unexpected finding for such an aggressive neoplasm.</p>
<p>doi: <a href="https://doi.org/10.1007/s12022-020-09622-5" class="uri">https://doi.org/10.1007/s12022-020-09622-5</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Simple mucinous cysts of the pancreas have heterogeneous somatic mutations</strong> </summary></p>
<p><em>Human pathology 2020 Jul;101():1-9</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32380013" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32380013</a></p>
<p>Simple mucinous cysts of the pancreas have an epithelial lining resembling pancreatic intraepithelial neoplasia but may have a clinical presentation similar to premalignant mucinous neoplasms such as intraductal papillary mucinous neoplasms. Whether the epithelial lining shares genomic alterations with other pancreatic preinvasive neoplasms such as PanIN and intraductal papillary mucinous neoplasm has not been determined. We performed targeted sequencing analysis using a custom-designed MiSeq panel including the full coding regions of 18 pancreatic cancer genes on 13 clinically and pathologically well-characterized simple mucinous cysts. We detected 59 mutations in 15 genes in the cohort, with a median of 4 mutations per cyst (range = 0-16 mutations per cyst). The mutated genes and rate of detected mutations were as follows: KMT2C (MLL3) (62%), KRAS (15%), BRAF (8%), RNF43 (8%), CDKN2a (8%), TP53 (15%), and SMAD4 (8%). No GNAS mutations were detected. Four cases (31%) had no mutations detected. These findings place the majority of simple mucinous cysts of the pancreas in the spectrum of early, low-grade mucinous neoplasia, albeit with a different spectrum of genomic alterations compared with PanIN and intraductal papillary mucinous neoplasm.</p>
<p>doi: <a href="https://doi.org/10.1016/j.humpath.2020.04.006" class="uri">https://doi.org/10.1016/j.humpath.2020.04.006</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I</strong> </summary></p>
<p><em>Nature 2020 05;581(7806):100-105</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32376951" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32376951</a></p>
<p>Immune evasion is a major obstacle for cancer treatment. Common mechanisms of evasion include impaired antigen presentation caused by mutations or loss of heterozygosity of the major histocompatibility complex class I (MHC-I), which has been implicated in resistance to immune checkpoint blockade (ICB) therapy1-3. However, in pancreatic ductal adenocarcinoma (PDAC), which is resistant to most therapies including ICB4, mutations that cause loss of MHC-I are rarely found5 despite the frequent downregulation of MHC-I expression6-8. Here we show that, in PDAC, MHC-I molecules are selectively targeted for lysosomal degradation by an autophagy-dependent mechanism that involves the autophagy cargo receptor NBR1. PDAC cells display reduced expression of MHC-I at the cell surface and instead demonstrate predominant localization within autophagosomes and lysosomes. Notably, inhibition of autophagy restores surface levels of MHC-I and leads to improved antigen presentation, enhanced anti-tumour T cell responses and reduced tumour growth in syngeneic host mice. Accordingly, the anti-tumour effects of autophagy inhibition are reversed by depleting CD8+ T cells or reducing surface expression of MHC-I. Inhibition of autophagy, either genetically or pharmacologically with chloroquine, synergizes with dual ICB therapy (anti-PD1 and anti-CTLA4 antibodies), and leads to an enhanced anti-tumour immune response. Our findings demonstrate a role for enhanced autophagy or lysosome function in immune evasion by selective targeting of MHC-I molecules for degradation, and provide a rationale for the combination of autophagy inhibition and dual ICB therapy as a therapeutic strategy against PDAC.</p>
<p>doi: <a href="https://doi.org/10.1038/s41586-020-2229-5" class="uri">https://doi.org/10.1038/s41586-020-2229-5</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>International Consensus Guidelines for Risk Factors in Chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club</strong> </summary></p>
<p><em>Pancreatology : official journal of the International Association of Pancreatology (IAP) … [et al.] 2020 Jun;20(4):579-585</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32376198" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32376198</a></p>
<p>BACKGROUND: Chronic pancreatitis (CP) is a complex inflammatory disease with remarkably impaired quality of life and permanent damage of the pancreas. This paper is part of the international consensus guidelines on CP and presents the consensus on factors elevating the risk for CP. METHODS: An international working group with 20 experts on CP from the major pancreas societies (IAP, APA, JPS, and EPC) evaluated 14 statements generated from evidence on four questions deemed to be the most clinically relevant in CP. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was used to evaluate the level of evidence available per statement. To determine the level of agreement, the working group voted on the 14 statements for strength of agreement, using a nine-point Likert scale in order to calculate Cronbach’s alpha reliability coefficient. RESULTS: Strong consensus and agreement were obtained for the following statements: Alcohol, smoking, and certain genetic alterations are risk factors for CP. Past history, family history, onset of symptoms, and life-style factors including alcohol intake and smoking history should be determined. Alcohol consumption dose-dependently elevates the risk of CP up to 4-fold. Ever smokers, even smoking less than a pack of cigarettes per day, have an increased risk for CP, as compared to never smokers. CONCLUSIONS: Both genetic and environmental factors can markedly elevate the risk for CP. Therefore, health-promoting lifestyle education and in certain cases genetic counselling should be employed to reduce the incidence of CP.</p>
<p>doi: <a href="https://doi.org/10.1016/j.pan.2020.03.014" class="uri">https://doi.org/10.1016/j.pan.2020.03.014</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Prognostic Impact of Pancreatic Invasion in Duodenal Carcinoma: A Single-Center Experience</strong> </summary></p>
<p><em>Annals of surgical oncology 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32367502" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32367502</a></p>
<p>BACKGROUND: The prognostic factors for duodenal carcinoma (DC) remain unclear because of its rarity. This study aimed to investigate the prognostic impact of pancreatic invasion (PI) on postoperative survival for patients with DC. METHODS: This study retrospectively analyzed 86 patients with DC, including 18 patients with PI, who underwent surgical resection between October 2002 and March 2018. The clinicopathologic features and survival outcomes of these patients were investigated to identify the prognostic factors in DC. The long-term survival for the DC patients with PI was compared with that for the patients who underwent resection for resectable pancreatic head carcinoma (RPHC) during the same period. RESULTS: The median survival time (MST) for the DC patients with PI was 25.7 months, which was significantly worse than for the patients with T2 or deeper DC without PI (p = 0.010). The multivariate analysis showed that the independent prognostic factors were PI (hazard ratio [HR] 7.59; p = 0.019) and lymph node metastasis (LNM) (HR 5.01; p = 0.026). The MST for the DC patients with PI did not differ significantly from that for the RPHC patients treated without adjuvant chemotherapy (p = 0.135). Comparable rates of microscopic venous invasion and hematogenous metastasis were observed for the DC patients with PI and the RPHC patients. CONCLUSIONS: Pancreatic invasion was an independent prognostic factor in DC. The survival outcomes for the DC patients with PI did not differ from those for the patients with RPHC, which was associated with a high rate of hematogenous recurrence.</p>
<p>doi: <a href="https://doi.org/10.1245/s10434-020-08512-8" class="uri">https://doi.org/10.1245/s10434-020-08512-8</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT)</strong> </summary></p>
<p><em>Endocrine pathology 2020 Jun;31(2):119-131</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32361926" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32361926</a></p>
<p>Peptide Receptor Radionuclide Therapy (PRRT) is an emerging therapeutic option for pancreatic neuroendocrine tumors (PanNETs). A possible role for PRRT as a neoadjuvant agent is still largely undetermined, explored only in case reports or small case series. Likewise, the histopathological and immunophenotypic changes induced by PRRT are poorly characterized. In the present study, 24 patients who underwent neoadjuvant PRRT on the basis of their disease’s characteristics were retrospectively matched with 24 patients who underwent upfront surgery. A comprehensive morphological and immunohistochemical evaluation was conducted to identify the differences in the two groups. The most significant findings were that the total percentage of stroma increased significantly in patients who underwent PRRT (p &lt; 0.0001) and the characteristics of the stroma were different in the two groups. The somatostatin receptors type 2A (SSTR2A) were retained in most patients (87%) after PRRT. The density of CD163+ M2-polarized macrophages was greater in the PRRT group (p = 0.022), and M2-polarized macrophages tended to assume an epithelioid morphology (p = 0.043). In the neoadjuvant PRRT group, none of the histological parameters considered were associated with progression-free survival (PFS). Neoadjuvant PRRT in PanNETs is associated with reduced tumor diameter, an increased percentage of stroma, preserved SSTR2A expression in most of the cases, and an increased CD163+ M2-polarized macrophages density.</p>
<p>doi: <a href="https://doi.org/10.1007/s12022-020-09623-4" class="uri">https://doi.org/10.1007/s12022-020-09623-4</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma</strong> </summary></p>
<p><em>Pathology, research and practice 2020 Jun;216(6):152985</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32360245" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32360245</a></p>
<p>Pancreatic ductal adenocarcinoma (PDAC) has an ominous prognosis and there are only few treatment options. It is therefore crucial to investigate possible predictive markers that may improve the treatment of this disease. Mismatch repair (MMR) deficiency (d-MMR), meaning MMR protein loss (l-MMR) and/or microsatellite instability (MSI), is predictive of response to immunotherapy, but its frequency has to our knowledge not been elucidated in Scandinavian PDACs. Our aims were to examine the frequency of d-MMR in a Danish cohort of PDACs. We constructed multi-punch tissue microarrays (TMAs) using primary tumor tissue. Immunohistochemistry (IHC) for the DNA MMR proteins MLH1, MSH2, MSH6 and PMS2 was performed, and their expression was evaluated using a scoring system from 0 to 4. If the overall score was between 0-2 or if IHC was inconclusive for technical reasons, IHC on whole-tissue sections and MSI using PCR was performed. A final score of 0, 1-2 or 3-4 defined the tumor as l-MMR, MMR reduced (r-MMR) or MMR proficient. In total, 4/164 (2.4 %), 2/164 (1.2 %) and 3/164 (1.8 %) were l-MMR, r-MMR, or inconclusive based on IHC. MSI testing of these specimens showed that two of the four l-MMR tumors were MSI-high, while the remaining cases were microsatellite stable (MSS). In conclusion, in this study of Danish PDACss, d-MMR was found in a small proportion of the tumors. For these patients, individualized treatment using immunotherapy could be considered.</p>
<p>doi: <a href="https://doi.org/10.1016/j.prp.2020.152985" class="uri">https://doi.org/10.1016/j.prp.2020.152985</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>RAF1 rearrangements are common in pancreatic acinar cell carcinomas</strong> </summary></p>
<p><em>Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32358589" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32358589</a></p>
<p>There is now evidence that gene fusions activating the MAPK pathway are relatively common in pancreatic acinar cell carcinoma with potentially actionable BRAF or RET fusions being found in ~30%. We sought to investigate the incidence of RAF1 fusions in pancreatic malignancies with acinar cell differentiation. FISH testing for RAF1 was undertaken on 30 tumors comprising 25 ‘pure’ acinar cell carcinomas, 2 mixed pancreatic acinar-neuroendocrine carcinomas, 1 mixed acinar cell-low grade neuroendocrine tumor and 2 pancreatoblastomas. RAF1 rearrangements were identified in 5 cases and confirmed by DNA and RNA sequencing to represent oncogenic fusions (GATM-RAF1, GOLGA4-RAF1, PDZRN3-RAF1, HERPUD1-RAF1 and TRIM33-RAF1) and to be mutually exclusive with BRAF and RET fusions, as well as KRAS mutations. Large genome-wide copy number changes were common and included 1q gain and/or 1p loss in all five RAF1 FISH-positive acinar cell carcinomas. RAF1 expression by immunohistochemistry was found in 3 of 5 (60%) of fusion-positive cases and no FISH-negative cases. Phospho-ERK1/2 expression was found in 4 of 5 RAF1-fusion-positive cases. Expression of both RAF1 and phospho-ERK1/2 was heterogeneous and often only detected at the tumor-stroma interface, thus limiting their clinical utility. We conclude that RAF1 gene rearrangements are relatively common in pancreatic acinar cell carcinomas (14.3% to 18.5% of cases) and can be effectively identified by FISH with follow up molecular testing. The combined results of several studies now indicate that BRAF, RET or RAF1 fusions occur in between one third and one-half of these tumors but are extremely rare in other pancreatic malignancies. As these fusions are potentially actionable with currently available therapies, a strong argument can be made to perform FISH or molecular testing on all pancreatic acinar cell carcinomas.</p>
<p>doi: <a href="https://doi.org/10.1038/s41379-020-0545-9" class="uri">https://doi.org/10.1038/s41379-020-0545-9</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma</strong> </summary></p>
<p><em>Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 Apr;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32350415" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32350415</a></p>
<p>Entosis is a type of regulated cell death that promotes cancer cell competition. Though several studies have revealed the molecular mechanisms that govern entosis, the clinical and genetic correlates of entosis in human tumors is less well understood. Here we reviewed entotic cell-in-cell (CIC) patterns in a large single institution sequencing cohort (MSK IMPACT clinical sequencing cohort) of more than 1600 human pancreatic ductal adenocarcinoma (PDAC) samples to identify the genetic and clinical correlates of this cellular feature. After case selection, 516 conventional PDACs and 21 ASCs entered this study and ~45,000 HPFs (median 80 HPFs per sample) were reviewed; 549 entotic-CICs were detected through our cohort. We observed that entotic-CIC occurred more frequently in liver metastasis compared with primary in PDAC. Moreover, poorly differentiated adenocarcinoma or adenosquamous carcinoma had more entotic-CIC than well or moderately differentiated adenocarcinoma. With respect to genetic features TP53 mutations, KRAS amplification, and MYC amplification were significantly associated with entosis in PDAC tissues. From a clinical standpoint entotic CICs were independently associated with a poor prognosis by multivariate Cox regression analysis when considering all cases or primary PDACs specifically. These results provide a contextual basis for understanding entosis in PDAC, a highly aggressive cancer for which molecular insights are needed to improve survival.</p>
<p>doi: <a href="https://doi.org/10.1038/s41379-020-0549-5" class="uri">https://doi.org/10.1038/s41379-020-0549-5</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications</strong> </summary></p>
<p><em>Gut 2020 Apr;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32350089" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32350089</a></p>
<p>OBJECTIVE: Recently, tumours with microsatellite instability (MSI)/defective DNA mismatch repair (dMMR) have gained considerable interest due to the success of immunotherapy in this molecular setting. Here, we aim to clarify clinical-pathological and/or molecular features of this tumour subgroup through a systematic review coupled with a comparative analysis with existing databases, also providing indications for a correct approach to the clinical identification of MSI/dMMR pancreatic ductal adenocarcinoma (PDAC). DESIGN: PubMed, SCOPUS and Embase were searched for studies reporting data on MSI/dMMR in PDAC up to 30 November 2019. Histological and molecular data of MSI/dMMR PDAC were compared with non-MSI/dMMR PDAC and with PDAC reference cohorts (including SEER database and The Cancer Genome Atlas Research Network - TCGA project). RESULTS: Overall, 34 studies with 8323 patients with PDAC were included in the systematic review. MSI/dMMR demonstrated a very low prevalence in PDAC (around 1%-2%). Compared with conventional PDAC, MSI/dMMR PDAC resulted strongly associated with medullary and mucinous/colloid histology (p&lt;0.01) and with a KRAS/TP53 wild-type molecular background (p&lt;0.01), with more common JAK genes mutations. Data on survival are still unclear. CONCLUSION: PDAC showing typical medullary or mucinous/colloid histology should be routinely examined for MSI/dMMR status using specific tests (immunohistochemistry, followed by MSI-PCR in cases with doubtful results). Next-generation sequencing (NGS) should be adopted either where there is limited tissue or as part of NGS tumour profiling in the context of precision oncology, acknowledging that conventional histology of PDAC may rarely harbour MSI/dMMR.</p>
<p>doi: <a href="https://doi.org/10.1136/gutjnl-2020-320726" class="uri">https://doi.org/10.1136/gutjnl-2020-320726</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Discoidin Domain Receptor 1 (DDR1) Is Necessary for Tissue Homeostasis in Pancreatic Injury and Pathogenesis of Pancreatic Ductal Adenocarcinoma</strong> </summary></p>
<p><em>The American journal of pathology 2020 Apr;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32339496" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32339496</a></p>
<p>Pancreatic ductal adenocarcinoma (PDA) and chronic pancreatitis are characterized by a dense collagen-rich desmoplastic reaction. Discoidin domain receptor 1 (DDR1) is a receptor tyrosine kinase activated by collagens that can regulate cell proliferation, migration, adhesion, and remodeling of the extracellular matrix. To address the role of DDR1 in PDA, Ddr1-null (Ddr-/-) mice were crossed with the KrasG12D/+; Trp53R172H/+; Ptf1aCre/+ (KPC) model of metastatic PDA. Ddr1-/-; KPC mice progress to differentiated PDA but resist progression to poorly differentiated cancer compared with KPC control mice. Strikingly, severe pancreatic atrophy accompanied tumor progression in Ddr1-/-; KPC mice. To further explore the effects of Ddr1 ablation, Ddr1-/- mice were crossed with the KrasG12D/+; Ptf1aCre/+ neoplasia model and subjected to cerulein-induced experimental pancreatitis. Similar to KPC mice, tissue atrophy was a hallmark of both neoplasia and pancreatitis models in the absence of Ddr1. Compared with controls, Ddr1-/- models had increased acinar cell dropout and reduced proliferation with no difference in apoptotic cell death between control and Ddr1-/- animals. In most models, organ atrophy was accompanied by increased fibrillar collagen deposition, suggesting a compensatory response in the absence of this collagen receptor. Overall, these data suggest that DDR1 regulates tissue homeostasis in the neoplastic and injured pancreas.</p>
<p>doi: <a href="https://doi.org/10.1016/j.ajpath.2020.03.020" class="uri">https://doi.org/10.1016/j.ajpath.2020.03.020</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Does IgG4 level evaluation in pancreatic mass play role in avoiding major surgery in uncertain presentation: A case report</strong> </summary></p>
<p><em>Indian journal of pathology &amp; microbiology 2020 4;63(2):282-285</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32317534" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32317534</a></p>
<p>A 66-year-old male presented with chief complaints of anorexia associated with mild dull, intermittent epigastric pain for 6 months. The patient was a known diabetic on oral hypoglycemic and on routine checkup was found to have deranged liver function profile. On radiology, an ill-defined hypoechoic enhancing lesion involving head, neck, and uncinate process of pancreas was noted. Whipple’s pancreaticodudenectomy was done and reported as IgG4-related autoimmune pancreatitis. Later, IgG (slightly) and IgG4 were found to be markedly raised. We report this case to highlight the importance of IgG4 evaluation prior to major surgery in uncertain pancreatic mass.</p>
<p>doi: <a href="https://doi.org/10.4103/IJPM.IJPM_289_19" class="uri">https://doi.org/10.4103/IJPM.IJPM_289_19</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma</strong> </summary></p>
<p><em>Annals of surgical oncology 2020 Apr;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32307617" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32307617</a></p>
<p>BACKGROUND: The authors hypothesized that in resected pancreatic adenocarcinoma (PDAC), pathologic characteristics, oncologic outcomes, prognostic factors, and the accuracy of the American Joint Committee on Cancer (AJCC) staging system might differ based on tumor location. METHODS: Patients undergoing pancreatectomy for PDAC at two academic institutions from 2000 to 2015 were retrieved. A comparative analysis between head (H-PDAC) and body-tail (BT-PDAC) tumors was performed using uni- and multivariable models. The accuracy of the eighth AJCC staging system was analyzed using C-statistics. RESULTS: Among 1466 patients, 264 (18%) had BT-PDAC, which displayed greater tumor size but significantly lower rates of perineural invasion and G3/4 grading. Furthermore, BT-PDAC was associated with a lower frequency of nodal involvement and a greater representation of earlier stages. The recurrence-free survival and disease-specific survival times were longer for BT-PDAC (16 vs 14 months [p = 0.020] and 33 vs 26 months [p = 0.026], respectively), but tumor location was not an independent predictor of recurrence or survival in the multivariable analyses. The recurrence patterns did not differ. Certain prognostic factors (i.e., CA 19.9, grading, R-status, and adjuvant treatment) were common, whereas others were site-specific (i.e., preoperative pain, diabetes, and multivisceral resection). The performances of the AJCC staging system were similar (C-statistics of 0.573 for H-PDAC and 0.597 for BT-PDAC, respectively). CONCLUSIONS: Despite differences in pathologic profile found to be in favor of BT-PDAC, tumor location was not an independent predictor of recurrence or survival after pancreatectomy. An array of site-specific prognostic factors was identified, but the AJCC staging system displayed similar prognostic power regardless of primary tumor location.</p>
<p>doi: <a href="https://doi.org/10.1245/s10434-020-08354-4" class="uri">https://doi.org/10.1245/s10434-020-08354-4</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Pancreatic Neuroendocrine Neoplasms: Landscape and Horizon</strong> </summary></p>
<p><em>Archives of pathology &amp; laboratory medicine 2020 Apr;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32298138" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32298138</a></p>
<p>CONTEXT.—: Since the initial description of pancreatic endocrine physiology and the recognition of islet cell tumors in the 1800s, there have been noteworthy advances in the pathobiology of pancreatic neuroendocrine neoplasms (PanNENs), and definition of the important distinction between well-differentiated neuroendocrine tumor (PanNET) and poorly differentiated neuroendocrine carcinoma (PanNEC). The evolving knowledge has resulted in a continuous update in terminology, classification, and grading system for this group of neoplasms. Pancreatic neuroendocrine tumors associated with hereditary conditions have been linked to unique molecular and genetic events, and sporadic PanNETs have specific gene signatures. Based on accumulative experience and knowledge, therapeutic strategies have been defined for this group of neoplasms. OBJECTIVE.—: To review the evolution and description of the pathologic-genomic evolution of PanNENs, and to facilitate accurate pathologic interpretation for the corresponding clinical management. DATA SOURCES.—: Literature review of published studies and author’s own work. CONCLUSIONS.—: Evolving experience and knowledge have established subtypes of pancreatic neuroendocrine neoplasms, based on their genotype and phenotype. Accurate pathologic interpretation of the specific neoplasm has significant implications for therapy and prognosis.</p>
<p>doi: <a href="https://doi.org/10.5858/arpa.2019-0654-RA" class="uri">https://doi.org/10.5858/arpa.2019-0654-RA</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>How does intestinal-type intraductal papillary mucinous neoplasm emerge? CDX2 plays a critical role in the process of intestinal differentiation and progression</strong> </summary></p>
<p><em>Virchows Archiv : an international journal of pathology 2020 Jul;477(1):21-31</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32291497" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32291497</a></p>
<p>Intestinal-type intraductal papillary mucinous neoplasm (IPMN) of the pancreas is clinicopathologically distinctive. Our research aimed to elucidate the molecular mechanism of the development and progression of the intestinal-type IPMN. In 60 intestinal-type IPMN specimens, histological transitions from gastric-type epithelia to intestinal-type epithelia were observed in 48 cases (80%). CDX2/MUC2/alcian blue triple staining indicated that CDX2 appeared to precede MUC2 expression and subsequent alcian blue-positive mucin production. Expression of p21 and Ki-67 seemed to be accelerated by CDX2 expression (p = 6.02e-13 and p = 3.1e-09, respectively). p21/Ki-67 double staining revealed that p21 was mostly expressed in differentiated cells in the apex of papillae, while Ki-67 was expressed in proliferative cells in the base of papillae. This clear cellular arrangement seemed to break down with the progression of atypical grade and development of invasion (p = 0.00197). Intestinal-type IPMNs harbored frequent GNAS mutations (100%, 25/25) and RNF43 mutations (57%, 8/14) and shared identical GNAS and KRAS mutations with concurrent gastric-type IPMNs or incipient gastric-type neoplasia (100%, 25/25). RNF43 mutations showed emerging or being selected in intestinal-type neoplasms along with ß-catenin aberration. Activation of protein kinase A and extracellular-regulated kinase was observed in CDX2-positive intestinal-type neoplasm. These results suggest that gastric-type epithelia that acquire GNAS mutations together with induction of intrinsic CDX2 expression may evolve with clonal selection and additional molecular aberrations including RNF43 and ß-catenin into intestinal-type IPMNs, which may further progress with complex villous growth due to disoriented cell cycle regulation, acceleration of atypical grade, and advance to show an invasive phenotype.</p>
<p>doi: <a href="https://doi.org/10.1007/s00428-020-02806-8" class="uri">https://doi.org/10.1007/s00428-020-02806-8</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>miR-375 Inhibits Autophagy and Further Promotes Inflammation and Apoptosis of Acinar Cells by Targeting ATG7</strong> </summary></p>
<p><em>Pancreas 2020 04;49(4):543-551</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32282768" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32282768</a></p>
<p>OBJECTIVES: MicroRNAs have been considered to be closely related with the development of severe acute pancreatitis (SAP), and microRNA-375 (miR-375) was believed to be a marker of SAP. We aim to investigate the role of miR-375 in regulating SP. METHODS: Cerulein and lipopolysaccharide were used to establish the models of SAP. AR42J cell line was chosen for study in vitro. Flow cytometry was applied for assessing apoptosis. The contents of inflammatory factors were detected with related enzyme-linked immunosorbent assay and quantitative real-time polymerase chain reaction assays. Hematoxylin and eosin staining was applied to observe the pathological changes of pancreatic tissues. Immunohistochemistry analysis was conducted for investigating the expression of light chain 3. RESULTS: The level of miR-375 in pancreatitis tissues and cell lines was upregulated. Overexpression of miR-375 promoted inflammation and the apoptosis of acinar cells through inhibiting autophagy. The binding site between miR-375 and ATG7 was identified, and miR-375 could directly regulate the ATG7. microRNA-375 suppressed autophagy and promoted inflammation and the apoptosis of acinar cells via targeting ATG7. CONCLUSIONS: We proved that miR-375 could inhibit autophagy and promote inflammation and the apoptosis of acinar cells through regulating ATG7. This study first proves that miR-375 modulates the development of SAP through targeting ATG7.</p>
<p>doi: <a href="https://doi.org/10.1097/MPA.0000000000001536" class="uri">https://doi.org/10.1097/MPA.0000000000001536</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Alteration of Transforming Growth Factor �� Signaling Pathway Predicts Worse Prognosis in Pancreatic Ductal Adenocarcinoma</strong> </summary></p>
<p><em>Pancreas 2020 04;49(4):534-542</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32282767" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32282767</a></p>
<p>OBJECTIVES: Transforming growth factor β (TGF-β) signaling pathway is one of the core pathways in pancreatic ductal adenocarcinoma (PDAC). Prognostic value of TGF-β pathway genes as a functionally related group in PDAC is rarely studied. METHODS: Seventy-two PDAC patients who underwent surgery between November 30, 2015, and September 13, 2017, in West China Hospital, Sichuan University, were identified and included in this study. Whole-exome sequencing or targeted next-generation sequencing was performed with tumor tissue. Clinicopathologic characteristics and survival data were retrospectively collected and analyzed. RESULTS: Genetic alterations were detected in 71 patients (98.6%). Although 1 patient (1.4%) had one genetic alteration, 33 patients (45.8%) had 2 to 4 alterations and 37 patients (51.4%) had 5 or more alterations. Twenty-five patients with TGF-β pathway alteration were identified as TGF-βm+ group. Other 47 patients were TGF-βm- group. Mutation of TGF-β pathway was independently associated with inferior survival (hazard ratio, 2.22, 95% confidence interval, 1.05-4.70, P = 0.04), especially in patients accepting radical surgery (hazard ratio, 3.25, 95% confidence interval, 1.01-10.49, P = 0.04). CONCLUSIONS: Inferior prognosis was observed in PDACs with mutations of TGF-β pathway. Genomic information could help screen out patients at risk after surgery, and adjuvant therapy might benefit this subgroup of PDACs.</p>
<p>doi: <a href="https://doi.org/10.1097/MPA.0000000000001522" class="uri">https://doi.org/10.1097/MPA.0000000000001522</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Aberration of ARID1A Is Associated With the Tumorigenesis and Prognosis of Sporadic Nonfunctional Pancreatic Neuroendocrine Tumors</strong> </summary></p>
<p><em>Pancreas 2020 04;49(4):514-523</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32282764" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32282764</a></p>
<p>OBJECTIVE: The genetic aberrations that underlie chromatin remodeling in sporadic nonfunctional pancreatic neuroendocrine tumors (NF-pNETs) remain largely unknown. Here, we investigated the dysregulation of the switch/sucrose nonfermentable (SWI/SNF) component ARID1A and its correlation with clinicopathological features and prognosis. METHODS: We sequenced the exomes of sporadic NF-pNETs. Quantitative real-time polymerase chain reaction and immunohistochemistry were used to determine messenger RNA level and protein expression. RESULTS: The sporadic NF-pNETs harbored 264 somatic mutations in 228 different genes, most commonly affecting the SWI/SNF components ARID1B (57.1%) and ARID1A (42.9%). The expression of ARID1A was remarkably downregulated in NF-pNETs and corresponding liver metastases compared with that in normal pancreatic islet tissue. Reduced expression of ARID1A was associated with malignant clinicopathological features (P &lt; 0.05). The loss of ARID1A was related to a high Ki-67 index (P &lt; 0.05). Patients with ARID1A-negative expression had a significantly worse overall survival rate than those with ARID1A-positive expression (P &lt; 0.05). The ARID1A status was an independent predictor of overall survival, and a nomogram integrating ARID1A with clinicopathological features was proposed. CONCLUSIONS: The loss of SWI/SNF components ARID1A may be associated with malignant behaviors and an unfavorable prognosis. Aberrations of ARID1A may contribute to tumorigenesis and metastasis in sporadic NF-pNETs.</p>
<p>doi: <a href="https://doi.org/10.1097/MPA.0000000000001535" class="uri">https://doi.org/10.1097/MPA.0000000000001535</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Roles of Autophagy and Pancreatic Secretory Trypsin Inhibitor in Trypsinogen Activation in Acute Pancreatitis</strong> </summary></p>
<p><em>Pancreas 2020 04;49(4):493-497</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32282761" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32282761</a></p>
<p>The focus of the review is on roles of autophagy and pancreatic secretory trypsin inhibitor (PSTI), an endogenous trypsin inhibitor, in trypsinogen activation in acute pancreatitis. Acute pancreatitis is a disease in which tissues in and around the pancreas are autodigested by pancreatic digestive enzymes. This reaction is triggered by the intrapancreatic activation of trypsinogen. Autophagy causes trypsinogen and cathepsin B, a trypsinogen activator, to colocalize within the autolysosomes. Consequently, if the resultant trypsin activity exceeds the inhibitory activity of PSTI, the pancreatic digestive enzymes are activated, and they cause autodigestion of the acinar cells. Thus, autophagy and PSTI play important roles in the development and suppression of acute pancreatitis, respectively.</p>
<p>doi: <a href="https://doi.org/10.1097/MPA.0000000000001519" class="uri">https://doi.org/10.1097/MPA.0000000000001519</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>DNA flow cytometric analysis of paraffin-embedded tissue for the diagnosis of malignancy in bile duct biopsies</strong> </summary></p>
<p><em>Human pathology 2020 May;99():80-87</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32272125" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32272125</a></p>
<p>Differentiation of reactive versus neoplastic epithelial changes can be challenging in bile duct biopsies. The samples are often scant, distorted, and mixed with significant inflammation, ulceration, and/or debris. Histological confirmation of malignancy is often required before the initiation of surgical therapy, and an erroneous diagnosis of malignancy can lead to unnecessary clinical management. Aneuploidy assessment by DNA flow cytometry was performed on formalin-fixed paraffin-embedded (FFPE) tissue from 63 bile duct biopsies: 10 with a malignant diagnosis (7 with adenocarcinoma and 3 with at least high-grade dysplasia [HGD]); 3 with an atypical diagnosis showing rare atypical glands/cells, concerning but not definite for malignancy; 28 likely reactive biopsies with acute/chronic inflammation, ulceration, and/or mild nuclear atypia; and 22 additional benign biopsies without significant inflammation, ulceration, or nuclear atypia. Aneuploidy was detected in 7 (70%) of the 10 biopsies with definite neoplasia (5 of 7 adenocarcinoma cases and 2 of 3 at least HGD cases), all 3 (100%) atypical biopsies, and none of the 50 benign biopsies. All 3 atypical cases with aneuploidy were subsequently found to have adenocarcinoma (n = 2) or HGD (n = 1). Among the 2 cases of at least HGD with aneuploidy, 1 case developed adenocarcinoma, but no follow-up information was available in the other case. The remaining 1 case of at least HGD, despite having normal DNA content, was found to have adenocarcinoma on follow-up. None of the 50 benign cases (further supported by normal DNA content) developed adenocarcinoma within a mean follow-up time of 37 months (range: 0-282 months). The estimated sensitivity of aneuploidy as a diagnostic marker of malignancy (adenocarcinoma and HGD) was 70%, with the specificity of 100%, positive predictive value of 100%, and negative predictive value of 94%. In conclusion, DNA flow cytometry using FFPE tissue from bile duct biopsies demonstrates a high rate of aneuploidy (70%) in malignant cases and normal DNA content in all benign biopsies. Although the sample size is small, the results indicate that this assay can be potentially useful in challenging atypical cases, where morphological evaluation is limited by scarcity of atypical glands/cells, inflammation, and/or ulceration.</p>
<p>doi: <a href="https://doi.org/10.1016/j.humpath.2020.04.002" class="uri">https://doi.org/10.1016/j.humpath.2020.04.002</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal Adenocarcinoma</strong> </summary></p>
<p><em>Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Mar;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32234757" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32234757</a></p>
<p>PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with dismal survival rates. Tumor microenvironment (TME), comprising of immune cells and cancer-associated fibroblasts, plays a key role in driving poor prognosis and resistance to chemotherapy. Herein, we aimed to identify a TME-associated, risk-stratification gene biomarker signature in PDAC. EXPERIMENTAL DESIGN: The initial biomarker discovery was performed in The Cancer Genome Atlas (TCGA, n = 163) transcriptomic data. This was followed by independent validation of the gene signature in the International Cancer Genome Consortium (ICGC, n = 95), E-MTAB-6134 (n = 288), and GSE71729 (n = 123) datasets for predicting overall survival (OS), and for its ability to detect poor molecular subtypes. Clinical validation and nomogram establishment was undertaken by performing multivariate Cox regression analysis. RESULTS: Our biomarker discovery effort identified a 15-gene immune, stromal, and proliferation (ISP) gene signature that significantly associated with poor OS [HR, 3.90; 95% confidence interval (CI), 2.36-6.41; P &lt; 0.0001]. This signature also robustly predicted survival in three independent validation cohorts ICGC [HR, 2.63 (1.56-4.41); P &lt; 0.0001], E-MTAB-6134 [HR, 1.53 (1.14-2.04); P = 0.004], and GSE71729 [HR, 2.33 (1.49-3.63); P &lt; 0.0001]. Interestingly, the ISP signature also permitted identification of poor molecular PDAC subtypes with excellent accuracy in all four cohorts; TCGA (AUC = 0.94), ICGC (AUC = 0.91), E-MTAB-6134 (AUC = 0.80), and GSE71729 (AUC = 0.83). The ISP-derived high-risk patients exhibited significantly poor OS in a clinical validation cohort [n = 119; HR, 2.62 (1.50-4.56); P = 0.0004]. A nomogram was established which included the ISP, CA19-9, and T- and N-stage for eventual clinical translation. CONCLUSIONS: We report a novel gene signature for risk-stratification and robust identification of patients with PDAC with poor molecular subtypes.</p>
<p>doi: <a href="https://doi.org/10.1158/1078-0432.CCR-19-4044" class="uri">https://doi.org/10.1158/1078-0432.CCR-19-4044</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Expression Patterns and Prognostic Value of DNA Damage Repair Proteins in Resected Pancreatic Neuroendocrine Neoplasms</strong> </summary></p>
<p><em>Annals of surgery 2020 Mar;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32209898" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32209898</a></p>
<p>OBJECTIVE: This study aimed to examine the expression profiles and prognostic value of multiple DDR proteins in resected PanNENs. BACKGROUND: DDR proteins play important roles in various cancers, including pancreatic ductal adenocarcinoma. However, the expression patterns and prognostic value of DDR proteins in PanNENs remain unclear. METHODS: This retrospective analysis included PanNEN patients who underwent resection at the Fudan University Shanghai Cancer Center from 2012 to 2018. Immunohistochemical staining was performed for 12 DDR proteins in tissue microarrays. The associations of DDR protein expression and clinicopathological features with recurrence-free survival (RFS) were examined via a Cox regression model and random survival forest. A recurrence signature was constructed using recursive partitioning analysis. RESULTS: In total, 131 PanNEN patients were included, with 32 (24.4%) cases of recurrence. Among the 12 DDR proteins, low checkpoint kinase 2 (CHK2) expression (P = 0.020) and loss of ataxia-telangiectasia-mutated (ATM) (P = 0.0007) significantly correlated with recurrence. Multivariable Cox regression analysis identified tumor size ≥3 cm, lymph node (LN) metastasis, high tumor grade, low CHK2 expression, and ATM loss as independent risk factors for recurrence. A recurrence signature was established based on the importance of recurrence-specific risk factors; patients with the LNnegTumorSize&lt;3cm signature had a 5-year RFS rate of 96.8%, whereas patients with the LNposCHK2low signature had the worst 5-year RFS rate (0%). Discrimination (concordance index: 0.770) and calibration plots indicated that the recurrence signature had a good ability to identify patients at risk for recurrence. CONCLUSIONS: By analyzing large-scale tissue microarrays of PanNENs, we evaluated 12 DDR protein expression profiles. We developed a recurrence signature that can identify distinct subpopulations according to RFS, which may help refine individual follow-up.</p>
<p>doi: <a href="https://doi.org/10.1097/SLA.0000000000003884" class="uri">https://doi.org/10.1097/SLA.0000000000003884</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing</strong> </summary></p>
<p><em>The Journal of molecular diagnostics : JMD 2020 Jun;22(6):748-756</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32205290" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32205290</a></p>
<p>Circulating tumor DNA (ctDNA) measurements can be used to estimate tumor burden, but avoiding false-positive results is challenging. Herein, digital next-generation sequencing (NGS) is evaluated as a ctDNA detection method. Plasma KRAS and GNAS hotspot mutation levels were measured in 140 subjects, including 67 with pancreatic ductal adenocarcinoma and 73 healthy and disease controls. To limit chemical modifications of DNA that yield false-positive mutation calls, plasma DNA was enzymatically pretreated, after which DNA was aliquoted for digital detection of mutations (up to 384 aliquots/sample) by PCR and NGS. A digital NGS score of two SDs above the mean in controls was considered positive. Thirty-seven percent of patients with pancreatic cancer, including 31% of patients with stages I/II disease, had positive KRAS codon 12 ctDNA scores; only one patient had a positive GNAS mutation score. Two disease control patients had positive ctDNA scores. Low-normal-range digital NGS scores at mutation hotspots were found at similar levels in healthy and disease controls, usually at sites of cytosine deamination, and were likely the result of chemical modification of plasma DNA and NGS error rather than true mutations. Digital NGS detects mutated ctDNA in patients with pancreatic cancer with similar yield to other methods. Detection of low-level, true-positive ctDNA is limited by frequent low-level detection of false-positive mutation calls in plasma DNA from controls.</p>
<p>doi: <a href="https://doi.org/10.1016/j.jmoldx.2020.02.010" class="uri">https://doi.org/10.1016/j.jmoldx.2020.02.010</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Validation of the T category for distal cholangiocarcinoma: Measuring the depth of invasion is complex but correlates with survival</strong> </summary></p>
<p><em>Annals of diagnostic pathology 2020 Mar;46():151489</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32169826" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32169826</a></p>
<p>According to the current 8th edition of the American Joint Committee of Cancer (AJCC), the T category of distal cholangiocarcinomas is classified based on the depth of invasion (DOI) (T1, &lt; 5 mm; T2, between 5 and 12 mm; T3, &gt; 12 mm). In consideration of the discrepancies between previous studies about the prognostic significance, we aimed to validate the current AJCC T staging system of distal cholangiocarcinomas. DOI was measured using three different methods: DOI1, DOI2, and DOI3. DOI1 was defined and stratified according to the AJCC 8th edition. DOI2 was measured as the distance from an imaginary curved line approximated along the distorted mucosal surface to the deepest invasive tumor cells. DOI3 was defined as the total tumor thickness. DOI2 and DOI3 were also divided into three categories using the same cut-off points as in the AJCC 8th edition. We compared these three DOI methods to the AJCC 7th edition as well. In contrast with the AJCC 7th edition, all three groups showed a correlation with patients’ overall survival. Above all, the DOI2 group demonstrated the best significance in multivariate analysis. However, when the C indices were compared between these groups, differential significance proved to be negligible (DOI1 vs DOI2, p = 0.915; DOI2 vs DOI3, p = 0.057). Therefore, the measurement of DOI does not need to be rigorously and stringently performed. In conclusion, we showed that the current T classification system better correlates with the overall survival of patients with distal cholangiocarcinomas than the previous system.</p>
<p>doi: <a href="https://doi.org/10.1016/j.anndiagpath.2020.151489" class="uri">https://doi.org/10.1016/j.anndiagpath.2020.151489</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer</strong> </summary></p>
<p><em>Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Mar;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32156747" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32156747</a></p>
<p>PURPOSE: To determine the impact of basal-like and classical subtypes in advanced pancreatic ductal adenocarcinoma (PDAC) and to explore GATA6 expression as a surrogate biomarker. EXPERIMENTAL DESIGN: Within the COMPASS trial, patients proceeding to chemotherapy for advanced PDAC undergo tumor biopsy for RNA-sequencing (RNA-seq). Overall response rate (ORR) and overall survival (OS) were stratified by subtypes and according to chemotherapy received. Correlation of GATA6 with the subtypes using gene expression profiling, in situ hybridization (ISH) was explored. RESULTS: Between December 2015 and May 2019, 195 patients (95%) had enough tissue for RNA-seq; 39 (20%) were classified as basal-like and 156 (80%) as classical. RECIST response data were available for 157 patients; 29 basal-like and 128 classical where the ORR was 10% versus 33%, respectively (P = 0.02). In patients with basal-like tumors treated with modified FOLFIRINOX (n = 22), the progression rate was 60% compared with 15% in classical PDAC (P = 0.0002). Median OS in the intention-to-treat population (n = 195) was 9.3 months for classical versus 5.9 months for basal-like PDAC (HR, 0.47; 95% confidence interval, 0.32-0.69; P = 0.0001). GATA6 expression by RNA-seq highly correlated with the classifier (P &lt; 0.001) and ISH predicted the subtypes with sensitivity of 89% and specificity of 83%. In a multivariate analysis, GATA6 expression was prognostic (P = 0.02). In exploratory analyses, basal-like tumors, could be identified by keratin 5, were more hypoxic and enriched for a T-cell-inflamed gene expression signature. CONCLUSIONS: The basal-like subtype is chemoresistant and can be distinguished from classical PDAC by GATA6 expression.</p>
<p>doi: <a href="https://doi.org/10.1158/1078-0432.CCR-19-3724" class="uri">https://doi.org/10.1158/1078-0432.CCR-19-3724</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma</strong> </summary></p>
<p><em>BMC cancer 2020 Mar;20(1):188</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32138704" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32138704</a></p>
<p>BACKGROUND: The American Joint Committee on Cancer (AJCC) and the European Neuroendocrine Tumor Society (ENETS) staging classifications are two broadly used systems for pancreatic neuroendocrine tumors. This study aims to identify the most accurate and useful tumor-node-metastasis (TNM) staging system for poorly differentiated pancreatic neuroendocrine carcinomas (pNECs). METHODS: An analysis was performed to evaluate the application of the ENETS, 7th edition (7th) AJCC and 8th edition (8th) AJCC staging classifications using the Surveillance, Epidemiology, and End Results (SEER) registry (N = 568 patients), and a modified system based on the analysis of the 7th AJCC classification was proposed. RESULTS: In multivariable analyses, only the 7th AJCC staging system allocated patients into four different risk groups, although there was no significant difference. We modified the staging classification by maintaining the T and M definitions of the 7th AJCC staging and adopting new staging definitions. An increased hazard ratio (HR) of death was also observed from class I to class IV for the modified 7th (m7th) staging system (compared with stage I disease; HR for stage II =1.23, 95% confidence interval (CI) = 0.73-2.06, P = 0.44; HR for stage III =2.20, 95% CI =1.06-4.56, P = 0.03; HR for stage IV =4.95, 95% CI =3.20-7.65, P &lt; 0.001). The concordance index (C-index) was higher for local disease with the m7th AJCC staging system than with the 7th AJCC staging system. CONCLUSIONS: The m7th AJCC staging system for pNECs proposed in this study provides improvements and may be assessed for potential adoption in the next edition.</p>
<p>doi: <a href="https://doi.org/10.1186/s12885-020-6634-9" class="uri">https://doi.org/10.1186/s12885-020-6634-9</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012</strong> </summary></p>
<p><em>Cancer 2020 Jun;126(11):2666-2678</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32129902" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32129902</a></p>
<p>BACKGROUND: Intrahepatic cholangiocarcinomas (ICCs) and extrahepatic cholangiocarcinomas (ECCs) are highly lethal bile duct tumors. Their incidence can be difficult to estimate because of changes in cancer coding over time. No studies to date have examined their global incidence and trends with high-quality topography- and histology-specific cancer registry data. Therefore, this study examined ICC and ECC incidence with the Cancer Incidence in Five Continents Plus database. METHODS: Regional and national cancer registry data were used to estimate age-standardized incidence rates (ASRs) per 100,000 person-years, 95% confidence intervals, and average annual percent changes (AAPCs) for ICC in 38 countries and for ECC in 33 countries from 1993 to 2012. ICC and ECC trends were tabulated and plotted by country. Rates versus birth cohort by age were plotted, and an age-period-cohort analysis was performed to assess age and cohort incidence rate ratios. RESULTS: The highest rates of ICC and ECC were in Asia, specifically South Korea (ASR for ICC, 2.80; ASR for ECC, 2.24), Thailand (ASR for ICC, 2.19; ASR for ECC, 0.71), and Japan (ASR for ICC, 0.95; ASR for ECC, 0.83). Between 1993 and 2012, incidence rates of both ICC and ECC increased in most countries. The largest ASR increases over the study period occurred in Latvia (AAPC, 20.1%) and China (AAPC, 11.1%) for ICC and in Thailand (AAPC, 8.8%) and Colombia (AAPC, 8.5%) for ECC. CONCLUSIONS: In the 20 years examined, ICC and ECC incidence increased in the majority of countries worldwide. ICC and ECC incidence may continue to increase because of metabolic and infectious etiologic factors. Efforts to further elucidate risk factors contributing to these increases in incidence are warranted.</p>
<p>doi: <a href="https://doi.org/10.1002/cncr.32803" class="uri">https://doi.org/10.1002/cncr.32803</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>INSM1 Is a Highly Specific Marker of Neuroendocrine Differentiation in Primary Neoplasms of the Gastrointestinal Tract, Appendix, and Pancreas</strong> </summary></p>
<p><em>American journal of clinical pathology 2020 May;153(6):811-820</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32128564" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32128564</a></p>
<p>OBJECTIVES: INSM1 has been described as a sensitive and specific neuroendocrine marker. This study aims to compare INSM1 with traditional neuroendocrine markers in gastrointestinal neuroendocrine neoplasms. METHODS: Retrospective review (2008-2018) was used to retrieve paraffin-embedded tissue from 110 gastrointestinal neuroendocrine neoplasms and controls that was subsequently stained with INSM1, synaptophysin, chromogranin, CD56, and Ki-67. RESULTS: INSM1 was positive in 16 of 17 (94.1%) gastric, 17 of 18 (94.4%) pancreatic, 13 of 18 (72.2%) small bowel, 17 of 21 (81.0%) colonic, and 26 of 36 (72.2%) appendiceal tumors. INSM1 was positive in 58 of 70 (82.9%) well-differentiated neuroendocrine tumors, 17 of 20 (85.0%) poorly differentiated neuroendocrine carcinomas, 8 of 11 (72.7%) low-grade goblet cell adenocarcinomas (grade 1), and 6 of 9 (66.7%) high-grade goblet cell adenocarcinomas (grade 2/3). INSM1 sensitivity for neuroendocrine neoplasms (80.9%) was less than that of synaptophysin (99.1%), chromogranin (88%), and CD56 (95.3%); specificity was higher (95.7% vs 86.0%, 87.3%, and 86.0%, respectively). CONCLUSIONS: INSM1 is a useful marker of neuroendocrine differentiation in gastrointestinal neuroendocrine and mixed neuroendocrine neoplasms. Compared with traditional neuroendocrine markers, INSM1 is less sensitive but more specific.</p>
<p>doi: <a href="https://doi.org/10.1093/ajcp/aqaa014" class="uri">https://doi.org/10.1093/ajcp/aqaa014</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Global, regional and national burden of pancreatic cancer, 1990 to 2017: Results from the Global Burden of Disease Study 2017</strong> </summary></p>
<p><em>Pancreatology : official journal of the International Association of Pancreatology (IAP) … [et al.] 2020 Apr;20(3):462-469</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32113937" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32113937</a></p>
<p>BACKGROUND: The global burden of pancreatic cancer (PCa) continues to grow. Detailed data on PCa epidemiology are essential for policy-making and appropriate healthcare resource allocation. METHODS: Estimates of incidence, death and disability-adjusted life years (DALYs) of PCa from 1990 to 2017 were collected from the Global Burden of Disease Study 2017. Decomposition analysis was conducted to detect the contributing factors related to PCa incidence variation. The estimated annual percentage change (EAPC) was calculated to quantify the PCa epidemiology trends over a specified interval. RESULTS: Globally, the incidence of PCa cases increased by 129.1% to 447 664 664 (95% uncertainty interval (UI) 438 597-456 295), death increased by 125.2% to 441 082 082 (95% UI 448 960-432 833), and DALYs increased by 107.3% to 9 080 004 (95% UI 8 894 128-9 256 346) between 1990 and 2017. Relatively higher sociodemographic index (SDI) regions were observed with greater incidences, more deaths and a greater number of DALYs of PCa, but relatively lower SDI regions experienced a sharply increasing trend in these measures. Decomposition analysis indicated that the global increase in PCa incidence was driven by the aging population from 2007 to 2017, especially in higher SDI regions. In addition, a significant negative correlation was found between EAPC and ASIR (in 1990) (r = -0.56, P &lt; 0.001). CONCLUSIONS: PCa remains a major public health burden globally. The unfavorable trend in PCa suggesting that further study for prevention should be conducted to forestall the increase in pancreatic cancer.</p>
<p>doi: <a href="https://doi.org/10.1016/j.pan.2020.02.011" class="uri">https://doi.org/10.1016/j.pan.2020.02.011</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>TRAIL receptors are differentially regulated and clinically significant in gallbladder cancer</strong> </summary></p>
<p><em>Pathology 2020 Apr;52(3):348-358</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32111400" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32111400</a></p>
<p>Deregulation of the receptors of TNF-related apoptosis inducing ligand (TRAIL) has been reported in various cancers. In an effort to define the role of these receptors we profiled their expression in gallbladder cancer (GBC) and explored their clinical significance. Expression of TRAIL receptors’ mRNA in GBC was analysed through reverse transcriptase polymerase chain reaction (RT-PCR), and protein through western blotting, immunohistochemistry and enzyme-linked immunosorbent assay (ELISA). mRNA data show frequent higher expression of TRAIL receptors in GBC samples. Death receptors DR4 and DR5 showed significant negative correlation with tumour stage, T stage and tumour grade; DcR1 transcript showed positive correlation with tumour stage, N stage, M stage and tumour grade. Similarly, IHC showed frequent positive staining for DR4, DR5 and DcR1in GBC samples. Cytoplasmic and nuclear DR4 protein showed negative correlation with T stage and tumour grade, whereas cytoplasmic DcR1 protein showed positive correlation with tumour stage and N stage. Nuclear DcR1 showed positive correlation with N stage. ELISA results showed significantly higher expression of secretory DcR1 in GBC patients. Kaplan-Meier analysis demonstrated significantly decreased mean survival of patients with positive staining of cytoplasmic DcR1. High level of death receptors identified the patients with early gallbladder cancer, whereas high DcR1 expression served as a prognostic factor for poor outcome.</p>
<p>doi: <a href="https://doi.org/10.1016/j.pathol.2019.12.001" class="uri">https://doi.org/10.1016/j.pathol.2019.12.001</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes</strong> </summary></p>
<p><em>Annals of surgical oncology 2020 Feb;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32108923" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32108923</a></p>
<p>BACKGROUND: Microsatellite instability (MSI) has emerged as a predictive biomarker for immune checkpoint inhibitor therapy. Cancer heterogeneity represents a potential obstacle for the analysis of predicitive biomarkers. MSI has been reported in pancreatic cancer, but data on the possible extent of intratumoral heterogeneity are lacking. METHODS: To study MSI heterogeneity in pancreatic cancer, a tissue microarray (TMA) comprising 597 tumors was screened by immunohistochemistry with antibodies for the mismatch repair (MMR) proteins MLH1, PMS2, MSH2, and MSH6. RESULTS: In six suspicious cases, large section immunohistochemistry and microsatellite analysis (Bethesda panel) resulted in the identification of 4 (0.8%) validated MSI cases out of 480 interpretable pancreatic ductal adenocarcinomas. MSI was absent in 55 adenocarcinomas of the ampulla of Vater and 7 acinar cell carcinomas. MMR deficiency always involved MSH6 loss, in three cases with additional loss of MSH2 expression. Three cancers were MSI-high and one case with isolated MSH6 loss was MSS in PCR analysis. The analysis of 44 cancer-containing tumor blocks revealed that the loss of MMR protein expression was always homogeneous in affected tumors. Automated digital image analysis of CD8 immunostaining demonstrated markedly higher CD8 + tumor infiltrating lymphocytes in tumors with (mean = 685, median = 626) than without (mean = 227; median = 124) MMR deficiency (p &lt; 0.0001), suggesting a role of MSI for immune response. CONCLUSIONS: Our data suggest that MSI occurs early in a small subset of ductal adenocarcinomas of the pancreas and that immunohistochemical MMR analysis on limited biopsy or cytology material may be sufficient to estimate MMR status of the entire cancer mass.</p>
<p>doi: <a href="https://doi.org/10.1245/s10434-020-08209-y" class="uri">https://doi.org/10.1245/s10434-020-08209-y</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes</strong> </summary></p>
<p><em>The Journal of pathology 2020 May;251(1):38-48</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32100878" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32100878</a></p>
<p>Intraductal papillary neoplasm of the bile duct (IPNB) is a grossly visible papillary biliary neoplasm with morphological variations and occasional invasion. Recently a new classification of IPNB into type 1 and type 2 was proposed in which the type 1 IPNBs consist of fine papillary neoplastic glands and the type 2 IPNBs consist of complex branching glands, seldom with foci of solid-tubular components. However, clinicopathological and molecular characteristics of these types of IPNBs are yet to be identified. We aimed to uncover clinicopathological and molecular characteristics of the types of IPNBs. Thirty-six IPNBs were studied retrospectively. Clinicopathological features as well as molecular alterations of 31 genes were evaluated by means of targeted next-generation sequencing and immunohistochemical examination of expression of mucin and cancer-associated molecules. The 36 IPNBs were classified into 22 of type 1 and 14 of type 2. The type 1 IPNBs were associated with a non-invasive phenotype, intestinal and oncocytic subtypes, development in the intrahepatic bile duct, overt mucin production, and a relatively good prognosis. The type 2 IPNBs were associated with an invasive phenotype, the pancreatobiliary subtype, development within the extrahepatic bile duct, and worse prognosis compared with the type 1 IPNBs. In the molecular analysis, recurrent mutations were found in TP53 (34.3%), KRAS (31.4%), STK11 (25.7%), CTNNB1 (17.1%), APC (14.3%), SMAD4 (14.3%), GNAS (11.4%), PBRM1 (11.4%), ELF3 (8.6%), KMT2C (8.6%), NF1 (8.6%), PIK3CA (8.6%), ARID1A (5.7%), ARID2 (5.7%), BAP1 (5.7%), BRAF (5.7%), EPHA6 (5.7%), ERBB2 (5.7%), ERBB3 (5.7%), KMT2D (5.7%), and RNF43 (5.7%). Mutations in KRAS and GNAS were enriched in the type 1 IPNBs, whereas mutations in TP53, SMAD4, and KMT2C were enriched in the type 2 IPNBs. These results indicate that IPNBs consist of two distinct types of neoplasms specifically associated with clinicopathological features and molecular phenotypes. © 2020 Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd.</p>
<p>doi: <a href="https://doi.org/10.1002/path.5398" class="uri">https://doi.org/10.1002/path.5398</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Tumor-insular Complex in Neoadjuvant Treated Pancreatic Ductal Adenocarcinoma Is Associated With Higher Residual Tumor</strong> </summary></p>
<p><em>The American journal of surgical pathology 2020 Jun;44(6):817-825</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32091434" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32091434</a></p>
<p>The tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC) plays a vital role in treatment response, and therefore, patient survival. We and others have observed an intimate association of neoplastic ductal cells with non-neoplastic islet cells, recapitulating the ductoinsular complex. We define this phenomenon as tumor-insular complex (TIC). Herein, we describe the clinicopathologic characteristics of TIC in neoadjuvant treated PDAC cases for the first time. We retrospectively reviewed the pathology of 105 cases of neoadjuvant treated PDAC resected at our institution. TIC was noted in 35 cases (33.3%), the mean tumor bed size was 2.7±1.0 cm, mean percentage of residual tumor 40±28% and mean Residual Tumor Index (RTI) (an index previously established as a prognostic parameter by our group) was 1.1±1.0. TIC was significantly associated with perineural invasion (P=0.001), higher tumor bed size (P=0.007), percentage of residual tumor (P=0.009), RTI (P=0.001), ypT stage (P=0.045), and poor treatment response, grouped by a previously established criteria (P=0.010). Using our prior binary reported prognostic cutoff for RTI of ≤0.35 and &gt;0.35, TIC was associated with a RTI &gt;0.35 (P=0.002). Moreover, patients who did not receive neoadjuvant radiation were associated with a higher frequency of TIC (P=0.003). In this cohort, RTI but not TIC was also shown to be a significant independent prognosticator for recurrence-free survival and overall survival on multivariate analysis. In conclusion, TIC is significantly associated with a more aggressive neoplasm which shows a poor treatment response. Further studies will be needed to better understand the tumor biology of TICs.</p>
<p>doi: <a href="https://doi.org/10.1097/PAS.0000000000001454" class="uri">https://doi.org/10.1097/PAS.0000000000001454</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Clinical Significance of CBS and CCL21 in Gallbladder Adenocarcinomas and Squamous Cell/Adenosquamous Carcinomas</strong> </summary></p>
<p><em>Applied immunohistochemistry &amp; molecular morphology : AIMM 2020 02;28(2):103-110</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32044878" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32044878</a></p>
<p>Gallbladder cancer (GBC) is a rare disease with high mortality. However, no biomarkers for the carcinogenesis, progression, prognosis, and early diagnosis are clinically available. This study investigated the expressions of cystathionine-β-synthase (CBS) and C-C chemokine receptor 7 (CCR7) protein and their clinical and pathologic significances in gallbladder squamous cell/adenosquamous carcinomas (SC/ASC) and adenocarcinomas (AC). CBS and chemokine ligand 21 (CCL21) expression was measured using immunohistochemistry in 69 SC/ASCs and 146 ACs. A significantly high percentage of patients with an age above 45 years, lymph node metastasis, and invasion was observed in the SCs/ASCs compared with ACs (P&lt;0.05). Both AC and SC/ASC patients with positive CBS and CCL21 expression exhibited a high tumor-lymph node-metastasis stage, lymph node metastasis, and invasion compared with patients with negative CBS and CCL21 expression (P&lt;0.05 or P&lt;0.01). SC/ASC patients with positive CBS expression was prone to have a larger tumor size than those with negative expression (P&lt;0.05). Positive CBS and CCL21 expression correlated with poor differentiation and larger tumor size in AC patients. Positive CBS and CCL21 are closely associated with a decreased overall survival in SC/ASC and AC patients (P&lt;0.05 or P&lt;0.01) and were independent factors for a poor-prognosis. Both CBS and CCL21 showed a good overall diagnostic performance for SC/ASC (AUC=0.742 and AUC=0.764, respectively) and AC (AUC=0.734 and AUC=0.718, respectively). In conclusion, positive CBS and CCL21 expression are closely associated with the clinical severity and poor prognosis in GBC, and can be a marker for the diagnosis of AC and SC/ASC type of GBC.</p>
<p>doi: <a href="https://doi.org/10.1097/PAI.0000000000000705" class="uri">https://doi.org/10.1097/PAI.0000000000000705</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings</strong> </summary></p>
<p><em>Cancer 2020 Jan;126(9):1995-2002</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32012241" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32012241</a></p>
<p>BACKGROUND: With limited information on germline mutations in biliary tract cancers, this study performed somatic and germline testing for patients at Memorial Sloan Kettering Cancer Center with known biliary tract carcinoma with the aim of determining the frequency and range of pathogenic germline alterations (PGAs). METHODS: Patients with biliary tract carcinoma were consented for somatic tumor and matched blood testing of up to 468 genes via the Memorial Sloan Kettering Cancer Center Integrated Mutation Profiling of Actionable Cancer Targets next-generation sequencing platform. A germline variant analysis was performed on a panel of up to 88 genes associated with an increased predisposition for cancer. Demographic and diagnostic details were collected. RESULTS: Germline mutations were tested in 131 patients. Intrahepatic cholangiocarcinoma was the most common cancer (63.4%), and it was followed by gallbladder adenocarcinoma (16.8%), extrahepatic cholangiocarcinoma (16%), and otherwise unspecified biliary tract cancer (3.8%). Known and likely PGAs were present in 21 patients (16.0%), with 9.9% harboring a PGA in a high/moderate-penetrance cancer predisposition gene. Among high-penetrance cancer susceptibility genes, PGAs were most commonly observed in BRCA1 and BRCA2 (33.3%), which made up 5.3% of the entire cohort, and they were followed by PALB2, BAP1, and PMS2. Mutations in ATM, MITF, and NBN, moderate-penetrance cancer susceptibility genes, were identified in 1 patient each. There was no observed difference in the types of mutations among the subtypes of biliary tract cancer. CONCLUSIONS: The frequency of PGAs found was comparable to existing data on the prevalence of germline mutations in other solid tumor types with matched tumor analysis. This provides support for the role of the BRCA1/2, ATM, and BAP1 genes in biliary tract cancer susceptibility.</p>
<p>doi: <a href="https://doi.org/10.1002/cncr.32740" class="uri">https://doi.org/10.1002/cncr.32740</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Smooth Muscle Distribution Patterns of Choledochal Cysts and Their Implications for Pathogenesis and Postoperative Complications</strong> </summary></p>
<p><em>American journal of clinical pathology 2020 May;153(6):760-771</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32010932" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32010932</a></p>
<p>OBJECTIVES: Histopathologic characteristics of choledochal cysts and their clinical implications have not been previously comprehensively studied. METHODS: Smooth muscle distribution patterns and other histologic findings (inflammation, metaplasia, dysplasia, and heterotopia) in 233 surgically resected choledochal cysts were evaluated. RESULTS: Mean patient age was 23.3 ± 19.8 years, with male:female ratio of 0.3. Most cases were Todani type I (175 cases, 75.1%) or IVa (56 cases, 24.1%). Choledochal cysts with thin scattered/no muscle fiber (175 cases, 75.1%) were the predominant pattern and were associated with more frequent postoperative biliary stricture (P = .031), less frequent pyloric metaplasia (P = .016), and mucosal smooth muscle aggregates (P &lt; .001) compared to cysts with thick muscle bundles. Severe chronic cholangitis (P = .049), pyloric metaplasia (P = .019), mucosal smooth muscle aggregates (P &lt; .001), biliary intraepithelial neoplasia (P = .021), and associated bile duct (P = .021) and gallbladder carcinomas (P = .03) were more common in adults (age &gt;20 years vs ≤20 years), suggesting that chronic irritation in association with developmental anomalies involves tumorigenesis from choledochal cysts. CONCLUSION: Smooth muscle distribution pattern of choledochal cyst may predict postoperative complication, raising clinical implications of smooth muscle patterns in postoperative management of choledochal cysts.</p>
<p>doi: <a href="https://doi.org/10.1093/ajcp/aqaa002" class="uri">https://doi.org/10.1093/ajcp/aqaa002</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Innervation of the proximal human biliary tree</strong> </summary></p>
<p><em>Virchows Archiv : an international journal of pathology 2020 Jan;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31993770" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31993770</a></p>
<p>The autonomic nervous system plays a role in a variety of liver regenerative and metabolic functions, including modulating bile secretion and cholangiocyte and hepatobiliary progenitors of the canals of Hering. However, the nature and location of nerves which link to the proximal biliary tree have remained uncertain. We investigate the anatomic relationship of nerves to the proximal biliary tree including the putative stem/progenitor cell niche of the canal of Hering. Using double immunostaining (fluorescence, histochemistry) to highlight markers of cholangiocytes (biliary-type keratins), nerves (S100, neurofilament protein, PGP9.5, tyrosine hydroxylase), and stellate cells (CRBP-1), we examined sections from normal adult livers from autopsy or surgical resections. There is extensive contact between nerves and interlobular bile ducts, bile ductules, and canals of Hering (CoH). In multiple serial sections from 4 normal livers, biliary-nerve contacts were seen in all of these structures and were more common in the interlobular bile ducts (78/137; 57%) than in the ductules and CoH (95/294; 33%) (p &lt; 0.001). Contacts appear to consist of nerves in juxtaposition to the biliary basement membrane, though crossing through basement membrane to interface directly with cholangiocytes is also present. These nerves are positive for tyrosine hydroxylase and are, thus, predominately adrenergic. Electron microscopy confirms nerves closely approximating ductules. Nerve fiber-hepatic stellate cell juxtaposition is observed but without stellate cell approximation to cholangiocytes. We present novel findings of biliary innervation, perhaps mediated in part, by direct cholangiocyte-nerve interactions. The implications of these findings are protean for studies of neuromodulation of biliary physiology and hepatic stem/progenitor cells.</p>
<p>doi: <a href="https://doi.org/10.1007/s00428-020-02761-4" class="uri">https://doi.org/10.1007/s00428-020-02761-4</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Luschka Ducts of the Gallbladder in Adults: Case Series Report and Review of the Medical Literature</strong> </summary></p>
<p><em>International journal of surgical pathology 2020 Aug;28(5):482-489</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31983263" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31983263</a></p>
<p>Luschka ducts (LD) of the gallbladder (GB) are rare congenital lesions. They are defined as bile ducts that connect directly the hepatic bile duct system to the GB. We aimed to present the characteristics of 55 cases of GB LDs as diagnosed on cholecystectomy specimens. Surgically resected GBs (55) were analyzed for LD morphological features (length, morphological pattern, and epithelial lesions) as well as for immunohistochemical features. The age varied between 24 and 88 years. The gender ratio was 30:25 (female-male). The diagnosis was acute and subacute/chronic cholecystitis (21 and 34 cases, respectively). GB abnormalities of Rokitansky-Aschoff sinus, adenomyoma, septate, and subserosal-liver types were present in 36, 6, 22, and 12 GBs, respectively, while adenocarcinoma was present in 2 GBs. A history of renal cyst, pancreatitis, and colon diverticulosis was observed in 8, 11, and 4 cases, respectively. The LDs were detected at subserosal, resection, or both sites (25, 4, and 26 cases, respectively). The length varied between &lt;1 and 36 mm. Duct-type LDs were observed in 17 cases, complex-type LDs in 5 cases, and mixed-type LDs in 33 cases. Mucosecretion was seen in 12 LDs and cystic dilatation in 8 cases. Epithelial atypia was observed in 2 cases and meganucleoli in 15 cases. Presence of LD-angulation correlated with chronic cholecystitis, while LD-nuclear atypia correlated with acute cholecystitis. In conclusion, LDs may harbor varied aspects, from duct-like or cystic, to nodular, biliary adenoma-like complexes. GB abnormalities of Rokitansky-Aschoff sinus, septa, or subserosal-liver types and extra-GB lesions such as renal cysts, pancreatitis, and colon diverticulosis were associated.</p>
<p>doi: <a href="https://doi.org/10.1177/1066896920901334" class="uri">https://doi.org/10.1177/1066896920901334</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors</strong> </summary></p>
<p><em>Cancer cytopathology 2020 Apr;128(4):269-277</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31977134" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31977134</a></p>
<p>BACKGROUND: Pancreatic neuroendocrine tumor (PNET) is a diagnostic challenge with limited samples in not only identification but grading. Prior studies have shown insulinoma-associated protein 1 (INSM1) to be a robust marker in identifying PNETs from other solid pancreatic tumors on resection specimens. In this study, we investigated the utility of INSM1 not only for identifying PNETs but also for grading in cell blocks (CBs) and surgical resections (SRs). METHODS: A search for PNET cases between 2000 and 2019 identified 55 samples (26 CBs and 29 SRs) that were further separated into high (2 CBs, 3 SRs), intermediate (4 CBs, 7 SRs), and low (20 CBs, 19 SRs) grades based on their final pathology report and Ki-67 level. Immunohistochemical (IHC) staining for INSM1 (C-8, Santa Cruz Biotechnology [1:100]) was performed and quantified using an H score of 0 to 300. Non-PNET solid pancreatic tumors were compared and included acinar cell carcinoma, solid pseudopapillary neoplasm, and ductal adenocarcinoma. RESULTS: All 55 cases of PNET demonstrated nuclear INSM1 staining. The average H scores for INSM1 staining of PNET were 254 and 252 in CB and SR, respectively. The H scores decreased with increasing tumor grade, with low-grade (G1), intermediate-grade (G2), and high-grade (G3) tumors showing average INSM1 H scores of 229 and 253, 266 and 253, and 30 and 33 in both CB and SR, respectively. CONCLUSION: IHC with INSM1 plays a role in identifying and potentially grading PNETs.</p>
<p>doi: <a href="https://doi.org/10.1002/cncy.22242" class="uri">https://doi.org/10.1002/cncy.22242</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Microscopic size measurements in post-neoadjuvant therapy resections of pancreatic ductal adenocarcinoma (PDAC) predict patient outcomes</strong> </summary></p>
<p><em>Histopathology 2020 Jul;77(1):144-155</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31965618" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31965618</a></p>
<p>AIMS: Pancreatic ductal adenocarcinomas (PDACs) are increasingly being treated with neoadjuvant therapy. However, the American Joint Committee on Cancer (AJCC) 8th edition T staging based on tumour size does not reflect treatment effect, which often results in multiple, small foci of residual tumour in a background of mass-forming fibrosis. Thus, we evaluated the performance of AJCC 8th edition T staging in predicting patient outcomes by the use of a microscopic tumour size measurement method. METHODS AND RESULTS: One hundred and six post-neoadjuvant therapy pancreatectomies were reviewed, and all individual tumour foci were measured. T stages based on gross size with microscopic adjustment (GS) and the largest single microscopic focus size (MFS) were examined in association with clinicopathological variables and patient outcomes. Sixty-three of 106 (59%) were locally advanced; 78% received FOLFIRINOX treatment. The average GS and MFS were 25 mm and 11 mm, respectively; nine cases each were classified as T0, 35 and 85 cases as T1, 42 and 12 cases as T2, and 20 and 0 cases as T3, based on the GS and the MFS, respectively. Higher GS-based and MFS-based T stages were significantly associated with higher tumour regression grade, lymphovascular and perineural invasion, and higher N stage. Furthermore, higher MFS-based T stage was significantly associated with shorter disease-free survival (DFS) (P &lt; 0.001) and shorter overall survival (OS) (P = 0.002). GS was significantly associated with OS (P = 0.046), but not with DFS. CONCLUSIONS: In post-neoadjuvant therapy PDAC resections, MFS-based T staging is superior to GS-based T staging for predicting patient outcomes, suggesting that microscopic measurements have clinical utility beyond the conventional use of GS measurements alone.</p>
<p>doi: <a href="https://doi.org/10.1111/his.14067" class="uri">https://doi.org/10.1111/his.14067</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends</strong> </summary></p>
<p><em>International journal of cancer 2020 Aug;147(4):978-989</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31922259" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31922259</a></p>
<p>Trends in gallbladder cancer incidence and mortality in populations across the Americas can provide insight into shifting epidemiologic patterns and the current and potential impact of preventative and curative programs. Estimates of gallbladder and extrahepatic bile duct cancer incidence and mortality for the year 2018 were extracted from International Agency for Research on Cancer (IARC) GLOBOCAN database for 185 countries. Recorded registry-based incidence from 13 countries was extracted from IARCs Cancer Incidence in Five Continents series and corresponding national deaths from the WHO mortality database. Among females, the highest estimated incidence for gallbladder and extrahepatic bile duct cancer in the Americas were found in Bolivia (21.0 per 100,000), Chile (11.7) and Peru (6.0). In the US, the highest incidence rates were observed among Hispanics (1.8). In the Chilean population, gallbladder cancer rates declined in both females and males between 1998 and 2012. Rates dropped slightly in Canada, Costa Rica, US Whites and Hispanics in Los Angeles. Gallbladder cancer mortality rates also decreased across the studied countries, although rising trends were observed in Colombia and Canada after 2010. Countries within Southern and Central America tended to have a higher proportion of unspecified biliary tract cancers. In public health terms, the decline in gallbladder cancer incidence and mortality rates is encouraging. However, the slight increase in mortality rates during recent years in Colombia and Canada warrant further attention. Higher proportions of unspecified biliary tract cancers (with correspondingly higher mortality rates) suggest more rigorous pathology procedures may be needed after surgery.</p>
<p>doi: <a href="https://doi.org/10.1002/ijc.32863" class="uri">https://doi.org/10.1002/ijc.32863</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Long-term outcomes of surgical resection for T1b gallbladder cancer: an institutional evaluation</strong> </summary></p>
<p><em>BMC cancer 2020 Jan;20(1):20</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31907021" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31907021</a></p>
<p>BACKGROUND: There is no comprehensive agreement concerning the overall performance of radical resection for T1b gallbladder cancer (GBC). This research focused on addressing whether T1b GBC may spread loco-regionally and whether radical resection is necessary. METHODS: A retrospective analysis was conducted of 1032 patients with GBC who underwent surgical resection at our centre and its affiliated institutions between January 1982 and December 2018. A total of 47 patients with T1b GBC, 29 (62%) of whom underwent simple cholecystectomy and 18 (38%) of whom underwent radical resection with regional lymph node dissection, were enrolled in the study. RESULTS: GBC was diagnosed pre-operatively in 16 patients (34%), whereas 31 patients (66%) had incidental GBC. There was no blood venous or perineural invasion in any patient on histology evaluation, except for lymphatic vessel invasion in a single patient. There were no metastases in any analysed lymph nodes. The open surgical approach was more prevalent among the 18 patients who underwent radical resection (open in all 18 patients) than among the 29 patients who underwent simple cholecystectomy (open in 21; laparoscopic in 8) (P = 0.017). The cumulative 10- and 20-year overall survival rates were 65 and 25%, respectively. The outcome following simple cholecystectomy (10-year overall survival rate of 66%) was akin to that following radical resection (64%, P = 0.618). The cumulative 10- and 20-year disease-specific survival rates were 93 and 93%, respectively. The outcome following simple cholecystectomy (10-year disease-specific survival rate of 100%) was equivalent to that following radical resection (that of 86%, P = 0.151). While age (&gt; 70 years, hazard ratio 5.285, P = 0.003) and gender (female, hazard ratio 0.272, P = 0.007) had a strong effect on patient overall survival, surgical procedure (simple cholecystectomy vs. radical resection) and surgical approach (open vs. laparoscopic) did not. CONCLUSIONS: Most T1b GBCs represent local disease. As pre-operative diagnosis, including tumour penetration of T1b GBC, is difficult, the decision of radical resection is justified. Additional radical resection is not required following simple cholecystectomy provided that the penetration depth is restricted towards the muscular layer and that surgical margins are uninvolved.</p>
<p>doi: <a href="https://doi.org/10.1186/s12885-019-6507-2" class="uri">https://doi.org/10.1186/s12885-019-6507-2</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - **** </summary></p>
<ul>
<li>;():*</li>
</ul>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=</a></p>
<p>doi: <a href="https://doi.org/" class="uri">https://doi.org/</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors</strong> </summary></p>
<p><em>Pancreas 2020 01;49(1):1-33</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31856076" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31856076</a></p>
<p>This manuscript is the result of the North American Neuroendocrine Tumor Society consensus conference on the surgical management of pancreatic neuroendocrine tumors from July 19 to 20, 2018. The group reviewed a series of questions of specific interest to surgeons taking care of patients with pancreatic neuroendocrine tumors, and for each, the available literature was reviewed. What follows are these reviews for each question followed by recommendations of the panel.</p>
<p>doi: <a href="https://doi.org/10.1097/MPA.0000000000001454" class="uri">https://doi.org/10.1097/MPA.0000000000001454</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Pathologic Evaluation of Endoscopically Resected Non-Ampullary Duodenal Lesions: A Single Center Experience</strong> </summary></p>
<p><em>Turk patoloji dergisi 2020 12;36(2):109-115</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31825518" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31825518</a></p>
<p>OBJECTIVE: Endoscopic resections are increasingly being used for superficial gastrointestinal lesions. However, application of these techniques in the duodenum remains challenging, due to the technical difficulties and high complication rates. This study projects a western tertiary center’s experience in the endoscopic treatment and diagnostic workup of 19 cases of non-ampullary duodenal lesions. MATERIAL AND METHOD: Specimens (12 endoscopic mucosal resections, 6 endoscopic submucosal dissections, and one endoscopic full-thickness resection) were processed following a strict protocol (photographed, mapped digitally and submitted totally) for histopathologic examination. Clinicopathologic characteristics, margin status and follow-up information were analyzed. RESULTS: The mean age of the 16 patients was 52 years (range: 22-81). Mean lesion size was 1.4 cm (range: 0.3-3.6 cm) for all cases, 2 cm for endoscopic submucosal dissections and 1.1 cm for endoscopic mucosal resections. Mean number of blocks submitted was 4/case. Seven neuroendocrine tumors, 3 tubulovillous adenomas were diagnosed along with nine benign lesions. For endoscopic submucosal dissections, en-bloc and R0 resection rates were 100% (n=6/6) and 83% (n=5/6); for endoscopic mucosal resections, they were 92% (n=11/12) and 83% (n=10/12), respectively. Only one patient had procedure-related late perforation that was managed endoscopically. No mortality was encountered. CONCLUSION: Duodenal endoscopic resections proved successful, safe and feasible methods in a tertiary center. The pathologist’s role is to designate the accurate diagnosis, related histopathologic parameters and margin status. The gross protocol was found to be essential in evaluating specimen margins and orientation, as well as in size measurement. We recommend following a standardized approach including gross photography and digital mapping when handling these specimens, for both diagnostic and data collection purposes.</p>
<p>doi: <a href="https://doi.org/10.5146/tjpath.2019.01474" class="uri">https://doi.org/10.5146/tjpath.2019.01474</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Intracholecystic Papillary-Tubular Neoplasms (ICPN) of the Gallbladder: A Short Review of Literature</strong> </summary></p>
<p><em>Applied immunohistochemistry &amp; molecular morphology : AIMM 2020 01;28(1):57-61</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31815746" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31815746</a></p>
<p>Increasing use of radiographic studies of the hepatobiliary system has led to a growing diagnostic rate of many asymptomatic polyps of the gallbladder which would have gone undiagnosed otherwise. Neoplastic polyps of the gallbladder are 5% of the total number of polyps of this organ. However, due to their malignant potential, the correct diagnosis and classification become of crucial importance. Lack of unified terminology and reporting criteria have led to a limited body of scientific evidence regarding their classification and management. Therefore in 2012 the novel and unified terminology, Intracholecystic papillary-tubular neoplasm was proposed for these lesions when they measure &gt;1 cm. Smaller lesions are usually of no adverse outcome. Intracholecystic papillary-tubular neoplasms show 5 histologic subcategories: (1) pyloric gland subtype which is the most commonly encountered neoplastic polyp in the gallbladder and has the lowest rate of harboring high-grade dysplasia and invasive carcinoma and it shows diffuse cytoplasmic positivity with MUC6, a specific pyloric marker; (2) biliary subtype which is diffusely positive for MUC1 and has the highest risk of concurrent adenocarcinoma; (3) gastric foveolar subtype which is MUC5AC positive in all the cases. Most of the cases in this category are associated with some extent of high-grade dysplasia; (4) intestinal subtype which is the easiest one to recognize as it mimics tubular adenomas of the gastrointestinal tract and show MUC2 and CDX2 positivity; and (5) oncocytic subtype which is the least common.</p>
<p>doi: <a href="https://doi.org/10.1097/PAI.0000000000000711" class="uri">https://doi.org/10.1097/PAI.0000000000000711</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Clinicopathologic and Prognostic Significance of Gallbladder and Cystic Duct Invasion in Distal Bile Duct Carcinoma</strong> </summary></p>
<p><em>Archives of pathology &amp; laboratory medicine 2020 Jun;144(6):755-763</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31755778" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31755778</a></p>
<p>CONTEXT.—: The roles of the gallbladder and cystic duct (CD) invasions in distal bile duct carcinoma (DBDC) have not been well elucidated. OBJECTIVE.—: To define the characteristics and prognostic significance of gallbladder or CD invasions in patients with DBDC. DESIGN.—: Organ invasion patterns with clinicopathologic features were assessed in 258 resected DBDCs. RESULTS.—: CD invasions (N = 31) were associated with frequent concomitant pancreatic and/or duodenal invasions (23 of 31, 74%) and showed stromal infiltration (16 of 31, 52%) and intraductal cancerization (15 of 31, 48%) patterns. In only 2 cases, invasions with intraductal cancerization were observed in the gallbladder neck. Conversely, all pancreatic (N = 175) and duodenal (83) invasions developed through stromal infiltration. CD invasions were associated with larger tumor size (P = .001), bile duct margin positivity (P = .001), perineural invasions (P = .04), and higher N categories (P = .007). Patients with pancreatic or duodenal invasions had significantly lower survival rates than those without pancreatic (median, 31.0 versus 93.9 months) or duodenal (27.5 versus 56.8 months, P &lt; .001, both) invasions. However, those with gallbladder or CD invasions did not have different survival times (P = .13). Patients with concomitant gallbladder/CD and pancreatic/duodenal invasions demonstrated significantly lower survival rates than those without organ invasions (P &lt; .001). CONCLUSIONS.—: Gallbladder invasions were rare in DBDCs as neck invasions with intraductal cancerization. CD invasions occurred by stromal infiltrations and intraductal cancerization, whereas all pancreatic and duodenal invasions had stromal infiltration patterns. Gallbladder and/or CD invasions did not affect survival rates of patients with DBDC, while pancreatic and duodenal invasions affected survival rates. Therefore, these differences in survival rates may originate from the different invasive patterns of DBDCs.</p>
<p>doi: <a href="https://doi.org/10.5858/arpa.2019-0218-OA" class="uri">https://doi.org/10.5858/arpa.2019-0218-OA</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Re-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual Disease</strong> </summary></p>
<p><em>Annals of surgical oncology 2020 Apr;27(4):1132-1142</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31741109" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31741109</a></p>
<p>BACKGROUND: Re-resection for incidental gallbladder cancer (iGBC) is associated with improved survival but little is known about residual disease (RD) and prognostic factors. In this study, survival after re-resection, RD, and prognostic factors are analyzed. METHODS: Patients with iGBC were identified from the Netherlands Cancer Registry, and pathology reports of re-resected patients were reviewed. Survival and prognostic factors were analyzed. RESULTS: Overall, 463 patients were included; 24% (n = 110) underwent re-resection after a median interval of 66 days. RD was present in 35% of patients and was most frequently found in the lymph nodes (23%). R0 resection was achieved in 93 patients (92%). Median overall survival (OS) of patients without re-resection was 13.7 (95% confidence interval [CI] 11.6-15.6), compared with 52.6 months (95% CI 36.3-68.8) in re-resected patients (p &lt; 0.001). After re-resection, median OS was superior in patients without RD versus patients with RD (not reached vs. 23.1 months; p &lt; 0.001). In patients who underwent re-resection, RD in the liver (hazard ratio [HR] 5.54; p &lt; 0.001) and lymph nodes (HR 2.35; p = 0.005) were the only significant prognostic factors in multivariable analysis. Predictive factors for the presence of RD were pT3 stage (HR 25.3; p = 0.003) and pN1 stage (HR 23.0; p = 0.022). CONCLUSION: Re-resection for iGBC is associated with improved survival but remains infrequently used and is often performed after the optimal timing interval. RD is the only significant prognostic factor for survival after re-resection and can be predicted by pT and pN stages.</p>
<p>doi: <a href="https://doi.org/10.1245/s10434-019-08074-4" class="uri">https://doi.org/10.1245/s10434-019-08074-4</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Non-neoplastic Polyps of the Gallbladder: A Clinicopathologic Analysis of 447 Cases</strong> </summary></p>
<p><em>The American journal of surgical pathology 2020 Apr;44(4):467-476</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31725469" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31725469</a></p>
<p>There is no systematic histopathologic analysis of non-neoplastic polyps in the gallbladder. In this study, in addition to a computer search for cases designated as “polyp,” a systematic review of 2533 consecutive routinely sampled archival and 203 totally submitted prospective cholecystectomies were analyzed for &gt;2 mm polyps (cut-off was based on radiologic sensitivity). A total of 447 non-neoplastic polyps were identified. The frequency was 3% in archival cases and 5% in totally submitted cases. Only 21 (5%) were ≥1 cm. The average age was 52 years, and the female to male ratio was 3.1. Two distinct categories were delineated: (1) injury-related polyps (n=273): (a) Fibro(myo)glandular polyps (n=214) were small (mean=0.4 cm), broad-based, often multiple (45%), almost always (98%) gallstone-associated, and were composed of a mixture of (myo)fibroblastic tissue/lobular glandular units with chronic cholecystitis. Dysplasia seen in 9% seemed to be secondary involvement. (b) Metaplastic pyloric glands forming polypoid collections (n=42). (c) Inflammatory-type polyps associated with acute/subacute injury (11 granulation tissue, 3 xanthogranulomatous, 3 lymphoid). (2) Cholesterol polyps (n=174) occurred in uninjured gallbladders, revealing a very thin stalk, edematous cores devoid of glands but with cholesterol-laden macrophages in 85%, and cholesterolosis in the uninvolved mucosa in 60%. Focal low-grade dysplasia was seen in 3%, always confined to the polyp, unaccompanied by carcinoma. In conclusion, non-neoplastic polyps are seen in 3% of cholecystectomies and are often small. Injury-related fibromyoglandular polyps are the most common. Cholesterol polyps have distinctive cauliflower architecture, often in a background of uninjured gallbladders with cholesterolosis and may lack the cholesterol-laden macrophages in the polyp itself. Although dysplastic changes can involve non-neoplastic polyps, they do not seem to be the cause of invasive carcinoma by themselves.</p>
<p>doi: <a href="https://doi.org/10.1097/PAS.0000000000001405" class="uri">https://doi.org/10.1097/PAS.0000000000001405</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and��Bile Duct</strong> </summary></p>
<p><em>Gastroenterology 2020 02;158(3):573-582.e2</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31678302" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31678302</a></p>
<p>BACKGROUND &amp; AIMS: Intraductal oncocytic papillary neoplasms (IOPNs) of the pancreas and bile duct contain epithelial cells with numerous, large mitochondria and are cystic precursors to pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CCA), respectively. However, IOPNs do not have the genomic alterations found in other pancreatobiliary neoplasms. In fact, no recurrent genomic alterations have been described in IOPNs. PDACs without activating mutations in KRAS contain gene rearrangements, so we investigated whether IOPNs have recurrent fusions in genes. METHODS: We analyzed 20 resected pancreatic IOPNs and 3 resected biliary IOPNs using a broad RNA-based targeted sequencing panel to detect cancer-related fusion genes. Four invasive PDACs and 2 intrahepatic CCAs from the same patients as the IOPNs, were also available for analysis. Samples of pancreatic cyst fluid (n = 5, collected before surgery) and bile duct brushings (n = 2) were analyzed for translocations. For comparison, we analyzed pancreatobiliary lesions from 126 patients without IOPN (controls). RESULTS: All IOPNs evaluated were found to have recurring fusions of ATP1B1-PRKACB (n = 13), DNAJB1-PRKACA (n = 6), or ATP1B1-PRKACA (n = 4). These fusions also were found in corresponding invasive PDACs and intrahepatic CCAs, as well as in matched pancreatic cyst fluid and bile duct brushings. These gene rearrangements were absent from all 126 control pancreatobiliary lesions. CONCLUSIONS: We identified fusions in PRKACA and PRKACB genes in pancreatic and biliary IOPNs, as well as in PDACs and pancreatic cyst fluid and bile duct cells from the same patients. We did not identify these gene fusions in 126 control pancreatobiliary lesions. These fusions might be used to identify patients at risk for IOPNs and their associated invasive carcinomas.</p>
<p>doi: <a href="https://doi.org/10.1053/j.gastro.2019.10.028" class="uri">https://doi.org/10.1053/j.gastro.2019.10.028</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma</strong> </summary></p>
<p><em>Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 04;33(4):648-656</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31676785" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31676785</a></p>
<p>Recently discovered DNAJB1-PRKACA oncogenic fusions have been considered diagnostic for fibrolamellar hepatocellular carcinoma. In this study, we describe six pancreatobiliary neoplasms with PRKACA fusions, five of which harbor the DNAJB1-PRKACA fusion. All neoplasms were subjected to a hybridization capture-based next-generation sequencing assay (MSK-IMPACT), which enables the identification of sequence mutations, copy number alterations, and selected structural rearrangements involving ≥410 genes (n = 6) and/or to a custom targeted, RNA-based panel (MSK-Fusion) that utilizes Archer Anchored Multiplex PCR technology and next-generation sequencing to detect gene fusions in 62 genes (n = 2). Selected neoplasms also underwent FISH analysis, albumin mRNA in-situ hybridization, and arginase-1 immunohistochemical labeling (n = 3). Five neoplasms were pancreatic, and one arose in the intrahepatic bile ducts. All revealed at least focal oncocytic morphology: three cases were diagnosed as intraductal oncocytic papillary neoplasms, and three as intraductal papillary mucinous neoplasms with mixed oncocytic and pancreatobiliary or gastric features. Four cases had an invasive carcinoma component composed of oncocytic cells. Five cases revealed DNAJB1-PRKACA fusions and one revealed an ATP1B1-PRKACA fusion. None of the cases tested were positive for albumin or arginase-1. Our data prove that DNAJB1-PRKACA fusion is neither exclusive nor diagnostic for fibrolamellar hepatocellular carcinoma, and caution should be exercised in diagnosing liver tumors with DNAJB1-PRKACA fusions as fibrolamellar hepatocellular carcinoma, particularly if a pancreatic lesion is present. Moreover, considering DNAJB1-PRKACA fusions lead to upregulated protein kinase activity and that this upregulated protein kinase activity has a significant role in tumorigenesis of fibrolamellar hepatocellular carcinoma, protein kinase inhibition could have therapeutic potential in the treatment of these pancreatobiliary neoplasms as well, once a suitable drug is developed.</p>
<p>doi: <a href="https://doi.org/10.1038/s41379-019-0398-2" class="uri">https://doi.org/10.1038/s41379-019-0398-2</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Clinicopathologic Characteristics of Gallbladder Adenomyomas and the Contribution of Macroscopic Sampling in Adenomyoma Diagnosis</strong> </summary></p>
<p><em>Turk patoloji dergisi 2020 10;36(1):11-16</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31633192" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31633192</a></p>
<p>OBJECTIVE: Adenomyoma, a reactive and hamartomatous lesion of the gallbladder, is included in the differential diagnosis of several benign and malignant lesions. Macroscopic sampling is very important in the determination of these lesions. The agreed macroscopy protocol in recent years has been prepared by the Hepatopancreatobiliary Pathology Working Group. We aimed to evaluate the clinicopathologic properties of adenomyoma cases in the gallbladder and the contribution of new macroscopy techniques to the diagnosis of adenomyoma in the pre-protocol and post-protocol parts of a one-year period. MATERIAL AND METHOD: Two institutes were included in the study. Adenomyoma cases diagnosed in the pre-protocol and post-protocol periods of one year duration were included in the study. Slides and demographic properties of the cases were reexamined. RESULTS: While adenomyoma was present in 22 of 1879 gallbladder before the protocol, it was observed in 32 of 1781 gallbladders in the post-protocol period. 17 of the cases were male and 37 were female. The mean age of the cases was 51.8. 52% of the lesions were located in the fundus. A gallstone was observed in 37 cases, and cholesterolosis in 14 cases. In the comparison of the two periods, the number of cases was lower in the post-protocol period but a 0.6% increase in the diagnosis of adenomyoma was found. CONCLUSION: Adenomyoma is one of the lesions of the gallbladder that should be recognized but can be easily overlooked macroscopically. When we conducted the sampling according to the last protocol, the increase in the diagnosis of adenomyoma showed that adequate and accurate sampling was very useful for the detection of adenomyoma in the gallbladder.</p>
<p>doi: <a href="https://doi.org/10.5146/tjpath.2019.01471" class="uri">https://doi.org/10.5146/tjpath.2019.01471</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Exome sequencing of 22 genes using tissue from patients with biliary tract cancer</strong> </summary></p>
<p><em>APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2020 Jan;128(1):3-9</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31628675" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31628675</a></p>
<p>Biliary tract cancers (BTC) are a rare heterogeneous disease group with a dismal prognosis and limited treatment options. The mutational landscape consists of genetic aberrations both shared by and characteristic for anatomical location. Here, we present exome sequencing data on 22 genes from a phase 2 trial using a clinically validated panel used in patients with colorectal cancer. A total of 56 patients were included in a one-armed phase 2 trial investigating the treatment combination of capecitabine, gemcitabine, oxaliplatin, and cetuximab. Tissue DNA yield and quality allowed analysis of 30 patients on our panel including 22 genes. ARID1A (33%) and TP53 (33%) were found to be most frequently mutated followed by KRAS mutations found in 20% of the patients. Mutational aberrations in ARID1A were found more prevalent than expected, whereas TP53 and KRAS were in concordance with earlier reported data. Mutation in CTNNB1 was significantly associated with poor prognosis. Our panel is clinically validated and suitable for a high volume of samples to detect mutations in patients with BTC. However, it is reasonable to assume that the clinical utility could be optimized in this patient group by extending the panel to include BTC specific mutations with potential therapeutic consequences such as IDH1/2, FGFR fusions, ERBB3, and BRCA1/2.</p>
<p>doi: <a href="https://doi.org/10.1111/apm.13003" class="uri">https://doi.org/10.1111/apm.13003</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas</strong> </summary></p>
<p><em>Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 04;33(4):657-664</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31558784" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31558784</a></p>
<p>Pancreatic acinar cell carcinoma is relatively rare (1 to 2% of pancreatic malignancies) but may be under-recognized. In contrast to pancreatic ductal adenocarcinoma, most acinar cell carcinomas lack mutations in KRAS, DPC, CDKN2A or TP53, but appear to have a high incidence of gene rearrangements, with up to 20% reported to be driven by BRAF fusions. With the development of a new class of RET-specific tyrosine kinase inhibitors, which appear to have particularly strong activity against RET gene rearranged tumours, there is now considerable interest in identifying RET gene rearrangements across a wide range of cancers. RET rearrangements have been reported to occur at a very low incidence (&lt;1%) in all pancreatic carcinomas. We postulated that given its unique molecular profile, RET gene rearrangements may be common in acinar cell carcinomas. We performed fluorescent in-situ hybridization (FISH) studies on a cohort of 40 acinar cell spectrum tumours comprising 36 pure acinar cell carcinomas, three pancreatoblastomas and one mixed acinar-pancreatic neuroendocrine tumour. RET gene rearrangements were identified in 3 (7.5%) cases and BRAF gene rearrangements in 5 (12.5%). All gene rearranged tumours were pure acinar cell carcinomas. Our findings indicate that amongst all pancreatic carcinomas, acinar carcinomas are highly enriched for potentially actionable gene rearrangements in RET or BRAF. FISH testing is inexpensive and readily available in the routine clinical setting and may have a role in the assessment of all acinar cell carcinomas-at this stage to recruit patients for clinical trials of new targeted therapies, but perhaps in the near future as part of routine care.</p>
<p>doi: <a href="https://doi.org/10.1038/s41379-019-0373-y" class="uri">https://doi.org/10.1038/s41379-019-0373-y</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Brush Cytology Performance for the Assessment of Biliopancreatic Strictures</strong> </summary></p>
<p><em>Acta cytologica 2019 Sep;():1-8</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31550713" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31550713</a></p>
<p>INTRODUCTION: Brush cytology is commonly used during endoscopic retrograde cholangiopancreatography for the diagnostic evaluation of biliopancreatic strictures. However, since the overall sensitivity of brush cytology is poor, the exclusion of malignancy is difficult. Recognition of factors related to the patient, technique or lesion may help improve the diagnostic yield of brush cytology. The objective of this study was to evaluate the diagnostic yield of brush cytology in the assessment of biliopancreatic strictures and identify predictive factors associated with a positive diagnosis of malignancy. METHODS: Retrospective study that evaluated all consecutive patients that underwent brush cytology for the investigation of biliopancreatic strictures in a tertiary center, between January 2012 and January 2018. RESULTS: One hundred and sixty-five patients that underwent 182 procedures were included. A diagnosis of malignancy was confirmed in 110 patients (66.7%), of whom 62 had positive brush cytology (sensitivity 53.7%, specificity 98.5%, accuracy 69.8%). On the multivariate analysis, age ≥68 years (OR 4.83, 95% CI 1.04-22.37) and lesions suspicious of metastasis on cross-sectional imaging (OR 8.58, 95% CI 1.70-43.38) were independently associated with a positive result. Subanalysis of the patients presenting with these two factors (n = 26) revealed an increase in the diagnostic yield (sensitivity 80.8%). CONCLUSION: Age ≥68 years and lesions suspicious of metastasis on cross-sectional imaging are independent factors associated with a positive result. Patient selection taking these factors into account may increase the diagnostic yield of brush cytology.</p>
<p>doi: <a href="https://doi.org/10.1159/000502791" class="uri">https://doi.org/10.1159/000502791</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Immunohistochemical profiling of liver metastases and matched-pair analysis in patients with metastatic pancreatic ductal adenocarcinoma</strong> </summary></p>
<p><em>Pancreatology : official journal of the International Association of Pancreatology (IAP) … [et al.] 2019 Oct;19(7):963-970</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31542399" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31542399</a></p>
<p>BACKGROUND: The purpose of the current study was to investigate the immunohistochemical (IHC) profile of liver metastases (LM) in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: Expression of 15 IHC markers in liver biopsies from 77 patients with PDAC, who were diagnosed between 2010 and 2014, were evaluated. In a separate subgroup analysis (n = 12), paired samples (LM and primary tumor) from the same patient were investigated for IHC profile differences. RESULTS: LM samples were classified as pancreatobiliary-type (PB-type) in 72 patients (93.5%), intestinal-type (INT-type) in four patients (5.2%), and squamous in one patient (1.3%). There was no significant difference in overall survival (OS) between LM of the PB-type or INT-type (p = 0.097). In a multivariate analysis, age &lt;70 years (p = 0.047), absence of SMAD4 mutation (p = 0.026), absence of CDX2 expression (p = 0.003), and well to moderate differentiation were significant prognostic factors for better OS in patients with LM (p = 0.031). Analysis of paired tissue samples from LM and the primary tumor revealed a difference in CDX2 (50% increase, p = 0.125) and SMAD4 (33% loss of SMAD4, p = 0.375). CONCLUSIONS: CDX2 expression and SMAD4 mutation indicate a poor outcome in patients with LM of PDAC. Matched-pair analysis revealed differences in distinct IHC marker expression.</p>
<p>doi: <a href="https://doi.org/10.1016/j.pan.2019.09.005" class="uri">https://doi.org/10.1016/j.pan.2019.09.005</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Clinicopathological features of pyloric gland adenomas of the duodenum: a multicentre study of 57 cases</strong> </summary></p>
<p><em>Histopathology 2020 Feb;76(3):404-410</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31529725" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31529725</a></p>
<p>AIMS: To determine the clinicopathological features of pyloric gland adenomas (PGA) that arise in the duodenum. METHODS AND RESULTS: Fifty-seven cases of duodenal PGA were identified and analysed from 56 patients. Clinicopathological and immunohistochemical analyses were performed. PGA tend to occur in older individuals (median age = 73.5), with a slight female predominance (25 males, 31 females). PGA arise more commonly in the proximal duodenum (68.75% in D1, 25% in D2 and 6.25% in D3) and usually present as mucosal nodules (98.2%) or plaques (1.8%), with a mean size of 14.8 mm. There is associated gastric heterotopia in 22.8% of cases. PGA showing features of high-grade dysplasia were significantly larger in size than PGA, showing only low-grade dysplasia (23.1 versus 8.7 mm; P = 0.0001) and more likely to show a tubulovillous rather than a pure tubular architecture (P = 0.025). In our series, 10 of 56 patients had intramucosal or invasive carcinoma associated with the duodenal PGA (17.9%). Three of these carcinomas showed lymph node metastasis. Following definitive treatment, local recurrence occurred in only three patients. CONCLUSIONS: Duodenal PGA tend to occur in the proximal duodenum of older individuals. Larger size and tubulovillous architecture correlates with high-grade dysplasia and associated adenocarcinoma. The low recurrence rate of these lesions would suggest that endoscopic management is appropriate, provided that the lesion can be completely resected.</p>
<p>doi: <a href="https://doi.org/10.1111/his.13996" class="uri">https://doi.org/10.1111/his.13996</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Comparison of the clinicopathological features of pancreatic solid pseudopapillary neoplasms between males and females: gender does matter</strong> </summary></p>
<p><em>Histology and histopathology 2020 Mar;35(3):257-268</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31478554" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31478554</a></p>
<p>BACKGROUND: Solid pseudopapillary neoplasms (SPN) of the pancreas are a rare and low-grade malignant entity with a female predominance. However, it also occurs in males, but the rarity and lack of concern makes its clinicopathological features unclarified. METHODS: The morphological, immunohistochemical, prognostic features and CTNNB1 exon 3 mutation status of SPN were compared semi-quantitively between 9 male and 21 female patients. RESULTS: SPN in males grew in a distinctive solid pattern, with abundant fibrotic stroma and clear cells. Collagen tended to be the main component of tumor stroma in males, while hyaluronan composed a considerable proportion in females. A much stronger expression of androgen receptor (AR) was found in males, and CD56 and/or synaptophysin (Syn) was expressed frequently in both genders. All patients survived. One male patient had post-operational liver nodules and accepted interventional therapy without biopsy. Mutations of CTNNB1 exon 3 were observed in all cases, distributed at codon 32, 33 and 37 in both genders, as well as 34, 41 and 62 in females. CONCLUSION: SPN in males presented with significantly different morphological features from that in females, which might be helpful in differential diagnosis, especially when with extensive positivity for CD56 and/or Syn. The stronger expression of AR in males might be a clue to explore the underlying mechanism of the gender difference.</p>
<p>doi: <a href="https://doi.org/10.14670/HH-18-156" class="uri">https://doi.org/10.14670/HH-18-156</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system</strong> </summary></p>
<p><em>Gut 2020 May;69(5):877-887</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31462556" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31462556</a></p>
<p>OBJECTIVE: Insulinomas and non-functional pancreatic neuroendocrine tumours (NF-PanNETs) have distinctive clinical presentations but share similar pathological features. Their genetic bases have not been comprehensively compared. Herein, we used whole-genome/whole-exome sequencing (WGS/WES) to identify genetic differences between insulinomas and NF-PanNETs. DESIGN: The mutational profiles and copy-number variation (CNV) patterns of 211 PanNETs, including 84 insulinomas and 127 NF-PanNETs, were obtained from WGS/WES data provided by Peking Union Medical College Hospital and the International Cancer Genome Consortium. Insulinoma RNA sequencing and immunohistochemistry data were assayed. RESULTS: PanNETs were categorised based on CNV patterns: amplification, copy neutral and deletion. Insulinomas had CNV amplifications and copy neutral and lacked CNV deletions. CNV-neutral insulinomas exhibited an elevated rate of YY1 mutations. In contrast, NF-PanNETs had all three CNV patterns, and NF-PanNETs with CNV deletions had a high rate of loss-of-function mutations of tumour suppressor genes. NF-PanNETs with CNV alterations (amplification and deletion) had an elevated risk of relapse, and additional DAXX/ATRX mutations could predict an increased relapse risk in the first 2-year period. CONCLUSION: These WGS/WES data allowed a comprehensive assessment of genetic differences between insulinomas and NF-PanNETs, reclassifying these tumours into novel molecular subtypes. We also proposed a novel relapse risk stratification system using CNV patterns and DAXX/ATRX mutations.</p>
<p>doi: <a href="https://doi.org/10.1136/gutjnl-2018-317233" class="uri">https://doi.org/10.1136/gutjnl-2018-317233</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Cell block processing is optimal for assessing endoscopic ultrasound fine needle aspiration specimens of pancreatic mucinous cysts</strong> </summary></p>
<p><em>Journal of clinical pathology 2020 Feb;73(2):102-106</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31462450" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31462450</a></p>
<p>AIMS: The cell block technique for assessing endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) specimens from pancreatic mucinous cystic lesions (MCLs) was systematically evaluated for the first time, including comparisons with three traditional methods of assessing such specimens. METHODS: The prospective arm comprised EUS-FNA specimens from EUS-suspected pancreatic MCLs. The retrospective arm comprised EUS-FNA specimens from pancreatic MCLs surgically resected before the study start. For each specimen, these data points were collected: macroscopic likelihood of mucin, cyst fluid carcinoembryonic antigen (CEA) level and presence of mucin in air-dried, direct smears and in cell block preparations. RESULTS: The prospective and retrospective arms of the study comprised 80 and 30 EUS-FNA specimens, respectively. Seven prospective cases led to surgical resections during the study, and therefore, 37 EUS-FNA specimens were confirmed to have originated from MCLs. In the prospective arm, macroscopic mucin was suspected, cyst fluid CEA level exceeded 192 ng/mL, mucin was detected in direct smears and cell block preparations in 78%, 30%, 39% and 73% of cases, respectively. Of the 37 specimens confirmed to originate from MCLs, macroscopic mucin assessment, cyst fluid CEA level, direct smear mucin assessment and cell block mucin assessment had sensitivities for diagnosing MCL of 87%, 45%, 45% and 81%, respectively. CONCLUSIONS: Cell block preparations are as likely to identify mucin from pancreatic MCLs as macroscopic assessment but are twice as likely to diagnose MCL than direct smears and fluid CEA biochemistry. The cell block technique is easy for sample collection and processing especially because these are identical for solid and cystic pancreatic lesions.</p>
<p>doi: <a href="https://doi.org/10.1136/jclinpath-2019-206079" class="uri">https://doi.org/10.1136/jclinpath-2019-206079</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Grading Pancreatic Neuroendocrine Tumors by Ki-67 Index Evaluated on Fine-Needle Aspiration Cell Block Material</strong> </summary></p>
<p><em>American journal of clinical pathology 2020 01;153(1):74-81</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31415691" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31415691</a></p>
<p>OBJECTIVES: This study aimed to determine whether Ki-67 index evaluated on cytologic material could reliably grade pancreatic neuroendocrine tumors (PanNETs). METHODS: Cases with adequate cell block and available surgical specimens were included. Ki-67 index was calculated using “eyeballing,” “hot spot,” and “complete” counting methods. RESULTS: The overall concordance rates between cytology and surgical specimens were 71%, 73%, and 59%, respectively, by using eyeballing, hot spot, and complete counting approaches. All grade 1 tumors were correctly graded on cytology, but in grade 2 tumors concordance rates were only 36%, 41%, and 9%, respectively. All grade 2 tumors were undergraded when cell blocks contained fewer than 1,000 cells, while concordance rate increased to 57%, 64%, and 14%, respectively, in cases with 1,000 cells or more. CONCLUSIONS: Grade 2 PanNETs can be significantly undergraded when Ki-67 index is evaluated on cell block material. In cases with 1,000 or more cells, the hot spot counting method has better correlation with surgical specimens.</p>
<p>doi: <a href="https://doi.org/10.1093/ajcp/aqz110" class="uri">https://doi.org/10.1093/ajcp/aqz110</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Sclerosing epithelioid mesenchymal neoplasm of the pancreas��-��a proposed new entity</strong> </summary></p>
<p><em>Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 03;33(3):456-467</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31383964" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31383964</a></p>
<p>We have encountered pancreatic tumors with unique histologic features, which do not conform to any of the known tumors of the pancreas or other anatomical sites. We aimed to define their clinicopathologic features and whether they are characterized by recurrent molecular signatures. Eight cases were identified; studied histologically and by immunohistochemistry. Selected cases were also subjected to whole-exome sequencing (WES; n = 4), RNA-sequencing (n = 6), Archer FusionPlex assay (n = 5), methylation profiling using the Illumina MethylationEPIC (850k) array platform (n = 6), and TERT promoter sequencing (n = 5). Six neoplasms occurred in females. The mean age was 43 years (range: 26-75). Five occurred in the head/neck of the pancreas. All patients were treated surgically; none received neoadjuvant/adjuvant therapy. All patients are free of disease after 53 months of median follow-up (range: 8-94). The tumors were well-circumscribed, and the median size was 1.8 cm (range: 1.3-5.8). Microscopically, the unencapsulated tumors had a geographic pattern of epithelioid cell nests alternating with spindle cell fascicles. Some areas showed dense fibrosis, in which enmeshed tumor cells imparted a slit-like pattern. The predominant epithelioid cells had scant cytoplasm and round-oval nuclei with open chromatin. The spindle cells displayed irregular, hyperchromatic nuclei. Mitoses were rare. No lymph node metastases were identified. All tumors were positive for vimentin, CD99 and cytokeratin (patchy), while negative for markers of solid pseudopapillary neoplasm, neuroendocrine, acinar, myogenic/rhabdoid, vascular, melanocytic, or lymphoid differentiation, gastrointestinal stromal tumor as well as MUC4. Whole-exome sequencing revealed no recurrent somatic mutations or amplifications/homozygous deletions in any known oncogenes or tumor suppressor genes. RNA-sequencing and the Archer FusionPlex assay did not detect any recurrent likely pathogenic gene fusions. Single sample gene set enrichment analysis revealed that these tumors display a likely mesenchymal transcriptomic program. Unsupervised analysis (t-SNE) of their methylation profiles against a set of different mesenchymal neoplasms demonstrated a distinct methylation pattern. Here, we describe pancreatic neoplasms with unique morphologic/immunophenotypic features and a distinct methylation pattern, along with a lack of abnormalities in any of key genetic drivers, supporting that these neoplasms represent a novel entity with an indolent clinical course. Given their mesenchymal transcriptomic features, we propose the designation of “sclerosing epithelioid mesenchymal neoplasm” of the pancreas.</p>
<p>doi: <a href="https://doi.org/10.1038/s41379-019-0334-5" class="uri">https://doi.org/10.1038/s41379-019-0334-5</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis</strong> </summary></p>
<p><em>Annals of surgery 2019 Jul;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31356277" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31356277</a></p>
<p>OBJECTIVE: To determine the prognostic role of metastatic lymph node (LN) number and the minimal number of LNs for optimal staging of patients with pancreatic neuroendocrine tumors (pNETs). BACKGROUND: Prognosis relative to number of LN metastasis (LNM), and minimal number of LNs needed to evaluate for accurate staging, have been poorly defined for pNETs. METHODS: Number of LNM and total number of LN evaluated (TNLE) were assessed relative to recurrence-free survival (RFS) and overall survival (OS) in a multi-institutional database. External validation was performed using Surveillance, Epidemiology and End Results (SEER) registry. RESULTS: Among 854 patients who underwent resection, 233 (27.3%) had at least 1 LNM. Patients with 1, 2, or 3 LNM had a comparable worse RFS versus patients with no nodal metastasis (5-year RFS, 1 LNM 65.6%, 2 LNM 68.2%, 3 LNM 63.2% vs 0 LNM 82.6%; all P &lt; 0.001). In contrast, patients with ≥4 LNM (proposed N2) had a worse RFS versus patients who either had 1 to 3 LNM (proposed N1) or node-negative disease (5-year RFS, ≥4 LNM 43.5% vs 1-3 LNM 66.3%, 0 LNM 82.6%; all P &lt; 0.05) [C-statistics area under the curve (AUC) 0.650]. TNLE ≥8 had the highest discriminatory power relative to RFS (AUC 0.713) and OS (AUC 0.726) among patients who had 1 to 3 LNM, and patients who had ≥4 LNM in the multi-institutional and SEER database (n = 2764). CONCLUSIONS: Regional lymphadenectomy of at least 8 lymph nodes was necessary to stage patients accurately. The proposed nodal staging of N0, N1, and N2 optimally staged patients.</p>
<p>doi: <a href="https://doi.org/10.1097/SLA.0000000000003478" class="uri">https://doi.org/10.1097/SLA.0000000000003478</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>The Presence of Pericholedochal Hyaline Cartilage in Biliary Atresia: A Report and A Review</strong> </summary></p>
<p><em>Fetal and pediatric pathology 2020 Apr;39(2):156-162</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31314631" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31314631</a></p>
<p>Background: The presence of cartilage in extra hepatic biliary tree is an unusual finding. An isolated presence of the cartilage is possibly heterotopic or occurs as a metaplastic response to the inflammatory insult.Material and methods: We had examined the liver biopsy and the resected specimen of a biliary atresia (BA) after Kasai procedure.Results: There was hyaline cartilage around the common hepatic and common bile duct in a 3-months-old male infant with distal obstructive cholangiopathy on liver biopsy and had positive serum IgM for cytomegalovirus (CMV). Similar findings could not be documented in the pericholedochal tissue of any of the 25 other pediatric cases operated for BA or choledochal cyst and three neonatal autopsies performed for liver-related deaths.Conclusion: Peri-bile duct cartilage is a unique finding and could represent an unusual form of heterotopia or connective tissue metaplasia.</p>
<p>doi: <a href="https://doi.org/10.1080/15513815.2019.1639091" class="uri">https://doi.org/10.1080/15513815.2019.1639091</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Development of the Intrahepatic and Extrahepatic Biliary Tract: A Framework for Understanding Congenital Diseases</strong> </summary></p>
<p><em>Annual review of pathology 2020 01;15():1-22</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31299162" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31299162</a></p>
<p>The involvement of the biliary tract in the pathophysiology of liver diseases and the increased attention paid to bile ducts in the bioconstruction of liver tissue for regenerative therapy have fueled intense research into the fundamental mechanisms of biliary development. Here, I review the molecular, cellular and tissular mechanisms driving differentiation and morphogenesis of the intrahepatic and extrahepatic bile ducts. This review focuses on the dynamics of the transcriptional and signaling modules that promote biliary development in human and mouse liver and discusses studies in which the use of zebrafish uncovered unexplored processes in mammalian biliary development. The review concludes by providing a framework for interpreting the mechanisms that may help us understand the origin of congenital biliary diseases.</p>
<p>doi: <a href="https://doi.org/10.1146/annurev-pathmechdis-012418-013013" class="uri">https://doi.org/10.1146/annurev-pathmechdis-012418-013013</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Significance of Lymph Node Metastasis in Resectable Well-differentiated Pancreatic Neuroendocrine Tumor</strong> </summary></p>
<p><em>Pancreas 2019 08;48(7):943-947</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31268980" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31268980</a></p>
<p>OBJECTIVES: Understanding the effect of lymph node metastasis (LNM) on prognosis in pancreatic neuroendocrine neoplasm is helpful for surgery and follow-up. In this study, we investigated the significance of LNM in well-differentiated pancreatic neuroendocrine tumors (PanNETs) according to the World Health Organization 2017 classification. METHODS: We retrospectively collected data for 95 consecutive patients with PanNET who underwent pancreatic resection with curative intent between January 2008 and December 2017 at 6 institutions. The clinicopathological factors were compared in patients with and without LNM, and prognostic factors were analyzed. RESULTS: Lymph node metastasis was significantly associated with malignant potential of PanNET, such as larger tumor size, higher Ki-67 index, higher tumor grade, and higher incidence of lymphatic, vessel, and neural invasion. Lymph node metastasis was also associated with disease-free but not overall survival. Multivariate analysis identified NET grade 2 (G2) and G3 as independent risk factors for recurrence after curative resection. CONCLUSIONS: World Health Organization 2017 classification was the most independent prognostic factor in patients with resectable well-differentiated PanNETs. Patients with G2 and higher-grade tumors require lymph node dissection to improve prognosis.</p>
<p>doi: <a href="https://doi.org/10.1097/MPA.0000000000001355" class="uri">https://doi.org/10.1097/MPA.0000000000001355</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome</strong> </summary></p>
<p><em>Gut 2020 02;69(2):317-328</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31201285" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31201285</a></p>
<p>INTRODUCTION: Transcriptional analyses have identified several distinct molecular subtypes in pancreatic ductal adenocarcinoma (PDAC) that have prognostic and potential therapeutic significance. However, to date, an indepth, clinicomorphological correlation of these molecular subtypes has not been performed. We sought to identify specific morphological patterns to compare with known molecular subtypes, interrogate their biological significance, and furthermore reappraise the current grading system in PDAC. DESIGN: We first assessed 86 primary, chemotherapy-naive PDAC resection specimens with matched RNA-Seq data for specific, reproducible morphological patterns. Differential expression was applied to the gene expression data using the morphological features. We next compared the differentially expressed gene signatures with previously published molecular subtypes. Overall survival (OS) was correlated with the morphological and molecular subtypes. RESULTS: We identified four morphological patterns that segregated into two components (‘gland forming’ and ‘non-gland forming’) based on the presence/absence of well-formed glands. A morphological cut-off (≥40% ‘non-gland forming’) was established using RNA-Seq data, which identified two groups (A and B) with gene signatures that correlated with known molecular subtypes. There was a significant difference in OS between the groups. The morphological groups remained significantly prognostic within cancers that were moderately differentiated and classified as ‘classical’ using RNA-Seq. CONCLUSION: Our study has demonstrated that PDACs can be morphologically classified into distinct and biologically relevant categories which predict known molecular subtypes. These results provide the basis for an improved taxonomy of PDAC, which may lend itself to future treatment strategies and the development of deep learning models.</p>
<p>doi: <a href="https://doi.org/10.1136/gutjnl-2019-318217" class="uri">https://doi.org/10.1136/gutjnl-2019-318217</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer</strong> </summary></p>
<p><em>Clinical cancer research : an official journal of the American Association for Cancer Research 2019 08;25(16):4973-4984</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31142500" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31142500</a></p>
<p>PURPOSE: In research settings, circulating tumor DNA (ctDNA) shows promise as a tumor-specific biomarker for pancreatic ductal adenocarcinoma (PDAC). This study aims to perform analytical and clinical validation of a KRAS ctDNA assay in a Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathology-certified clinical laboratory. EXPERIMENTAL DESIGN: Digital-droplet PCR was used to detect the major PDAC-associated somatic KRAS mutations (G12D, G12V, G12R, and Q61H) in liquid biopsies. For clinical validation, 290 preoperative and longitudinal postoperative plasma samples were collected from 59 patients with PDAC. The utility of ctDNA status to predict PDAC recurrence during follow-up was assessed. RESULTS: ctDNA was detected preoperatively in 29 (49%) patients and was an independent predictor of decreased recurrence-free survival (RFS) and overall survival (OS). Patients who had neoadjuvant chemotherapy were less likely to have preoperative ctDNA than were chemo-naïve patients (21% vs. 69%; P &lt; 0.001). ctDNA levels dropped significantly after tumor resection. Persistence of ctDNA in the immediate postoperative period was associated with a high rate of recurrence and poor median RFS (5 months). ctDNA detected during follow-up predicted clinical recurrence [sensitivity 90% (95% confidence interval (CI), 74%-98%), specificity 88% (95% CI, 62%-98%)] with a median lead time of 84 days (interquartile range, 25-146). Detection of ctDNA during postpancreatectomy follow-up was associated with a median OS of 17 months, while median OS was not yet reached at 30 months for patients without ctDNA (P = 0.011). CONCLUSIONS: Measurement of KRAS ctDNA in a CLIA laboratory setting can be used to predict recurrence and survival in patients with PDAC.</p>
<p>doi: <a href="https://doi.org/10.1158/1078-0432.CCR-19-0197" class="uri">https://doi.org/10.1158/1078-0432.CCR-19-0197</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia</strong> </summary></p>
<p><em>Gastroenterology 2019 09;157(3):823-837</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31078621" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31078621</a></p>
<p>BACKGROUND &amp; AIMS: Most pancreatic ductal adenocarcinomas (PDACs) express an activated form of KRAS, become hypoxic and dysplastic, and are refractory to chemo and radiation therapies. To survive in the hypoxic environment, PDAC cells upregulate enzymes and transporters involved in pH regulation, including the extracellular facing carbonic anhydrase 9 (CA9). We evaluated the effect of blocking CA9, in combination with administration of gemcitabine, in mouse models of pancreatic cancer. METHODS: We knocked down expression of KRAS in human (PK-8 and PK-1) PDAC cells with small hairpin RNAs. Human and mouse (KrasG12D/Pdx1-Cre/Tp53/RosaYFP) PDAC cells were incubated with inhibitors of MEK (trametinib) or extracellular signal-regulated kinase (ERK), and some cells were cultured under hypoxic conditions. We measured levels and stability of the hypoxia-inducible factor 1 subunit alpha (HIF1A), endothelial PAS domain 1 protein (EPAS1, also called HIF2A), CA9, solute carrier family 16 member 4 (SLC16A4, also called MCT4), and SLC2A1 (also called GLUT1) by immunoblot analyses. We analyzed intracellular pH (pHi) and extracellular metabolic flux. We knocked down expression of CA9 in PDAC cells, or inhibited CA9 with SLC-0111, incubated them with gemcitabine, and assessed pHi, metabolic flux, and cytotoxicity under normoxic and hypoxic conditions. Cells were also injected into either immune-compromised or immune-competent mice and growth of xenograft tumors was assessed. Tumor fragments derived from patients with PDAC were surgically ligated to the pancreas of mice and the growth of tumors was assessed. We performed tissue microarray analyses of 205 human PDAC samples to measure levels of CA9 and associated expression of genes that regulate hypoxia with outcomes of patients using the Cancer Genome Atlas database. RESULTS: Under hypoxic conditions, PDAC cells had increased levels of HIF1A and HIF2A, upregulated expression of CA9, and activated glycolysis. Knockdown of KRAS in PDAC cells, or incubation with trametinib, reduced the posttranscriptional stabilization of HIF1A and HIF2A, upregulation of CA9, pHi, and glycolysis in response to hypoxia. CA9 was expressed by 66% of PDAC samples analyzed; high expression of genes associated with metabolic adaptation to hypoxia, including CA9, correlated with significantly reduced survival times of patients. Knockdown or pharmacologic inhibition of CA9 in PDAC cells significantly reduced pHi in cells under hypoxic conditions, decreased gemcitabine-induced glycolysis, and increased their sensitivity to gemcitabine. PDAC cells with knockdown of CA9 formed smaller xenograft tumors in mice, and injection of gemcitabine inhibited tumor growth and significantly increased survival times of mice. In mice with xenograft tumors grown from human PDAC cells, oral administration of SLC-0111 and injection of gemcitabine increased intratumor acidosis and increased cell death. These tumors, and tumors grown from PDAC patient-derived tumor fragments, grew more slowly than xenograft tumors in mice given control agents, resulting in longer survival times. In KrasG12D/Pdx1-Cre/Tp53/RosaYFP genetically modified mice, oral administration of SLC-0111 and injection of gemcitabine reduced numbers of B cells in tumors. CONCLUSIONS: In response to hypoxia, PDAC cells that express activated KRAS increase expression of CA9, via stabilization of HIF1A and HIF2A, to regulate pH and glycolysis. Disruption of this pathway slows growth of PDAC xenograft tumors in mice and might be developed for treatment of pancreatic cancer.</p>
<p>doi: <a href="https://doi.org/10.1053/j.gastro.2019.05.004" class="uri">https://doi.org/10.1053/j.gastro.2019.05.004</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma</strong> </summary></p>
<p><em>Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Aug;25(15):4674-4681</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31068372" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31068372</a></p>
<p>PURPOSE: Gene fusions involving neuregulin 1 (NRG1) have been noted in multiple cancer types and have potential therapeutic implications. Although varying results have been reported in other cancer types, the efficacy of the HER-family kinase inhibitor afatinib in the treatment of NRG1 fusion-positive pancreatic ductal adenocarcinoma is not fully understood. EXPERIMENTAL DESIGN: Forty-seven patients with pancreatic ductal adenocarcinoma received comprehensive whole-genome and transcriptome sequencing and analysis. Two patients with gene fusions involving NRG1 received afatinib treatment, with response measured by pretreatment and posttreatment PET/CT imaging. RESULTS: Three of 47 (6%) patients with advanced pancreatic ductal adenocarcinoma were identified as KRAS wild type by whole-genome sequencing. All KRAS wild-type tumors were positive for gene fusions involving the ERBB3 ligand NRG1. Two of 3 patients with NRG1 fusion-positive tumors were treated with afatinib and demonstrated a significant and rapid response while on therapy. CONCLUSIONS: This work adds to a growing body of evidence that NRG1 gene fusions are recurrent, therapeutically actionable genomic events in pancreatic cancers. Based on the clinical outcomes described here, patients with KRAS wild-type tumors harboring NRG1 gene fusions may benefit from treatment with afatinib.See related commentary by Aguirre, p. 4589.</p>
<p>doi: <a href="https://doi.org/10.1158/1078-0432.CCR-19-0191" class="uri">https://doi.org/10.1158/1078-0432.CCR-19-0191</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Loss of SMAD4 protein expression in gastrointestinal and extra-gastrointestinal carcinomas</strong> </summary></p>
<p><em>Histopathology 2019 Oct;75(4):546-551</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31054158" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31054158</a></p>
<p>AIMS: SMAD4 (DPC4) is a tumour suppressor gene that is dysregulated in various tumour types, particularly pancreaticobiliary and gastrointestinal carcinomas. Corresponding loss of protein expression has been reported in approximately 50% of pancreatic and 25% of colonic adenocarcinomas. In the evaluation of carcinoma of unknown primary site, immunohistochemical loss of SMAD4 expression is often used to suggest pancreaticobiliary origin, but there are limited data on the spectrum of SMAD4 expression in carcinomas of other sites. This study evaluates the frequency of SMAD4 loss in a large cohort of carcinomas from diverse anatomical sites. METHODS AND RESULTS: Immunohistochemistry for SMAD4 was performed on tissue microarrays or whole tissue sections of 1210 carcinomas from various organs: gastrointestinal tract, liver, pancreas/biliary tract, lung, breast, thyroid, kidney, ovary and uterus. Expression was considered lost when there was complete absence of staining in tumour cell nuclei, in the presence of intact staining in non-neoplastic cells. SMAD4 loss was seen in 58% of pancreatic adenocarcinomas, 27% of appendiceal adenocarcinomas, 19% of colorectal adenocarcinomas, 16% of cholangiocarcinomas, 10% of lung adenocarcinomas and &lt;5% of oesophageal, breast, gastric and mucinous ovarian adenocarcinomas. All papillary thyroid, hepatocellular, non-mucinous ovarian, endometrial and renal cell carcinomas showed intact SMAD4 nuclear expression. CONCLUSION: In addition to pancreaticobiliary, appendiceal and colonic tumours, SMAD4 loss is also seen in a small subset of other carcinomas, specifically breast, lung, oesophageal and gastric adenocarcinomas, all of which are typically CK7-positive, similar to pancreaticobiliary carcinoma. Awareness of SMAD4 loss in these other carcinoma types is helpful in the evaluation of carcinomas of unknown or uncertain primary site.</p>
<p>doi: <a href="https://doi.org/10.1111/his.13894" class="uri">https://doi.org/10.1111/his.13894</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>The role of rapid on-site evaluation on diagnostic accuracy of endoscopic ultrasound fine needle aspiration for pancreatic, submucosal upper gastrointestinal tract and adjacent lesions</strong> </summary></p>
<p><em>Cytopathology : official journal of the British Society for Clinical Cytology 2019 09;30(5):499-503</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31034112" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31034112</a></p>
<p>BACKGROUND AND AIM: Our aim was to assess adequacy and diagnostic accuracy of endoscopic ultrasound-fine needle aspiration (EUS-FNA) specimens with or without rapid on-site evaluation (ROSE) from pancreatic, upper gastrointestinal tract (UGIT) and adjacent masses. METHOD: A retrospective cohort study based on patients’ files who underwent EUS-FNA in Galilee Medical Center in a 4 years period. Number of needle passes, repeated EUS and ROSE effect on tissue adequacy and diagnostic accuracy were reported. RESULTS: One-hundred sixty-one patients were included. Ninety-three patients (57.7%) underwent EUS-FNA without ROSE (group A) compared to 68 patients (42.3%) with ROSE (group B). The most common location was in the pancreas (55% in group A vs 81% in group B). Addition of ROSE yielded a significantly higher specimen adequacy (65% in group A vs 92.6% in group B (Chi-Square &lt; 0.0001, OR 6.72, 95% CI 2.45-18.38). The matching rate (accuracy) between ROSE diagnosis and final histopathological diagnosis was noticed in 61 out of 68 patients (89.7%, 95% CI 0.7993-0.9576). The Kappa coefficient correlations of matching rate between ROSE and final histopathological diagnosis of all lesion and in pancreatic lesions were 0.7558, (95% CI 0.625-0.887) and 0.7814, (95% CI 0.639-0.924), respectively. CONCLUSIONS: EUS-FNA with ROSE significantly improve specimen adequacy and was associated with high diagnostic accuracy.</p>
<p>doi: <a href="https://doi.org/10.1111/cyt.12712" class="uri">https://doi.org/10.1111/cyt.12712</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better Prognosis in Intraductal Pancreatic Mucinous Neoplasms</strong> </summary></p>
<p><em>Annals of surgical oncology 2019 Aug;26(8):2640-2650</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31025231" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31025231</a></p>
<p>BACKGROUND: The management of intraductal papillary mucinous neoplasms (IPMNs) is mainly based on imaging features and clinical symptoms, and remains challenging. OBJECTIVE: The aim of this study was to assess GNAS, RAS family (KRAS, NRAS and HRAS), BRAF, and PIK3CA mutation status in resected IPMNs and correlate it with clinicopathological characteristics and patient survival. METHODS: Overall, 149 consecutive unselected patients who underwent pancreatectomy for IPMNs were included. After dissection from formalin-fixed and paraffin-embedded tumors, GNAS mutational screening was assessed by allelic discrimination using Taqman® probes and confirmed by SNaPshot analysis. RAS family, BRAF, and PIK3CA mutational screening was assessed by high resolution melt and Sanger sequencing. RESULTS: Gastric- and intestinal-type IPMNs were the most frequent lesions (52% and 41%, respectively). Intestinal-type IPMNs were more frequently associated high-grade dysplasia (49%) and were the only IPMNs associated with colloid-type carcinoma. All pancreatobiliary IPMNs were invasive lesions, located in the main pancreatic duct. GNAS-activating mutations were strongly associated with the intestinal phenotype (p &lt; 10-4), while RAS pathway mutations were not associated with any particular phenotype. Mutations within other members of the epidermal growth factor receptor (EGFR) pathway were very rare (2%). GNAS-mutated IPMNs were rarely invasive (11%) and almost exclusively (83%) of the colloid type. For invasive lesions, multivariate analyses determined that only node negativity was associated with improved cancer-specific survival, but, in univariate analysis, GNAS mutation was associated with prolonged survival. CONCLUSION: In patients selected for surgery, GNAS mutation analysis and tumor phenotype can help to better predict patient prognosis. In the near future, a more precise mutational analysis of IPMNs might help to better tailor their management.</p>
<p>doi: <a href="https://doi.org/10.1245/s10434-019-07389-6" class="uri">https://doi.org/10.1245/s10434-019-07389-6</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group</strong> </summary></p>
<p><em>Annals of surgical oncology 2019 Aug;26(8):2517-2524</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31004295" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31004295</a></p>
<p>BACKGROUND: Preoperative factors that reliably predict lymph node (LN) metastases in pancreatic neuroendocrine tumors (PanNETs) are unclear. The number of LNs needed to accurately stage PanNETs has not been defined. METHODS: Patients who underwent curative-intent resection of non-functional PanNETs at eight institutions from 2000 to 2016 were analyzed. Preoperative factors associated with LN metastases were identified. A procedure-specific target for LN retrieval to accurately stage patients was determined. RESULTS: Of 695 patients who underwent resection, 33% of tumors were proximal (head/uncinate) and 67% were distal (neck/body/tail). Twenty-six percent of patients (n = 158) had LN-positive disease, which was associated with a worse 5-year recurrence-free survival (RFS; 60% vs. 86%; p &lt; 0.001). The increasing number of positive LNs was not associated with worse RFS. Preoperative factors associated with positive LNs included tumor size ≥ 2 cm (odds ratio [OR] 6.6; p &lt; 0.001), proximal location (OR 2.5; p &lt; 0.001), moderate versus well-differentiation (OR 2.1; p = 0.006), and Ki-67 ≥ 3% (OR 3.1; p &lt; 0.001). LN metastases were also present in tumors without these risk factors: &lt; 2 cm (9%), distal location (19%), well-differentiated (23%), and Ki-67 &lt; 3% (16%). Median LN retrieval was 13 for pancreatoduodenectomy (PD), but only 9 for distal pancreatectomy (DP). Given that PD routinely includes a complete regional lymphadenectomy, a minimum number of LNs to accurately stage patients was not identified. However, for DP, removal of less than seven LNs failed to discriminate 5-year RFS between LN-positive and LN-negative patients (less than seven LNs: 72% vs. 83%, p = 0.198; seven or more LNs: 67% vs. 86%; p = 0.002). CONCLUSIONS: Tumor size ≥ 2 cm, proximal location, moderate differentiation, and Ki-67 ≥ 3% are preoperative factors that predict LN positivity in resected non-functional PanNETs. Given the 9-23% incidence of LN metastases in patients without such risk factors, routine regional lymphadenectomy should be considered. PD inherently includes sufficient LN retrieval, while DP should aim to remove seven or more LNs for accurate staging.</p>
<p>doi: <a href="https://doi.org/10.1245/s10434-019-07367-y" class="uri">https://doi.org/10.1245/s10434-019-07367-y</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Clear Cell Variant of Solid Pseudopapillary Neoplasm of the Pancreas: A Report of a Rare Variant and Review of the Literature</strong> </summary></p>
<p><em>International journal of surgical pathology 2019 Aug;27(5):535-540</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=30845855" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=30845855</a></p>
<p>The clear cell variant of solid pseudopapillary neoplasm (ccSPN) of the pancreas was first described in 2006. In this article, we report a case of this rare variant and review the few published reports. Both the current and previous reports show that ccSPN has several morphologic differences from conventional SPN, including clear vacuoles, fewer pseudopapillary formations, more solid/diffuse architecture, less hemorrhage, and fewer cholesterol clefts. Some of these features peculiar to ccSPN, such as solid/diffuse architecture, have been proposed to suggest aggressive behavior, though reports of ccSPN are rare and often have limited clinical follow-up. ccSPN also appears to occur more frequently in males than conventional SPNs. These clinical and pathologic features lead to unique set of differential diagnostic considerations for ccSPN, including metastatic renal cell carcinoma, perivascular epithelial cell tumor, and clear cell variants of other carcinomas. These unique features, atypical differential, and uncertain prognostic ramifications all make ccSPN an important variant to be aware of and report.</p>
<p>doi: <a href="https://doi.org/10.1177/1066896919833790" class="uri">https://doi.org/10.1177/1066896919833790</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>STING signalling protects against chronic pancreatitis by modulating Th17 response</strong> </summary></p>
<p><em>Gut 2019 10;68(10):1827-1837</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=30705050" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=30705050</a></p>
<p>OBJECTIVE: Chronic pancreatitis (CP) is an inflammatory disease with progressive fibrosis leading to exocrine and endocrine dysfunction. Currently, there are no approved effective therapies for CP. Stimulator of interferon genes (STING) signalling is a key innate immune sensor of DNA. In this study, we evaluated the role of STING signalling in CP. DESIGN: We used an experimental model of CP to test the effect of STING signalling in STING wild-type and knockout mice as well as bone marrow chimaeras (BMCs). STING was activated using a pharmacological agent. Since we found changes in Th17 cells, we used neutralising and control antibodies to determine the role of IL-17A. The effect of STING signalling was further explored in IL-17A generation and we examined the effect of IL-17A on pancreatic stellate cells (PSCs). Human pancreas from patients with CP and without CP were also stained for IL-17A. RESULTS: STING activation decreased CP-associated pancreatic inflammation and fibrosis, whereas absence of STING led to worsening of the disease. BMCs showed that leucocytes play an important role in STING signalling-mediated amelioration of experimental CP. STING deletion was associated with increased Th17 cell infiltration in the pancreas, whereas STING agonist limited this Th17 response. Importantly, anti-IL-17A antibody treatment mitigated the severity of CP in the absence of STING signalling. STING deficiency promoted Th17 polarisation and PSCs express functional IL-17 receptor by upregulating fibrosis genes. Compared with tumour margins, pancreas from patients with CP had significant increase in IL-17A+ cells. CONCLUSION: Unlike acute pancreatitis, STING activation is protective in CP. STING signalling is important in regulating adaptive immune responses by diminishing generation of IL-17A during CP and presents a novel therapeutic target for CP.</p>
<p>doi: <a href="https://doi.org/10.1136/gutjnl-2018-317098" class="uri">https://doi.org/10.1136/gutjnl-2018-317098</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>High Expression of Long Noncoding RNA HOTAIRM1 is Associated with the Proliferation and Migration in Pancreatic Ductal Adenocarcinoma</strong> </summary></p>
<p><em>Pathology oncology research : POR 2019 Oct;25(4):1567-1577</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=30613920" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=30613920</a></p>
<p>Pancreatic ductal adenocarcinoma (PDAC) is an incurable malignancy. Long noncoding RNA (LncRNA) HOTAIRM1 (HOX antisense intergenic RNA myeloid 1) has been shown to play important roles in the progression of several type cancers. However, the exact role of HOTAIRM1 in PDAC development remains largely unknown. This study aims to evaluate the potential function of HOTAIRM1 in the development and progress of PDAC. HOTAIRM1 expression was measured by RT-qPCR in forty seven paired human PDAC tissues and five PDAC cell lines. SW1990 and PANC-1 cells were transfected with siHOTAIRM1 to achieve HOTAIRM1 silence. MTT assay and colony formation assay were used to detect the effect of HOTAIRM1 knockdown on cell proliferation. The impact of HOTAIRM1 silence on cell cycle and apoptosis was assessed by flow cytometry assay. Transwell migration assay was performed to explore the influence of HOTAIRM1 downregulation on the migratory potential of PDAC cells. Western blot assay was applied to determine the expression changes of cell cycle, apoptosis, and migration-related genes before and after downregulating HOTAIRM1. HOTAIRM1 expression was abnormally upregulated in PDAC tissues and cells when compared with the control samples, and was positively associated with the expression of KRAS gene mutation. In vitro functional experiments, HOTAIRM1 expression was significantly downregulated by transfection with siHOTAIRM1 in SW1990 and PANC cell lines. HOTAIRM1 knockdown attenuated cell proliferation by inducing cell cycle arrest at G0/G1 phase, promoted cell apoptosis, and inhibited cell migration in PDAC cells by regulating related-genes expression. In conclusion, HOTAIRM1 plays a critical role in PDAC progression, which may be a novel diagnostic and rational therapeutic target for the treatment of pancreatic ductal adenocarcinoma.</p>
<p>doi: <a href="https://doi.org/10.1007/s12253-018-00570-4" class="uri">https://doi.org/10.1007/s12253-018-00570-4</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>New Model for Predicting Malignancy in Patients With Intraductal Papillary Mucinous Neoplasm</strong> </summary></p>
<p><em>Annals of surgery 2020 Jul;272(1):155-162</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=30499803" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=30499803</a></p>
<p>OBJECTIVE: To create a simple, objective model to predict the presence of malignancy in patients with intraductal papillary mucinous neoplasm (IPMN), which can be easily applied in daily practice and, importantly, adopted for any lesion types. BACKGROUND: No predictive model for malignant IPMN has been widely applied in clinical practice. METHODS: The clinical details of 466 patients with IPMN who underwent pancreatic resection at 3 hospitals were retrospectively analyzed for model development. Then, the model was validated in 664 surgically resected patients at 8 hospitals in Japan.In the preoperative examination, endoscopic ultrasonography (EUS) was considered to be essential to observe mural nodules in both the model development and external validation sets. Malignant IPMNs were defined as those with high-grade dysplasia and associated invasive carcinoma. RESULTS: Of the 466 patients, 258 (55%) had malignant IPMNs (158 high-grade dysplasia, 100 invasive carcinoma), and 208 (45%) had benign IPMNs. Logistic regression analysis resulted in 3 variables (mural nodule size, main pancreatic duct diameter, and cyst size) being selected to construct the model. The area under the receiver operating characteristic curve (AUC) for the model was 0.763. In external validation sets, the pathological diagnosis was malignant and benign IPMN in 351 (53%) and 313 (47%) cases, respectively. For the external validation, the malignancy prediction ability of the model corresponded to an AUC of 0.725. CONCLUSION: This predictive model provides important information for physicians and patients in assessing an individual’s risk for malignancy and may help to identify patients who need surgery.</p>
<p>doi: <a href="https://doi.org/10.1097/SLA.0000000000003108" class="uri">https://doi.org/10.1097/SLA.0000000000003108</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After Pancreatectomy</strong> </summary></p>
<p><em>Annals of surgery 2020 Jul;272(1):163-169</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=30499795" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=30499795</a></p>
<p>OBJECTIVE: To characterize opioid discharge prescriptions for pancreatectomy patients. BACKGROUND: Wide variation in and over-prescription of opioids after surgery contribute to the United States opioid epidemic through persistent use past the postoperative period. Objective strategies guiding discharge opioid prescriptions for oncologic surgery are lacking, and factors driving prescription amount are not fully delineated. METHODS: Characteristics of pancreatectomy patients (March 2016-August 2017) were retrospectively abstracted from a prospective database. Discharge opioids prescriptions were converted to oral morphine equivalents (OME). Regression models identified variables associated with discharge OME. RESULTS: In 158 consecutive patients, median discharge OME was 250 mg (range 0-3950). Discharge OME was labeled “low” (&lt;200 mg) for 33 patients (21%) and “high” (&gt;400 mg) for 38 (24%). Only shorter operative time (odds ratio [OR]-0.14, P = 0.004) and inpatient team (OR-15.39, P &lt; 0.001) were independently associated with low discharge OME. Older age was the only variable associated with high discharge OME. Fifty-seven patients (36%) used zero opioids in the last 24-hours predischarge, yet 52 of 57 (91%) still received discharge opioids. Older age (OR-1.07), grade B/C pancreatic fistula (OR-3.84), and epidural use (OR-3.12) were independently associated with zero last-24-hours OME (all P ≤ 0.040). CONCLUSIONS: The wide variation in discharge opioid prescriptions is heavily influenced by provider routine/bias and not by objective criteria such as last-24-hours OME. Quality improvement strategies could include aggressive weaning protocols to increase the proportion of patients with zero/near-zero last-24-hour OME and limiting prescriptions to a conservative multiplier of the last-24-hour OME.</p>
<p>doi: <a href="https://doi.org/10.1097/SLA.0000000000003112" class="uri">https://doi.org/10.1097/SLA.0000000000003112</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth</strong> </summary></p>
<p><em>Gut 2019 08;68(8):1465-1476</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=30343272" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=30343272</a></p>
<p>BACKGROUND AND AIMS: Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive tumour with a poor prognosis using current treatments. Targeted therapies may offer a new avenue for more effective strategies. Dual-specificity tyrosine regulated kinase 1A (DYRK1A) is a pleiotropic kinase with contradictory roles in different tumours that is uncharacterised in PDAC. Here, we aimed to investigate the role of DYRK1A in pancreatic tumorigenesis. DESIGN: We analysed DYRK1A expression in PDAC genetic mouse models and in patient samples. DYRK1A function was assessed with knockdown experiments in pancreatic tumour cell lines and in PDAC mouse models with genetic reduction of Dyrk1a dosage. Furthermore, we explored a mechanistic model for DYRK1A activity. RESULTS: We showed that DYRK1A was highly expressed in PDAC, and that its protein level positively correlated with that of c-MET. Inhibition of DYRK1A reduced tumour progression by limiting tumour cell proliferation. DYRK1A stabilised the c-MET receptor through SPRY2, leading to prolonged activation of extracellular signal-regulated kinase signalling. CONCLUSIONS: These findings reveal that DYRK1A contributes to tumour growth in PDAC, at least through regulation of c-MET accumulation, suggesting that inhibition of DYRK1A could represent a novel therapeutic target for PDAC.</p>
<p>doi: <a href="https://doi.org/10.1136/gutjnl-2018-316128" class="uri">https://doi.org/10.1136/gutjnl-2018-316128</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases</strong> </summary></p>
<p><em>Annals of surgery 2020 03;271(3):566-573</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=30339629" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=30339629</a></p>
<p>OBJECTIVE: The aim of this study was to investigate the key molecular alterations in small primary pancreatic neuroendocrine tumors (PanNETs) associated with the development of liver metastases. BACKGROUND: Well-differentiated PanNETs with small size are typically indolent; however, a limited subset metastasize to the liver. METHODS: A total of 87 small primary PanNETs (&lt;3 cm), including 32 metastatic cases and 55 nonmetastatic cases after a 5-year follow-up, were immunolabeled for DAXX/ATRX and analyzed for alternative lengthening of telomeres (ALT) by Fluorescence In Situ Hybridization. A subset of these cases, 24 that metastasized and 24 that did not metastasize, were assessed by targeted next-generation sequencing and whole-genome copy number variation. RESULTS: In the entire cohort, high Ki-67 (OR 1.369; 95% CI 1.121-1.673; P = 0.002), N-stage (OR 4.568; 95% CI 1.458-14.312; P = 0.009), and ALT-positivity (OR 3.486; 95% CI 1.093-11.115; P = 0.035) were independently associated with liver metastases. In the subset assessed by next-generation sequencing and copy number variation analysis, 3 molecular subtypes with differing risks of liver metastases were identified. Group 1 (n = 15; 73% metastasized) was characterized by recurrent chromosomal gains, CN-LOH, DAXX mutations, and ALT-positivity. Group 2 (n = 19; 42% metastasized, including 5 G1 tumors) was characterized by limited copy number alterations and mutations. Group 3 (n = 14; 35% metastasized) were defined by chromosome 11 loss. CONCLUSIONS: We identified genomic patterns of small PanNETs associated with a different risk for liver metastases. Molecular alterations, such as DAXX mutations, chromosomal gains, and ALT, are associated with an increased risk of metastasis in small PanNETs. Therefore, targeted sequencing and/or ALT analysis may help in the clinical decisions for these small PanNETs.</p>
<p>doi: <a href="https://doi.org/10.1097/SLA.0000000000003022" class="uri">https://doi.org/10.1097/SLA.0000000000003022</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas</strong> </summary></p>
<p><em>Annals of surgery 2020 05;271(5):941-948</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=30308608" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=30308608</a></p>
<p>OBJECTIVE: To determine the factors predicting the subsequent development of pancreatic ductal adenocarcinoma in remnant pancreas (PDAC-RP) after partial pancreatectomy for PDAC. SUMMARY BACKGROUND DATA: PDAC-RP after partial pancreatectomy for PDAC is currently not so rare because of improved prognosis of PDAC patients due to recent advances in surgical techniques and adjuvant therapy. However, the predictive factors related to PDAC-RP remain unknown. METHODS: We retrospectively reviewed the clinicopathological data of a consecutive series of 379 patients with PDAC treated by partial pancreatectomy between 1992 and 2015; 14 patients (3.69%) had PDAC-RP. Clinicopathological variables were compared between PDAC-RP and non-PDAC-RP. RESULTS: In univariate analysis, concomitant intraductal papillary mucinous neoplasm (IPMN) (P = 0.0005), cancer location (body/tail) (P = 0.0060), and lower T factor in UICC (P = 0.0039) were correlated with PDAC-RP development. Multivariate analysis revealed concomitant IPMN (P = 0.0135) to be an independent predictive factor for PDAC-RP. PDAC concomitant with IPMN had higher cumulative incidence of PDAC-RP (47.5%/10 yrs) than PDAC without IPMN (9.96%/10 yrs) (P = 0.0071). Moreover, the density of pancreatic intraepithelial neoplasia lesions in the background pancreas of cases of PDAC concomitant with IPMN (1.86/cm) was higher than that of cases of PDAC without IPMN (0.91/cm) (P = 0.0007). CONCLUSIONS: Concomitant IPMN in PDAC is an independent predictive factor for the development of new PDAC in remnant pancreas. Cancer susceptibility of remnant pancreas after resection for PDAC concomitant with IPMN is probably due to an increased density of pancreatic intraepithelial neoplasia lesions.</p>
<p>doi: <a href="https://doi.org/10.1097/SLA.0000000000003060" class="uri">https://doi.org/10.1097/SLA.0000000000003060</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma</strong> </summary></p>
<p><em>Annals of surgery 2020 03;271(3):549-558</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=30216219" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=30216219</a></p>
<p>OBJECTIVE: We evaluated the prognostic impact of circulating tumor cells (CTCs) for patients with presumed resectable pancreatic and periampullary cancers. SUMMARY OF BACKGROUND DATA: Initial treatment decisions for this group are currently taken without a reliable prognostic marker. The CellSearch system allows standardized CTC-testing and has shown excellent specificity and prognostic value in other applications. METHODS: Preoperative blood samples from 242 patients between September 2009 and December 2014 were analyzed. One hundred seventy-nine patients underwent tumor resection, of whom 30 with stage-I tumors and duodenal cancer were assigned to the low-risk group, and the others to the high-risk group. Further 33 had advanced disease, 30 benign histology. Observation ended in December 2016. Cancer-specific survival (CSS) and disease-free survival (DFS) were calculated by log-rank and Cox regression. RESULTS: CTCs (CTC-positive; ≥1 CTC/7.5 mL) were detected in 6.8% (10/147) of the high-risk patients and 6.2% (2/33) with advanced disease. No CTCs (CTC-negative) were detected in the low-risk patients or benign disease. In high-risk patients, median CSS for CTC-positive versus CTC-negative was 8.1 versus 20.0 months (P &lt; 0.0001), and DFS 4.0 versus 10.5 months (P &lt; 0.001). Median CSS in advanced disease was 7.7 months. Univariate hazard ratio (HR) of CTC-positivity was 3.4 (P &lt; 0.001). In multivariable analysis, CTC-status remained independent (HR: 2.4, P = 0.009) when corrected for histological type (HR: 2.7, P = 0.030), nodal status (HR: 1.7, P = 0.016), and vascular infiltration (HR: 1.7, P = 0.001). CONCLUSION: Patients testing CTC-positive preoperatively showed a detrimental outcome despite successful tumor resections. Although the low CTC-rate seems a limiting factor, results indicate high specificity. Thus, preoperative analysis of CTCs by this test may guide treatment decisions and warrants further testing in clinical trials.</p>
<p>doi: <a href="https://doi.org/10.1097/SLA.0000000000003035" class="uri">https://doi.org/10.1097/SLA.0000000000003035</a></p>
</details>
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<hr />
<p><a href="#top" target="_self">Back to top</a></p>
<hr />
<div style="page-break-after: always;"></div>
</div>
<div id="gallbladder" class="section level2">
<h2>Gallbladder</h2>
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Role of Prophylactic Cholecystectomy After Endoscopic Sphincterotomy for Biliary Stone Disease: A Systematic Review and Meta-Analysis</strong> </summary></p>
<p><em>Annals of surgery 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32590541" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32590541</a></p>
<p>OBJECTIVE: The aim of this study was to perform a structured systematic review and meta-analysis to evaluate the effectiveness and complication rate of cholecystectomy deferral versus prophylactic cholecystectomy among patients post-endoscopic biliary sphincterotomy for common bile duct stones. BACKGROUND: Although previous reports suggest a decreased risk of biliary complications with prophylactic cholecystectomy, biliary endoscopic cholangiopancreatography (ERCP) with sphincterotomy may provide a role for deferring cholecystectomy with the gallbladder left in situ. METHODS: Searches of PubMed, EMBASE, Web of Science, and Cochrane Library databases were performed through August 2019 in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-Analysis of Observational Studies in Epidemiology guidelines. Measured outcomes included: mortality, recurrent biliary pain or cholecystitis, pancreatitis, cholangitis, and eventual need for cholecystectomy. Random effects models were used to determine pooled effect size and corresponding 95% confidence intervals (CIs). RESULTS: Nine studies (n = 1605) were included. A total of 53.8% (n = 864) patients had deferred cholecystectomy post-sphincterotomy. Deferral cholecystectomy as compared to prophylactic cholecystectomy resulted in a significant increased risk of mortality [odds raio (OR) 2.56 (95% confidence interval, CI 1.54-4.23); P &lt; 0.0001; I = 18.49]. Patients who did not undergo prophylactic cholecystectomy developed more recurrent biliary pain or cholecystitis [OR 5.10 (95% CI 3.39-7.67); P &lt; 0.0001; I = 0.00]. Rate of pancreatitis [OR 3.11 (95% CI 0.99-9.83); P = 0.053; I = 0.00] and cholangitis [OR 1.49 (95% CI 0.74-2.98); P = 0.264; I = 0.00] was unaffected. Overall, 26.00% (95% CI 14.00-40.00) of patients with deferred prophylactic cholecystectomy required eventual cholecystectomy. CONCLUSIONS: Prophylactic cholecystectomy remains the preferred strategy compared to a deferral approach with gallbladder in situ post-sphincterotomy for patients with bile duct stones. Future studies may highlight a subset of patients (ie, those with large balloon biliary dilation) that may not require cholecystectomy.</p>
<p>doi: <a href="https://doi.org/10.1097/SLA.0000000000003977" class="uri">https://doi.org/10.1097/SLA.0000000000003977</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Synchronous detection of SDHA-related gallbladder paraganglioma and pancreatic neuroendocrine tumor</strong> </summary></p>
<p><em>Pathology, research and practice 2020 Jul;216(7):153006</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32534711" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32534711</a></p>
<p>Primary gallbladder paragangliomas (PGLs) are exceedingly rare. PGLs are extraadrenal neuroendocrine tumors that are morphologically inseparable from intraadrenal pheochromocytomas. PGLs and pheochromocytomas are some of the most heritable tumor types in the body and are often associated with other tumors or part of a genetic syndrome. We report a case of gallbladder PGL presenting synchronously with pancreatic neuroendocrine tumor (NET) and pulmonary IgG4-related disease in a 74-year old male patient with disseminated prostate adenocarcinoma. Due to the high rate of germline mutations and the possible syndromal manifestation of PGLs as well as pancreatic NETs, this patient was offered genetic testing, and a pathogenic SDHA germline mutation was found. Immunohistochemically, there was loss of SDHA and SDHB in the PGL but neither in the NET nor in the prostate adenocarcinoma. To our knowledge, this case is the first report of gallbladder PGL associated with pancreatic NET. It is likely that the identified SDHA germline mutation played a role in the development of gallbladder PGL in this patient.</p>
<p>doi: <a href="https://doi.org/10.1016/j.prp.2020.153006" class="uri">https://doi.org/10.1016/j.prp.2020.153006</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Mixed adenoneuroendocrine carcinoma of the gallbladder, amphicrine type: Case report and review of literature</strong> </summary></p>
<p><em>Pathology, research and practice 2020 Jul;216(7):152997</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32534704" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32534704</a></p>
<p>Amphicrine type mixed adenoneuroendocrine carcinoma (MANEC), also known as amphicrine carcinoma, is an exceedingly rare neoplasm comprising of tumor cells simultaneously demonstrating both neuroendocrine and exocrine differentiation. Majority of reported cases were found in tubular gastrointestinal tracts such as colon. Herein, we report the first case of amphicrine carcinoma in gallbladder in a 57-year-old female who presented with abdominal pain, vomiting, and gallbladder mass on imaging followed by radical cholecystectomy. Macroscopically, the tumor was a polypoid solid mass with a firm and tan-white cut surface located at the gallbladder fundus. Histologically, the tumor cells were composed of monotonous-appearing signet-ring cells with fine chromatin, variably conspicuous nucleoli, brisk mitotic figures, and spotty necrosis. They were loosely clustered, forming nests and cords but no glandular formation. Immunohistochemically, the entire tumor showed strong and diffuse immunoreactivity for CDX2, p53, and synaptophysin, with patchy positivity for CD56, chromogranin, and INSM1. Kreyberg stain highlighted both intracytoplasmic and extracellular mucin. Ki-67 proliferation index was approximately 70%. Next-generation sequencing performed on a 724 cancer-related gene panel identified TP53 mutation at c.844C&gt;T (p.R282W). To our knowledge, this is the first case of amphicrine carcinoma in gallbladder. It highlights the complex dynamism and controversial pathogenesis of this unique entity, the exact mechanism and clinicopathologic behavior of which are not yet understood.</p>
<p>doi: <a href="https://doi.org/10.1016/j.prp.2020.152997" class="uri">https://doi.org/10.1016/j.prp.2020.152997</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Diagnostic role of fine needle aspiration cytology (FNAC) in the evaluation of gall bladder lesions: an institutional experience</strong> </summary></p>
<p><em>Diagnostic cytopathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32506819" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32506819</a></p>
<p>BACKGROUND: Carcinoma of the gall bladder is the most common malignancy of the biliary tract. Ultrasonography guided Fine Needle Aspiration Cytology (FNAC) plays a crucial role in early detection of gall bladder (GB) lesions. Early diagnosis of GB lesions is a necessity in view of rising trend in GB carcinoma related mortality in India. The aim of this study is to determine the diagnostic accuracy of pre-operative ultrasonography guided FNAC in the diagnosis of GB masses. METHODS: This was a retrospective observational study performed at a tertiary care university hospital over a period of one and a half years. A total of 47 patients with clinico-radiological suspicion of GB malignancy were subjected to USG guided FNA. 20 of these patients underwent diagnostic Trucut biopsy in addition to FNA. RESULTS: Forty-one out of 47 patients analyzed were positive for malignancy with female preponderance; MF ratio of 0.6:1. There were 29 females (61.8%) and 18 males (38.2%) in the range of 34 to 85 years. Cytomorphology was inconclusive for malignancy in two patients and unsatisfactory in one case. Two were labeled as chronic cholecystitis and one as acute cholecystitis. Adenocarcinoma was the most common malignancy found in 36 patients (76.6%). CONCLUSION: USG guided FNAC is a rapid, safe and successful diagnostic procedure with high sensitivity for diagnosis of GB lesions. In the present scenario of increasing incidence of GB malignancy, FNAC has proved to be a useful first choice of investigation in the detection of GB lesions.</p>
<p>doi: <a href="https://doi.org/10.1002/dc.24517" class="uri">https://doi.org/10.1002/dc.24517</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Expression of FAM83H and ZNF16 are associated with shorter survival of patients with gallbladder carcinoma</strong> </summary></p>
<p><em>Diagnostic pathology 2020 May;15(1):63</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32460791" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32460791</a></p>
<p>BACKGROUND: Recently, FAM83H was reported to have roles in cancer progression in conjunction with oncogenic molecules such as MYC and b-catenin. Moreover, the data from the public database indicates a molecular relationship between FAM83H and zinc finger proteins, especially between FAM83H and ZNF16. However, studies on FAM83H and ZNF16 in gallbladder cancer have been limited. METHODS: This study investigated the expression of FAM83H and ZNF16 in 105 gallbladder carcinomas. RESULTS: In human gallbladder carcinomas, immunohistochemical expression of FAM83H was significantly associated with ZNF16 expression. In univariate analysis, nuclear and cytoplasmic expression of FAM83H or ZNF16 were significantly associated with shorter survival of gallbladder carcinoma patients. Multivariate analysis revealed the nuclear expression of FAM83H as an independent indicator of poor prognosis of overall survival (p = 0.005) and relapse-free survival (p = 0.005) of gallbladder carcinoma patients. Moreover, co-expression patterns of nuclear FAM83H and ZNF16 were also independent indicators of shorter survival of gallbladder carcinoma patients (overall survival; p &lt;  0.001, relapse-free survival; p &lt;  0.001). CONCLUSIONS: This study suggests FAM83H and ZNF16 are associated with the progression of gallbladder carcinoma, and the expressions of FAM83H and ZNF16 might be novel prognostic indicators of gallbladder carcinoma patients.</p>
<p>doi: <a href="https://doi.org/10.1186/s13000-020-00985-1" class="uri">https://doi.org/10.1186/s13000-020-00985-1</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Testing for ROS1, ALK, MET, and HER2 rearrangements and amplifications in a large series of biliary tract adenocarcinomas</strong> </summary></p>
<p><em>Virchows Archiv : an international journal of pathology 2020 Jul;477(1):33-45</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32447492" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32447492</a></p>
<p>Biliary tract carcinomas are divided into intrahepatic, perihilar, distal extrahepatic cholangiocarcinomas, and gallbladder adenocarcinomas. Therapies targeting ROS1, ALK, MET, and HER2 alterations are currently evaluated in clinical trials. We assessed ROS1 and ALK translocations/amplifications as well as MET and HER2 amplifications for each tumor subtype by fluorescent in situ hybridization (FISH) and immunohistochemistry (IHC) in 73 intrahepatic, 40 perihilar bile duct, 36 distal extrahepatic cholangiocarcinomas, and 45 gallbladder adenocarcinomas (n = 194). By FISH, we detected targetable alterations in 5.2% of cases (n = 10): HER2 and MET amplifications were found in 4.1% (n = 8) and 1.0% (n = 2), respectively. The HER2-amplified cases were mostly gallbladder adenocarcinomas (n = 5). The MET- and HER2-amplified cases were all positive by IHC. Fourteen cases without MET amplification were positive by IHC, whereas HER2 over-expression was detected by IHC only in HER2-amplified cases. We detected no ALK or ROS1 translocation or amplification. Several alterations were consistent with aneuploidy: 24 cases showed only one copy of ROS1 gene, 4 cases displayed a profile of chromosomal instability, and an over-representation of centromeric alpha-satellite sequences was found in five cases. We confirm a relatively high rate of HER2 amplifications in gallbladder adenocarcinomas and the efficacy of IHC to screen these cases. Our results also suggest the value of IHC to screen MET amplification. Contrary to initial publications, ROS1 rearrangements seem to be very rare in biliary tract adenocarcinomas. We confirm a relatively high frequency of aneuploidy and chromosomal instability and reveal the over-representation of centromeric alpha-satellite sequences in intrahepatic cholangiocarcinomas.</p>
<p>doi: <a href="https://doi.org/10.1007/s00428-020-02822-8" class="uri">https://doi.org/10.1007/s00428-020-02822-8</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>The Contribution of Additional Sampling in Cholecystectomy Materials: A Multicenter Prospective Study</strong> </summary></p>
<p><em>Turk patoloji dergisi 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32364613" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32364613</a></p>
<p>OBJECTIVE: Cholecystectomy materials are frequently encountered in routine practice. The aim of this study was to determine the true frequency of gallbladder lesions, the diagnostic consistency, and standardization of reports after macroscopic sampling and microscopic evaluation based on previously defined criteria. MATERIAL AND METHOD: 14 institutions participated in the study within the Hepato-Pancreato-Biliary Pathology Study Group. Routinely examined cholecystectomies within the last year were included in the study in these institutions. Additional sampling was performed according to the indications and criteria. The number of blocks and samples taken in the first macroscopic examination and the number of blocks and samples taken in the additional sampling were determined and the rate of diagnostic contribution of the additional examination was determined. RESULTS: A total of 5,244 cholecystectomy materials from 14 institutions were included in the study. Additional sampling was found to be necessary in 576 cases (10.98%) from all institutions. In the first macroscopic sampling, the mean of the numbers of samples was approximately 4 and the number of blocks was 2. The mean of the numbers of additional samples and blocks was approximately 8 and 4, respectively. The diagnosis was changed in 144 of the 576 new sampled cases while the remaining 432 stayed unaltered. CONCLUSION: In this study, it was observed that new sampling after the first microscopic examination of cholecystectomy materials contributed to the diagnosis. It was also shown that the necessity of having standard criteria for macroscopic and microscopic examination plays an important role in making the correct diagnosis.</p>
<p>doi: <a href="https://doi.org/10.5146/tjpath.2020.01483" class="uri">https://doi.org/10.5146/tjpath.2020.01483</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>TRAIL receptors are differentially regulated and clinically significant in gallbladder cancer</strong> </summary></p>
<p><em>Pathology 2020 Apr;52(3):348-358</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32111400" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32111400</a></p>
<p>Deregulation of the receptors of TNF-related apoptosis inducing ligand (TRAIL) has been reported in various cancers. In an effort to define the role of these receptors we profiled their expression in gallbladder cancer (GBC) and explored their clinical significance. Expression of TRAIL receptors’ mRNA in GBC was analysed through reverse transcriptase polymerase chain reaction (RT-PCR), and protein through western blotting, immunohistochemistry and enzyme-linked immunosorbent assay (ELISA). mRNA data show frequent higher expression of TRAIL receptors in GBC samples. Death receptors DR4 and DR5 showed significant negative correlation with tumour stage, T stage and tumour grade; DcR1 transcript showed positive correlation with tumour stage, N stage, M stage and tumour grade. Similarly, IHC showed frequent positive staining for DR4, DR5 and DcR1in GBC samples. Cytoplasmic and nuclear DR4 protein showed negative correlation with T stage and tumour grade, whereas cytoplasmic DcR1 protein showed positive correlation with tumour stage and N stage. Nuclear DcR1 showed positive correlation with N stage. ELISA results showed significantly higher expression of secretory DcR1 in GBC patients. Kaplan-Meier analysis demonstrated significantly decreased mean survival of patients with positive staining of cytoplasmic DcR1. High level of death receptors identified the patients with early gallbladder cancer, whereas high DcR1 expression served as a prognostic factor for poor outcome.</p>
<p>doi: <a href="https://doi.org/10.1016/j.pathol.2019.12.001" class="uri">https://doi.org/10.1016/j.pathol.2019.12.001</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Long-term outcomes of surgical resection for T1b gallbladder cancer: an institutional evaluation</strong> </summary></p>
<p><em>BMC cancer 2020 Jan;20(1):20</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31907021" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31907021</a></p>
<p>BACKGROUND: There is no comprehensive agreement concerning the overall performance of radical resection for T1b gallbladder cancer (GBC). This research focused on addressing whether T1b GBC may spread loco-regionally and whether radical resection is necessary. METHODS: A retrospective analysis was conducted of 1032 patients with GBC who underwent surgical resection at our centre and its affiliated institutions between January 1982 and December 2018. A total of 47 patients with T1b GBC, 29 (62%) of whom underwent simple cholecystectomy and 18 (38%) of whom underwent radical resection with regional lymph node dissection, were enrolled in the study. RESULTS: GBC was diagnosed pre-operatively in 16 patients (34%), whereas 31 patients (66%) had incidental GBC. There was no blood venous or perineural invasion in any patient on histology evaluation, except for lymphatic vessel invasion in a single patient. There were no metastases in any analysed lymph nodes. The open surgical approach was more prevalent among the 18 patients who underwent radical resection (open in all 18 patients) than among the 29 patients who underwent simple cholecystectomy (open in 21; laparoscopic in 8) (P = 0.017). The cumulative 10- and 20-year overall survival rates were 65 and 25%, respectively. The outcome following simple cholecystectomy (10-year overall survival rate of 66%) was akin to that following radical resection (64%, P = 0.618). The cumulative 10- and 20-year disease-specific survival rates were 93 and 93%, respectively. The outcome following simple cholecystectomy (10-year disease-specific survival rate of 100%) was equivalent to that following radical resection (that of 86%, P = 0.151). While age (&gt; 70 years, hazard ratio 5.285, P = 0.003) and gender (female, hazard ratio 0.272, P = 0.007) had a strong effect on patient overall survival, surgical procedure (simple cholecystectomy vs. radical resection) and surgical approach (open vs. laparoscopic) did not. CONCLUSIONS: Most T1b GBCs represent local disease. As pre-operative diagnosis, including tumour penetration of T1b GBC, is difficult, the decision of radical resection is justified. Additional radical resection is not required following simple cholecystectomy provided that the penetration depth is restricted towards the muscular layer and that surgical margins are uninvolved.</p>
<p>doi: <a href="https://doi.org/10.1186/s12885-019-6507-2" class="uri">https://doi.org/10.1186/s12885-019-6507-2</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Clinicopathologic and Prognostic Significance of Gallbladder and Cystic Duct Invasion in Distal Bile Duct Carcinoma</strong> </summary></p>
<p><em>Archives of pathology &amp; laboratory medicine 2020 Jun;144(6):755-763</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31755778" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31755778</a></p>
<p>CONTEXT.—: The roles of the gallbladder and cystic duct (CD) invasions in distal bile duct carcinoma (DBDC) have not been well elucidated. OBJECTIVE.—: To define the characteristics and prognostic significance of gallbladder or CD invasions in patients with DBDC. DESIGN.—: Organ invasion patterns with clinicopathologic features were assessed in 258 resected DBDCs. RESULTS.—: CD invasions (N = 31) were associated with frequent concomitant pancreatic and/or duodenal invasions (23 of 31, 74%) and showed stromal infiltration (16 of 31, 52%) and intraductal cancerization (15 of 31, 48%) patterns. In only 2 cases, invasions with intraductal cancerization were observed in the gallbladder neck. Conversely, all pancreatic (N = 175) and duodenal (83) invasions developed through stromal infiltration. CD invasions were associated with larger tumor size (P = .001), bile duct margin positivity (P = .001), perineural invasions (P = .04), and higher N categories (P = .007). Patients with pancreatic or duodenal invasions had significantly lower survival rates than those without pancreatic (median, 31.0 versus 93.9 months) or duodenal (27.5 versus 56.8 months, P &lt; .001, both) invasions. However, those with gallbladder or CD invasions did not have different survival times (P = .13). Patients with concomitant gallbladder/CD and pancreatic/duodenal invasions demonstrated significantly lower survival rates than those without organ invasions (P &lt; .001). CONCLUSIONS.—: Gallbladder invasions were rare in DBDCs as neck invasions with intraductal cancerization. CD invasions occurred by stromal infiltrations and intraductal cancerization, whereas all pancreatic and duodenal invasions had stromal infiltration patterns. Gallbladder and/or CD invasions did not affect survival rates of patients with DBDC, while pancreatic and duodenal invasions affected survival rates. Therefore, these differences in survival rates may originate from the different invasive patterns of DBDCs.</p>
<p>doi: <a href="https://doi.org/10.5858/arpa.2019-0218-OA" class="uri">https://doi.org/10.5858/arpa.2019-0218-OA</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Non-neoplastic Polyps of the Gallbladder: A Clinicopathologic Analysis of 447 Cases</strong> </summary></p>
<p><em>The American journal of surgical pathology 2020 Apr;44(4):467-476</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31725469" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31725469</a></p>
<p>There is no systematic histopathologic analysis of non-neoplastic polyps in the gallbladder. In this study, in addition to a computer search for cases designated as “polyp,” a systematic review of 2533 consecutive routinely sampled archival and 203 totally submitted prospective cholecystectomies were analyzed for &gt;2 mm polyps (cut-off was based on radiologic sensitivity). A total of 447 non-neoplastic polyps were identified. The frequency was 3% in archival cases and 5% in totally submitted cases. Only 21 (5%) were ≥1 cm. The average age was 52 years, and the female to male ratio was 3.1. Two distinct categories were delineated: (1) injury-related polyps (n=273): (a) Fibro(myo)glandular polyps (n=214) were small (mean=0.4 cm), broad-based, often multiple (45%), almost always (98%) gallstone-associated, and were composed of a mixture of (myo)fibroblastic tissue/lobular glandular units with chronic cholecystitis. Dysplasia seen in 9% seemed to be secondary involvement. (b) Metaplastic pyloric glands forming polypoid collections (n=42). (c) Inflammatory-type polyps associated with acute/subacute injury (11 granulation tissue, 3 xanthogranulomatous, 3 lymphoid). (2) Cholesterol polyps (n=174) occurred in uninjured gallbladders, revealing a very thin stalk, edematous cores devoid of glands but with cholesterol-laden macrophages in 85%, and cholesterolosis in the uninvolved mucosa in 60%. Focal low-grade dysplasia was seen in 3%, always confined to the polyp, unaccompanied by carcinoma. In conclusion, non-neoplastic polyps are seen in 3% of cholecystectomies and are often small. Injury-related fibromyoglandular polyps are the most common. Cholesterol polyps have distinctive cauliflower architecture, often in a background of uninjured gallbladders with cholesterolosis and may lack the cholesterol-laden macrophages in the polyp itself. Although dysplastic changes can involve non-neoplastic polyps, they do not seem to be the cause of invasive carcinoma by themselves.</p>
<p>doi: <a href="https://doi.org/10.1097/PAS.0000000000001405" class="uri">https://doi.org/10.1097/PAS.0000000000001405</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Ultrastructural Characteristics of Gallbladder Epithelial Inclusions Mimicking Cystoisospora</strong> </summary></p>
<p><em>American journal of clinical pathology 2020 01;153(1):88-93</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31600399" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31600399</a></p>
<p>OBJECTIVES: There is recently reported increased prevalence of Isospora organisms in cholecystectomy specimens from immunocompetent patients, especially in acalculous cholecystectomies. We performed an ultrastructural and molecular evaluation of these specimens. METHODS: From 28 gallbladders with intraepithelial inclusions, two specimens with diffuse involvement of the gallbladder epithelium were analyzed by electron microscopy. Polymerase chain reaction was performed on five samples for the ITS2 region of C belli and eukaryotic 18S region. The 18S products were sequenced by next-generation sequencing. RESULTS: Electron microscopic analysis showed cytoplasmic condensations leading to vacuole formation. In contrast with true C belli, there were no identifiable organelles or organization. None of these cases showed amplified products other than human on molecular analysis. CONCLUSIONS: Electron microscopic analysis demonstrates that the inclusions are condensed cytoplasmic material and not true organisms.</p>
<p>doi: <a href="https://doi.org/10.1093/ajcp/aqz137" class="uri">https://doi.org/10.1093/ajcp/aqz137</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>IL-33 overexpression in gallbladder cancers associated with pancreatobiliary maljunction</strong> </summary></p>
<p><em>Histopathology 2019 Sep;75(3):365-375</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=30882917" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=30882917</a></p>
<p>AIMS: To investigate whether genetic or inflammatory pro-oncogenic factors are relevant to the increased risk of gallbladder cancers in patients with pancreaticobiliary maljunction (PBM). METHODS AND RESULTS: Mutations in KRAS exon 2 were examined by a highly sensitive, droplet digital PCR platform using surgically resected specimens of PBM-associated (n = 31) and non-associated gallbladder cancers (n = 49). The tissue expression of IL-6 and IL-33, which are suspected to promote biliary carcinogenesis, was analysed by quantitative real-time PCR and in-situ hybridisation. The incidence of KRAS mutations was similarly low in PBM-associated (five of 32 cases; 16%) and non-associated cancers (four of 49 cases; 8%) (P = 0.272). The tissue expression of IL-33 mRNA, but not IL-6 mRNA, was significantly higher in PBM-associated gallbladder cancers than in gallbladder cancers without PBM (P = 0.004). A similar degree of IL-33 overexpression was also observed in the background non-cancerous mucosa in cases of PBM-associated gallbladder cancers, and was significantly greater than that in PBM cases with cholecystitis alone (P &lt; 0.001). The results of in-situ hybridisation indicated that the source of IL-33 production in PBM-associated carcinomas was the endothelium, cancer cells and non-neoplastic biliary epithelium. In a combined PBM-associated and non-associated cohort, IL-33 overexpression in gallbladder cancers correlated with less aggressive features (e.g. a lower pT stage and longer overall survival), similar to recently reported findings on large-duct cholangiocarcinomas. CONCLUSIONS: KRAS mutations do not appear to be associated with a high risk of malignancy in PBM, while IL-33 overexpression may provide a pro-oncogenic microenvironment in the gallbladder mucosa of patients with PBM.</p>
<p>doi: <a href="https://doi.org/10.1111/his.13863" class="uri">https://doi.org/10.1111/his.13863</a></p>
</details>
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<hr />
<p><a href="#top" target="_self">Back to top</a></p>
<hr />
<div style="page-break-after: always;"></div>
</div>
<div id="bileducts" class="section level2">
<h2>Bile Ducts</h2>
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Role of Prophylactic Cholecystectomy After Endoscopic Sphincterotomy for Biliary Stone Disease: A Systematic Review and Meta-Analysis</strong> </summary></p>
<p><em>Annals of surgery 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32590541" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32590541</a></p>
<p>OBJECTIVE: The aim of this study was to perform a structured systematic review and meta-analysis to evaluate the effectiveness and complication rate of cholecystectomy deferral versus prophylactic cholecystectomy among patients post-endoscopic biliary sphincterotomy for common bile duct stones. BACKGROUND: Although previous reports suggest a decreased risk of biliary complications with prophylactic cholecystectomy, biliary endoscopic cholangiopancreatography (ERCP) with sphincterotomy may provide a role for deferring cholecystectomy with the gallbladder left in situ. METHODS: Searches of PubMed, EMBASE, Web of Science, and Cochrane Library databases were performed through August 2019 in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-Analysis of Observational Studies in Epidemiology guidelines. Measured outcomes included: mortality, recurrent biliary pain or cholecystitis, pancreatitis, cholangitis, and eventual need for cholecystectomy. Random effects models were used to determine pooled effect size and corresponding 95% confidence intervals (CIs). RESULTS: Nine studies (n = 1605) were included. A total of 53.8% (n = 864) patients had deferred cholecystectomy post-sphincterotomy. Deferral cholecystectomy as compared to prophylactic cholecystectomy resulted in a significant increased risk of mortality [odds raio (OR) 2.56 (95% confidence interval, CI 1.54-4.23); P &lt; 0.0001; I = 18.49]. Patients who did not undergo prophylactic cholecystectomy developed more recurrent biliary pain or cholecystitis [OR 5.10 (95% CI 3.39-7.67); P &lt; 0.0001; I = 0.00]. Rate of pancreatitis [OR 3.11 (95% CI 0.99-9.83); P = 0.053; I = 0.00] and cholangitis [OR 1.49 (95% CI 0.74-2.98); P = 0.264; I = 0.00] was unaffected. Overall, 26.00% (95% CI 14.00-40.00) of patients with deferred prophylactic cholecystectomy required eventual cholecystectomy. CONCLUSIONS: Prophylactic cholecystectomy remains the preferred strategy compared to a deferral approach with gallbladder in situ post-sphincterotomy for patients with bile duct stones. Future studies may highlight a subset of patients (ie, those with large balloon biliary dilation) that may not require cholecystectomy.</p>
<p>doi: <a href="https://doi.org/10.1097/SLA.0000000000003977" class="uri">https://doi.org/10.1097/SLA.0000000000003977</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Impact of Perioperative Steroid Administration in Patients Undergoing Major Hepatectomy with Extrahepatic Bile Duct Resection: A Randomized Controlled Trial</strong> </summary></p>
<p><em>Annals of surgical oncology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32578066" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32578066</a></p>
<p>BACKGROUND: To date, five randomized controlled trials have assessed the clinical benefit of perioperative steroid administration in hepatectomy; however, all of these studies involved a substantial number of ‘minor’ hepatectomies. The benefit of steroid administration for patients undergoing ‘complex’ hepatectomy, such as major hepatectomy with extrahepatic bile duct resection, is still unclear. This study aimed to evaluate the clinical benefit of perioperative steroid administration for complex major hepatectomy. METHODS: Patients with suspected hilar malignancy scheduled to undergo major hepatectomy with extrahepatic bile duct resection were randomized into either the control or steroid groups. The steroid group received hydrocortisone 500 mg immediately before hepatic pedicle clamping, followed by hydrocortisone 300 mg on postoperative day (POD) 1, 200 mg on POD 2, and 100 mg on POD 3. The control group received only physiologic saline. The primary endpoint was the incidence of postoperative liver failure. RESULTS: A total of 94 patients were randomized to either the control (n = 46) or steroid (n = 48) groups. The two groups had similar baseline characteristics; however, there were no significant differences between the groups in the incidence of grade B/C postoperative liver failure (control group, n = 8, 17%; steroid group, n = 4, 8%; p = 0.188) and other complications. Serum bilirubin levels on PODs 2 and 3 were significantly lower in the steroid group than those in the control group; however, these median values were within normal limits in both groups. CONCLUSION: Perioperative steroid administration did not reduce the risk of postoperative complications, including liver failure following major hepatectomy with extrahepatic bile duct resection.</p>
<p>doi: <a href="https://doi.org/10.1245/s10434-020-08745-7" class="uri">https://doi.org/10.1245/s10434-020-08745-7</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Peribiliary glands pathology in a large series of end-stage alcohol-related liver disease</strong> </summary></p>
<p><em>Virchows Archiv : an international journal of pathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32506156" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32506156</a></p>
<p>The peribiliary glands are intramural or extramural structures with multiple functions related to bile secretion. The peribiliary glands can develop cystic alterations in several conditions, such as alcohol addiction. Peribiliary cysts can enlarge till being radiologically visible and mimic cancer. We studied 217 consecutive explanted livers for end-stage alcohol-related liver disease from the Pathology Unit of the Liver Unit at the King’s College Hospital in Denmark Hill, with particular focus on peribiliary glands. Our cohort consisted of 31 females and 186 males, with a median age of 51 and of 56 years respectively. 92,2% had established cirrhosis, 73,3% had only alcohol-induced liver disease, whilst 26,7% had other co-morbidities. We found a mild ectasia of the peribiliary glands (&lt;2 mm) in 37,8% and peribiliary cysts (&gt; = 2 mm) in 22,6% of cases. The diameter of the peribiliary glands varied from 1 mm to 8 mm. Inflammation of the peribiliary glands was found in the majority of cases with dilatation (p value = 0,000). 4,6% of the peribiliary cysts had low-grade intraductal papillary neoplasm of the bile ducts confined to the peribiliary glands. Pancreatic heterotopia was found in 10,6% and associated with the presence of ectasia. Our findings fit with what is reported in literature, such as the alcohol-induced damage at the peribiliary glands. Moreover these results underline the possible role of peribiliary glands in the development of the intraductal papillary neoplasm of the bile ducts, the biliary counterpart of the branch type intraductal mucinous neoplasm of the pancreas.</p>
<p>doi: <a href="https://doi.org/10.1007/s00428-020-02851-3" class="uri">https://doi.org/10.1007/s00428-020-02851-3</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Three-dimensional analysis of extrahepatic cholangiocarcinoma and tumor budding</strong> </summary></p>
<p><em>The Journal of pathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32476131" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32476131</a></p>
<p>Advances in tissue clearing and microscopy make it possible to study human diseases in 3-dimensions (3-D). High-grade tumor budding (TB) is known to be associated with poor prognosis in various cancers; however, little is known about the 3-D architecture of TB. Using tissue clearing, we analyzed the 3-D structure of TB and E-cadherin expression in 31 extrahepatic cholangiocarcinomas. A total of 31 thick slabs (up to 5 mm) were harvested from surgically resected tumor tissue, including 27 hilar and 4 distal cholangiocarcinomas. Twenty-eight cases were adenocarcinoma, and three were undifferentiated carcinoma. After clearing, the tissues were immunolabeled with antibodies to cytokeratin 19 and to E-cadherin, and then visualized using light-sheet and confocal laser scanning microscopy. TB was evaluated in hematoxylin and eosin stained sections (2-D) using standard pathological criteria. Of the 31 cancers, 13 showed low-grade TB and 18 showed high-grade TB. First, 3-D analysis revealed that the neoplastic cells in tumor buds of adenocarcinoma were typically not individual islands of cells, but rather tips of attenuated protrusions connected to the main tumor. Second, adenocarcinomas with low-grade TB were predominantly composed of tubules that only focally form cords at the periphery. By contrast, adenocarcinomas with high-grade TB predominantly formed cords in both centers and peripheries of the tumors. Third, adenocarcinoma with low-grade TB was characterized by few short protrusions with few branches, while adenocarcinoma with high-grade TB was characterized by longer protrusions with more branching. Finally, immunolabeling of E-cadherin was stronger in the center of the adenocarcinoma but decreased at the tips of protrusions. E-cadherin loss was more extensive in the protrusions of high-grade TB than in the protrusions of low-grade TB. Our findings suggest that tumor buds as seen in 2-D are, in fact, cross-sections of attenuated but contiguous protrusions extending from the main tumor. This article is protected by copyright. All rights reserved.</p>
<p>doi: <a href="https://doi.org/10.1002/path.5474" class="uri">https://doi.org/10.1002/path.5474</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Prognostic Effects of Histology-Based Tumour Microenvironment Scores in Resected Distal Bile Duct Cancer</strong> </summary></p>
<p><em>Histopathology 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32473032" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32473032</a></p>
<p>AIMS: Histology-based tumour microenvironment (TME) scores are useful in predicting the prognosis of gastrointestinal cancer. However, their prognostic roles in distal bile duct cancer (DBDC) have not been previously studied. This study aimed to evaluate the prognostic significance of the TME scores using the Klintrup-Mäkinen (KM) grade, tumour stroma percentage (TSP), and the Glasgow microenvironment score (GMS), in resected DBDC. METHODS AND RESULTS: Eighty-one patients with DBDC who underwent curative resection were enrolled. DBDC was graded according to KM grade, TSP, and GMS. A high KM grade was found in 19 patients (24%), and a high TSP was found in 47 patients (58%). A high TSP was significantly correlated with a low KM grade (P&lt;0.001). The distribution of the GMS, which was developed by combining the KM grade and TSP, was as follows: 0 (n=19, 24%), 1 (n=19, 24%), and 2 (n=43, 52%). A low KM grade, high TSP, and high GMS were significantly associated with short overall survival (OS) (P&lt;0.001) and relapse-free survival (RFS) (P&lt;0.001). Furthermore, multivariate analysis showed that a low KM grade (hazard ratio [HR], 3.826; confidence interval [CI], 1.650-8.869; P=0.014), high TSP (HR, 2.193; CI, 1.173-4.100, P=0.002), and high GMS (HR, 7.148; CI, 2.811-18.173) were independent prognostic factors for short RFS; a low KM grade (HR, 4.324; CI, 1.594-11.733) and high GMS (HR, 6.332; CI, 2.743-14.594) were independent prognostic factors for short OS. CONCLUSION: Histology-based TME scores, including the KM grade, TSP, and GMS, are useful for predicting the survival of patients with resected DBDC.</p>
<p>doi: <a href="https://doi.org/10.1111/his.14163" class="uri">https://doi.org/10.1111/his.14163</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Tiny but mighty: use of next generation sequencing on discarded cytocentrifuged bile duct brushing specimens to increase sensitivity of cytological diagnosis</strong> </summary></p>
<p><em>Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 May;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32457409" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32457409</a></p>
<p>Bile duct brushing (BDB) is used to evaluate pancreatobiliary lesions as it widely samples lesions with a low complication rate. Cytological evaluation of BDB is a specific but insensitive test. There is limited literature on the use of post-cytocentrifuged (PCC) samples, which are usually discarded, for next-generation sequencing (NGS) as an adjunct to cytological diagnosis of BDB. In this study we investigate whether molecular analysis by NGS of PCC specimens improves the sensitivity of diagnosis. PCC samples from 100 consecutive BDB specimens spanning 93 unique patients were retained. DNA was extracted and mutational analysis was performed agnostic of morphologic or clinical findings. Each BDB specimen was characterized as negative, atypical or positive based on morphological analysis by trained cytopathologists. Performance characteristics for mutational profiling and morphological analysis were calculated on the basis of clinicopathologic follow-up. There was sufficient clinicopathologic follow-up to classify 94 of 100 cases as either malignant (n = 43) or benign (n = 51). Based on morphologic analysis of cytology, these 94 cases were classified as either benign (n = 55), atypical (n = 18), or as at least suspicious or positive for malignancy (n = 21). Morphologic analysis of cytology showed a sensitivity of 49% and a specificity of 100% if atypical cases were considered negative. NGS revealed oncogenic alterations in 40/43 (93%) of malignant cases based on clinicopathologic follow-up. The most common alterations were in KRAS and TP53, observed in 77% and 49% of malignant cases respectively. No alterations were observed in the 51 benign cases classified based on clinicopathologic follow-up. Supplementing cytomorphologic analysis with molecular profiling of PCC by targeted NGS analysis increased the sensitivity to 93% and maintained specificity at 100%. This study provides evidence for the utility of NGS molecular profiling of PCC specimens to increase the sensitivity of BDB cytology samples, although studies with larger cohorts are needed to verify these findings.</p>
<p>doi: <a href="https://doi.org/10.1038/s41379-020-0577-1" class="uri">https://doi.org/10.1038/s41379-020-0577-1</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Testing for ROS1, ALK, MET, and HER2 rearrangements and amplifications in a large series of biliary tract adenocarcinomas</strong> </summary></p>
<p><em>Virchows Archiv : an international journal of pathology 2020 Jul;477(1):33-45</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32447492" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32447492</a></p>
<p>Biliary tract carcinomas are divided into intrahepatic, perihilar, distal extrahepatic cholangiocarcinomas, and gallbladder adenocarcinomas. Therapies targeting ROS1, ALK, MET, and HER2 alterations are currently evaluated in clinical trials. We assessed ROS1 and ALK translocations/amplifications as well as MET and HER2 amplifications for each tumor subtype by fluorescent in situ hybridization (FISH) and immunohistochemistry (IHC) in 73 intrahepatic, 40 perihilar bile duct, 36 distal extrahepatic cholangiocarcinomas, and 45 gallbladder adenocarcinomas (n = 194). By FISH, we detected targetable alterations in 5.2% of cases (n = 10): HER2 and MET amplifications were found in 4.1% (n = 8) and 1.0% (n = 2), respectively. The HER2-amplified cases were mostly gallbladder adenocarcinomas (n = 5). The MET- and HER2-amplified cases were all positive by IHC. Fourteen cases without MET amplification were positive by IHC, whereas HER2 over-expression was detected by IHC only in HER2-amplified cases. We detected no ALK or ROS1 translocation or amplification. Several alterations were consistent with aneuploidy: 24 cases showed only one copy of ROS1 gene, 4 cases displayed a profile of chromosomal instability, and an over-representation of centromeric alpha-satellite sequences was found in five cases. We confirm a relatively high rate of HER2 amplifications in gallbladder adenocarcinomas and the efficacy of IHC to screen these cases. Our results also suggest the value of IHC to screen MET amplification. Contrary to initial publications, ROS1 rearrangements seem to be very rare in biliary tract adenocarcinomas. We confirm a relatively high frequency of aneuploidy and chromosomal instability and reveal the over-representation of centromeric alpha-satellite sequences in intrahepatic cholangiocarcinomas.</p>
<p>doi: <a href="https://doi.org/10.1007/s00428-020-02822-8" class="uri">https://doi.org/10.1007/s00428-020-02822-8</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>BRAF-associated bile duct adenomatosis: a new entity?</strong> </summary></p>
<p><em>Histopathology 2020 Jul;77(1):160-161</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32367668" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32367668</a></p>
<p>doi: <a href="https://doi.org/10.1111/his.14125" class="uri">https://doi.org/10.1111/his.14125</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Utility of DNA flow cytometry in distinguishing between malignant and benign intrahepatic biliary lesions</strong> </summary></p>
<p><em>Virchows Archiv : an international journal of pathology 2020 Apr;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32296928" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32296928</a></p>
<p>The distinction between well-differentiated intrahepatic cholangiocarcinoma (iCCA) from its morphological mimics such as bile duct adenoma (BDA) and hamartoma (BDH) can be challenging, particularly in small biopsies. Although a few cases of BDA and BDH have been reported to undergo malignant transformation into iCCA, their neoplastic versus benign nature remains debated. DNA flow cytometry was performed on 47 formalin-fixed paraffin-embedded samples of iCCA, 14 BDA, and 18 BDH. Aneuploidy was detected in 22 iCCA (47%) but in none of the 32 BDA and BDH samples. Among the 34 iCCA patients who underwent complete resection and were followed up to tumor recurrence, tumor-related death, or at least for 1 year, the overall recurrence or death rates (regardless of flow cytometric results) were 18, 56, and 71% within 1, 3, and 5 years, respectively. The 1-, 3-, and 5-year recurrence or death rates in 18 iCCA patients with aneuploidy were 28, 66, and 66%, respectively, whereas 16 iCCA patients in the setting of normal DNA content had 1-, 3-, and 5-year rates of 6, 44, and 72%, respectively. Although aneuploid tumors were associated with worse outcomes during the first 3 years, this difference was not statistically significant (hazard ratio = 1.4, p = 0.473) in the present sample size. In conclusion, the frequency of aneuploidy was significantly higher in iCCA (47%) than in its benign morphological mimics (0%), suggesting that it may potentially serve as a diagnostic marker of malignancy in challenging situations. Our findings also suggest that most BDAs and BDHs, if not all, are benign entities and may not represent precursor lesions to iCCAs that often harbor aneuploidy. Although a larger cohort will be necessary to further determine the prognostic significance of aneuploidy in iCCA patients after resection, the patients with aneuploid tumors may have a higher risk for tumor progression, especially during the first 3 years.</p>
<p>doi: <a href="https://doi.org/10.1007/s00428-020-02812-w" class="uri">https://doi.org/10.1007/s00428-020-02812-w</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>DNA flow cytometric analysis of paraffin-embedded tissue for the diagnosis of malignancy in bile duct biopsies</strong> </summary></p>
<p><em>Human pathology 2020 May;99():80-87</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32272125" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32272125</a></p>
<p>Differentiation of reactive versus neoplastic epithelial changes can be challenging in bile duct biopsies. The samples are often scant, distorted, and mixed with significant inflammation, ulceration, and/or debris. Histological confirmation of malignancy is often required before the initiation of surgical therapy, and an erroneous diagnosis of malignancy can lead to unnecessary clinical management. Aneuploidy assessment by DNA flow cytometry was performed on formalin-fixed paraffin-embedded (FFPE) tissue from 63 bile duct biopsies: 10 with a malignant diagnosis (7 with adenocarcinoma and 3 with at least high-grade dysplasia [HGD]); 3 with an atypical diagnosis showing rare atypical glands/cells, concerning but not definite for malignancy; 28 likely reactive biopsies with acute/chronic inflammation, ulceration, and/or mild nuclear atypia; and 22 additional benign biopsies without significant inflammation, ulceration, or nuclear atypia. Aneuploidy was detected in 7 (70%) of the 10 biopsies with definite neoplasia (5 of 7 adenocarcinoma cases and 2 of 3 at least HGD cases), all 3 (100%) atypical biopsies, and none of the 50 benign biopsies. All 3 atypical cases with aneuploidy were subsequently found to have adenocarcinoma (n = 2) or HGD (n = 1). Among the 2 cases of at least HGD with aneuploidy, 1 case developed adenocarcinoma, but no follow-up information was available in the other case. The remaining 1 case of at least HGD, despite having normal DNA content, was found to have adenocarcinoma on follow-up. None of the 50 benign cases (further supported by normal DNA content) developed adenocarcinoma within a mean follow-up time of 37 months (range: 0-282 months). The estimated sensitivity of aneuploidy as a diagnostic marker of malignancy (adenocarcinoma and HGD) was 70%, with the specificity of 100%, positive predictive value of 100%, and negative predictive value of 94%. In conclusion, DNA flow cytometry using FFPE tissue from bile duct biopsies demonstrates a high rate of aneuploidy (70%) in malignant cases and normal DNA content in all benign biopsies. Although the sample size is small, the results indicate that this assay can be potentially useful in challenging atypical cases, where morphological evaluation is limited by scarcity of atypical glands/cells, inflammation, and/or ulceration.</p>
<p>doi: <a href="https://doi.org/10.1016/j.humpath.2020.04.002" class="uri">https://doi.org/10.1016/j.humpath.2020.04.002</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Deficiency Promotes the Ductular Reaction, Macrophage Accumulation, and Hepatic Fibrosis in the Abcb4-/- Mouse</strong> </summary></p>
<p><em>The American journal of pathology 2020 06;190(6):1284-1297</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32240619" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32240619</a></p>
<p>The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL; TNFSF10) receptor (TR) is a pro-apoptotic receptor whose contribution to chronic cholestatic liver disease is unclear. Herein, we examined TRAIL receptor signaling in a mouse model of cholestatic liver injury. TRAIL receptor-deficient (Tnsf10 or Tr-/-) mice were crossbred with ATP binding cassette subfamily B member 4-deficient (Abcb4-/-, alias Mdr2-/-) mice. Male and female wild-type, Tr-/-, Mdr2-/-, and Tr-/-Mdr2-/- mice were assessed for liver injury, fibrosis, and ductular reactive (DR) cells. Macrophage subsets were examined by high-dimensional mass cytometry (time-of-flight mass cytometry). Mdr2-/- and Tr-/-Mdr2-/- mice had elevated liver weights and serum alanine transferase values. However, fibrosis was primarily periductular in Mdr2-/- mice, compared with extensive bridging fibrosis in Tr-/-Mdr2-/- mice. DR cell population was greatly expanded in the Tr-/-Mdr2-/- versus Mdr2-/- mice. The expanded DR cell population in Tr-/-Mdr2-/- mice was due to decreased cell loss by apoptosis and not enhanced proliferation. As assessed by time-of-flight mass cytometry, total macrophages were more abundant in Tr-/-Mdr2-/- versus Mdr2-/- mice, suggesting the DR cell population promotes macrophage-associated hepatic inflammation. Inhibition of monocyte-derived recruited macrophages using the CCR2/CCR5 antagonist cenicriviroc in the Mdr2-/- mice resulted in further expansion of the DR cell population. In conclusion, genetic deletion of TRAIL receptor increased the DR cell population, macrophage accumulation, and hepatic fibrosis in the Mdr2-/- model of cholestasis.</p>
<p>doi: <a href="https://doi.org/10.1016/j.ajpath.2020.02.013" class="uri">https://doi.org/10.1016/j.ajpath.2020.02.013</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Biliary intraductal tubule-forming neoplasm: a whole exome sequencing study of MUC5AC-positive and -negative cases</strong> </summary></p>
<p><em>Histopathology 2020 Jun;76(7):1005-1012</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32181510" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32181510</a></p>
<p>AIMS: Biliary intraductal tubular neoplasms that are non-mucinous and negative for mucin 5AC (MUC5AC) are called intraductal tubulopapillary neoplasms (ITPNs). Intraductal tubular neoplasms with mucinous cytoplasm and MUC5AC positivity also occur and their nature remains unclear, although some pathologists may classify these as ‘intraductal papillary neoplasms of the bile duct (IPNBs) of gastric type’. This study aimed to elucidate genetic features of biliary intraductal tubular neoplasms. METHODS AND RESULTS: Six resected cases of biliary intraductal neoplasm with &gt;70% tubular configuration were characterised by clinicopathological examination and whole exome sequencing, and the findings obtained were compared between MUC5AC-negative (n = 2) and -positive cases (n = 4). The intraductal tumours consisted of the pancreatobiliary-type epithelium with high-grade dysplasia arranged in back-to-back tubules. Both of the two MUC5AC-negative cases were non-invasive neoplasms and developed in the liver, whereas all MUC5AC-positive cases had invasive carcinoma and were present in the intrahepatic (n = 2), perihilar (n = 1) and distal bile ducts (n = 1). In an exome-sequencing study, MUC5AC-negative cases harboured mutations in CTNNB1, SF3B1, BAP1 and BRCA1 (one case each). KRAS mutations were observed in three of four MUC5AC-positive cases (75%) but none of the MUC5AC-negative neoplasms. Compared to published data, known driver genes of other intraductal neoplasms of the pancreatobiliary system (e.g. APC, CTNNB1, STK11, GNAS and PIK3CA) were wild-type in all but one MUC5AC-negative case with CTNNB1 mutation. Chromatin modifiers (ARID1A, BAP1 and KMT2C) were also altered in MUC5AC-positive cases, similar to usual cholangiocarcinomas. CONCLUSIONS: This exome-sequencing study suggested that MUC5AC-negative biliary ITPNs are genetically distinct from pancreatic ITPNs and IPNBs. They may also biologically differ from MUC5AC-positive tubular neoplasms despite morphological resemblance.</p>
<p>doi: <a href="https://doi.org/10.1111/his.14103" class="uri">https://doi.org/10.1111/his.14103</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Validation of the T category for distal cholangiocarcinoma: Measuring the depth of invasion is complex but correlates with survival</strong> </summary></p>
<p><em>Annals of diagnostic pathology 2020 Mar;46():151489</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32169826" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32169826</a></p>
<p>According to the current 8th edition of the American Joint Committee of Cancer (AJCC), the T category of distal cholangiocarcinomas is classified based on the depth of invasion (DOI) (T1, &lt; 5 mm; T2, between 5 and 12 mm; T3, &gt; 12 mm). In consideration of the discrepancies between previous studies about the prognostic significance, we aimed to validate the current AJCC T staging system of distal cholangiocarcinomas. DOI was measured using three different methods: DOI1, DOI2, and DOI3. DOI1 was defined and stratified according to the AJCC 8th edition. DOI2 was measured as the distance from an imaginary curved line approximated along the distorted mucosal surface to the deepest invasive tumor cells. DOI3 was defined as the total tumor thickness. DOI2 and DOI3 were also divided into three categories using the same cut-off points as in the AJCC 8th edition. We compared these three DOI methods to the AJCC 7th edition as well. In contrast with the AJCC 7th edition, all three groups showed a correlation with patients’ overall survival. Above all, the DOI2 group demonstrated the best significance in multivariate analysis. However, when the C indices were compared between these groups, differential significance proved to be negligible (DOI1 vs DOI2, p = 0.915; DOI2 vs DOI3, p = 0.057). Therefore, the measurement of DOI does not need to be rigorously and stringently performed. In conclusion, we showed that the current T classification system better correlates with the overall survival of patients with distal cholangiocarcinomas than the previous system.</p>
<p>doi: <a href="https://doi.org/10.1016/j.anndiagpath.2020.151489" class="uri">https://doi.org/10.1016/j.anndiagpath.2020.151489</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012</strong> </summary></p>
<p><em>Cancer 2020 Jun;126(11):2666-2678</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32129902" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32129902</a></p>
<p>BACKGROUND: Intrahepatic cholangiocarcinomas (ICCs) and extrahepatic cholangiocarcinomas (ECCs) are highly lethal bile duct tumors. Their incidence can be difficult to estimate because of changes in cancer coding over time. No studies to date have examined their global incidence and trends with high-quality topography- and histology-specific cancer registry data. Therefore, this study examined ICC and ECC incidence with the Cancer Incidence in Five Continents Plus database. METHODS: Regional and national cancer registry data were used to estimate age-standardized incidence rates (ASRs) per 100,000 person-years, 95% confidence intervals, and average annual percent changes (AAPCs) for ICC in 38 countries and for ECC in 33 countries from 1993 to 2012. ICC and ECC trends were tabulated and plotted by country. Rates versus birth cohort by age were plotted, and an age-period-cohort analysis was performed to assess age and cohort incidence rate ratios. RESULTS: The highest rates of ICC and ECC were in Asia, specifically South Korea (ASR for ICC, 2.80; ASR for ECC, 2.24), Thailand (ASR for ICC, 2.19; ASR for ECC, 0.71), and Japan (ASR for ICC, 0.95; ASR for ECC, 0.83). Between 1993 and 2012, incidence rates of both ICC and ECC increased in most countries. The largest ASR increases over the study period occurred in Latvia (AAPC, 20.1%) and China (AAPC, 11.1%) for ICC and in Thailand (AAPC, 8.8%) and Colombia (AAPC, 8.5%) for ECC. CONCLUSIONS: In the 20 years examined, ICC and ECC incidence increased in the majority of countries worldwide. ICC and ECC incidence may continue to increase because of metabolic and infectious etiologic factors. Efforts to further elucidate risk factors contributing to these increases in incidence are warranted.</p>
<p>doi: <a href="https://doi.org/10.1002/cncr.32803" class="uri">https://doi.org/10.1002/cncr.32803</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes</strong> </summary></p>
<p><em>The Journal of pathology 2020 May;251(1):38-48</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32100878" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32100878</a></p>
<p>Intraductal papillary neoplasm of the bile duct (IPNB) is a grossly visible papillary biliary neoplasm with morphological variations and occasional invasion. Recently a new classification of IPNB into type 1 and type 2 was proposed in which the type 1 IPNBs consist of fine papillary neoplastic glands and the type 2 IPNBs consist of complex branching glands, seldom with foci of solid-tubular components. However, clinicopathological and molecular characteristics of these types of IPNBs are yet to be identified. We aimed to uncover clinicopathological and molecular characteristics of the types of IPNBs. Thirty-six IPNBs were studied retrospectively. Clinicopathological features as well as molecular alterations of 31 genes were evaluated by means of targeted next-generation sequencing and immunohistochemical examination of expression of mucin and cancer-associated molecules. The 36 IPNBs were classified into 22 of type 1 and 14 of type 2. The type 1 IPNBs were associated with a non-invasive phenotype, intestinal and oncocytic subtypes, development in the intrahepatic bile duct, overt mucin production, and a relatively good prognosis. The type 2 IPNBs were associated with an invasive phenotype, the pancreatobiliary subtype, development within the extrahepatic bile duct, and worse prognosis compared with the type 1 IPNBs. In the molecular analysis, recurrent mutations were found in TP53 (34.3%), KRAS (31.4%), STK11 (25.7%), CTNNB1 (17.1%), APC (14.3%), SMAD4 (14.3%), GNAS (11.4%), PBRM1 (11.4%), ELF3 (8.6%), KMT2C (8.6%), NF1 (8.6%), PIK3CA (8.6%), ARID1A (5.7%), ARID2 (5.7%), BAP1 (5.7%), BRAF (5.7%), EPHA6 (5.7%), ERBB2 (5.7%), ERBB3 (5.7%), KMT2D (5.7%), and RNF43 (5.7%). Mutations in KRAS and GNAS were enriched in the type 1 IPNBs, whereas mutations in TP53, SMAD4, and KMT2C were enriched in the type 2 IPNBs. These results indicate that IPNBs consist of two distinct types of neoplasms specifically associated with clinicopathological features and molecular phenotypes. © 2020 Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd.</p>
<p>doi: <a href="https://doi.org/10.1002/path.5398" class="uri">https://doi.org/10.1002/path.5398</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Activation of the Akt/mammalian target of rapamycin pathway in combined hepatocellular carcinoma and cholangiocarcinoma: significant correlation between p-4E-BP1 expression in cholangiocarcinoma component and prognosis</strong> </summary></p>
<p><em>Virchows Archiv : an international journal of pathology 2020 Jun;476(6):881-890</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31927624" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31927624</a></p>
<p>The Akt/mammalian target of rapamycin (mTOR) pathway, which plays an important role in regulating cellular functions including proliferation, motility, and invasion, is known to be activated in many cancers. Combined hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) (cHCC-CC) has wide histological diversity characterized by relatively poor prognosis. Because of a lack of investigation into its molecular mechanisms, no effective systemic therapy is currently available for unresectable cHCC-CC tumors. Here, we retrospectively examined the clinicopathological and activation statuses of the Akt/mTOR pathway in 89 cases of cHCC-CC. Expression levels of molecular markers associated with this signaling pathway, including phosphatase and tensin homologue deleted on chromosome 10 (PTEN), phosphorylated Akt (p-Akt), p-mTOR, p-ribosomal protein S6 (p-S6RP), and p-eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (p-4E-BP1), were measured by immunohistochemical staining. In addition, such activation in different cHCC-CC morphological categories was compared by dividing cases into those with HCC (n = 86), CC (n = 78), and intermediate components (n = 60). Comparison of prognosis among these groups revealed that p-4E-BP1 immunopositivity in cHCC-CC cases containing CC a component was a significant risk factor for poorer overall survival (P = 0.041). By evaluating factors in p-4E-BP1 expression in 78 cHCC-CC cases with a CC component, only lymph node metastasis was significantly correlated with positive immunostaining for p-4E-BP1 (P = 0.0222). In conclusion, p-4E-BP1 expression, especially in cHCC-CC cases with a CC component, was a notable Akt/mTOR pathway-related factor associated with poor prognosis. Assessing histological structure and p-4E-BP1 expression in cHCC-CC may be helpful for both predicting prognosis and using molecular targeted therapy.</p>
<p>doi: <a href="https://doi.org/10.1007/s00428-019-02741-3" class="uri">https://doi.org/10.1007/s00428-019-02741-3</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>HER2 gene (ERBB2)��amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma</strong> </summary></p>
<p><em>Virchows Archiv : an international journal of pathology 2020 Jun;476(6):871-880</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31838585" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31838585</a></p>
<p>Gallbladder carcinoma (GBC) is an aggressive type of cancer with a dismal prognosis. Recent case reports have highlighted the human epidermal growth factor receptor 2 (HER2) as a promising target for individualized therapy in biliary tract cancer; however, current data on HER2 positivity in GBC is contradictory. This study aimed to assess the proportion of HER2 positivity and its clinical implications in a large and well-characterized European GBC cohort. HER2 status was determined in 186 cases of surgically resected gallbladder adenocarcinoma and a subset of coexistent high-grade biliary intraepithelial neoplasia (BilIN, n = 74) in accordance with the up-to-date consensus for HER2 testing in gastric cancer by immunohistochemistry and dual-color chromogenic in situ hybridization. Positivity for HER2 was observed in 5.4% of all cases (n = 10). In those patients with concomitant high-grade BilIN, two of four positive samples also showed amplification in the precursor lesion, while in the two remaining cases, positivity was either confined to invasive tumor or high-grade BilIN, exclusively. Equivocal staining found in eleven cases was not accompanied by gene amplification. Staging of the HER2-positive group was significantly different from the HER2-negative group with most cases presenting at stage IV, paralleled by a trend towards decreased survival. One patient who received dual HER2 inhibition almost went into full clinical remission despite treatment initiation in a metastasized state. Our results reveal a low prevalence of HER2 positivity and highlight HER2 gene amplification as an early, potentially driving event in gallbladder carcinogenesis. Prospective standardized HER2 testing and randomized control studies are needed to prove clinical efficacy of targeted HER2 inhibition in GBC.</p>
<p>doi: <a href="https://doi.org/10.1007/s00428-019-02706-6" class="uri">https://doi.org/10.1007/s00428-019-02706-6</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and��Bile Duct</strong> </summary></p>
<p><em>Gastroenterology 2020 02;158(3):573-582.e2</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31678302" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31678302</a></p>
<p>BACKGROUND &amp; AIMS: Intraductal oncocytic papillary neoplasms (IOPNs) of the pancreas and bile duct contain epithelial cells with numerous, large mitochondria and are cystic precursors to pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CCA), respectively. However, IOPNs do not have the genomic alterations found in other pancreatobiliary neoplasms. In fact, no recurrent genomic alterations have been described in IOPNs. PDACs without activating mutations in KRAS contain gene rearrangements, so we investigated whether IOPNs have recurrent fusions in genes. METHODS: We analyzed 20 resected pancreatic IOPNs and 3 resected biliary IOPNs using a broad RNA-based targeted sequencing panel to detect cancer-related fusion genes. Four invasive PDACs and 2 intrahepatic CCAs from the same patients as the IOPNs, were also available for analysis. Samples of pancreatic cyst fluid (n = 5, collected before surgery) and bile duct brushings (n = 2) were analyzed for translocations. For comparison, we analyzed pancreatobiliary lesions from 126 patients without IOPN (controls). RESULTS: All IOPNs evaluated were found to have recurring fusions of ATP1B1-PRKACB (n = 13), DNAJB1-PRKACA (n = 6), or ATP1B1-PRKACA (n = 4). These fusions also were found in corresponding invasive PDACs and intrahepatic CCAs, as well as in matched pancreatic cyst fluid and bile duct brushings. These gene rearrangements were absent from all 126 control pancreatobiliary lesions. CONCLUSIONS: We identified fusions in PRKACA and PRKACB genes in pancreatic and biliary IOPNs, as well as in PDACs and pancreatic cyst fluid and bile duct cells from the same patients. We did not identify these gene fusions in 126 control pancreatobiliary lesions. These fusions might be used to identify patients at risk for IOPNs and their associated invasive carcinomas.</p>
<p>doi: <a href="https://doi.org/10.1053/j.gastro.2019.10.028" class="uri">https://doi.org/10.1053/j.gastro.2019.10.028</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma</strong> </summary></p>
<p><em>Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 04;33(4):648-656</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31676785" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31676785</a></p>
<p>Recently discovered DNAJB1-PRKACA oncogenic fusions have been considered diagnostic for fibrolamellar hepatocellular carcinoma. In this study, we describe six pancreatobiliary neoplasms with PRKACA fusions, five of which harbor the DNAJB1-PRKACA fusion. All neoplasms were subjected to a hybridization capture-based next-generation sequencing assay (MSK-IMPACT), which enables the identification of sequence mutations, copy number alterations, and selected structural rearrangements involving ≥410 genes (n = 6) and/or to a custom targeted, RNA-based panel (MSK-Fusion) that utilizes Archer Anchored Multiplex PCR technology and next-generation sequencing to detect gene fusions in 62 genes (n = 2). Selected neoplasms also underwent FISH analysis, albumin mRNA in-situ hybridization, and arginase-1 immunohistochemical labeling (n = 3). Five neoplasms were pancreatic, and one arose in the intrahepatic bile ducts. All revealed at least focal oncocytic morphology: three cases were diagnosed as intraductal oncocytic papillary neoplasms, and three as intraductal papillary mucinous neoplasms with mixed oncocytic and pancreatobiliary or gastric features. Four cases had an invasive carcinoma component composed of oncocytic cells. Five cases revealed DNAJB1-PRKACA fusions and one revealed an ATP1B1-PRKACA fusion. None of the cases tested were positive for albumin or arginase-1. Our data prove that DNAJB1-PRKACA fusion is neither exclusive nor diagnostic for fibrolamellar hepatocellular carcinoma, and caution should be exercised in diagnosing liver tumors with DNAJB1-PRKACA fusions as fibrolamellar hepatocellular carcinoma, particularly if a pancreatic lesion is present. Moreover, considering DNAJB1-PRKACA fusions lead to upregulated protein kinase activity and that this upregulated protein kinase activity has a significant role in tumorigenesis of fibrolamellar hepatocellular carcinoma, protein kinase inhibition could have therapeutic potential in the treatment of these pancreatobiliary neoplasms as well, once a suitable drug is developed.</p>
<p>doi: <a href="https://doi.org/10.1038/s41379-019-0398-2" class="uri">https://doi.org/10.1038/s41379-019-0398-2</a></p>
</details>
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<hr />
<p><a href="#top" target="_self">Back to top</a></p>
<hr />
<div style="page-break-after: always;"></div>
</div>
<div id="ampulla" class="section level2">
<h2>Ampulla</h2>
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Clinical and histological features of secondary carcinomas in gastrointestinal tract biopsies</strong> </summary></p>
<p><em>Histopathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32590886" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32590886</a></p>
<p>BACKGROUND: Secondary carcinoma involving the gastrointestinal (GI) tract is an uncommon finding in biopsy specimens. The diagnosis can be challenging for tumours mimicking a primary carcinoma and when the clinical context is unknown. MATERIAL AND METHODS: A multicentre retrospective study was performed to evaluate the clinical and histological features of a series of secondary carcinoma in GI biopsies. RESULTS: A total of 197 cases from 190 patients (median age 67 years; 57% females) were reviewed. In 16% of patients, the primary carcinoma was unknown. Most lesions presented endoscopically as mucosal or submucosal masses (58%). In 13%, the endoscopy was non-suspicious for malignancy. The most common tumours were carcinomas of the breast (38%), kidney (13%), lung (12%), prostate (8%) and ovary (7%). The sites of involvement were the stomach (34%), colon (27%), rectum (18%), duodenum (13%), oesophagus (5%), jejunum (3%) and anus (0.5%). Histological patterns of infiltration were mucosal (76%), submucosal (41%), lymphatic (14%), and epithelial colonisation (8%). Submucosal infiltration was significantly more frequently found in carcinomas of the prostate (67%) and lung (62%), compared with carcinomas of the ovary (27%) and breast (23%). Histological obstructive changes were observed in 36% of all cases, with the highest rate in prostate carcinoma (53%) and the lowest rate in kidney carcinoma (8%). CONCLUSION: Awareness of the main clinical and histological patterns of secondary carcinomas in GI tract biopsies may help pathologists to raise the possibility of this uncommon diagnosis and confirm it with the judicious use of immunohistochemistry.</p>
<p>doi: <a href="https://doi.org/10.1111/his.14195" class="uri">https://doi.org/10.1111/his.14195</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Neuroendocrine Cells Are Commonly Absent in the Intestinal Crypts in Autoimmune Enteropathy</strong> </summary></p>
<p><em>The American journal of surgical pathology 2020 Jun;():</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32590456" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32590456</a></p>
<p>The absence of neuroendocrine (NE) cells in the intestinal mucosa in autoimmune enteropathy (AIE) has been occasionally reported. However, the status of NE cells has not been studied in detail in AIE. Small bowel and colonic biopsies were retrospectively retrieved from 18 AIE patients (26 baseline [18 small bowel and 8 colon]; and 15 follow-up [11 duodenum and 4 colon] biopsies in 11 patients). Thirty-three common variable immunodeficiency (CVID) patients (30 small bowel and 16 colon), 15 inflammatory bowel disease patients (5 duodenum and 10 colon), 13 immunoglobulinA deficiency patients (13 duodenum and 5 colon), and 10 normal controls (5 colon and 5 duodenum) were selected as control groups. Histologic features (villous atrophy, intraepithelial lymphocytosis, acute inflammation, crypt apoptosis, and absence or presence of goblet cells, Paneth cells and plasma cells) were recorded. Chromogranin immunostain was performed and chromogranin-positive NE cells were counted per 10 consecutive, well-oriented crypts. On the basis of the number of chromogranin-positive NE cells, cases were graded as being absent (≤3 NE cells), markedly decreased (≤15), and intact (&gt;15). The NE cell status correlated with histologic features. The median age of 18 AIE patients was 38.5 years (range: 11 to 74 y) and 14 patients were male. Fourteen of 18 (78%) patients showed loss (absent or markedly decreased) of NE cells in the small bowel and/or colon in the baseline biopsies including 12 (of 18) small bowel and 6 (of 8) colon biopsies. Follow-up biopsy was available in 11 patients. Six of 7 (85%) patients who showed loss of NE cells in the baseline biopsies regained NE cells in the follow-up biopsies, and 1 patient continued to show loss of NE cells. Four patients who showed intact NE cells in the baseline remained unchanged in the follow-up. Among the control groups, 3 of 33 (9%) CVID patients showed loss of NE cells. NE cells were not lost in the biopsies of all 15 and 13 patients with inflammatory bowel disease and immunoglobulinA deficiency, respectively, or the 10 normal controls. In all 41 biopsies (26 baseline plus 15 follow-up) with AIE, NE cell loss was significantly associated with increased crypt apoptosis and loss of goblet cells (P=0.001, both) but not with other histologic findings. In conclusion, our study suggests that NE cells may also be the target cells in AIE and commonly lost in the intestinal crypts in AIE, and consequently loss of NE cells can be used as an adjunct histologic feature for diagnosis of AIE.</p>
<p>doi: <a href="https://doi.org/10.1097/PAS.0000000000001516" class="uri">https://doi.org/10.1097/PAS.0000000000001516</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Whipple disease diagnosed by enteroscopy: first case report in Colombia of an underdiagnosed disease and literature review</strong> </summary></p>
<p><em>BMC gastroenterology 2020 Jun;20(1):197</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32576148" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32576148</a></p>
<p>BACKGROUND: Whipple’s disease is a rare systemic disease caused by a gram-positive bacillus called Tropheryma whipplei. First described in 1907 as an intestinal lipodystrophy with histological finding of vacuoles in the macrophages of the intestinal mucous. Usually the symptoms are localized according to the compromised organ. The differential diagnosis is wide. It can be fatal without proper treatment. Recurrence can occur in up to 33% of the cases and usually compromises the neurological system. CASE PRESENTATION: This article reports the case of a 46-year-old female patient with a history of a 6-month hypochromic microcytic anemia of unknown cause. She consulted for a 6-months oppressive abdominal pain located in the mesogastrium as well as abdominal distention associated with nausea and liquid stools; in addition, she had an 8-month small and medium joint pain, without edema or erythema. Physical examination without relevant findings. Multiple esophagogastroduodenoscopies with normal gastric and duodenal biopsies findings and a normal colonoscopy were performed. Endoscope capsule showed red spots in the duodenum and ulcerations in the jejunum and proximal ileum covered by fibrin; histological report showed macrophages with positive periodic acid-schiff reaction staining (PAS staining), disgnosing Whipple’s disease. Antibiotics were initiated. The patient is currently in the second phase of treatment without gastrointestinal and joint symptoms. CONCLUSION: This is the first case reported in Colombia. It is a rare entity and difficult to diagnose reason why it is important to continue with clinical investigations to give more clarity about the onset and appropriate diagnose to avoid the delay in treatment of this entity.</p>
<p>doi: <a href="https://doi.org/10.1186/s12876-020-01302-2" class="uri">https://doi.org/10.1186/s12876-020-01302-2</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker</strong> </summary></p>
<p><em>BMC cancer 2020 Mar;20(1):216</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=32171280" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=32171280</a></p>
<p>BACKGROUND: Periampullary cancers (PAC) including pancreatic, ampulla of Vater (AOV), and common bile duct (CBD) cancers are highly aggressive with a lack of useful prognostic markers beyond T stage. However, T staging can be biased due to the anatomic complexity of this region. Recently, several markers related to cancer stem cells and epithelial-mesenchymal transition (EMT) such as octamer transcription factor-4 (Oct4) and fibroblast growth factor receptor 1 (FGFR1) respectively, have been proposed as new promising markers in other solid cancers. The aim of this study was to assess the expression and prognostic significance of stem cell/EMT markers in PACs. METHODS: Formalin-fixed, paraffin-embedded tissues of surgically excised PACs from the laboratory archives from 1998 to 2014 were evaluated by immunohistochemical staining for stem cell/EMT markers using tissue microarray. The clinicopathologic parameters were documented and statistically analyzed with the immunohistochemical findings. Survival and recurrence data were collected and analyzed. RESULTS: A total of 126 PAC cases were evaluated. The average age was 63 years, with 76 male and 50 female patient samples. Age less than 74 years, AOV cancers, lower T &amp; N stage, lower tumor size, no lymphatic, vascular, perineural invasion and histologic well differentiation, intestinal type, no fibrosis, severe inflammation were significantly associated with the better overall survival High expression levels of FGFR1 as well as CK20, CDX2, and VEGF were significantly related to better overall survival, while other stem cell markers were not related. Similar findings were observed for tumor recurrence using disease-free survival. CONCLUSIONS: In addition to other clinicopathologic parameters, severe fibrosis was related to frequent tumor recurrence, and high FGFR1 expression was associated with better overall survival. Histologic changes such as extensive fibrosis need to be investigated further in relation to EMT of PACs.</p>
<p>doi: <a href="https://doi.org/10.1186/s12885-020-6673-2" class="uri">https://doi.org/10.1186/s12885-020-6673-2</a></p>
</details>
<hr />
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<details open>
<p><summary> - <strong>Poorly Cohesive (Signet Ring Cell) Carcinoma of the Ampulla of Vater</strong> </summary></p>
<p><em>International journal of surgical pathology 2020 May;28(3):236-244</em></p>
<p>PubMed: <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=31612756" class="uri">https://www.ncbi.nlm.nih.gov/pubmed/?term=31612756</a></p>
<p>In the ampulla of Vater, carcinomas with “diffuse-infiltrative”/“signet ring cell” morphology, designated as “poorly cohesive carcinoma” (PCC) in the WHO classification, are very rare and poorly characterized. Nine cases with a classical PCC morphology constituting &gt;50% of the tumor were identified. Mean age was 64.8 years (vs 64.6 in ampullary carcinomas [ACs]) and 6 were males, 3 females. The mean invasive tumor size was 2.5 cm (vs 1.9 in ACs). Other morphologic patterns displayed included cord-like infiltration (n=2), plasmacytoid cells (n=2), and microglandular component (n=4), including goblet cell adenocarcinoma-like foci. None of the cases were associated with dysplasia. By immunohistochemistry, the carcinomas did not show intestinal differentiation (CDX2 0/9, CK20 1/9, MUC2 3/9), MUC1 was positive in 4/9, MUC5AC was positive in 7/8. E-cadherin loss was noted in 4/9. All cases were advanced stage (6/9-pT3, 3/9-pT4) (vs 43% in ACs). Lymph node metastases were identified in 44% (vs 45% in AC). Six patients (67%) died of disease at a median of 25 months, 3 were alive at 13, 15, and 60 months. Overall median survival was significantly worse than that of intestinal-type ACs (26 vs 122 months, P = .006) and trended toward worse than pancreatobiliary type (26 vs 42 months, P = .1). In conclusion, PCCs constitute 2.45% of all ACs. These present as advanced tumors and express upper-gastrointestinal immunoprofile with frequent MUC5AC labeling, which may be helpful in identifying subtle infiltration in the surface mucosa since MUC5AC is not expressed in the ampullary mucosa. Patients have poor prognosis.</p>
<p>doi: <a href="https://doi.org/10.1177/1066896919880968" class="uri">https://doi.org/10.1177/1066896919880968</a></p>
</details>
<hr />
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<hr />
<p><a href="#top" target="_self">Back to top</a></p>
<hr />
<div style="page-break-after: always;"></div>
<hr />
<p><a href="#top" target="_self">Back to top</a></p>
<hr />
<div style="page-break-after: always;"></div>
</div>
</div>
<div id="feedback" class="section level1">
<h1>Feedback</h1>
<p><a href="https://docs.google.com/forms/d/e/1FAIpQLSeD3Z9J6Y7eMmiyM12f_SfAmHUlykb1zxZcwO6lg7cebGYQIQ/viewform">Google Feedback Form</a></p>
<script>var DISQUSWIDGETS,disqus_domain,disqus_shortname;
typeof DISQUSWIDGETS==="undefined"&&(DISQUSWIDGETS=function(){var f=document,a=f.getElementById("dsq-count-scr"),a=a&&a.src.match(/(https?:)?\/\/(?:www\.)?([\w_\-]+)\.((?:dev\.)?disqus\.(?:com|org)(?::\d+)?)/i),e={},s=f.head||f.body,j={},q={identifier:1,url:2};e.domain=a&&a[3]||disqus_domain||"disqus.com";e.forum=a&&a[2]||disqus_shortname;e.proto=a&&a[1]||"";e.getCount=function(b){var c;c=encodeURIComponent;var a=e.proto+"//"+e.forum+"."+e.domain+"/count-data.js?",d=[],k=0,l=10,r="",b=b||{};b.reset&&
(j={},r="&_="+ +new Date);for(var b=[f.getElementsByTagName("A"),f.getElementsByClassName&&f.getElementsByClassName("disqus-comment-count")||[]],m,i,g,h,n=0;n<b.length;n++){m=b[n];for(var o=0;o<m.length;o++){i=m[o];g=i.getAttribute("data-disqus-identifier");h=i.hash==="#disqus_thread"&&i.href.replace("#disqus_thread","")||i.getAttribute("data-disqus-url");if(g)h=q.identifier;else if(h)g=h,h=q.url;else continue;var p;j.hasOwnProperty(g)?p=j[g]:(p=j[g]={elements:[],type:h},d.push(c(h)+"="+c(g)));p.elements.push(i)}}d.sort();
for(c=d.slice(k,l);c.length;)b=f.createElement("script"),b.src=a+c.join("&")+r,s.appendChild(b),k+=10,l+=10,c=d.slice(k,l)};e.displayCount=function(b){for(var c,a,d,e=b.counts,b=b.text.comments;c=e.shift();)if(a=j[c.id]){switch(c.comments){case 0:d=b.zero;break;case 1:d=b.one;break;default:d=b.multiple}c=d.replace("{num}",c.comments);a=a.elements;for(d=a.length-1;d>=0;d--)a[d].innerHTML=c}};return e}());DISQUSWIDGETS.getCount();</script>
<div id="disqus_thread">

</div>
<script>

/**
*  RECOMMENDED CONFIGURATION VARIABLES: EDIT AND UNCOMMENT THE SECTION BELOW TO INSERT DYNAMIC VALUES FROM YOUR PLATFORM OR CMS.
*  LEARN WHY DEFINING THESE VARIABLES IS IMPORTANT: https://disqus.com/admin/universalcode/#configuration-variables*/
/*
var disqus_config = function () {
this.page.url = PAGE_URL;  // Replace PAGE_URL with your page's canonical URL variable
this.page.identifier = PAGE_IDENTIFIER; // Replace PAGE_IDENTIFIER with your page's unique identifier variable
};
*/
(function() { // DON'T EDIT BELOW THIS LINE
var d = document, s = d.createElement('script');
s.src = 'https://pbpath-org.disqus.com/embed.js';
s.setAttribute('data-timestamp', +new Date());
(d.head || d.body).appendChild(s);
})();
</script>
<noscript>
Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript">comments powered by Disqus.</a>
</noscript>
<hr />
<p><a href="#top" target="_self">Back to top</a></p>
<hr />
<div style="page-break-after: always;"></div>
<!-- rnb-text-end -->
</div>

<div id="rmd-source-code">---
title: "Pancreatobiliary Pathology Society Journal Watch"
output:
  html_notebook:
    code_folding: none
    fig_caption: yes
    highlight: null
    theme: paper
  pdf_document: 
    toc: yes
    number_sections: yes
    latex_engine: xelatex
    keep_tex: yes
  html_document:
    df_print: paged
date: "Last Update on `r format(Sys.Date())`"
subtitle: Recent Articles that will be Selected
header-includes:
- \renewcommand{\linethickness}{0.05em}
- \usepackage{booktabs}
- \usepackage{sectsty} \allsectionsfont{\nohang\centering \emph}
---

```{r global_options, include=FALSE}
knitr::opts_chunk$set(cache = TRUE)
```


```{r library, include=FALSE}
suppressPackageStartupMessages(library("tidyverse"))
suppressPackageStartupMessages(library("readxl"))
suppressPackageStartupMessages(library("RefManageR"))

```


```{r data load, include=FALSE}
articles <- readRDS("~/JournalWatchPBPath/articles.rds")
```


<style type="text/css">

h1{
  text-align: center;
}
h2{
  text-align: center;
}
h3{
  text-align: center;
}
h4{
  text-align: center;
}
h4.date{
  text-align: center;
}

</style>



<!-- Open all links in new tab-->  
<base target="_blank"/>  



---

# PBPath Journal Watch Articles {.tabset .tabset-fade .tabset-pills #pbpath_jw}


```{r strings , include=FALSE}
PubMedString <- "PubMed: https://www.ncbi.nlm.nih.gov/pubmed/?term="

doiString <- "doi: https://doi.org/"

```



```{r read PMID csv, include=FALSE, cache=FALSE}
pancreas_recent_PMID <-
    readr::read_csv(file      = "~/AutoJournalWatch/data/PMIDList_pancreas.csv",
                    col_names = c("PMID"),
                    readr::cols(PMID = readr::col_character()))

gallbladder_recent_PMID <-
    readr::read_csv(file      = "~/AutoJournalWatch/data/PMIDList_gallbladder.csv",
                    col_names = c("PMID"),
                    readr::cols(PMID = readr::col_character()))

bileducts_recent_PMID <-
    readr::read_csv(file      = "~/AutoJournalWatch/data/PMIDList_bileducts.csv",
                    col_names = c("PMID"),
                    readr::cols(PMID = readr::col_character()))

ampulla_recent_PMID <-
    readr::read_csv(file      = "~/AutoJournalWatch/data/PMIDList_ampulla.csv",
                    col_names = c("PMID"),
                    readr::cols(PMID = readr::col_character()))
```





```{r read PMID from previous JW, include=FALSE, cache=FALSE}
previousJW <- list.files(path = here::here("archive-of-published"),
                          pattern = ".Rmd",
                          full.names = TRUE)


text_previousJW <- unname(sapply(previousJW, readLines))
text_previousJW <- unlist(text_previousJW, use.names=FALSE)

# text_previousJW <- purrr::map(
#     .x = previousJW,
#     .f = readLines
# )



PMID_List_previousJW <-
    stringr::str_extract(
        string = text_previousJW,
        pattern =
            "PubMed_(\\d{8})"
    )


PMID_List_previousJW <- PMID_List_previousJW[!is.na(PMID_List_previousJW)]


PMID_List_previousJW <- PMID_List_previousJW %>%
  unique() %>%
  gsub(pattern = "PubMed_", replacement = "", x = .)

previousJW_PMID <- NULL
previousJW_PMID$PMID <- PMID_List_previousJW
previousJW_PMID <- as.data.frame(previousJW_PMID)

```




---

**Welcome to the PBPath Journal Watch!** 



This bi-monthly journal watch features exciting recently published pancreas and biliary pathology articles that will provide up to date medical knowledge in our field. These articles will be showcased in several convenient categories, including surgical pathology, cytopathology, molecular pathology, pancreas, gallbladder, bile ducts, and ampulla among others. The articles in each category are in no particular order. See the list of journals we search regularly [here](http://pbpath.org/pbpath-journal-watch/). Previous months’ issues may be found in our *[archive](http://pbpath.org/journal-watch-archive/)* and you may see [drafts of the upcoming issue here](http://pbpath.org/journal-watch-upcoming-issue/).  

We encourage members to actively participate by recommending new articles and providing feedback using the [forms provided below.](#feedback){target="_self"}  

**We hope that you will enjoy the new PBPath Journal Watch!**


```{r headerRecent,  child='~/JournalWatchPBPath/_headerRecent.Rmd'}
```



\pagebreak




## Pancreas {#pancreas}




```{r pancreasRecent,  child='~/JournalWatchPBPath/_pancreasRecent.Rmd'}
```

---

<a href="#top" target="_self">Back to top</a>

---

\pagebreak



## Gallbladder {#gallbladder}




```{r gallbladderRecent,  child='~/JournalWatchPBPath/_gallbladderRecent.Rmd'}
```


---

<a href="#top" target="_self">Back to top</a>

---

\pagebreak


## Bile Ducts {#bileducts}




```{r bileductsRecent,  child='~/JournalWatchPBPath/_bileductsRecent.Rmd'}
```



---

<a href="#top" target="_self">Back to top</a>

---

\pagebreak

## Ampulla {#ampulla}




```{r ampullaRecent,  child='~/JournalWatchPBPath/_ampullaRecent.Rmd'}
```



---

<a href="#top" target="_self">Back to top</a>

---

\pagebreak



---

<a href="#top" target="_self">Back to top</a>

---

\pagebreak


# Feedback {#feedback}


[Google Feedback Form](https://docs.google.com/forms/d/e/1FAIpQLSeD3Z9J6Y7eMmiyM12f_SfAmHUlykb1zxZcwO6lg7cebGYQIQ/viewform)  


<script id="dsq-count-scr" src="//pbpath-org.disqus.com/count.js" async></script>
<div id="disqus_thread"></div>
<script>

/**
*  RECOMMENDED CONFIGURATION VARIABLES: EDIT AND UNCOMMENT THE SECTION BELOW TO INSERT DYNAMIC VALUES FROM YOUR PLATFORM OR CMS.
*  LEARN WHY DEFINING THESE VARIABLES IS IMPORTANT: https://disqus.com/admin/universalcode/#configuration-variables*/
/*
var disqus_config = function () {
this.page.url = PAGE_URL;  // Replace PAGE_URL with your page's canonical URL variable
this.page.identifier = PAGE_IDENTIFIER; // Replace PAGE_IDENTIFIER with your page's unique identifier variable
};
*/
(function() { // DON'T EDIT BELOW THIS LINE
var d = document, s = d.createElement('script');
s.src = 'https://pbpath-org.disqus.com/embed.js';
s.setAttribute('data-timestamp', +new Date());
(d.head || d.body).appendChild(s);
})();
</script>
<noscript>Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript">comments powered by Disqus.</a></noscript>
                            


---

<a href="#top" target="_self">Back to top</a>

---

\pagebreak


</div>



</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});

$(document).ready(function () {
  $('.knitsql-table').addClass('kable-table');
  var container = $('.kable-table');
  container.each(function() {

    // move the caption out of the table
    var table = $(this).children('table');
    var caption = table.children('caption').detach();
    caption.insertBefore($(this)).css('display', 'inherit');
  });
});

</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open')
  });
});
</script>

<!-- code folding -->
<script>
$(document).ready(function () {
  window.initializeSourceEmbed("RecentPBPathJW.Rmd");
});
</script>


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
